Citrus Sinensis ID: 003963
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 783 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.346 | 0.290 | 0.610 | 7e-99 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.349 | 0.333 | 0.602 | 1e-93 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.351 | 0.213 | 0.426 | 8e-65 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.338 | 0.353 | 0.427 | 6e-63 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.324 | 0.395 | 0.439 | 6e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.334 | 0.286 | 0.411 | 9e-60 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.333 | 0.378 | 0.424 | 2e-59 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.325 | 0.153 | 0.397 | 5e-59 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.334 | 0.161 | 0.394 | 5e-55 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.326 | 0.155 | 0.404 | 6e-55 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 362 bits (928), Expect = 7e-99, Method: Compositional matrix adjust.
Identities = 166/272 (61%), Positives = 206/272 (75%), Gaps = 1/272 (0%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQE 553
D D + EI W DL I E+IG GS G VYHA W+G++ VAVK F Q++S + FR E
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTE-VAVKKFLDQDFSGAALAEFRSE 714
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 613
V +M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 673
A G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GTP+WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
APEVLRNEPS+EK DVYSFGVILWELAT ++PW +N MQV+GAVGF N+RLEIPK++DP
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
I+ CW +DP RPSF +L + L+ L R
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNR 926
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 344 bits (883), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 168/279 (60%), Positives = 217/279 (77%), Gaps = 5/279 (1%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEV 546
A ++ LD D D +I W DL I E+IG GS GTV+ A W+GS DVAVK+ Q++ E
Sbjct: 533 ANRELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAER 589
Query: 547 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWR 604
++ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD R
Sbjct: 590 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 649
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
RR+ MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K
Sbjct: 650 RRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 709
Query: 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR 724
+ GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN QV+ AVGF +R
Sbjct: 710 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 769
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
LEIP++++P+ AAI+E CW ++P RPSF ++D LR L
Sbjct: 770 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 8e-65, Method: Compositional matrix adjust.
Identities = 119/279 (42%), Positives = 178/279 (63%), Gaps = 4/279 (1%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
++E+ ++ IG +IG+G G V+ W G++ VAVK+ + ++I R+EV L+
Sbjct: 842 FEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTE-VAVKMLFNDNVNLKLISDLRKEVDLL 900
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 617
+LRHPN++LFMGA T P CIVTE+L RGSL +L + ++DW R+ + D ARG+
Sbjct: 901 CKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGM 960
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
+YLH NP IIHRDLK+ NLLVD W VKV DFGL+ +K T+ KT GT W+APEV
Sbjct: 961 TYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEV 1018
Query: 678 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737
L E EK+DVYS+ ++LWEL T IP+ N+MQV+ ++ +RL +P P++AA
Sbjct: 1019 LAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAA 1077
Query: 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 776
++ CW +DP RPSF E++ + + ++ + + ++
Sbjct: 1078 LMNRCWETDPTHRPSFPEILPIMEGMISEFQKEKKESIA 1116
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 6e-63, Method: Compositional matrix adjust.
Identities = 117/274 (42%), Positives = 169/274 (61%), Gaps = 9/274 (3%)
Query: 499 DYEILWE-------DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFR 551
DY+ L+E ++ + +IG+GSC V+ W G K E ++ ++
Sbjct: 476 DYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELA 535
Query: 552 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
QE ++M +LRHPN+ F+G +P + IV E++P GSL+R+L + LDW R MAL
Sbjct: 536 QEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMAL 595
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RL-KHETYLTTKTGKGT 669
DIA+G++YLH C+P +IHRDLKS NLLVD+H+ VK+ DFGLS R KH T T GT
Sbjct: 596 DIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGT 655
Query: 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
P W APEVLRN+P EK+DV+SF ++LWE+ T + P+ + + Q++ +VG R +P
Sbjct: 656 PCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPP 715
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
V + ++ CW DPQ RPSFQE+V +L +
Sbjct: 716 QVSAPFTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 113/257 (43%), Positives = 166/257 (64%), Gaps = 3/257 (1%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ IG +IG+G+ G VY W GSQ VAVK ++ ++ F +E++LMK LRHPNV+
Sbjct: 374 IKIGVRIGKGNYGEVYLGTWRGSQ-VAVKKLPAHNINENILKEFHREINLMKNLRHPNVI 432
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
F+G+ P +CI TE++PRGSL+ +L +L W I M +D A+GV YLH+ P
Sbjct: 433 QFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTPV 492
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
I+HRDLKS NLLVD++W VKV DFGLS ++ + T T GTP W +PEVLR++ EK
Sbjct: 493 ILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTEK 550
Query: 687 SDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 746
+DVYSFG+ILWE AT + P+ + QVI AVG R +P++ P++ ++ C + +
Sbjct: 551 ADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNEN 610
Query: 747 PQCRPSFQELVDKLRDL 763
P RP+ ++ +++L +
Sbjct: 611 PSHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 9e-60, Method: Compositional matrix adjust.
Identities = 109/265 (41%), Positives = 175/265 (66%), Gaps = 3/265 (1%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
D EI + +L I ++G+G+ G VY +W GS ++ ++ +++V+ FR+E++++
Sbjct: 654 DIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILS 713
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
RLRHPN++L M A T+P LC +TE+LP GSL+ L K++ + +A+ IA+G++
Sbjct: 714 RLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMN 773
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 678
YLH +IHRD+KS NLL+D+H VK+ DFGLS+LK ++ TK+ G+P WM+PE+L
Sbjct: 774 YLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKS-IGSPIWMSPELL 830
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
E EK DVY+FG+ILWEL T ++P+ L+S+Q+ AV + R IP + + +
Sbjct: 831 MGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHL 890
Query: 739 VESCWHSDPQCRPSFQELVDKLRDL 763
+++CWH DP RPSF E+++ L ++
Sbjct: 891 IQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (588), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 112/264 (42%), Positives = 165/264 (62%), Gaps = 3/264 (1%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+ + IG +IG+G+ G VY W GSQ VAVK ++ ++ F +E++LMK LRHPN
Sbjct: 389 QQIKIGVRIGKGNFGEVYLGTWRGSQ-VAVKKLPAHNINENILKEFHREINLMKNLRHPN 447
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
V+ F+G+ +CI TE++PRGSL+ +L K+ W M +D A+G+ YLH
Sbjct: 448 VIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLHGST 507
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
P I+HRDLKS NLLVD++W VKV DFGLS ++ + T T GTP W +PEVLR++
Sbjct: 508 PVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYT 565
Query: 685 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
EK+DVYSFG+ILWE AT + P+ + QVI AVG R PK P++ +++ C +
Sbjct: 566 EKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKDCLN 625
Query: 745 SDPQCRPSFQELVDKLRDLQRQYF 768
+P RP+ ++ ++ L ++ + F
Sbjct: 626 ENPSQRPTMEQCLEILESIETKGF 649
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (585), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 103/259 (39%), Positives = 171/259 (66%), Gaps = 4/259 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
I ++++ +GEQIG GS G VY W + DVA+K F +Q+ + + R+E++ +K+L
Sbjct: 1394 INYDEIKMGEQIGLGSYGVVYRGKW-KNVDVAIKKFIKQKIDENHLLGIREEIAFLKKLH 1452
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HPN++ +GA +CIVTE++ +G+L ++ T KL+W ++I + ++IA+G+SYLH
Sbjct: 1453 HPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLH 1512
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
+PPIIHRD+K SN+L+D++W VK+ DFG +R+K E + T+ GTP W APE++RN+
Sbjct: 1513 SFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTRC--GTPCWTAPEIIRND 1570
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741
DEK DV+SFG+++WE+ T K P+ N M++ + + R +IP+D +A ++
Sbjct: 1571 IYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAKLMRK 1629
Query: 742 CWHSDPQCRPSFQELVDKL 760
CWH+ RP+ +++ L
Sbjct: 1630 CWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (550), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 105/266 (39%), Positives = 165/266 (62%), Gaps = 4/266 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
I +++++IG+QIG GS G V++ W G DVAVK F +Q+ S+ + FR E++ + L+
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGV-DVAVKKFVKQKLSETQLLEFRAEMAFLSELK 1417
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
H N++ F+GA +CIVTE++ G+L +L+ K+ + ++ + A G+ YLH
Sbjct: 1418 HSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLH 1477
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
NP I+HRD+K +N+LVD+H+ VK+ DFG +R+K + TT T GTP W APEV+R E
Sbjct: 1478 SSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRGE 1535
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741
EK+DV+SFGV++WE+ T K P+ N M+V + R IP D +A +++
Sbjct: 1536 KYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFAKLIKK 1594
Query: 742 CWHSDPQCRPSFQELVDKLRDLQRQY 767
CWH+ RP+ E+V +L + Q+
Sbjct: 1595 CWHAKAHKRPTMTEVVQQLMLITEQF 1620
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 106/262 (40%), Positives = 164/262 (62%), Gaps = 6/262 (2%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
I ++D+ IG+QIG GS G V W + +VAVK F +Q+ ++ + FR E++ + +LR
Sbjct: 1389 INYDDIQIGKQIGVGSYGIVNMGKW-KNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQLR 1447
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HP+++L +GA +CIVTEF+ GSL +++ TTK +W+ +I M A G+ YLH
Sbjct: 1448 HPHIILMIGACLKRPNICIVTEFMGNGSLRNVIK--TTKPEWKLKIKMLYQTALGIGYLH 1505
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
+ +P IIHRD+K SN+LVD VK+ DFG +R+K E + T+ GTP W APE++R E
Sbjct: 1506 NSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVMTRC--GTPCWTAPEIIRGE 1563
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741
EK DV+SFG+++WE+ T K P+ N M+V + R +IP D + +++
Sbjct: 1564 KYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDI-LEGARPQIPSDCPIDFTKLMKQ 1622
Query: 742 CWHSDPQCRPSFQELVDKLRDL 763
CWH+ P RPS ++++ L D+
Sbjct: 1623 CWHAKPDKRPSMEDVIMGLNDM 1644
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 783 | ||||||
| 224108736 | 781 | predicted protein [Populus trichocarpa] | 0.980 | 0.983 | 0.747 | 0.0 | |
| 255556394 | 796 | map3k delta-1 protein kinase, putative [ | 0.982 | 0.966 | 0.766 | 0.0 | |
| 224101557 | 759 | predicted protein [Populus trichocarpa] | 0.961 | 0.992 | 0.742 | 0.0 | |
| 225431966 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.988 | 0.720 | 0.0 | |
| 356521762 | 770 | PREDICTED: uncharacterized protein LOC10 | 0.964 | 0.980 | 0.710 | 0.0 | |
| 356564864 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.965 | 0.980 | 0.711 | 0.0 | |
| 296083240 | 732 | unnamed protein product [Vitis vinifera] | 0.925 | 0.990 | 0.693 | 0.0 | |
| 147827145 | 760 | hypothetical protein VITISV_034769 [Viti | 0.946 | 0.975 | 0.687 | 0.0 | |
| 449462150 | 774 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.947 | 0.958 | 0.662 | 0.0 | |
| 357448913 | 744 | Protein kinase-like protein [Medicago tr | 0.929 | 0.978 | 0.659 | 0.0 |
| >gi|224108736|ref|XP_002314950.1| predicted protein [Populus trichocarpa] gi|222863990|gb|EEF01121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1191 bits (3080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/796 (74%), Positives = 672/796 (84%), Gaps = 28/796 (3%)
Query: 1 MDANTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVS 60
M++ AEELL+KIQ+LEAG HL+Q++SKLK+S +TTT QQRSHS+S
Sbjct: 1 MESTAPQAEELLKKIQQLEAGHHHLQQQMSKLKLS--------STTTDPKPTQQRSHSIS 52
Query: 61 PRRPRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNS 120
P+R +GP +R GG TG +AWK SASFRHSSPLQRES+ +S + + G+SN
Sbjct: 53 PQR---SGPRNRVAGGPTGSSFEAAWK-KGSASFRHSSPLQRESRSLNSNNA-SDGHSNG 107
Query: 121 G----------PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA 170
G PS+ FTD+QYLNILQS+GQSVHIFD S RIIYWNR+AE LYGYSA EA
Sbjct: 108 GGEGGDGNRGGPSSVKFTDKQYLNILQSVGQSVHIFDHSGRIIYWNRTAENLYGYSAAEA 167
Query: 171 LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGT 230
LGQDAIELL D RD+ VA IV R+ MGE+WTG+FP K K ER VVATNTP YDDDG
Sbjct: 168 LGQDAIELLIDSRDYAVANGIVQRVSMGEKWTGKFPVKNKMAERFTVVATNTPLYDDDGA 227
Query: 231 LVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKI 290
LVGI+CVS+DSRPFQE AL D++N + +S+ + PRN V +KLGLDSQQPLQA +ASKI
Sbjct: 228 LVGIICVSSDSRPFQEVGVALLDSRNLEAESSNSSPRNIVMSKLGLDSQQPLQAAVASKI 287
Query: 291 SNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRG 350
SNLA+KVSNKVKS+IR G+N MDREGGSGDSH+SDHG+SDAALSDHRED SSGASTPRG
Sbjct: 288 SNLASKVSNKVKSKIRPGENSMDREGGSGDSHYSDHGYSDAALSDHREDANSSGASTPRG 347
Query: 351 DVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNE 410
DV P PFGVFSH+D++SP +S R+SGDESEGKPAIHKI TSKAE W+GKKGLSWPWKGNE
Sbjct: 348 DVHPSPFGVFSHLDDRSPAQSCRESGDESEGKPAIHKIFTSKAEAWIGKKGLSWPWKGNE 407
Query: 411 REGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVN 470
+EGS+A+T RF WPW DQ++E+ Q+SPS G K ESH+ E NR NNEA GSWSSS+N
Sbjct: 408 KEGSEARTTRFGWPWLQNDQESETFHQRSPSSGAKSESHVSESNRPANNEASGSWSSSIN 467
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQ 530
VNSTSS SSC ++SS VNKVD D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS
Sbjct: 468 VNSTSSASSC-GSTSSTVNKVDPDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS- 525
Query: 531 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590
DVAVKVFS+QEYSD+VI +F+QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL
Sbjct: 526 DVAVKVFSKQEYSDDVILAFKQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 585
Query: 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650
FRLLQRNTTKLDWRRR MALDIARG++YLHH NPPIIHRDLKSSNLLVDK+WTVKVGDF
Sbjct: 586 FRLLQRNTTKLDWRRRAHMALDIARGMNYLHHYNPPIIHRDLKSSNLLVDKNWTVKVGDF 645
Query: 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 710
GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN
Sbjct: 646 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLN 705
Query: 711 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY--- 767
SMQVIGAVGFMNQ+LEIPKDVDP+WA+I+ SCWHSDPQCRP+FQEL++KLRDLQRQY
Sbjct: 706 SMQVIGAVGFMNQQLEIPKDVDPQWASIIGSCWHSDPQCRPTFQELLEKLRDLQRQYAIQ 765
Query: 768 FQASRSTVGDSTQKEL 783
FQA+RS GD+TQKEL
Sbjct: 766 FQAARSAAGDNTQKEL 781
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556394|ref|XP_002519231.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223541546|gb|EEF43095.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1174 bits (3038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/797 (76%), Positives = 671/797 (84%), Gaps = 28/797 (3%)
Query: 8 AEELLRKIQELEAGQEHLKQELSKLKISNDPKSET-----------ITTTTTTTHHQQRS 56
AEELL+KIQELEAGQ HLK+++SK K+++DP S++ QQRS
Sbjct: 7 AEELLKKIQELEAGQAHLKEQMSKFKLTSDPVSDSQLHHHHHHHHHHHRQQQQQQQQQRS 66
Query: 57 HSVSPRRPRLAGPASRRKGGGTGP---DAASAWKATNSASFRHSSPLQRESKGGDSGGSD 113
HS+SP+R +RR GGG G + +AWK S SFRHSSPLQRES+ + +
Sbjct: 67 HSISPQRT-----GTRRSGGGAGAGGFEVVAAWKK-GSTSFRHSSPLQRESRSSSADKIN 120
Query: 114 AA----GNSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEE 169
AA G + GPSA FTD+QYLNILQSMGQSVHIF LS RIIYWNR+AE LYGYS+ E
Sbjct: 121 AAVKEEGGNKCGPSAVKFTDKQYLNILQSMGQSVHIFYLSGRIIYWNRTAENLYGYSSAE 180
Query: 170 ALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDG 229
ALGQDAIELL D RDF VA +IVHR+ MGERWTGQFP K K ER VATNTPFYDDDG
Sbjct: 181 ALGQDAIELLVDPRDFAVANNIVHRVAMGERWTGQFPVKNKMGERFTAVATNTPFYDDDG 240
Query: 230 TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASK 289
TL+GI+CVS D RPFQETR AL KNS+ DS+ +RPR+TVT KLGLDSQQPLQA IASK
Sbjct: 241 TLIGIICVSGDVRPFQETRVALIGPKNSEADSSFSRPRSTVTTKLGLDSQQPLQAVIASK 300
Query: 290 ISNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPR 349
I+NLA++VSNKVKS+IRTGDN MDREGGSGDSH SDHGFSDAALSDHRED SSGASTPR
Sbjct: 301 ITNLASRVSNKVKSKIRTGDNIMDREGGSGDSHQSDHGFSDAALSDHREDANSSGASTPR 360
Query: 350 GDVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGN 409
GD+ P FG FSHVDEKSP K++RDSG ESEGKP IHKIITSKAE W+GKKGLSWPWKG
Sbjct: 361 GDIHPSQFGTFSHVDEKSPMKAIRDSGYESEGKPGIHKIITSKAEAWIGKKGLSWPWKGI 420
Query: 410 EREGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSV 469
EREG D KT+RF WPW DQ++E + Q+SP G KPES + E NR NNEA GSWSSSV
Sbjct: 421 EREGPDTKTSRFVWPWLQNDQESELLHQRSPPAGAKPESQLNESNRPTNNEASGSWSSSV 480
Query: 470 NVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS 529
NVNSTSS SSCGSTSSSA+NKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS
Sbjct: 481 NVNSTSSASSCGSTSSSAINKVDMDIDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS 540
Query: 530 QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 589
DVAVKVFS+QEYSD+VI +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI+TEFLPRGS
Sbjct: 541 -DVAVKVFSKQEYSDDVILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIITEFLPRGS 599
Query: 590 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649
LFRLLQRNTTKLDWRRRI MALDI RG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGD
Sbjct: 600 LFRLLQRNTTKLDWRRRIHMALDIVRGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGD 659
Query: 650 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 709
FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL
Sbjct: 660 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 719
Query: 710 NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY-- 767
NSMQVIGAVGFMNQRLEIPKDVDP WA+I+ESCWHSDPQCRP+FQEL++KLRDLQRQY
Sbjct: 720 NSMQVIGAVGFMNQRLEIPKDVDPLWASIIESCWHSDPQCRPTFQELLEKLRDLQRQYAI 779
Query: 768 -FQASRSTVGDSTQKEL 783
FQA+RS GD+TQKEL
Sbjct: 780 QFQAARSAAGDNTQKEL 796
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101557|ref|XP_002312329.1| predicted protein [Populus trichocarpa] gi|222852149|gb|EEE89696.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 581/782 (74%), Positives = 655/782 (83%), Gaps = 29/782 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELL+KI+ELEAG HL+QE+SKLK+S +TTT QQRSHS+SP+R
Sbjct: 3 STAPAEELLKKIEELEAGHHHLQQEVSKLKLS--------STTTDPRSTQQRSHSISPQR 54
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
+GP R GG TG +AW SAS RHSSPLQ+E G+ NSGPS
Sbjct: 55 ---SGPRRRVSGGPTGSSFEAAWNK-GSASSRHSSPLQKER-----------GDGNSGPS 99
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A FTD+QYLNILQSMGQSVHIFD+S RIIYWNR+AE LYGYSA EALGQDAI LL D R
Sbjct: 100 AVKFTDKQYLNILQSMGQSVHIFDVSGRIIYWNRTAENLYGYSAAEALGQDAIGLLIDPR 159
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A I+ R+ MGE+WTG+FP K K ER VATNTP YDDDG LVGI+CVS+DSRP
Sbjct: 160 DYALANGIIQRVSMGEKWTGKFPVKNKMAERFTAVATNTPLYDDDGALVGIICVSSDSRP 219
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
FQE AL D++N +T+S+ RP+NTV KLGLDSQQPLQ +ASKISNLA+KVSNKVKS
Sbjct: 220 FQEMEVALSDSRNLETESSHRRPKNTVMTKLGLDSQQPLQTAVASKISNLASKVSNKVKS 279
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSHV 363
+I G++ DRE GSGDSH+SDHG+SDAALSDHRED SSGASTPRGD+ P PFGVFS++
Sbjct: 280 KIHMGESNTDREVGSGDSHYSDHGYSDAALSDHREDANSSGASTPRGDLHPSPFGVFSNL 339
Query: 364 DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAW 423
D+KSP K RDSGDESEGKPAIHKIITSKAE W+GKKGLSWPWKGNE+EGS+A+T RF W
Sbjct: 340 DDKSPVKPSRDSGDESEGKPAIHKIITSKAEAWIGKKGLSWPWKGNEKEGSEARTTRFGW 399
Query: 424 PWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGST 483
PW DQ++E+ Q SPS G K ES + E R NEA GSW SS+NVNSTSS SSC +
Sbjct: 400 PWLQNDQESETYHQTSPSSGAKSESQVSESIRPATNEASGSW-SSINVNSTSSASSC-GS 457
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS 543
+SS VNKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS DVAVKVFS+QEYS
Sbjct: 458 TSSTVNKVDMDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS-DVAVKVFSKQEYS 516
Query: 544 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 603
D++I +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW
Sbjct: 517 DDIILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 576
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
RRR+ MALDIARG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLKHETYLTT
Sbjct: 577 RRRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLKHETYLTT 636
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 723
KTGKGTPQWMAPEVLRNEPSDEKSD+YS+GVILWEL+TEKIPWDNLNSMQVIGAVGFMNQ
Sbjct: 637 KTGKGTPQWMAPEVLRNEPSDEKSDIYSYGVILWELSTEKIPWDNLNSMQVIGAVGFMNQ 696
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ---YFQASRSTVGDSTQ 780
RLEIPKDVDP+WA+I+ESCWHSDP+CRP+FQEL++KLRDLQRQ QA+RS GD+TQ
Sbjct: 697 RLEIPKDVDPQWASIIESCWHSDPRCRPTFQELLEKLRDLQRQCAIQVQAARSATGDNTQ 756
Query: 781 KE 782
KE
Sbjct: 757 KE 758
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431966|ref|XP_002278360.1| PREDICTED: uncharacterized protein LOC100256793 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1110 bits (2871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/788 (72%), Positives = 658/788 (83%), Gaps = 26/788 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPA--SRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSG 121
R + PA S RKG G G D + W+ SASFRHSSPLQRES+ D + G
Sbjct: 52 SRFSSPATSSWRKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGG 106
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
P+A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D
Sbjct: 107 PAAYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSD 166
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
+D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS
Sbjct: 167 VQDYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDS 226
Query: 242 RPFQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNK 300
+PFQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNK
Sbjct: 227 QPFQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNK 286
Query: 301 VKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+ +I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+F
Sbjct: 287 VR-KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIF 345
Query: 361 SHV--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKT 418
S DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT
Sbjct: 346 SQATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKT 405
Query: 419 ARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
RF WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVS
Sbjct: 406 NRFGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVS 464
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFS 538
SCGSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGS DVA+KVFS
Sbjct: 465 SCGSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGS-DVAIKVFS 523
Query: 539 RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT 598
+QEYSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT
Sbjct: 524 KQEYSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT 583
Query: 599 TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658
++LDWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHE
Sbjct: 584 SRLDWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHE 643
Query: 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV 718
TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN+MQVIGAV
Sbjct: 644 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNTMQVIGAV 703
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ---YFQASRSTV 775
GFMNQRL+IPK+VD RWA+I+ESCWHSDP+ RP+FQEL+ K +D+ RQ FQA+R+
Sbjct: 704 GFMNQRLDIPKEVDLRWASIIESCWHSDPRSRPTFQELLGKFKDILRQQTMQFQAARAAA 763
Query: 776 GDSTQKEL 783
GD+TQKEL
Sbjct: 764 GDNTQKEL 771
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521762|ref|XP_003529520.1| PREDICTED: uncharacterized protein LOC100800867 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1094 bits (2830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 561/790 (71%), Positives = 637/790 (80%), Gaps = 35/790 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGD------SGGSDAAGNS 118
RL P +R DA +AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRS------DAPAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGGEEAA--P 103
Query: 119 NSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIEL 178
GPSA NFT+RQYLNILQSMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IEL
Sbjct: 104 RRGPSAVNFTERQYLNILQSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIEL 163
Query: 179 LTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVS 238
L D RD D+A + V+R+ MGE WTGQFP K K E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 164 LVDPRDLDLANNTVNRVMMGESWTGQFPIKNKMGEKFLAVATNTPFYDDDGSLVGLICVS 223
Query: 239 TDSRPFQETRAALWDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 224 IDLRPFLEMKVPMPSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 283
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI TG+N +DRE GSG+SHHS+H S++ + RED SSGASTPRGDVPP
Sbjct: 284 VGNKVKSRIWTGENNLDRESGSGESHHSEHSLSESVFLEQREDANSSGASTPRGDVPPSH 343
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG F HV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 344 FGAFPHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 401
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A PW DQ+NESV QK S K ES E NR N+EA GSWSS NVNSTSS
Sbjct: 402 ANVRVAGPWRQNDQENESVNQKILSSSLKQESQAGESNRPTNHEASGSWSS-FNVNSTSS 460
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVK 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS DVAVK
Sbjct: 461 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS-DVAVK 519
Query: 536 VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 595
VFS+QEYSD+VI SFRQEVS+MKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSL RLL
Sbjct: 520 VFSKQEYSDDVILSFRQEVSVMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLCRLLH 579
Query: 596 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
RNT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRL
Sbjct: 580 RNTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRL 639
Query: 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 715
KHET+LTTKTG+GTPQWMAPEVLRNEPSDEKSDVY FGVILWE+ TEKIPWDNLNSMQVI
Sbjct: 640 KHETFLTTKTGRGTPQWMAPEVLRNEPSDEKSDVYGFGVILWEIVTEKIPWDNLNSMQVI 699
Query: 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASR 772
GAVGFMNQRLEIPK+VDPRWA+I+ESCWHSDP CRP+F EL+++LRDLQ+QY FQA+R
Sbjct: 700 GAVGFMNQRLEIPKNVDPRWASIIESCWHSDPACRPTFPELLERLRDLQKQYAIQFQAAR 759
Query: 773 STVGDSTQKE 782
ST +STQKE
Sbjct: 760 STAKESTQKE 769
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564864|ref|XP_003550667.1| PREDICTED: uncharacterized protein LOC100785569 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1092 bits (2825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/790 (71%), Positives = 638/790 (80%), Gaps = 34/790 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG-----DSGGSDAAGNSN 119
RL P +R A+AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRSDA-----PAAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGEEAA--PR 104
Query: 120 SGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
GPSA NFT+RQYLNIL+SMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IELL
Sbjct: 105 RGPSAVNFTERQYLNILRSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIELL 164
Query: 180 TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVST 239
D RD D+A + V+R+ MGE WTGQFP K KT E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 165 VDPRDLDLANNTVNRVMMGESWTGQFPVKNKTGEKFLAVATNTPFYDDDGSLVGLICVSI 224
Query: 240 DSRPFQETRAAL-WDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 225 DLRPFLEMKVPMPTSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 284
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI G+N +DRE GSG+SHHS+H ++ + RED SSGASTPRGDVPP
Sbjct: 285 VGNKVKSRIWMGENNLDRESGSGESHHSEHSLLESVFLEQREDANSSGASTPRGDVPPSH 344
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG FSHV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 345 FGAFSHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 402
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A W DQ+NESV QK S G K ES E NR NNEA GSWSS NVNSTSS
Sbjct: 403 MNVRVAGSWRQNDQENESVNQKILSSGLKQESQAGESNRPTNNEASGSWSS-FNVNSTSS 461
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVK 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS DVAVK
Sbjct: 462 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS-DVAVK 520
Query: 536 VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 595
VFS+QEYSD+VI SFRQEVS+MKRLRHPN+LL+MGAVTSPQRLCIVTEFLPRGSL RLL
Sbjct: 521 VFSKQEYSDDVILSFRQEVSVMKRLRHPNILLYMGAVTSPQRLCIVTEFLPRGSLCRLLH 580
Query: 596 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
RNT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRL
Sbjct: 581 RNTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRL 640
Query: 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 715
KHETYLTTKTG+GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE+ATEKIPWDNLNSMQVI
Sbjct: 641 KHETYLTTKTGRGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEIATEKIPWDNLNSMQVI 700
Query: 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASR 772
GAVGFMNQRLEIPK+VDPRWA+I+ESCWHSDP CRP+F EL+DKL++LQ+QY FQA+R
Sbjct: 701 GAVGFMNQRLEIPKNVDPRWASIIESCWHSDPACRPTFPELLDKLKELQKQYAIQFQAAR 760
Query: 773 STVGDSTQKE 782
ST +STQKE
Sbjct: 761 STAKESTQKE 770
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083240|emb|CBI22876.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1068 bits (2763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/786 (69%), Positives = 633/786 (80%), Gaps = 61/786 (7%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
R + PA+ + GP+
Sbjct: 52 SRFSSPAT------------------------------------------STAGGGGGPA 69
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 70 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 129
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 130 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 189
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNKV+
Sbjct: 190 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNKVR 249
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 250 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 308
Query: 363 V--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 309 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 368
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVSSC
Sbjct: 369 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVSSC 427
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQ 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGS DVA+KVFS+Q
Sbjct: 428 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGS-DVAIKVFSKQ 486
Query: 541 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 600
EYSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT++
Sbjct: 487 EYSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTSR 546
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660
LDWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHETY
Sbjct: 547 LDWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHETY 606
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 720
LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN+MQVIGAVGF
Sbjct: 607 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNTMQVIGAVGF 666
Query: 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ---YFQASRSTVGD 777
MNQRL+IPK+VD RWA+I+ESCWHSDP+ RP+FQEL+ K +D+ RQ FQA+R+ GD
Sbjct: 667 MNQRLDIPKEVDLRWASIIESCWHSDPRSRPTFQELLGKFKDILRQQTMQFQAARAAAGD 726
Query: 778 STQKEL 783
+TQKEL
Sbjct: 727 NTQKEL 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827145|emb|CAN70981.1| hypothetical protein VITISV_034769 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1051 bits (2719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/798 (68%), Positives = 636/798 (79%), Gaps = 57/798 (7%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H Q
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQ--------- 42
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
RKG G G D + W+ SASFRHSSPLQRES+ D + GP+
Sbjct: 43 ---------RKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGGPA 88
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 89 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 148
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 149 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 208
Query: 244 FQETRAALWDTKNSDTDSNIN-RPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ N ++ +AKLGLD QQP+QA IASKISNL VSNKV+
Sbjct: 209 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNL---VSNKVR 265
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 266 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 324
Query: 363 --VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 325 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 384
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSW SS NVNSTSSVSSC
Sbjct: 385 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSW-SSFNVNSTSSVSSC 443
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQ 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGS DVA+KVFS+Q
Sbjct: 444 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGS-DVAIKVFSKQ 502
Query: 541 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL---------- 590
EYSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L
Sbjct: 503 EYSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRCVLCFPIENFLKQ 562
Query: 591 --FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 648
F L NT++LDWRRR+LMALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVG
Sbjct: 563 AYFMCLALNTSRLDWRRRVLMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVG 622
Query: 649 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 708
DFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDN
Sbjct: 623 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDN 682
Query: 709 LNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ-- 766
LN+MQVIGAVGFMNQRL+IPK+VD RWA+I+ESCWHSDP+ RP+FQEL+ K +D+ RQ
Sbjct: 683 LNTMQVIGAVGFMNQRLDIPKEVDLRWASIIESCWHSDPRSRPTFQELLGKFKDILRQQT 742
Query: 767 -YFQASRSTVGDSTQKEL 783
FQA+R+ GD+TQKEL
Sbjct: 743 MQFQAARAAAGDNTQKEL 760
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462150|ref|XP_004148804.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101221874 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/782 (66%), Positives = 605/782 (77%), Gaps = 40/782 (5%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T PAEELLRK+QELE GQ HLK+E+SKL +S + + + S+
Sbjct: 3 TPPAEELLRKVQELEEGQAHLKKEMSKLLLSVQ-----LRPPNPPSPPSPSTFSI----- 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESK--------GGDSGGSDAAG 116
GG G AA+AWK S+SFRHSSPLQ+E+ +S D G
Sbjct: 53 -------HTTGGLDG--AAAAWK-RGSSSFRHSSPLQKEALPRFDISPLQRESRTRDPIG 102
Query: 117 NSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAI 176
S GP+A NFT++QYLNILQS+GQ V+IFDL+ IIYWNR+AE++YGYSA EALGQDAI
Sbjct: 103 CS--GPAAVNFTNKQYLNILQSLGQPVYIFDLNYHIIYWNRAAEIVYGYSAAEALGQDAI 160
Query: 177 ELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVC 236
ELL D DF + ++ R+ GE WTG P K K ++ +VVATNTPFYDD G L+GI+C
Sbjct: 161 ELLVDPEDFAITNHVILRVMAGENWTGHLPVKNKMGQKFVVVATNTPFYDD-GALIGIIC 219
Query: 237 VSTDSRPFQETRAAL-WDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLAT 295
+S+DSRPFQ+ + L +K D DS++ R R V+ KLGLD QQPLQ IASK+SNLA+
Sbjct: 220 ISSDSRPFQDLKIPLSIGSKQQDADSSMVRSRVPVSVKLGLDPQQPLQVAIASKLSNLAS 279
Query: 296 KVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPC 355
KVSNKVKS+IRTG+N +DREGGSGD +HSDHG DA L D+R+D SSGASTPRGD
Sbjct: 280 KVSNKVKSKIRTGENSLDREGGSGDGYHSDHGHPDAVLCDNRDDANSSGASTPRGD--ST 337
Query: 356 PFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREG-S 414
G FS V+EK G+ VRDS DE +GKP I KI++SKAE+W+ KKGLSWPWKG E+EG S
Sbjct: 338 AHGAFSQVEEKLSGRLVRDSSDEGKGKPTIQKILSSKAEEWIAKKGLSWPWKGTEQEGGS 397
Query: 415 DAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNST 474
+ + ARF WPW DQ+ E KS S K E +G+R+VNNEA GSWSS +++
Sbjct: 398 ETRAARFVWPWVQIDQEAEPANHKSSSISGKLEMQQNDGHRAVNNEASGSWSSININSTS 457
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAV 534
S S STSSSAVNKV+ D DCLD+EILWEDLTIGEQIGQGSCGTVYHA+WYGS DVAV
Sbjct: 458 SVSSCG-STSSSAVNKVESDMDCLDHEILWEDLTIGEQIGQGSCGTVYHALWYGS-DVAV 515
Query: 535 KVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 594
KVFS+QEYSD+VI SF+QEVSLMK+LRHPN+LLFMG VTSPQRLCIVTEFLPRGSLFRLL
Sbjct: 516 KVFSKQEYSDDVILSFKQEVSLMKKLRHPNILLFMGVVTSPQRLCIVTEFLPRGSLFRLL 575
Query: 595 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
QRNT KLDWRRR+ MALDIARG++YLHHCNPPIIHRDLKSSNLL+DK+WTVKVGDFGLSR
Sbjct: 576 QRNTGKLDWRRRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLIDKNWTVKVGDFGLSR 635
Query: 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 714
LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD+YSFGVILWELATEKIPW+NLNSMQV
Sbjct: 636 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDIYSFGVILWELATEKIPWENLNSMQV 695
Query: 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQAS 771
IGAVGFMNQRLEIPKDVDP+W +I+ESCWHS+P RPSFQ L++KLRDLQR+Y QA+
Sbjct: 696 IGAVGFMNQRLEIPKDVDPQWISIIESCWHSEPSNRPSFQVLIEKLRDLQRKYTIQLQAA 755
Query: 772 RS 773
RS
Sbjct: 756 RS 757
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448913|ref|XP_003594732.1| Protein kinase-like protein [Medicago truncatula] gi|355483780|gb|AES64983.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2580), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/786 (65%), Positives = 610/786 (77%), Gaps = 58/786 (7%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRPRL 66
P ELL+KI+ LEAGQ HLKQE+SKLK+S ++RSHSVSP+R RL
Sbjct: 6 PEAELLKKIERLEAGQVHLKQEMSKLKLS----------------QRRRSHSVSPQRSRL 49
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG---DSGGSDAAGNSNSGPS 123
G A+SA A +++S SSPLQRES+ +GG
Sbjct: 50 ------------GASASSASSAASASSKGCSSPLQRESRSSHDPQNGGG----------- 86
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
+YLNILQS+G SVHI DL RIIYWN SAE LYGY+AEE LG D IE+L D
Sbjct: 87 -------KYLNILQSIGHSVHILDLQCRIIYWNPSAENLYGYTAEEVLGLDGIEVLVDPS 139
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
+FD+A DI +R+KMGE WTGQFP K K +R +VVAT+TPFYDDDG+LVG++CV++DSRP
Sbjct: 140 EFDIANDIFNRVKMGESWTGQFPVKNKIGDRFVVVATDTPFYDDDGSLVGVICVTSDSRP 199
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
F E KN + DS +N PR +T KLGLD +QPLQ +ASKISNLATKVSNKVKS
Sbjct: 200 FLENIVPFSARKNEEKDSGVNFPRIAITNKLGLDPEQPLQNALASKISNLATKVSNKVKS 259
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDG-MSSGASTPRGDVPPCPFGVFSH 362
+IRT +N ++ EGGS +SHHS+HGFSD SD REDG SSGASTP G+VPP PFG FS
Sbjct: 260 KIRTRENNVNGEGGSSESHHSEHGFSDYGHSDQREDGGNSSGASTPAGEVPPTPFGSFSR 319
Query: 363 VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFA 422
+E+S GK++R+SGDESE KP IHKIITS+AE W+ KK +SWPWK N+RE S+AK R +
Sbjct: 320 AEERSQGKTMRNSGDESEEKP-IHKIITSRAEAWIQKKTMSWPWKTNDREESEAKNVRVS 378
Query: 423 WPWSHGDQDNESVQQKSPSYGTKP-ESHMYEGNRSVNNEAWGSWSS--SVNVNSTSSVSS 479
WPW GDQD E QK+ S G KP ES E + V NEA GSWSS + + +STSS S
Sbjct: 379 WPWLQGDQDKEPANQKNASSGLKPPESRAVESYQPVQNEATGSWSSFNANSTSSTSSCGS 438
Query: 480 CGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSR 539
+SS+A N+VD+D+DCLDYEILWEDLTIGE IGQGSCGTVYHA+WYGS DVAVKVFS+
Sbjct: 439 GSGSSSAANNRVDVDSDCLDYEILWEDLTIGESIGQGSCGTVYHALWYGS-DVAVKVFSK 497
Query: 540 QEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 599
QEYS++VI SFRQEVSLMKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT+
Sbjct: 498 QEYSEDVIQSFRQEVSLMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTS 557
Query: 600 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659
K DWRRR+ MA+DIARGV+YLHHCNPPIIHRDLK+SNLLVDK+WTVKVGDFGLSR+KHET
Sbjct: 558 KPDWRRRVHMAVDIARGVNYLHHCNPPIIHRDLKTSNLLVDKNWTVKVGDFGLSRIKHET 617
Query: 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 719
YL TKTGKGTPQWMAPEVLRNEPS+EKSDVYSFGVI+WELATEKIPWD LN+MQVIGAVG
Sbjct: 618 YLETKTGKGTPQWMAPEVLRNEPSNEKSDVYSFGVIMWELATEKIPWDTLNAMQVIGAVG 677
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASRSTVG 776
FMN RLEIP+D+DP+WA+I+ESCWH+DP RP+FQEL+++L++LQR+Y FQA+RS G
Sbjct: 678 FMNHRLEIPEDIDPQWASIIESCWHTDPALRPTFQELLERLKELQRRYAIQFQAARSAGG 737
Query: 777 DSTQKE 782
+ TQKE
Sbjct: 738 EKTQKE 743
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 783 | ||||||
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.954 | 0.966 | 0.586 | 4.9e-243 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.943 | 0.966 | 0.574 | 4.7e-240 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.703 | 0.663 | 0.492 | 3.6e-229 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.784 | 0.915 | 0.591 | 1.2e-208 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.349 | 0.372 | 0.571 | 6.2e-112 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.351 | 0.266 | 0.606 | 8.9e-92 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.337 | 0.3 | 0.615 | 4.6e-89 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.352 | 0.278 | 0.595 | 9.6e-89 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.346 | 0.290 | 0.610 | 2e-88 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.346 | 0.330 | 0.605 | 5.4e-86 |
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2342 (829.5 bits), Expect = 4.9e-243, P = 4.9e-243
Identities = 463/790 (58%), Positives = 567/790 (71%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRL 66
PAEELL+KI ELE QEHLKQE+S+LK+S + + QRSHSVSP RP
Sbjct: 5 PAEELLKKILELEESQEHLKQEMSRLKVSTELR--------------QRSHSVSPHRP-- 48
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFN 126
+RR G + A +W+ + +ASFR++SPL++ES+ PSA
Sbjct: 49 ----ARRNIG----EGAPSWRKSGAASFRNASPLRKESRIQNSMRLRSEVGGGG-PSAGK 99
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
FTD+QYLNILQSM Q+VH FDL+ RII+WN AE +YGYSA EALG++ I ++ D RD
Sbjct: 100 FTDKQYLNILQSMAQAVHAFDLNMRIIFWNAMAEKVYGYSAAEALGENPINVIADDRDAA 159
Query: 187 VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
A +I R GE WTG+FP K+K+ +R V T +PFYDDDG L+GI+C+++++ P+
Sbjct: 160 FAMNIARRCVRGESWTGEFPVKSKSGDRFSAVTTCSPFYDDDGALMGIICITSNTAPYLN 219
Query: 247 TRAALWDTKNSDTDSNINRP-RNT------------VTAKLGLDSQQPLQATIASKISNL 293
R +L K + + P RN+ V +KLGLDS QP+Q IASKIS+L
Sbjct: 220 PRISLAKLKAQEEGETSSIPARNSFASKLGLDSRGAVISKLGLDSDQPIQVAIASKISDL 279
Query: 294 ATKVSNKVKSRIRTGDNFMD-REXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDV 352
A+KVSNKV+S++R GDN E A L DHR+D SSGASTPRGD
Sbjct: 280 ASKVSNKVRSKMRAGDNSATLSEGGSGDSHQKDHNVFGATLVDHRDDAASSGASTPRGDF 339
Query: 353 PPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNERE 412
PFGVF+ DEK K +DS DES+GKPAIHK++TSKAE+WM KKGLSWPWKGNE+E
Sbjct: 340 IQSPFGVFTCNDEKFVSKPFKDSSDESDGKPAIHKVLTSKAEEWMVKKGLSWPWKGNEQE 399
Query: 413 GSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXX 472
GS + WPW +Q E Q +PS G + ESH +E N+ +NNE
Sbjct: 400 GSKGRPTNSVWPWVQNEQKKERCHQINPSAGVQYESHAFESNKPINNEASSLWSSPINAN 459
Query: 473 XXXXXXXXXXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV 532
NKVD D++ L+YEILW+DLTIGEQ+GQGSCGTVYH +W+GS DV
Sbjct: 460 STSSASSCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGS-DV 518
Query: 533 AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 592
AVKVFS+QEYS EVI SF+QEV LMKRLRHPNVLLFMGAVTSPQRLCIV+EFLPRGSLFR
Sbjct: 519 AVKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFR 578
Query: 593 LLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652
LLQ++T+KLDWRRRI MALDIARG++YLHHC+PPIIHRDLKSSNLLVDK+WTVKV DFGL
Sbjct: 579 LLQKSTSKLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGL 638
Query: 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712
SR+KHETYLT+K+GKGTPQWMAPEVLRNE +DEKSD+YSFGV+LWELATEKIPW+ LNSM
Sbjct: 639 SRIKHETYLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSM 698
Query: 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQ 769
QVIGAVGFM+QRLEIPKD+DPRW +++ESCWHSD + RP+FQEL+DKLRDLQR+Y FQ
Sbjct: 699 QVIGAVGFMDQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQRKYMIQFQ 758
Query: 770 ASRSTVGDST 779
A+R+ + D++
Sbjct: 759 ATRAALSDNS 768
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2218 (785.8 bits), Expect = 4.7e-240, Sum P(2) = 4.7e-240
Identities = 446/777 (57%), Positives = 539/777 (69%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + ++RSHS SP+RP SRR G P
Sbjct: 9 EKLLKKIRELEESQEDLKREMSKLKVSAEIKRRSHSSSPKRP------SRRNSGEGTP-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES PSA FTD+QYLNILQSM Q+
Sbjct: 61 --LWRKTGAASFRHASPLRKESHSKDGVAGGGDG-----PSAGKFTDKQYLNILQSMAQA 113
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D+I +L DG+D VA +I R GE WT
Sbjct: 114 VHVFDLNGQIIFWNSMAEKLYGFSAAEALGKDSINILVDGQDAAVAKNIFQRCSSGESWT 173
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSN 262
G+FP K K ER VV T +PFYDDDG L+GI+C++ DS FQ R + + DS+
Sbjct: 174 GEFPVKNKMGERFSVVTTISPFYDDDGLLIGIICITNDSALFQRPRVPPAKNRWQEGDSS 233
Query: 263 INRPRN------------TVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGDN 310
R N V +KLGLDSQQP+QA IASKIS+LA+KV NKV+S++R GDN
Sbjct: 234 FCRGTNGVASRLGFDSKEAVVSKLGLDSQQPIQAAIASKISDLASKVGNKVRSKMRAGDN 293
Query: 311 FMDR-EXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSPG 369
E AA SD RED ++ ASTPRG++ PFGVF D+KS
Sbjct: 294 NASHPEGGNGGSHQSDQGFFDAAFSDQREDAETNDASTPRGNLIQSPFGVFLCNDDKSSS 353
Query: 370 KSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHGD 429
K+ +S DE++ + K +TSK E+WM KKGLSWPWKGNEREG + + A WPW H +
Sbjct: 354 KASGESNDENDRNSVVPKKLTSKTEEWMVKKGLSWPWKGNEREGLERRNAHSVWPWVHNE 413
Query: 430 QDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXXN 489
Q E + K ES E N+ NNE N
Sbjct: 414 QQKEEAHHSNSYNSVKSESLASESNKPANNENMGSVNVNSASSASSCGSTSSSVM----N 469
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHS 549
KVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GS DVAVKVFS+QEYS+E+I S
Sbjct: 470 KVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGS-DVAVKVFSKQEYSEEIITS 528
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 609
F+QEVSLMKRLRHPNVLLFMGAV SPQRLCIVTEFLPRGSLFRLLQRN +KLD RRRI M
Sbjct: 529 FKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHM 588
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 669
A DIARG++YLHHC+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KHETYLTT G+GT
Sbjct: 589 ASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGT 647
Query: 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
PQWMAPEVLRNE +DEKSDVYSFGV+LWEL TEKIPW+NLN+MQVIGAVGFMNQRLE+PK
Sbjct: 648 PQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPK 707
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASRS-TVGDSTQKE 782
DVDP+W A++ESCWHS+PQCRPSFQEL+DKLR+LQR+Y FQA+R+ ++ +S+ KE
Sbjct: 708 DVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQRKYTIQFQAARAASIDNSSLKE 764
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1369 (487.0 bits), Expect = 3.6e-229, Sum P(3) = 3.6e-229
Identities = 288/585 (49%), Positives = 359/585 (61%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + +QRSHS SP+RP R GT P
Sbjct: 9 EELLKKIRELEESQEHLKREMSRLKVSAEMKQRSHSASPQRP-----VRRNSNDGT-P-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES SA FTD+QYLNILQSM Q+
Sbjct: 61 --MWRKTGAASFRHASPLRKESHAKVAGGGGEGQ------SAGKFTDKQYLNILQSMAQA 112
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D I++L D +D VA +I R GE WT
Sbjct: 113 VHVFDLNGQIIFWNSMAEKLYGFSASEALGKDPIDILVDVQDASVAQNITRRCSSGESWT 172
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS-DTDS 261
G+FP K K ER VV T +P YDDDG L+GI+C++ DS FQ+ R + T+ + ++
Sbjct: 173 GEFPVKNKAGERFSVVTTMSPSYDDDGCLIGIICITNDSALFQDPRGSPAKTRRGQEGET 232
Query: 262 NINR------------PRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ +R + V +KLGLDSQQP+Q IASKIS+L V NKVKS++R GD
Sbjct: 233 SFSRVTSSVASKLGLDSKEAVVSKLGLDSQQPIQVAIASKISDL---VGNKVKSKMRAGD 289
Query: 310 N-FMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSP 368
N + E AA +D RED +SGA TPRGD PFGVF DEK+
Sbjct: 290 NNAANLEGGSGDSHQSDQGFFDAAFADRREDAATSGADTPRGDFIQSPFGVFLRSDEKAS 349
Query: 369 GKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHG 428
K RDS DES+G + K +TSKAE+WM KKGLSWPWKGNEREG + + + WPW
Sbjct: 350 TKPFRDSSDESDGNSVVPKTLTSKAEEWMVKKGLSWPWKGNEREGLEGRRSHSVWPWVRN 409
Query: 429 DQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXX 488
+Q + Q + ++ K ES E ++ +NE
Sbjct: 410 EQQKQQAYQSNSNHSVKSESQACESIKASSNEPMGYWSSSVNVNSTSSSSSCGSTSSSVM 469
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIH 548
NKVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GS DVAVKVFS+QEYS+E+I
Sbjct: 470 NKVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGS-DVAVKVFSKQEYSEEIIT 528
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 593
SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L L
Sbjct: 529 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRFGLITL 573
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1945 (689.7 bits), Expect = 1.2e-208, Sum P(2) = 1.2e-208
Identities = 369/624 (59%), Positives = 456/624 (73%)
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
PS FTD+QYLNILQS+ QSVH+ DL+ RII+WN +E LYGYSA E +G++ + ++ D
Sbjct: 56 PSPGKFTDKQYLNILQSLAQSVHVLDLNTRIIFWNAMSEKLYGYSAAEVVGRNPVHVIVD 115
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
++ A ++ R GE WTG+FP KTK+ + V T +PFYDD+GT+VGI+ +++D
Sbjct: 116 DQNAAFALNVARRCANGESWTGEFPVKTKSGKIFSAVTTCSPFYDDNGTVVGIISITSDI 175
Query: 242 RPFQETRAALWDTKNSDTDSNINRP-RNTVTAKLGLDSQQPLQATIASKISNLATKVSNK 300
P+ R +L K + + + + V +K GLDS QP+Q +IASKIS+LA+K+SNK
Sbjct: 176 APYLNPRLSLPRLKPQEPERKLGLDSKGAVISKPGLDSDQPIQVSIASKISSLASKLSNK 235
Query: 301 VKSRIRTGDNFMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+S++R GDN LSDHR+D SSGASTPRGD PFGVF
Sbjct: 236 VRSKMRAGDN-----SACGDSHHSDHDVFGDTLSDHRDDAASSGASTPRGDFIQSPFGVF 290
Query: 361 SHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
+ D+K P K +DS D KPAIHK+ TSKAE+WM KKGLS PWKGNE+EGS +
Sbjct: 291 TCYDDKFPSKPSKDSSDR---KPAIHKVPTSKAEEWMVKKGLSRPWKGNEQEGSRVRPTH 347
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXX 480
W W +Q+ + Q PS G K ESH E N+ ++E
Sbjct: 348 SVWSWVENEQEKDKYHQIYPSAGVKSESHGSESNKPTDDEASNMWSSSINANSTNSASSC 407
Query: 481 XXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQ 540
+KVD+D+D L++EILW+DLTIGEQIG+GSCGTVYH +W+GS DVAVKVFS+Q
Sbjct: 408 GSTSRSVMDKVDIDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGS-DVAVKVFSKQ 466
Query: 541 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 600
EYS+ VI SF +EVSLMKRLRHPNVLLFMGAVTSPQRLCIV+EF+PRGSLFRLLQR+ +K
Sbjct: 467 EYSESVIKSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSK 526
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660
LDWRRRI MALDIARG++YLH C+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KH+TY
Sbjct: 527 LDWRRRINMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTY 586
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 720
LT+K+GKGTPQWMAPEVLRNE +DEKSD+YSFGV+LWELATEKIPW+NLNSMQVIGAVGF
Sbjct: 587 LTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGF 646
Query: 721 MNQRLEIPKDVDPRWAAIVESCWH 744
MNQRLEIPKD DP W +++ESCWH
Sbjct: 647 MNQRLEIPKDTDPDWISLIESCWH 670
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 6.2e-112, Sum P(2) = 6.2e-112
Identities = 159/278 (57%), Positives = 220/278 (79%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIH 548
N++ D+ C EI WEDL +GE++G+GS V+ VW GS DVA+KV+ +Y+ +
Sbjct: 453 NRLVTDSSC---EIRWEDLQLGEEVGRGSFAAVHRGVWNGS-DVAIKVYFDGDYNAMTLT 508
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
++E+++MK+LRHPNVLLFMGAV + ++ I+ E++PRGSLF++L LD +RR+
Sbjct: 509 ECKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLR 568
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668
MALD+ARG++YLH NPPI+HRDLKSSNLLVDK+W VKVGDFGLS+ K+ T+L+TK+GKG
Sbjct: 569 MALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKG 628
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 728
TPQWMAPEVLR+EPS+EK DV+SFGVILWEL T +PWD LNS+QV+G VGFM++RL++P
Sbjct: 629 TPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLP 688
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
+ ++PR A+I++ CW +DP RPSF+EL+ ++ L R+
Sbjct: 689 EGLNPRIASIIQDCWQTDPAKRPSFEELISQMMSLFRK 726
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 896 (320.5 bits), Expect = 8.9e-92, Sum P(2) = 8.9e-92
Identities = 168/277 (60%), Positives = 212/277 (76%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIH 548
+K D D D D EILWE++T+GE+IG GS G VY W+G++ VAVK F Q+ + E +
Sbjct: 731 SKSDCD-DVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTE-VAVKKFLDQDLTGEALE 788
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
FR EV +MK+LRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD RRR+
Sbjct: 789 EFRSEVRIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLR 848
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668
MALD ARG++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ G
Sbjct: 849 MALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAG 908
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 728
T +WMAPEVLRNEP+DEK DVYS+GVILWEL T + PW +N MQV+GAVGF ++RL+IP
Sbjct: 909 TAEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIP 968
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
VDP A ++ CW +D + RPSF E++ L+ LQ+
Sbjct: 969 DFVDPAIADLISKCWQTDSKLRPSFAEIMASLKRLQK 1005
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 889 (318.0 bits), Expect = 4.6e-89, P = 4.6e-89
Identities = 163/265 (61%), Positives = 207/265 (78%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI+WEDL IGE+IG GS G VY A W G++ VAVK F Q++S + + F+ E+ +M R
Sbjct: 602 WEIMWEDLQIGERIGIGSYGEVYRAEWNGTE-VAVKKFLDQDFSGDALTQFKSEIEIMLR 660
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
LRHPNV+LFMGAVT P I+TEFLPRGSL+RLL R +LD +RR+ MALD+A+G++Y
Sbjct: 661 LRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNY 720
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
LH +P ++HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GTP+WMAPEVLR
Sbjct: 721 LHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLR 780
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
NEP++EK DVYSFGVILWELAT ++PW LN MQV+GAVGF N+RLEIP D+D A I+
Sbjct: 781 NEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVAQII 840
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQ 764
CW ++P RPSF +L+ L+ LQ
Sbjct: 841 RECWQTEPHLRPSFTQLMQSLKRLQ 865
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
Identities = 165/277 (59%), Positives = 212/277 (76%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEV 554
+D + EILWE++T+ E+IG GS G VY W+G+ VAVK F Q+ + E + FR EV
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTA-VAVKKFIDQDITGEALEEFRSEV 761
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+M+RLRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD R+R+ MALD A
Sbjct: 762 RMMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAA 821
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
RG++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+K TYL++K+ GT +WMA
Sbjct: 822 RGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMA 881
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
PEVLRNEP+DEK DVYS+GVILWEL T + PW +N MQV+GAVGF ++RL+IP+ VDP
Sbjct: 882 PEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPG 941
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771
A I+ CW +DP+ RPSF E++D L+ LQ+ +A+
Sbjct: 942 IADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAA 978
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 2.0e-88, P = 2.0e-88
Identities = 166/272 (61%), Positives = 206/272 (75%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQE 553
D D + EI W DL I E+IG GS G VYHA W+G++ VAVK F Q++S + FR E
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTE-VAVKKFLDQDFSGAALAEFRSE 714
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 613
V +M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+
Sbjct: 715 VRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDV 774
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 673
A G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GTP+WM
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
APEVLRNEPS+EK DVYSFGVILWELAT ++PW +N MQV+GAVGF N+RLEIPK++DP
Sbjct: 835 APEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
I+ CW +DP RPSF +L + L+ L R
Sbjct: 895 VVGRIILECWQTDPNLRPSFAQLTEVLKPLNR 926
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
Identities = 167/276 (60%), Positives = 216/276 (78%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHS 549
++ LD D D +I W DL I E+IG GS GTV+ A W+GS DVAVK+ Q++ E ++
Sbjct: 536 ELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNE 592
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRI 607
F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RRR+
Sbjct: 593 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 652
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667
MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+
Sbjct: 653 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 712
Query: 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 727
GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN QV+ AVGF +RLEI
Sbjct: 713 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 772
Query: 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
P++++P+ AAI+E CW ++P RPSF ++D LR L
Sbjct: 773 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 783 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-82 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-81 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-81 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-75 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-71 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-70 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-58 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-51 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-50 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-48 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-47 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-47 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-47 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-47 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-45 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-44 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-44 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-44 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-44 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-43 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-43 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-43 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-43 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-41 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-41 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-39 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-39 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-39 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-38 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-38 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-38 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-37 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-37 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-37 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-37 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-36 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-35 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-35 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-35 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-34 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-34 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-34 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-34 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-34 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-33 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-33 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-33 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-33 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-33 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-33 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-33 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-32 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-32 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-32 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-32 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-31 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-31 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-31 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-30 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-30 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-29 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-29 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-28 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-27 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-27 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-26 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-26 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-26 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-26 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-26 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-26 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-23 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-20 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-19 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-17 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-16 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-15 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 9e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| pfam08448 | 110 | pfam08448, PAS_4, PAS fold | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| COG3829 | 560 | COG3829, RocR, Transcriptional regulator containin | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| pfam13188 | 64 | pfam13188, PAS_8, PAS domain | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| PRK11360 | 607 | PRK11360, PRK11360, sensory histidine kinase AtoS; | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| PRK11359 | 799 | PRK11359, PRK11359, cyclic-di-GMP phosphodiesteras | 0.004 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 4e-82
Identities = 98/262 (37%), Positives = 150/262 (57%), Gaps = 12/262 (4%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS-----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
L +G+++G+G+ G VY G VAVK ++ S+E F +E S+MK+L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HPN++ +G T + L IVTE++P G L L+++ KL + + MAL IA+G+ YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQ-WMAPEVLR 679
N +HRDL + N LV ++ VK+ DFGLSR +E Y + G P WMAPE L+
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 680 NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
+ KSDV+SFGV+LWE+ T + P+ +++ +V+ + RL P++ +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 739 VESCWHSDPQCRPSFQELVDKL 760
+ CW DP+ RP+F ELV+ L
Sbjct: 237 MLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 260 bits (667), Expect = 2e-81
Identities = 100/263 (38%), Positives = 151/263 (57%), Gaps = 15/263 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HPNV+ +G T + L IV E++ G L L++N KL + AL IARG+ YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
N IHRDL + N LV ++ VK+ DFGLSR L + Y + GK +WMAPE L+
Sbjct: 120 SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 681 EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAA 737
KSDV+SFGV+LWE+ T + P+ +++ +V+ + G+ RL P + P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY---RLPQPPNCPPELYD 234
Query: 738 IVESCWHSDPQCRPSFQELVDKL 760
++ CW DP+ RP+F ELV+ L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 4e-81
Identities = 99/262 (37%), Positives = 150/262 (57%), Gaps = 12/262 (4%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYL 620
HPN++ +G T + L IV E++P G L L++N +L + AL IARG+ YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLR 679
N IHRDL + N LV ++ VK+ DFGLSR L + Y K GK +WMAPE L+
Sbjct: 120 ESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 680 NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
KSDV+SFGV+LWE+ T + P+ +++ +V+ + RL P + P +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 739 VESCWHSDPQCRPSFQELVDKL 760
+ CW DP+ RP+F ELV+ L
Sbjct: 237 MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 1e-75
Identities = 93/268 (34%), Positives = 148/268 (55%), Gaps = 23/268 (8%)
Query: 511 EQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+++G+G+ G VY G + +VAVK +++ S+E F +E +MK+L HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVS 618
+G T + L +V E++ G L L+++ + L + + A+ IA+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPE 676
YL +HRDL + N LV + VK+ DFGLSR + + Y KTG P +WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733
L++ KSDV+SFGV+LWE+ T P+ L++ +V+ + G+ RL P+
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEYCPD 234
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLR 761
++ SCW DP+ RP+F ELV++L
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 16/269 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+ ++G GS GTVY A G+ VAVK+ ++ + + R+E+ +++RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ + A L +V E+ G LF L R L +AL I RG+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSD 684
IIHRDLK N+L+D++ VK+ DFGL++ ++ + T GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 685 EKSDVYSFGVILWELATEKIPW---DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI--V 739
K DV+S GVIL+EL T K P+ + L+ +Q+I + + PK A +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
+ C + DP RP+ +E+ LQ +F
Sbjct: 238 KKCLNKDPSKRPTAEEI------LQHPWF 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 4e-71
Identities = 82/269 (30%), Positives = 129/269 (47%), Gaps = 24/269 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I E++G+GS G VY A + + VA+KV +++ + +E+ ++K+L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIV 60
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNP 625
+L +V E+ G LF LL++ D R I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 685
I+HRDLK N+L+D+ VK+ DFGL+R T T GTP++MAPEVL + +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGK 175
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW------AAIV 739
D++S GVIL+EL T K P+ + + + F P P W ++
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
DP+ R + +E LQ +F
Sbjct: 232 RKLLVKDPEKRLTAEEA------LQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 1e-70
Identities = 84/251 (33%), Positives = 123/251 (49%), Gaps = 39/251 (15%)
Query: 513 IGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571
+G+G GTVY A + + VA+K+ +E S ++ +E+ ++K+L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-KEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 572 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 631
L +V E+ GSL LL+ N KL + + L I G+ YLH IIHRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRD 117
Query: 632 LKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDV 689
LK N+L+D + VK+ DFGLS+L KT GTP +MAPEVL + EKSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749
+S GVIL+EL P ++ DP+
Sbjct: 178 WSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204
Query: 750 RPSFQELVDKL 760
RPS +E+++ L
Sbjct: 205 RPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 3e-58
Identities = 86/258 (33%), Positives = 135/258 (52%), Gaps = 11/258 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHA--VWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ T GE +G+GS G+VY A G +AVK S+E + + +E+ ++ L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSLQHP 59
Query: 564 NVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
N++ + G+ ++ L I E++ GSL LL++ KL I G++YLH
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH 118
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTPQWMAPEVLR 679
I+HRD+K +N+LVD VK+ DFG ++ + T + +GTP WMAPEV+R
Sbjct: 119 SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
E +D++S G + E+AT K PW L N M + +G + EIP+ +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 739 VESCWHSDPQCRPSFQEL 756
+ C DP+ RP+ EL
Sbjct: 237 LRKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 88/257 (34%), Positives = 136/257 (52%), Gaps = 8/257 (3%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+LT +++G G G V+ W G DVA+K+ S++ F +E +M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ G T + + IVTE++ G L L+ KL + M D+ + YL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSD 684
IHRDL + N LV + VKV DFGL+R + T+ G P +W PEV
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 685 EKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
KSDV+SFGV++WE+ +E K+P++ ++ +V+ +V RL PK I+ SCW
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCW 238
Query: 744 HSDPQCRPSFQELVDKL 760
H P+ RP+F++L+ +L
Sbjct: 239 HEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 96/284 (33%), Positives = 152/284 (53%), Gaps = 28/284 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVY----HAVWYGSQD--VAVKVFSRQEYSDEVIHSFRQE 553
+E+ E +T+ ++GQGS G VY V G + VA+K + E I F E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ------RNTTKLD---WR 604
S+MK +V+ +G V++ Q +V E + +G L L+ N L +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
+ I MA +IA G++YL +HRDL + N +V + TVK+GDFG++R +ET K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 665 TGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQV---IGAV 718
GKG P +WMAPE L++ KSDV+SFGV+LWE+AT + P+ L++ +V +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762
G ++ P++ + ++ CW +P+ RP+F E+V L+D
Sbjct: 238 GHLDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 96/273 (35%), Positives = 142/273 (52%), Gaps = 11/273 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD----VAVKVFSRQEYSDEVIHSFRQEVS 555
YEI ED+T+G IG+G G VY V+ ++ VAVK + S V F QE
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAY 59
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 615
+M++ HP+++ +G V + + IV E P G L LQ N LD IL + ++
Sbjct: 60 IMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMA 674
++YL +HRD+ + N+LV VK+GDFGLSR L+ E+Y GK +WMA
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 675 PEVLRNEPSDEKSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
PE + SDV+ FGV +WE L P+ + + VIG + +RL +P + P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 235
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
+++ CW DP RP F EL +L D+ ++
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 27/278 (9%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
L +Q+G+G G V + D VAVK ++ F +E+ +++ L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64
Query: 562 HPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
H N++ + G P L ++ E+LP GSL LQR+ +++ +R +L + I +G+ Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPE 676
L + IHRDL + N+LV+ VK+ DFGL+++ + Y + G+ W APE
Sbjct: 125 LG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 677 VLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIG-AVGFM-----------N 722
LR SDV+SFGV L+EL T + +++IG A G M
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
+RL P +++ CW ++PQ RPSF +L+ +
Sbjct: 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 90/268 (33%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + ++G G G V+ W G+ VAVK S E +F QE +MK+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 618
LRH ++ + + + IVTE++ +GSL L+ KL + + MA IA G++
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
YL N IHRDL + N+LV ++ K+ DFGL+RL + T + G P +W APE
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
KSDV+SFG++L E+ T ++P+ + + +V+ V G+ R+ P +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RMPRPPNCPEE 232
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRD 762
++ CW DP+ RP+F+ L L D
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 29/267 (10%)
Query: 511 EQIGQGSCGTVYHAVWYGSQ----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+++G GS G V W S VAVK + SD ++ F +E ++M L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLI 59
Query: 567 LFMGAV-TSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGVS 618
G V T P L +VTE P GSL L+++ +T D+ A+ IA G+
Sbjct: 60 RLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMR 111
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQWMAP 675
YL IHRDL + N+L+ VK+GDFGL R + Y+ + K W AP
Sbjct: 112 YLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 676 EVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
E LR SDV+ FGV LWE+ T E+ PW L+ Q++ + +RLE P+
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEE-PWAGLSGSQILKKIDKEGERLERPEACPQ 228
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKL 760
++ CW +P RP+F L + L
Sbjct: 229 DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 89/258 (34%), Positives = 138/258 (53%), Gaps = 12/258 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
++L +G IG+G G V + G Q VAVK +F E S+M LRHPN
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRG-QKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPN 61
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHC 623
++ +G V L IVTE++ +GSL L+ R + +++ ALD+ G+ YL
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
N +HRDL + N+LV + KV DFGL++ E +GK +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 684 DEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
KSDV+SFG++LWE+ + ++P+ + V+ V R+E P+ P +++ C
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKDC 235
Query: 743 WHSDPQCRPSFQELVDKL 760
W DP RP+F++L ++L
Sbjct: 236 WELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 9e-47
Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 35/267 (13%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 561
I E+IG+G G VY + ++VA+KV +E +++I E+ ++K+ +
Sbjct: 1 LFEILEKIGKGGFGEVY-KARHKRTGKEVAIKVIKLESKEKKEKII----NEIQILKKCK 55
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIAR 615
HPN++ + G+ L IV EF GSL LL+ L + +L L+
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE--- 112
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 674
YLH IIHRD+K++N+L+ VK+ DFGLS +L T GTP WMA
Sbjct: 113 ---YLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMVGTPYWMA 165
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
PEV+ +P D K+D++S G+ ELA K P+ L M+ + F P +P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL----FKIATNGPPGLRNPE 221
Query: 735 WA-----AIVESCWHSDPQCRPSFQEL 756
++ C +P+ RP+ ++L
Sbjct: 222 KWSDEFKDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 87/267 (32%), Positives = 130/267 (48%), Gaps = 9/267 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI + + ++G G G V+ +W + VAVK + F E +MK+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 618
LRHP ++ T + + IVTE + GSL LQ L + I MA +A G++
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
YL N IHRDL + N+LV ++ KV DFGL+R+ E + G P +W APE
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
KSDV+SFG++L E+ T ++P+ + + +V+ V R+ P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763
I+ CW DP RP+F+ L KL D
Sbjct: 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 34/274 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLM 557
YEI+ +QIG+GS G VY +K S++ EV ++
Sbjct: 1 KYEII-------KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRIL 608
K+L HPN++ + + +LCIV E+ G L + +++ + LDW ++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668
+AL YLH I+HRD+K N+ + + VK+GDFG+S++ T KT G
Sbjct: 114 LALK------YLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD--NLNS--MQVIGAVGFMNQR 724
TP +++PE+ +N+P + KSD++S G +L+EL T K P++ NL ++++ Q
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-----QY 220
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 758
IP +V S DP+ RPS +++
Sbjct: 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 73/252 (28%), Positives = 135/252 (53%), Gaps = 5/252 (1%)
Query: 506 DLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+ +G+ IG+G+ G VY + VA+K S ++ +E + S QE+ L+K L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
++ ++G++ + L I+ E+ GSL +++++ + + +G++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH--E 117
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
+IHRD+K++N+L K VK+ DFG++ ++ + GTP WMAPEV+ +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 685 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
SD++S G + EL T P+ +LN M + + + +P+ + P + C+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236
Query: 745 SDPQCRPSFQEL 756
DP RP+ ++L
Sbjct: 237 KDPNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-44
Identities = 81/257 (31%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQD-VAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
GE +G GS G+VY + D AVK + + E + QE++L+ +L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL 620
+ ++G L I E +P GSL +LL++ + R+IL+ G+ YL
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------GLEYL 118
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
H N +HRD+K +N+LVD + VK+ DFG+++ + + K+ KG+P WMAPEV+
Sbjct: 119 HDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 681 E-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
+ +D++S G + E+AT K PW L + + +G + IP + +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 740 ESCWHSDPQCRPSFQEL 756
C DP RP+ EL
Sbjct: 236 LKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 86/255 (33%), Positives = 135/255 (52%), Gaps = 8/255 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+DLT +++G G G V + W G DVA+K+ S++ F +E +M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
++ G T + + IVTE++ G L L+ + + + + M D+ G++YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--S 118
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPS 683
IHRDL + N LVD VKV DFGLSR + T+ G P +W PEVL
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 684 DEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
KSDV++FGV++WE+ + K+P++ N+ + + V RL P + AI+ SC
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237
Query: 743 WHSDPQCRPSFQELV 757
WH + RP+FQ+L+
Sbjct: 238 WHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 92/263 (34%), Positives = 139/263 (52%), Gaps = 14/263 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+E+ D+T+ ++G G G VY VW S VAVK + F +E ++MK
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGV 617
++HPN++ +G T I+TEF+ G+L L+ N +++ + MA I+ +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 676
YL N IHRDL + N LV ++ VKV DFGLSRL T G P +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733
L KSDV++FGV+LWE+AT + P+ ++ QV + G+ R+E P+ P
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPP 232
Query: 734 RWAAIVESCWHSDPQCRPSFQEL 756
+ ++ +CW +P RPSF E+
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 7e-44
Identities = 81/258 (31%), Positives = 133/258 (51%), Gaps = 7/258 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
E+ T+ ++G G G V+ +W VA+K+ F++EV +KRLRH +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKH 63
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHC 623
++ + + + I+TE + +GSL L+ + L I MA +A G++YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
N IHRDL + N+LV + KV DFGL+RL E + K +W APE +
Sbjct: 124 N--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 684 DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
KSDV+SFG++L+E+ T ++P+ +N+ +V + R+ P I+ C
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLEC 240
Query: 743 WHSDPQCRPSFQELVDKL 760
W ++P+ RPSF+ L ++L
Sbjct: 241 WAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 93/266 (34%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSQ--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
+TI + IG G G V G + DVA+K + SD+ F E S+M +
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFD 63
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HPN++ G VT + + I+TE++ GSL + L+ N K + + M IA G+ YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVL 678
N +HRDL + N+LV+ + KV DFGLSR + TY TTK GK +W APE +
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-TTKGGKIPIRWTAPEAI 180
Query: 679 RNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
SDV+SFG+++WE+ + E+ P+ ++++ VI AV G+ RL P D
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGER-PYWDMSNQDVIKAVEDGY---RLPPPMDCPSA 236
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKL 760
++ CW D RP+F ++V L
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 82/273 (30%), Positives = 139/273 (50%), Gaps = 21/273 (7%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
L + +G G+ GTVY VW + VA+KV R+E S + E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVD 67
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL- 620
HP+V+ +G S Q + ++T+ +P G L ++ + + + + + IA+G+SYL
Sbjct: 68 HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 621 -HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEV 677
++HRDL + N+LV VK+ DFGL++L E + GK +WMA E
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 678 LRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ + KSDV+S+GV +WEL T P++ + ++++ + +RL P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVY 241
Query: 737 AIVESCWHSDPQCRPSFQELVDKL----RDLQR 765
++ CW D + RP+F+EL+++ RD QR
Sbjct: 242 MVLVKCWMIDAESRPTFKELINEFSKMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 7e-43
Identities = 89/259 (34%), Positives = 135/259 (52%), Gaps = 12/259 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+LT +++G G G V+ W VA+K + S+E F +E +M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ G T + L IVTEF+ G L L++ KL + M D+ G+ YL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS- 120
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSD 684
IHRDL + N LV VKV DFG++R + T+ +G P +W PEV
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 685 EKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVES 741
KSDV+SFGV++WE+ TE K+P++ ++ +V+ + GF RL PK ++ S
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---RLYRPKLASMTVYEVMYS 236
Query: 742 CWHSDPQCRPSFQELVDKL 760
CWH P+ RP+F EL+ +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 8/254 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
E I E++G+GS G+VY A+ Q VA+KV +E + +E+S++K+ P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
++ + G+ L IV E+ GS+ +++ L + +G+ YLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
IHRD+K+ N+L+++ K+ DFG+S +T T GTP WMAPEV++
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESC 742
+ K+D++S G+ E+A K P+ +++ M+ I + L P+ P + V+ C
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 743 WHSDPQCRPSFQEL 756
DP+ RPS +L
Sbjct: 237 LVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 85/253 (33%), Positives = 135/253 (53%), Gaps = 7/253 (2%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
E+IG+G+ G VY V G+ +VAVK R ++ F QE ++K+ HPN++ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
Q + IV E +P GSL L++ +L ++ + M+LD A G+ YL N IHR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHR 117
Query: 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTP-QWMAPEVLRNEPSDEKSD 688
DL + N LV ++ +K+ DFG+SR + T G K P +W APE L +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 689 VYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747
V+S+G++LWE + P+ +++ Q + R+ P+ ++ CW DP
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 748 QCRPSFQELVDKL 760
+ RPSF E+ ++L
Sbjct: 237 ENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 95/268 (35%), Positives = 147/268 (54%), Gaps = 14/268 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + +++G G G V+ W G+ VAVK S E SF +E +MK+
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 618
LRH + L+ + AV S + + IVTE++ +GSL L+ + L + MA +A G++
Sbjct: 58 LRH-DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
Y+ N IHRDL+S+N+LV K+ DFGL+RL + T + G P +W APE
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
KSDV+SFG++L EL T+ ++P+ +N+ +V+ V G+ R+ P+D
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPIS 231
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRD 762
++ CW DP+ RP+F+ L L D
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-41
Identities = 88/260 (33%), Positives = 138/260 (53%), Gaps = 12/260 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+LT+ ++IG G G V+ W + VA+K S+E F +E +M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
++ G T +C+V EF+ G L L+ K + M LD+ G++YL N
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPS 683
+IHRDL + N LV ++ VKV DFG++R + T+ TG P +W +PEV
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 684 DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVE 740
KSDV+SFGV++WE+ +E K P++N ++ +V+ + GF RL P+ +++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 741 SCWHSDPQCRPSFQELVDKL 760
CW P+ RPSF L+ +L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 76/257 (29%), Positives = 138/257 (53%), Gaps = 25/257 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IG+G+ G VY A + ++VA+K ++ + E+I E+ +MK +HPN++ +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYY 81
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ L +V E++ GSL ++ +N +++ + + ++ +G+ YLH + +IH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQNVIH 139
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-----GTPQWMAPEVLRNEPSD 684
RD+KS N+L+ K +VK+ DFG + LT + K GTP WMAPEV++ +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFA-----AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 685 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP-RWAAI----V 739
K D++S G++ E+A + P+ ++ + F+ IP +P +W+ +
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPPLKNPEKWSPEFKDFL 250
Query: 740 ESCWHSDPQCRPSFQEL 756
C DP+ RPS +EL
Sbjct: 251 NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 93/268 (34%), Positives = 147/268 (54%), Gaps = 14/268 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK+
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 618
LRH L+ + AV S + + IVTE++ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRHEK-LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
KSDV+SFG++L EL T+ ++P+ + + +V+ V G+ R+ P +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 231
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRD 762
++ CW +P+ RP+F+ L L D
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 6e-39
Identities = 87/264 (32%), Positives = 142/264 (53%), Gaps = 18/264 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
++L + + IG+G G V + G++ VAVK +D +F E S+M +LRH N
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIK----NDATAQAFLAEASVMTQLRHSN 60
Query: 565 VLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHH 622
++ +G + + L IVTE++ +GSL L+ R + L + +LD+ + YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
N +HRDL + N+LV + KV DFGL++ E T TGK +W APE LR +
Sbjct: 121 NN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKK 175
Query: 683 SDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIV 739
KSDV+SFG++LWE+ + ++P+ + V+ V G+ +++ P P ++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVYDVM 232
Query: 740 ESCWHSDPQCRPSFQELVDKLRDL 763
+ CWH D RPSF +L ++L +
Sbjct: 233 KQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 87/266 (32%), Positives = 143/266 (53%), Gaps = 10/266 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+E+ E L + +++G G G V+ + G VA+K + S E +F E +LMK+
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 618
L+HP L+ + AV + + + I+TE++ GSL L+ KL + I MA IA G++
Sbjct: 58 LQHPR-LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
++ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ KSDV+SFG++L E+ T +IP+ + + +VI + R+ P +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRD 762
++ CW P+ RP+F+ L L D
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-39
Identities = 85/260 (32%), Positives = 141/260 (54%), Gaps = 18/260 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+ LT+GE IG+G G V + G Q VAVK D +F +E ++M +L H N
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTG-QKVAVKNIK----CDVTAQAFLEETAVMTKLHHKN 60
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHC 623
++ +G + L IV E + +G+L L+ R + + + +LD+A G+ YL
Sbjct: 61 LVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE-- 117
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
+ ++HRDL + N+LV + KV DFGL+R+ +K +W APE L+++
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEALKHKKF 174
Query: 684 DEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVE 740
KSDV+S+GV+LWE+ + + P+ ++ +V V G+ R+E P+ ++
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYVLMT 231
Query: 741 SCWHSDPQCRPSFQELVDKL 760
SCW ++P+ RPSF +L +KL
Sbjct: 232 SCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 8e-39
Identities = 86/265 (32%), Positives = 134/265 (50%), Gaps = 30/265 (11%)
Query: 510 GEQIGQGSCGTVY--HAVWYGSQDVAVKVF----SRQEYSDEVIHSFRQEVSLMKRLRHP 563
G+ +GQG+ G VY + V G +++AVK E EV ++ E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTG-RELAVKQVPFDPDSPETKKEV-NALECEIQLLKNLQHE 64
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGS------LFRLLQRNTTKLDWRRRILMALDIARGV 617
++ + G + + L I E++P GS + L T+ + R+IL GV
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQIL------EGV 117
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLK----HETYLTTKTGKGTPQW 672
YLH + I+HRD+K +N+L D VK+GDFG S RL+ T + + TG TP W
Sbjct: 118 EYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG--TPYW 173
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
M+PEV+ E K+DV+S G + E+ TEK PW +M I + ++P V
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233
Query: 733 PRWAAIVESCWHSDPQCRPSFQELV 757
P + + + + RPS +EL+
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 94/283 (33%), Positives = 147/283 (51%), Gaps = 37/283 (13%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+Q+G+G+ G+V + QD VAVK Q + E + F +E+ ++K L+H N+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 566 LLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ + G S R L +V E+LP GSL LQ++ +LD R+ +L A I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLRN 680
+ +HRDL + N+LV+ VK+GDFGL+++ E Y + G+ W APE L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNS------MQVIG--AVGFM----------- 721
SDV+SFGV+L+EL T + + + M+++G G M
Sbjct: 186 SKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
N RL P AI++ CW++DP RPSF EL ++ ++
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 92/266 (34%), Positives = 144/266 (54%), Gaps = 10/266 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + ++GQG G V+ W G+ VA+K E +F QE +MK+
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKK 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 618
LRH + L+ + AV S + + IVTEF+ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRH-DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
Y+ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
KSDV+SFG++L EL T+ ++P+ + + +V+ V R+ P+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRD 762
+++ CW DP RP+F+ + L D
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 80/260 (30%), Positives = 135/260 (51%), Gaps = 15/260 (5%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
G +IG G+ G VY AV + ++ AVK Q+ + I E+ +++ L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
G +++ I E+ G+L LL + LD + L + G++YLH I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK---GTPQWMAPEVLRNEPSD 684
HRD+K +N+ +D + +K+GDFG + +LK+ T + + GTP +MAPEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 685 EK---SDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAI-- 738
+D++S G ++ E+AT K PW L N Q++ VG + IP +
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDSLQLSPEGKDF 240
Query: 739 VESCWHSDPQCRPSFQELVD 758
++ C SDP+ RP+ EL+
Sbjct: 241 LDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 95/291 (32%), Positives = 150/291 (51%), Gaps = 28/291 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY----GSQD--VAVKVFSRQEYSDEVIHSFRQE 553
+E+ E +T+ ++GQGS G VY G + VAVK + E I F E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-------QRNTTKL--DWR 604
S+MK +V+ +G V+ Q +V E + G L L + N + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
I MA +IA G++YL+ +HRDL + N +V +TVK+GDFG++R +ET K
Sbjct: 120 EMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 665 TGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--- 718
GKG +WMAPE L++ SD++SFGV+LWE+ + + P+ L++ QV+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
G+++Q P + R ++ CW +P+ RP+F E+V+ L+D F
Sbjct: 238 GYLDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 86/257 (33%), Positives = 134/257 (52%), Gaps = 14/257 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
E T+ E IG+GS G VY A+ + VA+KV +E DE I +QE+ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ + G+ +L I+ E+ GS LL+ KLD + ++ G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
IHRD+K++N+L+ + VK+ DFG+S T T GTP WMAPEV++
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA----IV 739
DEK+D++S G+ ELA + P +L+ M+V+ F+ + P +++ V
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVL----FLIPKNNPPSLEGNKFSKPFKDFV 231
Query: 740 ESCWHSDPQCRPSFQEL 756
C + DP+ RPS +EL
Sbjct: 232 SLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 86/281 (30%), Positives = 136/281 (48%), Gaps = 50/281 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLM 557
DYE++ ++IG G+ G VY A + + VA+KV + + +QE+S++
Sbjct: 4 DYELI-------QRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISML 54
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 614
K RHPN++ + G+ +L IV E+ GSL + Q R L L IA
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-------RGPLSELQIAYVC 107
Query: 615 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670
+G++YLH IHRD+K +N+L+ + VK+ DFG+S T K+ GTP
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP 165
Query: 671 QWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 727
WMAPEV R D K D+++ G+ ELA + P +L+ M+ + F+ I
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----FL-----I 216
Query: 728 PKDVDP--------RWAAI----VESCWHSDPQCRPSFQEL 756
K P +W+ + ++ C DP+ RP+ +L
Sbjct: 217 SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 84/264 (31%), Positives = 131/264 (49%), Gaps = 22/264 (8%)
Query: 511 EQIGQGSCGTVYHAVWY---GSQ-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+++G G+ G+V V+ G + +VAVK QE+ F +E S+M +L HP ++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARGVSYLHHCN 624
+G L +V E P G L + L+ R D +A +A G++YL +
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKH 115
Query: 625 PPIIHRDLKSSN-LLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQWMAPEVLRN 680
+HRDL + N LLV++H K+ DFG+SR + Y T G+ +W APE +
Sbjct: 116 --FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 681 EPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
KSDV+S+GV LWE + K P+ + +VI + +RL P++ +I
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAK-PYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSI 230
Query: 739 VESCWHSDPQCRPSFQELVDKLRD 762
+ SCW P+ RP+F EL R
Sbjct: 231 MLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 92/292 (31%), Positives = 141/292 (48%), Gaps = 38/292 (13%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEV 554
EI + E++G+G+ G VY G + VA+K ++ +V FRQE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEA 59
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------T 599
LM L+HPN++ +G T Q C++ E+L G L L RN+ +
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 600 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-- 655
LD + +A+ IA G+ YL HH +HRDL + N LV + TVK+ DFGLSR
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQV 714
+ Y +WM PE + +SD++SFGV+LWE+ + + P+ ++ +V
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 715 IGAVGFM---NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
I M Q L P+D R A++ CW+ P RP F+++ +LR
Sbjct: 236 I----EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 91/263 (34%), Positives = 132/263 (50%), Gaps = 20/263 (7%)
Query: 511 EQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
IG+G G VYH S AVK +R +EV F +E +MK HPNVL
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 567 LFMGAVTSPQRL-CIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
+G + +V ++ G L R N T D I L +A+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETY-LTTKTGKGTP-QWMAPEVL 678
+ +HRDL + N ++D+ +TVKV DFGL+R E Y + TG P +WMA E L
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 679 RNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737
+ + KSDV+SFGV+LWEL T P+ +++S + + +RL P+
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYE 233
Query: 738 IVESCWHSDPQCRPSFQELVDKL 760
++ SCWH P+ RP+F ELV ++
Sbjct: 234 VMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 76/266 (28%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSQDVAVKVFSRQEYSDEVI-HSFRQEVSLMKRLR 561
DL + +GQGS G VY G A+K DE +E+ ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKI-YALKKI--HVDGDEEFRKQLLRELKTLRSCE 57
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL--DIARGVSY 619
P V+ GA + IV E++ GSL LL++ +L + I +G+ Y
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDY 114
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
LH IIHRD+K SNLL++ VK+ DFG+S++ T T GT +M+PE ++
Sbjct: 115 LHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW---- 735
E +D++S G+ L E A K P+ F I P
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQP------SFFELMQAICDGPPPSLPAEE 227
Query: 736 -----AAIVESCWHSDPQCRPSFQEL 756
+ +C DP+ RPS EL
Sbjct: 228 FSPEFRDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 89/281 (31%), Positives = 149/281 (53%), Gaps = 22/281 (7%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQE 553
+E+ E +T+ ++GQGS G VY + G VA+K + E I F E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---------WR 604
S+MK +V+ +G V+ Q ++ E + RG L L+ +++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +ET K
Sbjct: 120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 665 TGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721
GKG +WM+PE L++ SDV+SFGV+LWE+AT + P+ +++ QV+ V
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-ME 236
Query: 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762
L+ P + ++ CW +P+ RPSF E++ +++
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 86/290 (29%), Positives = 139/290 (47%), Gaps = 63/290 (21%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA---------VW----YGSQDVAVKVFSRQEYSDE 545
DYE+L E IG+GS GTV VW YG+ + +E
Sbjct: 1 DYEVL-------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-------MTEKEKQQL 46
Query: 546 VIHSFRQEVSLMKRLRHPNVLLFMG--AVTSPQRLCIVTEFLPRGSLFRLLQR---NTTK 600
V EV++++ L+HPN++ + S Q L IV E+ G L +L+Q+
Sbjct: 47 VS-----EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY 101
Query: 601 LD----WRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDF 650
++ WR IL L +A L+ C ++HRDLK +N+ +D + VK+GDF
Sbjct: 102 IEEEFIWR--ILTQLLLA-----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154
Query: 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 710
GL+++ KT GTP +M+PE L + DEKSD++S G +++EL P+ N
Sbjct: 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
Query: 711 SMQVIGAVGFMNQRLEIPKDVDPRWA----AIVESCWHSDPQCRPSFQEL 756
+Q+ + + + + R++ +++S + DP RPS +EL
Sbjct: 215 QLQLASKI----KEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 82/267 (30%), Positives = 142/267 (53%), Gaps = 9/267 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E + + +++G G G V+ + S VAVK S + +F +E +LMK
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 618
L+H ++ VT + + I+TE++ +GSL L+ + K+ + I + IA G++
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
Y+ N IHRDL+++N+LV + K+ DFGL+R+ + T + G P +W APE
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 678 LRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ KSDV+SFG++L+E+ T KIP+ +++ V+ A+ R+ ++
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763
I+++CW + RP+F L L D
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 73/265 (27%), Positives = 131/265 (49%), Gaps = 32/265 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW------YGSQDVAVKVFSRQEYSDEVIHSFRQ 552
D+EIL +IG+GS G V+ V Y + + + +R+E + +
Sbjct: 1 DFEIL-------NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-----D 48
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRI 607
E ++ +L ++ + + +L IV E+ G L +LL + WR I
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667
+ L G+++LH + I+HRD+KS NL +D + VK+GD G+++L + T
Sbjct: 109 QILL----GLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162
Query: 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE- 726
GTP +++PE+ ++P +EKSDV++ GV+L+E T K P+D N +I + +
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRGVFPP 220
Query: 727 IPKDVDPRWAAIVESCWHSDPQCRP 751
+ + + A +++ C D + RP
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDE--------VIHSFRQEVSLMKRL 560
GE IG+G+ G VY A+ + ++ AVK ++ + R E+ +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
H N++ ++G T+ + L I E++P GS+ L R + + + + G++YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVL 678
H + I+HRDLK+ NLLVD K+ DFG+S+ + Y + +G+ WMAPEV+
Sbjct: 125 H--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 679 RNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ K D++S G ++ E+ + PW + ++ + +G IP DV +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 737 AI----VESCWHSDPQCRPSFQEL 756
+ + +C+ +P RP+ +EL
Sbjct: 243 PVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 74/259 (28%), Positives = 126/259 (48%), Gaps = 17/259 (6%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
D + +++G+GS G+VY +Q A+K S + E+ ++ + HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGV 617
++ + A +LCIV E+ P G L + + + + WR + + + RG+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
LH I+HRDLKS+N+L+ + VK+GD G+S++ + T+ G TP +MAPEV
Sbjct: 117 QALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG--TPHYMAPEV 172
Query: 678 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737
+ P KSD++S G +L+E+AT P+ SMQ + + IP
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231
Query: 738 IVESCWHSDPQCRPSFQEL 756
+ S P+ RP+ ++
Sbjct: 232 FIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 86/280 (30%), Positives = 129/280 (46%), Gaps = 42/280 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
DYE++ E IG G+ VY A+ ++ VA+K ++ V R+EV M
Sbjct: 2 DYELI-------EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAM 53
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 614
+ HPNV+ + + L +V +L GSL ++ K + R L IA
Sbjct: 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM-----KSSYPRGGLDEAIIATVL 108
Query: 615 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTG 666
+G+ YLH + IHRD+K+ N+L+ + +VK+ DFG+S + T KT
Sbjct: 109 KEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 667 KGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-- 723
GTP WMAPEV+ D K+D++SFG+ ELAT P+ M+V M
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQ 221
Query: 724 ----RLEIPKDVDPRWAA---IVESCWHSDPQCRPSFQEL 756
LE D + ++ C DP RP+ +EL
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 89/295 (30%), Positives = 142/295 (48%), Gaps = 47/295 (15%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVF----SRQEYSDEVIHS 549
+E+ + LT+G+ +G+G+ G V A G + VAVK+ + ++ SD V
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV--- 63
Query: 550 FRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN----------- 597
E+ +MK + +H N++ +G T L +V E+ G+L L+
Sbjct: 64 --SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 598 ----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653
L + + A +ARG+ +L + IHRDL + N+LV + +K+ DFGL+
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 654 RLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIP 705
R H KT G P +WMAPE L + +SDV+SFGV+LWE+ T IP
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239
Query: 706 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
+ L + G R+E P++ ++ CWH P RP+F++LV+ L
Sbjct: 240 VEELFKLLKEG------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 34/283 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+ + + ++G+G+ G V+ Y + VAVK ++ S++ F +E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLT 63
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRR 605
+H N++ F G T +V E++ G L + L+ + +L +
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 606 RILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLT 662
+ +A+ IA G+ YL H +HRDL + N LV VK+GDFG+SR + T Y
Sbjct: 124 LLQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 663 TKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 720
P +WM PE + +SDV+SFGV+LWE+ T K PW L++ +VI
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---EC 236
Query: 721 MNQR--LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761
+ Q L+ P+ I+ CW DPQ R + +++ ++L+
Sbjct: 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 84/277 (30%), Positives = 137/277 (49%), Gaps = 25/277 (9%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
L +G+ +G+G G+V SQD VAVK ++ I F E + MK
Sbjct: 1 LKLGKILGEGEFGSVMEGQL--SQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF 58
Query: 561 RHPNVLLFMG------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWRRRILM 609
HPNV+ +G ++ + ++ F+ G L F L R KL + +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGK 667
+DIA G+ YL + N IHRDL + N ++ + TV V DFGLS+ + Y + K
Sbjct: 119 MVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLE 726
+W+A E L + KSDV++FGV +WE+AT + P+ + + ++ + RL+
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLK 235
Query: 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
P+D ++ SCW +DP+ RP+F +L + L ++
Sbjct: 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 85/270 (31%), Positives = 149/270 (55%), Gaps = 16/270 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + +++G G G V+ A + VAVK S + +F E ++MK
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 618
L+H + L+ + AV + + + I+TEF+ +GSL L+ + +K + I + IA G++
Sbjct: 58 LQH-DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
++ N IHRDL+++N+LV K+ DFGL+R+ + T + G P +W APE
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLE-IPKDVDP 733
+ KSDV+SFG++L E+ T +IP+ +++ +VI A+ G+ R E P+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL-- 232
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ ++ CW + P+ RP+F+ + L D
Sbjct: 233 -YNIMMR-CWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 83/274 (30%), Positives = 133/274 (48%), Gaps = 42/274 (15%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQDV------AVKVFSRQEYS----DEVIHSFRQEVSLMKR 559
G+Q+G G+ + Y A +DV AVK + + +EV+ + R+E+ LM R
Sbjct: 5 GQQLGTGAFSSCYQA-----RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIA 614
L HP+++ +GA + E++ GS+ LL + +++ ++L
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL------ 113
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLS-RLKHETYLTTKTGK----- 667
RG+SYLH IIHRD+K +NLL+D +++ DFG + RL T G+
Sbjct: 114 RGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQL 168
Query: 668 -GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN---LNSMQVIGAVGFMNQ 723
GT +MAPEVLR E DV+S G ++ E+AT K PW+ N + +I +
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757
IP+ + P + C P+ RP +EL+
Sbjct: 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-34
Identities = 82/274 (29%), Positives = 138/274 (50%), Gaps = 31/274 (11%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVF----SRQEYSDEVIHSFRQEVSLMK 558
W T GE +G+G+ GTVY + Q +AVK S +++ ++EV L+K
Sbjct: 1 EW---TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARG 616
L+H N++ ++G + I EF+P GS+ +L R + + + LD G
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---G 114
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKG 668
V+YLH+ ++HRD+K +N+++ + +K+ DFG +R H L K+ G
Sbjct: 115 VAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHG 170
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 728
TP WMAPEV+ KSD++S G ++E+AT K P +++ + + +G R +P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG--AHRGLMP 228
Query: 729 KDVDPRWAA----IVESCWHSDPQCRPSFQELVD 758
+ + ++A V SC D RPS +L+
Sbjct: 229 R-LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-34
Identities = 84/267 (31%), Positives = 138/267 (51%), Gaps = 28/267 (10%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQDV-AVKVF-------SRQEYSDEVIHSFRQEVSLMKRLR 561
G IG GS G+VY + S ++ AVK S ++ ++ + +E++L+K L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARG 616
H N++ ++G+ L I E++P GS+ LL T ++ R+IL +G
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL------KG 118
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----- 671
++YLH N IIHRD+K +N+LVD +K+ DFG+S+ L+TKT P
Sbjct: 119 LNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 672 -WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
WMAPEV++ K+D++S G ++ E+ T K P+ + +Q I +G N EIP +
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSN 235
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELV 757
+ +E + D RP+ EL+
Sbjct: 236 ISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 83/256 (32%), Positives = 142/256 (55%), Gaps = 23/256 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IG+GS G VY + +++V A+K+ +E DE I +QE++++ + P + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYY 68
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
G+ +L I+ E+L GS LL+ + + IL +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR--EILKGLDYLH--SERKIH 124
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+K++N+L+ + VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR--------WAAIVES 741
+S G+ ELA + P +L+ M+V+ F+ IPK+ P + VE+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVL----FL-----IPKNSPPTLEGQYSKPFKEFVEA 235
Query: 742 CWHSDPQCRPSFQELV 757
C + DP+ RP+ +EL+
Sbjct: 236 CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 88/275 (32%), Positives = 135/275 (49%), Gaps = 21/275 (7%)
Query: 507 LTIGEQIGQGSCGTVYHAVWY---GS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 562
T+G +G+G G+V A GS Q VAVK+ +S I F +E + MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 563 PNVLLFMGAV---TSPQRLCI---VTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 611
PNV+ +G + RL I + F+ G L F L+ R L + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGT 669
DIA G+ YL N IHRDL + N +++++ TV V DFGLS+ + Y K
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIP 728
+W+A E L + SDV++FGV +WE+ T + P+ + + ++ + RL+ P
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQP 237
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
D ++ CW +P+CRPSFQ L D+L +
Sbjct: 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 85/263 (32%), Positives = 134/263 (50%), Gaps = 16/263 (6%)
Query: 509 IGEQIGQGSCGTVY--HAVWYGSQD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
I E IG G G V G ++ VA+K + Y+++ F E S+M + HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
++ G VT + + I+TEF+ G+L L++N + + + M IA G+ YL N
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-----TYLTTKTGKGTPQWMAPEVLR 679
+HRDL + N+LV+ + KV DFGLSR + TY ++ GK +W APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 680 NEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737
SDV+S+G+++WE+ + E+ WD +++ VI A+ + RL P D
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIE-QDYRLPPPMDCPTALHQ 242
Query: 738 IVESCWHSDPQCRPSFQELVDKL 760
++ CW D RP F ++V L
Sbjct: 243 LMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 87/257 (33%), Positives = 129/257 (50%), Gaps = 16/257 (6%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IG+G+ G V+ VAVK R+ ++ F QE ++K+ HPN++ +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--HCNPPI 627
G T Q + IV E + G L+ +L + I M + A G+ YL HC
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-TYLTTKTGKGTP-QWMAPEVLRNEPSDE 685
IHRDL + N LV + +K+ DFG+SR + + Y +T K P +W APE L
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 686 KSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
+SDV+SFG++LWE + +P+ NL++ Q A+ RL P+ ++E CW
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234
Query: 745 SDPQCRPSF----QELV 757
DP RPSF QEL
Sbjct: 235 YDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 78/254 (30%), Positives = 131/254 (51%), Gaps = 10/254 (3%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
E +G+G+ G V+ VAVK +++ E+ F E ++K+ HPN++ +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
T Q + IV E +P G L++ +L ++ + ALD A G++YL N IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHR 117
Query: 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDV 689
DL + N LV ++ +K+ DFG+SR + + ++ K P +W APE L +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 690 YSFGVILWELATEKI-PWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSD 746
+S+G++LWE + + P+ + + Q V G+ R+ P+ +++ CW
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQRCWDYK 234
Query: 747 PQCRPSFQELVDKL 760
P+ RP F EL +L
Sbjct: 235 PENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 96/295 (32%), Positives = 141/295 (47%), Gaps = 56/295 (18%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD-----------------VAVKVFSRQEYSDEVIHS 549
L E++G+G G V+ G QD VAVKV R + SD
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNARED 65
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----------NTT 599
F +EV ++ RL PN+ +G T LC++ E++ G L + LQ+ N+
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 600 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659
L + + MA IA G+ YL N +HRDL + N LV K++T+K+ DFG+SR
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR---NL 180
Query: 660 YLTT--KTGKGTP---QWMAPE-VLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLN 710
Y + + P +WMA E VL + + KSDV++FGV LWE L E+ P+++L
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQ-PYEHLT 238
Query: 711 SMQVIGAVGFMNQR------LEIPKDVDPRWAAIVE---SCWHSDPQCRPSFQEL 756
QVI G + L P + P+ I E CW D + RP+F+E+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNC-PK--DIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 5e-33
Identities = 84/269 (31%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 513 IGQGSCGTVYH-------AVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+G G+ G VY G VAVK + E F +E LM HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTK----LDWRRRILMALDIARGVSY 619
+ +G + I+ E + G L L+ R L + + + LD+A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 620 LHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR--LKHETYLTTKTGKGTPQW 672
L + IHRDL + N LV D VK+GDFGL+R K + Y G +W
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
MAPE L + +SDV+SFGV++WE+ T + P+ LN+ +V+ V RL+ P++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPENC 238
Query: 732 DPRWAAIVESCWHSDPQCRPSFQELVDKL 760
+ ++ +CW DP RP+F + + L
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 76/268 (28%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 512 QIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPN 564
+G+G G V+ A G ++ V VK Q+ DE + S FR+E+ + ++L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--------RILMALDIARG 616
V+ +G + ++ E+ G L + L+ +K + + ++ + IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAP 675
+ +L N +HRDL + N LV VKV LS+ + + Y + +W+AP
Sbjct: 130 MDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 676 EVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
E ++ + KSDV+SFGV++WE+ T ++P+ L+ +V+ + L +P+ R
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRD 762
++ CW +P+ RPSF ELV L +
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-33
Identities = 84/279 (30%), Positives = 139/279 (49%), Gaps = 36/279 (12%)
Query: 511 EQIGQGSCGTVYHAVWY-----GSQDVAVKVF----SRQEYSDEVIHSFRQEVSLMKRLR 561
E++G+ + G +Y Y +Q VA+K + Q++ + F+QE SLM L
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-----FQQEASLMAELH 65
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--------------QRNTTK--LDWRR 605
HPN++ +G VT Q +C++ E+L +G L L + T K LD
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTK 664
+ +A+ IA G+ YL + +H+DL + N+L+ + VK+ D GLSR + Y +
Sbjct: 126 FLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 665 TGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMN 722
P +WM PE + SD++SFGV+LWE+ + + P+ ++ +VI V
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-KR 242
Query: 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761
Q L +D PR +++ CW P RP F+++ +LR
Sbjct: 243 QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 8e-33
Identities = 71/243 (29%), Positives = 121/243 (49%), Gaps = 13/243 (5%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV--LL 567
+G+GS G V + + A+KV +++ EV H+ E +++ R+ HP + L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+ A + ++L +V E+ P G LF L + + R R A +I + YLH I
Sbjct: 60 Y--AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSLG--I 114
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687
I+RDLK N+L+D +K+ DFGL++ T T GTP+++APEVL + +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747
D +S GV+L+E+ T K P+ + ++ + + L P+ + P ++ DP
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQKDP 232
Query: 748 QCR 750
R
Sbjct: 233 TKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 40/292 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRL-R 561
+D G+ IG+GS TV A + ++ A+K+ +++ E + + E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR----RILMALDIARG 616
HP ++ + L V E+ P G L + +++ + R IL+AL+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE---- 116
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--------- 667
YLH IIHRDLK N+L+DK +K+ DFG +++
Sbjct: 117 --YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 668 -----------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 716
GT ++++PE+L +P+ + SD+++ G I++++ T K P+ N
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
+ + P + P ++E DPQ R E D+L+ +F
Sbjct: 233 KI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK--AHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 82/277 (29%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+G+G G V + + D VAVK R E + +++E++++K L H N+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENI 68
Query: 566 LLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ + G + + L ++ E++P GSL L ++ KL+ + +L A I G++YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH-- 124
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLRN 680
+ IHRDL + N+L+D VK+GDFGL++ HE Y + G W A E L+
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIG-AVGFMN-----------QRLE 726
SDV+SFGV L+EL T + ++IG G M RL
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244
Query: 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
PK+ ++++CW ++ + RP+F+ L+ L+++
Sbjct: 245 CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 84/256 (32%), Positives = 139/256 (54%), Gaps = 23/256 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IG+GS G V+ + +Q V A+K+ +E DE I +QE++++ + P V +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
G+ +L I+ E+L GS LL+ LD + + +I +G+ YLH + IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--SEKKIH 124
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+K++N+L+ +H VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA--------IVES 741
+S G+ ELA + P L+ M+V+ F+ IPK+ P VE+
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVL----FL-----IPKNNPPTLEGNYSKPLKEFVEA 235
Query: 742 CWHSDPQCRPSFQELV 757
C + +P RP+ +EL+
Sbjct: 236 CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 3e-32
Identities = 75/267 (28%), Positives = 121/267 (45%), Gaps = 25/267 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRLRHP-NV 565
I ++G+GS G VY A + VA+KV +++ S F +E+ ++ L HP N+
Sbjct: 3 RILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHC 623
+ L +V E++ GSL LL++ L + + I + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 624 NPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL------KHETYLTTKTGKGTPQWMAPE 676
IIHRD+K N+L+D+ VK+ DFGL++L T GTP +MAPE
Sbjct: 121 G--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 677 VLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
VL + SD++S G+ L+EL T P++ + +Q L+I ++
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS------ATSQTLKIILELPT 232
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKL 760
A S + + +L+ KL
Sbjct: 233 PSLASPLS-PSNPELISKAASDLLKKL 258
|
Length = 384 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 80/256 (31%), Positives = 137/256 (53%), Gaps = 23/256 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IG+GS G V+ + +Q V A+K+ +E DE I +QE++++ + P V +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
G+ +L I+ E+L GS LL+ D + M +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLH--SEKKIH 124
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+K++N+L+ + VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP--------RWAAIVES 741
+S G+ ELA + P +++ M+V+ IPK+ P + +++
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 742 CWHSDPQCRPSFQELV 757
C + DP RP+ +EL+
Sbjct: 236 CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 86/302 (28%), Positives = 146/302 (48%), Gaps = 45/302 (14%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDE 545
L + WE L +G+ +G+G G V A YG + VAVK+ + +D+
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDK 59
Query: 546 VIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-------------- 590
+ E+ LMK + +H N++ +G T L ++ E+ +G+L
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY 119
Query: 591 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649
F + + +L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ D
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIAD 177
Query: 650 FGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------ 701
FGL+R H+ Y T G+ +WMAPE L + +SDV+SFG+++WE+ T
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
Query: 702 EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761
IP + L + G R++ P + ++ CWH+ P RP+F++LV+ L
Sbjct: 238 PGIPVEELFKLLREG------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
Query: 762 DL 763
+
Sbjct: 292 KV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 562
T+ + + +G+ G +++ + ++V VK S+ + QE L+ L H
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSH 67
Query: 563 PNVLLFMGAVTS-PQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIA 614
N+L + + ++ ++ G+L LQ+ N L ++ + MA+ IA
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QW 672
G+SYLH +IH+D+ + N ++D+ VK+ D LSR L Y + P +W
Sbjct: 128 CGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMNQRLEIPK 729
MA E L N+ SDV+SFGV+LWEL T + P+ ++ ++ + G+ RL P
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPI 242
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
+ A++ CW DP+ RPSF +LV L D Q
Sbjct: 243 NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 83/287 (28%), Positives = 143/287 (49%), Gaps = 30/287 (10%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVI 547
L Y++ WE +L+ G+ +G G+ G V A YG VAVK+ +S E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER- 82
Query: 548 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR 605
+ E+ +M L H N++ +GA T + ++TE+ G L L+R L
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTK 664
+ + +A+G+++L N IHRDL + N+L+ VK+ DFGL+R + +++ K
Sbjct: 143 LLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 665 TGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWDNLNSMQVIGA 717
P +WMAPE + N +SDV+S+G++LWE+ + +P D+ +
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI--K 258
Query: 718 VGF-MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
G+ M Q P ++ I+++CW +DP RP+F+++V +
Sbjct: 259 EGYRMAQPEHAPAEI----YDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 83/267 (31%), Positives = 138/267 (51%), Gaps = 16/267 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHP 563
+ I + IG G G V G +++ V + + + Y+++ F E S+M + HP
Sbjct: 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ G VT + + IVTE++ GSL L+++ + + + M IA G+ YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--S 123
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQWMAPEVLRN 680
+ +HRDL + N+LV+ + KV DFGLSR+ E TT+ GK +W APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 681 EPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWA 736
SDV+S+G+++WE+ + E+ W+ +++ VI A+ G+ RL P D
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQDVIKAIEEGY---RLPAPMDCPAALH 239
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763
++ CW D RP F+++V L L
Sbjct: 240 QLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 83/284 (29%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIH-SFRQEVSLMKR 559
WED+ + IG+G+ G V A+ + A+K+ +E++ E H F E+ ++ +
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEVLCK 58
Query: 560 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDW 603
L HPN++ +GA + L I E+ P G+L L+++ + L
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
++ + A D+A G+ YL IHRDL + N+LV ++ K+ DFGLSR E Y+
Sbjct: 119 QQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKK 175
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GF 720
G+ +WMA E L KSDV+SFGV+LWE+ + P+ + ++ + G+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235
Query: 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
R+E P++ D ++ CW P RP F ++ +L +
Sbjct: 236 ---RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 85/262 (32%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 513 IGQGSCGTVYHAVWY--GSQDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG G G V+ + G ++VAV + + + Y+++ F E S+M + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
G VT + I+TE++ G+L + L+ + + + + M IA G+ YL N +H
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVH 130
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTGKGTPQWMAPEVLRNEPSDE 685
RDL + N+LV+ + KV DFGLSR+ + TY TT GK +W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 686 KSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVES 741
SDV+SFG+++WE+ + E+ WD +++ +V+ A+ GF RL P D ++
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQ 245
Query: 742 CWHSDPQCRPSFQELVDKLRDL 763
CW D RP F ++V+ L L
Sbjct: 246 CWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 40/266 (15%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH---PNVL 566
E IG+G+ G VY + VA+K+ + D+V ++EV+L+ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNIT 65
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIARGVSYL 620
+ G+ RL I+ E+ GS+ L++ + + R +L+AL Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVAL------KYI 117
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
H +IHRD+K++N+LV VK+ DFG++ L ++ T GTP WMAPEV+
Sbjct: 118 HKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 681 EPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR----- 734
D K+D++S G+ ++E+AT P+ ++++ + + + IPK PR
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---------MLIPKSKPPRLEDNG 226
Query: 735 WAA----IVESCWHSDPQCRPSFQEL 756
++ V +C +P+ R S +EL
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 86/287 (29%), Positives = 139/287 (48%), Gaps = 40/287 (13%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD-----------------VAVKVFSRQEYSDEVIHS 549
LT E++G+G G V+ G + VAVK+ R++ + +
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARND 65
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----------NTT 599
F +E+ +M RL+ PN++ + + LC++TE++ G L + L R +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 600 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHE 658
+ + I MA IA G+ YL N +HRDL + N LV K++T+K+ DFG+SR L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 659 TYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVI 715
Y + P +WM+ E + SDV++FGV LWE+ T ++ P+ L+ QVI
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
Query: 716 GAVG--FMNQRLEI----PKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
G F +Q ++ P ++ SCW + + RPSFQE+
Sbjct: 244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 84/262 (32%), Positives = 132/262 (50%), Gaps = 15/262 (5%)
Query: 513 IGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+G G+ GTVY +W + VA+KV R+ S + E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 568 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
+G +TS +L VT+ +P G L ++ N ++ + + + IA+G+SYL
Sbjct: 74 LLGICLTSTVQL--VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR-- 129
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSD 684
++HRDL + N+LV VK+ DFGL+RL ET GK +WMA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 685 EKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
+SDV+S+GV +WEL T P+D + + ++ + +RL P I+ CW
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDVYMIMVKCW 248
Query: 744 HSDPQCRPSFQELVDKLRDLQR 765
D +CRP F+ELVD+ + R
Sbjct: 249 MIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 85/295 (28%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+L +G+ +G+G G V A + G VAVK+ S E + E +L+K+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQ 59
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLD-- 602
+ HP+V+ GA + L ++ E+ GSL L+ RN++ LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 603 ------WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656
I A I+RG+ YL ++HRDL + N+LV + +K+ DFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 657 HE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWDN 708
+E +Y+ G+ +WMA E L + +SDV+SFGV+LWE+ T I +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 709 LNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
L ++ G R+E P++ ++ +CW +P RP+F ++ +L +
Sbjct: 238 LFNLLKTG------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-30
Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 24/278 (8%)
Query: 505 EDLTIGEQIGQGSCGTVY----HAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
D+ + ++G+G+ G V+ H + + V V + +E S+ F++E L+ L
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL 64
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------TTKLDWRRR 606
+H +++ F G T + L +V E++ G L R L+ + +L +
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 607 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 666
+ +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR + T G
Sbjct: 125 LAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 667 KGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQ 723
+ P +WM PE + +SD++SFGV+LWE+ T K PW L++ + I + +
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGR 241
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761
LE P+ P AI++ CW +PQ R +++ +L+
Sbjct: 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-30
Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 31/280 (11%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIH-SFRQEVSLMKR 559
W D+ + IG+G+ G V A D A+K +EY+ + H F E+ ++ +
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCK 63
Query: 560 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL---------------FRLLQRNTTKLDW 603
L HPN++ +GA L + E+ P G+L F + + L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 124 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 180
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GF 720
G+ +WMA E L SDV+S+GV+LWE+ + P+ + ++ + G+
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240
Query: 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
RLE P + D ++ CW P RPSF +++ L
Sbjct: 241 ---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 66/256 (25%), Positives = 126/256 (49%), Gaps = 15/256 (5%)
Query: 513 IGQGSCG--TVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
+G+G+ G T+Y S V K + S++ E+ ++ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSL-VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 571 AVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
L I E+ G+L+ +++++ + + I VSY+H I+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILH 124
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+K+ N+ + K +K+GDFG+S++ Y +T GTP +M+PE+ + + KSD+
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDI 184
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA----IVESCWHS 745
++ G +L+EL T K +D N + ++ V + V +++ +V S
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLV--VKIVQGNYT---PVVSVYSSELISLVHSLLQQ 239
Query: 746 DPQCRPSFQELVDKLR 761
DP+ RP+ E++D+
Sbjct: 240 DPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 74/260 (28%), Positives = 132/260 (50%), Gaps = 31/260 (11%)
Query: 513 IGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571
+G+G+ G V+ Q V +K ++ + + + + E ++K L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 572 VTSPQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCN 624
+ L IV E+ P G+L +Q+ T L + +IL+AL H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVHT 119
Query: 625 PPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTK----TGKGTPQWMAPEVLR 679
I+HRDLK+ N+L+DKH V K+GDFG+S++ L++K T GTP +++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCE 174
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737
+P ++KSD+++ G +L+ELA+ K ++ NL ++ + G I P
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQ 231
Query: 738 IVESCWHSDPQCRPSFQELV 757
++ S + DP RP +++
Sbjct: 232 LILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 80/270 (29%), Positives = 138/270 (51%), Gaps = 28/270 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+DL ++G G+ G V + + + AVK R E ++ + +E+ ++ + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSP 59
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARGVSYLH 621
++ F GA + + I E++ GSL ++L+ ++ RIL +A+ + +G++YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLH 117
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKGTPQWMAPEVL 678
IIHRD+K SN+LV+ +K+ DFG+S L KT GT +MAPE +
Sbjct: 118 E-KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-----MQVIGAVGFMNQ---RLEIPKD 730
+ KSD++S G+ L ELAT + P+ N +++ + +N+ RL P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--VNEPPPRL--PSG 227
Query: 731 V-DPRWAAIVESCWHSDPQCRPSFQELVDK 759
P + V C DP+ RPS++EL++
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 67/258 (25%), Positives = 126/258 (48%), Gaps = 30/258 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLR 561
+D + +G GS G V GS A+K+ S+ + +V H E +++ +R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSIR 59
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRR----RILMALDIARG 616
HP ++ G+ L +V E++P G LF L+++ R ++++AL+
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE---- 115
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAP 675
YLH + I++RDLK NLL+D +K+ DFG + R+K TY T GTP+++AP
Sbjct: 116 --YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLAP 167
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDVD 732
E++ ++ + D ++ G++++E+ P+ + N +Q+ I + ++ P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-----LEGKVRFPSFFS 222
Query: 733 PRWAAIVESCWHSDPQCR 750
P ++ + D R
Sbjct: 223 PDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 39/294 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQD---------------VAVKVFSRQEYSDEVIHS 549
+ L + E++G+G G V+ G + VAVK+ R + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARND 63
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QR----------NT 598
F +E+ +M RL++PN++ +G S LC++TE++ G L + L QR N
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 599 TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKH 657
+ + MA+ IA G+ YL N +HRDL + N LV H+T+K+ DFG+SR L
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 658 ETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQV 714
Y + P +WMA E + SDV++FGV LWE+ T ++ P+ L+ QV
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
Query: 715 IGAVG--FMNQRLEIPKDVDPRWAA----IVESCWHSDPQCRPSFQELVDKLRD 762
I G F NQ +I P + ++ CW D + RP+F ++ LR+
Sbjct: 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 7e-29
Identities = 88/293 (30%), Positives = 145/293 (49%), Gaps = 41/293 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFR 551
+E+ LT+G+ +G+G G V A G VAVK+ + + +D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLV 65
Query: 552 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDW------ 603
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +D+
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 604 --------RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
+ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 656 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWD 707
H + Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T IP +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
Query: 708 NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
L + G R++ P + I+ CWH+ P RP+F++LV+ L
Sbjct: 244 ELFKLLKEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 83/293 (28%), Positives = 144/293 (49%), Gaps = 41/293 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD--------VAVKVFSRQEYSDEVIHSFR 551
+E+ + L +G+ +G+G G V A G VAVK+ + + +++ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLI 71
Query: 552 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------- 597
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 598 --TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
+L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 656 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWD 707
H + Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T +P +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 708 NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
L + G R++ P + ++ CWH+ P RP+F++LV+ L
Sbjct: 250 ELFKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 84/293 (28%), Positives = 146/293 (49%), Gaps = 41/293 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFR 551
+E + LT+G+ +G+G G V A G + VAVK+ + + +++ +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV 68
Query: 552 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILM 609
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +++ I
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 610 ALD--------------IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
D +ARG+ YL + IHRDL + N+LV ++ +K+ DFGL+R
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 656 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWD 707
+ + Y T G+ +WMAPE L + +SDV+SFGV++WE+ T IP +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 708 NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
L + G R++ P + ++ CWH+ P RP+F++LV+ L
Sbjct: 247 ELFKLLKEG------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 83/269 (30%), Positives = 130/269 (48%), Gaps = 32/269 (11%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 562
WE IGE +G G+ G VY A A K+ + S+E + F E+ ++ +H
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKH 61
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
PN++ A +L I+ EF G+L ++ L + + + +++LH
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH- 120
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL---- 678
+ +IHRDLK+ N+L+ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 679 -RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP---- 733
++ P D K+D++S G+ L ELA + P LN M+V+ L+I K P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEPPTLDQ 230
Query: 734 --RWAA----IVESCWHSDPQCRPSFQEL 756
+W++ ++SC DP RP+ EL
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 83/268 (30%), Positives = 129/268 (48%), Gaps = 27/268 (10%)
Query: 511 EQIGQGSCGTVYHAVWY---GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
++IG G G V + V VK DE + F QEV + L HPNVL
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRIL--MALDIARGVSYLHHC 623
+G +V EF P G L L+ N ++ +L MA ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTP-QWMAPEVLRNE 681
+ IH DL N + +VK+GD+GL+ ++ E Y TK P +W+APE++
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 682 PSD-------EKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPK---- 729
D +KS+++S GV +WEL T P+ +L+ QV+ V Q +++PK
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLD 236
Query: 730 -DVDPRWAAIVESCWHSDPQCRPSFQEL 756
RW +++ CW DP+ RP+ +E+
Sbjct: 237 LKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 65/208 (31%), Positives = 119/208 (57%), Gaps = 5/208 (2%)
Query: 511 EQIGQGSCGTVYHA-VWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
++IG+GS G +Y A S+ +K + + + ++EV L+ +++HPN++ F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPII 628
+ RL IV E+ G L + + R L +IL + I+ G+ ++H + I+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKIL 123
Query: 629 HRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687
HRD+KS N+ + K+ V K+GDFG++R +++ T GTP +++PE+ +N P + K+
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQVI 715
D++S G +L+EL T K P++ N Q++
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 20/279 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHS-FRQEVS 555
E+ + +T+ +G G+ G VY ++ G + ++ V V + E E S F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL------QRNTTKLDWRRRILM 609
+M + H N++ +G I+ E + G L L + L + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTTKTG 666
A D+A+G YL + IHRD+ + N L+ K+ DFG++R + K G
Sbjct: 122 ARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 667 KGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQ 723
+ P +WM PE + K+DV+SFGV+LWE+ + +P+ + +V+ V
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGGG 238
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762
RL+ PK I+ CW P+ RP+F ++++++
Sbjct: 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 32/265 (12%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPNVLLFMG 570
I +G+ G V+ A + D+ A+KV + + + + E ++ + + P V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD--WRR----RILMALDIARGVSYLHHCN 624
+ + L +V E+LP G L LL N LD R I++AL+ YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALE------YLHSNG 113
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLS------RLKHETYLTTKTGK--GTPQWMAPE 676
IIHRDLK N+L+D + +K+ DFGLS R + + + GTP ++APE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
V+ + + D +S G IL+E P+ ++ + +N ++E P+DV+
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIEWPEDVEVSDE 229
Query: 737 AI--VESCWHSDPQCRP---SFQEL 756
AI + DP+ R S +E+
Sbjct: 230 AIDLISKLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 80/245 (32%), Positives = 129/245 (52%), Gaps = 30/245 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS---QDVAVKVF----SRQEYSDEVIHSFRQEVSLM 557
+ +G+ +G+G+ G VY + Y + +++AVK QE S EV ++ E+ L+
Sbjct: 2 VNWRLGKLLGRGAFGEVY--LCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLL 58
Query: 558 KRLRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILM 609
K LRH ++ + G + P+ +L I E++P GS+ + L N T+ + R+IL
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQIL- 116
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTG 666
+GVSYLH + I+HRD+K +N+L D VK+GDFG S+ ++ K+
Sbjct: 117 -----QGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 667 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 726
GTP WM+PEV+ E K+DV+S + E+ TEK PW +M I + +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM 229
Query: 727 IPKDV 731
+P V
Sbjct: 230 LPDGV 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 513 IGQGSCGTVYHAVWYG---SQD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
IGQG+ G V+ A G + VAVK+ ++E S ++ F++E +LM HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------------------LDWRR 605
+G + +C++ E++ G L L+ + + L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTK 664
++ +A +A G++YL +HRDL + N LV ++ VK+ DFGLSR + Y
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 665 TGKGTP-QWMAPE-VLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFM 721
P +WM PE + N + E SDV+++GV+LWE+ + + P+ + +VI V
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248
Query: 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
N L P + ++ CW P RPSF + R LQR
Sbjct: 249 NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN---RILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 78/256 (30%), Positives = 123/256 (48%), Gaps = 12/256 (4%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572
+G+G+ G VY A +Q V + + E + +E++L L+H N++ ++G+
Sbjct: 16 LGKGTYGIVYAARDLSTQ-VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 573 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR--ILMALDIARGVSYLHHCNPPIIHR 630
+ I E +P GSL LL+ L + I I G+ YLH + I+HR
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHR 132
Query: 631 DLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS--DEKS 687
D+K N+LV+ + VK+ DFG S+ T+T GT Q+MAPEV+ P +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 746
D++S G + E+AT K P+ L Q + VG EIP+ + + C+ D
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD 252
Query: 747 PQCRPSFQELVDKLRD 762
P R S +L L+D
Sbjct: 253 PDKRASAHDL---LQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 73/286 (25%), Positives = 134/286 (46%), Gaps = 47/286 (16%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSQDVAVKVFSRQEYSDEVIHSFRQ----EVSLMK 558
+ I ++IG+G VY A+ G + VA+K E D RQ E+ L+K
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDG-RVVALKKVQIFEMMDA---KARQDCLKEIDLLK 57
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIAR 615
+L HPNV+ ++ + L IV E G L R++ ++ + R + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-----GTP 670
+ ++H + I+HRD+K +N+ + VK+GD GL R + ++KT GTP
Sbjct: 118 ALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTP 170
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLE-- 726
+M+PE + + KSD++S G +L+E+A + P+ D +N + +++E
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-------KKIEKC 223
Query: 727 ----IPKDVDPRWAA----IVESCWHSDPQCRPSFQELVDKLRDLQ 764
+P D ++ +V C + DP+ RP ++ +++
Sbjct: 224 DYPPLPAD---HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 31/206 (15%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHS--FRQEVSLMKRLRH 562
E++G+G+ G VY A +D VA+K R + +E I S R E+SL+K L+H
Sbjct: 5 EKLGEGTYGVVYKA-----RDKKTGEIVALKKI-RLDNEEEGIPSTALR-EISLLKELKH 57
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH- 621
PN++ + + + ++L +V E+ L + L + L + + RG++Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-APE 676
H I+HRDLK N+L+++ +K+ DFGL+R T + W APE
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPE 168
Query: 677 VLRNEPSDEKS-DVYSFGVILWELAT 701
+L + D++S G I E+ T
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 44/279 (15%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 565
+ E IG+G+ G VY A + Q VA+K+ + ++ ++E +++++ HPN+
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 566 LLFMGA------VTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIA 614
F GA + +L +V E GS+ L++ K +W IL +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR--ETL 123
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
RG++YLH +IHRD+K N+L+ K+ VK+ DFG+S T T GTP WMA
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 675 PEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
PEV+ + D +SDV+S G+ ELA K P +++ M+ + +IP+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL---------FKIPR 232
Query: 730 DVDPR------WAA----IVESCWHSDPQCRPSFQELVD 758
+ P W+ + C + + RP +EL++
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 27/269 (10%)
Query: 513 IGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL-RHPNVLL 567
IG+G+ G V A D A+K +EY+ + H F E+ ++ +L HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALD 612
+GA L + E+ P G+L L+++ + L ++ + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQW 672
+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+ G+ +W
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRW 177
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
MA E L SDV+S+GV+LWE+ + P+ + ++ + RLE P +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 732 DPRWAAIVESCWHSDPQCRPSFQELVDKL 760
D ++ CW P RPSF +++ L
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 76/262 (29%), Positives = 130/262 (49%), Gaps = 15/262 (5%)
Query: 513 IGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+G G+ GTVY +W + VA+K R+ S + E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 568 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
+G +TS +L +T+ +P G L ++ + + + + + IA+G++YL
Sbjct: 74 LLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR-- 129
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
++HRDL + N+LV VK+ DFGL++L E + GK +WMA E + +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 685 EKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
+SDV+S+GV +WEL T P+D + + + I ++ +RL P I+ CW
Sbjct: 190 HQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCW 248
Query: 744 HSDPQCRPSFQELVDKLRDLQR 765
D RP F+EL+ + + R
Sbjct: 249 MIDADSRPKFRELIIEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 76/245 (31%), Positives = 117/245 (47%), Gaps = 22/245 (8%)
Query: 532 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLPRGS 589
VAVK + E I ++E+ +++ L H N++ + G T + ++ EFLP GS
Sbjct: 36 VAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 590 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649
L L RN K++ ++++ A+ I +G+ YL +HRDL + N+LV+ VK+GD
Sbjct: 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGD 152
Query: 650 FGLSRL--KHETYLTTKTGKGTPQ-WMAPEVLRNEPSDEKSDVYSFGVILWELATE---- 702
FGL++ + Y T K +P W APE L SDV+SFGV L+EL T
Sbjct: 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212
Query: 703 --------KIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWAAIVESCWHSDPQCRPS 752
K+ M V V + + RL P + ++ CW P R +
Sbjct: 213 SSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT 272
Query: 753 FQELV 757
FQ L+
Sbjct: 273 FQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-27
Identities = 74/260 (28%), Positives = 127/260 (48%), Gaps = 26/260 (10%)
Query: 513 IGQGSCGTV---YHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+GS G V H + +K + + S + QE L+ +L+HPN++ +
Sbjct: 8 VGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 570 GAVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVSYLH 621
+ L IV F G L+ L+ KL +W +I MAL YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLH 119
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
+ I+HRDLK+ N+ + + +KVGD G++R+ T GTP +M+PE+ N+
Sbjct: 120 EKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 682 PSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
P + KSDV++ G ++E+AT K ++ ++NS+ G + +PKD P ++
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELI 234
Query: 740 ESCWHSDPQCRPSFQELVDK 759
+ P+ RPS + ++ +
Sbjct: 235 ATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 59/298 (19%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+IG+G+ G VY A VA+K + S+ + + +E+ L+K L HPN++
Sbjct: 5 GKIGEGTYGVVYKA--RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+ L +V EF+ L++L++ L + +G+++ H I
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--I 119
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQ----WM-APEVLR 679
+HRDLK NLL++ +K+ DFGL+R Y T W APE+L
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--------THYVVTRWYRAPELLL 171
Query: 680 NEPS-DEKSDVYSFGVILWELATEKIPW------DNLNSM-QVIG------------AVG 719
+ D++S G I EL + + + D L + + +G
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231
Query: 720 FMN------QRLEIPK---DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
+ +PK + P+ ++ H DP R + ++ L YF
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA------LAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 79/279 (28%), Positives = 138/279 (49%), Gaps = 22/279 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG---SQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
++ + ++G+G+ G V+ A Y QD + V V + ++ SD F +E L+ L+
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------TTKLDWRRRILM 609
H +++ F G L +V E++ G L + L+ + +L + + +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKG 668
A IA G+ YL + +HRDL + N LV ++ VK+GDFG+SR + T Y
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 669 TP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLE 726
P +WM PE + +SDV+S GV+LWE+ T K PW L++ +VI + + L+
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQ 242
Query: 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
P+ ++ CW +P R + +E+ L++L +
Sbjct: 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 84/267 (31%), Positives = 134/267 (50%), Gaps = 31/267 (11%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEV---IHSFRQEVSLMKRLRH 562
+G+ +GQG+ G VY + Y + +++AVK S E +++ E+ L+K L H
Sbjct: 6 LGKLLGQGAFGRVY--LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 563 PNVLLFMGAVTSPQR--LCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIA 614
++ + G + P L I E +P GS+ + L N T+ + R+IL
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQIL------ 116
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG----KGTP 670
GVSYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG GTP
Sbjct: 117 EGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASK-RLQTICLSGTGMKSVTGTP 173
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
WM+PEV+ E K+D++S G + E+ TEK PW +M I + +P
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELV 757
V ++ + + + RPS EL+
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 91/292 (31%), Positives = 139/292 (47%), Gaps = 45/292 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQ-EYSDEVIHSFRQEVSL 556
D E L+ DL +IG GS G VY A ++ VA+K S + S+E +EV
Sbjct: 12 DPEKLFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA-- 614
+++LRHPN + + G +V E+ L + L+ ++ L ++IA
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAI 120
Query: 615 -----RGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668
+G++YLH H IHRD+K+ N+L+ + TVK+ DFG + L + G
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANSFVG 173
Query: 669 TPQWMAPEVL--RNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL 725
TP WMAPEV+ +E D K DV+S G+ ELA K P N+N+M + + N
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSP 232
Query: 726 EIPKDVDPRWA----AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773
+ + W+ V+SC PQ RPS +EL L+ ++ R
Sbjct: 233 TLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEEL------LKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 64/258 (24%), Positives = 128/258 (49%), Gaps = 19/258 (7%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLRHPNVL----L 567
I + ++Y + + +++V ++ F + + +I E+ ++R+ N+L
Sbjct: 28 IKENDQNSIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPP 626
+ V RL ++ E+ RG L +L L ++ ++ MA+D +G+ L+ + N P
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP 145
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRN--EP 682
+++L S + LV +++ +K+ GL E L++ K + + ++L +
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNFMVYFSYKMLNDIFSE 198
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
K D+YS GV+LWE+ T KIP++NL + ++ + N L++P D IVE+C
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258
Query: 743 WHSDPQCRPSFQELVDKL 760
D RP+ +E++ L
Sbjct: 259 TSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 17/265 (6%)
Query: 513 IGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+G G+ GTVY +W + VA+K+ + + F E +M + HP+++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+G SP + +VT+ +P G L + + + + + + IA+G+ YL +
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--L 130
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDE 685
+HRDL + N+LV VK+ DFGL+RL E GK +WMA E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190
Query: 686 KSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
+SDV+S+GV +WEL T P+D + + ++ + +RL P ++ CW
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVMVKCWM 249
Query: 745 SDPQCRPSFQELVDKL----RDLQR 765
D RP F+EL + RD QR
Sbjct: 250 IDADSRPKFKELAAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 71/313 (22%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA-VWYGSQDVAVKVFSRQEYSDEVIH--SFRQEVSL 556
YE+L +G+G+ G V + VA+K F ++ DE + + R EV +
Sbjct: 3 YEVL-------GVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALR-EVKV 53
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRILMALDIA 614
+++LRH N++ A RL +V E++ R +L LL+ + L R + L
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--L 110
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-------TYLTTKTGK 667
+ ++Y H N IIHRD+K N+LV + +K+ DFG +R Y+ T+
Sbjct: 111 QAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--- 165
Query: 668 GTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEKIPWDNLNS-------MQVIG-- 716
W APE+L + + K DV++ G I+ EL + + + + +G
Sbjct: 166 ----WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221
Query: 717 -----------------AVGFMNQRLEI----PKDVDPRWAAIVESCWHSDPQCRPSFQE 755
A +Q + P V +++C DP+ R + E
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 756 LVDKLRDLQRQYF 768
L LQ YF
Sbjct: 282 L------LQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 14/259 (5%)
Query: 512 QIGQGSCGTV---YHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
++G G+ GTV + + + VAVK+ + +E ++M++L +P ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+G + + +V E G L + LQ+N + + + ++ G+ YL N +
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN--FV 117
Query: 629 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKT-GKGTPQWMAPEVLRNEPSD 684
HRDL + N LLV +H+ K+ DFGLS+ E Y KT GK +W APE +
Sbjct: 118 HRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 685 EKSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
KSDV+SFGV++WE + + P+ + +V + +R+E P+ P +++ CW
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCW 235
Query: 744 HSDPQCRPSFQELVDKLRD 762
RP F + +LR+
Sbjct: 236 TYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 76/241 (31%), Positives = 119/241 (49%), Gaps = 8/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+GS G V A AVKV ++ E H + L+K L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + ++L V +++ G LF LQR L+ R R A ++A + YLH N II+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRAR-FYAAEVASAIGYLHSLN--IIY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D V + DFGL + E TT T GTP+++APEVLR EP D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749
+ G +L+E+ P+ + + Q+ +++ L++P ++ H D +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYD--NILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 750 R 750
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 71/257 (27%), Positives = 128/257 (49%), Gaps = 10/257 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRH 562
L +IG+GS G V A + + VAVK R++ E++ + EV +M+ +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQH 75
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
PN++ + L +V EFL G+L ++ T+++ + + L + + +S+LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH- 132
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+IHRD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+ P
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVES 741
+ D++S G+++ E+ + P+ N +Q + + +L+ V PR + ++
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251
Query: 742 CWHSDPQCRPSFQELVD 758
DP R + EL++
Sbjct: 252 MLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 74/246 (30%), Positives = 121/246 (49%), Gaps = 18/246 (7%)
Query: 513 IGQGSCGTVYHA------VWYGSQDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPN 564
IG+GS G V A +Y AVKV ++ E H + L+K ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFY-----AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
++ + + +L V +++ G LF LQR + + R R A +IA + YLH N
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR-FYAAEIASALGYLHSLN 116
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
II+RDLK N+L+D V + DFGL + E TT T GTP+++APEVLR +P D
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 685 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
D + G +L+E+ P+ + ++ ++ + +N+ L + ++ ++E
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNISVSARHLLEGLLQ 232
Query: 745 SDPQCR 750
D R
Sbjct: 233 KDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 86/281 (30%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQD-----VAVK-----VFSRQEYSDEVIHSFRQEVSL 556
L +G+ +G+G G+V +QD VAVK + +R E D F E
Sbjct: 1 LALGKTLGEGEFGSVMEGQL--NQDDSILKVAVKTMKIAICTRSEMED-----FLSEAVC 53
Query: 557 MKRLRHPNVLLFMG---------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLD 602
MK HPNV+ +G SP ++ F+ G L F L R L
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLP 110
Query: 603 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETY 660
+ + DIA G+ YL + IHRDL + N +++++ V V DFGLS+ + Y
Sbjct: 111 TQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 719
+ K +W+A E L + KSDV+SFGV +WE+AT + P+ + + ++ +
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
N RL+ P D +++ SCW +P+ RPSF+ L +L
Sbjct: 229 QGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 532 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 591
VA+ R SD+ F E + + H N++ G +T + IVTE++ G+L
Sbjct: 36 VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 592 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651
L+++ +L + + M +A G+ YL +H+ L + +LV+ K+ F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 652 -LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDN 708
L K E TT +GK W APE ++ SDV+SFG+++WE+ + E+ WD
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD- 211
Query: 709 LNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
++ VI AV GF RL P++ ++ CW + RP F ++ L
Sbjct: 212 MSGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-26
Identities = 74/253 (29%), Positives = 120/253 (47%), Gaps = 31/253 (12%)
Query: 532 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 591
VAVK+ R + + + F +EV ++ RL+ PN++ +G LC++TE++ G L
Sbjct: 49 VAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 592 RLLQRNTTK------------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 633
+ L + + + + +AL IA G+ YL N +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLA 165
Query: 634 SSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYS 691
+ N LV ++ T+K+ DFG+SR L Y + P +WMA E + SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 692 FGVILWELAT--EKIPWDNLNSMQVIGAVG--FMNQRLEI----PKDVDPRWAAIVESCW 743
FGV LWE+ ++ P+ L QVI G F +Q ++ P ++ CW
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCW 285
Query: 744 HSDPQCRPSFQEL 756
D + RPSF ++
Sbjct: 286 SRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/160 (32%), Positives = 92/160 (57%), Gaps = 15/160 (9%)
Query: 551 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNT-----TKLDW 603
R+EV+++ ++HPN++ + + L IV ++ G L++ + QR LDW
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
+I +AL H + I+HRD+KS N+ + K T+K+GDFG++R+ + T
Sbjct: 107 FVQICLALK--------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK 703
+T GTP +++PE+ N P + KSD+++ G +L+E+ T K
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 82/275 (29%), Positives = 133/275 (48%), Gaps = 29/275 (10%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG---SQD---VAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
D+ + ++G+G+ G V+ A Y ++D VAVK + F++E L+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTN 63
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLDWR 604
L+H +++ F G L +V E++ G L + L+ + +L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTT 663
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR + T Y
Sbjct: 124 QMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 664 KTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFM 721
P +WM PE + +SDV+SFGVILWE+ T K PW L++ +VI +
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-Q 240
Query: 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ LE P+ I+ CW +PQ R + +E+
Sbjct: 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 72/257 (28%), Positives = 127/257 (49%), Gaps = 13/257 (5%)
Query: 509 IGEQIGQGSCGTVY-----HAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ +++G+GS GTVY AV V ++ + +E + + QE L+ +L HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHP 62
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYL 620
++ F + CI+TE+ L L+ L + + + GV Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
H I+HRDLK+ N+ + + +K+GDFG+SRL + T GTP +M+PE L++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740
+ D KSD++S G IL+E+ ++ N + V+ + +P+ + +I++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQ 238
Query: 741 SCWHSDPQCRPSFQELV 757
S + DP RPS E++
Sbjct: 239 SMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 84/265 (31%), Positives = 135/265 (50%), Gaps = 29/265 (10%)
Query: 510 GEQIGQGSCGTVY--HAVWYGSQDVAVKVF---SRQEYSDEVIHSFRQEVSLMKRLRHPN 564
G+ +GQG+ G VY + V G + A +V E S EV + E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQHER 65
Query: 565 VLLFMGAVT--SPQRLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIARG 616
++ + G + + + L I E++P GS+ + L + T+ + R+IL G
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQIL------EG 118
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG----KGTPQW 672
+SYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG GTP W
Sbjct: 119 MSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICMSGTGIRSVTGTPYW 175
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
M+PEV+ E K+DV+S G + E+ TEK PW +M I + ++P +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS 235
Query: 733 PRWAAIVESCWHSDPQCRPSFQELV 757
+ C + + RPS +EL+
Sbjct: 236 EHARDFL-GCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 82/300 (27%), Positives = 136/300 (45%), Gaps = 41/300 (13%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFR 551
DL N EDL +G G+ G+V + V K V
Sbjct: 1 DLRN---------EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQIL 51
Query: 552 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMA 610
+E+ +M R P ++ F GA + +C+ EF+ GSL R+ ++ ++ +I A
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--A 109
Query: 611 LDIARGVSYL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTG 666
+ + G++YL H I+HRD+K SN+LV+ +K+ DFG+S L + T
Sbjct: 110 VAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTF 162
Query: 667 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMNQR 724
GT +M+PE ++ KSDV+S G+ + ELA K P+ N++ +G ++
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222
Query: 725 LEIPKDVDPRWAA---------IVESCWHSDPQCRPSFQELVDKLRDLQRQYF-QASRST 774
+I ++ PR + V++C DP RP+ Q+L F QA R++
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA------MPPFIQALRAS 276
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 72/249 (28%), Positives = 128/249 (51%), Gaps = 8/249 (3%)
Query: 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IGQG+ GTV+ A+ Q+VA+K + Q+ + + E+ +MK L++PN++ F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ L +V E+L GSL ++ T +D + + + + + +LH +IH
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDPQ 748
+S G++ E+ + P+ N N ++ + + L+ P+ + P + + C D +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 749 CRPSFQELV 757
R S +EL+
Sbjct: 259 KRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 30/248 (12%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
E+IGQG+ GTVY A+ + Q+VA+K + +Q+ E+I + E+ +M+ +HPN++ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKHPNIVNY 81
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 137
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 688
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 689 VYSFGVILWELATEKIPWDNLNSMQVIGAVG-------------------FMNQRLEIPK 729
++S G++ E+ + P+ N N ++ + + F+N+ LE+
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM-- 255
Query: 730 DVDPRWAA 737
DV+ R +A
Sbjct: 256 DVEKRGSA 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/258 (26%), Positives = 131/258 (50%), Gaps = 14/258 (5%)
Query: 512 QIGQGSCGTVYHAVWYGSQ---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
++G G+ G V V+ + DVA+KV + E V +E +M +L +P ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+G V + L +V E G L + L ++ + + ++ G+ YL N +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FV 117
Query: 629 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-QWMAPEVLRNEPSD 684
HRDL + N LLV++H+ K+ DFGLS+ ++Y ++ P +W APE +
Sbjct: 118 HRDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 685 EKSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
+SDV+S+G+ +WE + + P+ + +V+ + +RL+ P + P A+++ CW
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCW 235
Query: 744 HSDPQCRPSFQELVDKLR 761
+ RP+F ++ +++R
Sbjct: 236 IYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 84/274 (30%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAV-KVFSRQEYSDEVIHSFRQEVSL 556
LD +WE IGE +G G+ G VY A + +A KV + S+E + + E+ +
Sbjct: 8 LDPNEVWE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEI 62
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWR---RRILMA 610
+ HP ++ +GA +L I+ EF P G++ + L R T+ + R++L A
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670
L YLH + IIHRDLK+ N+L+ +K+ DFG+S +T + GTP
Sbjct: 123 L------QYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 671 QWMAPEV-----LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QR 724
WMAPEV +++ P D K+D++S G+ L E+A + P LN M+V+ +
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 758
L P + +++ P+ RPS +L++
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 89/277 (32%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQ-EYSDEVIHSFRQEVSL 556
D E L+ DL +IG GS G VY A + +V A+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
+++LRHPN + + G +V E+ GS LL+ + L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + GTP WMAPE
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANXFVGTPYWMAPE 181
Query: 677 V---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
V + D K DV+S G+ ELA K P N+N+M + + + E P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSG 237
Query: 734 RWAA----IVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
W+ V+SC PQ RP+ E++ K R + R+
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPT-SEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 85/271 (31%), Positives = 131/271 (48%), Gaps = 23/271 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQ-EYSDEVIHSFRQEVSL 556
D E L+ DL +IG GS G VY A ++ VA+K S + S+E +EV
Sbjct: 22 DPEKLFTDL---REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
++R++HPN + + G +V E+ GS LL+ + L + +G
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
++YLH N +IHRD+K+ N+L+ + VK+ DFG + + + GTP WMAPE
Sbjct: 138 LAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFVGTPYWMAPE 191
Query: 677 V---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
V + D K DV+S G+ ELA K P N+N+M + + + E P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPTLQSN 247
Query: 734 RWA----AIVESCWHSDPQCRPSFQELVDKL 760
W+ V+SC PQ RP+ +EL+ +
Sbjct: 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGT---VYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVS 555
Y +L +G+GS G V H Q A+K R S + R+E
Sbjct: 1 QYNVL-------RVVGEGSFGRALLVQHVN--SDQKYAMKEI-RLPKSSSAVEDSRKEAV 50
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM-ALDIA 614
L+ +++HPN++ F + + L IV E+ G L + ++ KL IL + +
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
GV ++H ++HRD+KS N+ + ++ VK+GDFG +RL T GTP ++
Sbjct: 111 LGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIP-----WDNL 709
PE+ N P + KSD++S G IL+EL T K P W NL
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 73/259 (28%), Positives = 128/259 (49%), Gaps = 24/259 (9%)
Query: 511 EQIGQGSCGTVYHAVWY---GSQDVAVK-VFSR-------QEYSDEVIHSFRQEVSLMK- 558
E +G G+ G VY V G +A+K + + D+ I EV+++K
Sbjct: 6 EHLGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFL---PRGSLFRLLQRNTTKLDWRRRILMALDIAR 615
+LRHPN++ + RL IV + + P G F L+ + R + + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTPQWMA 674
+ YLH I+HRDL +N+++ + V + DFGL++ K E+ LT+ G T +
Sbjct: 125 ALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG--TILYSC 181
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-IPKDV-D 732
PE+++NEP EK+DV++FG IL+++ T + P+ + N + + A + E +P+ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--ATKIVEAVYEPLPEGMYS 239
Query: 733 PRWAAIVESCWHSDPQCRP 751
++ SC D + RP
Sbjct: 240 EDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/252 (26%), Positives = 120/252 (47%), Gaps = 28/252 (11%)
Query: 513 IGQGSCGTVYHAVWYGSQDV--AVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLF 568
+G G G V V S++ A+K ++ + H F E +++ HP ++
Sbjct: 1 LGVGGFGRVE-LVKVKSKNRTFALKCVKKRHIVETGQQEHIF-SEKEILEECNHPFIVKL 58
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYL 620
+ + ++ E+ G L+ +L R R L AR YL
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---------RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
H+ II+RDLK NLL+D + VK+ DFG ++ K ++ T T GTP+++APE++ N
Sbjct: 110 HNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILN 166
Query: 681 EPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
+ D D +S G++L+EL T + P+ D+ + M++ + N +LE P +D +
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226
Query: 739 VESCWHSDPQCR 750
++ +P+ R
Sbjct: 227 IKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 83/268 (30%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 511 EQIGQGSCGTVYHA---VWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
++IG G G V Y V VK E + F +E + L+H N+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRIL--MALDIARGVSYLHHC 623
+G T +V EF P G L L+ R + L MA +IA G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTP-QWMAPEVLRNE 681
N IH DL N L+ TVK+GD+GLS K+ E Y T P +W+APE++
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 682 PSD-------EKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQRLEIPK---- 729
+ ++S+V+S GV +WEL P+ +L+ QV+ Q+L++PK
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPKPRLK 236
Query: 730 -DVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ RW +++ CW P+ RPS +E+
Sbjct: 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
+L + +G G GTV+ +W D VA+K + + + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSL 66
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
H ++ +G L +VT+ P GSL ++++ LD +R + + IA+G+ YL
Sbjct: 67 DHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 621 H-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTPQWMA 674
H ++HR+L + N+L+ V++ DFG++ L K Y KT +WMA
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT---PIKWMA 179
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
E + +SDV+S+GV +WE+ + P+ + +V + +RL P+
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTI 238
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
++ CW D RP+F+EL ++ + R
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 72/246 (29%), Positives = 122/246 (49%), Gaps = 8/246 (3%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+GS G V A + AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + +L V +++ G LF LQR L+ R R A +IA + YLH N I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR-FYAAEIASALGYLHSLN--IVY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D + + DFGL + E TT T GTP+++APEVL +P D D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749
+ G +L+E+ P+ + N+ ++ + +N+ L++ ++ ++E D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 750 RPSFQE 755
R ++
Sbjct: 238 RLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 512 QIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 568
IG G+ G V AV + VA+K S D++I + R +E+ L++ LRH N++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 569 MGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ + P IVTE + L ++++ D + + I RG+ YLH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYLHSA 122
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--HETYLTTKTGKGTPQWM-APEVLRN 680
N +IHRDLK SN+LV+ + +K+ DFGL+R E T +W APE+L +
Sbjct: 123 N--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 681 EPSDEKS-DVYSFGVILWELATEKIPW---DNLNSMQVI 715
K+ D++S G I EL T K + D ++ + +I
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 34/278 (12%)
Query: 511 EQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
E++G+ G VY +G +Q VA+K + + + F+ E + RL+HPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRILMALD------- 612
++ +G VT Q L ++ + L L + D + + L+
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 613 ---IARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTG 666
IA G+ +L HH ++H+DL + N+LV VK+ D GL R + Y
Sbjct: 130 VTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 667 KGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQR 724
P +WM+PE + SD++S+GV+LWE+ + + P+ ++ VI + Q
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQV 244
Query: 725 LEIPKDVDPRWA-AIVESCWHSDPQCRPSFQELVDKLR 761
L P D P W ++ CW+ P RP F+++ +LR
Sbjct: 245 LPCPDDC-PAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 73/254 (28%), Positives = 125/254 (49%), Gaps = 24/254 (9%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH 562
D +GE +G GS G V A G+ + A+K ++E +V H QE S++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGV 617
P ++ M + R+ + EF+ G LF L++ N + +++A +
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----- 132
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 676
YLH + II+RDLK NLL+D VKV DFG + ++ T+ T GTP+++APE
Sbjct: 133 -YLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPE 185
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
V++++ + D ++ GV+L+E P+ + ++ + + RL+ P D R
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPNWFDGRAR 243
Query: 737 AIVESCWHSDPQCR 750
+V+ +D R
Sbjct: 244 DLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 82/267 (30%), Positives = 133/267 (49%), Gaps = 31/267 (11%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 568
E +G G+ G VY + Q A+KV E +E I + E++++K+ H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI---KLEINMLKKYSHHRNIATY 78
Query: 569 MGAVT--SP----QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 619
GA SP +L +V EF GS+ L++ N K DW I +I RG+++
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAH 136
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 137 LHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 680 NEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
+ + D +SD++S G+ E+A P +++ M+ + F+ R PK +
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKLKSKK 250
Query: 735 WA----AIVESCWHSDPQCRPSFQELV 757
W+ +E C + RPS ++L+
Sbjct: 251 WSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMK 558
Y DL +IG G+CG VY + + V AVK R +E ++K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 616
P ++ G + + I E L L +LL+R + IL M + I +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR--IQGPIPEDILGKMTVAIVKA 126
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
+ YL +IHRD+K SN+L+D VK+ DFG+S ++ T++ G +MAPE
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPE 184
Query: 677 VLRNEPSDEK------SDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQ---RLE 726
R +P D +DV+S G+ L ELAT + P+ N + +V+ + + + L
Sbjct: 185 --RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--LQEEPPSLP 240
Query: 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ P + + V+ C D + RP ++EL
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 9e-23
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNV 565
+ +Q+G G+ G+VY A + + VA+K ++ YS +E + + R+ SL K HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNEHPNI 60
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVS 618
+ L V E++ G+L++L++ K +IL L
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA------ 113
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL-----SRLKHETYLTTKTGKGTPQWM 673
++H HRDLK NLLV VK+ DFGL SR + Y++T+ W
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WY 164
Query: 674 -APEV-LRNEPSDEKSDVYSFGVILWELAT 701
APE+ LR+ D+++ G I+ EL T
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 81/267 (30%), Positives = 134/267 (50%), Gaps = 31/267 (11%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 568
E +G G+ G VY + Q A+KV +E I +QE++++K+ H N+ +
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRNIATY 68
Query: 569 MGAVTSPQ------RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 619
GA +L +V EF GS+ L++ NT K +W I +I RG+S+
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSH 126
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 680 NEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
+ + D KSD++S G+ E+A P +++ M+ + F+ R P+ +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPAPRLKSKK 240
Query: 735 WA----AIVESCWHSDPQCRPSFQELV 757
W+ + +ESC + RP+ ++L+
Sbjct: 241 WSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 6/198 (3%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
IG+G+ G V ++ + A+K ++Q+ + + E +++ L HP ++
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
+ + + +V + L G L L + + + + + +I + YLH IIHR
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--IIHR 124
Query: 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVY 690
D+K N+L+D+ V + DF ++ LTT + GTP +MAPEVL + D +
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPGYMAPEVLCRQGYSVAVDWW 183
Query: 691 SFGVILWELATEKIPWDN 708
S GV +E K P+
Sbjct: 184 SLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 56/165 (33%), Positives = 88/165 (53%), Gaps = 4/165 (2%)
Query: 544 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 603
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
R R A +I + YLH C+ +++RDLK NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 708
KT GTP+++APEVL + D + GV+++E+ ++P+ N
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 82/271 (30%), Positives = 126/271 (46%), Gaps = 46/271 (16%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY----SDEVIHSFRQE 553
L+ E WE IGE +G G+ G VY A Q+ V + + S+E + + E
Sbjct: 1 LNPEEFWE--IIGE-LGDGAFGKVYKA-----QNKETGVLAAAKVIDTKSEEELEDYMVE 52
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWRRRILMA 610
+ ++ HPN++ + A L I+ EF G++ + L+R T+ R
Sbjct: 53 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQT 112
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670
L+ ++YLH IIHRDLK+ N+L +K+ DFG+S T + GTP
Sbjct: 113 LE---ALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 671 QWMAPEVL-----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG------ 719
WMAPEV+ ++ P D K+DV+S G+ L E+A + P LN M+V+ +
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 227
Query: 720 -------------FMNQRLEIPKDVDPRWAA 737
F+ + LE K+VD RW
Sbjct: 228 LAQPSRWSSEFKDFLKKCLE--KNVDARWTT 256
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 6/207 (2%)
Query: 544 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 603
DEV H+ E +++ RHP + A + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTV-TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 95
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
R R A +I + YLH + +++RD+K NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 723
KT GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + +
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LME 210
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ P+ + P +++ DP+ R
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-22
Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 34/298 (11%)
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVA 533
S SS S+SSSA L +L +IG G+ GTVY + + + A
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSL------SELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 534 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 593
+KV + D V +E+ +++ + HPNV+ + ++ EF+ GSL
Sbjct: 104 LKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--- 159
Query: 594 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653
T D + +A I G++YLH + I+HRD+K SNLL++ VK+ DFG+S
Sbjct: 160 --EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK-----SDVYSFGVILWELATEKIP--- 705
R+ +T + GT +M+PE + + + D++S GV + E + P
Sbjct: 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
Query: 706 -----WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 758
W +L M I M+Q E P + + C +P R S +L+
Sbjct: 276 GRQGDWASL--MCAIC----MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 71/250 (28%), Positives = 130/250 (52%), Gaps = 10/250 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
E+IGQG+ GTVY A+ + Q+VA+K + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 81
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH--SNQVI 137
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 688
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 689 VYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDP 747
++S G++ E+ + P+ N N ++ + + L+ P+ + + + C D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257
Query: 748 QCRPSFQELV 757
R S +EL+
Sbjct: 258 DRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 80/273 (29%), Positives = 128/273 (46%), Gaps = 40/273 (14%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+D+ E +G G+ GTVY A ++ + AVKV + + E+ E+ ++ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSP 59
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMALDIARGV 617
++ F GA R+ I TEF+ GSL D R+I +A+ + +G+
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGL 108
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
+YL I+HRD+K SN+LV+ VK+ DFG+S + KT GT +MAPE
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPER 164
Query: 678 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN--QRLEIPKDVDP-- 733
+ E SDV+S G+ ELA + P+ Q+ G + Q L+ D DP
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPY-----PQIQKNQGSLMPLQLLQCIVDEDPPV 219
Query: 734 --------RWAAIVESCWHSDPQCRPSFQELVD 758
++ + C P+ RP+ + L+D
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 76/263 (28%), Positives = 135/263 (51%), Gaps = 18/263 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVA-VKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
ED + ++IG G+ G VY A + ++A +KV + D + +QE+ +MK +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ + G+ +L I EF GSL + + T L + ++ + +G+ YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLH-- 123
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL---RN 680
+ +HRD+K +N+L+ + VK+ DFG+S T K+ GTP WMAPEV R
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDP-RWAA- 737
++ D+++ G+ ELA + P +L+ M+ A+ M + + PK D +W+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLKDKMKWSNS 240
Query: 738 ---IVESCWHSDPQCRPSFQELV 757
V+ +P+ RP+ ++L+
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 15/273 (5%)
Query: 492 DLDNDCLDYEILWEDLTIG-EQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQ-EYSDEVIH 548
D + L Y+ E++ +G +IG GS G VY A + ++ VAVK S + ++E
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ 66
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
+EV +++L+HPN + + G +V E+ GS LL+ + L
Sbjct: 67 DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA 125
Query: 609 MALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667
+ +G++YLH H +IHRD+K+ N+L+ + VK+ DFG + +
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFV 178
Query: 668 GTPQWMAPEV---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR 724
GTP WMAPEV + D K DV+S G+ ELA K P N+N+M + + +
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757
+ + V+ C PQ RP+ EL+
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 68/247 (27%), Positives = 123/247 (49%), Gaps = 20/247 (8%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEV-SLM--KRL-----RHP 563
+G+GS G V A G+ ++ AVKV + D ++ +V M KR+ +HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQ--DDDVECTMTEKRVLALAGKHP 56
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ + RL V E++ G L +QR + + D R A +I G+ +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
II+RDLK N+L+D +K+ DFG+ + +TT T GTP ++APE+L +P
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
D ++ GV+L+E+ + P++ + ++ ++ + + P+ + +I++S
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLSKEAKSILKSFL 231
Query: 744 HSDPQCR 750
+P+ R
Sbjct: 232 TKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 1e-21
Identities = 73/265 (27%), Positives = 137/265 (51%), Gaps = 16/265 (6%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
E+IGQG+ GTVY A+ + Q+VA++ + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 82
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 138
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 688
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 689 VYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDP 747
++S G++ E+ + P+ N N ++ + + L+ P+ + + + C D
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 748 QCRPSFQELVDKLRDLQRQYFQASR 772
+ R S +EL LQ Q+ + ++
Sbjct: 259 EKRGSAKEL------LQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDE--VIHSFRQEVSL 556
YE + QIG+G+ G VY A + + VA+K R E E I + R E+ L
Sbjct: 1 YEKI-------AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIR-EIKL 51
Query: 557 MKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDI 613
+++LRHPN++ VTS + + +V E++ L LL K + + + M +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM-KQL 109
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ-- 671
G+ YLH I+HRD+K SN+L++ +K+ DFGL+R Y + T +
Sbjct: 110 LEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVI 163
Query: 672 --WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
W PE+L + D++S G IL EL K
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 5/207 (2%)
Query: 544 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 603
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
R R A +I + YLH +++RDLK NL++DK +K+ DFGL + + T
Sbjct: 96 RARFYGA-EIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 723
KT GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + +
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LME 211
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ P+ + P +++ DP+ R
Sbjct: 212 EIRFPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 36/258 (13%)
Query: 513 IGQGSCGTVYHAVWYGSQD-VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
I +G+ G+VY A + D A+KV + + ++V + + +M + P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+ S L +V E+L G L++ DW ++ ++ GV LH II
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG--II 119
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 688
HRD+K NLL+D+ +K+ DFGLSR L K GTP ++APE + D+ SD
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 689 VYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES--CWHSD 746
+S G +++E G+ E P V + I+ W +
Sbjct: 176 WWSLGCVIFEFLF-----------------GYPPFHAETPDAV---FDNILSRRINWPEE 215
Query: 747 PQ--CRPSFQELVDKLRD 762
+ C P +L+++L
Sbjct: 216 VKEFCSPEAVDLINRLLC 233
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 6/207 (2%)
Query: 544 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 603
DEV H+ E ++K RHP + + + RLC V E++ G LF L R +
Sbjct: 37 DEVAHTL-TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED 95
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
R R A +I + YLH + I++RDLK NL++DK +K+ DFGL + T
Sbjct: 96 RTRFYGA-EIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 723
KT GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + +
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LME 210
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCR 750
++ P+ + +++ DP R
Sbjct: 211 DIKFPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 54/148 (36%), Positives = 89/148 (60%), Gaps = 16/148 (10%)
Query: 620 LHHCNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---GTPQWMAP 675
+HH + +IHRD+KS+N+L+ + VK+GDFG S++ T ++ G+ GTP ++AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYVAP 214
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-----IPKD 730
E+ R +P +K+D++S GV+L+EL T K P+D N +V M++ L +P
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKTLAGRYDPLPPS 268
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVD 758
+ P IV + SDP+ RPS +L++
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLN 296
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 6/190 (3%)
Query: 513 IGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+GS G V A + AVKV ++ + E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + ++L V +F+ G LF LQR + + R R A +IA + YLH N I++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN--IVY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D V + DFGL + TT T GTP+++APEV+R +P D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 690 YSFGVILWEL 699
+ G +L+E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 19/167 (11%)
Query: 607 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 664
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLNSMQVIGAVGFM 721
+ +WMAPE + ++ +SDV+SFGV+LWE L P ++ F
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFC 286
Query: 722 NQ-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ R+ P+ P +I+ CWH++P+ RP+F ELV+ L DL
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 70/266 (26%), Positives = 135/266 (50%), Gaps = 19/266 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVA-VKVFSRQEYSDEVIHSFRQEVSLM 557
DYE++ +++G G+ G VY A + ++A VK+ + D + +QE+ ++
Sbjct: 10 DYELI-------QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMV 60
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 617
K +H N++ + G+ S ++L I E+ GSL + + T L + + + +G+
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQGL 119
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
+YLH + +HRD+K +N+L+ + VK+ DFG++ T K+ GTP WMAPEV
Sbjct: 120 AYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 678 L---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---VIGAVGFMNQRLEIPKDV 731
+N ++ D+++ G+ ELA + P +L+ M+ ++ F +L+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237
Query: 732 DPRWAAIVESCWHSDPQCRPSFQELV 757
+ V+ +P+ RP+ + L+
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 10/249 (4%)
Query: 512 QIGQGSCGTVYHAVW-YGSQDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+IG+GS G V A + + VAVK R++ E++ + EV +M+ H NV+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMY 85
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ L +V EFL G+L ++ T+++ + + L + R +SYLH N +IH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH--NQGVIH 141
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+KS ++L+ +K+ DFG + K+ GTP WMAPEV+ P + D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748
+S G+++ E+ + P+ N +Q + + + R++ V ++ +P
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
Query: 749 CRPSFQELV 757
R + QEL+
Sbjct: 262 QRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-20
Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 19/167 (11%)
Query: 607 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 664
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 177 ICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234
Query: 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLNSMQVIGAVGFM 721
+ + +WMAPE + ++ +SDV+SFGV+LWE L P +N F
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFC 287
Query: 722 NQ-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ R+ P++ P I+ +CW DP+ RP+F LV+ L DL
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 68/260 (26%), Positives = 123/260 (47%), Gaps = 23/260 (8%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 563
+ I ++IG+G VY A + VA+K E D + +E+ L+K+L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 620
NV+ ++ + L IV E G L ++++ + +L R + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
H + ++HRD+K +N+ + VK+GD GL R + GTP +M+PE +
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 681 EPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLE------IPKD-V 731
+ KSD++S G +L+E+A + P+ D +N + Q++E +P +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-------QKIEQCDYPPLPTEHY 233
Query: 732 DPRWAAIVESCWHSDPQCRP 751
+ +V C + DP RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 38/277 (13%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR- 561
WE I E IG+G+ G V+ + AVK+ DE I + E +++K L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA---EYNILKALSD 73
Query: 562 HPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
HPNV+ F G V + +L +V E GS+ L++ + + ++A +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 617 VSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675
+ L H IHRD+K +N+L+ VK+ DFG+S T L T GTP WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 676 EVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
EV+ E D + DV+S G+ EL P +L+ M+ + +IP++
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPRN 244
Query: 731 VDPR------WAA----IVESCWHSDPQCRPSFQELV 757
P W+ + C D + RP+ +L+
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 512 QIGQGSCGTVYHAVWYGS-QDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+IG+GS G V A S + VAVK R++ E++ + EV +M+ +H NV+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMY 83
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ L +V EFL G+L ++ T+++ + + L + + +S LH +IH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLH--AQGVIH 139
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+KS ++L+ VK+ DFG + K+ GTP WMAPE++ P + D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 690 YSFGVILWELATEKIPWDN---LNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 746
+S G+++ E+ + P+ N L +M++I + +L+ V P ++ D
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 747 PQCRPSFQELV 757
P R + EL+
Sbjct: 258 PAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 24/205 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
G+++G+G+ VY A + + VA+K + R+E D + + +E+ L++ L+HP
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVSYL 620
N++ + + +V EF+ L ++++ + L D + +LM L RG+ YL
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYL 118
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-AP 675
H I+HRDLK +NLL+ +K+ DFGL+R ++ + K T Q W AP
Sbjct: 119 HSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNR-KMTHQVVTRWYRAP 171
Query: 676 EVLRNEPSDEKS-DVYSFGVILWEL 699
E+L D++S G I EL
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 69/239 (28%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRH 562
D I Q+GQG G V+ A + + VA+K + +EV H E ++ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKS 60
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLH 621
++ + A + L + E++P G FR L N L R MA ++ V LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
IHRDLK N L+D +K+ DFGLS+ + G+P +MAPEVLR +
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740
D D +S G +L+E P+ + + + + L+ P DPR+ E
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 23/265 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
++G+G+ G+V + + A+K + + ++ +E+ + K + P ++ +
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 570 GAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRIL--MALDIARGVSYLHHC 623
GA + I E+ GSL + ++ K R ++L +A + +G+SYLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKK-VKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
IIHRD+K SN+L+ + VK+ DFG+S + T T GT +MAPE ++ +P
Sbjct: 125 K--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--GTSFYMAPERIQGKPY 180
Query: 684 DEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFM----NQRLEIPKDVDPRWA- 736
SDV+S G+ L E+A + P+ + + I + ++ N L+ +W+
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 737 ---AIVESCWHSDPQCRPSFQELVD 758
++ C DP RP+ ++++
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 511 EQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 568
E+IG+G+ G VY A + VA+K R E DE + S +E+SL+K L HPN++
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMAL-DIARGVSYLHHCNPP 626
+ V S +L +V EFL L + + T LD I L + +G++Y H +
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--SHR 119
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAPEVL 678
++HRDLK NLL+D+ +K+ DFGL+R HE T + APE+L
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--------TLWYRAPEIL 171
Query: 679 RNEPSDEKS-DVYSFGVILWELATEK 703
D++S G I E+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 62/224 (27%), Positives = 115/224 (51%), Gaps = 16/224 (7%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 565
+G+GS G V A G+ ++ A+K+ + D +I E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ RL V E++ G L +Q+ K + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 685
II+RDLK N+++D +K+ DFG+ + TT+T GTP ++APE++ +P +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
D ++FGV+L+E+ + P+D + ++ ++ M + PK
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 607 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 664
I + +A+G+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 182 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQ 723
+ +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
R+ P P + CWH +P RP+F ELV+ L +L
Sbjct: 300 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEV-SLM--KRL-------R 561
+G+G G V A + + ++ A+K + + R EV SLM KR+ R
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA------RDEVESLMCEKRIFETANSER 60
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HP ++ + +C V E+ G L + + R + A + G+ YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV--FSEPRAVFYAACVVLGLQYLH 118
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
I++RDLK NLL+D VK+ DFGL + T T GTP+++APEVL
Sbjct: 119 ENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 682 PSDEKSDVYSFGVILWEL 699
D + GV+++E+
Sbjct: 177 SYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 44/281 (15%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL- 560
WE I E IG+G+ G VY GS AVK+ DE I + E ++++ L
Sbjct: 24 WE---IIETIGKGTYGKVYKVTNKKDGSL-AAVKILDPISDVDEEIEA---EYNILQSLP 76
Query: 561 RHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALD 612
HPNV+ F G + L +V E GS+ L++ +LD +
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQW 672
G+ +LH N IIHRD+K +N+L+ VK+ DFG+S T L T GTP W
Sbjct: 137 ALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194
Query: 673 MAPEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 727
MAPEV+ E D + DV+S G+ EL P +++ ++ + +I
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FKI 245
Query: 728 PKDVDP------RWAA----IVESCWHSDPQCRPSFQELVD 758
P++ P +W + C D + RPS L++
Sbjct: 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 83/272 (30%), Positives = 130/272 (47%), Gaps = 36/272 (13%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDVA---VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
++IG G G V + Y VA VK S E + F Q+ + L+HPN+L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR---IL----MALDIARGVSYL 620
+G +V E+ G L L + W RR +L MA +IA GV+++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE----QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL--SRLKHETYLTTKTGKGTP-QWMAPEV 677
H N +H DL N + TVKVGD+G+ SR K E Y+ T+ K P +W+APE+
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAPEL 172
Query: 678 -------LRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
L + S+V++ GV LWEL P+ +L+ +V+ V +Q++++ K
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLFK 231
Query: 730 -----DVDPRWAAIVESCWHSDPQCRPSFQEL 756
RW +++ CW S P+ R + +E+
Sbjct: 232 PQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 66/245 (26%), Positives = 122/245 (49%), Gaps = 16/245 (6%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 565
+G+GS G V A G+ ++ A+K+ + D VI E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ RL V E++ G L +Q+ + + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 685
II+RDLK N+++D +K+ DFG+ + +TTKT GTP ++APE++ +P +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 745
D ++FGV+L+E+ + P++ + ++ ++ M + PK + AI +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTK 238
Query: 746 DPQCR 750
P R
Sbjct: 239 HPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 70/255 (27%), Positives = 128/255 (50%), Gaps = 20/255 (7%)
Query: 512 QIGQGSCGTVYHAVW-YGSQDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+IG+GS G V A + + VAVK+ R++ E++ + EV +M+ +H NV+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMY 84
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + L ++ EFL G+L ++ + T+L+ + + + + + YLH + +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIH 140
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+ P + D+
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP------KDVDPRWAAIVESCW 743
+S G+++ E+ + P+ + + +Q + + R P + P +E
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDSPPPKLKNAHKISPVLRDFLERML 255
Query: 744 HSDPQCRPSFQELVD 758
+PQ R + QEL+D
Sbjct: 256 TREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 54/294 (18%)
Query: 513 IGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571
+G+GS G V + Q VA+K F E V +E+ ++K+LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 572 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 631
+RL +V EF+ ++ L++ LD R I RG+ + H N IIHRD
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRD 125
Query: 632 LKSSNLLVDKHWTVKVGDFGLSRL------KHETYLTTKTGKGTPQWM-APEVLRNEPSD 684
+K N+LV + VK+ DFG +R + Y+ T+ W APE+L +
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-------WYRAPELLVGDTKY 178
Query: 685 EKS-DVYSFGVILWELATEK--IPWD-NLNSM-QVIGAVG---------------FMNQR 724
++ D+++ G ++ E+ T + P D +++ + +I +G F R
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238
Query: 725 LEIPKDVD------PRWAAIV----ESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
L K+++ P+ + +V + C DP RPS +L L ++F
Sbjct: 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL------LHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 15/256 (5%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKRLR 561
+ I ++IG+G VY A D + + D + R E+ L+K+L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVS 618
HPNV+ + + L IV E G L R+++ + +L + + + + +
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 678
++H + ++HRD+K +N+ + VK+GD GL R + GTP +M+PE +
Sbjct: 121 HMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLEIPKD-VDPRW 735
+ KSD++S G +L+E+A + P+ D +N + + + +P D
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEEL 237
Query: 736 AAIVESCWHSDPQCRP 751
+V C + DP+ RP
Sbjct: 238 RQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 513 IGQGSCGTVYHAVWYGSQD-VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
IG+G+ G VY A S + VA+K V E I S R E++L+ LRHPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73
Query: 571 AVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 627
V + +V E+ + L LL T + + L + RG+ YLH + I
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-APEVLRNEP 682
IHRDLK SNLL+ +K+ DFGL+R TP+ W APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-----KPMTPKVVTLWYRAPELLLGCT 184
Query: 683 SDEKS-DVYSFGVILWELATEK 703
+ + D+++ G IL EL K
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHP 563
D T E+IG+G+ G VY + Q VA+K R E +E + S +E+SL+K L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHP 59
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH- 622
N++ + RL ++ EFL L + L ++ +D SYL+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKG------QYMDAELVKSYLYQI 110
Query: 623 ------CNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGK 667
C+ ++HRDLK NLL+D +K+ DFGL+R HE
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV------- 163
Query: 668 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEK 703
T + APEVL P D++S G I E+AT+K
Sbjct: 164 -TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I +IG+G+ G V+ A + + VA+K + + + + +E+ ++ +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 567 LFMGAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
+ +V E++P + R +R + + + M L GV+Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----W-MAPEVLR 679
I+HRDLK +NLL+ +K+ DFGL+RL + + + Q W APE+L
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 680 NEPS-DEKSDVYSFGVILWEL 699
D D+++ G I EL
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 13/228 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLL 567
+ +G+GS G V+ A G+ Q A+K + D+V + ++ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+ + L V E+L G L +Q + K D R A +I G+ +LH + I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLH--SKGI 117
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687
++RDLK N+L+D +K+ DFG+ + T T GTP ++APE+L + +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
D +SFGV+L+E+ + P+ + ++ F + R++ P PRW
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP--CYPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 40/242 (16%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFR--QEV 554
+ +WE +G G+ G V A + VA+K SR S IH+ R +E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYREL 65
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKL-DWRRRI 607
L+K + H NV+ + T L +VT + L +++ KL D +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK--CQKLSDDHIQF 122
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTK 664
L I RG+ Y+H IIHRDLK SN+ V++ +K+ DFGL+R + Y+ T+
Sbjct: 123 L-VYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 665 TGKGTPQW-MAPEVLRNEPSDEKS-DVYSFGVILWELATEKI------PWDNLNS-MQVI 715
W APE++ N ++ D++S G I+ EL T K D L M ++
Sbjct: 180 -------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232
Query: 716 GA 717
G
Sbjct: 233 GT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 64/243 (26%), Positives = 124/243 (51%), Gaps = 34/243 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFS-------RQEYSDEVIHSFRQEVSL 556
+DL + +G G+ G V+ A+KV + +QE + +H+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE---QHVHN---EKRV 54
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMAL 611
+K + HP ++ + L ++ E++P G LF L+ N+T L + I+ AL
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP 670
+ YLH I++RDLK N+L+DK +K+ DFG ++ L+ T+ T GTP
Sbjct: 115 E------YLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTP 162
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
+++APEV++++ ++ D ++ G++++E+ P+ + N + + + +LE P+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRH 220
Query: 731 VDP 733
+D
Sbjct: 221 LDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 12/243 (4%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSR----QEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+G+GS G V A S + AVKV + Q+ E + ++ +SL + HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+P RL V EF+ G L +Q+ + + D R A +I + +LH + I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLH--DKGI 117
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687
I+RDLK N+L+D K+ DFG+ + TT T GTP ++APE+L+
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747
D ++ GV+L+E+ P++ N + A+ +N + P + I+++ +P
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWLSQDAVDILKAFMTKNP 235
Query: 748 QCR 750
R
Sbjct: 236 TMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 34/211 (16%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPN 564
+IG+G+ GTVY A + VA+K + + S +E++L+K+L HPN
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 565 VLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQR--------NTTKLDWRRRILMAL 611
++ + P+ L +V E + + L L + T K D R++L
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL--- 117
Query: 612 DIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGT 669
RGV +LH H I+HRDLK N+LV VK+ DFGL+R+ E LT+
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---V 168
Query: 670 PQWM-APEVLRNEPSDEKSDVYSFGVILWEL 699
W APEVL D++S G I EL
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 61/241 (25%), Positives = 120/241 (49%), Gaps = 8/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+GS G V A G+ ++ A+K+ + D+V + ++ L + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ RL V E++ G L +Q+ K + + A +I+ G+ +LH II+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG--IIY 124
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+++D +K+ DFG+ + +TT+T GTP ++APE++ +P + D
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749
+++GV+L+E+ + P+D + ++ ++ M + PK + +I + P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 750 R 750
R
Sbjct: 243 R 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 34/258 (13%)
Query: 529 SQDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLP 586
+VA+K+ +E FR+E +L RL HPN V L P L V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 587 RGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 641
+L +L + + R +L LD ++ H N I+HRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAH--NQGIVHRDLKPQNIMVSQTGV 117
Query: 642 HWTVKVGDFGLSRL---KHETYLTTKTGK----GTPQWMAPEVLRNEPSDEKSDVYSFGV 694
KV DFG+ L + + T T GTP + APE LR EP SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 695 ILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD-PRW------AAIVESCWHSDP 747
I E T + + +++ + P DV P W ++ + DP
Sbjct: 178 IFLECLTGQRVVQGASVAEIL-------YQQLSPVDVSLPPWIAGHPLGQVLRKALNKDP 230
Query: 748 QCRP-SFQELVDKLRDLQ 764
+ R S L ++ R L+
Sbjct: 231 RQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 57/180 (31%), Positives = 91/180 (50%), Gaps = 25/180 (13%)
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 667
+A+ I + + YLH +IHRD+K SN+L++++ VK+ DFG+S YL K
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKT 161
Query: 668 ---GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAV 718
G +MAPE + E + D KSDV+S G+ + ELAT + P+D+ + Q+ V
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 719 GFMNQRLEIPKD-VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 777
+ +L P + P + V C + + RP++ EL LQ +F+ S D
Sbjct: 222 EEPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPEL------LQHPFFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH- 562
EDL +IG+G+ GTV + S + AVK R ++ ++ ++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRIL--MALDIARGVS 618
P ++ F GA+ I E L SL + + L IL +A+ + ++
Sbjct: 63 PYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 619 YL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK----GTPQ 671
YL IIHRD+K SN+L+D++ +K+ DFG+S L K G
Sbjct: 122 YLKEELK----IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRP 172
Query: 672 WMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFMNQRL- 725
+MAPE + + D +SDV+S G+ L+E+AT K P+ NS+ Q+ V L
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232
Query: 726 -EIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
++ P + + C D RP ++EL
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 13/243 (5%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+GS G V +Q + R+ + EV H+ E +++ ++ P ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTL-AERTVLAQVNCPFIVPLK 59
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ SP++L +V F+ G LF LQR R R A ++ + LH N +I+
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKFN--VIY 116
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D + + DFGL +L + T T GTP+++APE+L + D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 690 YSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747
++ GV+L+E+ T P+ +N+N M + + L P D ++ DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMY----RKILQEPLRFPDGFDRDAKDLLIGLLSRDP 232
Query: 748 QCR 750
R
Sbjct: 233 TRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
P V + +R ++ + +L+ + LD + + +A+G+S+L
Sbjct: 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS 232
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRN 680
N IHRDL + N+L+ K+ DFGL+R +++++ K P +WMAPE + N
Sbjct: 233 KN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 681 EPSDEKSDVYSFGVILWELAT------EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
+SDV+S+G++LWE+ + +P D+ ++I G+ R+ P+
Sbjct: 291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKE-GY---RMLSPECAPSE 345
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKL 760
I++SCW +DP RP+F+++V +
Sbjct: 346 MYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQD---VAVKVFSRQEY--SDEVIHSFRQEVSLMK 558
+ED +G GS G V A Y ++D VA+K F + + +V H F E ++
Sbjct: 29 YEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILN 86
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
+ HP + G+ L +V EF+ G F L+RN + A I
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFE 145
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 678
YL N I++RDLK NLL+DK +K+ DFG +++ +T T T GTP+++APE+L
Sbjct: 146 YLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DT--RTYTLCGTPEYIAPEIL 200
Query: 679 RNEPSDEKSDVYSFGVILWEL 699
N + +D ++ G+ ++E+
Sbjct: 201 LNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 6/138 (4%)
Query: 571 AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
A + LC+V + G L + + R I A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVY 118
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 688
RDLK N+L+D H V++ D GL+ LK K GTP +MAPEVL+ E D D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 689 VYSFGVILWELATEKIPW 706
++ G L+E+ + P+
Sbjct: 177 WFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 6/201 (2%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+GS G V A G+ +V A+KV + D+V + ++ L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ RL V E++ G L +QR + K D R A ++ + +LH +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG--VIY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D K+ DFG+ + +TT T GTP ++APE+L+ D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 690 YSFGVILWELATEKIPWDNLN 710
++ GV+++E+ + P++ N
Sbjct: 180 WALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 513 IGQGSCGTV---YHAVWYGSQDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLL 567
IG G+ G V Y V Q+VA+K SR V H+ R +E+ LMK + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRP--FQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 568 FMGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
+ T PQ+ + +V E + +L +++Q + LD R + + G+ +L
Sbjct: 80 LLNVFT-PQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL 134
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
H + IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 135 H--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILG 191
Query: 681 EPSDEKSDVYSFGVILWELATEKI 704
E D++S G I+ E+ +
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLR 561
+D + + IG+G+ G V+ + V A+KV + + +++ H R E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59
Query: 562 HPNVL-LFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRR----RILMALDIAR 615
P ++ L+ + + L +V E++P G L LL R + + R +++ALD
Sbjct: 60 SPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-------------RLKHETYLT 662
+ + IHRD+K N+L+D +K+ DFGL H
Sbjct: 119 KLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 663 TKTGK----------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 698
GTP ++APEVLR P + D +S GVIL+E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 65/247 (26%), Positives = 123/247 (49%), Gaps = 19/247 (7%)
Query: 513 IGQGSCGTVYHAVWYGSQDV----AVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRHPNVL 566
+GQGS G V+ D A+KV + + D V + E ++ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV--RTKMERDILAEVNHPFIV 61
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
A + +L ++ +FL G LF L + + + +A ++A + +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG-- 118
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
II+RDLK N+L+D+ +K+ DFGLS+ + + GT ++MAPEV+ +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 687 SDVYSFGVILWELATEKIPW---DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
+D +SFGV+++E+ T +P+ D +M +I + +L +P+ + P +++ + +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-----LKAKLGMPQFLSPEAQSLLRALF 233
Query: 744 HSDPQCR 750
+P R
Sbjct: 234 KRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 67/258 (25%), Positives = 123/258 (47%), Gaps = 27/258 (10%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFM 569
IG+GS V ++ + A+KV ++ + DE I + E + + HP ++
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ RL V EF+ G L +QR KL + +I+ +++LH II+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 690 YSFGVILWELATEKIPWDNLNS------------MQVIGAVGFMNQRLEIPKDVDPRWAA 737
++ GV+++E+ + P+D + QVI + +++ IP+ + + ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-----LEKQIRIPRSLSVKASS 234
Query: 738 IVESCWHSDPQ----CRP 751
+++ + DP+ C P
Sbjct: 235 VLKGFLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY---SDEVIHSFRQEVSLMKRL 560
ED + + IG+G+ G V SQ V A+K+ S+ E SD F +E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARG 616
P V+ A + L +V E++P G L L+ W + +++ALD
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 160
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTPQWMAP 675
+ +IHRD+K N+L+DKH +K+ DFG ET + T GTP +++P
Sbjct: 161 MG--------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 676 EVLRNEPSD----EKSDVYSFGVILWELATEKIPW 706
EVL+++ D + D +S GV L+E+ P+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-16
Identities = 29/96 (30%), Positives = 47/96 (48%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204
+ D RI+Y N +A L GY+ EE LG+ +L G D + + ++ G +
Sbjct: 3 VLDPDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGGEVEVE 62
Query: 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ K E V+ + +P D+DG +VGIV + D
Sbjct: 63 LELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRD 98
|
Length = 101 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 30/252 (11%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMKR------LRHPNV 565
+G+GS G V A G+ + A+K + D V+ E ++++R HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK----DVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ + L V E+L G L +Q ++ + D R A +I G+ +LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHKKG- 116
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRNEPS 683
II+RDLK N+L+DK +K+ DFG+ K K GTP ++APE+L+ +
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW-----AAI 738
+E D +SFGV+L+E+ + P+ + ++ F + + P PRW
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPH--FPRWISKEAKDC 226
Query: 739 VESCWHSDPQCR 750
+ + DP R
Sbjct: 227 LSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 49/224 (21%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFR--QEVSL 556
Y+ + E IG G+ G V A+ S + VA+K D + R +E+ +
Sbjct: 7 YKPI-------ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAKRTLRELKI 57
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-------LLQRNTTKLDWRRRILM 609
++ +H N++ I P G+ F+ L++ + + + L
Sbjct: 58 LRHFKHDNII------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 610 A-------LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------K 656
+ RG+ Y+H N +IHRDLK SNLLV++ +++GDFG++R +
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 657 HETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 699
H+ ++T T + APE+L + P D++S G I E+
Sbjct: 164 HKYFMTEYV--ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 50/280 (17%)
Query: 513 IGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 569
+G G+ G V A Q+VA+K + +S V+ ++R E+ L+K LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 570 GAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
SP + + VTE L L RLL + L+ + I RG+ Y+H ++
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG--VV 130
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLK--HET-YLTTKTGKGTPQWMAPEV-LRNEPSD 684
HRDLK SN+L++++ +K+ DFGL+R++ T Y++T+ + APE+ L + D
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR------YYRAPEIMLTWQKYD 184
Query: 685 EKSDVYSFGVILWELATEK--IPW-DNLNSMQVI------------------GAVGFMN- 722
+ D++S G I E+ K P D++N +I + F+
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
Query: 723 --QRLEIP-----KDVDPRWAAIVESCWHSDPQCRPSFQE 755
+R +P K+ DP ++E DPQ R S E
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HP ++ + RL V E++ G L +QR KL + +I+ ++YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH 113
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
II+RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E
Sbjct: 114 ERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNS------------MQVIGAVGFMNQRLEIPK 729
D ++ GV+++E+ + P+D + S QVI + +++ IP+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----LEKQIRIPR 226
Query: 730 DVDPRWAAIVESCWHSDPQCR 750
+ + A++++S + DP+ R
Sbjct: 227 SLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 509 IGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQ-------------EV 554
G +G+G+ G V A + VA+K E S++V RQ E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKD-RQLVGMCGIHFTTLREL 71
Query: 555 SLMKRLRHPNVLLFMGAV---TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
+M ++H N+ MG V + +V + + L +++ R + + + ++ L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-L 126
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP 670
I G++ LH +HRDL +N+ ++ K+ DFGL+R + Y T + T
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 671 Q------------WM-APEVLRN-EPSDEKSDVYSFGVILWELATEK 703
Q W APE+L E D++S G I EL T K
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 513 IGQGSCGTVYHAVWYGSQD-VAVK----VFSRQEYSDEVIHSFR--QEVSLMKRLRHPNV 565
IG+G+ G V A + + VA+K F D I + R +E+ L++ L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF------DNRIDAKRTLREIKLLRHLDHENV 66
Query: 566 LLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
+ + P R + IV E L L ++++ + T D + + + RG+ Y+
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYI 124
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET------YLTTKTGKGTPQWMA 674
H N ++HRDLK SNLL++ + +K+ DFGL+R E Y+ T+ + A
Sbjct: 125 HSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR------WYRA 176
Query: 675 PEVLRNEPSDEKS---DVYSFGVILWELATEK 703
PE+L N E + DV+S G I EL K
Sbjct: 177 PELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 47/234 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFR------ 551
DYEIL ++G+G+ G VY A + VA+K ++H+ +
Sbjct: 9 DYEIL-------GKLGEGTFGEVYKARQIKTGRVVALKKI--------LMHNEKDGFPIT 53
Query: 552 --QEVSLMKRLRHPNV--LLFMGAVTSPQ----RLCI--VTEFLPRGSLFRLLQRNTTKL 601
+E+ ++K+L+HPNV L+ M + R + VT ++ L LL+ + KL
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKL 112
Query: 602 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661
+ L + G++YLH N I+HRD+K++N+L+D +K+ DFGL+R
Sbjct: 113 TESQIKCYMLQLLEGINYLH-ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 662 TTKTGKG-----------TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 703
K G G T + PE+L E + D++ G + E+ T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 23/242 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSR-QEYSDEVIHSFRQEVSLMKRLRH 562
+D + +G+G G V + D+ A+KV + + E + F +E ++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD------WRRRILMALDIARG 616
P + A L +V E+ P G L LL R + D + +++A+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAP 675
+ Y +HRD+K N+L+D+ +K+ DFG + RL + +K GTP ++AP
Sbjct: 121 MGY--------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 676 EVLRNEPSDEKS------DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
EVL D K D +S GVI +E+ + P+ S + + + L+ P+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE 232
Query: 730 DV 731
D
Sbjct: 233 DP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 66/225 (29%), Positives = 117/225 (52%), Gaps = 11/225 (4%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH--PNVLL 567
IG+G+ G VY ++ + A+KV S++E EV H+ + L++ L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+ + L +VT+++ G LF LQ+ + R + +A ++ + +LH + I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--I 117
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687
++RDLK N+L+D + + DFGLS+ TT T GT +++APEVL +E K
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 688 -DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
D +S GV+++E+ P+ ++ Q+ + F R PK+V
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--PKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRL 560
IG+G+ G V A + VA+K F Q + + R E+ +++R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC---QRTLR-EIKILRRF 60
Query: 561 RHPNVLLFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 615
+H N++ + + P + IV E + L++L++ T L I R
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILR 117
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTP 670
G+ Y+H N ++HRDLK SNLL++ + +K+ DFGL+R+ H +LT T
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV--ATR 173
Query: 671 QWMAPEVLRNEPSDEKS-DVYSFGVILWEL 699
+ APE++ N K+ D++S G IL E+
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 35/273 (12%)
Query: 511 EQIGQGSCGTVYHAVW-------YGSQDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRLRH 562
E +GQG+ +Y V V V + SD +F + SLM +L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYL 620
+++ G V +V E++ G L L R L W+ + L A + YL
Sbjct: 61 KHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASALHYL 117
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYLTTKTGKGTPQWM 673
+ ++H ++ N+LV ++ +K+ D G+ T L+ + W+
Sbjct: 118 E--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERIPWI 171
Query: 674 APEVLRNEPS--DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
APE +RN + +D +SFG L E+ + + P L+S + F + +P
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQDQHRLPMP 228
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
A ++ CW DP RPSF+ LRDL
Sbjct: 229 DCAELANLINQCWTYDPTKRPSFR---AILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 49/292 (16%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
IG+ + + VAVK + S E + +QE+ ++L+HPN+L +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL---DIARGVSYLHHCNP 625
+ + L +V+ + GS LL+ + + + +A D+ + Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG- 121
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDF--GLSRLKH-----ETYLTTKTGKGTPQWMAPEVL 678
IHR +K+S++L+ V + +S +KH + K+ W++PEVL
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 679 RNEPS--DEKSDVYSFGVILWELA---------------TEKI-------------PWDN 708
+ +EKSD+YS G+ ELA EK+ P
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 709 LNSMQVIGAVGFMN--QRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ Q + N ++ P + + VE C DP+ RPS +L
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 15/159 (9%)
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP- 670
+ARG+ +L N +HRDL + N+L+ + VK+ DFGL+R + H++ +K P
Sbjct: 246 VARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQ-----R 724
+WMAPE + + SDV+S+G++LWE+ + P+ + I F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM-----IVDSTFYNKIKSGYR 358
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ P I+ CW+S+P+ RPSF L D + L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 66/252 (26%), Positives = 124/252 (49%), Gaps = 17/252 (6%)
Query: 513 IGQGSCGTVYHA-VWYGSQDVAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 569
IG+GS V + Q A+KV ++ + DE I + E + ++ +P ++
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ RL +V E++ G L +QR KL A +I +++LH II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 690 YSFGVILWELATEKIPWD------NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
++ GV+++E+ + P+D ++N+ + V + + + IP+ + + + +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFL 238
Query: 744 HSDPQ----CRP 751
+ DP+ C+P
Sbjct: 239 NKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 568
E+IG+G+ GTV+ A + + VA+K R + DE + S +E+ L+K L+H N++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
+ S ++L +V E+ + L + +D + +G+++ H N ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VL 121
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAPEVLRN 680
HRDLK NLL++K+ +K+ DFGL+R E T + P+VL
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--------TLWYRPPDVLFG 173
Query: 681 EPSDEKS-DVYSFGVILWELATEKIP 705
S D++S G I ELA P
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 23/228 (10%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY---SDEVI 547
D N D + ED + + IG+G+ G V ++ V A+K+ S+ E SD
Sbjct: 30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 548 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-- 605
F +E +M P V+ A + L +V E++P G L L+ W R
Sbjct: 90 --FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 147
Query: 606 --RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLT 662
+++ALD + + IHRD+K N+L+DK +K+ DFG ++ E +
Sbjct: 148 TAEVVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199
Query: 663 TKTGKGTPQWMAPEVLRNEPSD----EKSDVYSFGVILWELATEKIPW 706
T GTP +++PEVL+++ D + D +S GV L+E+ P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 38/230 (16%)
Query: 513 IGQGSCGTVYHAVWYGS-QDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL---- 566
+G GS G V+ AV + VAVK + S V H+ R E+ +++RL H N++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 567 -LF---------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
L +G++T + IV E++ L +L++ + R L + RG
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHAR--LFMYQLLRG 126
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRL-----KHETYLTTKTGKGTP 670
+ Y+H N ++HRDLK +N+ ++ V K+GDFGL+R+ H+ YL+
Sbjct: 127 LKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL---VT 181
Query: 671 QWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK--IPWDN-LNSMQVI 715
+W +P +L + + K+ D+++ G I E+ T K + L MQ+I
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-15
Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 22/156 (14%)
Query: 553 EVSLMKRLRHPNVL-----LFMGAVTSPQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRR 605
E L++ + HP+V+ L GA+T C+V LP L+ L + + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAIT-----CMV---LPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTT 663
+++ I G+ YLH IIHRD+K+ N+ ++ V +GD G ++ + +L
Sbjct: 159 ALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 699
GT + APEVL + + K+D++S G++L+E+
Sbjct: 217 ---AGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E+IG+G+ G VY A + + VA+K ++ V + +E+SL+K L HPN++ +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 570 GAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
+ + +L +V EFL + + L + L L +G+++ H + +
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH--SHRV 121
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EPSDE 685
+HRDLK NLL++ +K+ DFGL+R + T T + W APE+L +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 686 KSDVYSFGVILWELATEK 703
D++S G I E+ T +
Sbjct: 181 AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 513 IGQGSCGTV---YHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG G+ G V Y AV ++VA+K SR + +E+ LMK + H N++ +
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCN 624
T PQ+ + EF + L+ N +LD R + + G+ +LH
Sbjct: 83 NVFT-PQK--SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 140 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYK 196
Query: 685 EKSDVYSFGVILWELATEKI 704
E D++S G I+ E+ KI
Sbjct: 197 ENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 12/192 (6%)
Query: 578 LCIVTEFLPRGSL-FRL--LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634
LC+V + G L + + + R I G+ +LH II+RDLK
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKP 125
Query: 635 SNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 694
N+L+D V++ D GL+ + TK GTP +MAPE+L+ E D D ++ GV
Sbjct: 126 ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGV 185
Query: 695 ILWELATEKIPW----DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
L+E+ + P+ + + + ++ + +N + P P + E+ DP+ R
Sbjct: 186 TLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALLAKDPEKR 243
Query: 751 PSFQ-ELVDKLR 761
F+ D LR
Sbjct: 244 LGFRDGNCDGLR 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 67/246 (27%), Positives = 114/246 (46%), Gaps = 33/246 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEY---SDEVIHSFRQEVSLMKRL 560
ED + + IG+G+ G V S+ V A+K+ S+ E SD F +E +M
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHA 100
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARG 616
++ A + L +V E++P G L L+ W R +++ALD
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAP 675
+ + IHRD+K N+L+DK +K+ DFG ++ + T GTP +++P
Sbjct: 161 MGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
Query: 676 EVLRNEPSD----EKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVG-FMNQR--LE 726
EVL+++ D + D +S GV L+E+ P+ D+L +G M+ + L
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSLT 267
Query: 727 IPKDVD 732
P D++
Sbjct: 268 FPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 511 EQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 568
E+IG+G+ G VY A ++ +A+K R E DE + S +E+SL+K ++H N++
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--RILMAL--DIARGVSYLHHCN 624
V S +RL +V E+L L + + D+ + R++ I RG++Y H +
Sbjct: 67 QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--S 120
Query: 625 PPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAP 675
++HRDLK NLL+D+ +K+ DFGL+R HE T + AP
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--------TLWYRAP 172
Query: 676 EVLRNEPS-DEKSDVYSFGVILWELATEK 703
E+L D++S G I E+ +K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 8/192 (4%)
Query: 511 EQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E++G+GS TVY + Q VA+KV S + + V + +E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + + L V E++ L + + ++ L L + RG++Y+H + I+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILH 126
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 687
RDLK NLL+ +K+ DFGL+R K T + T + P+VL +D S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA-TDYSSAL 185
Query: 688 DVYSFGVILWEL 699
D++ G I E+
Sbjct: 186 DIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-14
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP- 670
+A G+ +L N +HRDL + N+L+ + VK+ DFGL+R + ++ +K P
Sbjct: 248 VANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
+WMAPE + N SDV+SFG++LWE+ T P+ L + R+ P
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPA 365
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
I++ CW + RP F +LV + DL
Sbjct: 366 HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 551 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWR 604
+ E ++++ ++HP ++ + A + +L ++ E+L G LF L+R +T +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YL 106
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
I +AL+ +LH II+RDLK N+L+D VK+ DFGL + T
Sbjct: 107 SEISLALE------HLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR 724
T GT ++MAPE+L + D +S G +++++ T P+ N + I + + +
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--LKGK 216
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCR 750
L +P + P +++ +P R
Sbjct: 217 LNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+++G+G+ TV+ +++ VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + + L +V E+L L + L + + + RG+SY H I+H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK--RKILH 126
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 687
RDLK NLL+++ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYSTP 184
Query: 688 -DVYSFGVILWELAT 701
D++ G IL+E+AT
Sbjct: 185 IDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 513 IGQGSCGTV---YHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG G+ G V Y A+ ++VA+K SR + +E+ LMK + H N++ +
Sbjct: 32 IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 570 GAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
T PQ+ + IV E + +L +++Q +LD R + + G+ +LH
Sbjct: 90 NVFT-PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS 144
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 145 AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMG 201
Query: 683 SDEKSDVYSFGVILWELATEKI 704
E D++S G I+ E+ +
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 511 EQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 568
E++G+G+ TVY + VA+K ++E S +E+SLMK L+H N++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRL 63
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRILMALDIARGVSYLHHCNPP 626
+ + +L +V E++ L + + + + LD + +G+++ H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
++HRDLK NLL++K +K+ DFGL+R T T + AP+VL +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 687 S-DVYSFGVILWELAT 701
S D++S G I+ E+ T
Sbjct: 181 SIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 66/263 (25%), Positives = 120/263 (45%), Gaps = 23/263 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
+++G+G+ G+VY + + R E + + E+ ++ + P ++ F G
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL----DWRRRILMALDIARGVSYLHHCNPP 626
A + + E++ GSL +L D RRI A + +G+ +L
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE-EHN 123
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDE 685
IIHRD+K +N+LV+ + VK+ DFG+S + KT G +MAPE +++ P+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 686 -----KSDVYSFGVILWELATEKIPW-----DNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
+SDV+S G+ + E+A + P+ N+ + Q+ V L P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QLSAIVDGDPPTL--PSGYSDDA 238
Query: 736 AAIVESCWHSDPQCRPSFQELVD 758
V C + P RP++ +L++
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIH--SFRQEVSLMKRLRHPNVLL 567
+IG+GS G V+ + Q VA+K F E D VI + R E+ ++K+L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALR-EIRMLKQLKHPNLVN 64
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---WRRRILMALDIARGVSYLHHCN 624
+ ++L +V E+ ++ L++N + ++ I L V++ H N
Sbjct: 65 LIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQ---AVNFCHKHN 120
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
IHRD+K N+L+ K +K+ DFG +R+
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 511 EQIGQGSCGTVYHA-VWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
E++G+GS TVY + VA+KV QE + R E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + + L +V E++ L + + ++ L L + RG+SY+H I+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ--RYILH 126
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 687
RDLK NLL+ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTC 184
Query: 688 -DVYSFGVILWEL 699
D++ G I E+
Sbjct: 185 LDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 69/248 (27%), Positives = 116/248 (46%), Gaps = 22/248 (8%)
Query: 513 IGQGSCGTVYHAVWYGSQD-VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+GS G V A G + AVK + D+V + ++ L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + L V EFL G L +Q + + D R A +I G+ +LH + II+
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLH--SKGIIY 119
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWMAPEVLRNEPSDEKS 687
RDLK N+++D+ +K+ DFG+ K + + T GTP ++APE+L+
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA-----IVESC 742
D +SFGV+L+E+ + P+ + ++ F + R++ P PRW I+E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTPH--YPRWITKESKDILEKL 230
Query: 743 WHSDPQCR 750
+ DP R
Sbjct: 231 FERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 70/278 (25%), Positives = 127/278 (45%), Gaps = 46/278 (16%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD--------VAVKVF--SRQEYSDEVIHSFRQEVSLMKRL 560
E +GQG+ ++ + D V +KV S + YS+ SF + S+M +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE----SFFEAASMMSQL 56
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY- 619
H +++L G +V E++ GSL L++N ++ I L++A+ +++
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN----ISWKLEVAKQLAWA 112
Query: 620 LHHC-NPPIIHRDLKSSNLLV-----DKHWT---VKVGDFGLSRLKHETYLTTKTGKGTP 670
LH + + H ++ + N+L+ K +K+ D G+S T L +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS----ITVLPKEILLERI 168
Query: 671 QWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIP 728
W+ PE + N + +D +SFG LWE+ + P L+S + + F R ++P
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLP 225
Query: 729 KDVDPRW---AAIVESCWHSDPQCRPSFQELVDKLRDL 763
P+W A ++ C +P RPSF+ ++ RDL
Sbjct: 226 A---PKWTELANLINQCMDYEPDFRPSFRAII---RDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+++G+GS TVY + VA+K + + R E SL+K L+H N++
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + + L +V E+L L + + L L + RG++Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLH 126
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG---TPQWMAPEVLRNEPSDEK 686
RDLK NLL+ + +K+ DFGL+R K + +KT T + P+VL S E
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVVTLWYRPPDVLLG--STEY 181
Query: 687 S---DVYSFGVILWELAT 701
S D++ G I +E+AT
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 83/337 (24%), Positives = 136/337 (40%), Gaps = 90/337 (26%)
Query: 512 QIGQGSCG--TVYHA--VWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+IG+G C +VY A G+ V V++ + ++E + + + EV L RHPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTL-VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMT 63
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWRRRILMALDIARGVSYLH 621
T+ L +++ F+ GS LL+ + + IL RG++YLH
Sbjct: 64 SWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI---GNILFG--ALRGLNYLH 118
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT------PQ---- 671
IHR++K+S++L+ V + GLS L Y + G+ PQ
Sbjct: 119 QNG--YIHRNIKASHILISGDGLVSLS--GLSHL----YSLVRNGQKAKVVYDFPQFSTS 170
Query: 672 ---WMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNL----------------- 709
W++PE+LR + + KSD+YS G+ ELAT ++P+ ++
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230
Query: 710 -------------------------NSMQVIGAVGFMN-QRLEIP--KDVDPRWAAIVES 741
S+ G M +RL P K P + +VE
Sbjct: 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290
Query: 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 778
C DP+ RPS L L +F+ + S
Sbjct: 291 CLQQDPEKRPSASSL------LSHAFFKQVKEQTQGS 321
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
E++G+G+ TV+ ++++ R E+ + + +EVSL+K L+H N++
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
V + + L +V E+L + L + + + + I RG++Y H ++HR
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RRKVLHR 128
Query: 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS--- 687
DLK NLL+++ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYSTQI 186
Query: 688 DVYSFGVILWELAT 701
D++ G I +E+A+
Sbjct: 187 DMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-13
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 34/183 (18%)
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLT-------- 662
I + Y+H + ++HRDLK N+L+ V + D+G + K E L
Sbjct: 122 ICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 663 ------TKTGK--GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 714
T GK GTP +MAPE L P+ E +D+Y+ GVIL+++ T P+ ++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 715 IGAVGFMNQRLEIP------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
+ P +++ P + I DP R + V +L+ +
Sbjct: 240 S-----YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER--YSS-VQELKQDLEPHL 291
Query: 769 QAS 771
Q S
Sbjct: 292 QGS 294
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 43/153 (28%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGK 667
+ +A+G+ +L N IHRD+ + N+L+ K+ DFGL+R + Y+ +
Sbjct: 218 SSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNL---NSMQVIGAVGFMNQ 723
+WMAPE + + +SDV+S+G++LWE+ + K P+ + + + G+
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
R P P +I++ CW+ +P RP+F ++
Sbjct: 336 R---PDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+D ++G G+ G V + S + + E + + +E+ ++ P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI----LMALDIA--RGVS 618
++ F GA S + I E + GSL ++L++ RI L + IA RG++
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLRGLT 113
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 678
YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L
Sbjct: 114 YLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERL 170
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIP 705
+ +SD++S G+ L E+A + P
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 50/192 (26%), Positives = 95/192 (49%), Gaps = 4/192 (2%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
+++G+G+ TVY + ++ R E+ + + +EVSL+K L+H N++
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
+ + + L +V E+L + L + L ++ L + RG++Y H ++HR
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR--RKVLHR 128
Query: 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDV 689
DLK NLL+++ +K+ DFGL+R K T T + P++L + D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 690 YSFGVILWELAT 701
+ G I +E++T
Sbjct: 189 WGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 551 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 608
R E +++ +R P ++ A + +L ++ +++ G LF L QR R+
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVY 110
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 667
+A +I + +LH II+RD+K N+L+D V + DFGLS+ +L + +
Sbjct: 111 IA-EIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERA 163
Query: 668 ----GTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPW---DNLNSMQVIGAV 718
GT ++MAPEV+R D+ D +S GV+ +EL T P+ NS I +
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-SR 222
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ + PK + ++ DP+ R
Sbjct: 223 RILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+D ++G G+ G V S + + E + + +E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR---RILMALDIA--RGVSY 619
++ F GA S + I E + GSL ++L+ + +R IL + IA RG++Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK------EAKRIPEEILGKVSIAVLRGLAY 118
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
L I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 119 LRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQ 175
Query: 680 NEPSDEKSDVYSFGVILWELATEKIP 705
+SD++S G+ L ELA + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 46/225 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEV----IH 548
+YE L +I +G+ G VY A +D VA+K + + E I
Sbjct: 6 EYEKL-------NRIEEGTYGVVYRA-----RDKKTGEIVALK---KLKMEKEKEGFPIT 50
Query: 549 SFRQEVSLMKRLRHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 604
S R E++++ +L+HPN++ + +G ++ ++ +V E++ L L++
Sbjct: 51 SLR-EINILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS 106
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-----LKHET 659
+ L + GV++LH I+HRDLK+SNLL++ +K+ DFGL+R LK T
Sbjct: 107 EVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT 164
Query: 660 YLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEK 703
L T + APE+L D++S G I EL T+K
Sbjct: 165 QLVV-----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 497 CLD-YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSQDVAVKVFSRQEYSDEVIHSFRQE 553
C+D ++I+ QIG+G+ G VY A G KV E I + R E
Sbjct: 5 CVDKFDII-------GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-E 56
Query: 554 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL-- 611
+ ++++L H N++ VT Q +F F L+ ++ LM L
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQD---ALDFKKDKGAFYLV------FEYMDHDLMGLLE 107
Query: 612 ----------------DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655
+ G++Y H N +HRD+K SN+L++ +K+ DFGL+RL
Sbjct: 108 SGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 656 KHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
+ T K W PE+L E + DV+S G IL EL T+K
Sbjct: 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 611
E +++++ P ++ A S LC+V + G L + + L+ R I +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTP 670
I G+ +LH + I++RD+K N+L+D ++ D GL+ LK +T + G T
Sbjct: 103 QITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG--TN 158
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 708
+MAPE+L+ EP D ++ G ++E+ + P+ +
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 612
E++ M +L+HPN++ +G S + ++ E++ +L +L RN L W RR +A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-RN---LSWERRRKIAIG 788
Query: 613 IARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG-TP 670
IA+ + +LH C+P ++ +L +++D D RL L T T +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISS 842
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 707
++APE + EKSD+Y FG+IL EL T K P D
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 25/217 (11%)
Query: 513 IGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 569
+G G+ G+V A + VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 570 GAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
T + L +VT + G+ + + D + L+ I RG+ Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-E 681
+ IIHRDLK SNL V++ +K+ DFGL+R + TG +W APE++ N
Sbjct: 140 D--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWM 193
Query: 682 PSDEKSDVYSFGVILWELATEKIPW---DNLNSMQVI 715
++ D++S G I+ EL T + + D+++ +++I
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 8/203 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+D ++G G+ G V+ S + + E + + +E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--RGVSYLHH 622
++ F GA S + I E + GSL ++L++ ++ +IL + IA +G++YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIP--EQILGKVSIAVIKGLTYLRE 121
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGTH 178
Query: 683 SDEKSDVYSFGVILWELATEKIP 705
+SD++S G+ L E+A + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 511 EQIGQGSCGTVYHAV--WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568
+Q+G G+ GTV A+ G++ VA+K R S+ +E+ L+K ++H NV+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAK-VAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 569 MGAVTSPQRLCIVTEF---LP-RGS-LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ T L +F +P G+ L +L++ KL R + + +G+ Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-E 681
IIHRDLK NL V++ +K+ DFGL+R + TG +W APEV+ N
Sbjct: 138 G--IIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILNWM 191
Query: 682 PSDEKSDVYSFGVILWELATEKIPW---DNLNSMQVI 715
+ D++S G I+ E+ T K + D+L+ + I
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 611
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 671
+I G+ LH I++RDLK N+L+D H +++ D GL+ E T K GT
Sbjct: 110 EICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVG 166
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
+MAPEV++NE D ++ G +L+E+ + P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-12
Identities = 55/219 (25%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 551 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QRNTTKLDWRR---- 605
R E+ + H ++ S +L ++ E+ G L + + QR L ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 606 ----RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661
+I++ALD +H + ++HRDLKS+N+ + +K+GDFG S+ ++ +
Sbjct: 173 LLFYQIVLALD------EVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSV 223
Query: 662 TTKTGK---GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV 718
+ GTP ++APE+ + +K+D++S GVIL+EL T P+ + +++ V
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757
+ P V A+++ +P RP+ Q+L+
Sbjct: 284 LYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR--GSLFRLLQRNTTKLDWRRRI--- 607
E +++ + HP+++ G T + C++ LPR L+ L +R I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA-------KRNIAIC 182
Query: 608 -LMALD--IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
++A++ + R + YLH IIHRD+K+ N+ ++ V +GDFG + +
Sbjct: 183 DILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 665 TG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 701
G GT APE+L +P D++S G++L+E+AT
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 512 QIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLL 567
+IG G+ GTVY A S VA+K Q D + S +EV+L+KRL HPN++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 568 FMGAVTSPQ-----RLCIVTEFLP---RGSLFRL----LQRNTTKLDWRRRILMALDIAR 615
M + + ++ +V E + R L ++ L T K D R+ L R
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK-DLMRQFL------R 119
Query: 616 GVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
G+ +LH +C I+HRDLK N+LV VK+ DFGL+R+ + + T + A
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRA 175
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEK 703
PEVL D++S G I E+ K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 512 QIGQGSCGTVYHAVW---YGSQDVAVKVF-SRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
IG+G+ G VY A ++ A+K F +E + S +E++L++ L+H NV+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 568 FMGAVTSPQRLCI--VTEFLP----------RGSLFRLLQRNTTK-LDWRRRILMALDIA 614
+ + + ++ R + + + K L W+ I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKG-- 668
GV YLH + ++HRDLK +N+LV + VK+GD GL+RL +
Sbjct: 119 NGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 669 -TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELAT 701
T + APE+L K+ D+++ G I EL T
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 60/193 (31%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 513 IGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571
IG G+ G V A +VAVK SR + +E+ L+K + H N++ +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 572 VTSPQRLCIVTEFLPRGSLFRLLQRNTTK-----LDWRRRILMALDIARGVSYLHHCNPP 626
T PQ+ + EF + L+ N + LD R + + G+ +LH
Sbjct: 89 FT-PQK--SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG-- 143
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
IIHRDLK SN++V T+K+ DFGL+R ++ T T + APEV+ E
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY-VVTRYYRAPEVILGMGYKEN 202
Query: 687 SDVYSFGVILWEL 699
D++S G I+ EL
Sbjct: 203 VDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 513 IGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571
+G+G+ G V +++ VA+K F E ++EV + +E+ +++ L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 572 VTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNP-PII 628
+L +V E++ + ++ LL+ N + R + L + +H C+ I+
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQL-----IKAIHWCHKNDIV 122
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS 687
HRD+K NLL+ + +K+ DFG +R E T +W +PE+L P +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 688 DVYSFGVILWELA 700
D++S G IL EL+
Sbjct: 183 DMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 34/168 (20%)
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR------ 615
+P V+ + + + LC+V E++ G LL +N L +D+AR
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGAL--------PVDMARMYFAET 110
Query: 616 --GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--------HETYLTTKT 665
+ YLH N I+HRDLK NLL+ +K+ DFGLS++ +E ++ T
Sbjct: 111 VLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 666 GK-------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
+ GTP+++APEV+ + + D ++ G+IL+E +P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 32/219 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVK-VFSRQEYSDEVIHSFRQEVSLM 557
YEIL +++G+G+ G V+ A+ +++ VA+K +F + + +FR E+ +
Sbjct: 9 YEIL-------QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFL 60
Query: 558 KRLR-HPNV--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+ L HPN+ LL + + + + +V E++ L +++ N + +R I+ L
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMYQL--L 117
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP---- 670
+ + Y+H N +IHRDLK SN+L++ VK+ DFGL+R + + P
Sbjct: 118 KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTD 171
Query: 671 ----QWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
+W APE+L K D++S G IL E+ K
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLR 561
+E L IGQG+ G V+ A ++ VA+K V E I + R E+ +++ L+
Sbjct: 14 YEKLAK---IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK 69
Query: 562 HPNVLLFMGAVTSPQR--------LCIVTEFLPRGSLFRLLQRNTTKLDW---RRRILMA 610
H NV+ + + +V EF L LL K ++ + M
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG-- 668
L+ G+ Y+H I+HRD+K++N+L+ K +K+ DFGL+R + +K K
Sbjct: 129 LN---GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNR 179
Query: 669 ------TPQWMAPEVLRNEPS-DEKSDVYSFGVILWELAT 701
T + PE+L E D++ G I+ E+ T
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 513 IGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLL 567
+G G+ G+V A Y + Q VAVK SR S +IH+ R +E+ L+K ++H NV+
Sbjct: 23 VGSGAYGSVCSA--YDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIG 78
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCN 624
+ T + E +L N K L + + RG+ Y+H
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EP 682
IIHRDLK SN+ V++ +++ DFGL+R + TG +W APE++ N
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNWMH 192
Query: 683 SDEKSDVYSFGVILWELATEKI 704
++ D++S G I+ EL K
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-11
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 1/109 (0%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
IL+S+ + + D RI+Y N +AE L G S EE +G+ ++L+ + D +VA
Sbjct: 1 EDLRAILESLPDGIFVVDEDGRILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAE 60
Query: 190 DIVHRIKMGERW-TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
+ + GE + + V +P D G + G + V
Sbjct: 61 LLRQALLQGEESRGFEVSFRVPDGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 23/199 (11%)
Query: 516 GSCGTVYHAVWY--GSQDVAV-KVFSRQEYS-DEV-IHSFRQEVSLMKRLRHPNVLLFMG 570
G G V V +Q + V K+ + ++ E +H LMK +PN +
Sbjct: 27 GKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPMVHQ------LMKD--NPNFIKLYY 76
Query: 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
+VT+ + ++ +++ G LF LL++ KL + + ++ LH N IIH
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHN 133
Query: 631 DLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
D+K N+L D+ + + D+GL ++ T GT + +PE ++ D D
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKIIG----TPSCYDGTLDYFSPEKIKGHNYDVSFDW 189
Query: 690 YSFGVILWELATEKIPWDN 708
++ GV+ +EL T K P+
Sbjct: 190 WAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 611
E +++++ V+ A + LC+V + G L F + D R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 671
+I G+ LH I++RDLK N+L+D + +++ D GL+ ++ T + GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVG 166
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
+MAPEV++NE D + G +++E+ K P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 511 EQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLF 568
+ +G+G G V+ G+ + A+KV ++E + E ++ L HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRR----RILMALDIARGVSYLH 621
+ + LC+V ++ P G LFRLLQR K + R +L+AL+ YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE------YLH 120
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK------------- 667
I++RDLK N+L+ + + + DF LS + E +K +
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 668 ---------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 699
GT +++APEV+ + D ++ G++L+E+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 2/103 (1%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKM 197
+ V + DL RI+Y N +AE L GYS EE +G+ ++L+ D + + + + +
Sbjct: 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLI-HPEDREELRERLENLLSG 59
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
GE T + + K + V+ + TP D+ G ++G++ V D
Sbjct: 60 GEPVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 551 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 608
R E +++ +R P ++ A + +L ++ +++ G LF L QR + + +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQI 109
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 667
+ +I + +LH II+RD+K N+L+D + V + DFGLS+ + + +
Sbjct: 110 YSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK----EFHEDEVERA 163
Query: 668 ----GTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVG 719
GT ++MAP+++R D+ D +S GV+++EL T P+ D + Q +
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ P+++ I++ DP+ R
Sbjct: 224 ILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 58/238 (24%), Positives = 109/238 (45%), Gaps = 16/238 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 562
ED I + IG+G+ G V + V A+K+ ++ E FR+E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 619
+ A L +V ++ G L LL + +L D R L + IA V
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVL 678
LH+ +HRD+K N+L+D + +++ DFG +L + + + GTP +++PE+L
Sbjct: 121 LHY-----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 679 RNEPSDE-----KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
+ + + D +S GV ++E+ + P+ + ++ G + +R + P V
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 513 IGQGSCGTVYHAVWYGSQD---VAVK----VFSRQEYSDEVIHSFRQEVSLMKRLR-HPN 564
+GQG+ G V A + + VA+K VFS++ + + +E+ L++ R H N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRHFRGHKN 63
Query: 565 V--LLFMGAVT-SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
+ L M V + E L L +++ R+ L I G+ Y+H
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---TGKGTPQWM-APEV 677
N ++HRDLK NLLV+ +K+ DFGL+R E T +W APE+
Sbjct: 123 SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 678 LRNEPSDEKS-DVYSFGVILWEL 699
+ + S K+ DV+S G IL EL
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 532 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 591
V V+ + + ++E++ + E+ + K HPN++ + + L +VT F+ GS
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87
Query: 592 RLLQRNTTKLDWRRRILMA---LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 648
L+ T +D + +A + + + Y+HH +HR +K+S++L+ V +
Sbjct: 88 DLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLS 143
Query: 649 DF--GLSRLKHETYLTT-----KTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWEL 699
LS + H L K W++PEVL+ + D KSD+YS G+ EL
Sbjct: 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203
Query: 700 ATEKIPWDNLNSMQVI 715
A +P+ ++ + Q++
Sbjct: 204 ANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 512 QIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
Q+G G+ G+V A+ + + VA+K SR S+ +E++L+K ++H NV+ +
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 571 AVTSPQRLCIVTEF-LPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
TS +F L + LQ+ L + + + G+ Y+H II
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--II 139
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS 687
HRDLK NL V++ +K+ DFGL+R H TG +W APEV+ N ++
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR--HAD--AEMTGYVVTRWYRAPEVILNWMHYNQT 195
Query: 688 -DVYSFGVILWELATEK 703
D++S G I+ E+ T K
Sbjct: 196 VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 46/218 (21%)
Query: 512 QIGQGSCGTVYHAV--WYGSQDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
IG G+ G V+ G + VA+K VF V FR E+ ++ +H NV
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKR-VALKKMPNVFQNLVSCKRV---FR-ELKMLCFFKHDNV 61
Query: 566 LLFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA-------LDI 613
L + + P + + +VTE L+Q + K+ + L + I
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTE---------LMQSDLHKIIVSPQPLSSDHVKVFLYQI 112
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------KHETYLTTKTGK 667
RG+ YLH I+HRD+K NLLV+ + +K+ DFGL+R+ KH T
Sbjct: 113 LRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV---- 166
Query: 668 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKI 704
T + APE+L D++S G I EL +I
Sbjct: 167 -TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 512 QIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPN 564
+IG+G+ V A Q A+K + S E +++ R E+ ++RL HPN
Sbjct: 6 KIGEGTFSEVLKA-----QSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPN 59
Query: 565 VLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
+L + + RL +V E L +L+ L++ L +R + + + ++H
Sbjct: 60 ILRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFG-----LSRLKHETYLTTKTGKGTPQWM-APE 676
I HRD+K N+L+ +K+ DFG S+ + Y++T+ W APE
Sbjct: 119 NG--IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-------WYRAPE 168
Query: 677 VLRNEPS-DEKSDVYSFGVILWELAT 701
L + K D+++ G + +E+ +
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 49/244 (20%)
Query: 478 SSCGSTSS----SAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-- 531
C +TSS S V + Y IL + GS G V+ +G +
Sbjct: 76 EPCETTSSSDPASVVR--------MQYNIL-------SSLTPGSEGEVFVCTKHGDEQRK 120
Query: 532 -VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP--RG 588
V VK + + + +E+ ++K + H ++ + A +C+V +P +
Sbjct: 121 KVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKC 170
Query: 589 SLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643
LF + R+ + +RR+L AL +YLH IIHRD+K+ N+ +D+
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEAL------AYLH--GRGIIHRDVKTENIFLDEPE 222
Query: 644 TVKVGDFGLS-RLKHETYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 701
+GDFG + +L G GT + +PE+L +P K+D++S G++L+E++
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 702 EKIP 705
+ +
Sbjct: 283 KNVT 286
|
Length = 392 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 513 IGQGSCGTVYHAVWYGSQDV----AVKVFSRQ---EYSDEVIHSFRQEVSLMKRLRH-PN 564
+G G+ G V+ D A+KV + + + V H+ R E ++++ +R P
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLEHVRQSPF 66
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR----RILMALDIARGVSY 619
++ A + +L ++ +++ G +F L QR+ D R I++AL+ +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE------H 120
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVL 678
LH I++RD+K N+L+D V + DFGLS+ E T + GT ++MAPE++
Sbjct: 121 LHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 679 RNEPSDEKS-DVYSFGVILWELATEKIPW 706
R + K+ D +S G++++EL T P+
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 512 QIGQGSCGTVYHA--VWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVL 566
+IG+G+ G V+ A + G + VA+K Q + + S +EV++++ L HPNV+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 567 LFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
T + +L +V E + + L + + M + RG+ +LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
+ ++HRDLK N+LV +K+ DFGL+R+ T T + APEVL
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQS 184
Query: 682 PSDEKSDVYSFGVILWEL 699
D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 551 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 610
R +SL+ P ++ A +P +LC + + + G L L ++ + R A
Sbjct: 45 RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR-FYA 103
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL----SRLKHETYLTTKTG 666
+I G+ ++H N +++RDLK +N+L+D+H V++ D GL S+ K +
Sbjct: 104 TEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----- 156
Query: 667 KGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPW 706
GT +MAPEVL+ + D +D +S G +L++L P+
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 59.5 bits (142), Expect = 9e-10
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 2/113 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ +L++ + + D RI+Y N +AE L GYS EE LG+ +L+ +
Sbjct: 112 ERLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERREL 171
Query: 190 DIVHRIKMGER--WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ + G ++ + K ERV + + DDG +VG+V ++ D
Sbjct: 172 ELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDDGEIVGVVGIARD 224
|
Length = 232 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 551 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNT-TKLDWRRRIL 608
R +SL+ P ++ A +P +L + + + G L + L Q ++ + R
Sbjct: 45 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR---F 101
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL----SRLKHETYLTTK 664
A +I G+ ++H N +++RDLK +N+L+D+H V++ D GL S+ K +
Sbjct: 102 YAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 665 TGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA-VGFMN 722
GT +MAPEVL + D +D +S G +L++L P+ + +
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
Query: 723 QRLEIPKDVDPRWAAIVE 740
+E+P P +++E
Sbjct: 214 MAVELPDSFSPELRSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 611
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 671
+I G+ LH N ++RDLK N+L+D + +++ D GL+ +K + + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
+MAPEVL N+ D + G +++E+ + P+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-09
Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 55/243 (22%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
++IG G G V+ +Q+ ++ + +E S VI EV++M+ L+H N
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVMRELKHKN 73
Query: 565 VLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQR---------NTTKLDWRRRILMALDI 613
++ ++ + Q+L I+ EF G L R +Q+ +D R++L AL
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL-- 131
Query: 614 ARGVSYLHHCN-----PPIIHRDLKSSNLLVD---KHW--------------TVKVGDFG 651
+Y H+ ++HRDLK N+ + +H K+GDFG
Sbjct: 132 ----AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 652 LSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDN 708
LS+ + E+ + GTP + +PE+L +E D+KSD+++ G I++EL + K P+
Sbjct: 188 LSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 709 LNS 711
N+
Sbjct: 246 ANN 248
|
Length = 1021 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 62/300 (20%)
Query: 423 WPWSHGDQDNESVQQKSPSYGT----KPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
WP E K+ G+ + + E RS NN A +++ + S
Sbjct: 4 WPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS 63
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVK-V 536
S +G IG GS G VY A+ S+ VA+K V
Sbjct: 64 PNKS------------------------YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV 99
Query: 537 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL-----FMGAVTSPQR---LCIVTEFLPRG 588
+Y + +E+ +MK L H N++ + ++ L +V EF+P+
Sbjct: 100 LQDPQYKN-------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 589 --SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 645
+ RN L L + + R ++Y+H + I HRDLK NLL+D T+
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTL 210
Query: 646 KVGDFG-----LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 699
K+ DFG L+ + +Y+ ++ + APE++ + D++S G I+ E+
Sbjct: 211 KLCDFGSAKNLLAGQRSVSYICSRF------YRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 30/125 (24%), Positives = 60/125 (48%), Gaps = 4/125 (3%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT-DGRDFDV 187
+ +Y I +S ++ + DL I+Y N + E ++GYSAEE +G++ +EL+ + R+
Sbjct: 2 EERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVR 61
Query: 188 AYDIVHRIKMGERWTGQ-FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
I R++ + + K + V + +P +G +G+V + D ++
Sbjct: 62 ER-IERRLEGEREPVSEERRVRRKDGSEIWVEVSVSP-IRTNGGELGVVGIVRDITERKQ 119
Query: 247 TRAAL 251
AL
Sbjct: 120 AEEAL 124
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 578 LCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 636
LC+V + G L F + D +R I A ++ G+ L I++RDLK N
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132
Query: 637 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 696
+L+D +++ D GL+ E T + GT +MAPEV+ NE D + G ++
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLI 191
Query: 697 WELA---------TEKIPWDNLN 710
+E+ E++ + ++
Sbjct: 192 YEMIQGQSPFRKRKERVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 45/260 (17%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+G+ G V + + A+K + E ++V H R E ++ +P V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADNPWVVKLY 67
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ L ++ E+LP G + LL + T + R +A + + +H IH
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIH 124
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLS-------------RLKH-------ETYLTTKTGK-- 667
RD+K NLL+D +K+ DFGL L H + + K
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 668 ----------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 711
GTP ++APEV +++ D +S GVI++E+ P+ + N
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 712 MQVIGAVGFMNQRLEIPKDV 731
+ + + L+ P +V
Sbjct: 245 QETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 50/221 (22%)
Query: 511 EQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHP 563
E+IG+G+ G VY A +D VA+K +R E +E I +E+SL++ L
Sbjct: 7 EKIGEGTYGKVYKA-----RDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60
Query: 564 NVLLFMGAVTSPQR------LCIVTEFLP----------RGSLFRLLQRNTTKLDWRRRI 607
++ + V + L +V E+L R L T K
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS------ 114
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSR-----LKHETYL 661
+ +GV++ H ++HRDLK NLLVDK + K+ D GL R +K T+
Sbjct: 115 -FMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 662 TTKTGKGTPQWMAPEVLRNEPSDEKS-DVYSFGVILWELAT 701
T + APEVL D++S G I E++
Sbjct: 172 IV-----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 15/173 (8%)
Query: 538 SRQEYSDEVI------HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP--RGS 589
S +Y V+ S E L++RL HP VL + C+V LP R
Sbjct: 189 SHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSD 245
Query: 590 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649
L+ L L + +A + + Y+H IIHRD+K+ N+LV+ + +GD
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGD 303
Query: 650 FGLSRLKHETYLT-TKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELA 700
FG + ++ T G GT APEVL +P D++S G++++E A
Sbjct: 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-08
Identities = 20/50 (40%), Positives = 31/50 (62%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ IL+S+ + + DL RI+Y N +AE L GYS EE +G+ +EL+
Sbjct: 1 ERLRAILESLPDGIFVLDLDGRILYANPAAEELLGYSPEELIGKSLLELI 50
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 637
L ++ EFLP G + LL + T + + +A + + +H IHRD+K NL
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDNL 132
Query: 638 LVDKHWTVKVGDFGL------------------------------SRLKHETYLTTK--- 664
L+D VK+ DFGL S+ K ET+ +
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 665 --TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 722
+ GTP ++APEV ++ D +S GVI++E+ P+ + + V
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWK 252
Query: 723 QRLEIPKDV 731
+ L P +V
Sbjct: 253 ETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSQDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 562
I E IG+GS G V A+ + + VA+K VF + SD +E+ L++ LRH
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDA--TRILREIKLLRLLRH 58
Query: 563 PNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 617
P+++ + P R + +V E L L ++++ N + + + R +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL-YQLLRAL 116
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWM-A 674
Y+H N + HRDLK N+L + +K+ DFGL+R+ T T +W A
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 675 PEVLRNEPSDEKS--DVYSFGVILWELATEK 703
PE+ + S D++S G I E+ T K
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 38/159 (23%)
Query: 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635
+ L ++ EFLP G + LL + T + + +A + + +H IHRD+K
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPD 130
Query: 636 NLLVDKHWTVKVGDFGL------------------------------SRLKHETYLTTK- 664
NLL+D VK+ DFGL S+ K ET+ +
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 665 ----TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 699
+ GTP ++APEV ++ D +S GVI++E+
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 21/224 (9%)
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
+F + SLM ++ H ++ G +V EF+ G L L++ ++ +I
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYL 661
+A +A +SYL N ++H ++ + N+L+ + +K+ D G+S T L
Sbjct: 122 VAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TAL 175
Query: 662 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 719
+ + W+APE + S +D +SFG L E+ + ++P L
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPSEKER 232
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
F ++ +P+ A ++ C +P RPSF+ + LRDL
Sbjct: 233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTI---LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 48/218 (22%), Positives = 96/218 (44%), Gaps = 18/218 (8%)
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
+F + S+M+++ H +++L G +V EF+ G L + R + L +
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYL 661
+A +A +SYL + ++H ++ + N+L+ + +K+ D G+ T L
Sbjct: 110 VAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVL 163
Query: 662 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 719
+ + W+APE + + + +D +SFG LWE+ +IP L +
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP---LKDKTLAEKER 220
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757
F + + A ++ C + DP RP F+ ++
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 40/172 (23%), Positives = 66/172 (38%), Gaps = 46/172 (26%)
Query: 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 637
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--KMGFIHRDIKPDNI 132
Query: 638 LVDKHWTVKVGDFGLS-------------------------------------------R 654
L+D+ +K+ DFGL R
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
+ + GTP ++APEVL + D +S GVIL+E+ + P+
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 51/238 (21%), Positives = 109/238 (45%), Gaps = 16/238 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 562
+D I + IG+G+ G V ++ + A+K+ ++ E FR+E +++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 619
+ A L +V ++ G L LL + +L D R + + +A +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVL 678
LH+ +HRD+K N+L+D + +++ DFG ++ + + + GTP +++PE+L
Sbjct: 121 LHY-----VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 679 RNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
+ + D +S GV ++E+ + P+ + ++ G + +R + P +
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|219845 pfam08448, PAS_4, PAS fold | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 1/105 (0%)
Query: 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI 195
L S+ ++ + D R+ Y N +A L+G EE LG+ ELL + + +
Sbjct: 1 LDSLPDALAVLDPDGRVRYANAAAAELFGLPPEELLGKTLAELLPPEDAARLERALRRAL 60
Query: 196 KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ E EER + TP D DG ++G++ +S D
Sbjct: 61 EGEEPIDFLEELLLNGEERHYEL-RLTPLRDPDGEVIGVLVISRD 104
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 110 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 15/48 (31%), Positives = 29/48 (60%)
Query: 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712
+ P +MAPEV++ + EK+D+YS G+ L+E ++P++ +
Sbjct: 63 QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 562
E+ I + I +G+ G VY + + AVKV + + ++ ++H + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMALDIARGV 617
P ++ ++ S + +V E+L G + LL + + + +ALD
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD----- 118
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656
YLH IIHRDLK N+L+ +K+ DFGLS++
Sbjct: 119 -YLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 50/170 (29%)
Query: 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635
Q L ++ EFLP G L +L + T + R MA + + +H IHRD+K
Sbjct: 74 QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVHKLG--FIHRDIKPD 130
Query: 636 NLLVDKHWTVKVGDFGLSRLKHETY--------LTTKTGK-------------------- 667
N+L+D+ +K+ DFGLS H+ + L K+ K
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS 190
Query: 668 -------------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 698
GTP ++APE+ + ++ D +S G I++E
Sbjct: 191 KDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|226350 COG3829, RocR, Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 16/121 (13%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD---F 185
RQ L IL S+ + + D IIY+N++ L G S EE LG+ +++++ G D
Sbjct: 116 RQRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGEDSTLL 175
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245
+V ++V N DG L+G+V +S D +
Sbjct: 176 EVLRTGKPIRD----------VVQTYNGNKIIV--NVAPVYADGQLIGVVGISKDVSELE 223
Query: 246 E 246
Sbjct: 224 R 224
|
Length = 560 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 578 LCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIARGVSYLHHCNPPIIHRD 631
L +V ++ G L LL + +L D R +++A+D V L + +HRD
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID---SVHQLGY-----VHRD 127
Query: 632 LKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS--- 687
+K N+L+DK+ +++ DFG RL + + + GTP +++PE+L+ +
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187
Query: 688 --DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
D +S GV ++E+ + P+ + ++ G + + + P DV
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
G ++G+G+ G VY A +D + E + + + R E++L++ L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQ 64
Query: 570 GAVT--SPQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL--DIARGVSYL 620
S +++ ++ ++ R + N + R ++ +L I G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 621 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKG---TPQWM 673
H ++HRDLK +N+LV + VK+ D G +RL + T +
Sbjct: 125 H--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 674 APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
APE+L K+ D+++ G I EL T +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
G ++G+G+ G VY A +D + E + + + R E++L++ L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQ 64
Query: 570 GAVTS--PQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL--DIARGVSYL 620
S +++ ++ ++ R + N + R ++ +L I G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 621 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKG---TPQWM 673
H ++HRDLK +N+LV + VK+ D G +RL + T +
Sbjct: 125 H--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 674 APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
APE+L K+ D+++ G I EL T +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|221967 pfam13188, PAS_8, PAS domain | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-05
Identities = 12/57 (21%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
+ + ++ + + D DRI+Y N +A L GY L + ++ L +
Sbjct: 1 ERLRALFENAPDGILVLD-GDRILYANPAALELLGYELLGELLGELLDDLEALAEEA 56
|
Length = 64 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 12/127 (9%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG------SQD 531
S SS + +D L Y+ WE +L +G +G G+ G V A +G +
Sbjct: 10 SVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMK 69
Query: 532 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590
VAVK+ S E + E+ +M L H N++ +GA T + I+TE+ G L
Sbjct: 70 VAVKMLKSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDL 128
Query: 591 FRLLQRN 597
L RN
Sbjct: 129 VDYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE--------FLPRGSLFRLLQRNTTKLDWR 604
E+ + RL H N+L + S ++T+ F+ + L +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQ 268
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664
R +M + V Y+H + +IHRD+K N+ ++ + +GDFG + +
Sbjct: 269 TRAIMK-QLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 665 TG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 704
G GT +PE+L + E +D++S G+IL ++ +
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|236901 PRK11360, PRK11360, sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/108 (17%), Positives = 43/108 (39%), Gaps = 4/108 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL+S+ V D +I N +AE++ G E +G+ EL F +
Sbjct: 266 LILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTPF---ASPLL 322
Query: 194 R-IKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + + + + + + ++ G ++G + + +D
Sbjct: 323 DTLEHGTEHVDLEISFPGRDRTIELSVSTSLLHNTHGEMIGALVIFSD 370
|
Length = 607 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 44/176 (25%), Positives = 69/176 (39%), Gaps = 50/176 (28%)
Query: 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 637
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHRDIKPDNI 132
Query: 638 LVDKHWTVKVGDFGL---------------------------------------SRLKHE 658
L+D +K+ DFGL RLK
Sbjct: 133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTL 192
Query: 659 TYLTTKTGK--------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
TK + GTP ++APEVL + + D +S GVIL+E+ + P+
Sbjct: 193 EQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 52/177 (29%)
Query: 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 637
L V +++P G + LL R + R +A ++ V +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHRDIKPDNI 132
Query: 638 LVDKHWTVKVGDFGL---------------------------------------SRLK-- 656
L+D+ +K+ DFGL RLK
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 657 -------HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706
H+ L + GTP ++APEVL + D +S GVIL+E+ + P+
Sbjct: 193 ERRAARQHQRCL-AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 12/110 (10%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG--SQD----VAVKVFSRQEYSDEVI 547
L Y WE +L G+ +G G+ G V A +G +D VAVK+ ++DE
Sbjct: 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER- 85
Query: 548 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 596
+ E+ ++ L +H N++ +GA T + ++TE+ G L L++
Sbjct: 86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 25/100 (25%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH--------------RIKM 197
IIYW+ E + GY+ E EL + + D+VH +K
Sbjct: 1 IIYWSPRFEEILGYTPE--------ELKSSYEGW---LDLVHPEDRERVRRALQEFSLKK 49
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
GE ++G++ + K E V A P D++G V ++ V
Sbjct: 50 GEPYSGEYRIRRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 29/159 (18%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH---- 562
I +G+ +Y + G +K + Y DE I R +E +M R R
Sbjct: 4 IKRGAEAEIYLGDFLGI-KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVN 62
Query: 563 -PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
P V P+ IV E++ L L+ N + ++ +I R V LH
Sbjct: 63 VPAVYFV-----DPENFIIVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKLH 112
Query: 622 HCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHE 658
IIH DL +SN+++ K + + DFGL+ +
Sbjct: 113 SAG--IIHGDLTTSNMILSGGKIYLI---DFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|183097 PRK11359, PRK11359, cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW- 201
V + D RI+ NR+ ++GY EA G LL + ++
Sbjct: 149 VIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARD 208
Query: 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+F T+T E++ + A+ +P YD L +V +D
Sbjct: 209 QDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSD 247
|
Length = 799 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 33/152 (21%), Positives = 55/152 (36%), Gaps = 26/152 (17%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNV- 565
I QG+ +Y + G VK + Y + R+E ++ + R V
Sbjct: 4 IKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVP 62
Query: 566 ---LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
+ P IV E++ G L + R + ++ R V LH
Sbjct: 63 VPIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKLHK 110
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
I+H DL +SN+++ + DFGL
Sbjct: 111 AG--IVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 783 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.6 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.54 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.51 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.24 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.24 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.21 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.2 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 99.19 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.13 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 99.12 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 99.11 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 99.01 | |
| COG5002 | 459 | VicK Signal transduction histidine kinase [Signal | 99.01 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.98 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 98.98 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.94 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| PRK11086 | 542 | sensory histidine kinase DcuS; Provisional | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| PRK11006 | 430 | phoR phosphate regulon sensor protein; Provisional | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.75 | |
| PRK10820 | 520 | DNA-binding transcriptional regulator TyrR; Provis | 98.73 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 98.72 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 98.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.48 | |
| COG3290 | 537 | CitA Signal transduction histidine kinase regulati | 98.44 | |
| COG3852 | 363 | NtrB Signal transduction histidine kinase, nitroge | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| PRK15053 | 545 | dpiB sensor histidine kinase DpiB; Provisional | 98.25 | |
| PRK09959 | 1197 | hybrid sensory histidine kinase in two-component r | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.18 | |
| PF14598 | 111 | PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W | 98.18 | |
| COG5000 | 712 | NtrY Signal transduction histidine kinase involved | 98.13 | |
| COG2202 | 232 | AtoS FOG: PAS/PAC domain [Signal transduction mech | 98.09 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 98.08 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=415.93 Aligned_cols=260 Identities=30% Similarity=0.475 Sum_probs=230.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc-
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 577 (783)
..+...+++.++.||+|..|+|||+.++.+ +-+|+|++ .........+++.+|+++++..+|||||.+|++|+.++.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 345667888899999999999999999865 55999999 445567788899999999999999999999999999995
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
++|+||||++|+|.+++... .++++.....++.++++||.|||+ ++ ||||||||+||||+..|.|||||||.+...
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999999999864 569999999999999999999996 66 999999999999999999999999999877
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhcccccccCCCC-
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-----NSMQVIGAVGFMNQRLEIPKD- 730 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~- 730 (783)
... ...+++||..|||||.+.+..|+.++||||||++|+||++|+.||... ...+++..|. ....+.+|..
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~ 306 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE 306 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence 666 556889999999999999999999999999999999999999999764 5566666663 3356677776
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+++++++||..||++||.+||++.++ ++|+|++...
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qL------l~Hpfi~~~~ 342 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQL------LQHPFIKKFE 342 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHH------hcCHHHhhcc
Confidence 99999999999999999999999999 7788886543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=429.64 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=236.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE-eCCceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~-~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+|+.++.||+|+|+.||.+.+ ..++.||+|++.+... ...+.+.+.+||+|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999998 5567899999988654 3456788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+|..++|..++++ +.++++..+..+++||+.||.|||+++ |||||||..|++++++.+|||+|||+|.........
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999984 567999999999999999999999999 999999999999999999999999999988877778
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
..+.||||.|.|||++....++..+||||+|||||-||+|++||+..+-.+.+..|. ...+.+|..++.++++||.++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHH
Confidence 889999999999999999999999999999999999999999999988888888874 446777889999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
|+++|.+|||+++| |.|+||+
T Consensus 253 L~~~P~~Rpsl~~v------L~h~Ff~ 273 (592)
T KOG0575|consen 253 LRPNPSERPSLDEV------LDHPFFK 273 (592)
T ss_pred hcCCcccCCCHHHH------hcCHhhh
Confidence 99999999999999 7899994
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=402.15 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=230.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|+++++||+|+||+||.++.++. +-||+|++++..... ........|..||..++||+||+++..|++..++|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 357899999999999999999998764 569999998876544 356678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|+||+.||.|+.+|++.+ .+++..+..++.+|+.||.|||++| ||||||||+|||+|.+|+|+|+|||+++......
T Consensus 103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999998754 6999999999999999999999999 9999999999999999999999999999777666
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
....+.|||+.|||||++.+..++..+|+||||+++|||++|.+||...+..+.+..+.... ....|..++.+.++||+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence 67778999999999999999999999999999999999999999999999988888874322 35566669999999999
Q ss_pred HhhhhCCCCCC----CHHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRP----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RP----sa~ell~~L~~L~~~~f~~~ 771 (783)
++|++||++|. ++.+| =.|+||..+
T Consensus 259 ~LL~rdp~~RLg~~~d~~~i------k~HpfF~~i 287 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEI------KRHPFFKGI 287 (357)
T ss_pred HHhccCHHHhcCCCCChHHh------hcCcccccC
Confidence 99999999996 45554 357787543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=413.73 Aligned_cols=275 Identities=49% Similarity=0.811 Sum_probs=248.2
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ- 576 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 576 (783)
..+++...++.+.+.||.|+||+||++.+.+...||||++............|.+|+.+|.+++|||||+|+|++..+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4456667778888889999999999999998767999999888777666889999999999999999999999999887
Q ss_pred ceEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCc
Q 003963 577 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 654 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~ 654 (783)
.++|||||+++|+|.+++.. ....+++..++.|+.||++||.|||++++ ||||||||+||||+.++ ++||+|||+++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 47789999999999999999999999875 99999999999999998 99999999998
Q ss_pred ccccccccccCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
.............||+.|||||++. ...++.|+||||||++||||+||+.||......+....+.....++.+|..++
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 7766543333468999999999999 56899999999999999999999999999999888888887888999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
+.+..||..||..||..||++.+++..|+.+...+-.....
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~ 313 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE 313 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence 99999999999999999999999999999998877644333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=408.13 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=222.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..+.|.+.+.||+|+||.|-+|..+. ++.||||++.+..... .......+|+++|++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678999999999999999999765 5779999998765432 11223569999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC---CcEEEEecCCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLS 653 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla 653 (783)
..||||||+.||+|.+.+-.++ .+.+.....+++||+.|+.|||++| |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999997654 4888888999999999999999999 9999999999999766 78999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccc--cccC
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQ--RLEI 727 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~--~~~~ 727 (783)
+..++.. ...+.||||.|.|||++.++.. ..++|||||||+||-+|+|.+||.+..... ..+.+..... .+..
T Consensus 327 K~~g~~s-fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSGEGS-FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccccce-ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 9887543 4458899999999999987654 347899999999999999999997665544 5555533332 2344
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+..++.+..+||.+||..||++|||+.++ |+|+||+...+.
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~ea------L~hpW~~~~~~~ 446 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEA------LNHPWFKDAPCL 446 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHH------hcChhhhccccc
Confidence 56789999999999999999999999999 789999977644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=396.01 Aligned_cols=259 Identities=26% Similarity=0.483 Sum_probs=229.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
..+|.+.+.||.|+|++||+|+++. +..||||.+.+.....+..+-+..|+.+|+.|+|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4689999999999999999999865 478999999998888888888999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC------CcEEEEecCCCccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------WTVKVGDFGLSRLK 656 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~------~~vkL~DFGla~~~ 656 (783)
|||.||+|.+++++.+ .+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998754 6999999999999999999999999 9999999999999764 46899999999988
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-cCCCCCCHHH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-EIPKDVDPRW 735 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l 735 (783)
... ....+.||+|.|||||+++..+|+.|+|+||+|++||+|++|++||...+..+++..+....... .++..++..+
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 754 35568899999999999999999999999999999999999999999999999888776555433 3455677788
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+|+...|++++..|-++.+. +.+++.....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~------~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDF------FDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHh------hhhhhcccCc
Confidence 899999999999999887776 4556554444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=382.02 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=225.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEece-eecCC-ce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQ-RL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~-~~ 578 (783)
....+|+|.++||+|.||.||++.+.. +..+|.|.+.-...+....+....|+.+|++|+|||||++|++ |..+. .+
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 345689999999999999999999754 5679999998777777888899999999999999999999983 44444 48
Q ss_pred EEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCC--EEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 579 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPP--IIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
+||||||.+|+|..+++. .+..++++.+|+++.|++.||..+|..-++ |+||||||.||+|+.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999863 456799999999999999999999994444 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC-CCCC
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP-KDVD 732 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s 732 (783)
+.+........+.+|||.||+||++.+.+|+.++|||||||++|||+.-.+||.+.+-..+...|... ..+++| ..+|
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhh
Confidence 98887766677889999999999999999999999999999999999999999999888888787544 344466 6789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
.++..||..|+..||+.||+...++..+
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 9999999999999999999865554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=397.73 Aligned_cols=257 Identities=25% Similarity=0.449 Sum_probs=229.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 579 (783)
...+|.+++.||+|+|++||+|+.+. +++|||||+.+..+.. .-.+-+.+|-.+|.+| .||.||+||..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45799999999999999999999865 5789999998765433 2345567899999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+|+||+++|+|.++|.+. ..+++.-+..++.||+.||+|||++| ||||||||+||||+.++++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999999875 46999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccc-----------c--cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc
Q 003963 660 YLT-----------T--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 726 (783)
Q Consensus 660 ~~~-----------~--~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 726 (783)
... . .+++||..|.+||++.....++.+|||+||||||+|+.|.+||...+....+..|. ...+.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDYE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hhccc
Confidence 211 1 45789999999999999999999999999999999999999999999988888874 45678
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+|+.+++.+.+||+++|..||.+|++..+| -+|+||..
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI------k~HpFF~~ 343 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQI------KAHPFFEG 343 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHH------hhCccccc
Confidence 899999999999999999999999999999 57899843
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=375.00 Aligned_cols=254 Identities=24% Similarity=0.436 Sum_probs=230.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++++.||.|+||+|.+++.+.+ .-||+|++.+...- ..+.+...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4457899999999999999999998765 45999999887654 367778889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
|||||++||.|+.+|++. .+++++.+..++.||+.||+|||+++ |++|||||+|||+|.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999999874 46999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
+.+.||||.|+|||++..+.++.++|+|+||+++|||+.|.+||...++.+.+..| +.....+|..+++++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHHHH
Confidence 56889999999999999999999999999999999999999999999999998888 5677889999999999999
Q ss_pred HHhhhhCCCCC-----CCHHHHHHHHHHHHHHHhh
Q 003963 740 ESCWHSDPQCR-----PSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 740 ~~cL~~dP~~R-----Psa~ell~~L~~L~~~~f~ 769 (783)
+++|+.|-.+| ....+| -.|+||+
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dI------k~H~wF~ 301 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDI------KNHPWFK 301 (355)
T ss_pred HHHHhhhhHhhhcCcCCCcccc------ccCcccc
Confidence 99999999999 344555 4577774
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=376.07 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=222.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+.|+.+.++|+|+||+||+++++.+ +-||||+|....-++...+-..+|+++|++|+|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5688899999999999999998764 669999998777667777888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
||+. ++.+-|++....++.+.+..+++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9976 777778887888999999999999999999999999 9999999999999999999999999999887655555
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 003963 664 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------ 724 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 724 (783)
...+.|..|+|||.+.| .+|+..+|||++||++.||++|.+-|.+.+..+.+..|....+.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 56778999999999998 77999999999999999999999999998887766554322111
Q ss_pred -ccCC----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 725 -LEIP----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 725 -~~~~----------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
++.+ +.++.-+.+|+++||+.||.+|++-.++ |.|+||+
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql------l~H~yFd 288 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL------LHHPYFD 288 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH------hcChHHH
Confidence 1111 2345678999999999999999999999 6778884
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=394.12 Aligned_cols=258 Identities=30% Similarity=0.523 Sum_probs=230.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC---HHHHHHHHHHHHHHHhCC-CCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 576 (783)
...+.|.+++.||+|+||+|++|.+.. +..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456799999999999999999998754 578999987765222 234556778999999999 999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~ 655 (783)
.+|+|||||.||+|++++.. ..++.+..+..+++||+.|++|||++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999988 667999999999999999999999999 9999999999999999 9999999999987
Q ss_pred cccccccccCCCCCCcccCcccccCCC-C-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCC-C
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEP-S-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV-D 732 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-s 732 (783)
.........+.+||+.|+|||++.+.. | +.++||||+|++||.|++|..||.+.+...++..+ ......+|..+ +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 743334566889999999999999977 7 58899999999999999999999998888877775 55677888888 9
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
++++.||.+||..||.+|+++.++ +.|+||+.
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i------~~h~w~~~ 280 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEI------LEHPWFQK 280 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHH------hhChhhcc
Confidence 999999999999999999999999 67999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=383.49 Aligned_cols=258 Identities=31% Similarity=0.547 Sum_probs=220.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC--ceEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIV 581 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV 581 (783)
.+|..++.||+|+||.||++.+.. +..+|||.+....... .+.+.+|+.+|.+|+|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 457788999999999999999876 5679999987763222 677899999999999999999999754444 69999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCccccc--
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHE-- 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~-- 658 (783)
|||+++|+|.+++.+.+.++++..+..+.+||++||.|||++| ||||||||+||||+. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999987667999999999999999999999998 999999999999999 79999999999886653
Q ss_pred -ccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 -TYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDN-LNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 -~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.........||+.|||||++.+ .....++|||||||++.||+||+.||.. ......+..+......+.+|..+++++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1223345689999999999985 3345699999999999999999999988 455555555555555678999999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
++||.+|+.++|.+|||+.++ |.|+|.+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eL------L~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEEL------LEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHH------hhChhhhccc
Confidence 999999999999999999999 6777775543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=398.70 Aligned_cols=258 Identities=33% Similarity=0.520 Sum_probs=234.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecc-cCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+-|++++.||.|+.|.|-+|++. .++.+|||++.+. .........+.+|+.||+.|.||||+++|++|+...++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56899999999999999999975 4678999999887 555666778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||++||.|+++|-+. .++++..++++++||+.|+.|||..+ |+|||+||+|+|++..+.+||+|||+|.+.... ..
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 999999999999774 46999999999999999999999998 999999999999999999999999999865543 34
Q ss_pred ccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
..+.||+|.|.|||++.|.+| +.++||||+|||||.||||++||.+.+...++..+ ..+.+.+|.++++++++||.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 568899999999999999998 68999999999999999999999999988888777 456788999999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
||..||.+|.|..+| +.|+|+++..+.
T Consensus 246 ml~VDp~~RiT~~eI------~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEI------LKHPFLSGYTSL 272 (786)
T ss_pred HhccCccccccHHHH------hhCchhhcCCCC
Confidence 999999999999999 788998776554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=392.83 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=232.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|.+.+.||+|.||+||||+.+.. +.||||.+.+....+...+.+.+|++|++.|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5789999999999999999997664 679999999988888888999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
||.| +|+.+|... ..++++.+..++.+++.||.|||+++ |+|||+||.|||+..+|.+|+||||+++.........
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9976 999999874 46999999999999999999999998 9999999999999999999999999999877766666
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....|||.|||||++.+.+|+..+|+|||||++|||++|++||......++...| .......|...+..+..|+..+|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I--~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI--LKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH--hcCCCCCcccccHHHHHHHHHHh
Confidence 6778999999999999999999999999999999999999999888777777666 44556667789999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||.+|.+..++ +.|+|.+.
T Consensus 236 ~kdP~~RltW~~L------l~HpF~k~ 256 (808)
T KOG0597|consen 236 IKDPAQRLTWTDL------LGHPFWKG 256 (808)
T ss_pred hcChhhcccHHHH------hcChHHhh
Confidence 9999999999999 67887754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=395.80 Aligned_cols=259 Identities=25% Similarity=0.440 Sum_probs=233.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCc
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 577 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 577 (783)
....++|.++++||+|.||+|+++..+++ +.||||++++..+ .++.++..+.|.+|+.... ||++++++..|+...+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34568999999999999999999998765 5699999998764 4466788889999999885 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+||||+.||++..+.+ ...+++..+..++.+|+.||.|||++| |||||||.+|||+|.+|++||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999999544433 456999999999999999999999999 9999999999999999999999999998776
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
-....+.++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+++..| .+....+|..++.+..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--~~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCCCCCCCcccHHHHH
Confidence 5666788999999999999999999999999999999999999999999999999999988 56677888999999999
Q ss_pred HHHHhhhhCCCCCCCH-----HHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRPSF-----QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa-----~ell~~L~~L~~~~f~~~ 771 (783)
+++++|.++|++|..+ .+| .+|+||..|
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i------~~hpFFr~i 630 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDI------KKHPFFRSI 630 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhh------hhCCccccC
Confidence 9999999999999854 566 578999765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=388.43 Aligned_cols=262 Identities=37% Similarity=0.651 Sum_probs=236.2
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..|++..+.+++++.||+|.||.||+|.+.+..+||+|.++....+. +.|.+|+++|+.|+|+|||+++++|..++.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 45677778889999999999999999999998899999998876554 467799999999999999999999999889
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|||||||+.|+|.++|+. .+..+.....+.++.||++||+||++++ +|||||.+.||||+++..+||+|||+++..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999999986 6677999999999999999999999999 999999999999999999999999999965
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.+... ......-+..|.|||.+....++.++|||||||+||||+| |+.||.+++..+++..+. .+.+++-|..+|++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDE 432 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHH
Confidence 54433 3333445679999999999999999999999999999999 999999999999998885 56788899999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+.+++..||+.+|++|||+..+...|+++..
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 9999999999999999999988888776643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.06 Aligned_cols=259 Identities=24% Similarity=0.409 Sum_probs=224.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|+++++||+|+||.||+|+.+.+ .-||+|++++... ...++.-++.|-.+|....+|+||++|..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 467999999999999999999998765 5589999988764 34677888999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc--
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-- 658 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~-- 658 (783)
||||++||++..+|.+. ..|++..+..++.+++.|+..||++| +|||||||+|+|||..|++||+|||++.-...
T Consensus 219 iMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999874 46999999999999999999999999 99999999999999999999999999852111
Q ss_pred ---------------------ccc------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHH
Q 003963 659 ---------------------TYL------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFG 693 (783)
Q Consensus 659 ---------------------~~~------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG 693 (783)
... .....+|||.|||||++.+..|+...|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 01123599999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHh
Q 003963 694 VILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYF 768 (783)
Q Consensus 694 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~LI~~cL~~dP~~RPs---a~ell~~L~~L~~~~f 768 (783)
|||||||.|.+||...++.+....+......+.+|. .+++++.+||.+||. ||++|.. +.|| -.|+||
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI------K~HPfF 448 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI------KKHPFF 448 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH------hcCCcc
Confidence 999999999999999999999988866555555554 478999999999999 9999975 6666 578999
Q ss_pred hcC
Q 003963 769 QAS 771 (783)
Q Consensus 769 ~~~ 771 (783)
+.+
T Consensus 449 ~~v 451 (550)
T KOG0605|consen 449 KGV 451 (550)
T ss_pred ccC
Confidence 653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.68 Aligned_cols=265 Identities=22% Similarity=0.368 Sum_probs=228.4
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
......+|++++.||+|.-|+||++...+. ..+|+|++.+.... .+...++..|.+||+.++||.++.+|..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 345567899999999999999999998775 67999999887654 4556778889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.|+|||||+||+|..+++++ ...+++..+..++.+++-||+|||..| ||+|||||+||||-++|+|+|+||.++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999999764 455999999999999999999999999 999999999999999999999999986421
Q ss_pred cc-----------------------------------c---------------------cccccCCCCCCcccCcccccC
Q 003963 657 HE-----------------------------------T---------------------YLTTKTGKGTPQWMAPEVLRN 680 (783)
Q Consensus 657 ~~-----------------------------------~---------------------~~~~~~~~Gt~~Y~aPE~~~~ 680 (783)
.. . .....+++||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 011234579999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCC----HHHH
Q 003963 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS----FQEL 756 (783)
Q Consensus 681 ~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPs----a~el 756 (783)
..++.++|+|+|||+|||||.|..||.+.+..+.+.++......++-...++-.+++||+++|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999988885443333333467899999999999999999987 7777
Q ss_pred HHHHHHHHHHHhhcCc
Q 003963 757 VDKLRDLQRQYFQASR 772 (783)
Q Consensus 757 l~~L~~L~~~~f~~~~ 772 (783)
-+|+||+..+
T Consensus 390 ------K~HpFF~gVn 399 (459)
T KOG0610|consen 390 ------KRHPFFEGVN 399 (459)
T ss_pred ------hcCccccCCC
Confidence 5799997644
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.81 Aligned_cols=265 Identities=29% Similarity=0.509 Sum_probs=227.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.|-...++|++..+||.|..+.||+|++.. +..||||++..++.+.+ +..+.+|+..|+.++||||++++..|..+..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 344556899999999999999999999854 46799999998887666 7899999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|+||.||.+|++.+++.. -...+++..+..|.+++++||.|||++| .||||||+.||||+.+|.|||+|||.+...
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999975 3445999999999999999999999999 999999999999999999999999987655
Q ss_pred ccccccc----cCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc----
Q 003963 657 HETYLTT----KTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE---- 726 (783)
Q Consensus 657 ~~~~~~~----~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 726 (783)
....... .+.+||+.|||||+++. ..|+.|+||||||++..||.+|+.||..+.+.+++... ++..++
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCccc
Confidence 4433222 45689999999999543 45789999999999999999999999999998876443 222222
Q ss_pred ------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 727 ------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 727 ------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
....++..++.+|..||++||.+|||+.++ |.|+|||..+.-
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL------lkh~FFk~~k~~ 302 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL------LKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH------hccHHHhhccch
Confidence 123466789999999999999999999999 788999876653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=380.38 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=223.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCC-ceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ-RLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~~ 579 (783)
..++|.++++||.|+||.||+|+.+. +..||||.|++...+-+.+.. .||+.-|++|+ |||||++.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45789999999999999999999754 467999999888776554444 46999999998 999999999998887 899
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||| ..+|+++++.++..+++..+..|+.||++||+|+|.+| +.|||+||+||||..+..|||+|||+|+.....
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccccC
Confidence 999999 45999999988889999999999999999999999999 999999999999998889999999999976654
Q ss_pred cccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-------------
Q 003963 660 YLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------------- 725 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 725 (783)
...+ ..+.|..|+|||++. ...|+.+.|||++|||++|+++-++.|.+.+..+.+..+....+.+
T Consensus 164 pPYT-eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 PPYT-EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred CCcc-hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3333 456799999999865 5678999999999999999999999999998877666553222111
Q ss_pred ----c-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 726 ----E-----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 726 ----~-----------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
. +.+.++.++.+||..||.+||.+||||.++ |+++|||.....
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a------l~~pffq~~~~~ 300 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA------LQHPFFQVGRAS 300 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH------hcCccccccccc
Confidence 1 113478899999999999999999999999 789999876654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=382.24 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=227.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
...|...++||+|+.|.||.+.... ++.||||.+........ +-+.+|+.+|+..+|+|||++++.|-..+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 4578888999999999999998754 46799999987665443 46789999999999999999999998889999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|||+||+|-+.+... .+++.++..|++++++||+|||.+| |||||||.+|||++.+|.|||+|||++..+......
T Consensus 350 Eym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999999999864 4999999999999999999999999 999999999999999999999999999877766556
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~~ 741 (783)
..+.+|||.|||||++....|++++||||||++.+||+.|.+||-+.++.+.+..+..- ...+..+..+++.+++|+.+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 66889999999999999999999999999999999999999999888887777666432 23556678899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
||..|+.+|+++.+| |+|+||+
T Consensus 506 cL~~dv~~RasA~eL------L~HpFl~ 527 (550)
T KOG0578|consen 506 CLVVDVEQRASAKEL------LEHPFLK 527 (550)
T ss_pred HhhcchhcCCCHHHH------hcChhhh
Confidence 999999999999999 7889984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=347.13 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=223.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.+|...++||+|.||.||+|.+.. ++.||||+++.....+.......+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999754 5789999999887776666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|++. +|+..++.....++...+..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+++.+.......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9964 999999988889999999999999999999999999 9999999999999999999999999999888765555
Q ss_pred cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------------
Q 003963 664 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----------------- 725 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------- 725 (783)
...+-|..|+|||.+.|. .|+..+||||.||++.||+.|.+-|.+.+..+.+..+-...+.+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 555779999999998875 48999999999999999999999999888776665432111110
Q ss_pred ---c------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 726 ---E------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 726 ---~------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+ +....+.++.+|+.+||..||.+|+++.|+ |+++||+.
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa------L~~~yf~~ 286 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA------LKHPYFKS 286 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH------hcchhhhc
Confidence 0 112346678999999999999999999999 78899986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=379.12 Aligned_cols=272 Identities=39% Similarity=0.665 Sum_probs=238.4
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.+|++..+.+.++..||+|.||+||+|.+.+ .||||++......++..+.|++|+.+|++-+|.||+-|+|++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5788999999999999999999999999986 79999999999999999999999999999999999999999999887
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.||.-+|+|-+|+.+|.-...++.....+.|++||++||.|||.++ |||||||..||++.+++.|||+|||++....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999887888999999999999999999999998 9999999999999999999999999986543
Q ss_pred ccc--ccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---cccccCCC
Q 003963 658 ETY--LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM---NQRLEIPK 729 (783)
Q Consensus 658 ~~~--~~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~ 729 (783)
.-. .......|...|||||+++ ..+|++.+|||||||++|||++|.+||...+..+.+..+... .....+..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 321 1223445788999999986 356799999999999999999999999977776666555433 22334456
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+++.++++|+..||..++++||.+.+|+..|+.++...-+=.||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~ 664 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSA 664 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCc
Confidence 788899999999999999999999999999999988655556655
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=375.26 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=224.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--CceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 579 (783)
..+.|+.+++||+|+||.||+|++.. ++.||+|++......+.......+||.||++|.||||+++.++.... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34678999999999999999999865 46799999998887777778888999999999999999999998876 6799
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||+|||+. +|..++......+++.++..++.||+.||.|||.+| |+|||||.+|||||++|.+||+|||+|+++...
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999976 999999888889999999999999999999999999 999999999999999999999999999976654
Q ss_pred ccc-ccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------cccCC-
Q 003963 660 YLT-TKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--------RLEIP- 728 (783)
Q Consensus 660 ~~~-~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--------~~~~~- 728 (783)
... ....+-|..|+|||.+.|.. |+.++|+||+||||.||++|+++|.+.+..+.+..|-.+-+ ...+|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 322 34557799999999998864 89999999999999999999999999988877766532211 11111
Q ss_pred ------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 729 ------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 729 ------------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..++....+|+..||..||.+|.|+.++ |+++||....
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a------L~seyF~t~p 407 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA------LQSEYFTTEP 407 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH------hcCcccccCC
Confidence 2467788999999999999999999999 7889994433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.06 Aligned_cols=263 Identities=30% Similarity=0.562 Sum_probs=215.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEecee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 572 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 572 (783)
|++..++|++.++||+|+||.||+|.+.. ++.||||++.... .......+.+|+.++..+ +|||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45667899999999999999999997532 2469999987543 333456788999999999 899999999988
Q ss_pred ecC-CceEEEEEecCCCCHHHHHhhcC-----------------------------------------------------
Q 003963 573 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 598 (783)
Q Consensus 573 ~~~-~~~~lV~E~~~ggsL~~~L~~~~----------------------------------------------------- 598 (783)
... ..++++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46899999999999999986532
Q ss_pred --------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc--cccccCCCC
Q 003963 599 --------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKG 668 (783)
Q Consensus 599 --------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~G 668 (783)
.++++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 23677888999999999999999998 999999999999999999999999999754322 112223345
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 669 t~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
++.|+|||++.+..++.++|||||||+||||++ |..||........+............+..+++.+.+||.+||..||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999997 9999987654333322222333455677889999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHH
Q 003963 748 QCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~ 765 (783)
.+||++.++++.|+++.+
T Consensus 319 ~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 319 KERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=343.49 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=230.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCc-eEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++++.||+|-||.||.|+.+.+. -||+|++.+..... ...+++.+|++|...|+||||+++|++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 44679999999999999999999987664 59999998776533 45578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+++||.++|+|+..|+.. ..++++.....++.|++.||.|+|.++ ||||||||+|+|++..+.+||+|||.+...+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999843 345999999999999999999999988 9999999999999999999999999997655
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.....+.|||..|++||+..+..++..+|+|++|++.||++.|.+||......+.+..+.. .+..+|..++..++++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFPSTISGGAADL 252 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCCcccChhHHHH
Confidence 3455678999999999999999999999999999999999999999999988888888754 3566779999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|.+||.++|.+|....++ +.|+|-.+.
T Consensus 253 I~~ll~~~p~~r~~l~~v------~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEV------MDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHH------hhhHHHHhc
Confidence 999999999999999999 567776543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=372.89 Aligned_cols=256 Identities=32% Similarity=0.534 Sum_probs=224.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
..|+..+.||+|.||.||+|.+.. .+.||||++..+...+ ....+.+|+.+|..++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 356777999999999999999865 4669999998776544 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
||.||++.+.|+... .+.+..+..++++++.||.|||..+ .+|||||+.||||..+|.|||+|||.+..........
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999997643 4588888899999999999999998 9999999999999999999999999998777766666
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
.+++|||.|||||++.+..|+.++||||||++.+||++|.+||....++.++..|. ....+.+...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 88999999999999999999999999999999999999999999999876654443 22334445578999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+||+.||+|.++ |+|+|.+..
T Consensus 248 ~k~P~~RpsA~~L------LKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKEL------LKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHH------hhhHHHHhc
Confidence 9999999999999 567777653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.26 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=219.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.++||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 478999999999999999999864 567999998764432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999999764 46889999999999999999999998 999999999999999999999999998765432
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..+++.+.+||.+|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHHH
Confidence 224568999999999999999999999999999999999999999888776666553 334567778899999999999
Q ss_pred hhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003963 743 WHSDPQCRPS-----FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 743 L~~dP~~RPs-----a~ell~~L~~L~~~~f~~ 770 (783)
|+.||.+||+ +.++ +.|+||+.
T Consensus 233 l~~dp~~R~~~~~~~~~~~------l~h~~~~~ 259 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDV------KNHRWFKS 259 (291)
T ss_pred cCCCHHHccCCccCCHHHH------hcCccccC
Confidence 9999999995 8888 67899864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=369.61 Aligned_cols=249 Identities=25% Similarity=0.484 Sum_probs=215.5
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
+.||+|+||.||++.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999754 56799999986543 2344566788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 668 (783)
+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999999764 46899999999999999999999998 999999999999999999999999998754333333345679
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 669 t~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.+||..||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999998877766655542 345567888999999999999999999
Q ss_pred CCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 749 CRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 749 ~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
+|| ++.++ +.|+||+.
T Consensus 236 ~R~~~~~~~~~~l------l~h~~f~~ 256 (323)
T cd05571 236 QRLGGGPEDAKEI------MEHRFFAS 256 (323)
T ss_pred HcCCCCCCCHHHH------HcCCCcCC
Confidence 999 79998 67888855
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=369.46 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=221.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 35789999999999999999999865 567999999765432 2445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 99999999999999764 46889999999999999999999998 999999999999999999999999999765432
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++..+.+||.
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHH
Confidence 224578999999999999999999999999999999999999998887776666553 3456677889999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003963 741 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 741 ~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~ 770 (783)
+||+.||.+||+ +.++ +.|+||+.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~l------l~hp~f~~ 276 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADV------KNHPYFHG 276 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHH------hcCCccCC
Confidence 999999999996 6787 67788854
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=374.00 Aligned_cols=251 Identities=35% Similarity=0.645 Sum_probs=224.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.||+.++...-++-||.|+.|.||+|+.+ ++.||||+++..+ ..+|.-|++|+||||+.|.|+|.....+
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 56788888888889999999999999976 4589999875322 2478889999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|||||||..|.|+..|+. +.++.......|..+|+.||+|||.+. |||||||.-||||+.+..|||+|||.++...+
T Consensus 188 CIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999999999976 456888889999999999999999998 99999999999999999999999999987665
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
. .+...++||-.|||||++.+.+.+.|+|||||||||||||||..||.+.+...++.-+..-...+++|..+|+.|+=|
T Consensus 265 ~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence 4 455678999999999999999999999999999999999999999999887766655554445678899999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
|+.||+.+|..||++.+|+.+|+-.
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999998743
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=371.13 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=231.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc-eEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lV 581 (783)
.++|.++++||+|+||.+++++++.. ..|++|.+..............+|+.++++++|||||.+++.|+.++. +|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 36899999999999999999998754 579999998888777666788899999999999999999999999888 9999
Q ss_pred EEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 582 TEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|+||+||+|.+.+...+ ..++++.++.|+.||+.||.|||+++ |+|||||+.||+++.++.|+|.|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999997654 67999999999999999999999887 9999999999999999999999999999888776
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
....+.+|||.||+||++.+.+|+.++|||||||++|||++-+++|...+...+...+.... ..++|..++.+++.+|+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence 56678899999999999999999999999999999999999999999999888877764333 56788899999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 003963 741 SCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~ 759 (783)
.||.++|..||++.+||.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=369.23 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=222.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC--ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS--QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
....++|++.++||+|+||.||+|.+... ..||+|++..... .......+.+|+.+++.++|||||++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 44567899999999999999999987653 4799999876543 23445678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999764 35899999999999999999999998 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+. .....+|..+++.+.+
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNCKH 257 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHH
Confidence 32 234578999999999999989999999999999999999999999887766665553 3345677889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
+|++||+.||.+|+ ++.++ +.|+||+..
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~------~~hp~f~~~ 290 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNV------KEHPWFGNI 290 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHH------HcCCCcCCC
Confidence 99999999999995 89988 678888654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.03 Aligned_cols=251 Identities=24% Similarity=0.453 Sum_probs=222.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE-eCCceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
....+|++.+.||+|+||+|-+|+. ..++.||||.+++..+.+ .-+-.+++|++||..|+||||+.+|.+|+..+.++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3456899999999999999999986 567889999999887654 44567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
|||||..+|.|++|+... ..+++..+..+++||+.|+.|||.++ ++|||||.+|||+|.++++||+|||++.++...
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999999874 46999999999999999999999998 999999999999999999999999999887765
Q ss_pred cccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
. ..+++||+|-|.+||++.|.+| ++.+|.||||++||-|+.|..||++.+...+...|....++ - +.-+....-|
T Consensus 207 k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--E-P~~PSdA~gL 282 (668)
T KOG0611|consen 207 K-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--E-PETPSDASGL 282 (668)
T ss_pred c-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--C-CCCCchHHHH
Confidence 3 4458899999999999999998 67899999999999999999999999988888777543332 2 2345677889
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~ 759 (783)
|++||..+|++|.|+.+|..+
T Consensus 283 IRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHHhcCcccchhHHHHhhh
Confidence 999999999999999999654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=353.28 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=214.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.|++.+.||+|+||.||++.+.. ++.||+|++....... .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999754 5789999987654332 233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence 99999999887543 345899999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--cccccccCCCCCCHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~s~~l~~LI~ 740 (783)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .......++..+++++.+||.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 234578999999999999999999999999999999999999998665432211111 122344566778999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~~ 771 (783)
+||..||.+||+ +.++ ++|+||+.+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~------~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGV------KQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHH------hcCHhhcCC
Confidence 999999999997 7888 678888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.44 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=209.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH------------HHHHHHHHHHHHHHhCCCCceeeE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD------------EVIHSFRQEVSLMKRLRHPNVLLF 568 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~l 568 (783)
...++|++++.||+|.||.|.+|++.. ++.||||++.+..... .-.+...+||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 456899999999999999999999865 4679999997653211 123578899999999999999999
Q ss_pred eceeecC--CceEEEEEecCCCCHHHHHhhcCCc-chHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcE
Q 003963 569 MGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 645 (783)
Q Consensus 569 ~~~~~~~--~~~~lV~E~~~ggsL~~~L~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~v 645 (783)
+++..++ +.+|||+|||..|.+...=. ..+ +++.++++++++++.||.|||.+| ||||||||+|+||+.+|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcE
Confidence 9999876 57999999999887754322 233 899999999999999999999999 9999999999999999999
Q ss_pred EEEecCCCccccccc-----ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 003963 646 KVGDFGLSRLKHETY-----LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 716 (783)
Q Consensus 646 kL~DFGla~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~----~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~ 716 (783)
||+|||.+....... ......+|||.|+|||.+.+.. .+.+.|||||||+||.|+.|++||-+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 999999987653321 1222357999999999987733 3678999999999999999999999988888888
Q ss_pred HhhcccccccCCC--CCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 717 AVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 717 ~i~~~~~~~~~~~--~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
.|. +..+.+|. .+...+++||.+||.+||++|.+..+|.
T Consensus 330 KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 330 KIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred HHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 874 44455554 4799999999999999999999999994
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=363.67 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=218.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.++||+|+||.||+|.+.. ++.||||++...... ......+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 479999999999999999999865 578999999765432 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999999754 45889999999999999999999998 99999999999999999999999999876543 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC------CCCCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP------KDVDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~------~~~s~~l~ 736 (783)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........+ ..+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 335578999999999999999999999999999999999999999887776655543322222222 24689999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||.+||..+|.+||++.++ +.|+||+..
T Consensus 235 ~li~~~l~~~~~rr~s~~~l------l~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDI------KNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHH------HhCcccCCC
Confidence 99999999999999999999 667888653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=359.17 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=234.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEE-eCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+.+=|.+.+.||+|-|.+|.+|++ ..+.+||||++.+.+.+.-....+.+|++.|+.++|||||++|++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 445688889999999999999987 4577899999999888877777888999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEEEecCCCccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~ 660 (783)
+|+-++|+|++|+.++...+.+..+.+++.||+.|+.|||+.. +|||||||+||.+- +-|-|||+|||++..+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 9999999999999998888999999999999999999999988 99999999998875 5689999999999766543
Q ss_pred ccccCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s-~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
....+.||+..|-|||++.|..|+ +++||||||+|||-|++|++||+..+..+.+..| +...+.+|..++.++++||
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHH
Confidence 345578999999999999999986 5799999999999999999999999998888777 5567888999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..||.+||.+|.+.++| ..+.|.|.+-
T Consensus 251 ~sMLvRdPkkRAslEeI------~s~~Wlq~~D 277 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEI------VSTSWLQAGD 277 (864)
T ss_pred HHHHhcCchhhccHHHH------hccccccCCC
Confidence 99999999999999999 5678887653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=345.34 Aligned_cols=263 Identities=26% Similarity=0.455 Sum_probs=231.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
....++|..+++||+|+||+|-+++.+.. +-||||+++++.. ..+.+..-..|-++|+..+||++..+-..|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34567899999999999999999997664 5699999988754 334455556799999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+||||..||.|+-+|.+. ..+++.....+..+|+.||.|||+.+ ||+||||.+|+|+|.+|++||+|||+++....
T Consensus 244 CFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999999999774 46999999999999999999999988 99999999999999999999999999987777
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
......++||||.|+|||++....|+.++|+|.+|++||||++|++||.+.+..+++..| +-....+|..++++.+.|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCHHHHHH
Confidence 777888999999999999999999999999999999999999999999999998888777 455778999999999999
Q ss_pred HHHhhhhCCCCCC--CHHHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRP--SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RP--sa~ell~~L~~L~~~~f~~~ 771 (783)
+..+|.+||.+|. ..+++.+. .+|.||..+
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi---~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEI---MRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHH---HhhhhhccC
Confidence 9999999999995 22333222 678888543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=367.58 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=220.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||+|.+. .++.||||++....... .....+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999986 45789999997654322 44567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 660 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 660 (783)
||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999765 56899999999999999999999988 9999999999999999999999999987654432
Q ss_pred ---------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 003963 661 ---------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 713 (783)
Q Consensus 661 ---------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~ 713 (783)
.......||+.|+|||++.+..++.++|||||||+||+|++|..||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12234568999999999999999999999999999999999999999888766
Q ss_pred HHHHhhcccccccCCC--CCCHHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHHHHHHhhcC
Q 003963 714 VIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS-FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 714 ~~~~i~~~~~~~~~~~--~~s~~l~~LI~~cL~~dP~~RPs-a~ell~~L~~L~~~~f~~~ 771 (783)
....+........+|. .+++++.+||.+||. ||.+||+ +.++ +.|+||+..
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l------l~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI------KSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH------hcCCCcCCC
Confidence 6655544223333333 369999999999997 9999999 9999 678888653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.34 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=210.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3679999999999999999999764 567999998654322 12345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++ +|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99965 999998776666889999999999999999999998 999999999999999999999999998765433333
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------c
Q 003963 663 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------R 724 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~ 724 (783)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+..... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 334568999999999876 5579999999999999999999999987766554433211100 0
Q ss_pred -----------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 -----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 -----------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
......+++++.+||.+||+.||.+|||+.++ ++|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~------l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA------LRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH------hcCCCC
Confidence 00113467889999999999999999999999 677876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=361.48 Aligned_cols=249 Identities=25% Similarity=0.462 Sum_probs=213.7
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
+.||+|+||.||++.+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999754 57899999976532 2344566778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 668 (783)
+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 999988764 46899999999999999999999998 999999999999999999999999998754333223334578
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 669 t~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..+++++.+||.+||..||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999998877766655542 334567788999999999999999999
Q ss_pred CCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 749 CRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 749 ~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
+|| ++.++ +.|+||..
T Consensus 236 ~R~~~~~~~~~~~------l~h~~~~~ 256 (323)
T cd05595 236 QRLGGGPSDAKEV------MEHRFFLS 256 (323)
T ss_pred HhCCCCCCCHHHH------HcCCCcCC
Confidence 998 88888 56777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.45 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=213.2
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||+|+||.||+|.+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999865 46799999876432 334456778899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCC
Q 003963 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670 (783)
Q Consensus 591 ~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 670 (783)
.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9999764 46899999999999999999999998 99999999999999999999999999875433333334567999
Q ss_pred cccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 671 ~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+ ......++..+++++.+||.+||..||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--HcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 999999999999999999999999999999999999888777666554 334566778899999999999999999999
Q ss_pred CC---HHHHHHHHHHHHHHHhhc
Q 003963 751 PS---FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 751 Ps---a~ell~~L~~L~~~~f~~ 770 (783)
|+ +.++ +.|+||+.
T Consensus 236 ~~~~~~~e~------l~hp~~~~ 252 (312)
T cd05585 236 LGYNGAQEI------KNHPFFSQ 252 (312)
T ss_pred CCCCCHHHH------HcCCCcCC
Confidence 75 5666 67788864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.03 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=210.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
....+|+++++||+|+||.||++.+.. ++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 345678899999999999999999764 5789999986543 34456778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+.+++|.... ...+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 150 v~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999999986532 3556778889999999999999998 9999999999999999999999999998665443
Q ss_pred ccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--hcccccccCCCCCCH
Q 003963 661 LTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~s~ 733 (783)
.......||..|+|||++.. ...+.++|||||||++|+|++|+.||...........+ .........+..++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 33345679999999998743 33457899999999999999999999743322221111 112334456678899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
++.+||.+||..||.+||++.++ ++|+||...
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~el------l~hp~~~~~ 334 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQL------LQHPFILRA 334 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHH------hcCcccccC
Confidence 99999999999999999999999 678999654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=361.65 Aligned_cols=249 Identities=25% Similarity=0.465 Sum_probs=213.9
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
+.||+|+||.||++.+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999764 56799999976543 2344567888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 668 (783)
+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 999988754 46899999999999999999999998 999999999999999999999999998754333223345579
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 669 t~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+ ......+|..+++++.+||.+||.+||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--ccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999887776665554 3345567888999999999999999999
Q ss_pred CCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 749 CRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 749 ~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
+|+ ++.++ +.|+||..
T Consensus 236 ~R~~~~~~~~~~i------l~h~~~~~ 256 (328)
T cd05593 236 KRLGGGPDDAKEI------MRHSFFTG 256 (328)
T ss_pred HcCCCCCCCHHHH------hcCCCcCC
Confidence 997 89999 45677643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=359.82 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=213.6
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHH---HhCCCCceeeEeceeecCCceEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLM---KRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
|++.+.||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6789999999999999998764 57899999976542 223345667776665 456799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|..++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988864 35899999999999999999999998 99999999999999999999999999875433333
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++.+.+||.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH
Confidence 3445679999999999999999999999999999999999999999887777665553 33455777899999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 742 CWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 742 cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
||..||.+|| ++.++ ++|+||+.
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l------~~~~~f~~ 262 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDV------KKQPFFRD 262 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHH------hhCCCcCC
Confidence 9999999999 56777 56777754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=351.32 Aligned_cols=255 Identities=20% Similarity=0.290 Sum_probs=210.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||+|+||.||++.+.. ++.||+|++............+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999865 4679999997665444555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-c
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 662 (783)
|++++.|..+. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99886665444 44456899999999999999999999998 99999999999999999999999999976543221 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------c
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR-----------------L 725 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~ 725 (783)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||...+.......+...... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 22346899999999999988999999999999999999999999876654433222111000 0
Q ss_pred -------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 726 -------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 726 -------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.....++..+.+||++||+.||++|||+.++ |+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~------l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC------LNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH------hcCCCC
Confidence 0112367889999999999999999999999 567876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=355.02 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=210.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||+|+||.||+|.+.. ++.||||++....... ....+.+|+.+++.++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 689999999999999999999864 5679999987543222 22356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+. ++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 995 6888888776667899999999999999999999998 9999999999999999999999999987544333333
Q ss_pred cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccc-----------------
Q 003963 664 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQR----------------- 724 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~----------------- 724 (783)
....|++.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 445789999999998764 5789999999999999999999999875432 222111100000
Q ss_pred --c--cCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 725 --L--EIP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 725 --~--~~~---------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
. ..+ ..+++.+.+||.+||+.||.+|||+.++ +.|+||+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~------l~h~~f~~~~~~ 297 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA------LSHEYFSDLPPR 297 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH------hcCcccccCChh
Confidence 0 000 1245678999999999999999999999 789999876543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=363.36 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=214.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.++||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 479999999999999999998765 56799999976443 2344567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
|||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999764 46899999999999999999999998 99999999999999999999999999875432100
Q ss_pred ----------------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 662 ----------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 662 ----------------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123479999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhcccccccCCC--CCCHHHHHHHHHhhh--hCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 708 NLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWH--SDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 708 ~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~LI~~cL~--~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
..+.......+........+|. .+++++++||.+|+. .++..||++.+| ++|+||+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei------~~hp~f~~ 298 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEI------KTNPFFEG 298 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHH------hCCCCCCC
Confidence 8887776666644333344443 468999999998664 223346899999 67888854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.09 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=218.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..++|++.+.||+|+||.||+|.+.. ...||+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 35689999999999999999998642 3579999987643 334456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999998764322
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ....+.+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLLH 238 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHH
Confidence 21 11123345678999999999999999999999999999875 9999998887776665542 234456778999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+++.+||+.+|.+||++.+|++.|.++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=337.41 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=220.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+.|.+.+.||+|.|+.||++.+.. ++.+|+|++....+.....+.+.+|++|.+.|+|||||++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3678899999999999999998754 577999998877776666788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc---CCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~ 659 (783)
|+|.|++|..-+-.. ..+++..+-..++||+++|.|+|.++ |||||+||+|+|+. ...-|||+|||++.... .
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999996555332 45888899999999999999999999 99999999999994 34569999999998777 4
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--cCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~ 737 (783)
......++|||.|||||++...+++..+|||+.|++||-||.|.+||.+.+...+++.+....... +.+..++++.++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 455667899999999999999999999999999999999999999999988888888886554433 345689999999
Q ss_pred HHHHhhhhCCCCCCCHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell 757 (783)
||++||..||.+|.|+.|.|
T Consensus 246 LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HHHHHhccChhhhccHHHHh
Confidence 99999999999999999984
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=357.68 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=215.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCC-ceeeEeceeecCCceEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 582 (783)
+|++.+.||+|+||.||+|.+..+ +.||||++.+... .......+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999998654 6799999976533 233456778899999999764 6889999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999998764 45889999999999999999999998 999999999999999999999999998643322223
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..+++++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 335578999999999999999999999999999999999999999888777666653 344567788999999999999
Q ss_pred hhhCCCCCCCH-----HHHHHHHHHHHHHHhhc
Q 003963 743 WHSDPQCRPSF-----QELVDKLRDLQRQYFQA 770 (783)
Q Consensus 743 L~~dP~~RPsa-----~ell~~L~~L~~~~f~~ 770 (783)
|.+||.+|++. .++ +.|+||+.
T Consensus 236 l~~~P~~R~~~~~~~~~~~------~~hp~~~~ 262 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDI------REHAFFRR 262 (324)
T ss_pred hhcCHHHcCCCCCCCHHHH------hcCCCcCC
Confidence 99999999976 555 56677754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.93 Aligned_cols=248 Identities=24% Similarity=0.446 Sum_probs=214.1
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeec----CCceEEEEEec
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIVTEFL 585 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~ 585 (783)
..||+|++|.||+|.+ .++.||||++...... ....+.+.+|+.+|+.++|||||++++++.+ ...+++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5689999999999987 4678999998765433 3445778899999999999999999999876 34689999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||++.++.+||+|||++...... ..
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~ 178 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PF 178 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhccc---cc
Confidence 999999999764 4688999999999999999999984 6 889999999999999999999999998754432 12
Q ss_pred CCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 665 TGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
...|+..|+|||++.+ ..++.++|||||||++|||++|..||...+..+....+........++..+++.+.+||.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 4568899999999976 67899999999999999999999999988877776666445556667777899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~ 765 (783)
|+.||.+|||+.++++.|+.++.
T Consensus 259 l~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 259 TSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred hcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999987754
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=359.06 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=212.7
Q ss_pred eeeccCCcEEEEEEEEe----CCceEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 511 EQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++||+|+||.||++... .++.||||++...... ......+..|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 3467999999765322 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|.+++... ..+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 9999999999764 35788888999999999999999998 99999999999999999999999999875433333334
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..+++.+.+||.+||.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHcc
Confidence 4578999999999999889999999999999999999999999888776665553 34566788899999999999999
Q ss_pred hCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 745 SDPQCRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 745 ~dP~~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
+||.+|| ++.++ +.|+||+.
T Consensus 237 ~~p~~R~~~~~~~~~~l------~~h~~~~~ 261 (323)
T cd05584 237 RNPSSRLGAGPGDAAEV------QSHPFFRH 261 (323)
T ss_pred cCHhHcCCCCCCCHHHH------hcCCCcCC
Confidence 9999999 78888 56777743
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=365.17 Aligned_cols=257 Identities=22% Similarity=0.381 Sum_probs=217.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999864 56799999976543 2344567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
|||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999999764 35899999999999999999999998 99999999999999999999999999864322110
Q ss_pred -------------------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 003963 662 -------------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 704 (783)
Q Consensus 662 -------------------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~ 704 (783)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0113469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcccccccCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhcC
Q 003963 705 PWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 705 Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~LI~~cL~~dP~~RPs---a~ell~~L~~L~~~~f~~~ 771 (783)
||...+..+....+........++. .+++++.+||.+||. +|.+|++ +.++ ++|+||+..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l------l~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI------KSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH------hcCCCcCCC
Confidence 9998887776665543333334443 478999999999996 9999997 8988 678888543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=367.37 Aligned_cols=259 Identities=28% Similarity=0.483 Sum_probs=229.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCce-EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~-vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+-|.|+..||.|+||.||+|..+.... .|.|++... +.+.+..+.-||+||..+.||+||++++.|+.++.++|+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 457888999999999999999876543 567776443 45667888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
||.||-+..++-.-+..+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998887888999999999999999999999998 9999999999999999999999999987666555556
Q ss_pred cCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccCCCCCCHHHHH
Q 003963 664 KTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAA 737 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~ 737 (783)
.++.|||.|||||++. ..+|++++||||||++|.||..+.+|....+++.++..+..... .+..|..|+..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 6889999999999865 56789999999999999999999999999999998887765433 44567789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
|+.+||.+||..||++.+| |+|+||++..|
T Consensus 268 fLk~cL~Knp~~Rp~aaql------l~Hpfv~~~~S 297 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQL------LKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHhcCCccCCCHHHH------hhCcccccCCc
Confidence 9999999999999999999 78999987654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.96 Aligned_cols=249 Identities=26% Similarity=0.473 Sum_probs=213.2
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
+.||+|+||.||++.+.. ++.||+|++...... ......+..|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999754 567999999865432 234566778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
+|..++... ..+++..++.++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||++..............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999988754 468999999999999999999997 67 99999999999999999999999999875433323333557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||+||+|++|..||...+.......+ ......+|..+++++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999887776665554 234556778899999999999999999
Q ss_pred CCCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 748 QCRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
.+|+ ++.++ ++|+||+.
T Consensus 236 ~~R~~~~~~~~~~i------l~h~~~~~ 257 (325)
T cd05594 236 KQRLGGGPDDAKEI------MQHKFFAG 257 (325)
T ss_pred HHhCCCCCCCHHHH------hcCCCcCC
Confidence 9996 89999 56777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.18 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=217.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCceEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCI 580 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 580 (783)
.++|+.++.|++|+||.||+|+++.. +-||+|.++.+.-....--.-.+||.+|.+++|||||.+-.+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46789999999999999999998664 569999997765433333456789999999999999999887753 457999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||||+. +|..++..-+.++....+..++.|+++||+|||.++ |+||||||+|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999976 999999988889999999999999999999999999 9999999999999999999999999999887764
Q ss_pred ccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------------
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-------------- 725 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 725 (783)
......+-|..|+|||.+.|.. |+.++|+||+|||+.||+++++-|.+......+..|-...+.+
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 4444556799999999998755 8999999999999999999999999888776665542211100
Q ss_pred ---------------cCCCC-CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 726 ---------------EIPKD-VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 726 ---------------~~~~~-~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.++.. ++..-.+|+..+|..||.+|.|+.+. |.|.||....
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~------L~h~~F~e~P 368 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG------LKHEYFRETP 368 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh------hcccccccCC
Confidence 01111 45778999999999999999999999 7899996643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.31 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=212.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.|++++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++|||||++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999998765 46799999976543 33456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc---
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--- 660 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--- 660 (783)
||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999999764 35889999999999999999999998 9999999999999999999999999875321000
Q ss_pred --------------------------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHH
Q 003963 661 --------------------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 696 (783)
Q Consensus 661 --------------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il 696 (783)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234799999999999999899999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhcccccccCC--CCCCHHHHHHHHHhh--hhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 697 WELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAIVESCW--HSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 697 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~LI~~cL--~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
|||++|..||...+.......+........++ ..+++++.+||.+|+ ..++..||++.++ +.|+||+.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~------l~hp~f~~ 310 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI------KAHPFFSE 310 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH------hcCcccCC
Confidence 99999999998877655544443223333333 358999999999954 5566669999999 67899865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=357.63 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=214.7
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||||++.+... .......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 46799999876532 223456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999998764 46899999999999999999999998 99999999999999999999999999875433323334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....++..+++++.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999888777766653 34456677899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 748 QCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+||++.++...-+-+.|+||+..
T Consensus 236 ~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 236 TMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999998333222222688998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.24 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=214.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.+.||+|+||.||++.+.. +..||+|++.... .......+.+|+++++.++||||+++++++..++.+++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45789999999999999999999875 4568999886543 345567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999764 35889999999999999999999852 2999999999999999999999999998755432
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--------------------
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-------------------- 721 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 721 (783)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 223456899999999999999999999999999999999999999766554432221100
Q ss_pred -------------------------cccccC-CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 722 -------------------------NQRLEI-PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 722 -------------------------~~~~~~-~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
...... ...+++++++||.+||+.||++|||+.++ +.|+||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el------l~h~~~~~~ 307 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML------MNHTFIKRS 307 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH------hcChHHhhc
Confidence 000111 12467899999999999999999999999 678888654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=372.63 Aligned_cols=261 Identities=23% Similarity=0.444 Sum_probs=216.8
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEec-eeec
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG-AVTS 574 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~-~~~~ 574 (783)
..+++..-+++|.++|.+|||+.||+|.+..+ .+||+|.+... ++..+..+.+||++|+.|+ |+|||.|++ ....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 34456667899999999999999999998776 89999998765 5677889999999999997 999999999 3321
Q ss_pred ---C---CceEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEE
Q 003963 575 ---P---QRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 647 (783)
Q Consensus 575 ---~---~~~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL 647 (783)
+ -.++|+||||.||.|.+++.. ....|++..+++|++++++|+++||.+..+|||||||-+||||+.+|++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 247899999999999999963 334599999999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccccc---------cCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003963 648 GDFGLSRLKHETYLTT---------KTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 715 (783)
Q Consensus 648 ~DFGla~~~~~~~~~~---------~~~~Gt~~Y~aPE~~---~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~ 715 (783)
||||.+.......... ....-|+.|+|||++ .+...++|+|||+|||+||-||....||+.....
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 9999986433221110 011248999999986 5788899999999999999999999999875332
Q ss_pred HHhhcccccccCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 716 GAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 716 ~~i~~~~~~~~~~--~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.| ++..+.+| +.++..+.+||+.||+.||.+||++-+++..+-+|+..
T Consensus 265 -aI--lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 -AI--LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -eE--EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 23 44444444 57899999999999999999999999999998877643
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=364.98 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=213.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|+++++||+|+||.||++.+.. ++.||||++.+... .......+.+|+.+++.++|||||++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999998764 56799999876432 3345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999764 46889999999999999999999999 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHH
Q 003963 662 ----------------------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVI 695 (783)
Q Consensus 662 ----------------------------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~i 695 (783)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHhhcccccccCCC--CCCHHHHHHHHHhhhhCCCCC---CCHHHHHHHHHHHHHHHhhc
Q 003963 696 LWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCR---PSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 696 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~LI~~cL~~dP~~R---Psa~ell~~L~~L~~~~f~~ 770 (783)
||||++|.+||...+....+..+........+|. .++.++.+||.+||. +|.+| +++.++ +.|+||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~------l~hp~~~~ 310 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI------KSHPFFRG 310 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH------hcCCCcCC
Confidence 9999999999988777666555543333344443 478999999999997 67765 599999 67888864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.75 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=213.3
Q ss_pred eeeccCCcEEEEEEEEe----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecC
Q 003963 511 EQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
+.||+|+||.||++.+. .++.||+|++............+.+|+.+++.++||||+++++++..++.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999999863 34679999998755444444567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCC
Q 003963 587 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 666 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 666 (783)
+++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999754 45899999999999999999999998 9999999999999999999999999987654443334456
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhC
Q 003963 667 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 746 (783)
Q Consensus 667 ~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~d 746 (783)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..+++.+.+||.+||+.|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 78999999999999889999999999999999999999999887776665553 3445677889999999999999999
Q ss_pred CCCCCCHHHH-HHHHHHHHHHHhhc
Q 003963 747 PQCRPSFQEL-VDKLRDLQRQYFQA 770 (783)
Q Consensus 747 P~~RPsa~el-l~~L~~L~~~~f~~ 770 (783)
|.+||++.+. ++.+ +.|+||+.
T Consensus 237 P~~R~~a~~~~~~~~--~~~~~~~~ 259 (318)
T cd05582 237 PANRLGAGPDGVEEI--KRHPFFST 259 (318)
T ss_pred HhHcCCCCCCCHHHH--hCCCCcCC
Confidence 9999995441 1111 45666643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=353.64 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=208.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----CceE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QRLC 579 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 579 (783)
+|++.++||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58999999999999999999764 57899999875433333445788999999999999999999987543 2479
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+|||||. ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999994 6899988764 35899999999999999999999998 999999999999999999999999998754322
Q ss_pred c---ccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-------------
Q 003963 660 Y---LTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM------------- 721 (783)
Q Consensus 660 ~---~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~------------- 721 (783)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+...
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234578999999999876 56889999999999999999999999776543322211000
Q ss_pred -----------cccc-----cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCC
Q 003963 722 -----------NQRL-----EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 775 (783)
Q Consensus 722 -----------~~~~-----~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~ 775 (783)
.... .....+++.+.+||.+||..||++||++.++ +.|+||+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~------l~hp~f~~~~~~~ 300 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA------LADPYFKGLAKVE 300 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH------hcCchhhhcCccc
Confidence 0000 0113467889999999999999999999999 6789997766543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.97 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=215.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+|.+.+.||+|+||.||+|.+..+ +.||||++.+.... ......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999998654 67999999865432 23345567788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998764 45889999999999999999999998 999999999999999999999999998754433333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..++.++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999888777666653 334567788999999999999
Q ss_pred hhhCCCCCCCH-----HHHHHHHHHHHHHHhhc
Q 003963 743 WHSDPQCRPSF-----QELVDKLRDLQRQYFQA 770 (783)
Q Consensus 743 L~~dP~~RPsa-----~ell~~L~~L~~~~f~~ 770 (783)
|+.||.+|++. .++ +.|+||+.
T Consensus 236 l~~~p~~R~~~~~~~~~~i------~~h~~~~~ 262 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDI------KEHAFFRY 262 (323)
T ss_pred cccCHHhcCCCCCCCHHHH------hcCCCcCC
Confidence 99999999974 555 46677753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=360.82 Aligned_cols=262 Identities=26% Similarity=0.478 Sum_probs=216.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEecee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 572 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 572 (783)
+....++|++.+.||+|+||.||+|.+.. ...||||++..... ......+.+|+.+++.+ +|+|||++++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34556789999999999999999998632 13699999876543 33456788999999999 899999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC------------------------------------------------------
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT------------------------------------------------------ 598 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~------------------------------------------------------ 598 (783)
...+.+++|||||++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999985421
Q ss_pred ---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc--
Q 003963 599 ---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 661 (783)
Q Consensus 599 ---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 661 (783)
.++++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 24678889999999999999999998 99999999999999999999999999875443221
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
......++..|||||++.+..++.++|||||||++|+|++ |+.||.....................+..+++++.++|.
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK 349 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence 1112235678999999998889999999999999999997 999998765544333333333344556678999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+||+.||.+||++.++++.|+++.
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=363.54 Aligned_cols=268 Identities=33% Similarity=0.571 Sum_probs=239.2
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEeCC----ce-EEEEEEecc-cCCHHHHHHHHHHHHHHHhCCCCceeeEec
Q 003963 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS----QD-VAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570 (783)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~-vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 570 (783)
-..|++..++..+.++||+|+||.||+|..+.. .. ||+|..... ....+...++.+|+++|+.++|||||+|||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 356888889999999999999999999987542 23 899998763 356788899999999999999999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
++.....+++|||+|+||+|.++|++++..++....+.++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999988777999999999999999999999998 999999999999999999999999
Q ss_pred CCCccccccccccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCC
Q 003963 651 GLSRLKHETYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 728 (783)
Q Consensus 651 Gla~~~~~~~~~~~-~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 728 (783)
|+++... .+.... ...-...|+|||.+....++.++|||||||++||+++ |..||.+....+....+.....+..+|
T Consensus 307 GLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 307 GLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred ccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 9987654 222222 2234679999999999999999999999999999999 888999999998888887677888889
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
...+.++..++..||..+|+.||++.++.+.|+.+....
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999999887663
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.60 Aligned_cols=260 Identities=22% Similarity=0.353 Sum_probs=218.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
....++|++.++||+|+||.||++.+.. ++.||+|++.+.... ......+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4456799999999999999999999865 567999999764322 23345577899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999998753 4788889999999999999999998 99999999999999999999999999876543
Q ss_pred cc-ccccCCCCCCcccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC--CC
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNE----PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DV 731 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~----~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~ 731 (783)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+....+..+........+|. .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 22 122355799999999998754 368899999999999999999999998887766666643333344444 57
Q ss_pred CHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003963 732 DPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~ 770 (783)
+.++.+||.+||..+|.+ |+++.++ +.|+||+.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~el------l~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEI------KSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHH------hcCcccCC
Confidence 999999999999999987 9999999 67888864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=346.61 Aligned_cols=256 Identities=30% Similarity=0.506 Sum_probs=210.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-----------------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-----------------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----------------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI 565 (783)
..++|++.++||+|+||.||+|.+.. +..||+|++.... .......+.+|+.++..++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 34689999999999999999998532 2359999987543 34456678999999999999999
Q ss_pred eeEeceeecCCceEEEEEecCCCCHHHHHhhcC------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCE
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT------------------TKLDWRRRILMALDIARGVSYLHHCNPPI 627 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~I 627 (783)
+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 999999999999999999999999999986421 23677889999999999999999998 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CC
Q 003963 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EK 703 (783)
Q Consensus 628 vHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt--G~ 703 (783)
+||||||+|||++.++.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987543321 11223345789999999998889999999999999999986 67
Q ss_pred CCCCCCChHHHHHHhhcc------cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 704 IPWDNLNSMQVIGAVGFM------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 704 ~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.||...+..+....+... ......+..++..+.+||.+||..||.+|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 899887766655443211 1122345678899999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=359.00 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=218.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|.+.+.||+|+||.||++.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999764 56799999986543 2345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc-c
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-L 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~ 661 (783)
||+++++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999876667999999999999999999999998 9999999999999999999999999997654322 1
Q ss_pred cccCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC--CCCCH
Q 003963 662 TTKTGKGTPQWMAPEVLR------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDP 733 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~------~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~ 733 (783)
......||+.|+|||++. +..++.++|||||||++|+|++|..||...+....+..+........+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457899999999987 4557889999999999999999999998887766665554333333333 35789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+.+||.+||. +|.+||++.++ +.|+||+.
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l------~~h~~~~~ 268 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGL------CCHPFFSK 268 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHH------hCCCCcCC
Confidence 99999999997 99999999999 67888865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=374.88 Aligned_cols=265 Identities=32% Similarity=0.589 Sum_probs=230.7
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEec
Q 003963 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570 (783)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 570 (783)
....++...+.+..+.||+|+||+||+|...+ ..-||||.++... +....+.|++|++++..|+|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34456777889999999999999999998643 2349999987655 4456789999999999999999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhc-------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCE
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 637 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NI 637 (783)
+|..++.+|||+|||..|+|.++|..+ +.+++..+.+.|+.||+.||.||-++. +|||||-.+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 999999999999999999999999642 123888999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEEecCCCcccc-ccccccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 003963 638 LVDKHWTVKVGDFGLSRLKH-ETYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQV 714 (783)
Q Consensus 638 Ll~~~~~vkL~DFGla~~~~-~~~~~~~-~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~ 714 (783)
||+++..|||+|||+++..- ..|.... ...-..+|||||.+....++.++||||+||+|||+++ |+.||.++...++
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 99999999999999998432 2222211 2234679999999999999999999999999999999 9999999999999
Q ss_pred HHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 715 ~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
++.+....- +.-|.++|.++++|+..||+.+|.+||++.||-..|.++-.
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 998875544 88899999999999999999999999999999998877644
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.17 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=212.9
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||||++..... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999865 46799999976532 234455677889998866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999988764 45889999999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+. .....+|..+++++.+||.+||.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 8999999999999999999999999999999999999999888877766653 33455677789999999999999999
Q ss_pred CCCC-------CHHHHHHHHHHHHHHHhhc
Q 003963 748 QCRP-------SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RP-------sa~ell~~L~~L~~~~f~~ 770 (783)
.+|| ++.++ +.|+||+.
T Consensus 236 ~~R~~~~~~~~~~~~~------~~hp~~~~ 259 (321)
T cd05591 236 NKRLGCVASQGGEDAI------KQHPFFKE 259 (321)
T ss_pred HHcCCCCCCCCCHHHH------hcCCccCC
Confidence 9999 78888 56777744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=363.85 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=204.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 575 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 34689999999999999999999854 5689999886533 1234699999999999999998876432
Q ss_pred --CceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEe
Q 003963 576 --QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGD 649 (783)
Q Consensus 576 --~~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~D 649 (783)
..+++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 246799999965 78777642 3456899999999999999999999998 99999999999998664 799999
Q ss_pred cCCCcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----
Q 003963 650 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----- 723 (783)
Q Consensus 650 FGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----- 723 (783)
||+++...... ......||+.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+..+.+..+.....
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998654332 22345789999999998764 689999999999999999999999988766544433221100
Q ss_pred ----------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 724 ----------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 724 ----------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
...+|...++++.+||.+||..||.+|||+.++ |+|+||+..+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~------l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA------LADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH------hCChhHHhhhc
Confidence 011344578899999999999999999999999 78899977654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=347.19 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=205.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEe--CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC---CCCceeeEeceee-----c
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT-----S 574 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~ 574 (783)
++|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999874 346799999876544333334556677777766 6999999999875 3
Q ss_pred CCceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
...+++||||++ ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 5999998653 345889999999999999999999998 999999999999999999999999998
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------- 724 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 724 (783)
...... .......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+......
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 765433 2233456899999999999988999999999999999999999999887766554443211100
Q ss_pred ----------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 ----------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 ----------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
..+...+++.+.+||.+||+.||++|||+.++ |+|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~------l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH------hcCCCC
Confidence 01123467889999999999999999999999 567776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=364.30 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=213.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+|+++++||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+|+.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 379999999999999999999765 567999998754322 234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc---
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--- 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--- 659 (783)
|||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999764 45888999999999999999999998 999999999999999999999999997422100
Q ss_pred ----------------------------------------cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHH
Q 003963 660 ----------------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 699 (783)
Q Consensus 660 ----------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~el 699 (783)
.......+||+.|||||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134699999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHhhcccccccCC--CCCCHHHHHHHHHhhhhCCCCCC---CHHHHHHHHHHHHHHHhhcC
Q 003963 700 ATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRP---SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 700 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~LI~~cL~~dP~~RP---sa~ell~~L~~L~~~~f~~~ 771 (783)
++|+.||...+.......+........++ ..+++++.+||.+|+ .+|.+|+ ++.++ +.|+||+..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el------l~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI------KAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH------hCCCCcCCC
Confidence 99999999887766555543332233333 368899999999976 5999999 89999 678888653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=358.98 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=213.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEe------CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEecee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 572 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 572 (783)
+++..++|++.++||+|+||.||+|.+. ....||||++...... .....+.+|+.++..+ +|||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3455678999999999999999999753 2346999998654332 3346788999999999 899999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC------------------------------------------------------
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT------------------------------------------------------ 598 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~------------------------------------------------------ 598 (783)
...+..++|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986432
Q ss_pred --------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 599 --------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 599 --------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 14678888999999999999999998 99999999999999999999999999876543
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....................+...+.++
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 346 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM 346 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence 221 1112334678999999999999999999999999999998 8999987654433333322223444566778999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
.+||.+||..||++||++.++++.|++
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=344.70 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=225.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+-|.++.+||+|+||.||++.++.+ +.+|||.+..+. -++++..|+.|+++++.|+||++||.|.....++||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4577889999999999999998764 668999876543 35678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
||..|++.++++..+.+++++.+..+++..++||+|||... =||||||..|||++.+|..||+|||.+-...+.....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 99999999999988889999999999999999999999987 7999999999999999999999999998887777777
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~~c 742 (783)
.+..|||.|||||++..-.|+.++||||||++..||..|++||.+..+...+..+... ...+.-|..++.++.+||++|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 7889999999999999999999999999999999999999999998887655444221 123445667899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|.++|++|.|+.++ ++|+|.++.
T Consensus 267 LiK~PE~R~TA~~L------~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRL------CEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHH------hhhhhhcCC
Confidence 99999999999999 678887653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=362.71 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=213.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+|+++++||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++|||||++++++...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999865 46799999876543 23456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc---
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--- 660 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--- 660 (783)
||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999999764 45889999999999999999999998 9999999999999999999999999975321000
Q ss_pred --------------------------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHH
Q 003963 661 --------------------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 696 (783)
Q Consensus 661 --------------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il 696 (783)
......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001234689999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhcccccccCC--CCCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhcC
Q 003963 697 WELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 697 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~LI~~cL~~dP~~RPs---a~ell~~L~~L~~~~f~~~ 771 (783)
|||++|++||...+.......+........+| ..+++++.++|.+|+ .+|.+|++ +.++ +.|+||+..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei------~~hp~f~~~ 311 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI------KAHPFFKTI 311 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH------hcCCCcCCc
Confidence 99999999999887766555543333333333 468999999999976 59999987 8888 578888653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=336.90 Aligned_cols=258 Identities=31% Similarity=0.561 Sum_probs=220.0
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|++..++|++.++||+|+||.||+|.+..+..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 4566789999999999999999999987778899998765432 2467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999998653 356888899999999999999999988 99999999999999999999999999976544
Q ss_pred cccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... ...+.+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHH
Confidence 3221 122345678999999998889999999999999999998 99999887776666555322 23444567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
++|.+||..+|++||+++++++.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.45 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=217.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++.+.||+|+||.||++.+.. ++.||+|++.+... .......+.+|+.+++.++||||+++++++..+..+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999865 46799999875432 2233456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+|||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999999754 4888999999999999999999998 999999999999999999999999999765432
Q ss_pred c-ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC--CCC
Q 003963 660 Y-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVD 732 (783)
Q Consensus 660 ~-~~~~~~~Gt~~Y~aPE~~~~~~----~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s 732 (783)
. ......+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+....+..+........+|. .++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 2 1233567999999999987643 67899999999999999999999998887766666644333444444 568
Q ss_pred HHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcC
Q 003963 733 PRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~~ 771 (783)
..++++|..||..++.+ |+++.++ ++|+||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~------l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEI------KQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHH------hcCcccCCC
Confidence 99999999999855543 8899999 678999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.53 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=208.9
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
++||+|+||.||+|.+.. ++.||||++...... ......+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 467999999765322 23344556677777654 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999998764 46899999999999999999999998 99999999999999999999999999975443333334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..++.++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777666553 34556778899999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHHHHHhhc
Q 003963 748 QCRPSFQ-ELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RPsa~-ell~~L~~L~~~~f~~ 770 (783)
.+||++. ++ +.|+||+.
T Consensus 236 ~~R~~~~~~l------~~h~~~~~ 253 (316)
T cd05592 236 TKRLGVDGDI------RQHPFFRG 253 (316)
T ss_pred HHcCCChHHH------HcCcccCC
Confidence 9999875 45 34666643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=355.10 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=230.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCC-CCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 578 (783)
.....|++.+.||.|.||.||++..+. ++.+|+|++.+..... .....+.+|+.+|+++. |||||.++++|+....+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345689999999999999999999877 6789999998776543 24567889999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC----CCcEEEEecCCCc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFGLSR 654 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~----~~~vkL~DFGla~ 654 (783)
++|||+|.||.|++.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+.. ++.+|++|||++.
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999776 3999999999999999999999999 999999999999953 3589999999999
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVD 732 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s 732 (783)
.... .......+||+.|+|||++....++..+||||+|+++|.|++|.+||...+.......+..... ..+....++
T Consensus 188 ~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 8777 4455678999999999999999999999999999999999999999999988877777655444 233446689
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
..+++||+.||..||..|+++.++ |+|+|.+.....
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~------L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQA------LQHPWIKSIGEA 302 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHH------hcCccccCCccc
Confidence 999999999999999999999999 568998765433
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.44 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=210.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--C---ce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--Q---RL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~---~~ 578 (783)
-.|...+++|.|+||.||.|..... ++||||++-.+..-. .+|+++|+.++|||||++..+|... . ++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3678889999999999999998665 789999986654322 3699999999999999999887532 2 46
Q ss_pred EEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCCCc
Q 003963 579 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 654 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~ 654 (783)
.+|||||+. +|++.++. .+..++.-.++.+..||++||+|||+.| |+||||||.|+|||.+ |.+||||||.|+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 789999965 99999874 3567888899999999999999999988 9999999999999976 999999999999
Q ss_pred ccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-------- 725 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 725 (783)
........ .+...|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|.+.+....+..+..+.+.+
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 77655433 455679999999998875 58999999999999999999999999988776665443221111
Q ss_pred -------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 726 -------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 726 -------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
-+....++++.+|+.++|+.+|.+|.++.++ |.|+||+.-|..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~------l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA------LAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH------hcchhhHHhhCc
Confidence 0234578999999999999999999999999 789999766554
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.26 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=211.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccCC--HHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCce
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 578 (783)
+|++.++||+|+||.||++... .++.||+|++.+.... ......+..|+.+++.++ ||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 3467999999764322 234456788999999995 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999998753 45899999999999999999999998 99999999999999999999999999875433
Q ss_pred cc-ccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhcccccccCCCCCC
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s 732 (783)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+ ......++..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 21 2223457899999999998754 78899999999999999999999964322 2222222 234456777899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 733 PRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
+.+.+||.+||..||.+|| ++.++ +.|+||+..
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~------l~h~~~~~~ 273 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEI------KEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHH------HcCCCcCCC
Confidence 9999999999999999999 77888 677888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.01 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=209.5
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHH-HHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||||++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999864 577999999765332 222334444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999999764 46889999999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..+++.+.+||.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 8999999999999999999999999999999999999999887776665553 33455667789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhc
Q 003963 748 QCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||++.+.+..+ +.|+||..
T Consensus 236 ~~R~~~~~~~~~i--l~~~~~~~ 256 (323)
T cd05575 236 TKRLGAKDDFLEI--KNHVFFSS 256 (323)
T ss_pred HhCCCCCCCHHHH--HcCCCcCC
Confidence 9999985333222 56788754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=341.12 Aligned_cols=256 Identities=34% Similarity=0.603 Sum_probs=218.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..++|++.+.||+|+||.||+|.+... ..|++|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 456899999999999999999987543 358999886443 3455677899999999999999999999999989
Q ss_pred ceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 641 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~ 641 (783)
..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 9999999999999999997532 35788899999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003963 642 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 718 (783)
Q Consensus 642 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i 718 (783)
++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543221 12223456788999999998889999999999999999998 99999988877766555
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
. .......+..+++++.+|+.+||..||.+||++.+|++.|+.
T Consensus 240 ~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3 223445677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.35 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=213.0
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 46799999986542 223455677899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999988764 36899999999999999999999998 99999999999999999999999999865333333333457
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..++..+.+||.+||..||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 8999999999999999999999999999999999999998887776665553 33455677899999999999999999
Q ss_pred CCCCCH-----HHHHHHHHHHHHHHhhc
Q 003963 748 QCRPSF-----QELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RPsa-----~ell~~L~~L~~~~f~~ 770 (783)
.+||++ .++ +.|+||+.
T Consensus 236 ~~R~s~~~~~~~~l------l~~~~~~~ 257 (318)
T cd05570 236 EKRLGCLPTGEQDI------KGHPFFRE 257 (318)
T ss_pred HHcCCCCCCCHHHH------hcCCCcCC
Confidence 999999 777 56778755
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.40 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=210.2
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
++||+|+||.||+|.+.. ++.||+|++...... ......+..|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999865 467999999765321 22345566788888754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.............+
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999998764 45889999999999999999999998 99999999999999999999999999864332222334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..++.++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 8999999999999999999999999999999999999998888776666553 23455677899999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHHHHHhhcC
Q 003963 748 QCRPSFQ-ELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 748 ~~RPsa~-ell~~L~~L~~~~f~~~ 771 (783)
.+||++. ++ +.|+||+..
T Consensus 236 ~~R~~~~~~~------~~h~~f~~~ 254 (316)
T cd05620 236 TRRLGVVGNI------RGHPFFKTI 254 (316)
T ss_pred HHcCCChHHH------HcCCCcCCC
Confidence 9999974 55 457888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.62 Aligned_cols=260 Identities=22% Similarity=0.383 Sum_probs=214.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
+..++|++.++||.|+||.||++.+.. +..+|+|++.... .......+.+|+++++.++||||+++++++..++.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 345789999999999999999999875 4568888876543 34456678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999764 3588999999999999999999974 5 999999999999999999999999998755432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-------------------
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF------------------- 720 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~------------------- 720 (783)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 22345689999999999998899999999999999999999999976554333211100
Q ss_pred ------------------------ccccccCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 721 ------------------------MNQRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 721 ------------------------~~~~~~~~-~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
......++ ..++.++++||.+||+.||.+||++.++ ++|+||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el------l~h~~~~~~~~ 307 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL------MVHAFIKRSEA 307 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH------hhCHHHhcCcc
Confidence 00001111 1357889999999999999999999999 67899987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.14 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=217.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 580 (783)
+....|+++++||+||.+.||++...+.+.||+|.+.....+...+.-|.+|+.+|..|+ |.+||++|+|-..++++||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 456789999999999999999999887888999998888888888999999999999996 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc-
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET- 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~- 659 (783)
||||- ..+|..+|++.....+.-.+..++.||+.++.++|.+| |||.||||.|+|+-. |.+||+|||+|..+...
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 99998 45999999876655554478889999999999999999 999999999999965 49999999999866543
Q ss_pred -cccccCCCCCCcccCcccccCCC-----------CCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccc
Q 003963 660 -YLTTKTGKGTPQWMAPEVLRNEP-----------SDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLE 726 (783)
Q Consensus 660 -~~~~~~~~Gt~~Y~aPE~~~~~~-----------~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~ 726 (783)
.....+.+||+.||+||.+.... .++++||||||||||+|+.|++||.... ....+..+...+..++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 33445668999999999986433 3578999999999999999999997654 3333444433333445
Q ss_pred CCCCCCHH-HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 727 IPKDVDPR-WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 727 ~~~~~s~~-l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+|..-+.. +.++++.||.+||++||+..+| |+|+|.+-
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eL------LqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPEL------LQHPFLQI 632 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHH------hcCccccc
Confidence 55544443 9999999999999999999999 67888765
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=353.48 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=208.5
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||++.+.. ++.||||++.+.... ......+..|+.+++.+ +||||+++++++.....+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999865 467999999875433 23456678899999988 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999988654 46999999999999999999999998 99999999999999999999999999875333233334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--------HHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--------MQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....... .......+|..++.++.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-ILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-HHcCCCCCCCCCCHHHHHHH
Confidence 99999999999999999999999999999999999999963211 1111111 12345567888999999999
Q ss_pred HHhhhhCCCCCCC------HHHHHHHHHHHHHHHhhc
Q 003963 740 ESCWHSDPQCRPS------FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 740 ~~cL~~dP~~RPs------a~ell~~L~~L~~~~f~~ 770 (783)
.+||..||.+|++ +.++ +.|+||+.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i------~~hp~~~~ 267 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDI------KSHPFFRN 267 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHH------hcCCCCCC
Confidence 9999999999997 5666 67888854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.45 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=215.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||++.+.. ++.||||++..... .......+..|+.++..++||||+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478999999999999999999865 56799999975432 2345567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 660 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 660 (783)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999764 45899999999999999999999998 9999999999999999999999999986432110
Q ss_pred ---------------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 661 ---------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 661 ---------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123479999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhcccccccCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhcC
Q 003963 708 NLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 708 ~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~LI~~cL~~dP~~RPs---a~ell~~L~~L~~~~f~~~ 771 (783)
..+.......+........+|. .+++++++||.+|+. ||.+|++ +.++ +.|+||+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei------~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEI------KSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH------hcCCCCCCC
Confidence 8887776666543333334443 378999999999874 9999985 6677 689999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.10 Aligned_cols=250 Identities=34% Similarity=0.590 Sum_probs=214.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++|++.+.||+|+||.||++.+.....+|+|.+....... ..+.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccH---HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 5789999999999999999998777789999886554332 4678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc-c
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-T 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 663 (783)
+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999999765556899999999999999999999998 999999999999999999999999998754332211 1
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+... .....+...+..+.++|.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHH
Confidence 22235668999999998889999999999999999999 99999988877766665432 23445666889999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L 760 (783)
|..+|.+||++.++++.|
T Consensus 238 ~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 238 WHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ccCCcccCcCHHHHHHhh
Confidence 999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.35 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=209.8
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHh-CCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||||++...... ......+..|..++.. ++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 467999999765321 2233456667888876 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999763 45889999999999999999999998 99999999999999999999999999875433222334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...++..++.++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhccCH
Confidence 899999999999999999999999999999999999999988877766665332 344667789999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHHHHHhhcC
Q 003963 748 QCRPSFQ-ELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 748 ~~RPsa~-ell~~L~~L~~~~f~~~ 771 (783)
.+||++. ++ ++|+||+..
T Consensus 236 ~~R~~~~~~l------~~h~~~~~~ 254 (316)
T cd05619 236 ERRLGVKGDI------RQHPFFREI 254 (316)
T ss_pred hhcCCChHHH------HcCcccCCC
Confidence 9999997 55 567777553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=362.30 Aligned_cols=250 Identities=32% Similarity=0.531 Sum_probs=221.9
Q ss_pred eeccCCcEEEEEEEEeCCc-eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 512 QIGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~~~-~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
+||+|+||+||-|++..++ .+|||-+.... ....+.+..|+.+.++|+|.|||+++|.+..++++-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6899999999999998764 58999886544 23457889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcc--hHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEEEecCCCcccccccccccCCC
Q 003963 591 FRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 591 ~~~L~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
..+|+..=.++ .+...-.+.+||++||.|||++. |||||||-+||||+ ..|.+||+|||.++........+.++.
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99998765566 88899999999999999999998 99999999999996 579999999999988776667778899
Q ss_pred CCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 668 GTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~--~s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
||..|||||++..++ |+.++|||||||++.||.||++||..+...+ ....+......+++|..++.+++.||.+|+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 999999999997654 7889999999999999999999998775443 4456666777899999999999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 745 SDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 745 ~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||..||++.++ |+++|.|-+
T Consensus 818 pd~~~R~sA~~L------L~DpFlq~~ 838 (1226)
T KOG4279|consen 818 PDPCDRPSAKDL------LQDPFLQHN 838 (1226)
T ss_pred CCcccCccHHHh------ccCcccccC
Confidence 999999999999 788888665
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.33 Aligned_cols=258 Identities=32% Similarity=0.583 Sum_probs=222.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
|....+|++.++||.|+||.||+|.+..++.+++|++..... .....+..|+.+++.++||||+++++++......++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 344568999999999999999999988888899999876543 234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+|+.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999999753 345889999999999999999999998 999999999999999999999999999766544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
........++..|++||.+.+..++.++|||||||++|+|++ |+.||...+....+..+. .......+..+++.+.++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence 333334456778999999998889999999999999999998 899998887766666554 233456677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
|.+||+.||.+|||+.++++.|+.+
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=363.96 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=217.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 576 (783)
...++|.+.+.||+|+||.||++.+.. ++.||||++............+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345799999999999999999998754 578999999877766666778889999999999999999988775432
Q ss_pred ----ceEEEEEecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 577 ----RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 577 ----~~~lV~E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
.+++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999998642 346889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC
Q 003963 650 FGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 727 (783)
Q Consensus 650 FGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 727 (783)
||+++..... .......+||+.|+|||++.+..++.++|||||||+||+|++|+.||...+....+..+.. .....+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCC
Confidence 9998765432 1123355799999999999999999999999999999999999999998877666555432 223456
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~ 759 (783)
+..+++++.+||.+||..||.+||++.+++++
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 78899999999999999999999999999643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.72 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=212.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|.+.++||+|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3679999999999999999999864 467999998754322 22345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++ +|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99965 898888776666889999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------c
Q 003963 663 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------R 724 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~ 724 (783)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+..... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 334567899999998865 4578999999999999999999999987765443332211100 0
Q ss_pred c-----------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 725 L-----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 725 ~-----------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
. .....+++++.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~------l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA------MKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH------hcChhhhhcc
Confidence 0 1113478899999999999999999999999 6799998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.35 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=207.7
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||+|+||.||++.+.. ++.||+|++....... .....+..|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999998764 5689999987654332 3345677899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 591 FRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 591 ~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 888743 2345899999999999999999999998 99999999999999999999999999876554333334457
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--hcccccccCCCCCCHHHHHHHHHhhhh
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHS 745 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~s~~l~~LI~~cL~~ 745 (783)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ........++..+++.+.+|+.+||+.
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 899999999999999999999999999999999999999765332111111 112234456677899999999999999
Q ss_pred CCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 746 DPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 746 dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
||.+|| ++.++ +.|+||+..
T Consensus 239 ~P~~R~~~~~~~~~~~------l~h~~~~~~ 263 (280)
T cd05608 239 DPEKRLGFRDGNCDGL------RTHPLFRDL 263 (280)
T ss_pred CHHHhcCCCCCCHHHH------hcChhhhcC
Confidence 999999 66777 568999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=349.15 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=215.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+|++.+.||+|+||.||+|.+.. ++.||||++.+... .......+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47888999999999999999765 56799999976532 2234456778899998886 577888999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999998764 45899999999999999999999998 999999999999999999999999998754333333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++.++.+++.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHHH
Confidence 445578999999999999999999999999999999999999999888776666653 334567788999999999999
Q ss_pred hhhCCCCCCCHHH-HHHHHHHHHHHHhhcC
Q 003963 743 WHSDPQCRPSFQE-LVDKLRDLQRQYFQAS 771 (783)
Q Consensus 743 L~~dP~~RPsa~e-ll~~L~~L~~~~f~~~ 771 (783)
|.++|.+|++..+ ..+.+ +.|+||+..
T Consensus 236 l~~~p~~R~~~~~~~~~~i--~~h~~f~~~ 263 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDI--REHAFFRRI 263 (323)
T ss_pred cccCHhhCCCCCCCCHHHH--hcCcccCCC
Confidence 9999999997432 11222 577888653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.01 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=207.9
Q ss_pred eeeccCCcEEEEEEEEeCC-ceEEEEEEecccCC-HHHHHHHHHHH-HHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS-DEVIHSFRQEV-SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~-~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+..+ +.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999998654 57999999764322 12223344444 457889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|.+++... ..+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999764 45788888999999999999999998 99999999999999999999999999875433333344567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+. .....++..+++.+.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999888776665552 23445667899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhc
Q 003963 748 QCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||++.+.+..+ +.|+||..
T Consensus 236 ~~R~~~~~~~~~i--~~~~~~~~ 256 (325)
T cd05602 236 TKRLGAKDDFMEI--KNHIFFSP 256 (325)
T ss_pred HHCCCCCCCHHHH--hcCcccCC
Confidence 9999887554333 45666643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.82 Aligned_cols=258 Identities=33% Similarity=0.567 Sum_probs=219.4
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|++..++|++.+.||+|+||.||+|.+..++.||+|.+...... ...+.+|+.+++.++||||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34566789999999999999999999877778999998754432 356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999997543 46899999999999999999999998 99999999999999999999999999876553
Q ss_pred ccccc-cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~-~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
..... .....+..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.. ......+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPKELY 234 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHH
Confidence 32111 11123457999999999899999999999999999999 9999988877766655532 233455667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+++.+||+.+|.+||++.+++..|+++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.65 Aligned_cols=261 Identities=27% Similarity=0.351 Sum_probs=216.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc-eeeEeceeecCC-----
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQ----- 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~----- 576 (783)
...|..+++||+|+||+||+|+.+. ++.||+|++......+..-....+|+.+|+.|+|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4567778889999999999999865 467999999776543333356678999999999999 999999998777
Q ss_pred -ceEEEEEecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 577 -RLCIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 577 -~~~lV~E~~~ggsL~~~L~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
.+++||||+. -+|..++.... ..++...+..+++||+.||+|||+++ |+||||||.||||++.|.+||+|||+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 7999999995 59999998765 45788899999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------ 725 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------ 725 (783)
|+...-+.......++|..|+|||++.|. .|+...||||+||+++||+++++-|.+......+..+-...+.+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 98665444444556789999999999987 68999999999999999999999999888876665542221111
Q ss_pred ----------cCC------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 726 ----------EIP------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 726 ----------~~~------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.++ +..++...+++.+||+.+|.+|.|+..+ |.|+||+....
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a------l~h~yf~~~~~ 310 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA------LTHPYFSELPE 310 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH------hcChhhccccc
Confidence 011 1233578999999999999999999999 78899977644
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=354.31 Aligned_cols=264 Identities=28% Similarity=0.477 Sum_probs=217.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEec
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG 570 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~ 570 (783)
..|+...++|+++++||+|+||.||+|.+... ..||||++.... .....+.+.+|+.+|+.+. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 45667778999999999999999999986431 359999986543 3344567899999999996 999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcC----------------------------------------------------
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------------------------------------------- 598 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------------------------------------------- 598 (783)
++.....+|||||||++|+|.+++..+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999886421
Q ss_pred -------------------------------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCC
Q 003963 599 -------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635 (783)
Q Consensus 599 -------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~ 635 (783)
..+++..++.++.||+.||+|||+.+ |+|+||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 23677788899999999999999988 999999999
Q ss_pred CEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 003963 636 NLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 712 (783)
Q Consensus 636 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~ 712 (783)
|||++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999987543321 12223356788999999999999999999999999999997 99999876544
Q ss_pred HHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
...............+..++..+.++|.+||..+|++||++.+|.+.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 3332222233345566788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=355.20 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=215.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.++..++|++.+.||+|+||.||++.+.. ++.||+|++.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34556899999999999999999999865 46799999875432 22334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+|||||++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999999999754 4788889999999999999999998 9999999999999999999999999987654
Q ss_pred ccc-ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC--CC
Q 003963 658 ETY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KD 730 (783)
Q Consensus 658 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~----~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~ 730 (783)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+........+| ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 322 1233567999999999987643 6889999999999999999999999888776666664433333333 46
Q ss_pred CCHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003963 731 VDPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~ 770 (783)
++..+++||..||...+.+ |+++.++ ++|+||+.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei------~~h~~~~~ 309 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEI------KRHLFFKN 309 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHH------hcCcccCC
Confidence 8999999999999844433 7899999 56777755
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.45 Aligned_cols=256 Identities=34% Similarity=0.558 Sum_probs=219.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.++|++.+.||+|+||.||+|.+.. ...||||++.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 4679999999999999999998753 2468999886543 3445567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc-
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE- 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~- 658 (783)
++|||+++++|.+++......+++..++.++.|++.||+|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999876667899999999999999999999988 99999999999999999999999999987642
Q ss_pred -ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 -TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 -~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ....+.+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 238 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSALY 238 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 1112223345678999999999889999999999999999998 9999988877766655532 223455667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+|+.+||+.+|.+||++.++++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=350.97 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=207.9
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||++.+.. ++.||+|++.+.... ......+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 467999999875432 34456678899888877 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999888654 46899999999999999999999998 99999999999999999999999999875433333334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--------SMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ .......+|..++..+.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-ILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-HhcCCCCCCCCCCHHHHHHH
Confidence 8999999999999999999999999999999999999995321 11111111 13345567888999999999
Q ss_pred HHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPsa------~ell~~L~~L~~~~f~~~ 771 (783)
.+||..||.+||++ .++ +.|+||+..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i------~~hp~f~~~ 268 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADI------QGHPFFRNV 268 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHH------hcCCCCCCC
Confidence 99999999999984 566 678888653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.87 Aligned_cols=268 Identities=33% Similarity=0.536 Sum_probs=222.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 573 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 573 (783)
|++..++|++.++||+|+||.||+|.++. ...||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 45667899999999999999999997642 2469999876543 2333456788999999999999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
.....|+||||+++|+|.+++.... ..+....++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 9999999999999999999996522 23456778899999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003963 645 VKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 645 vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~ 721 (783)
++|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875433221 1122345778999999999889999999999999999998 799998877766555442 2
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
......+..+++.+.++|.+||+.+|.+||++.++++.|++..+++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 23445566788999999999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.50 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=217.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
++|++.+.||+|+||.||++.+.. +++|++|++....... .....+.+|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468999999999999999998754 5789999987554322 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999999764 35888999999999999999999998 9999999999999999999999999987543321
Q ss_pred ccc---cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 661 LTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 661 ~~~---~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+................++..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23457889999999999989999999999999999999999998776665555554444556677889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+|.+||..+|.+||++.++ ++++||
T Consensus 239 li~~~l~~~p~~Rpt~~~l------l~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEEL------LRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHH------hhCCCC
Confidence 9999999999999999999 455654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=361.92 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=212.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC--CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG--SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
..|.+.+.||+|+||.||+|.... ++.||+|++... .......+.+|+.+|+.++|||||++++++..++.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 459999999999999999998754 356888876433 2344456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||+++|+|.+++.. ...++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999998853 2345889999999999999999999998 999999999999999999999999999865433
Q ss_pred cc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 YL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ....++..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHH
Confidence 21 233457999999999999999999999999999999999999999888776666555322 233456778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~ 758 (783)
||.+||.+||.+||++.+++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999964
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.55 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=215.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.++||+|+||.||+|.+. .++.||||++.... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999976 45789999886533 33455667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988853 2345788999999999999999999998 999999999999999999999999998766543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.........+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3333345688999999999988899999999999999999999999965432 33333332222222223457789999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+|.+||..+|.+||++.++++.|+.++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.61 Aligned_cols=259 Identities=27% Similarity=0.506 Sum_probs=217.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-c----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-Q----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..+|++.+.||+|+||.||+|.+... . .||+|++.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46899999999999999999987533 2 38999986432 344556788999999999999999999998764 57
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++++||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccC
Confidence 8999999999999999877667889999999999999999999998 99999999999999999999999999986543
Q ss_pred cccc--ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~~~--~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.... .....++..|++||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHH
Confidence 2211 122334678999999999999999999999999999998 999998877665543332 333455567788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.++|.+||..+|.+||++.+++..|.++....
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 99999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=330.83 Aligned_cols=251 Identities=33% Similarity=0.595 Sum_probs=214.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.++|++.+.||+|+||.||++.+.+...||+|.+....... ..+.+|+.+++.++||||+++++++.....++++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH---HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 36799999999999999999988777679999987554432 467889999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-c
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 662 (783)
|+.+++|.+++......+++..++.++.||+.||+|||+.+ |+|+||||.|||++.++.+||+|||+++....... .
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999999876557899999999999999999999998 99999999999999999999999999875543321 1
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
.....++..|++||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ......+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 112235678999999998889999999999999999998 9999988877666555532 23344566678999999999
Q ss_pred hhhhCCCCCCCHHHHHHHH
Q 003963 742 CWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L 760 (783)
||..+|.+||++.+|+..|
T Consensus 237 cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HcCCCcccCCCHHHHHHhh
Confidence 9999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.99 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=213.0
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.|++.++||+|+||.||++.+.. ++.||+|++....... .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999754 5789999987654332 233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999888653 346899999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--ccccccCCCCCCHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~LI~ 740 (783)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.. ......++..+++.+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 2345789999999999998899999999999999999999999987655332222211 12234456678999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 741 SCWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 741 ~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
+||..||.+|| ++.++ ++|+||..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l------~~~~~~~~ 266 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEV------KAHPFFRT 266 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHH------hcCcCccC
Confidence 99999999999 88898 56777743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.43 Aligned_cols=256 Identities=32% Similarity=0.586 Sum_probs=218.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|++..++|++.++||+|+||.||+|....++.||+|.+....... ..+.+|+.+++.++|+||+++++++. .+.++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 466778999999999999999999998888899999987655433 46788999999999999999999874 56789
Q ss_pred EEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++|||+.+++|.+++... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999998653 346889999999999999999999998 99999999999999999999999999876552
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |++||...+..+....+.. ......+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 22 11223345678999999998889999999999999999999 9999988877666555432 234456677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
++|.+||..+|++||++++++..|+.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=330.48 Aligned_cols=258 Identities=34% Similarity=0.607 Sum_probs=218.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
|++...+|.+.++||+|+||.||+|.+.. ++.|++|++.... .....+.+|+.+++.++||||+++++++.....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 35566789999999999999999999765 5679999986543 2245688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 579 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999999999653 345889999999999999999999988 9999999999999999999999999987654
Q ss_pred cccccc-cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 658 ETYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 658 ~~~~~~-~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
...... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.. ......+..++.++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKV 234 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHH
Confidence 432111 12234568999999999999999999999999999998 9999988777666555432 23456677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.++|.+||..+|.+||++.++++.|+.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.62 Aligned_cols=258 Identities=21% Similarity=0.355 Sum_probs=213.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||++.+.. ++.||+|++.+... .......+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 479999999999999999999765 56799999975332 2334566888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999876667899999999999999999999998 99999999999999999999999999865443221
Q ss_pred cccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC---CCCCH
Q 003963 662 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---KDVDP 733 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~-----~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~ 733 (783)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223468999999999873 346789999999999999999999998877766655553333223333 34789
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003963 734 RWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+++||.+||..++++ |+++.++ +.|+||..
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~------l~hp~~~~ 271 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDF------KDHPFFEG 271 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHH------hcCCCCCC
Confidence 9999999988654443 7899999 67888854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.71 Aligned_cols=259 Identities=21% Similarity=0.366 Sum_probs=214.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.++||+|+||.||++.+.. ++.||+|++.+... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999865 45699999865432 2233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc-cc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~ 661 (783)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999876667899999999999999999999998 999999999999999999999999998654322 12
Q ss_pred cccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC---CCCCH
Q 003963 662 TTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---KDVDP 733 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~ 733 (783)
.....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+.+..+........+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999888777766664433333333 35799
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcC
Q 003963 734 RWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~~ 771 (783)
++.+||.+||..++.+ |+++.++ ++|+||+..
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~------~~h~~f~~~ 272 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDF------KQHPFFTGI 272 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHH------hCCCCcCCC
Confidence 9999999999655444 6899999 678888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.71 Aligned_cols=263 Identities=30% Similarity=0.536 Sum_probs=214.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEecee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 572 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 572 (783)
|++..++|++.+.||+|+||.||+|.+.+ ++.||+|++.... .......+..|+.++..+ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45566799999999999999999997533 2579999987543 233456778899999999 799999999988
Q ss_pred ec-CCceEEEEEecCCCCHHHHHhhcC-----------------------------------------------------
Q 003963 573 TS-PQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 598 (783)
Q Consensus 573 ~~-~~~~~lV~E~~~ggsL~~~L~~~~----------------------------------------------------- 598 (783)
.. ...++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 456889999999999999985421
Q ss_pred -------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--ccccCCCCC
Q 003963 599 -------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGT 669 (783)
Q Consensus 599 -------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt 669 (783)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999998 9999999999999999999999999997643221 122234457
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 670 ~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
..|+|||++.+..++.++|||||||+||+|++ |..||......+.+............+..+++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999775443333222222234445667889999999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 003963 749 CRPSFQELVDKLRDLQR 765 (783)
Q Consensus 749 ~RPsa~ell~~L~~L~~ 765 (783)
+||++.+++++|+++.+
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.12 Aligned_cols=266 Identities=30% Similarity=0.570 Sum_probs=222.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 569 (783)
.+++..++|.+.+.||+|+||.||++.+.. ...+|+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 456777899999999999999999998643 1359999987643 233456788899999999 799999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+++...+..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999997532 24788899999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccccc--ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+|||++.++.++|+|||++......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998755432111 112234578999999999889999999999999999998 8999988776
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+....+. .......+..++.++.+||.+||..+|.+||++.++++.|+++.....
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 66555443 233456677889999999999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=356.10 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=210.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-C-----CceeeEeceeecCC
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H-----PNVLLFMGAVTSPQ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~ 576 (783)
.-+|+|.+.||+|+||.|.+|.+.. ++.||||+++... ....+...|+.+|..|+ | -|||+++++|...+
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3489999999999999999999876 5779999997654 45566778999999997 4 38999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC--CCcEEEEecCCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLS 653 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla 653 (783)
++|||+|.+ ..+|+++|+.+ ...++...+..++.||+.||.+||+.+ |||+||||+||||.. ...|||+|||.|
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999999 56999999764 355899999999999999999999998 999999999999964 347999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------- 724 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 724 (783)
+....... +.+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+.+..|....+.
T Consensus 339 c~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 87765432 556789999999999999999999999999999999999999988877666543211100
Q ss_pred -----------------------------------------ccCCC-----------CCCHHHHHHHHHhhhhCCCCCCC
Q 003963 725 -----------------------------------------LEIPK-----------DVDPRWAAIVESCWHSDPQCRPS 752 (783)
Q Consensus 725 -----------------------------------------~~~~~-----------~~s~~l~~LI~~cL~~dP~~RPs 752 (783)
...|. .-...+.+||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00110 11235799999999999999999
Q ss_pred HHHHHHHHHHHHHHHhh
Q 003963 753 FQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 753 a~ell~~L~~L~~~~f~ 769 (783)
+.+. |+|+||.
T Consensus 496 p~qa------l~Hpfl~ 506 (586)
T KOG0667|consen 496 PAQA------LNHPFLT 506 (586)
T ss_pred HHHH------hcCcccc
Confidence 9999 7899986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=348.60 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=206.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 576 (783)
..++|++.+.||+|+||.||++.+.. ++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35789999999999999999999754 578999999766545555667889999999999999999999986543
Q ss_pred -ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 -~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999965 67776643 3788889999999999999999998 99999999999999999999999999875
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--------------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-------------- 721 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-------------- 721 (783)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 173 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 43322 223457899999999999999999999999999999999999999876543322111000
Q ss_pred ------cccc--------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 722 ------NQRL--------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 722 ------~~~~--------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.... ......++++.+||.+||..||.+|||+.++ |.|+||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~------l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA------LRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH------hcCchhhh
Confidence 0000 0112246789999999999999999999999 67788764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=356.45 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=200.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC------CceeeEeceeecC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH------PNVLLFMGAVTSP 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 575 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++.... .....+..|+.+++.++| .+|+++++++...
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 35789999999999999999999865 4679999986432 223445667777777754 4588999888764
Q ss_pred -CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCC----------
Q 003963 576 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW---------- 643 (783)
Q Consensus 576 -~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~---------- 643 (783)
.++|+|||++ +++|.+++.+. ..+++..+..++.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccc
Confidence 5789999999 77899988764 468999999999999999999997 58 99999999999998665
Q ss_pred ------cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 003963 644 ------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA 717 (783)
Q Consensus 644 ------~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~ 717 (783)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||+||||++|++||...+....+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998754322 22356789999999999999999999999999999999999999987765543332
Q ss_pred hhcccccc-------------------------cC-C--------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 718 VGFMNQRL-------------------------EI-P--------------KDVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 718 i~~~~~~~-------------------------~~-~--------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
+......+ .. + ...++.+.+||.+||+.||.+|||+.|+
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~- 435 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM- 435 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH-
Confidence 21111000 00 0 0113567899999999999999999999
Q ss_pred HHHHHHHHHHhhcCcC
Q 003963 758 DKLRDLQRQYFQASRS 773 (783)
Q Consensus 758 ~~L~~L~~~~f~~~~~ 773 (783)
|.|+||+....
T Consensus 436 -----L~Hp~~~~~~~ 446 (467)
T PTZ00284 436 -----TTHPYVLKYYP 446 (467)
T ss_pred -----hcCccccccCC
Confidence 67899976433
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=350.55 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=209.6
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHH-HHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||||++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999764 568999999765322 223344555554 57789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999988753 46899999999999999999999998 99999999999999999999999999875433333334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..++..+.++|.+||..+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999999999999999887776665553 23445566789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhc
Q 003963 748 QCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||++.+.++.+ +.|+||+.
T Consensus 236 ~~R~~~~~~~~~i--~~h~~f~~ 256 (325)
T cd05604 236 QRRLGAKEDFLEI--QEHPFFES 256 (325)
T ss_pred HhcCCCCCCHHHH--hcCCCcCC
Confidence 9999886443333 57788864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.19 Aligned_cols=251 Identities=34% Similarity=0.608 Sum_probs=214.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
..+|++.+.||+|+||.||++.+..+..+|+|++....... ..+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 35788999999999999999998777789999987554433 357789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|.+++......+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999876667899999999999999999999998 9999999999999999999999999987654322111
Q ss_pred -cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 664 -KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 664 -~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .......+..++..+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHH
Confidence 11223457999999999899999999999999999999 899998877766655543 233445667789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHH
Q 003963 742 CWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L 760 (783)
||..+|.+||++.++++.|
T Consensus 237 cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HhcCChhhCcCHHHHHHHh
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.18 Aligned_cols=254 Identities=30% Similarity=0.556 Sum_probs=215.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.++|.+.+.||+|+||.||+|.+.. .+.||||++.... ..+....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4678999999999999999998643 2579999986543 33455788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC-------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNT-------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCe
Confidence 999999999999999997542 34788899999999999999999998 999999999999999999
Q ss_pred EEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003963 645 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 645 vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~ 721 (783)
++|+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 9999999987543221 11223345788999999999999999999999999999998 999998887776665554 2
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
......+..++..+.+||.+||..||.+||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2233455678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.85 Aligned_cols=249 Identities=39% Similarity=0.682 Sum_probs=208.8
Q ss_pred eEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 508 TIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++.+.||.|.||.||+|.+. .+..|+||++.. ....+....+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999988 135699999954 334455788999999999999999999999999888899999
Q ss_pred EecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc--c
Q 003963 583 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--T 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~--~ 659 (783)
|||++|+|.++|... ...+++..++.|+.||+.||.|||+++ |+|+||+++||||+.++.+||+|||++..... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999876 567999999999999999999999998 99999999999999999999999999876522 1
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+ ........+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 122233346788999999999889999999999999999999 78999999888777676 3445566778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L 760 (783)
|..||..+|.+||++.++++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=333.57 Aligned_cols=257 Identities=33% Similarity=0.574 Sum_probs=214.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
+...++|++.+.||+|+||.||++.+.+ ...||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4556789999999999999999998643 2469999886433 23344568899999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcE
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 645 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~v 645 (783)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence 999999999999999999986532 23567788999999999999999988 9999999999999999999
Q ss_pred EEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003963 646 KVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 646 kL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~ 722 (783)
+|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999875433211 1122345788999999999889999999999999999999 799998887766665543 22
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.....+..++..+.++|.+||+.+|.+||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 344567788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=351.50 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=209.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----ceE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 579 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 579 (783)
+|++.++||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999975 4578999998655434445567889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999995 588888765 346899999999999999999999998 999999999999999999999999998754332
Q ss_pred cc-cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------
Q 003963 660 YL-TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------- 723 (783)
Q Consensus 660 ~~-~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------- 723 (783)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+.....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 11 12234678999999999875 478999999999999999999999988776554433321100
Q ss_pred ----------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 724 ----------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 724 ----------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
...+....++++.+||.+||+.||.+|||+.++ +.|+||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~------l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA------LAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH------hcCHhhCCC
Confidence 012234568899999999999999999999999 678998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=336.08 Aligned_cols=259 Identities=30% Similarity=0.572 Sum_probs=216.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC---ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 579 (783)
+++|++.+.||+|+||.||+|.+... ..+++|.++... .....+.+.+|+.++.++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 46899999999999999999987543 247888876432 334456788999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 580 IVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
++|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996532 24788999999999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q 003963 645 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ 723 (783)
Q Consensus 645 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 723 (783)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ..
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 235 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CC
Confidence 9999999986433211 1112233567999999999889999999999999999997 9999988877766555432 23
Q ss_pred cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 724 ~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
....+..++..+.+||.+||..+|.+||++.++++.|+.+...+
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 44566779999999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=349.24 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=209.4
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|.+.. ++.||+|++.+.... ......+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 467999999875433 34456788899999888 599999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988754 35999999999999999999999998 99999999999999999999999999875333333334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN------SMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
||+.|+|||++.+..++.++|||||||+||+|++|..||.... ........ .......+|..++..+.++|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-HHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999999995321 22222221 1234556788899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
||..||.+|+++......-+-+.|+||+.+
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999985322111112678888654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.63 Aligned_cols=252 Identities=30% Similarity=0.418 Sum_probs=207.2
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHH-HHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEV-SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
++||+|+||.||+|.+.. ++.||+|++.+.... ......+..|. .+++.++||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 467999999765432 22234445554 467889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999888753 45888899999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++...+..+.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 8999999999999999999999999999999999999999887766665553 34556777889999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhh
Q 003963 748 QCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+||++..-+ ++-+.|+||+
T Consensus 236 ~~R~~~~~~~--~~~~~~~~~~ 255 (321)
T cd05603 236 RRRLGAKADF--LEIKNHVFFS 255 (321)
T ss_pred hhcCCCCCCH--HHHhCCCCcC
Confidence 9999764221 1225666664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.59 Aligned_cols=257 Identities=25% Similarity=0.329 Sum_probs=212.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-----CCc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 577 (783)
...|..++.||+|+||.|+.+.++. ++.||||++.......-..++..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3566668999999999999999865 4679999998665566667888899999999999999999998865 245
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+|+|+| +.+|..+++.. ..++...+..+++||++||.|+|+.+ |+||||||.|+|++.+..+||||||+|+...
T Consensus 101 vYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeecc
Confidence 89999999 66999999764 34999999999999999999999999 9999999999999999999999999999775
Q ss_pred cc--cccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003963 658 ET--YLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 723 (783)
Q Consensus 658 ~~--~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 723 (783)
.. .......+-|..|+|||++. ...|+.+.||||+||+|.||++|++-|.+.+....+..+....+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 11112346799999999865 56689999999999999999999999988776554433211110
Q ss_pred ----------ccc--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 724 ----------RLE--------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 724 ----------~~~--------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+. +.+..++.+.+|+.+||..||.+|+|+.|. |.|+|+..
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA------L~hPYl~~ 315 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA------LAHPYLAP 315 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH------hcChhhhh
Confidence 111 124678999999999999999999999999 78898843
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.66 Aligned_cols=253 Identities=33% Similarity=0.539 Sum_probs=211.9
Q ss_pred eeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
|+++++||+|+||.||++.+... +.||+|++..............+|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999998765 47999999887655555555567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccC
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 665 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 665 (783)
.+++|.+++.. ...+++..++.++.||+.||.+||+++ |+|+||||+|||++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999983 446899999999999999999999998 999999999999999999999999998754333334445
Q ss_pred CCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc---c--cccCCCCCCHHHHHHH
Q 003963 666 GKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN---Q--RLEIPKDVDPRWAAIV 739 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~--~~~~~~~~s~~l~~LI 739 (783)
..+++.|+|||++. +...+.++||||||+++|+|++|..||...........+.... . ........+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 67899999999998 8888999999999999999999999999874333222221111 1 1111122348999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+||+.||++||++.++ ++|+||
T Consensus 238 ~~~l~~~p~~R~~~~~l------~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEEL------LKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHH------HTSGGG
T ss_pred HHHccCChhHCcCHHHH------hcCCCC
Confidence 99999999999999999 677876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.27 Aligned_cols=256 Identities=34% Similarity=0.593 Sum_probs=214.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
++..++|++.++||+|+||.||+|.+..+..||+|++....... ..+.+|+.+++.++||||+++++++. ....++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 45567899999999999999999998777789999987644333 46788999999999999999999875 456899
Q ss_pred EEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999753 345788999999999999999999988 999999999999999999999999998765433
Q ss_pred ccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 YLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~-~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. ......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHH
Confidence 221 122345678999999988889999999999999999999 8999988776665554432 2234445678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
||.+||+++|.+||++.++++.|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=332.04 Aligned_cols=258 Identities=34% Similarity=0.582 Sum_probs=218.9
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 573 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 573 (783)
|++..++|++.+.||+|+||.||++.+... ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 456678999999999999999999987532 469999976543 3334567889999999999999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
.....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 9999999999999999999986422 23678889999999999999999988 999999999999999999
Q ss_pred EEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003963 645 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 645 vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~ 721 (783)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 9999999987544322 12223456789999999988889999999999999999998 999998888777666554 3
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.....+|..++.++.+||.+||..+|++|||+.+++..|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3455677888999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.25 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=217.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|.+.+.||+|+||.||++.+.. ++.|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58889999999999999999864 56799999877665566667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 456889999999999999999999988 9999999999999999999999999987665543333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+. ......++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 44568899999999999989999999999999999999999998877655544432 22234455578899999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 003963 744 HSDPQCRPSFQELVD 758 (783)
Q Consensus 744 ~~dP~~RPsa~ell~ 758 (783)
+.+|++||++.++++
T Consensus 238 ~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 238 TKDYRQRPDTFQLLR 252 (256)
T ss_pred cCCcccCcCHHHHhh
Confidence 999999999999954
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.61 Aligned_cols=258 Identities=20% Similarity=0.354 Sum_probs=213.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||++.+.. ++.||+|++.+... .......+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999865 46799999876432 2233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
||++||+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999875567899999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC---CCCH
Q 003963 662 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK---DVDP 733 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~-----~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---~~s~ 733 (783)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+.+..+........+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2223568999999999876 4578899999999999999999999988877766665543333344443 4689
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003963 734 RWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~ 770 (783)
++.+||.+||..++.+ |+++.++ +.|+||+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~------~~h~~f~~ 271 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDF------KKHAFFEG 271 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHH------hcCCCcCC
Confidence 9999999999866544 4688888 56777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.69 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=215.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-CCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E 583 (783)
.|++.+.||.|+||.||++.+.. ++.||+|++............+.+|+.+++.++|+||+++++.+.. +..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48999999999999999999765 4679999997766555566778899999999999999999998764 446899999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++++|.+++... ...+++..++.++.+++.||.+||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999999753 345899999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ......+..+++++.+||.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHH
Confidence 3455689999999999999999999999999999999999999987766554443321 223345677899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
|..+|.+||++.++ ++|+||
T Consensus 238 l~~~p~~Rp~~~~~------l~~~~~ 257 (257)
T cd08223 238 LSKRPEKRPSVKSI------LRQPYI 257 (257)
T ss_pred hccCcccCCCHHHH------hcCCCC
Confidence 99999999999999 556664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.51 Aligned_cols=256 Identities=31% Similarity=0.573 Sum_probs=214.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.+.+|++.++||+|+||.||+|.+. ....|++|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 3568999999999999999999853 23569999987543 33445678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc----------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC
Q 003963 578 LCIVTEFLPRGSLFRLLQRN----------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 641 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~ 641 (783)
.|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~ 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence 99999999999999998532 124778889999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003963 642 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 718 (783)
Q Consensus 642 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i 718 (783)
++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543221 12223345778999999998889999999999999999998 99999887765555444
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
. .......+..+++.+.++|.+||+.||.+||++.++++.|+.
T Consensus 240 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3 233455677889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.42 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=205.4
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||+|+||.||++.+.. ++.||+|++....... .....+..|+++++.++||||+++++++..+..+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998764 5789999987543322 2234456799999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCC
Q 003963 591 FRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 669 (783)
Q Consensus 591 ~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt 669 (783)
.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9887543 345889999999999999999999998 9999999999999999999999999987654432 22244689
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHhhccccccc-CCCCCCHHHHHHHHHhhh
Q 003963 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM----QVIGAVGFMNQRLE-IPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 670 ~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~-~~~~~s~~l~~LI~~cL~ 744 (783)
..|+|||++.+..++.++|||||||++|+|++|..||...... ...... ...... ....+++++.+||.+||+
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT--LEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh--hccccccccccCCHHHHHHHHHHhc
Confidence 9999999999988999999999999999999999999765332 121111 111111 224689999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 745 SDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 745 ~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.||.+||++.++++.+ +.|+||+..
T Consensus 236 ~~P~~R~~~~~~~~~~--~~h~~f~~~ 260 (277)
T cd05607 236 KKPEDRLGSREKNDDP--RKHEFFKTI 260 (277)
T ss_pred cCHhhCCCCccchhhh--hcChhhcCC
Confidence 9999999998776544 579999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=317.78 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=212.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC---
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--- 576 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 576 (783)
.+..++|++.+.||+|||+.||++.... .+-||+|++.... .+..+..++|++..+.++||||++++++.....
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4566899999999999999999998654 4569999987655 344577889999999999999999999875443
Q ss_pred --ceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 577 --RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 577 --~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
..||+++|...|+|.+.++. .+..+++.+++.|+.+|++||.+||+...+++||||||.|||+++.+.++|+|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 38999999999999999864 3446899999999999999999999998889999999999999999999999999
Q ss_pred CCccccccccc---------ccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh
Q 003963 652 LSRLKHETYLT---------TKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 719 (783)
Q Consensus 652 la~~~~~~~~~---------~~~~~Gt~~Y~aPE~~~~---~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~ 719 (783)
.++...-.... ......|..|+|||.+.- ...+.++|||||||+||.||.|..||+..-.....-.+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 98754322111 112246899999999864 445889999999999999999999996543321111222
Q ss_pred cccccccCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 720 FMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 720 ~~~~~~~~~--~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
..+..+.+| ..++..+.+||++||+.||.+||++.+++..+++|.
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 233334444 348899999999999999999999999999998874
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=338.64 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=212.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++..++.+++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4689999999999999999998764 567999998654322 22345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||++ ++|.+++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9996 5999998776667899999999999999999999998 999999999999999999999999998765433333
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------c
Q 003963 663 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------R 724 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~ 724 (783)
.....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+..... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 3344678999999998764 478899999999999999999999987766544332211000 0
Q ss_pred c-----------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 725 L-----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 725 ~-----------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
. .....+++.+++||.+||+.||.+|||+.++ ++|+||++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei------l~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA------MKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH------hcCccccccc
Confidence 0 1123578899999999999999999999999 7899997754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=348.85 Aligned_cols=259 Identities=35% Similarity=0.573 Sum_probs=210.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-ceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV 581 (783)
..++|.-...||+|+||.||+|...++..||||.+....... ..+|.+|+.++.+++|||+|+++|||.+.+ ..+||
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 357898889999999999999999888899999877655432 356999999999999999999999999988 59999
Q ss_pred EEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCC-CCEEecCCCCCCEEEcCCCcEEEEecCCCccccc-
Q 003963 582 TEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCN-PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE- 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~-~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~- 658 (783)
+|||+.|+|.++|..... +++|..+++|+.++++||+|||... ++||||||||.|||+|.++..||+|||+|+..+.
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999987655 8999999999999999999999854 4799999999999999999999999999976654
Q ss_pred ccccccCC-CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHH----hhc--cc--cccc
Q 003963 659 TYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGA----VGF--MN--QRLE 726 (783)
Q Consensus 659 ~~~~~~~~-~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~---~~~~~~~----i~~--~~--~~~~ 726 (783)
... ..+. .||..|++||.+.....+.++||||||++|+||+||+.|.+... ....... +.. .. -.+.
T Consensus 231 ~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 231 DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 211 1122 78999999999999999999999999999999999998876432 1111111 100 00 0112
Q ss_pred CC-CCCC--H---HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 727 IP-KDVD--P---RWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 727 ~~-~~~s--~---~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+. ...+ . .+..+...|++.+|..||++.++++.|+.+.
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 22 2333 2 3567888999999999999999988885554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=351.59 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=203.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
+...+|++.++||+|+||.||++.+.. ++.||||+... ..+.+|+.+++.|+|||||++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 345689999999999999999999864 46799996432 345789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc-
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET- 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~- 659 (783)
|||++. ++|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999994 6898888654 45889999999999999999999998 999999999999999999999999998653322
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHhhc-c----------
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-------SMQVIGAVGF-M---------- 721 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~-------~~~~~~~i~~-~---------- 721 (783)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+.. .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 122234579999999999999999999999999999999999998764321 0011100000 0
Q ss_pred -------------cccccCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 722 -------------NQRLEIP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 722 -------------~~~~~~~---------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
......+ ..++.++.+||.+||+.||.+|||+.++ |+|+||+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el------L~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL------LDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH------hcChhhccCC
Confidence 0000000 1346789999999999999999999999 6899998754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.59 Aligned_cols=259 Identities=30% Similarity=0.536 Sum_probs=218.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
.+.+|.+.+.||+|+||.||++.+.. ...+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45789999999999999999998532 235889987643 2344567889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcC------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCc
Confidence 9999999999999999996432 24899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003963 645 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 645 vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~ 721 (783)
++|+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||...........+..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~- 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ- 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence 9999999987543221 11223345778999999999999999999999999999998 9999988877666655532
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
......+..++.++.+|+.+||+.||.+||++.++++.|+++.+.
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 223445667899999999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.41 Aligned_cols=260 Identities=29% Similarity=0.472 Sum_probs=218.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+.|++.++||.|+||.||+|.+.. +..|++|++... .....+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3679999999999999999999865 567999998654 3445677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|..++.+....+++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999999999888765667899999999999999999999988 999999999999999999999999998754433333
Q ss_pred ccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~ 736 (783)
.....+++.|+|||.+. ...++.++|||||||++|+|++|.+||...+.......+.... .....+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 33456789999999985 3446789999999999999999999998777655444432221 12334567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
+||.+||..+|++||++.++ +.|+||.....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~~ 277 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQL------LEHPFVSSVTS 277 (292)
T ss_pred HHHHHHhcCCcccCcCHHHH------hcCcccccccc
Confidence 99999999999999999999 67899866544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.21 Aligned_cols=256 Identities=34% Similarity=0.607 Sum_probs=216.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|++..++|++.++||+|+||.||+|.+..+..||+|.+....... ..+.+|+.+++.++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 345667899999999999999999998877789999987655433 46889999999999999999999875 45689
Q ss_pred EEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++|||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999999753 345889999999999999999999998 99999999999999999999999999876543
Q ss_pred ccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
... ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+.. ....+.+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHH
Confidence 221 1122335668999999988889999999999999999999 9999988777666655532 234556677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
+|+.+||.++|.+|||+.++++.|+.
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.29 Aligned_cols=257 Identities=33% Similarity=0.597 Sum_probs=219.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|++..++|++.++||.|+||.||++.+.+++.|+||.+....... ..+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH---HHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 355678999999999999999999998777889999987654432 46788999999999999999999999889999
Q ss_pred EEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999997643 46899999999999999999999998 99999999999999999999999999876543
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.. ......+...+.++.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELY 234 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 21 11112234678999999999889999999999999999998 9999988777666655532 224455667789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
+++.+||..+|.+||++.++++.|+.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=328.02 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=211.0
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCc---eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------Cc
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQ---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------QR 577 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 577 (783)
|.++++||+|+||.||+|.+.... .||+|.+............+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999876543 589999877655566677889999999999999999999976432 24
Q ss_pred eEEEEEecCCCCHHHHHhh-----cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 578 LCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
.+++|||+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 6899999999999988742 2344789999999999999999999988 99999999999999999999999999
Q ss_pred Ccccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 653 SRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 653 a~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 876543221 1223345778999999999999999999999999999999 8999988777665555432 23345566
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.++..+.++|.+||..||.+|||+.++++.|+++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.41 Aligned_cols=271 Identities=29% Similarity=0.553 Sum_probs=222.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-c--eEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCc
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-Q--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 577 (783)
+.+++|++.+.||+|+||.||+|.+... . .+++|.+... ........+.+|+.++.++ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 3467899999999999999999997543 2 3577766532 2344556788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 642 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~ 642 (783)
+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 999999999999999996532 24789999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003963 643 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 643 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~ 721 (783)
+.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 238 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 99999999998643221 11222234678999999988889999999999999999998 999998777666555442 2
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCCCC
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 777 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~~~ 777 (783)
......+..+++++.+||.+||..+|.+||++.+++..|.++...-.....+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~~~~ 294 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 294 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhhhhc
Confidence 22344556688999999999999999999999999999998877766666555543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.11 Aligned_cols=247 Identities=32% Similarity=0.557 Sum_probs=208.5
Q ss_pred eeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCC
Q 003963 511 EQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 589 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 589 (783)
++||+|+||.||+|.+. .++.||+|.+... ...+....+.+|+++++.++||||+++++++.....+++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999986 4577999987643 344556778999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc--cCCC
Q 003963 590 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGK 667 (783)
Q Consensus 590 L~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~ 667 (783)
|.+++......+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999766666899999999999999999999998 9999999999999999999999999987543321111 1112
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhC
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 746 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~d 746 (783)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+|+.+||..+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999999889999999999999999998 9999987776655544432 2344566778999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 003963 747 PQCRPSFQELVDKLR 761 (783)
Q Consensus 747 P~~RPsa~ell~~L~ 761 (783)
|.+||++.++++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.97 Aligned_cols=259 Identities=31% Similarity=0.552 Sum_probs=216.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCC-c----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-Q----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
...+|++.++||+|+||.||+|.+... . .||+|++.... .......+.+|+.+++.+.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 346899999999999999999986543 2 38999986543 34445678899999999999999999999875 45
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.+++|||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 78999999999999999876667899999999999999999999998 9999999999999999999999999987654
Q ss_pred ccccc--ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 658 ETYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 658 ~~~~~--~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... .....+++.|++||.+.+..++.++|||||||++|||++ |..||...........+. .......+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCHH
Confidence 32211 112234678999999998889999999999999999998 999998877665554443 23344556778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+.++|.+||..||.+||++.+++..|+++...
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 99999999999999999999999888776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=346.39 Aligned_cols=255 Identities=27% Similarity=0.335 Sum_probs=207.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 575 (783)
..++|++.+.||+|+||.||++.+.. ++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999999999754 56799999976554455566788899999999999999999987543
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..+|+||||+++ +|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999964 78877753 3788889999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 723 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 723 (783)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 176 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 54432 22345789999999999999999999999999999999999999987765544333211000
Q ss_pred --------cc--------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 724 --------RL--------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 724 --------~~--------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+ ......+..+++||.+||+.||.+|||+.++ |+|+||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~------L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA------LQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH------hcCccccc
Confidence 00 0111234678999999999999999999999 67888864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=370.25 Aligned_cols=266 Identities=24% Similarity=0.399 Sum_probs=215.0
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--C
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--P 575 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 575 (783)
+.+....+|+++++||.|+||.||+|.+... ..||+|++............+..|+.+|+.|+|||||+++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3456678999999999999999999998664 568999988766666667789999999999999999999998854 4
Q ss_pred CceEEEEEecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCC-----CCEEecCCCCCCEEEcC------
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN-----PPIIHRDLKSSNLLVDK------ 641 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~IvHrDIKp~NILl~~------ 641 (783)
..+|||||||++++|.++|... ...+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998652 346899999999999999999999853 34999999999999964
Q ss_pred -----------CCcEEEEecCCCcccccccccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 003963 642 -----------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDN 708 (783)
Q Consensus 642 -----------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~ 708 (783)
.+.+||+|||++....... .....+||+.|+|||++.+ ..++.++||||||||||+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999997654332 2234578999999999864 4578999999999999999999999976
Q ss_pred CChHHHHHHhhcccccccCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 709 LNSMQVIGAVGFMNQRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 709 ~~~~~~~~~i~~~~~~~~~~-~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.+....+.... ...+.++ ..++.++.+||..||..+|.+||++.++ |.++|++....
T Consensus 246 ~~~~~qli~~l--k~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql------L~h~~ik~i~~ 303 (1021)
T PTZ00266 246 ANNFSQLISEL--KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQC------LGYQIIKNVGP 303 (1021)
T ss_pred CCcHHHHHHHH--hcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHH------hccHHHhhcCC
Confidence 65443332221 1112222 3578999999999999999999999999 45678865543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.77 Aligned_cols=246 Identities=27% Similarity=0.516 Sum_probs=209.0
Q ss_pred eeccCCcEEEEEEEEe---CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 512 QIGQGSCGTVYHAVWY---GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
+||+|+||.||+|.+. .+..+|+|++............+.+|+.+++.+.||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 3467999998766555566778999999999999999999999876 45678999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc---ccC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKT 665 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~ 665 (783)
+|.+++... ..+++..++.++.|++.||+|||+++ |+|+||||.|||++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999754 46899999999999999999999998 999999999999999999999999998765433211 122
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 666 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ......|..+++++.+||.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHhc
Confidence 234678999999988889999999999999999998 9999998877766665543 23456777899999999999999
Q ss_pred hCCCCCCCHHHHHHHHHH
Q 003963 745 SDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 745 ~dP~~RPsa~ell~~L~~ 762 (783)
.||.+||++.+|.+.|++
T Consensus 237 ~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 237 YGVDERPGFAVVELRLRN 254 (257)
T ss_pred cCchhCcCHHHHHHHHhc
Confidence 999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.99 Aligned_cols=262 Identities=31% Similarity=0.585 Sum_probs=220.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEece
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 571 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 571 (783)
.+++..++|++.+.||+|+||.||++.+... ..+|+|++..... ......+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456667899999999999999999987532 4689999875433 33456788999999999 79999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCC
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 636 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~N 636 (783)
+...+.++++|||+++++|..++... ...+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999999642 345889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 003963 637 LLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 713 (783)
Q Consensus 637 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~ 713 (783)
||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999976543221 1222335678999999999999999999999999999997 999998887766
Q ss_pred HHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 714 ~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
....+. .......+..++..+.+|+.+||..+|.+|||+.++++.|+++.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 665543 23344566778899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.46 Aligned_cols=256 Identities=31% Similarity=0.525 Sum_probs=216.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
..+|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 36789999999999999999987532 258999886543 3445668899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccc---ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 660 YLT---TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 660 ~~~---~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... .....++..|++||.+.+..++.++|+|||||++|++++ |..||......+....+... ...+.+..+++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHH
Confidence 211 112233568999999998889999999999999999887 99999887766555554322 2344556788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.+++.+||+++|.+||++.++++.|+++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.42 Aligned_cols=257 Identities=25% Similarity=0.442 Sum_probs=215.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||+|.+. .++.||+|.++.... .......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999987 567899999875433 3344678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||+++++|..++.. ....+++..++.++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999864 2345889999999999999999999998 999999999999999999999999998765443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhcccccccCCC-CCCHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--SMQVIGAVGFMNQRLEIPK-DVDPRWA 736 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~-~~s~~l~ 736 (783)
........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .......+.. ......+. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 333334568899999999999889999999999999999999999996543 2223333221 12233343 6788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
++|.+||..+|.+||++.+|++.|..++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.41 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=214.5
Q ss_pred eeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc-----
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR----- 577 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 577 (783)
|++.+.||+|+||.||+|.+.. ...||||++............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5788999999999999998753 2569999998766555666788999999999999999999998865543
Q ss_pred -eEEEEEecCCCCHHHHHhhc-----CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 578 -LCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 578 -~~lV~E~~~ggsL~~~L~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
.+++|||+++++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998532 235889999999999999999999988 9999999999999999999999999
Q ss_pred CCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCC
Q 003963 652 LSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 728 (783)
Q Consensus 652 la~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 728 (783)
+++...... .......++..|++||.+.+..++.++|||||||++|||++ |.+||......+....+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-GNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 987543321 11222334678999999998889999999999999999999 9999988877776655532 3345567
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
..++.++.++|.+||..||.+||++.++++.|++|
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 78999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=334.08 Aligned_cols=256 Identities=27% Similarity=0.496 Sum_probs=215.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...+|++.++||+|+||.||+|.+.. ++.||||++.... .......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 34578899999999999999998753 3569999987543 3345567889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 641 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~ 641 (783)
..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence 999999999999999998521 234788889999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003963 642 HWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 718 (783)
Q Consensus 642 ~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i 718 (783)
++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999875433221 1223345789999999988889999999999999999998 89999888777666655
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
... .....+..++..+.+|+..||+.+|.+||++.+|+..|+.
T Consensus 240 ~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 432 2345677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=345.83 Aligned_cols=254 Identities=28% Similarity=0.350 Sum_probs=206.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 575 (783)
..++|++.+.||+|+||.||++.+.. ++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45799999999999999999998754 56799999976655555567788899999999999999999988643
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 347999999965 77777753 3788889999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------- 722 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------- 722 (783)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 54432 2234578999999999999999999999999999999999999998766443322110000
Q ss_pred -------c--------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 723 -------Q--------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 723 -------~--------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
. ....+...+.++.+||.+||..||.+|||+.++ |+|+||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el------l~hp~~~ 315 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA------LQHPYIN 315 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH------hcCcchh
Confidence 0 000112245678999999999999999999999 6788886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.66 Aligned_cols=256 Identities=31% Similarity=0.462 Sum_probs=220.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+.|.-++.||.|+||.||.|++..+ +.||||++..... +.+--+.+..|+.+|+.|+|||+|.+-++|-.+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466678899999999999998654 6699999976543 3344467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||| -|+-.+++.-++.++.+-.+..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.+.....
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 999 56999999888888999999999999999999999999 99999999999999999999999999865443
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
..+++|||.|||||++. .+.|+-++||||||++..||...++|+-+++.+..+..|.......-....|+..+..|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 34789999999999976 466899999999999999999999999999999888887533333333457899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
..||++-|.+|||..++ |.|.|....|+
T Consensus 259 d~CLqKipqeRptse~l------l~H~fv~R~Rp 286 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEEL------LKHRFVLRERP 286 (948)
T ss_pred HHHHhhCcccCCcHHHH------hhcchhccCCC
Confidence 99999999999999999 55666655554
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.04 Aligned_cols=259 Identities=31% Similarity=0.529 Sum_probs=217.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...+|.+.+.||+|+||.||++.+.. ...+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 35689999999999999999998542 2358888875433 233467889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 641 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~ 641 (783)
..++||||+++++|.+++..+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 9999999999999999996532 34788999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003963 642 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 718 (783)
Q Consensus 642 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i 718 (783)
++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543321 11223456788999999999999999999999999999999 99999888776665554
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
. .......+..++..+.+|+.+||+.+|.+||++.++++.|+++...
T Consensus 239 ~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 T-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred h-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 3 2233345667889999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.19 Aligned_cols=255 Identities=33% Similarity=0.593 Sum_probs=214.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
++..++|.+.++||.|+||.||++.+..+..+|+|++...... ...+.+|+.+++.++||||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4455789999999999999999999877778999987654432 356788999999999999999999875 456899
Q ss_pred EEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999999753 334788999999999999999999998 999999999999999999999999999765432
Q ss_pred cc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 YL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHH
Confidence 21 1122345678999999998889999999999999999999 9999988777665554432 2334556778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
++.+||.+||.+||+++++++.|++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.35 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=214.9
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.++||.|+||.||++.+.. ++.||+|.+..... ....+.+..|+.+++.++||||+++++.+...+.+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 58899999999999999999864 57799999865442 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999998864 3345789999999999999999999998 9999999999999999999999999987655443333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.+||.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 34568999999999999889999999999999999999999998877666554443 22344566778999999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 003963 744 HSDPQCRPSFQELVDK 759 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~ 759 (783)
..||.+||++.+++..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=334.87 Aligned_cols=253 Identities=27% Similarity=0.336 Sum_probs=201.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC---CCCceeeEeceeec-----CC
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS-----PQ 576 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~ 576 (783)
+|++.+.||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58899999999999999999865 56799999876433322223455677777665 69999999998764 24
Q ss_pred ceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.++++|||+++ +|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999964 8988886533 34899999999999999999999998 99999999999999999999999999876
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---------c--
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---------R-- 724 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------~-- 724 (783)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|++||........+..+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54332 22234679999999999998999999999999999999999999987765544333211100 0
Q ss_pred --------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 --------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 --------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
......++..+.+||.+||+.||.+|||+.++ +.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~------l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA------LQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH------hcCCCC
Confidence 01123567889999999999999999999999 567776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.13 Aligned_cols=263 Identities=29% Similarity=0.491 Sum_probs=218.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEece
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA 571 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~ 571 (783)
.|++..++|.+.++||+|+||.||+|.+.+ +..||||++..... ....+.+.+|+.+|..+. |||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 467788899999999999999999998642 34699999976433 334457889999999997 9999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhcC-----------------------------------------------------
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 598 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~~----------------------------------------------------- 598 (783)
+...+.+++|||||++|+|.+++.++.
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred --------------------------------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 599 --------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 599 --------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
..+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp 267 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA 267 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence 12566778889999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999987543221 11223356789999999998889999999999999999998 8999987665
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
.+..............|..++.++.+||.+||..+|.+||++.+|++.|+++.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 55433332233345567778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.77 Aligned_cols=258 Identities=23% Similarity=0.409 Sum_probs=215.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+|++.+.||.|+||.||++.+. .++.|+||.+..... .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999975 567899998865443 3345567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998863 2345899999999999999999999998 999999999999999999999999998765543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.........+..+++.+.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 3333345688999999999998899999999999999999999999965433 22222332222222233457889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+|.+||..+|.+|||+.+|++.+++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.07 Aligned_cols=247 Identities=35% Similarity=0.634 Sum_probs=215.7
Q ss_pred eeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecC
Q 003963 511 EQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
++||+|+||.||++.+.. ...|++|++....... ....+.+|+.+++.++|+||+++++++.....++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999864 5679999987655433 46788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 587 RGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 587 ggsL~~~L~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+++|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 467999999999999999999999988 99999999999999999999999999976654
Q ss_pred cc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+..+++++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22334567889999999998889999999999999999999 6999998887776666543 44556777889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.++|.+||..+|.+||++.++++.|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=369.51 Aligned_cols=263 Identities=30% Similarity=0.573 Sum_probs=228.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
+..+..++...||+|.||.||+|...+. ..||||.+.+.. +......|.+|..+|+.++|||||+++|++...
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3456788999999999999999987542 138999886644 455678899999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhc------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
...+|++|||.||+|..+|++. ...+.....+.++.+|++|+.||++++ +|||||..+|+||+....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999876 566899999999999999999999988 99999999999999999999999
Q ss_pred cCCCcc-cccccccccCC-CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccc
Q 003963 650 FGLSRL-KHETYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLE 726 (783)
Q Consensus 650 FGla~~-~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 726 (783)
||+|+. +...+...... .-...|||||.+....++.|+|||||||+|||+++ |..||...+..+++..+... .+++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-gRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-GRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-CccC
Confidence 999983 33333222222 33569999999999999999999999999999999 99999999999888755434 4899
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.|..++..+.++|..||+.+|++||++..|++.+..+...+.
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 999999999999999999999999999999998877765543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.82 Aligned_cols=254 Identities=28% Similarity=0.362 Sum_probs=206.0
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||.|+||.||+|.+.. +..||||++............+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58899999999999999999864 57899999876543333445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 585 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 585 ~~ggsL~~~L~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
++ ++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 96 58988886432 56899999999999999999999998 999999999999999999999999998755433222
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------------
Q 003963 663 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------------- 722 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------------- 722 (783)
.....+++.|+|||++.+. .++.++|||||||++|+|++|++||...........+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2344678899999988764 46889999999999999999999998665433222110000
Q ss_pred --------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 723 --------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 723 --------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
........+++++.+||.+||..||.+|||+.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l------l~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA------LNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH------hcCCCC
Confidence 0011123578999999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.15 Aligned_cols=258 Identities=30% Similarity=0.479 Sum_probs=219.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.+.||.|+||.||++.+.. +..||+|++... .......+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 4679999999999999999999754 577999998644 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999876667999999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~ 736 (783)
.....+++.|++||.+. +..++.++|||||||++|+|++|++||...+.......+.... .....+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456899999999975 3446789999999999999999999998887666554443221 12344567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||.+||..+|.+||++.++ ++|+||...
T Consensus 240 ~li~~~l~~~p~~Rps~~~i------l~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAEL------LKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHH------hcChhhccc
Confidence 99999999999999999999 678998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=320.39 Aligned_cols=260 Identities=24% Similarity=0.402 Sum_probs=221.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC------CHHHHHHHHHHHHHHHhC-CCCceeeEeceeec
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 574 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 574 (783)
.+..|.-.+.||.|..++|.++.++ +++++|+|++..... ..+..+.-.+|+.||+++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3567888899999999999998765 457899999854321 234556677899999998 59999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
+..+++|+|.|+.|.|+++|.. ...++++....|++|+++|+.|||..+ ||||||||+|||++++.++||+|||+++
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999976 456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-- 726 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-- 726 (783)
...... .....||||.|+|||.+.. ..|+..+|+|++|++||-|+.|.+||......-.+..+...+..+.
T Consensus 172 ~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 776543 3446799999999999853 3467789999999999999999999988777777777755444333
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
-+.+++...++||.+||+.||.+|.|+.++ |.|+||+.+.
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~------LaHpff~q~~ 290 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEA------LAHPFFIQIA 290 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHH------hcChHHHHHH
Confidence 335678889999999999999999999999 7899995543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.72 Aligned_cols=264 Identities=29% Similarity=0.579 Sum_probs=221.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 569 (783)
.+++...+|.+.+.||+|+||.||++.+.. ...||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 356677899999999999999999997531 2358999886543 334456788999999999 799999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+++......+++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999997532 24678889999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999876543221 1223345678999999999889999999999999999998 8999988877
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+....+. .......+..++..+.+||.+||..+|.+||++.++++.|+++...
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 77665553 2234455677899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.78 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=205.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...+|+++++||+|+||.||++...+ ...|++|.+.... .+.+|+.+|+.++|||||++++++.....+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 45689999999999999999997643 3569999876432 3457999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++||++. ++|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.++|+|||++......
T Consensus 163 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999995 689998854 456899999999999999999999998 999999999999999999999999998755433
Q ss_pred cc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc-c------------
Q 003963 660 YL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGF-M------------ 721 (783)
Q Consensus 660 ~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~~~i~~-~------------ 721 (783)
.. ......||+.|+|||++.+..++.++|||||||+||+|++|..||...... ..+..+.. .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 21 223457899999999999999999999999999999999999999654321 11111100 0
Q ss_pred ----------c----ccccCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 722 ----------N----QRLEIP-----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 722 ----------~----~~~~~~-----~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
. ....++ ..++.++.+||.+||..||.+||++.++ |.|+||+....
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~------l~~p~f~~~~~ 383 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI------LSLPLFTKEPI 383 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH------hhCchhhccch
Confidence 0 001111 1346788999999999999999999999 78899976443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.91 Aligned_cols=257 Identities=26% Similarity=0.475 Sum_probs=212.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-c----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-Q----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.++|++.+.||+|+||.||+|.+... + .+++|.+.... .......+..|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 36789999999999999999987543 2 37777764322 23445677888889999999999999998754 557
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++++||+++|+|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 8899999999999999876667899999999999999999999988 99999999999999999999999999976533
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... ......++..|++||.+.+..++.++|||||||++|||++ |..||...........+. .......+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHHH
Confidence 211 1223346778999999998889999999999999999998 999998877665444442 233445566678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
..++.+||..+|.+||++.++++.|..+..
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.50 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=215.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
-|++.++||.|+||.||++.+.. +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 36888999999999999999865 4568888875432 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|..++.+...++++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999999988765567899999999999999999999998 99999999999999999999999999876544333334
Q ss_pred CCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHH
Q 003963 665 TGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~L 738 (783)
...+++.|+|||++. +..++.++|||||||++|+|++|.+||...+.......+... ......+..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 456899999999974 445678999999999999999999999887766554444222 22334556788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
|.+||..+|.+||++.++ ++|+||+...
T Consensus 242 i~~~l~~~p~~Rp~~~~i------l~~~~~~~~~ 269 (282)
T cd06643 242 LKKCLEKNVDARWTTTQL------LQHPFVTVNS 269 (282)
T ss_pred HHHHccCChhhCcCHHHH------hcCCCEeccC
Confidence 999999999999999999 7889987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.20 Aligned_cols=263 Identities=30% Similarity=0.601 Sum_probs=220.0
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 570 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 570 (783)
+.+..++|.+.++||+|+||.||++.+.+ ...||+|++.... .......+..|+.+++.+ +||||+++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 45666899999999999999999997532 2358999887543 334456788999999999 5999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCC
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~ 635 (783)
++...+.++++|||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccce
Confidence 9999999999999999999999996532 34788899999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 003963 636 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 712 (783)
Q Consensus 636 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~ 712 (783)
|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999976543211 1122234568999999999889999999999999999999 89999888776
Q ss_pred HHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+....+.. ......+..++.++.+||.+||..+|.+||++.++++.|.++...
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 66655532 233456677899999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.77 Aligned_cols=254 Identities=23% Similarity=0.430 Sum_probs=218.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||+|+||.||++.... ++.|++|.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58999999999999999998754 57899999876655555566889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
+.+++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999998753 345789999999999999999999998 9999999999999999999999999987655433333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....|++.|+|||++.+...+.++|+|||||++|+|++|..||...+.......+. .......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHh
Confidence 34467889999999999889999999999999999999999998777666554442 23344567788999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+.+|.+||++.++ ++|+||
T Consensus 238 ~~~p~~Rp~~~~v------l~~~~~ 256 (256)
T cd08218 238 KRNPRDRPSVNSI------LEKNFI 256 (256)
T ss_pred hCChhhCcCHHHH------hhCcCC
Confidence 9999999999999 556665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.12 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=216.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
..+|++.+.||+|+||.||+|.+... ..|+||++.... .......+..|+.+++.++||||+++++++.....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35789999999999999999997643 259999986543 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999998755432
Q ss_pred cccc-----cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 660 YLTT-----KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 660 ~~~~-----~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
.... .....+..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+. .....+.+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCH
Confidence 2110 11112457999999999999999999999999999986 999998887776665553 2234455667899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.+.+++.+||..+|.+||++.+++..|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.20 Aligned_cols=263 Identities=29% Similarity=0.518 Sum_probs=212.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEe------CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEecee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 572 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 572 (783)
|+...++|++.+.||+|+||.||+|.+. .++.||||++..... ......+.+|+.++..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 4556679999999999999999999853 245799999875443 33456788899999999 689999999987
Q ss_pred ecC-CceEEEEEecCCCCHHHHHhhcC-----------------------------------------------------
Q 003963 573 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 598 (783)
Q Consensus 573 ~~~-~~~~lV~E~~~ggsL~~~L~~~~----------------------------------------------------- 598 (783)
... ..++++||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46899999999999999986421
Q ss_pred -------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--ccc
Q 003963 599 -------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTT 663 (783)
Q Consensus 599 -------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 663 (783)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 23577788899999999999999998 9999999999999999999999999987543221 111
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....++..|+|||++.+..++.++|||||||++|+|++ |..||.....................+..+++++.+++..|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999999899999999999999999997 99999776543333222223334556667889999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~ 765 (783)
|+.+|.+||++.+|+++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=323.28 Aligned_cols=247 Identities=26% Similarity=0.526 Sum_probs=207.2
Q ss_pred eeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 512 QIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 48999999999998752 2358999886543 3445567899999999999999999999886 45789999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc---ccC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKT 665 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~ 665 (783)
+|.+++......+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999766667899999999999999999999998 999999999999999999999999998754332111 112
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 666 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 233578999999998889999999999999999996 999999888776665543 233456677889999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHH
Q 003963 745 SDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 745 ~dP~~RPsa~ell~~L~~L 763 (783)
.+|++||++.++++.|+.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.52 Aligned_cols=256 Identities=23% Similarity=0.403 Sum_probs=211.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||+|+||.||++.+.. +..+|+|.+... ........+.+|+++++.++||||+++++++..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 368999999999999999999765 456888887643 234556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++++|.+++... ..+++..+..++.||+.||.|||+ ++ ++|+||||+|||++.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999764 468899999999999999999997 57 9999999999999999999999999987554332
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------------
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------- 723 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------- 723 (783)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 2345789999999999888899999999999999999999999976554333222211100
Q ss_pred ----------------cccCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 724 ----------------RLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 724 ----------------~~~~~-~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+..| ..++.++++||.+||..+|++||++.++ ++++||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l------l~~~~~~~~~ 294 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL------TKHPFIKRAE 294 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH------hcChhhhhcc
Confidence 01111 1367889999999999999999999999 7889997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=323.88 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=216.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
...+|+..+.||+|+||.||+|.+... ..+++|++.... .......+..|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 346789999999999999999997642 258999886543 344456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999999875543
Q ss_pred ccccc---cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 659 TYLTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 659 ~~~~~---~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... .....+..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... ...+.+..++..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCHH
Confidence 22111 11223457999999998889999999999999999997 99999887776666665432 344445568899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+.+++.+||+.+|.+||++.++++.|+++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.48 Aligned_cols=251 Identities=35% Similarity=0.635 Sum_probs=216.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+..++|++.+.||.|+||.||++... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 34578999999999999999999876 56899999876543 456788999999999999999999999998999999
Q ss_pred EEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 582 TEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999997543 25899999999999999999999998 9999999999999999999999999987653322
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
. ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..+++.+.++|
T Consensus 157 ~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 D---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred c---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHH
Confidence 1 2344667999999988889999999999999999997 9999988877666555432 234456677899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHH
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
.+||..+|.+||++.++++.|..
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=331.84 Aligned_cols=262 Identities=28% Similarity=0.497 Sum_probs=217.0
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEece
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 571 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 571 (783)
.++...++|.+.+.||+|+||.||++.+.. ...||+|++..... ......+.+|+.+++.+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345667799999999999999999998532 23689998865432 34456788999999999 79999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
+...+.++++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997543 33899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccC
Q 003963 651 GLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEI 727 (783)
Q Consensus 651 Gla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 727 (783)
|++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....................
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99875443211 1122345778999999999999999999999999999998 99999877655443333222223345
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+...++++.+|+.+||.++|++||++.++++.|+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 566789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.67 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=211.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.|++.+.||+|+||.||++.+.. ++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37788999999999999999865 5689999987654332 334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999988543 345899999999999999999999998 9999999999999999999999999987544322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhcccccccCCCCCCHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---VIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+. .......+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 223478999999999999999999999999999999999999997654321 111111 1112345667899999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003963 740 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 740 ~~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~ 770 (783)
.+||+.||.+||| +.++ +.|+||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~------~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREV------KEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHH------HcChhhhc
Confidence 9999999999999 8888 67888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=324.34 Aligned_cols=260 Identities=35% Similarity=0.618 Sum_probs=218.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
++..++|.+.++||+|+||.||+|.+... ..|+||...... .....+.+.+|+.+++.+.||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 44567899999999999999999987543 358999875443 24456788999999999999999999998875 5
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
..++||||+++++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 578999999999999999876666899999999999999999999998 999999999999999999999999998755
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHH
Confidence 43321 1112234568999999988889999999999999999986 9999988877665555432 2344567788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+.++|.+||..+|.+||++.+++..|+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.16 Aligned_cols=252 Identities=23% Similarity=0.441 Sum_probs=218.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||++.+.. ++.||+|++...... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999864 578999998765432 344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|.||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999765 46899999999999999999999988 999999999999999999999999998765443
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
.....|++.|+|||.+.+...+.++||||||+++|+|++|..||...+.......+. .....++..++..++++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 234468999999999988888999999999999999999999998877655554442 445667788899999999999
Q ss_pred hhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 743 WHSDPQCRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 743 L~~dP~~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
|..||.+|+ ++.++ +.|+||+.
T Consensus 233 l~~~p~~R~~~~~~~~~~l------~~~~~~~~ 259 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDI------KNHPWFAG 259 (290)
T ss_pred ccCCHHHccCcccCCHHHH------HcCccccc
Confidence 999999999 77888 56788754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=333.76 Aligned_cols=260 Identities=23% Similarity=0.394 Sum_probs=217.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||+|.+.. ++.||||.+....... .....+..|+++++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999865 6789999998765443 45667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 583 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+|+.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998753 356899999999999999999999998 99999999999999999999999998764322110
Q ss_pred -----------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003963 662 -----------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712 (783)
Q Consensus 662 -----------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~ 712 (783)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 111236788999999999998999999999999999999999999887766
Q ss_pred HHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCC----HHHHHHHHHHHHHHHhhcCc
Q 003963 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS----FQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPs----a~ell~~L~~L~~~~f~~~~ 772 (783)
..+..+............+++.+.+||.+||..+|.+||+ +.++ +.|+||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l------l~~~~~~~~~ 296 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI------KQHPFFRGVN 296 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH------HcCchhhcCC
Confidence 6555443222222222337899999999999999999999 7777 6688987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.12 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=218.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.....+|++.+.||.|+||.||++.+.. ++.|++|.+....... ...+.+|+.+++.+.||||+++++.+......|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 3445789999999999999999998754 5789999987655432 356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999999998653 4788899999999999999999998 999999999999999999999999998754433
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~L 738 (783)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ......+..++..+.+|
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 22223446889999999999888999999999999999999999999876654433222211 11223456688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
|.+||..+|.+||++.++ +.++||...++.
T Consensus 250 i~~~l~~~p~~Rpt~~ei------l~~~~~~~~~~~ 279 (296)
T cd06654 250 LNRCLDMDVEKRGSAKEL------LQHQFLKIAKPL 279 (296)
T ss_pred HHHHCcCCcccCcCHHHH------hhChhhhccCCc
Confidence 999999999999999999 678998766553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.91 Aligned_cols=252 Identities=31% Similarity=0.524 Sum_probs=216.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||.|+||.||++.+.. ++.|++|.+..... ...+.+|+++++.++||||+++++++.....+|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 679999999999999999999875 57899999865422 5688899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||+|.||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999999876777999999999999999999999998 9999999999999999999999999988665443333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-ccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-MNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .......+..++..+.+||.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 345578999999999999999999999999999999999999987766554433321 1122334556788999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
|+.+|.+||++.++ |.++||
T Consensus 237 l~~~P~~Rps~~~i------l~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQL------LQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHH------hcCCCC
Confidence 99999999999999 556664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.59 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=208.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecC------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------ 575 (783)
.+.|++.+.||+|+||.||+|.+.. ++.||+|++...... ...+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3578889999999999999998765 467999998654322 24677899999998 699999999998653
Q ss_pred CceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..+|++|||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||++++++.++|+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999999763 346889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
.............|++.|+|||++. +..++.++|||||||++|+|++|..||...........+.........+.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 6544333344567899999999986 34578899999999999999999999987665544433322222333445
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.++..+.+||.+||..+|.+||++.++ +.|+||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~i------l~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQL------MKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHH------hhCCCC
Confidence 678999999999999999999999999 566765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.88 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=216.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|++..++|++.++||+|+||.||++.+..+..+++|++.... .....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 567788999999999999999999987777789999876532 234678889999999999999999999887 7789
Q ss_pred EEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++|||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999999753 345788889999999999999999988 99999999999999999999999999875543
Q ss_pred ccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
... ......++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+.......+. .......+...+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 211 1122345678999999998889999999999999999999 999998877766555443 2223445567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
+++.+||..+|.+||++.++++.|+.
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=327.34 Aligned_cols=256 Identities=30% Similarity=0.566 Sum_probs=214.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
+|++.+.||+|+||.||+|.+.. ...+++|++.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999998642 1358888876543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhc-----------------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCC
Q 003963 580 IVTEFLPRGSLFRLLQRN-----------------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 636 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~N 636 (783)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999998642 134788899999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 003963 637 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 713 (783)
Q Consensus 637 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~ 713 (783)
||+++++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987543221 11223345678999999998889999999999999999998 999998887766
Q ss_pred HHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 714 ~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
....+. .......+..++.++.+||..||+.+|.+||++.++++.|+++.+
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 555443 223445577789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.06 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=217.9
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||.|+||.||.+.... ++.+++|.+............+.+|+.+++.++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58999999999999999998754 56799999887666666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|++++|.+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 456899999999999999999999998 9999999999999999999999999987655443233
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+.. ......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHc
Confidence 455689999999999988889999999999999999999999988777666555532 2233345668899999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 003963 744 HSDPQCRPSFQELVDK 759 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~ 759 (783)
..+|.+||++.+++++
T Consensus 238 ~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 238 QQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccCcccCCCHHHHhhC
Confidence 9999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.03 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=214.0
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCC----HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+|++.+.||.|+||.||+|....++.+|+|.+...... ......+.+|+.+++.++|+||+++++++...+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999998877778999998754322 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc--
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 659 (783)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999764 35889999999999999999999988 999999999999999999999999998754211
Q ss_pred ----cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHH
Q 003963 660 ----YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPR 734 (783)
Q Consensus 660 ----~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~ 734 (783)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... .....++..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122345889999999999988999999999999999999999999876655444333222 2234567778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+.+||.+||.++|.+||++.++ +.|+||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~------l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQL------LRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHH------hcCCCC
Confidence 9999999999999999999999 566665
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.90 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=206.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||+|+||.||+|.+.. ++.||+|++.... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 468889999999999999998754 4679999987543 34445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999986542 3678888999999999999999998 999999999999999999999999998755433 22
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-------HHHHHhhcccccccCCCCCCHHHH
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-------QVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+............+++++.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 3457899999999999999999999999999999999999999653321 111111111111112345788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||.+||+.+|.+||++.++ +.++||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~ei------l~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENL------MDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHH------hcCcccccc
Confidence 99999999999999999999 678888654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.46 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=205.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||+|+||.||+|.+.. ++.|++|++............+.+|+.+++.++||||+++++++.....+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 58899999999999999999864 56799999876544333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
++ ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 5888888765667999999999999999999999998 99999999999999999999999999876544333333
Q ss_pred CCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHhhccc---------------c---c
Q 003963 665 TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPW-DNLNSMQVIGAVGFMN---------------Q---R 724 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf-~~~~~~~~~~~i~~~~---------------~---~ 724 (783)
...+++.|+|||++.+.. ++.++|||||||++|+|++|..|| ...+....+..+.... . .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 446789999999987754 689999999999999999998885 3333332222211000 0 0
Q ss_pred ---------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 ---------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 ---------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
......+++++.+||.+||..||.+|||+.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i------l~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA------LQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH------hcCCCC
Confidence 01123477899999999999999999999999 556775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=322.34 Aligned_cols=251 Identities=33% Similarity=0.604 Sum_probs=211.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee-cCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~l 580 (783)
+...+|++.+.||+|+||.||++... +..|++|.+.... ....+.+|+.+++.++|+||+++++++. .....++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 44578999999999999999999765 5579999886433 2356888999999999999999999754 5567899
Q ss_pred EEEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+|||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999999976433 4789999999999999999999998 999999999999999999999999998754332
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. ......+..+++.+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence 2 23344678999999999889999999999999999997 9999988776666555532 23445567789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
|.+||..+|.+|||+.++++.|+.+
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=344.34 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=203.6
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC---CCCceeeEeceeecCCceEEEEEecCC
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
||+|+||.||+|.+.. ++.||||++.+.... ......+..|..++..+ .||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999865 578999999764332 22334455566776655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.++|+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999998764 46899999999999999999999998 99999999999999999999999999875443333344567
Q ss_pred CCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC-CCCCHHHHHHHHHhhhh
Q 003963 668 GTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP-KDVDPRWAAIVESCWHS 745 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~l~~LI~~cL~~ 745 (783)
||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... ...++ ..+++++.+||.+||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHcCC
Confidence 99999999998765 4789999999999999999999999888777666555332 22333 35789999999999999
Q ss_pred CCCCCC----CHHHHHHHHHHHHHHHhhc
Q 003963 746 DPQCRP----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 746 dP~~RP----sa~ell~~L~~L~~~~f~~ 770 (783)
||.+|| ++.++ +.|+||+.
T Consensus 236 ~P~~R~~~~~~~~~l------l~h~~~~~ 258 (330)
T cd05586 236 NPQHRLGAHRDAVEL------KEHPFFAD 258 (330)
T ss_pred CHHHCCCCCCCHHHH------hcCccccC
Confidence 999998 46666 57888864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.34 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=206.0
Q ss_pred EeeeeccC--CcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 509 IGEQIGQG--SCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 509 i~~~LG~G--~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
++++||+| +|+.||++.+.. ++.||||++............+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 789999998765 567999999776655666677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc----
Q 003963 586 PRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---- 660 (783)
Q Consensus 586 ~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---- 660 (783)
++++|.+++..+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999999654 345889999999999999999999998 9999999999999999999999998654322111
Q ss_pred ---ccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003963 661 ---LTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 723 (783)
Q Consensus 661 ---~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 723 (783)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01122356778999999876 4588999999999999999999999987654433222110000
Q ss_pred --------------------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 724 --------------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 724 --------------------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.......+++.+.+||.+||+.||.+|||+.++ ++|+||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el------l~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL------LNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH------hcChhhhhc
Confidence 001122357789999999999999999999999 688999764
Q ss_pred c
Q 003963 772 R 772 (783)
Q Consensus 772 ~ 772 (783)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.11 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=220.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.....+|++.++||.|+||.||++.+. .++.|+||.+...... ....+.+|+.+++.++||||+++++++.....+|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 334578999999999999999999875 4578999998754432 2356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|..++... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999999998753 4899999999999999999999998 999999999999999999999999998755433
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~L 738 (783)
........+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+... ......+..+++.+.+|
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 22233446889999999999988999999999999999999999999887765544333211 12334566789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
|.+||..||.+||++.++ ++|+||+.-+.
T Consensus 249 i~~~l~~dp~~Rpt~~~i------l~~~~~~~~~~ 277 (296)
T cd06655 249 LNRCLEMDVEKRGSAKEL------LQHPFLKLAKP 277 (296)
T ss_pred HHHHhhcChhhCCCHHHH------hhChHhhhccc
Confidence 999999999999999999 78999976553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.05 Aligned_cols=256 Identities=26% Similarity=0.350 Sum_probs=207.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 575 (783)
..++|++.+.||.|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34789999999999999999999754 46799999876544434456677899999999999999999987543
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
...|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 3478999998 7799988864 35899999999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 723 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 723 (783)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 234568999999999877 5688999999999999999999999987655443322211000
Q ss_pred ----------ccc--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 724 ----------RLE--------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 724 ----------~~~--------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
... .....++.+.+||.+||..||.+|||+.++ +.|+||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el------l~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA------LAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCcchhccC
Confidence 000 112356778999999999999999999999 6789997644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.37 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=212.0
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
|+..+.||+|+||.||++.+.. ++.||+|++....... .....+.+|+.+++.++|+||+.+++++..++..|++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 7788999999999999998864 5679999987654332 2344577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cc
Confidence 9999999888643 346899999999999999999999998 9999999999999999999999999986543321 22
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--ccccccCCCCCCHHHHHHHHH
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~l~~LI~~ 741 (783)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.. ......++..++..+.+|+..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 345789999999999998899999999999999999999999987665433322211 222344566789999999999
Q ss_pred hhhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003963 742 CWHSDPQCRPS-----FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 742 cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~ 770 (783)
||+.||.+||+ +.++ +.|+||+.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l------~~~~~~~~ 266 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEV------KRHPFFRN 266 (285)
T ss_pred HccCCHhHcCCCcccChHHH------HcChhhhc
Confidence 99999999999 6777 56777744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.04 Aligned_cols=257 Identities=33% Similarity=0.534 Sum_probs=218.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||.|+||.||++.+.. ++.|++|++.... .......+.+|+.+++.++|+||+++++++..+..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 468889999999999999999764 5679999987654 23344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999764 6899999999999999999999988 9999999999999999999999999997765443333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCC-CCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD-VDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~s~~l~~LI~~c 742 (783)
....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ....++.. ++..+.++|.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence 4556888999999999988999999999999999999999999877665554443322 22333334 789999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
|..+|.+||++.++ ++|+||+....
T Consensus 235 l~~~p~~Rpt~~~i------l~~~~~~~~~~ 259 (274)
T cd06609 235 LNKDPKERPSAKEL------LKHKFIKKAKK 259 (274)
T ss_pred hhCChhhCcCHHHH------hhChhhcCCCc
Confidence 99999999999999 67899976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=312.66 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=210.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 579 (783)
...++.+.+..||.|+.|.|+++..+.. .-.|||.+.+..- .+..+++...+.++...+ .|+||+.+|+|..+..++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 3455677888999999999999998764 5689999987653 444567777777666554 899999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++||.| ..-+..+|.+-..++++..+-++...+++||.||.+++ +||||||||+|||+|..|.|||||||++-...+.
T Consensus 168 IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 999999 45778888877788999999999999999999998653 4999999999999999999999999999877665
Q ss_pred cccccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccccccCC--CCCCH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIP--KDVDP 733 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~--~~~s~ 733 (783)
...+ ...|.+.|||||.+... .|+.++||||||++|+||.||..||.+.+ ..+++..+.. ...+.++ ...++
T Consensus 246 kAht-rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 246 KAHT-RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSP 323 (391)
T ss_pred cccc-cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCH
Confidence 4433 45789999999998644 57889999999999999999999998754 3455544432 2223333 34899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+.+|+..||++|+.+||.+.++ |+|+|+.
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~L------l~h~Fi~ 353 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKL------LEHPFIK 353 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHH------hcCccee
Confidence 99999999999999999999999 5566653
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.96 Aligned_cols=255 Identities=33% Similarity=0.554 Sum_probs=213.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-----------------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCcee
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-----------------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----------------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 566 (783)
.++|++.++||+|+||.||++.+... ..||+|++.... .......+.+|+++++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 46899999999999999999986431 348999887543 335567889999999999999999
Q ss_pred eEeceeecCCceEEEEEecCCCCHHHHHhhcC----------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCC
Q 003963 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 636 (783)
Q Consensus 567 ~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~N 636 (783)
++++++..++..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence 99999999999999999999999999997643 25899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChH
Q 003963 637 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSM 712 (783)
Q Consensus 637 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt--G~~Pf~~~~~~ 712 (783)
|+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ +..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999987543321 12223456788999999998889999999999999999998 78899887766
Q ss_pred HHHHHhhcc------cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 713 QVIGAVGFM------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 713 ~~~~~i~~~------~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
..+..+... ......+..++.++.+||.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 665554322 1112334567899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.39 Aligned_cols=253 Identities=30% Similarity=0.530 Sum_probs=213.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-------HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
+|.+.+.||.|+||.||+|.+.. ++.||+|.+...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999998754 578999988654332 1344678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999764 45888999999999999999999998 9999999999999999999999999987654
Q ss_pred cccc------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCC
Q 003963 658 ETYL------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 658 ~~~~------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 731 (783)
.... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.. .....++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 2111 11223578899999999998899999999999999999999999988766554444322 2344567788
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+..+.++|.+||+.||.+||++.++ ++++||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i------l~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAEL------LKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHH------hhCCCC
Confidence 9999999999999999999999999 556665
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.32 Aligned_cols=256 Identities=27% Similarity=0.517 Sum_probs=212.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
+..++|.+.+.||+|+||.||+|.+.. ...|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 345789999999999999999999864 3468899875443 233345688899999999999999999999998
Q ss_pred CceEEEEEecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---cEE
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVK 646 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~---~vk 646 (783)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+|||++.++ .+|
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 99999999999999999997543 24889999999999999999999998 99999999999998654 599
Q ss_pred EEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q 003963 647 VGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ 723 (783)
Q Consensus 647 L~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 723 (783)
|+|||+++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999876532211 1112233568999999999999999999999999999997 999998877766555443 233
Q ss_pred cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 724 ~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
....+..++..+.+|+.+||+.+|.+||++.+++++|.
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 45567788999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.44 Aligned_cols=260 Identities=29% Similarity=0.487 Sum_probs=217.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-CC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 576 (783)
..++|++.+.||+|+||.||+|.+.. ...|++|++... ........+.+|+.+++.++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 45789999999999999999999876 567999987643 345556778899999999999999999998765 56
Q ss_pred ceEEEEEecCCCCHHHHHhhcC-------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT-------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
..+++++|+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECC
Confidence 7899999999999999996532 45889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccc
Q 003963 650 FGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLE 726 (783)
Q Consensus 650 FGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 726 (783)
||+++....... ......++..|+|||++.+..++.++|||||||++|++++ |++||...+.......+.. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCC
Confidence 999975432211 1122345678999999999889999999999999999999 9999988777665544432 22334
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+..+++++.+++.+||..+|++||++.++++.|.++...
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 4566789999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=320.81 Aligned_cols=247 Identities=30% Similarity=0.547 Sum_probs=208.5
Q ss_pred eeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecC
Q 003963 511 EQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
++||+|+||.||+|.+... ..||+|.+...... .....+.+|+.+++.+.|||||++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 4699999999999986432 47999998766543 44567889999999999999999999876 456899999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc---c
Q 003963 587 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---T 663 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~ 663 (783)
+++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997654 6899999999999999999999998 999999999999999999999999998765432211 1
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+.. ......+..++..+.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 12223567999999999999999999999999999998 9999988877666555532 334456778899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L 763 (783)
|..+|.+||++.++++.|+++
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.55 Aligned_cols=247 Identities=30% Similarity=0.568 Sum_probs=210.2
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
++||+|+||.||++....++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999997777889999886543 344455788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc-cCCCCC
Q 003963 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT-KTGKGT 669 (783)
Q Consensus 591 ~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~Gt 669 (783)
.+++......+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++.......... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9999766666889999999999999999999998 9999999999999999999999999987543322111 122346
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 670 ~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
..|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++..+.+|+.+||..+|.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999998889999999999999999998 999998877666555543 2334456677899999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003963 749 CRPSFQELVDKLR 761 (783)
Q Consensus 749 ~RPsa~ell~~L~ 761 (783)
+||++.++++.|.
T Consensus 237 ~Rp~~~~l~~~l~ 249 (250)
T cd05085 237 NRPKFSELQKELA 249 (250)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=339.89 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=199.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
..+|++.+.||+|+||.||+|.+... +.||+|+..... ...|+.+++.++||||+++++++......++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 35799999999999999999998654 579999754322 245899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+. ++|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++....... .
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 212 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-A 212 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc-c
Confidence 9994 6899998776677999999999999999999999998 9999999999999999999999999987533221 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChH----------HHHHHhhcccc-cccC---
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLNSM----------QVIGAVGFMNQ-RLEI--- 727 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~P-f~~~~~~----------~~~~~i~~~~~-~~~~--- 727 (783)
.....||+.|+|||++.+..++.++|||||||++|||+++..| |...... .....+..... ...+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 2345689999999999999999999999999999999985444 4432111 01111100000 0000
Q ss_pred ---------------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 728 ---------------------------PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 728 ---------------------------~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
...++.++.+||.+||+.||.+|||+.++ |.|+||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~------l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI------LNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHH------hcCchhcc
Confidence 01356677889999999999999999999 78999985
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.27 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=213.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 578 (783)
.+|++.+.||+|+||.||++.+.. +..|++|++...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999998754 578999998654322 2445678899999999999999999998865 3568
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+++|||+++++|.+++.... .+++...+.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999997643 5888999999999999999999988 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|..||..................+.++..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 111234578899999999998899999999999999999999999987766555544433334556677788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
++|| .||..+|.+||++.++ +.|+||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~ei------l~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEEL------LRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHH------hcCcccc
Confidence 9999 6888999999999999 7889886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.16 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=208.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||+|+||.||++.+.. ++.||+|++..........+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999864 5789999987554333334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|++++.|..++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9998888777654 346899999999999999999999998 9999999999999999999999999998665443223
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------cc
Q 003963 664 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------RL 725 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~ 725 (783)
....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+..... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34457889999999876 4578999999999999999999999987765544333211000 00
Q ss_pred c------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 726 E------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 726 ~------------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
. ....++..+.+||.+||..+|++||++.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei------l~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL------LEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH------hcCCCC
Confidence 0 012467889999999999999999999999 667776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.93 Aligned_cols=257 Identities=31% Similarity=0.516 Sum_probs=211.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC---------------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCcee
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS---------------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---------------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 566 (783)
+...+|++.++||+|+||.||++.+... ..||+|++.... .......+.+|+++++.++||||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3456899999999999999999986432 248999987543 344556788999999999999999
Q ss_pred eEeceeecCCceEEEEEecCCCCHHHHHhhcC-----------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCC
Q 003963 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635 (783)
Q Consensus 567 ~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~ 635 (783)
++++++......++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR 158 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence 99999999999999999999999999986432 13678889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCh
Q 003963 636 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNS 711 (783)
Q Consensus 636 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt--G~~Pf~~~~~ 711 (783)
|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ +..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999875433211 1122345678999999998889999999999999999988 7789988776
Q ss_pred HHHHHHhhcc------cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 712 MQVIGAVGFM------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 712 ~~~~~~i~~~------~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.+....+... ......+..+++.+.+||.+||..+|.+||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6655443211 1123345567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.04 Aligned_cols=251 Identities=31% Similarity=0.494 Sum_probs=212.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||.|+||.||+|.+.. ++.+++|++...... ....+.+|+.+++.++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 3689999999999999999999754 567999998765432 4578889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999876567999999999999999999999998 999999999999999999999999998765543323
Q ss_pred ccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---cccCCCCCCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---RLEIPKDVDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~---~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~s~~l~ 736 (783)
.....++..|++||.+.+. .++.++|+|||||++|+|++|.+||......+....+..... ....+..++.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3345688899999999877 788999999999999999999999988776554444322211 1122344678899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~ 758 (783)
+||.+||..+|..||++.+++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999999999954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.99 Aligned_cols=247 Identities=33% Similarity=0.575 Sum_probs=212.6
Q ss_pred eeeccCCcEEEEEEEEeC-C---ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecC
Q 003963 511 EQIGQGSCGTVYHAVWYG-S---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
++||+|+||.||+|.+.. + ..||||++...... ...+.+.+|+.+++.++||||+++++++.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998754 2 25899998776654 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc---cc
Q 003963 587 RGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LT 662 (783)
Q Consensus 587 ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~ 662 (783)
+++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997654 56899999999999999999999998 9999999999999999999999999987654321 11
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+.........+..++..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 223456788999999999899999999999999999998 9999988877776666554444555667789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHH
Q 003963 742 CWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~ 761 (783)
||..+|.+||++.++++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=341.42 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=201.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
...|.+.+.||+|+||.||++.+.. ++.||||.... ..+.+|+++|+.|+|+|||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4579999999999999999999865 46799996322 23567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
|++. ++|..++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9994 6999998766667999999999999999999999998 99999999999999999999999999976543211
Q ss_pred -cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHhhccccc-ccC----
Q 003963 662 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--------SMQVIGAVGFMNQR-LEI---- 727 (783)
Q Consensus 662 -~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~--------~~~~~~~i~~~~~~-~~~---- 727 (783)
......||+.|+|||++.+..++.++|||||||+||||++|..|+-... ..+....+...... ..+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1223569999999999999999999999999999999999876542211 12222222111100 000
Q ss_pred ---------------------------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 728 ---------------------------PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 728 ---------------------------~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
...++..+.+||.+||+.||.+|||+.|+ |.|+||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el------L~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL------LRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH------hhCcccCC
Confidence 01345688999999999999999999999 78899974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=341.24 Aligned_cols=263 Identities=33% Similarity=0.605 Sum_probs=231.2
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC---c--eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS---Q--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 572 (783)
-+|++..+..++.++||.|.||.||+|.+..- + .||||..+.....++ .+.|.+|.-+|+.++|||||+++|+|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeee
Confidence 46677777888899999999999999987432 2 389998877554444 78899999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
.+ ...+||||+++.|.|..+|+.+...++......++.||+.||+|||+.+ +|||||...||||.....|||+|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 85 5689999999999999999999999999999999999999999999988 99999999999999999999999999
Q ss_pred Ccccccc-cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 653 SRLKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 653 a~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
+++.... +.......-...|||||.+.-..++.++|||.||+.|||++. |..||.+....+++..+. ...+++.|++
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCCC
Confidence 9987654 333334445779999999999999999999999999999876 999999988877765553 4568899999
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+|+.+..|+.+||..+|.+||.+.+|...|.++..
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988866
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.29 Aligned_cols=259 Identities=23% Similarity=0.419 Sum_probs=215.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||+|+||.||++.+. .++.||+|.+.... .......+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46889999999999999999986 45789999886542 34445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 584 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 584 ~~~ggsL~~~L~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|+++++|..++... ...+++..+..++.||+.||.|||+ ++ |+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998753 2368999999999999999999996 47 999999999999999999999999998755432
Q ss_pred ccccCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--ccccccCCCCCC
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIPKDVD 732 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~------~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s 732 (783)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.. ......++..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 223446788999999986543 47899999999999999999999976655443332221 122345666789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.++.+||.+||..+|.+||++.++ +.++||...+..
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l------~~~~~~~~~~~~ 271 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQL------LEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHH------hcChhhhhccCC
Confidence 999999999999999999999999 578998776654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.95 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=205.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||+|+||.||+|.+.. ++.||+|++...... ....+.+|+.+++.++||||+++++++.....+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 4689999999999999999999754 567999998654322 2346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999998653 46899999999999999999999998 999999999999999999999999998765433222
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---ccCCCCCCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---LEIPKDVDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~s~~l~ 736 (783)
.....|++.|+|||.+. ...++.++|||||||++|+|++|..||...........+...... ...+..++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 33456889999999885 344678999999999999999999999766544332222111111 112235688999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~ 759 (783)
+||.+||..+|++||++.+++++
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcC
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=341.69 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=227.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
......|.+.+.||+|.|+.|.++++.. +..||||++.+...+....+.+.+|+++|+.|+|||||+++.+.+....+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 4456789999999999999999999754 578999999998888877778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+.+|.++++|.+++. ..+..+..++.|+++|++|||+++ |||||||++||||+.+..+||+|||++..+. .
T Consensus 132 lV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~ 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD-Y 207 (596)
T ss_pred EEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec-c
Confidence 99999999999999988764 555889999999999999999998 9999999999999999999999999998877 4
Q ss_pred cccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.....+.+|++.|.|||++.|..+ ++.+|+||||++||-|+.|.+||++.+....-..+ +.+.+.+|..++.++.++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--l~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--LRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--eeeeecccceeechhHHH
Confidence 456678999999999999999887 67899999999999999999999988776655444 455677888899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~ 759 (783)
|+++|..+|.+|++.+++.+.
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HHHhhccCccccCCHHHhhhh
Confidence 999999999999999999543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.27 Aligned_cols=250 Identities=33% Similarity=0.616 Sum_probs=213.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
.+|++.+.||.|+||.||++.+..+..+++|++....... ..+.+|+++++.++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 5789999999999999999998767789999987654433 3578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc-c
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-T 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 663 (783)
+++++|.+++......+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999999876667899999999999999999999998 999999999999999999999999998754332211 1
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... .....+...+..+.+|+.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHH
Confidence 12234678999999998889999999999999999998 99999887766666554322 23344566789999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L 760 (783)
|..+|.+||++.++++.|
T Consensus 238 l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 238 WKERPEDRPSFSLLLHQL 255 (256)
T ss_pred cccChhhCCCHHHHHHhh
Confidence 999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=320.10 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=214.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCceEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVT 582 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~ 582 (783)
+|++.+.||.|+||.||++.+.. ++.||+|++............+..|+.+++.++||||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58899999999999999998754 4679999998766666667788899999999999999999997754 45689999
Q ss_pred EecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHH-----hCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 583 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLH-----HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 583 E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
||+++++|.+++... ..++++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999999653 456899999999999999999999 777 9999999999999999999999999988
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. .....++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccCHH
Confidence 765543323345689999999999998899999999999999999999999988776655555432 2334567788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~ 758 (783)
+.+++.+||..+|.+||++.+|++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhh
Confidence 999999999999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=330.86 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=217.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
...+|++.+.||.|+||.||++.+. .++.||+|.+....... ...+.+|+.+++.++||||+++++++...+..|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 4478999999999999999999975 46789999987654332 35678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999998653 4788899999999999999999998 99999999999999999999999999875543322
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~ 740 (783)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... ......+..++..+.+||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 233446889999999999988999999999999999999999999776554332222111 1122345668899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+||..+|.+||++.++ ++|+||+.-+..
T Consensus 251 ~~l~~~p~~Rps~~~i------l~~~~~~~~~~~ 278 (297)
T cd06656 251 RCLEMDVDRRGSAKEL------LQHPFLKLAKPL 278 (297)
T ss_pred HHccCChhhCcCHHHH------hcCchhcccccc
Confidence 9999999999999999 678999765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.97 Aligned_cols=247 Identities=33% Similarity=0.597 Sum_probs=210.8
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
++||.|+||.||++.+..++.|++|++...... .....+.+|+.+++.+.|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877788999998765543 4556789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc--cCCCC
Q 003963 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKG 668 (783)
Q Consensus 591 ~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~G 668 (783)
.+++......++...++.++.+++.+|+|||+++ ++||||||+|||++.++.++|+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999776667889999999999999999999998 9999999999999999999999999987554221111 12233
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 669 t~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+||.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999999 8999988776655544432 23445667789999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003963 748 QCRPSFQELVDKLR 761 (783)
Q Consensus 748 ~~RPsa~ell~~L~ 761 (783)
.+||++.++++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.36 Aligned_cols=254 Identities=31% Similarity=0.557 Sum_probs=212.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
.+.+|.+.++||+|+||.||++.... +..+++|.+... .......+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45788999999999999999997532 345888886543 3444567899999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcC--------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 642 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~ 642 (783)
..+++|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+|+||||+|||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence 9999999999999999997543 24788999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 003963 643 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVG 719 (783)
Q Consensus 643 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~ 719 (783)
+.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999987543221 11222345788999999999999999999999999999998 999998877766555543
Q ss_pred cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 720 ~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
. ......+..+++.+.+||.+||..||.+||++.++++.|+
T Consensus 239 ~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 Q-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2 2234556778999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.00 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=205.5
Q ss_pred cce-eEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--C
Q 003963 505 EDL-TIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--Q 576 (783)
Q Consensus 505 ~~y-~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 576 (783)
++| ++.+.||+|+||.||++.+. .+..||+|++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 89999999999999887532 34579999987543 233456788999999999999999999987653 4
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.++++|||+++++|.+++... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccccc
Confidence 589999999999999999764 4899999999999999999999998 999999999999999999999999998765
Q ss_pred ccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HH------------HHhh
Q 003963 657 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--VI------------GAVG 719 (783)
Q Consensus 657 ~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~------------~~i~ 719 (783)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||......- .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221 1122345677999999998889999999999999999999999986543210 00 0000
Q ss_pred cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 720 ~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
........+..++.++.+++..||+.+|++||++.+++..|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111223346678899999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.69 Aligned_cols=264 Identities=31% Similarity=0.583 Sum_probs=220.4
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 568 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 568 (783)
..|+....+|++++.||+|+||.||+|.+.. ...||+|++... ........+.+|+.+++.+ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3566777789999999999999999998642 125899987643 2344567888999999999 79999999
Q ss_pred eceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 003963 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 633 (783)
Q Consensus 569 ~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIK 633 (783)
++++...+.++++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 999999999999999999999999996532 24778888999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003963 634 SSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 710 (783)
Q Consensus 634 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~ 710 (783)
|+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875543221 1222334568999999999999999999999999999998 899998887
Q ss_pred hHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 711 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 711 ~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
..+....+. .......+..++.++.+||.+||+.+|.+||++.++++.|+++..
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 776665543 223445667788999999999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.26 Aligned_cols=257 Identities=29% Similarity=0.542 Sum_probs=218.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..+|++.+.||+|+||.||+|.+... ..+|+|++..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 46899999999999999999987542 2489998765543 4455678899999999999999999999887 789
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999999877667999999999999999999999988 99999999999999999999999999976543
Q ss_pred cccc--ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~~~--~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.... .....++..|+|||.+....++.++|+|||||++|+|++ |..||......+....+. .......+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHH
Confidence 2211 112223568999999988889999999999999999998 999999887766655553 233455667788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.+++.+||..+|..||++.++++.|+++..
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.67 Aligned_cols=254 Identities=28% Similarity=0.491 Sum_probs=214.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||.|+||.||++.+.. ++.|++|++..... ......+.+|+.+++.++||||+++++++.....++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 367888999999999999999874 57799999876543 3455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++++|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999998765678999999999999999999999 88 999999999999999999999999998655433221
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHhhcccccccCCCC-CCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-----SMQVIGAVGFMNQRLEIPKD-VDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~-~s~~l~ 736 (783)
...++..|+|||.+.+..++.++|||||||++|+|++|..||.... .......+. .......+.. ++.++.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 2567899999999999999999999999999999999999997552 222222221 1122333443 889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+||.+||..+|.+||++.++ +.++||+.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~l------l~~~~~~~ 262 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKEL------LEHPFIKK 262 (265)
T ss_pred HHHHHHcCCCchhCcCHHHH------hhCchhhc
Confidence 99999999999999999999 67899975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.37 Aligned_cols=256 Identities=32% Similarity=0.543 Sum_probs=209.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-----------------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-----------------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----------------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI 565 (783)
..++|++.++||+|+||.||++.+.. ...||+|++.... .......+.+|+.+++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999986432 2358999886543 34445678899999999999999
Q ss_pred eeEeceeecCCceEEEEEecCCCCHHHHHhhcC----------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCC
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~ 635 (783)
+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 999999999999999999999999999987532 23667889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCh
Q 003963 636 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNS 711 (783)
Q Consensus 636 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt--G~~Pf~~~~~ 711 (783)
|||++.++.++|+|||++........ ......+++.|++||+..+..++.++|||||||++|||++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999875433211 1112234678999999888889999999999999999998 7899987776
Q ss_pred HHHHHHhhc------ccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 712 MQVIGAVGF------MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 712 ~~~~~~i~~------~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.+....... .....+.+..+++.+.+||.+||+.||.+||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 655443211 11123445668899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.61 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=213.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..++|++.+.||+|+||.||+|.+.+ ...||+|++.... .......+.+|+.+++.+.||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 35689999999999999999998642 4579999986543 3445567889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcC---------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~ 635 (783)
.++++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 9999999999999999996421 24678889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 003963 636 NLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 712 (783)
Q Consensus 636 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~ 712 (783)
|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987543221 11222344678999999999899999999999999999997 88999888777
Q ss_pred HHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
+....+... .....+..++.++.+||.+||+.+|.+||++.++++.|+
T Consensus 240 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYVRDG-NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 666555322 233456678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.34 Aligned_cols=248 Identities=33% Similarity=0.565 Sum_probs=213.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+|+..+.||+|+||.||+|... .++.|++|++..... ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999986 567899999865432 245567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++.+.. .+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999997643 5889999999999999999999998 9999999999999999999999999987654332
Q ss_pred cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
......|+..|++||.+.... ++.++|+|||||++|+|++|..||...........+........++..+++.+.+||.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 223456889999999988776 8999999999999999999999998777655554544434455677788999999999
Q ss_pred HhhhhCCCCCCCHHHHH
Q 003963 741 SCWHSDPQCRPSFQELV 757 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell 757 (783)
+||..+|.+||++.+++
T Consensus 237 ~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 237 KCLQRDPSLRPTAAELL 253 (258)
T ss_pred HHhhcCcccCcCHHHHh
Confidence 99999999999999994
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=347.95 Aligned_cols=253 Identities=31% Similarity=0.506 Sum_probs=215.6
Q ss_pred eEeeeeccCCcEEEEEEEEeCC-ceEEEEEEec--ccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc--eEEEE
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSR--QEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR--LCIVT 582 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~--~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~lV~ 582 (783)
+...+||+|+|-+||+|.+... -+||--.++. ...+...+++|..|+.+|+.|+|||||+||.+|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4457899999999999998543 3454333222 22345667899999999999999999999999987665 78899
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCcccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 661 (783)
|.+..|+|..|+++.+ +++...+..|++||++||.|||++.++|||||||.+||+|+. .|.|||+|+|+|........
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999998765 588999999999999999999999999999999999999975 58999999999998777644
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
. ..+|||.|||||++. ..|+..+||||||+.|+||+|+.+||... ++.+++..+......-.+.+.-+++.++||.
T Consensus 202 k--svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 202 K--SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred c--eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 3 368999999999998 77999999999999999999999999765 5667777775555555566667899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||.. ..+|||+.|| |.++||...
T Consensus 279 kCl~~-~~~R~sa~eL------L~d~Ff~~d 302 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKEL------LKDPFFDED 302 (632)
T ss_pred HHhcC-chhccCHHHH------hhChhhccc
Confidence 99999 8999999999 789999876
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.81 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=211.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--Cce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 578 (783)
.+|++.+.||+|+||.||++.+.. +..|+||++..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478999999999999999999765 56899998864332 234567888999999999999999999988763 468
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998764 34788889999999999999999998 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....................|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 11 112234588899999999988899999999999999999999999987765555444433333455667788899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.++|.+||. +|.+||++.++ ++|+|+
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~i------l~~~~~ 264 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADEL------LRHTFV 264 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHH------hcCccc
Confidence 999999995 99999999999 566665
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.27 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=211.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||.|+||.||+|.+.. ++.|++|++............+.+|+.+++.++||||+++++++.....+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999754 57899999987665455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-cc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 663 (783)
+ +++|.+++......+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999776677999999999999999999999998 99999999999999999999999999876544321 12
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 003963 664 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------ 724 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 724 (783)
....|+..|+|||++.+.. ++.++|||||||++|+|++|.+||...........+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 2446899999999987644 689999999999999999999888766654433222110000
Q ss_pred ----------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 ----------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
..+...++..+.+||.+||..+|.+||++.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~------l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA------LRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH------hhCcCc
Confidence 01123467899999999999999999999999 677876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.78 Aligned_cols=249 Identities=31% Similarity=0.574 Sum_probs=206.5
Q ss_pred eeeccCCcEEEEEEEEeCC-c--eEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEEecC
Q 003963 511 EQIGQGSCGTVYHAVWYGS-Q--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~-~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
+.||+|+||.||+|.+..+ . .+++|.+.... .......+.+|+.++..+ +||||+++++++...+.+++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 3689999999999997654 2 46888876432 334456788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 587 RGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 587 ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
+++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999996532 24788999999999999999999988 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.. ......+..
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLN 235 (270)
T ss_pred Cccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCc
Confidence 98633221 11112234567999999998889999999999999999997 9999988776665555432 234456667
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
++.++.+|+.+||..+|.+||++.+++..|+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.74 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=213.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||+|+||.||++.+.. ++.+|+|.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58899999999999999998754 56799999987666666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCCCccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~ 662 (783)
+++++|.+++... ...+++..++.++.+++.+|+|||+++ |+|+||||+||+++.+ +.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 345889999999999999999999998 9999999999999855 468999999987655432 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ......++..+++++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHHH
Confidence 224567899999999998888999999999999999999999998877655544442 2223456677899999999999
Q ss_pred hhhCCCCCCCHHHHH
Q 003963 743 WHSDPQCRPSFQELV 757 (783)
Q Consensus 743 L~~dP~~RPsa~ell 757 (783)
|..+|.+|||+.+++
T Consensus 237 l~~~p~~Rpt~~~ll 251 (256)
T cd08220 237 LNLDPSKRPQLSQIM 251 (256)
T ss_pred ccCChhhCCCHHHHh
Confidence 999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.92 Aligned_cols=250 Identities=33% Similarity=0.563 Sum_probs=204.6
Q ss_pred eeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee-cCCceEEEEEec
Q 003963 511 EQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLCIVTEFL 585 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~~ 585 (783)
+.||+|+||.||+|.+.. ...||||.+.... .......+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998643 2469999875432 3344567889999999999999999999765 456689999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc----c
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----L 661 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----~ 661 (783)
.+++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999876556778888899999999999999988 9999999999999999999999999987543211 1
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+. .......+..+++.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 1112345778999999998889999999999999999999 577787776665554442 22334456667899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+||..+|++||++.++++.|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.57 Aligned_cols=264 Identities=26% Similarity=0.329 Sum_probs=213.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--CceEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCI 580 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 580 (783)
.++|++.+.||.|+||.||+|.+.. ++.||+|++............+.+|+.+++.++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4689999999999999999999864 57899999875543333333456799999999999999999998754 46899
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+. ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999996 5899988776667899999999999999999999998 9999999999999999999999999987655432
Q ss_pred ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------
Q 003963 661 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---------------- 723 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 723 (783)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22223345788999999876 4578999999999999999999999988877665544322110
Q ss_pred -cccC-----------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCCC
Q 003963 724 -RLEI-----------PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 776 (783)
Q Consensus 724 -~~~~-----------~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~~ 776 (783)
...+ ....++.+.+||.+||..||++|||+.++ +.|+||+...-..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i------l~h~~f~~~~~~~~ 301 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA------LESSYFKEKPLPCE 301 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH------hcChhhccCCCCCC
Confidence 0001 12257889999999999999999999999 67999986655544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.05 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=205.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||+|+||.||+|.+.. ++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3588999999999999999998764 56799999865432 22346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 999999999998754 36899999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc---CCCCCCHHHH
Q 003963 663 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE---IPKDVDPRWA 736 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~s~~l~ 736 (783)
.....|++.|+|||++. ...++.++|+|||||++|+|++|..||.................... ....++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34557899999999874 45578899999999999999999999976554433322211111111 1124678999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~ 758 (783)
+||.+||..+|++||++.++++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhc
Confidence 9999999999999999999953
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.29 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=216.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
..|+..++||.|+||.||+|.+.. +..||||++..... ......+.+|+.+++.+.||||+++++++..+..+|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 457888999999999999999764 57899999875433 3445788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999875 35888899999999999999999988 9999999999999999999999999987654433233
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++..+.+||.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 34467889999999998889999999999999999999999998777665544332 22234455667889999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..+|.+||++.++ ++++||....
T Consensus 238 ~~~p~~Rp~~~~i------l~~~~~~~~~ 260 (277)
T cd06640 238 NKDPSFRPTAKEL------LKHKFIVKNA 260 (277)
T ss_pred ccCcccCcCHHHH------HhChHhhhcc
Confidence 9999999999999 5677775543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=331.00 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=190.1
Q ss_pred eeeeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCceEEEEEe
Q 003963 510 GEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVTEF 584 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 584 (783)
+++||+|+||.||+|.+.. .+.||+|++...... ..+.+|+.+++.++||||+++++++.. ...+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4689999999999998753 467999998765433 346689999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE----cCCCcEEEEecCC
Q 003963 585 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 652 (783)
Q Consensus 585 ~~ggsL~~~L~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 652 (783)
+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 95 5888887532 235889999999999999999999998 9999999999999 4567899999999
Q ss_pred Cccccccc---ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHhh
Q 003963 653 SRLKHETY---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM---------QVIGAVG 719 (783)
Q Consensus 653 a~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---------~~~~~i~ 719 (783)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 97654322 122345789999999998874 5789999999999999999999999643210 1111100
Q ss_pred c-ccc-------------------------cc----------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 720 F-MNQ-------------------------RL----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 720 ~-~~~-------------------------~~----------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
. ... .. ......+.++.+||.+||+.||.+|||+.++ |
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~------l 312 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA------M 312 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH------h
Confidence 0 000 00 0011235678999999999999999999999 6
Q ss_pred HHHHh
Q 003963 764 QRQYF 768 (783)
Q Consensus 764 ~~~~f 768 (783)
+|+||
T Consensus 313 ~hp~f 317 (317)
T cd07868 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 77876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=366.21 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=228.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
+..++|.|+++||+|+||.|.+++++.. +.||+|++.+.... .....-|+.|-.+|-..+.+=||+++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 3467999999999999999999998775 56999999875433 234467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc-c
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-E 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~-~ 658 (783)
+||||++||+|..++.+.. ++++..+++++.+|+.||..||+.| +|||||||+|||||..|+|||+|||.+..+. +
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999998876 8999999999999999999999999 9999999999999999999999999887665 5
Q ss_pred ccccccCCCCCCcccCccccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC--CCC
Q 003963 659 TYLTTKTGKGTPQWMAPEVLR----N-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDV 731 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~----~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 731 (783)
+...+...+|||.|.+||++. + +.|+.-.|+|||||++|||+.|..||...+..+.+..|......+.+| ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 556677789999999999986 3 567899999999999999999999999999999998887776677777 568
Q ss_pred CHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhc
Q 003963 732 DPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPs---a~ell~~L~~L~~~~f~~ 770 (783)
|.++++||++.+. +|+.|.. +.++ -.|+||..
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedi------k~HpFF~g 343 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDI------KNHPFFEG 343 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHH------HhCccccC
Confidence 9999999999774 5777776 8888 57899943
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.01 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=214.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+|++.+.||.|+||.||+|.+.. ++.|+||++...... ......+..|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 48889999999999999999764 578999999766544 33445677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+ +++|.+++......+++..++.++.||++||.|||+++ |+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999999765546899999999999999999999998 99999999999999999999999999976654433
Q ss_pred cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------
Q 003963 662 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------- 723 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 723 (783)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||........+..+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3333456888999998865 4578999999999999999999888876665443322211000
Q ss_pred ---------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCC
Q 003963 724 ---------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 775 (783)
Q Consensus 724 ---------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~ 775 (783)
.......++..+.+||.+||.++|.+||++.++ +.++||++...-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~------l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA------LEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH------hhCccccCCCCCC
Confidence 000123457889999999999999999999999 6799998866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.13 Aligned_cols=255 Identities=30% Similarity=0.497 Sum_probs=207.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+++.....||+|+||.||+|.+.. +..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444455689999999999999765 4579999876543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcc--hHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~ 659 (783)
||+++++|.+++......+ +...+..++.||+.||+|||+.+ |+|+||||+||+++. .+.++|+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999999997654445 78888899999999999999988 999999999999976 679999999998755433
Q ss_pred cccccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccccCCCCCCHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
........|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... .............++..+++++.
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence 22233445789999999986644 7889999999999999999999997654322 22222222334557778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+|+.+||..+|.+||++.++ +.|+||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~l------l~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDL------LQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHH------HhCCCC
Confidence 99999999999999999999 566765
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.22 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=205.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceee-----
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT----- 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----- 573 (783)
....++|++.+.||+|+||.||++.+.. ++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 3456899999999999999999998754 46799998754322 224677899999999 6999999999873
Q ss_pred cCCceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
....+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 34568999999999999998753 2346888999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cc
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QR 724 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~ 724 (783)
|++..............|++.|+|||++.. ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 998765443333334568999999999753 446889999999999999999999998776544433322111 12
Q ss_pred ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003963 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 725 ~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~ 758 (783)
...+..++..+.+||.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2344567889999999999999999999999954
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.96 Aligned_cols=255 Identities=33% Similarity=0.543 Sum_probs=205.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCc
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 577 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 577 (783)
.+|++.+.||+|+||.||++... .+..||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 57899999999999999999743 35679999986543 3445678899999999999999999998754 346
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999776667899999999999999999999998 9999999999999999999999999988654
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---------------HHHhh
Q 003963 658 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---------------IGAVG 719 (783)
Q Consensus 658 ~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~---------------~~~i~ 719 (783)
.... ......++..|+|||++.+..++.++|||||||++|||++|..|+........ +..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11122334569999999998899999999999999999998776543221100 00111
Q ss_pred cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 720 ~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
........+..++.++.+||.+||..+|++|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11223345567889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.43 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=207.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeec------C
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS------P 575 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~ 575 (783)
.+.|++.+.||.|+||.||+|.+.. ++.||+|++.... .....+..|+.+++.+ +||||+++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 4688999999999999999999854 4679999886532 2335678899999998 69999999998853 4
Q ss_pred CceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..+|++|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 5789999999999999999753 345788889999999999999999998 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
.............|++.|+|||++. +..++.++|||||||++|+|++|..||...........+...........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 5543333334557899999999876 34578899999999999999999999977665544433322222222344
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.++.++.+||.+||..||.+||++.+| +.|+||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~el------l~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQL------LKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHH------hcCCCC
Confidence 688999999999999999999999999 566665
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=326.07 Aligned_cols=255 Identities=26% Similarity=0.344 Sum_probs=208.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 478999999999999999999864 5789999987654444445678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|..+... ...+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999888877654 345899999999999999999999998 9999999999999999999999999987654433333
Q ss_pred cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------------
Q 003963 664 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------- 723 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------- 723 (783)
....++..|+|||++.+. .++.++|||||||++|+|++|.+||...........+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 344678899999998763 468899999999999999999999976554332222111000
Q ss_pred ----------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 724 ----------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 724 ----------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.....+.++..+.+|+.+||..+|.+||++.++ ++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i------l~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL------LHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH------hcCCCC
Confidence 001123578899999999999999999999999 667776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.13 Aligned_cols=256 Identities=30% Similarity=0.475 Sum_probs=218.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.+|++.+.||.|++|.||+|.+.. ++.|++|++...... .....+.+|+.++..++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 368899999999999999999875 678999998765433 456788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|+++++|.+++... ..+++..++.++.||+.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999764 568999999999999999999999 88 999999999999999999999999998766544333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhcccccccCCCC-CCHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGAVGFMNQRLEIPKD-VDPRWAAI 738 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~-~s~~l~~L 738 (783)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. .......+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334467889999999999989999999999999999999999997774 333333332 2233445555 88999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|..||..+|++||++.++ +.++|++..
T Consensus 236 i~~~l~~~p~~R~~~~~l------l~~~~~~~~ 262 (264)
T cd06623 236 ISACLQKDPKKRPSAAEL------LQHPFIKKA 262 (264)
T ss_pred HHHHccCChhhCCCHHHH------HhCHHHHhc
Confidence 999999999999999999 667888654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.51 Aligned_cols=255 Identities=28% Similarity=0.529 Sum_probs=214.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.++|++.+.||.|+||.||+|..+. .+.|++|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 3689999999999999999998643 2468999876533 23356778999999999999999999999999899
Q ss_pred eEEEEEecCCCCHHHHHhhcC--------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 578 LCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
.|+||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999997543 15899999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccc-cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccC
Q 003963 650 FGLSRLKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEI 727 (783)
Q Consensus 650 FGla~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 727 (783)
||++...... ........++..|++||.+.+..++.++|||||||++|+|++ |..||...........+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 9998643221 112223356778999999988888999999999999999999 89999887776666555433334455
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
+..++..+.++|.+||..+|.+||++.+++..|.
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 6678999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.95 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=212.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||.|+||.||+|.... +..+++|++....... ....+.+|+.+++.++|+||+++++.+......+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 479999999999999999999754 4679999987655444 55778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 584 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 584 ~~~ggsL~~~L~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999753 245899999999999999999999998 99999999999999999999999999875544322
Q ss_pred c----ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccC---CCCCC
Q 003963 662 T----TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEI---PKDVD 732 (783)
Q Consensus 662 ~----~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~---~~~~s 732 (783)
. .....|+..|++||++... .++.++|+|||||++|+|++|+.||...+..+.......... .... ...++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 1 1334688999999998776 788999999999999999999999988776554443322111 1111 13578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+.+.+||.+||..||.+||++.++ +.|+||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~l------l~~p~~ 267 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEEL------LKHKFF 267 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHH------hhCCCC
Confidence 899999999999999999999999 567776
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.12 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=214.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+|++.+.||.|+||.||+|.+.. ++.|++|++....... ...+.+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999864 5789999998654332 456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+.+++|.+++... .++++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999765 46899999999999999999999998 9999999999999999999999999987654432 22
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+. ....... .......+..++..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHH
Confidence 345678899999999988899999999999999999999999987764 3222222 11456677788999999999
Q ss_pred HhhhhCCCCCCCH--HHHHHHHHHHHHHHh
Q 003963 741 SCWHSDPQCRPSF--QELVDKLRDLQRQYF 768 (783)
Q Consensus 741 ~cL~~dP~~RPsa--~ell~~L~~L~~~~f 768 (783)
+||..||.+||++ .++ +.|+||
T Consensus 235 ~~l~~~p~~R~~~~~~~l------~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDL------KNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHH------hcCCCC
Confidence 9999999999999 776 455655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.00 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=214.1
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||.|+||.||++.+.. ++.|++|++...... ......+.+|+.+++.++||||+++++++..+..++++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999864 578999999765443 34557789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCC
Q 003963 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670 (783)
Q Consensus 591 ~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 670 (783)
.+++.+. ..+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 9999764 35889999999999999999999988 9999999999999999999999999987665432 223446789
Q ss_pred cccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 671 ~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
.|++||.+.+..++.++|+|||||++|+|++|..||.... .......+.........|..+++++.++|.+||.++|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 55555554433456667777899999999999999999
Q ss_pred CCCC-----HHHHHHHHHHHHHHHhhc
Q 003963 749 CRPS-----FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 749 ~RPs-----a~ell~~L~~L~~~~f~~ 770 (783)
+||+ +.++ ++|+||+.
T Consensus 237 ~R~~~~~~~~~~l------~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDI------KKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHH------hcChhhhC
Confidence 9999 8888 67899975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=358.11 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=209.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.++||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999999865 57899999875433 2345567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc----------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 583 EFLPRGSLFRLLQRN----------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 583 E~~~ggsL~~~L~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
||++|++|.+++... ....+...++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999998642 123456678889999999999999998 99999999999999999999999999
Q ss_pred Cccccccc------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 003963 653 SRLKHETY------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 714 (783)
Q Consensus 653 a~~~~~~~------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~ 714 (783)
+....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 97652110 011124699999999999999999999999999999999999999987554433
Q ss_pred HHHhhccccc--ccCCCCCCHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHH
Q 003963 715 IGAVGFMNQR--LEIPKDVDPRWAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 765 (783)
Q Consensus 715 ~~~i~~~~~~--~~~~~~~s~~l~~LI~~cL~~dP~~RP-sa~ell~~L~~L~~ 765 (783)
..... .... ......+++.+.+++.+||..||++|| ++.++++.|+.+..
T Consensus 240 ~~~~~-i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDV-ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh-ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 22211 1111 112246889999999999999999996 56677777766543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.77 Aligned_cols=260 Identities=28% Similarity=0.536 Sum_probs=215.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-c----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-Q----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.++|++.+.||+|+||.||++.+... . .||+|++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 46789999999999999999987543 2 478888765432 33345688899999999999999999988754 46
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++++||+++|+|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccC
Confidence 7999999999999999876667899999999999999999999998 99999999999999999999999999976543
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... ......++..|++||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 221 1222345678999999999999999999999999999997 999998776555444332 333445566788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+++..||..+|.+||++.++++.|.++.+...
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 999999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.97 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=209.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecC-----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP----- 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----- 575 (783)
..++|.+.+.||+|+||.||++.... ++.+|+|++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 45789999999999999999999854 56799999865432 234567899999998 799999999998653
Q ss_pred CceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
..+|+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998853 3456899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccc
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLE 726 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~ 726 (783)
+..............|+..|+|||++.... ++.++|||||||++|+|++|++||...........+... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 876554333333456889999999986543 578999999999999999999999887665544443211 11223
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+..++..+.+||.+||+.+|.+||++.++ ++|+||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i------l~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHL------LEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHH------hcCcccC
Confidence 345677899999999999999999999999 6778874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.27 Aligned_cols=255 Identities=28% Similarity=0.487 Sum_probs=207.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--Cc
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QR 577 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 577 (783)
.-|++.+.||+|+||.||++.+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34788999999999999999742 34579999986543 344456789999999999999999999998775 56
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.++||||+++++|.+++.+....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999776556899999999999999999999998 9999999999999999999999999987654
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------------hHHHHHHhh
Q 003963 658 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---------------SMQVIGAVG 719 (783)
Q Consensus 658 ~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~---------------~~~~~~~i~ 719 (783)
.... ......++..|+|||++.+..++.++|||||||++|+|+++..|+.... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL- 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-
Confidence 3221 1123456778999999998889999999999999999999876642210 01111111
Q ss_pred cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 720 ~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
......+.+..++..+.+||.+||+.+|.+||++.++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11223445667899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.65 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=204.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHH-HHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||++.+.. ++.||||++......... ..+..|+.+ ++.++||||+++++++..++..|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 478999999999999999999865 578999998765443333 344456554 66778999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 583 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 583 E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
||++ ++|.+++.. ....+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 688888754 234689999999999999999999986 7 99999999999999999999999999876543
Q ss_pred ccccccCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccccccCC-CCCC
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRN----EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIP-KDVD 732 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~-~~~s 732 (783)
... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.... ..+.+..+. ......++ ..++
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SVA-KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred ccc-cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 321 123467889999999865 446889999999999999999999997543 222222221 11222233 3578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.++.+||.+||..+|.+||++.++ +.++||+....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~~ 269 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPEL------LQHPFFELHLS 269 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHH------hcCchhhhccc
Confidence 999999999999999999999999 67899876553
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.03 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=206.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||.|+||.||+|.+.. ++.||||++............+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48899999999999999999864 56799999876544444446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
+. ++|..++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 95 5898888643 346889999999999999999999998 9999999999999999999999999987654433333
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------------
Q 003963 664 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------- 723 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------- 723 (783)
....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+.......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3445788999999887654 58899999999999999999999977655433222110000
Q ss_pred --------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 724 --------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 724 --------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
...+...+++++.++|.+||+.||.+||++.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~------l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA------LAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH------hcCCCC
Confidence 001123578899999999999999999999999 566776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.10 Aligned_cols=248 Identities=31% Similarity=0.581 Sum_probs=209.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|.+.+.||+|+||.||++.+. .++.|++|++............+.+|+.+++.++|+||+++++++.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5889999999999999999875 457899999987766556778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc-
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 663 (783)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999764 35788999999999999999999998 9999999999999999999999999987654432211
Q ss_pred ---cCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccccCCCC--CCHH
Q 003963 664 ---KTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLEIPKD--VDPR 734 (783)
Q Consensus 664 ---~~~~Gt~~Y~aPE~~~~~~---~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~--~s~~ 734 (783)
....+++.|++||++.+.. .+.++|||||||++|+|++|..||..... ......+. ......+|.. +++.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHH
Confidence 1346788999999998776 78999999999999999999999976633 22222222 2333344444 4899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell 757 (783)
+.+||.+||+.+|.+||++.+++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHh
Confidence 99999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.99 Aligned_cols=260 Identities=30% Similarity=0.526 Sum_probs=223.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.|+......+.++||+|-||.|.++...+...||+|.++..... .....|..|+++|.+|+|||||.++++|..++.+|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 35666788899999999999999999887789999999876643 44678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcc-hHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc-
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH- 657 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l-~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~- 657 (783)
+|+||++.|+|.++|.++..+. .-.....|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++..-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999998874333 55667789999999999999999 9999999999999999999999999998432
Q ss_pred -cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChHHHHHHhhcccc------cccCC
Q 003963 658 -ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQ------RLEIP 728 (783)
Q Consensus 658 -~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt--G~~Pf~~~~~~~~~~~i~~~~~------~~~~~ 728 (783)
+.+......+-..+|||||.+...+++.++|+|+||+++||+++ ...||..+...+..++...... -+..|
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 22322333455789999999999999999999999999999765 7899999999888877654332 24567
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
..++..+.++|.+||..+..+||+++++...|.+
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 8899999999999999999999999999766544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.78 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=212.0
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC----HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
+|+..+.||+|+||.||++.+.. ++.||+|++...... ......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999998744 577999998754321 2345788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~ 659 (783)
||||+++++|.+++... .++++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999764 46889999999999999999999998 99999999999998775 5999999998765432
Q ss_pred cc----cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhcccccccCCCCCC
Q 003963 660 YL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 660 ~~----~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~s 732 (783)
.. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...... .....+........++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 112345788999999999888999999999999999999999999654432 22222222334556677789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
+++.++|.+||..+|.+||++.++ +.|+||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~l------l~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSREL------LKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHH------hcCcccC
Confidence 999999999999999999999999 6778874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.92 Aligned_cols=254 Identities=27% Similarity=0.498 Sum_probs=214.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.+.||+|+||.||++.+.. +..||+|.+............+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58899999999999999999865 56799999876544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCccccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 662 (783)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++ .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999998653 335789999999999999999999998 99999999999998875 4699999998766544333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+. ......++..++.++.++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334468899999999988889999999999999999999999998776655554432 2233445567889999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
|..+|++||++.++ +.++||
T Consensus 238 l~~~p~~Rpt~~~l------l~~~~~ 257 (257)
T cd08225 238 FKVSPRDRPSITSI------LKRPFL 257 (257)
T ss_pred hccChhhCcCHHHH------hhCCCC
Confidence 99999999999999 455654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.52 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=209.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--CceEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIV 581 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 581 (783)
++|++.+.||.|+||.||+|.+.. ++.+++|.+............+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 578999999999999999999864 56799999876554444445677899999999999999999998877 889999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||++ ++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||++........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99996 4999998776667899999999999999999999998 99999999999999999999999999876554432
Q ss_pred cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------------
Q 003963 662 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------------ 722 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 722 (783)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...........+....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 333445788999999987654 6899999999999999999999998776554443321100
Q ss_pred -----------ccccCCCC-CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 723 -----------QRLEIPKD-VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 723 -----------~~~~~~~~-~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
....++.. +++.+.+||.+||+.+|++|||+.++ +.|+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el------l~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA------LKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH------hcCCCC
Confidence 00112222 58889999999999999999999999 566765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.02 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=203.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||.|+||.||++.+.. ++.||||.+....... ....+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 3689999999999999999999864 5789999987543221 1234567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+.+ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 999998776667899999999999999999999998 999999999999999999999999998754332222
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcc-c-----------------
Q 003963 663 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFM-N----------------- 722 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~-~----------------- 722 (783)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+... .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 223356889999999876 457899999999999999999999997654 22211111000 0
Q ss_pred -ccc---------cCCCCCC--HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 723 -QRL---------EIPKDVD--PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 723 -~~~---------~~~~~~s--~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
... .....++ .++.++|.+||..+|++||++.++ ++++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~------l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA------MKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH------hcCCCC
Confidence 000 0001234 788999999999999999999999 566766
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=347.86 Aligned_cols=259 Identities=18% Similarity=0.255 Sum_probs=194.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCCc--eEEEEEE---------------ecccCCHHHHHHHHHHHHHHHhCCCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQ--DVAVKVF---------------SRQEYSDEVIHSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~vAiK~i---------------~~~~~~~~~~~~~~~Ei~il~~l~HpnI 565 (783)
..++|+++++||+|+||.||++..+... .+++|.+ +...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998764321 1222211 1111122345568899999999999999
Q ss_pred eeEeceeecCCceEEEEEecCCCCHHHHHhhcC----CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 641 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~ 641 (783)
|++++++...+..|+||+++. ++|..++.... .......++.++.||+.||.|||+++ ||||||||+||||+.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 999999999999999999994 57887775322 22345667789999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCcccccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCC--hH-HHHH
Q 003963 642 HWTVKVGDFGLSRLKHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLN--SM-QVIG 716 (783)
Q Consensus 642 ~~~vkL~DFGla~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~P-f~~~~--~~-~~~~ 716 (783)
++.+||+|||++........ .....+||+.|+|||++.+..++.++|||||||+||||++|..+ |.... .. +...
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999976544321 22345799999999999999999999999999999999998754 43221 11 1111
Q ss_pred Hhhccc---cc-----------------c----c-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 717 AVGFMN---QR-----------------L----E-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 717 ~i~~~~---~~-----------------~----~-----~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.+.... .. . . ....++.++.++|.+||+.||.+|||+.|+ |.|+|
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el------L~hp~ 456 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL------LALPL 456 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH------hhChh
Confidence 111000 00 0 0 011356678889999999999999999999 67888
Q ss_pred hhc
Q 003963 768 FQA 770 (783)
Q Consensus 768 f~~ 770 (783)
|+.
T Consensus 457 f~~ 459 (501)
T PHA03210 457 FSA 459 (501)
T ss_pred hhc
Confidence 865
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=313.20 Aligned_cols=250 Identities=38% Similarity=0.679 Sum_probs=212.4
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+++.+.||.|+||.||++.+.. ...||+|++..... ......+..|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3577899999999999999764 25699999865432 33557888999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCc-chHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||+++++|.+++...... +++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999765444 899999999999999999999998 9999999999999999999999999987655431
Q ss_pred cccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 661 LTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 661 ~~~~-~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.... ...+++.|++||.+.+..++.++|||||||++|+|++ |.+||...+.......+... .....+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-YRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHH
Confidence 1111 2236789999999988889999999999999999998 89999887777766655432 3445666789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L 760 (783)
+.+||..+|.+|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.58 Aligned_cols=247 Identities=33% Similarity=0.606 Sum_probs=208.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
..++|++.+.||+|+||.||++.. .++.||+|++.... ....+.+|+.+++.++||||+++++++..+ ..+++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 347899999999999999999874 45679999986432 235678899999999999999999998754 479999
Q ss_pred EecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 583 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999999997543 35789999999999999999999988 9999999999999999999999999987543321
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |++||...........+.. ...+..+..++..+.++|.
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHH
Confidence 12234578999999998889999999999999999997 9999988877666555432 2344456678999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHH
Q 003963 741 SCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~ 761 (783)
+||..+|.+||++.++++.|+
T Consensus 232 ~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 232 SCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHcCCChhhCcCHHHHHHHHc
Confidence 999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=311.75 Aligned_cols=254 Identities=34% Similarity=0.569 Sum_probs=219.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--CceEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVT 582 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 582 (783)
+|.+.+.||+|++|.||+|.+. .++.|++|++............+.+|+.+++.++||||+++++.+... ..++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999987 457899999877665556678899999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
||+++++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998654 7899999999999999999999988 99999999999999999999999999876655432
Q ss_pred -cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 662 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 662 -~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
......++..|++||.+.+...+.++||||||+++|+|++|..||.... .......+........++..++..+.+||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334568899999999998889999999999999999999999998766 33333333323445667788899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+||..+|.+||++.++ ++|+||
T Consensus 238 ~~~l~~~p~~Rp~~~~l------l~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADEL------LQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHH------hhCCCC
Confidence 99999999999999999 566665
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.19 Aligned_cols=253 Identities=31% Similarity=0.529 Sum_probs=212.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+.|++.+.||+|+||.||+|.+.. ++.||+|++..... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 457778899999999999998754 46799998865432 3445688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999999864 35889999999999999999999988 9999999999999999999999999987654433233
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++..+.+||.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 34467889999999999889999999999999999999999998766555443332 12233445567889999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
..+|.+||++.+++ +|+||+
T Consensus 238 ~~~p~~Rp~~~~il------~~~~~~ 257 (277)
T cd06642 238 NKDPRFRPTAKELL------KHKFIT 257 (277)
T ss_pred cCCcccCcCHHHHH------HhHHHH
Confidence 99999999999994 556664
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=370.48 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=219.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCCc-eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~-~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++.-+.+||.|.||.||-+.+..++ -.|+|-+.-..........+.+|+.+|..|+|||+|++||+-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 5667789999999999999986654 479998876665556667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc----
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---- 660 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---- 660 (783)
|.+|+|.++++. +...++.....+..|++.|++|||++| ||||||||+||+++.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999999976 445777777888899999999999999 9999999999999999999999999998765442
Q ss_pred ccccCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccccCCCCCCHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~---~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
...+..+||+.|||||++.+.. ...+.||||||||+.||+||+.||.+++.. .....+. +...+.+|..++++-+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHH
Confidence 2234567999999999998644 578999999999999999999999877653 4555554 5667889999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
+||..||..||+.|+++.|| +.|.|-+..+.
T Consensus 1472 dFle~Cl~~dP~~Rw~~~ql------le~~f~~~~~d 1502 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQL------LEHAFGKSCTD 1502 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHH------HHhhccccccc
Confidence 99999999999999999999 45565544433
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.46 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=221.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|.+.+.||.|+||.||++.+.. +..|++|++............+.+|+++++.++|||++++++.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58899999999999999999864 57899999987766556667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 585 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 585 ~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
+++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 367999999999999999999999998 99999999999999999999999999876655432
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......... .....++..++..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 33445688999999999998899999999999999999999999988776665555432 23455667889999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
||..+|.+||++.++ +.++||
T Consensus 238 ~l~~~p~~Rp~~~~l------l~~~~~ 258 (258)
T cd08215 238 LLQKDPEERPSIAQI------LQSPFI 258 (258)
T ss_pred HcCCChhhCcCHHHH------hcCCCC
Confidence 999999999999999 555664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.75 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=209.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||+|+||.||+|.+.. ++.|++|++............+.+|+++++.++|+||+++++++...+.++++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 479999999999999999999864 5689999987655445556788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-c
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 662 (783)
|++++.|..++. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 998766655554 3456899999999999999999999998 99999999999999999999999999876554432 2
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------------
Q 003963 663 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------ 723 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 723 (783)
.....++..|+|||++.+. .++.++||||||+++|+|++|++||........+..+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678899999999888 789999999999999999999999986655433322211000
Q ss_pred ------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 724 ------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 724 ------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
....+..++.++.+||++||..+|++||++.++ ++++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i------l~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL------LQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH------hcCCCC
Confidence 001233458899999999999999999999999 566665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=321.95 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=213.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|++.+.||+|+||.||++.+... +.|++|.+...... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999998654 67999998765432 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
||++|++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999764 45889999999999999999999998 99999999999999999999999998864211100
Q ss_pred --------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccc
Q 003963 662 --------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLE 726 (783)
Q Consensus 662 --------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~ 726 (783)
......++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+....+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 01123578899999999888899999999999999999999999988776665555432221 122
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
....+++++.+||.+||+.+|.+||+..++++. +.++||...
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l---l~~~~~~~~ 279 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEV---KQHRFFLGL 279 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHH---HhCccccCC
Confidence 223678999999999999999999986444333 678888553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=322.03 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=215.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
...+|++.+.||+|+||.||++... .++.|++|++..... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 3478999999999999999999875 456799999864432 2245678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999999753 4788899999999999999999998 99999999999999999999999998875544332
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~ 740 (783)
......|++.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+... ......+..++..+.+||.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 333446888999999998888899999999999999999999999876554332222111 1122234457889999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+||..+|.+||++.++ +.|+||+.-+
T Consensus 251 ~~l~~~p~~Rp~~~~i------l~h~~~~~~~ 276 (293)
T cd06647 251 RCLEMDVEKRGSAKEL------LQHPFLKIAK 276 (293)
T ss_pred HHccCChhhCcCHHHH------hcCHHHhcCc
Confidence 9999999999999999 7899998666
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=318.70 Aligned_cols=255 Identities=31% Similarity=0.529 Sum_probs=210.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCc
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 577 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 577 (783)
++|++.+.||+|+||.||++.+.. +..||+|++...... .....+.+|+.+++.+.||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 578888999999999999998642 467999998765543 456788999999999999999999999877 557
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.+++|||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 89999999999999999876667999999999999999999999998 9999999999999999999999999998665
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------------HHHHhh
Q 003963 658 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---------------VIGAVG 719 (783)
Q Consensus 658 ~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~---------------~~~~i~ 719 (783)
.... ......++..|++||.+.+..++.++|||||||++|+|++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL- 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-
Confidence 3211 1112344567999999998889999999999999999999999986432211 11111
Q ss_pred cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 720 ~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
........+..++.++.+|+.+||..+|.+||++.+++++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11223344566789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.70 Aligned_cols=250 Identities=30% Similarity=0.471 Sum_probs=205.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCC----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ---- 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---- 576 (783)
..++|++.+.||.|+||.||+|.+.. ++.|++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35789999999999999999999864 46799999875442 235788999999999 6999999999997644
Q ss_pred --ceEEEEEecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 577 --RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 577 --~~~lV~E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
.+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998653 356899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccc
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRL 725 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~ 725 (783)
++..............|+..|+|||++.. ..++.++|||||||+||+|++|..||...........+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765544333345568999999998754 345788999999999999999999998765544443332211 122
Q ss_pred cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 726 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 726 ~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
..+..++..+.+||.+||..||.+|||+.+++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 22334788999999999999999999999994
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.75 Aligned_cols=254 Identities=29% Similarity=0.544 Sum_probs=207.9
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC--------CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY--------SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
+|.+.+.||.|+||.||+|.... ++.||+|.+..... .....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 57889999999999999998754 56799998864321 1123457888999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999765 46889999999999999999999998 999999999999999999999999998754
Q ss_pred ccccc--cccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC----
Q 003963 657 HETYL--TTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---- 728 (783)
Q Consensus 657 ~~~~~--~~~~~~Gt~~Y~aPE~~~~~~--~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 728 (783)
..... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||...........+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 43211 122345788999999987654 7889999999999999999999997665554433332222222222
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
..++..+.++|.+||..+|.+||++.++ ++|+||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~i------l~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTAREL------LQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHH------hhCCCC
Confidence 3568899999999999999999999999 556654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.98 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=208.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999864 5789999986654433444677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCcccccccc
Q 003963 584 FLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 661 (783)
|++ ++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 995 58888875433 33678888899999999999999998 999999999999985 56799999999976543322
Q ss_pred cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------
Q 003963 662 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------- 723 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 723 (783)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 2234467889999998876 4578999999999999999999999987665444332211000
Q ss_pred ----c------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 724 ----R------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 724 ----~------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
. ......+++++.++|.+||+.+|++||++.++ +.++||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~------l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA------LEHEYFKDLG 291 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH------hcCchHhHHh
Confidence 0 00123568889999999999999999999999 5689997654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.83 Aligned_cols=257 Identities=32% Similarity=0.456 Sum_probs=213.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..+.|.+.++||+|+||.||+|.+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34679999999999999999998754 57899999865433 34455678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999996 5888887665667899999999999999999999998 999999999999999999999999998654322
Q ss_pred ccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
....+++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 2346788999999874 3557889999999999999999999998877665544443222222223457889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+|.+||..+|.+||++.++ +.++||+...
T Consensus 246 li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~ 274 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEEL------LKHRFVLRER 274 (307)
T ss_pred HHHHHhcCChhhCcCHHHH------hcChhhcccC
Confidence 9999999999999999999 5678886544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.24 Aligned_cols=253 Identities=29% Similarity=0.579 Sum_probs=219.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.++||+|++|.||++.+.. ++.|++|.+............+.+|++++..++||||+++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58899999999999999998764 56899999987766556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|.+++... ..+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999765 56899999999999999999999998 99999999999999999999999999987655443333
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
...++..|++||.+.+...+.++|||+||+++|+|++|..||............. ......++..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4567899999999988888999999999999999999999998776544443332 234455677889999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 745 SDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 745 ~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+|++||++.++ +.++||
T Consensus 237 ~~p~~R~~~~~~------l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQL------LKHPWI 254 (254)
T ss_pred CChhhCcCHHHH------hcCCCC
Confidence 999999999999 455664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=319.01 Aligned_cols=257 Identities=28% Similarity=0.493 Sum_probs=217.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..+.|++.+.||.|+||.||++.+. .++.|++|++..... ....+.+|+++++.++|+||+++++++......|++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567899999999999999999986 467899999876543 346788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++......+++..++.++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999876557999999999999999999999988 99999999999999999999999998865543332
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~LI~ 740 (783)
......++..|++||.+.+..++.++|+|||||++|+|++|..||...+.......+..... ....+..++..+.+||.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 23344578899999999988899999999999999999999999987776554444322111 22223348899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+||+.+|.+||++.++ +.++||+.
T Consensus 252 ~~l~~~p~~Rpt~~~i------l~~~~~~~ 275 (286)
T cd06614 252 KCLVKDPEKRPSAEEL------LQHPFLKK 275 (286)
T ss_pred HHhccChhhCcCHHHH------hhChHhhc
Confidence 9999999999999999 66888865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.48 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=212.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+.|.....||+|+||.||++.+.. +..||||++.... ......+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 455666789999999999998754 5679999886533 2334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++..........
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999999998864 34889999999999999999999998 9999999999999999999999999987554333333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~~c 742 (783)
....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+....+..+... .........++..+.+||.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 3456889999999999888999999999999999999999999877765554443221 122223345788999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|..||.+|||+.++ ++++||+..
T Consensus 256 l~~~P~~Rpt~~~i------l~~~~~~~~ 278 (292)
T cd06658 256 LVREPSQRATAQEL------LQHPFLKLA 278 (292)
T ss_pred ccCChhHCcCHHHH------hhChhhhcc
Confidence 99999999999999 678999644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=329.74 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=205.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 575 (783)
..++|++.+.||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999976 457899999876544445556778899999999999999999988644
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
...|+||||+. ++|.+.+... ++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999995 5888888643 888899999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 723 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 723 (783)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 554322 2234678999999999999999999999999999999999999986654332222110000
Q ss_pred --------cc---------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 724 --------RL---------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 724 --------~~---------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.. ..+...+..+.+||.+||+.||.+||++.++ |.|+||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei------L~~~~~~ 315 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA------LQHPYIN 315 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH------hcChhHh
Confidence 00 0012346678999999999999999999999 5667664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.87 Aligned_cols=256 Identities=24% Similarity=0.314 Sum_probs=205.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCc-----
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR----- 577 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----- 577 (783)
++|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468999999999999999999864 578999998665433333456788999999995 6999999999877665
Q ss_pred eEEEEEecCCCCHHHHHhhc----CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 652 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGl 652 (783)
.|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 898888643 235799999999999999999999998 999999999999998 88999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------- 724 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------- 724 (783)
+..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8755433322333456889999998865 45789999999999999999999999876655443322110000
Q ss_pred -------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 725 -------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 725 -------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
....+.++.++.+||.+||..||.+||++.++ +.|+||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei------l~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA------LTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH------hcCCCcC
Confidence 00113578899999999999999999999999 6778875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.70 Aligned_cols=253 Identities=31% Similarity=0.538 Sum_probs=214.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
-|++.++||.|+||.||++.+.. +..||||++..... ......+.+|+.++..++||||+++++++..+...|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 47788999999999999998754 56799998765433 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||||.||+++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999998743 5889999999999999999999988 99999999999999999999999999876544322233
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4467889999999988888999999999999999999999998777655554442 223344566788999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 745 SDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 745 ~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+|.+||++.++ ++|+||+.
T Consensus 239 ~~p~~Rp~~~~~------l~~~~~~~ 258 (277)
T cd06641 239 KEPSFRPTAKEL------LKHKFIVR 258 (277)
T ss_pred CChhhCcCHHHH------HhCHHHhh
Confidence 999999999999 55677754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=317.64 Aligned_cols=238 Identities=22% Similarity=0.403 Sum_probs=195.1
Q ss_pred eeccCCcEEEEEEEEeCC-------------------------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCcee
Q 003963 512 QIGQGSCGTVYHAVWYGS-------------------------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~~-------------------------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 566 (783)
+||+|+||.||+|..... ..|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999974211 247888875432 23456788899999999999999
Q ss_pred eEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---
Q 003963 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW--- 643 (783)
Q Consensus 567 ~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~--- 643 (783)
++++++......++||||+++++|..++......+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999776667899999999999999999999988 99999999999997643
Q ss_pred ----cEEEEecCCCcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHH
Q 003963 644 ----TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELA-TEKIPWDNLNSMQVIGA 717 (783)
Q Consensus 644 ----~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~ell-tG~~Pf~~~~~~~~~~~ 717 (783)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||...........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987543221 23356788999998875 55799999999999999985 79999987765544332
Q ss_pred hhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 718 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 718 i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
. .....++...++.+.++|.+||..+|.+||++.++++.|
T Consensus 234 ~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 Y---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2 223344555678999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.00 Aligned_cols=239 Identities=21% Similarity=0.409 Sum_probs=194.7
Q ss_pred eeeccCCcEEEEEEEEeCC-------------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 511 EQIGQGSCGTVYHAVWYGS-------------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~-------------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
+.||+|+||.||+|..... ..|++|++.... ......+.+|+.++..++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3689999999999975321 247888865432 3345678889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc-------EEEEec
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDF 650 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~-------vkL~DF 650 (783)
.+++|||+++++|..++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998766667899999999999999999999998 999999999999987654 899999
Q ss_pred CCCcccccccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHhhcccccccCC
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELA-TEKIPWDNLNSMQVIGAVGFMNQRLEIP 728 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 728 (783)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||......+.... ........
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~~~~~~~~ 229 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---YEGQCMLV 229 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---HhcCccCC
Confidence 988654322 2345788999999886 566889999999999999998 58999977654433221 11222333
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
...++++.+||.+||+.||.+||++.+|++.|
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 44568899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.34 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=210.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC--CceEEEEEEeccc--------CCHHHHHHHHHHHHHHHh-CCCCceeeEeceeec
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG--SQDVAVKVFSRQE--------YSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS 574 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~--~~~vAiK~i~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 574 (783)
.|++.+.||+|+||.||++.+.. ++.+|+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999866 4679999875432 223445667788888865 799999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
++..+++|||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+ |+|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 34568999999999999999999996 56 999999999999999999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
|++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...........+............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9987654432 233456889999999999988999999999999999999999999877766555554322222222336
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
+++.+.+||.+||+.||.+||++.++..+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999988874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.39 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=189.0
Q ss_pred eeeeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCceEEEEEe
Q 003963 510 GEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVTEF 584 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 584 (783)
+.+||+|+||.||+|.+.. ...||+|.+...... ..+.+|+.+++.++||||+++++++.. +..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4689999999999998754 357999998755432 346789999999999999999998853 5678999999
Q ss_pred cCCCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE----cCCCcEEEEecCC
Q 003963 585 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 652 (783)
Q Consensus 585 ~~ggsL~~~L~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 652 (783)
+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 95 5888877421 234788899999999999999999998 9999999999999 4667999999999
Q ss_pred Ccccccccc---cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH----------HHHHHh
Q 003963 653 SRLKHETYL---TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM----------QVIGAV 718 (783)
Q Consensus 653 a~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~----------~~~~~i 718 (783)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|+||.+||...... ......
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 976543321 12234689999999998774 5789999999999999999999999643211 000000
Q ss_pred hccc-------------------------cc----------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 719 GFMN-------------------------QR----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 719 ~~~~-------------------------~~----------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.... .. .......+..+.+||.+||..||.+|||+.++ |
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~------l 312 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQA------L 312 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHH------h
Confidence 0000 00 00111245678899999999999999999999 6
Q ss_pred HHHHh
Q 003963 764 QRQYF 768 (783)
Q Consensus 764 ~~~~f 768 (783)
+|+||
T Consensus 313 ~hp~f 317 (317)
T cd07867 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 77876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.59 Aligned_cols=246 Identities=30% Similarity=0.508 Sum_probs=195.7
Q ss_pred eeeccCCcEEEEEEEEeCC---ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|..... ..+++|.+.... .......+.+|+.+++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 3689999999999975433 357888765433 334456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCC----cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc--cc
Q 003963 588 GSLFRLLQRNTT----KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YL 661 (783)
Q Consensus 588 gsL~~~L~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~ 661 (783)
|+|.+++..... ..++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999976432 2457778899999999999999998 999999999999999999999999998643221 11
Q ss_pred cccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc----cccCCC
Q 003963 662 TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ----RLEIPK 729 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~-------~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~----~~~~~~ 729 (783)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||........+..+..... ...++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 2223345778999998743 456789999999999999999 8899988776554444322111 223445
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
.+++.+.+++..|| .||.+||++.+|++.|
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 68899999999999 5999999999998775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.37 Aligned_cols=247 Identities=32% Similarity=0.583 Sum_probs=205.5
Q ss_pred eeeccCCcEEEEEEEEeCC-------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 511 EQIGQGSCGTVYHAVWYGS-------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+.||+|+||.||+|.+... ..|+||.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 3689999999999986532 468999876543 23345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-----cEEEEecCC
Q 003963 584 FLPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-----TVKVGDFGL 652 (783)
Q Consensus 584 ~~~ggsL~~~L~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-----~vkL~DFGl 652 (783)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999999642 234788899999999999999999988 99999999999999877 899999999
Q ss_pred Cccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 653 SRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 653 a~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
+....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 236 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPE 236 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCcc
Confidence 87543221 11123345788999999999999999999999999999998 999998877666554442 233455667
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.++..+.+||.+||..+|.+||++.++++.|.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 78999999999999999999999999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.80 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=201.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.+.||+|+||.||+|.+.. ++.|++|++...... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 679999999999999999998754 578999998654322 222356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+. ++|..++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6888777655556788888999999999999999998 9999999999999999999999999987544332233
Q ss_pred cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhc-cc------------------
Q 003963 664 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGF-MN------------------ 722 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~-~~------------------ 722 (783)
....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... +.+..+.. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 344578999999998764 4788999999999999999999999765532 11111100 00
Q ss_pred c--cccCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 723 Q--RLEIP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 723 ~--~~~~~---------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
. ....+ ...++.+.+||.+||..||.+|||+.++ +.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~------l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA------LLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH------hcCCCC
Confidence 0 00000 0125688999999999999999999999 667776
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.41 Aligned_cols=258 Identities=21% Similarity=0.360 Sum_probs=231.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCce-EEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
..+.+++++..||.|+||+|-++....... +|+|++++...- ..+.+.+..|-.||..++.|+||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 345678888999999999999998765543 899998876543 355667788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++||-|-||.|+.+|+.. ..++...+.+++..+++|++|||++| ||+|||||+|+|++.+|-+||.|||+|+.....
T Consensus 497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999999764 56999999999999999999999999 999999999999999999999999999987765
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
. .+.++||||.|.|||++.++.++.++|.||||+++||||+|.+||...++++.+..|......+.+|..++....+||
T Consensus 574 ~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 R-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred C-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 4 456899999999999999999999999999999999999999999999999999988878888999999999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhh
Q 003963 740 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 740 ~~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~ 769 (783)
+++...+|.+|.. +.+| -+|.||.
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DI------kkH~Wf~ 681 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDI------KKHRWFE 681 (732)
T ss_pred HHHHhcCcHhhhccccCChHHH------Hhhhhhh
Confidence 9999999999975 4555 3578874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.83 Aligned_cols=254 Identities=31% Similarity=0.544 Sum_probs=210.0
Q ss_pred eeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 576 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 576 (783)
|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5778899999999999998642 467999999776655666678889999999999999999999886432
Q ss_pred ceEEEEEecCCCCHHHHHhhc-----CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
..+++++|+.+++|..++... ...++...++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247899999999999887432 224788899999999999999999988 9999999999999999999999999
Q ss_pred CCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCC
Q 003963 652 LSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 728 (783)
Q Consensus 652 la~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 728 (783)
+++...... .......+++.|++||.+.+..++.++|||||||++|+|++ |.+||...+.......+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCcCCCC
Confidence 987653321 11223345678999999998889999999999999999999 8999988777665554432 2234455
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
..++..+.+++.+||..+|.+||++.+++..|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.73 Aligned_cols=256 Identities=27% Similarity=0.497 Sum_probs=213.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC---CCceeeEeceeecCCceEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 581 (783)
.|++.+.||.|+||.||+|.+. .++.|++|++.... .......+.+|+.+++.++ ||||+++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 4778899999999999999975 45779999986543 2334567888999999996 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999998653 6889999999999999999999998 99999999999999999999999999876654433
Q ss_pred cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC-CCCHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK-DVDPRWAAIV 739 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~s~~l~~LI 739 (783)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... ....++. .++.++.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3344568999999998865 45689999999999999999999999877665544333221 1223333 3788999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.+||..||.+||++.++ +.++||+....
T Consensus 236 ~~~l~~~p~~R~~~~~i------l~~~~~~~~~~ 263 (277)
T cd06917 236 AACLDEEPKERLSAEEL------LKSKWIKAHSK 263 (277)
T ss_pred HHHcCCCcccCcCHHHH------hhChHhhcccc
Confidence 99999999999999999 56899977653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=321.85 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=210.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
.|.....||.|+||.||++.+. .++.||+|++...... ....+.+|+.+++.++||||+++++++...+..|++|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3445568999999999999875 4578999998654322 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|..++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999998864 34889999999999999999999998 99999999999999999999999999875544333333
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHHHHHHHhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~LI~~cL 743 (783)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... .....+..++..+.++|.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 4568999999999999889999999999999999999999998776665554442211 122334567889999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
+.+|.+||++.++ ++++||.
T Consensus 256 ~~~P~~Rps~~~l------l~~~~~~ 275 (297)
T cd06659 256 TREPQERATAQEL------LDHPFLL 275 (297)
T ss_pred cCCcccCcCHHHH------hhChhhc
Confidence 9999999999999 5667774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.90 Aligned_cols=246 Identities=30% Similarity=0.438 Sum_probs=195.4
Q ss_pred eeeccCCcEEEEEEEEeCC---ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||+|+||.||+|....+ ..+++|.+..... ......+.+|+.+++.++||||+++++++.....+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 3689999999999986432 4689998765543 23335688899999999999999999999998999999999999
Q ss_pred CCHHHHHhhcC----CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--c
Q 003963 588 GSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--L 661 (783)
Q Consensus 588 gsL~~~L~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 661 (783)
++|.+++.... ...++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999996532 23566778889999999999999998 9999999999999999999999999986543321 1
Q ss_pred cccCCCCCCcccCcccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc-cc---cccCCC
Q 003963 662 TTKTGKGTPQWMAPEVLRNE-------PSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM-NQ---RLEIPK 729 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~-------~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~---~~~~~~ 729 (783)
......++..|+|||++.+. .++.++|||||||++|+|++ |..||......+........ .. ...+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 22234578889999998643 34789999999999999996 99999877665543322111 11 122233
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
..++.+.+++..|| .+|++|||+.+|+..|
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 56788999999999 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=317.57 Aligned_cols=253 Identities=27% Similarity=0.368 Sum_probs=205.9
Q ss_pred eeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 507 LTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
|++.++||.|++|.||+|.+. .+..||+|++............+.+|+.+++.++||||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999875 4678999998765544444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 586 PRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 586 ~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+ ++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999987644 45899999999999999999999988 99999999999999999999999999875543322223
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc----------------------
Q 003963 665 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM---------------------- 721 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------------- 721 (783)
...+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988764 4689999999999999999999999876654332221100
Q ss_pred -----cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 722 -----NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 722 -----~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.........++..+.++|.+||+.+|.+||++.++ +.++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i------l~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA------LQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH------hcCCCC
Confidence 00011234577899999999999999999999999 456665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.50 Aligned_cols=239 Identities=23% Similarity=0.436 Sum_probs=197.9
Q ss_pred eeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 511 EQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+.||.|+||.||+|.+.. ..+|++|.+.... ......+.+|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999998643 1247888775432 234467888999999999999999999999989999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc--------EEEEecCCCc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSR 654 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~--------vkL~DFGla~ 654 (783)
||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++|+|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999876667899999999999999999999998 999999999999987654 6999999886
Q ss_pred ccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
.... .....++..|+|||++.+. .++.++|||||||++|+|++| .+||........... ......+|...+
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (258)
T cd05078 157 TVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAPKW 229 (258)
T ss_pred ccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCCCc
Confidence 4432 2234678899999999874 578999999999999999998 577766655443322 223455666778
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
.++.+||.+||+.+|.+|||+.++++.|
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.40 Aligned_cols=247 Identities=33% Similarity=0.559 Sum_probs=211.0
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|.+.+.||.|++|.||++.+. .++.+++|++..... .....+.+|+.+++.++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 5888999999999999999986 456799999876543 3456888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|.+++......+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999876567899999999999999999999988 99999999999999999999999999876654332 33
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC--CCCCCHHHHHHHHHh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRWAAIVESC 742 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~LI~~c 742 (783)
...++..|++||.+.+...+.++|+||||+++|+|++|..||...+.......... ...... +..++..+.++|.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 45688999999999988899999999999999999999999988765554444332 222222 233489999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 003963 743 WHSDPQCRPSFQELVD 758 (783)
Q Consensus 743 L~~dP~~RPsa~ell~ 758 (783)
|..||.+|||+.++++
T Consensus 235 l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 235 LQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999954
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.59 Aligned_cols=237 Identities=25% Similarity=0.441 Sum_probs=195.4
Q ss_pred eeeccCCcEEEEEEEEeCCc-----------eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 511 EQIGQGSCGTVYHAVWYGSQ-----------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~-----------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
++||+|+||.||++.+.... .+++|++...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999986543 4777776543321 5678899999999999999999999887 7789
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-------cEEEEecCC
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-------TVKVGDFGL 652 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-------~vkL~DFGl 652 (783)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999876657899999999999999999999988 99999999999999887 799999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
+..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||............. .....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCC
Confidence 876443 2234567889999999877 78999999999999999999 688887765433322221 1222233
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
.....+.++|.+||..+|.+||++.++++.|
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3348999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.36 Aligned_cols=261 Identities=34% Similarity=0.597 Sum_probs=229.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..||+...+..+..+||-|.||.||.|+|+. .-.||||.++.+.. .+++|..|+.+|+.++|||+|+++++|..+-
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4677777889999999999999999999875 45699999876543 3578999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+|||.|||..|+|.+||+.+.. .++.-..+.++.||..||.||..++ +|||||...|+||.++..||++|||++++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999987543 3566677788999999999999988 99999999999999999999999999998
Q ss_pred ccccccccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 656 KHETYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 656 ~~~~~~~~~-~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
+.....+.. ...-...|.|||.+....++.|+|||+||++|||+.| |..||.+.+..+++..+. ...++.-|..|++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence 765433222 2234678999999999999999999999999999998 999999999998887764 5678899999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
...+|++.||++.|..||++.++-+.|+.+.
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 9999999999999999999999999988663
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.20 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=204.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 576 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 345789999999999999999999864 568999998765433333345668999999999999999999886544
Q ss_pred ----ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 577 ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 577 ----~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
..++||||+. ++|.+++......+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3599999995 5898888766557899999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccccc----ccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---
Q 003963 653 SRLKHETYLT----TKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--- 724 (783)
Q Consensus 653 a~~~~~~~~~----~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--- 724 (783)
+......... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8765432211 12345788999999887654 688999999999999999999999877655443332221110
Q ss_pred --------------ccCC-------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 --------------LEIP-------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 --------------~~~~-------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
..++ ...++.+.+||.+||..||.+||++.++ ++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~------l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA------LNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH------hcCCCC
Confidence 0011 1235678899999999999999999999 567776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.45 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=213.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|...++||+|++|.||++.+. .++.+++|++.... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 4555679999999999999875 45679999886433 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|.+++.. .+++...+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 45889999999999999999999998 99999999999999999999999998865544333333
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccCCCCCCHHHHHHHHHhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~LI~~cL 743 (783)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 45689999999999988899999999999999999999999987776655544432211 12223347899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..+|.+||++.++ ++|+||+..+
T Consensus 254 ~~~p~~Rpt~~~i------l~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAEL------LNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHH------ccCcccccCC
Confidence 9999999999999 6789997655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.66 Aligned_cols=253 Identities=27% Similarity=0.497 Sum_probs=216.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC-CHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 581 (783)
++|.+.+.||+|+||.||++.+. .++.|++|++..... .......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999986 457899999876433 2344567888999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc-
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 660 (783)
|||+++++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999997653 6999999999999999999999998 9999999999999999999999999987554322
Q ss_pred -------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q 003963 661 -------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 661 -------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~ 721 (783)
.......++..|++||++.+..++.++|||||||++++|++|..||........+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 11223457889999999988889999999999999999999999998877655554442
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCH----HHHHHHHHHHHHHHh
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSF----QELVDKLRDLQRQYF 768 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa----~ell~~L~~L~~~~f 768 (783)
.....++..+++.+.+||.+||+.+|.+||++ .++ ++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~l------l~~~~~ 280 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL------KAHPFF 280 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHH------hcCCCC
Confidence 34556777889999999999999999999999 777 566765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.12 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=210.9
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||.|+||.||++.+.. ++.|++|++..... .......+.+|+.+++.++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 67899999876543 234567788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc--------c
Q 003963 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--------T 662 (783)
Q Consensus 591 ~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--------~ 662 (783)
.+++.+.. .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997654 6899999999999999999999998 99999999999999999999999999875433211 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCC--CCHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD--VDPRWAAIVE 740 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--~s~~l~~LI~ 740 (783)
.....++..|++||.+.+...+.++||||||+++|+|++|..||...........+.. .....+.. ++..+.+||.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHH
Confidence 2234578899999999888899999999999999999999999988877766655543 22333444 4899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||+.+|.+||++..+.+. +.++||+.+
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~---l~~~~~~~~ 263 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEI---KNHPFFKGI 263 (265)
T ss_pred HHhcCCHhhcCCCccHHHH---hcCccccCC
Confidence 9999999999999443332 679999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=318.03 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=209.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
..+|++.++||+|+||.||++.+.. ++.||+|++.... .......+.+|+++++.++||||+++++++.....+++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4689999999999999999999764 5679999886543 2344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||+++++|.+++... ..+++..+..++.+++.+|.|||+ ++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 83 EFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred ecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999999998764 458999999999999999999997 56 999999999999999999999999998654322
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHhhcccccccCCC-
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-----------QVIGAVGFMNQRLEIPK- 729 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~- 729 (783)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ......++.
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCch
Confidence 122457899999999998888999999999999999999999999765442 1111111 111222333
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.++.++.+||.+||..||.+||++.++ ++++||..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~------~~~~~~~~ 271 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQL------CAMPPFIQ 271 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHH------hcCccccc
Confidence 378899999999999999999999999 55566643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.47 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=205.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.++||.|++|.||+|.+.. +..||||++...... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 58999999999999999999864 567999998765432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 585 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 585 ~~ggsL~~~L~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8988886543 45899999999999999999999998 999999999999999999999999998755443333
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------------ccc
Q 003963 663 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----------------QRL 725 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------------~~~ 725 (783)
.....+++.|++||++.+. .++.++|||||||++|+|++|..||...+..+....+.... ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3344578899999998764 46889999999999999999999998766544333221100 000
Q ss_pred -----------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 726 -----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 726 -----------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+.+.+++.+.++|.+||+.||.+||++.++ ++++||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~------l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA------LQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH------hcCCCC
Confidence 0113457889999999999999999999999 566776
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=312.93 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=209.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCceEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIV 581 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 581 (783)
++|+..+.||.|++|.||++.+.. ++.||+|.+..... ......+.+|+++++.++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468899999999999999999854 56799999875433 2445678899999999999999999998854 3468999
Q ss_pred EEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988753 3455889999999999999999999998 99999999999999999999999999865443
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHhhcccccccCC-----
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-----SMQVIGAVGFMNQRLEIP----- 728 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~----- 728 (783)
... ....++..|++||.+.+..++.++|||||||++|+|++|..||.... ..+....+... ....++
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPGN 234 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCCC
Confidence 221 23456889999999999899999999999999999999999997652 22332222211 111111
Q ss_pred -CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 729 -KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 729 -~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
..+++.+.+||.+||..+|.+|||+.++ +.|+||++..+.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~ei------l~~~~~~~~~~~ 275 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDM------LEHPWIKAQMKK 275 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHH------HhCccccccccc
Confidence 2356789999999999999999999999 788999766553
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.70 Aligned_cols=259 Identities=26% Similarity=0.349 Sum_probs=214.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----ceE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 579 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 579 (783)
+|++.+.||.|+||.||+|.+.. ++.|+||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58999999999999999999865 578999998765433445567889999999999999999999988775 789
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++|||++ ++|.+++.... .+++..++.++.||+.||+|||+.| |+|+||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999996 58999887643 7999999999999999999999998 999999999999999999999999998865543
Q ss_pred c---ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 003963 660 Y---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------- 724 (783)
Q Consensus 660 ~---~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 724 (783)
. .......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...+..+.+..+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 122344678899999999888 7899999999999999999999999877765544332211100
Q ss_pred ------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 725 ------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 725 ------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
......++..+.+||.+||.++|.+||++.++ +.|+||+..+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l------l~~~~~~~~~~~ 298 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA------LAHPYLAQLHDP 298 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH------HhCccHHhhccc
Confidence 01123467889999999999999999999999 688999776665
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=328.44 Aligned_cols=244 Identities=28% Similarity=0.445 Sum_probs=209.9
Q ss_pred eeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 510 GEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
.++||.|.||+||-|.++ .++.||||++.+..+.......+++|+.||+.++||.||.+...|+..+.+|+|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999875 4688999999999988877789999999999999999999999999999999999999664
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC---CcEEEEecCCCcccccccccccC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHETYLTTKT 665 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~ 665 (783)
-|.-+|.....++++....+++.||+-||.|||.++ |+|+||||+|||+... -+|||||||+++.+.+.... .+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-rs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-RS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhh-hh
Confidence 455556666778999999999999999999999998 9999999999999653 47999999999998876433 36
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 666 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
.+|||.|+|||+++++.|+..-|+||+|+++|--|.|..||..... .+.+.+..+ -.....+.+++++..+||..+|+
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF-MyPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF-MYPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc-ccCCCchhhcCHHHHHHHHHHHH
Confidence 6899999999999999999999999999999999999999965433 333333222 23344556789999999999999
Q ss_pred hCCCCCCCHHHHH
Q 003963 745 SDPQCRPSFQELV 757 (783)
Q Consensus 745 ~dP~~RPsa~ell 757 (783)
.+-.+|.|.+..+
T Consensus 805 Vkm~kRysvdk~l 817 (888)
T KOG4236|consen 805 VKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHhcchHhhc
Confidence 9999999998773
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.03 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=204.6
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||+|+||.||++.+.. ++.|++|++...... ......+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998764 567999998764432 23345667899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCC
Q 003963 591 FRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 669 (783)
Q Consensus 591 ~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt 669 (783)
.+++.... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99987543 35899999999999999999999998 999999999999999999999999998755432 222344678
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--hcccccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 670 ~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
..|++||++.+..++.++|||||||++|+|++|+.||...........+ .........+..+++.+.++|.+||+.+|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 8999999999888999999999999999999999999765431111111 11223445667789999999999999999
Q ss_pred CCCC-----CHHHHHHHHHHHHHHHhhc
Q 003963 748 QCRP-----SFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 748 ~~RP-----sa~ell~~L~~L~~~~f~~ 770 (783)
.+|| ++.++ +.|+||+.
T Consensus 238 ~~R~~~~~~~~~~l------l~h~~~~~ 259 (277)
T cd05577 238 EKRLGCRGGSADEV------REHPLFKD 259 (277)
T ss_pred hHccCCCcccHHHH------HhChhhhc
Confidence 9999 66666 56888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.24 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=200.8
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecC--CceEEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVT 582 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~ 582 (783)
|++.++||+|+||.||++.+.. ++.||+|++.......... ...+|+.++.++. |+||+++++++... +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 6789999999999999999764 5679999987653333322 3346888888885 99999999999887 8899999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++. +.+||+|||++........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9996 5888888765567899999999999999999999998 999999999999999 9999999999876543322
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------------ccc
Q 003963 663 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----------------QRL 725 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------------~~~ 725 (783)
.....++..|+|||.+.. ..++.++|||||||++|+|++|.+||...+.......+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 123457899999997654 556889999999999999999999998776554333221100 001
Q ss_pred c-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 726 E-----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 726 ~-----------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
. +...++..+.+||.+||.++|.+||++.++ ++|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~------l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA------LRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH------hhCCCC
Confidence 1 123567899999999999999999999999 567775
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.46 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=199.7
Q ss_pred eeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHH---hCCCCceeeEeceeecCCceEEEEEecC
Q 003963 512 QIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMK---RLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
.||+|+||.||++.+.. ++.||+|++....... .....+.+|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999864 5689999987654332 11223344444433 4479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCC
Q 003963 587 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 666 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 666 (783)
+++|.+++..+ ..+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 99999998764 35899999999999999999999998 999999999999999999999999998654332 12234
Q ss_pred CCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 667 KGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--VIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 667 ~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
.|++.|+|||.+. +..++.++|||||||++|+|++|..||....... ..... .......++..+++++.++|.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 4568899999999999999999999997543221 11111 122345567789999999999999
Q ss_pred hhCCCCCC-----CHHHHHHHHHHHHHHHhhcCc
Q 003963 744 HSDPQCRP-----SFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 744 ~~dP~~RP-----sa~ell~~L~~L~~~~f~~~~ 772 (783)
..||.+|| ++.++ ++|+||+...
T Consensus 235 ~~~p~~R~~~~~~~~~~~------~~h~~~~~~~ 262 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEV------KEHVFFKGID 262 (279)
T ss_pred cCCHHHhcCCCCCCHHHH------HhCccccCCC
Confidence 99999999 59888 7788987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.11 Aligned_cols=248 Identities=31% Similarity=0.450 Sum_probs=208.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.+.|...+.||+|+||.||++.+.. +..||+|++..... ..+....+.+|+.+++.++|||++++++++......++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3458889999999999999999754 56799999875432 334556788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+.+ +|.+++.....++++..+..++.||+.||.|||+++ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 999964 888888766667899999999999999999999998 99999999999999999999999998865432
Q ss_pred cccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||...........+.........+..+++.+.+|
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 22446789999999874 45678999999999999999999999987766655555433333333445678899999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~ 758 (783)
|.+||+.+|.+||++.++++
T Consensus 257 i~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred HHHHccCCcccCcCHHHHHh
Confidence 99999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.30 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=218.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..+.|..-++||+|+||.||-+.... ++.||+|.+.+..+.. .......+|..||..++.++||.+-.+|+..+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34578888999999999999998765 4669999987766543 233456789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||..|+||+|.-+|...+ ..++++.++.++.+|+-||.+||+.+ ||+||+||+|||+|+.|+|.|+|+|+|..+...
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999988886544 35999999999999999999999988 999999999999999999999999999877765
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--cccccccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~s~~l~~ 737 (783)
... ...+||..|||||++.+..|+...|+|||||+||||+.|+.||........-+.+. ......+++...++++++
T Consensus 341 ~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 341 KPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred Ccc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 433 34589999999999999999999999999999999999999997654432222221 133456677889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
|.+.+|.+||.+|. ++.++ -+|+||+..
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~ev------k~HpfFk~l 452 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEV------KEHPFFKDL 452 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchh------hhCcccccC
Confidence 99999999999996 45566 478999754
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.24 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=205.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 582 (783)
++|+..++||+|+||.||++.+.. ++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 467778899999999999999865 478999998765433 34567888999999996 999999999999999999999
Q ss_pred EecCCCCHHHHHh----hcCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 583 EFLPRGSLFRLLQ----RNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 583 E~~~ggsL~~~L~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
||+. ++|.++.. .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.++|+|||++....
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9995 46655432 1235689999999999999999999974 7 9999999999999999999999999987554
Q ss_pred cccccccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccc----CCC
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLE----IPK 729 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~ 729 (783)
.... .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...... +....+.. ...+. .+.
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEER 237 (288)
T ss_pred cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCC
Confidence 3322 2234678999999998876 6789999999999999999999999765421 12112111 11111 223
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.++.++.+||.+||+++|.+||++.++ +.++||+..+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i------~~~~~~~~~~~~ 276 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKEL------LEHPFIKDYEER 276 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHH------hcChhhhchhhc
Confidence 478999999999999999999999999 778999766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.20 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=209.6
Q ss_pred eeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 507 LTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
|++.+.||.|++|.||++.+. +++.+++|.+............+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999875 4577999998776555445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccC
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 665 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 665 (783)
++ +|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 65 898888776567999999999999999999999998 999999999999999999999999998766554322233
Q ss_pred CCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------------------
Q 003963 666 GKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR-------------------- 724 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------- 724 (783)
..++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+..+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4578899999998877 6899999999999999999999999877655443322110000
Q ss_pred --------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 --------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 --------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
..+...++.++.+||.+||.+||.+||++.++ +.++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l------l~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA------LAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH------hhCCCC
Confidence 01223467899999999999999999999999 566665
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=309.54 Aligned_cols=246 Identities=27% Similarity=0.451 Sum_probs=194.7
Q ss_pred eeeccCCcEEEEEEEEeCCc---eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYGSQ---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~---~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
++||+|+||.||++...... .+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36999999999999765443 35666655433 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc--ccc
Q 003963 588 GSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLT 662 (783)
Q Consensus 588 gsL~~~L~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~ 662 (783)
++|.+++.... ...+...++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999997532 33567778889999999999999988 999999999999999999999999987542221 112
Q ss_pred ccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc----ccccCCCC
Q 003963 663 TKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN----QRLEIPKD 730 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-------~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~ 730 (783)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||........+..+.... ....++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 234567889999998753 235779999999999999997 678998777665554432111 12334456
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
+++.+.+++..|| .+|++||++.++++.|
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 7899999999999 6799999999998776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.61 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=209.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----Cc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 577 (783)
..+|.+.++||+|+||.||++.+.. ++.||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3579999999999999999999754 57899999876433333345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 6899988754 46899999999999999999999998 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--------------
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-------------- 722 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------------- 722 (783)
..........++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43222334467889999998765 468899999999999999999999997665432222111000
Q ss_pred ----------c-----cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 723 ----------Q-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 723 ----------~-----~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
. .......+++++.+||.+||+.+|.+||++.++ ++|+||+..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el------l~h~~~~~~~~~ 300 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA------LAHPYLASLHDP 300 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH------HcCcchhhhcCc
Confidence 0 011234678999999999999999999999999 678888665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=308.07 Aligned_cols=250 Identities=30% Similarity=0.505 Sum_probs=210.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--Cce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 578 (783)
.+|.+.+.||+|+||.||++.+.. +..|++|++.... ........+.+|+.+++.++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999754 5679999875432 1234556888999999999999999999998764 458
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+++|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999987643 4788899999999999999999998 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 659 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 659 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.. .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+........+|..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 21 111234578999999999998899999999999999999999999988776665555544444566788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~ 758 (783)
.++|.+||. +|..||++.+++.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhc
Confidence 999999999 4799999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.94 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=200.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC---CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--CceE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 579 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 579 (783)
.|.+.++||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999865 47899999876431 122335677899999999999999999999888 7899
Q ss_pred EEEEecCCCCHHHHHhhc----CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC----CCcEEEEecC
Q 003963 580 IVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFG 651 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~----~~~vkL~DFG 651 (783)
+||||+++ +|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999964 777776432 235889999999999999999999998 999999999999999 8999999999
Q ss_pred CCcccccccc---cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------HHHHh
Q 003963 652 LSRLKHETYL---TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---------VIGAV 718 (783)
Q Consensus 652 la~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~---------~~~~i 718 (783)
++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||....... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543322 22234678899999988764 57899999999999999999999997544321 00000
Q ss_pred -hc-----------------------ccccccCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 719 -GF-----------------------MNQRLEIP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 719 -~~-----------------------~~~~~~~~-----------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.. .......+ ...+.++.++|.+||+.||++|||+.++ +
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei------l 311 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA------L 311 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH------h
Confidence 00 00001111 1567789999999999999999999999 6
Q ss_pred HHHHh
Q 003963 764 QRQYF 768 (783)
Q Consensus 764 ~~~~f 768 (783)
.|+||
T Consensus 312 ~~~~f 316 (316)
T cd07842 312 EHPYF 316 (316)
T ss_pred cCCCC
Confidence 67776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.07 Aligned_cols=264 Identities=31% Similarity=0.518 Sum_probs=235.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
..|+.....+|.++||.|-||.||+|..+.. ..||||.++... .+.+...|..|+.||-++.||||++|.|+...
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 3355566788999999999999999997542 349999987644 56677899999999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
...+.||.|||+.|+|..+|+.+...+...++..+++.|+.||.||-+++ +|||||.+.||||+.+...|++|||+++
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999999999998888999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccc---cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 655 LKHETYLTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 655 ~~~~~~~~~---~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
...+..... ....-..+|.|||.+....++.++||||+|++|||.|+ |..||.++...+++..+. ...+++.|..
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmD 858 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMD 858 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCC
Confidence 775543222 22233579999999999999999999999999999887 999999999999998885 5678888899
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+|..|.+|+..||++|-.+||.+.+|+..|++|...
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999988654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.71 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=205.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 576 (783)
...++|++.++||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 445789999999999999999999864 567999998765433333456778999999999999999999987654
Q ss_pred ------ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 577 ------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 577 ------~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
.+++||||+++ +|..++......+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999975 888888765567899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccccc-cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q 003963 651 GLSRLKHETYL-TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--- 725 (783)
Q Consensus 651 Gla~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--- 725 (783)
|++........ ......++..|++||.+.+. .++.++|||||||++|+|++|++||...+..+.+..+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99876544321 11223457889999988654 46889999999999999999999998776655443332211000
Q ss_pred -------------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 726 -------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 726 -------------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
.....+++.+.+||..||..||.+||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 11234688999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.80 Aligned_cols=248 Identities=29% Similarity=0.488 Sum_probs=214.5
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|++.++||.|+||.||++.+.. ++.+++|++............+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58899999999999999998754 46799999987665555667788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 585 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 585 ~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999998652 345889999999999999999999998 999999999999999999999999998766544
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. ......++..++.++.++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2233567899999999999989999999999999999999999998887765554443 223344566788999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 003963 742 CWHSDPQCRPSFQELVD 758 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~ 758 (783)
||..+|.+||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 236 MLQVKPKLRPNCDKILA 252 (256)
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999953
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.03 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=216.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCc-eEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
+...+|..+.+||+|+||.|.++..+++. -||||++++...- ++-++--+.|.++|... +-|.+++++.+|+..+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 44568899999999999999999987764 5999999876532 22233344577777766 468999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+||||+.||+|--.++.- .++.+..+..++.+|+-||-+||++| ||+||||.+|||++.+|+|||+|||+++....
T Consensus 426 yFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999998888764 46889999999999999999999999 99999999999999999999999999987666
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
...++.+.+|||.|+|||++.-.+|+..+|+||+|++|||||.|.+||++.+..+++..| +.....+|+.++.++.++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCcccccHHHHHH
Confidence 667788999999999999999999999999999999999999999999999999999888 445667889999999999
Q ss_pred HHHhhhhCCCCCC
Q 003963 739 VESCWHSDPQCRP 751 (783)
Q Consensus 739 I~~cL~~dP~~RP 751 (783)
++..|.+.|.+|.
T Consensus 581 ckg~ltK~P~kRL 593 (683)
T KOG0696|consen 581 CKGLLTKHPGKRL 593 (683)
T ss_pred HHHHhhcCCcccc
Confidence 9999999999995
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=305.93 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=204.2
Q ss_pred eeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHH-HhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
+.||.|+||.||+|.+.. ++.||+|++.+.... ......+..|..++ ..++|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999998754 578999998754432 22233444555544 455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999764 45899999999999999999999998 99999999999999999999999998865433 22446
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCCCCHHHHHHHHHhhhh
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWAAIVESCWHS 745 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~LI~~cL~~ 745 (783)
+++.|++||.+.+..++.++||||||+++|+|++|..||...+.......+..... .......+++.+.++|.+||..
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 78899999999988889999999999999999999999988777665555432221 2223446889999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 746 DPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 746 dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+|.+||++.++.+. +.|+||+.+
T Consensus 235 ~p~~R~~~~~~~~~---l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEI---KSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHH---HcChHhhcC
Confidence 99999976544332 678999765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.00 Aligned_cols=254 Identities=31% Similarity=0.461 Sum_probs=210.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+-|...++||+|+||.||+|.+.. ++.|++|++..... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 346777889999999999998754 56799999876543 3344567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+. ++|.+++.....++++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9995 5888888766667899999999999999999999998 99999999999999999999999998864322
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+............++..+.+||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 22456889999999984 456788999999999999999999999887766555444332222223345778899999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+||+.+|.+||++.++ +.++||...
T Consensus 254 ~~~l~~~P~~Rp~~~~~------l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAEL------LRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHH------hcCcccCCC
Confidence 99999999999999999 566777543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=312.86 Aligned_cols=264 Identities=27% Similarity=0.438 Sum_probs=210.3
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCc
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 577 (783)
+....++|++.+.||+|+||.||+|.+.. ++.||||++....... ....+..|+.++..+. ||||+++++++.....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34556889999999999999999999875 6789999987654333 3455666777666665 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|+||||+. ++|..++......+++..+..++.||+.||+|||+ ++ |+|+||+|+||+++.++.+||+|||++...
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999995 58888877655678999999999999999999997 57 999999999999999999999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccc-ccccCCCC
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMN-QRLEIPKD 730 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~ 730 (783)
...... ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... .+.+..+.... ........
T Consensus 166 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 166 VDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred cCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 433222 2335788999999987654 78899999999999999999999976433 22222221111 11222234
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
++.++.+||.+||..||.+||++.++ ++++||+..+..
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~~~ 282 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYREL------LQHPFIRRYETA 282 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHH------hcChhhhccchh
Confidence 78999999999999999999999999 678888776554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=309.00 Aligned_cols=246 Identities=21% Similarity=0.352 Sum_probs=199.6
Q ss_pred cceeEeeee--ccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 505 EDLTIGEQI--GQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 505 ~~y~i~~~L--G~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
++|.+.+.+ |.|+||.||++..+. +..+|+|++........ |+.....+ +||||+++++++..++.+|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 466666666 999999999999765 46799999876543221 22222222 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~ 659 (783)
||||+++++|.+++.... .+++..++.++.||++||.|||+.+ ++|+||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999997654 7899999999999999999999998 99999999999999988 9999999998755432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHhhcccccccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV--IGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
....++..|+|||++.+..++.++|||||||++|+|++|..||........ .............+..+++.+.+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 234678999999999998999999999999999999999999975433221 11111122334555679999999
Q ss_pred HHHHhhhhCCCCCCC-HHHHHHHHHHHHHHHhhc
Q 003963 738 IVESCWHSDPQCRPS-FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 738 LI~~cL~~dP~~RPs-a~ell~~L~~L~~~~f~~ 770 (783)
||.+||+.+|.+||+ ++++ |+|+||++
T Consensus 240 li~~~l~~~p~~R~~~~~~~------l~h~~~~~ 267 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEI------IKHPFLKI 267 (267)
T ss_pred HHHHHhccChhhCCchHHHH------hcCCcccC
Confidence 999999999999995 6999 68899874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.71 Aligned_cols=257 Identities=21% Similarity=0.352 Sum_probs=206.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec----CCceE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLC 579 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 579 (783)
.+|++.+.||.|+||.||+|.+.. ++.||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999764 5789999987654333445677789999999999999999998763 34689
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 6899988654 45899999999999999999999998 999999999999999999999999998755432
Q ss_pred ccc----ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-------------
Q 003963 660 YLT----TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM------------- 721 (783)
Q Consensus 660 ~~~----~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~------------- 721 (783)
... .....|+..|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 123468899999999865 45789999999999999999999999776543322211110
Q ss_pred -----------ccccc-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 722 -----------NQRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 722 -----------~~~~~-----~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
..... +...++.++.++|.+||+.+|.+||++.++ +.|+||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~------l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA------LQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH------HhChhhhhc
Confidence 00011 124568899999999999999999999999 678998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=329.08 Aligned_cols=254 Identities=33% Similarity=0.577 Sum_probs=223.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC--C--ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG--S--QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
|..++.++.++||+|.||+|+.|.|.. + -.||||++....... ....|.+|+.+|.+|+|+|++++||+.-+ ..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 344677888999999999999998854 2 248999998776554 56789999999999999999999999887 77
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+.||||++++|+|.+.|.+ ....|.......++.||+.||.||..++ +|||||-..||||.....|||||||+.+-+
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceecc
Confidence 8999999999999999987 5566888888899999999999999988 999999999999998889999999999866
Q ss_pred ccc---cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 657 HET---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 657 ~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
... |.......-...|+|||.+....++.++|+|++||+||||++ |..||.+....+++..+. ...++.-|+.++
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~cs 341 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCS 341 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCCh
Confidence 543 223333345678999999999999999999999999999999 899999999999999887 677888999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
.++++++..||..+|.+||++..|.+.+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999999999999999996543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=319.16 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=203.1
Q ss_pred eeeccC--CcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQG--SCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G--~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
..||.| +||.||++.+. .++.||+|++..........+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999985 457899999987665666668899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc------
Q 003963 588 GSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY------ 660 (783)
Q Consensus 588 gsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~------ 660 (783)
++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999998754 235889999999999999999999998 9999999999999999999999998643221110
Q ss_pred -ccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------
Q 003963 661 -LTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------- 723 (783)
Q Consensus 661 -~~~~~~~Gt~~Y~aPE~~~~~--~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------- 723 (783)
.......++..|++||++.+. .++.++|||||||++|+|++|.+||.................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 011122346679999998764 468899999999999999999999987655443322110000
Q ss_pred -------------------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 724 -------------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 724 -------------------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
....+..+++.+.+||++||..||++|||+.++ ++|+||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~------l~~~~~~~~~ 315 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL------LSHAFFKQVK 315 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH------hhCHHHHHHH
Confidence 001123356789999999999999999999999 7788886655
Q ss_pred CC
Q 003963 773 ST 774 (783)
Q Consensus 773 ~~ 774 (783)
..
T Consensus 316 ~~ 317 (328)
T cd08226 316 EQ 317 (328)
T ss_pred Hh
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.65 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=210.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 576 (783)
..++|++.+.||+|+||.||++.+.. +..||||++............+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45789999999999999999998754 567999998665444445567889999999999999999999987654
Q ss_pred -ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 -~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 7799988864 35889999999999999999999998 99999999999999999999999999875
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 723 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 723 (783)
.... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.....
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 5432 223457889999999876 4578999999999999999999999987655433222111000
Q ss_pred ------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 724 ------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 724 ------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
...+...+++.+.++|.+||..||.+||++.++ +.|+||+..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~------l~~~~~~~~~~~ 307 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA------LAHPYFEEFHDP 307 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH------hcCccHhhhcCc
Confidence 011224678889999999999999999999999 678999876543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.37 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=203.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 575 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 575 (783)
.++|++.++||.|+||.||+|.+.. ++.|+||++............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4799999999999999999999764 57799999876543333334567899999999999999999987543
Q ss_pred -CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 576 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 576 -~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..+++||||+.+ +|...+......+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999954 788887765667999999999999999999999998 9999999999999999999999999987
Q ss_pred ccccccccc-----------cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 003963 655 LKHETYLTT-----------KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 655 ~~~~~~~~~-----------~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~ 722 (783)
......... ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 544322111 123467889999987654 57899999999999999999999998777655443321110
Q ss_pred cc---------------------ccC-------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 723 QR---------------------LEI-------PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 723 ~~---------------------~~~-------~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.. ... ...+++.+.+||.+||..||.+|||+.++ +.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el------l~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA------LEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH------hcCCCC
Confidence 00 000 12345678999999999999999999999 567776
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=318.90 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=203.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----Cc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 577 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3689999999999999999998754 57899999864322 23445677899999999999999999887543 35
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588888864 35899999999999999999999998 9999999999999999999999999987543
Q ss_pred cccc---cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-----------
Q 003963 658 ETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----------- 722 (783)
Q Consensus 658 ~~~~---~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------- 722 (783)
.... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3211 1123467899999998755 567899999999999999999999997655433221110000
Q ss_pred -------------cccc-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 723 -------------QRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 723 -------------~~~~-----~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.... ....+++++.+||.+||+.+|++||++.++ +.|+||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~------l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA------LAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH------hcCccccccC
Confidence 0000 113467889999999999999999999999 6788887554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.53 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=206.2
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--CceEEEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTE 583 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~E 583 (783)
|++.++||.|+||.||+|.+.. ++.+|+|++............+.+|+.+++.++||||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6788999999999999999865 56799999987643344456778899999999999999999999888 88999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-c
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 662 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 662 (783)
|+++ +|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9964 899998765567999999999999999999999998 99999999999999999999999999876554321 1
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------
Q 003963 663 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------------- 724 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 724 (783)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 123356788999998765 45789999999999999999999999877765544332211000
Q ss_pred ----c--------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 ----L--------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 ----~--------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
. .+...+++.+.++|.+||..+|.+||++.++ +.++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~------l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA------LQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH------hhCcCC
Confidence 0 0111238889999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.25 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=199.6
Q ss_pred eeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHH---HHHHhCCCCceeeEeceeecCCceEEEEEecC
Q 003963 512 QIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEV---SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
.||+|+||.||++.+.. ++.||+|++....... .....+..|. .+++...||||+++++++...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998765 5689999987654332 1112233343 34455679999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCC
Q 003963 587 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 666 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 666 (783)
|++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 99999988754 46899999999999999999999998 999999999999999999999999998754332 22345
Q ss_pred CCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-HhhcccccccCCCCCCHHHHHHHHHhhh
Q 003963 667 KGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG-AVGFMNQRLEIPKDVDPRWAAIVESCWH 744 (783)
Q Consensus 667 ~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~s~~l~~LI~~cL~ 744 (783)
.|+..|+|||++.+. .++.++|||||||++|+|++|+.||.......... ..........++..+++++.++|.+||.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 789999999998754 68899999999999999999999997663221111 1111223456677789999999999999
Q ss_pred hCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 745 SDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 745 ~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
.+|.+|| ++.++ ++|+||+..
T Consensus 236 ~~p~~R~~~~~~~~~~l------l~~~~~~~~ 261 (278)
T cd05606 236 RDVNRRLGCLGRGAQEV------KEHPFFRSL 261 (278)
T ss_pred cCHHhccCCCCCCHHHH------HhCccccCC
Confidence 9999999 99999 568888554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=282.16 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=214.9
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+|.-.++||+|+||+||+++.... +-||+|.++...-++..-....+|+.+|+.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999998765 4599999987766555556778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
|.. +|..++......++.+.+..++.|+++||.|+|+++ +.|||+||.|+||+.+|.+||+|||+++-+.-+.....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 954 999999888888999999999999999999999999 99999999999999999999999999998776654445
Q ss_pred CCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc---------cCC-----
Q 003963 665 TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRL---------EIP----- 728 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~---------~~~----- 728 (783)
..+-|..|++|.++.|.. |+...|+||.||++.|+.. |++.|.+.+....+..+-...+.+ .+|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 556799999999998865 7899999999999999997 788888887766555542221110 011
Q ss_pred -------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 729 -------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 729 -------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+.++..-++++.++|.-+|.+|.+++.. ++|+||.-.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa------lqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA------LQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH------hcCcccccc
Confidence 1122234889999999999999999988 789998643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.29 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=208.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+|.+.++||+|+||.||++.+... ..+++|+++... ........+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999987654 346666654322 2223334567789999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998863 3456899999999999999999999998 999999999999976 5799999999876554
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ....+..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333445568899999999988888999999999999999999999998766655444432 223444566788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
|.+||..+|.+||++.++ ++|+||
T Consensus 237 i~~~l~~~p~~Rp~~~~i------l~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEI------LRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHH------hhCCCC
Confidence 999999999999999999 566664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.15 Aligned_cols=252 Identities=27% Similarity=0.345 Sum_probs=203.7
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC---CCCceeeEeceeecCCc-----
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQR----- 577 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----- 577 (783)
|++.+.||+|+||.||++.+.. ++.||+|++............+.+|+.+++.+ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999875 57899999975544333445566788877766 59999999999987776
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
++++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999964 8999887643 35899999999999999999999998 999999999999999999999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---c---------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---R--------- 724 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~--------- 724 (783)
..... .....++..|+|||++.+..++.++|||||||++|+|++|.+||......+.+..+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 43321 1233578899999999999999999999999999999999999988776554443311100 0
Q ss_pred -------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 -------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 -------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
......+++.+.+||.+||..||.+||++.++ ++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i------l~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA------LQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH------hcCcCC
Confidence 00012346788999999999999999999999 566765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.89 Aligned_cols=245 Identities=28% Similarity=0.447 Sum_probs=210.9
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 590 (783)
||.|+||.||++.+.. ++.|++|++...... ......+..|+.+++.++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999864 578999998776543 23566788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCC
Q 003963 591 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670 (783)
Q Consensus 591 ~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 670 (783)
.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99997653 5899999999999999999999988 99999999999999999999999999876544322334456788
Q ss_pred cccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 671 ~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
.|++||.+.+...+.++|+||||+++|+|++|..||...+.......+.. ....++..++..+.++|.+||..||.+|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999988889999999999999999999999987776555555432 4567788889999999999999999999
Q ss_pred CCH---HHHHHHHHHHHHHHh
Q 003963 751 PSF---QELVDKLRDLQRQYF 768 (783)
Q Consensus 751 Psa---~ell~~L~~L~~~~f 768 (783)
|++ .++ +.|+||
T Consensus 236 ~~~~~~~~l------~~~~~f 250 (250)
T cd05123 236 LGSGGAEEI------KAHPFF 250 (250)
T ss_pred CCcccHHHH------HhCCCC
Confidence 999 566 566665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.28 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=205.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecC--Cce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP--QRL 578 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~ 578 (783)
..++|++.+.||+|+||.||+|.+.. ++.+|+|++............+.+|+.+++.+ +||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45789999999999999999999764 56799998865433334445677899999999 999999999988654 368
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+||||++ ++|..++... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999996 5999988754 6888899999999999999999998 99999999999999999999999999875543
Q ss_pred ccc-----cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------
Q 003963 659 TYL-----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN---------- 722 (783)
Q Consensus 659 ~~~-----~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------- 722 (783)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 2223468899999998765 457889999999999999999999997665443322211000
Q ss_pred ----------------c---cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 723 ----------------Q---RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 723 ----------------~---~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
. .....+.++.++.+||.+||+.+|.+|||+.++ ++++||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i------l~~~~~~~~ 301 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA------LEHPYVAQF 301 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH------hhChhhhhh
Confidence 0 011123478899999999999999999999999 556777554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.32 Aligned_cols=256 Identities=17% Similarity=0.205 Sum_probs=190.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCH--HH-------HHHHHHHHHHHHhCCCCceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSD--EV-------IHSFRQEVSLMKRLRHPNVLL 567 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~--~~-------~~~~~~Ei~il~~l~HpnIv~ 567 (783)
++..++|++.++||+|+||.||+|.+... ..+++|+........ +. ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557899999999999999999997654 346666543222111 10 011222334455678999999
Q ss_pred EeceeecCC----ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC
Q 003963 568 FMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 568 l~~~~~~~~----~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~ 643 (783)
+++++.... ..+++|+++ ..++.+.+... ...++..++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998765443 347888888 44777777543 33577888999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccccc-------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHH
Q 003963 644 TVKVGDFGLSRLKHETY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVI 715 (783)
Q Consensus 644 ~vkL~DFGla~~~~~~~-------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~ 715 (783)
.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999997653211 111234689999999999999999999999999999999999999987732 2211
Q ss_pred HH-----hhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003963 716 GA-----VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 716 ~~-----i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L 760 (783)
.. +............+++.+.+++..||..+|.+||++.+|++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 1111111112345689999999999999999999999998765
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.44 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=208.9
Q ss_pred ceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccCC--HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
+|++.+.||.|+||.||+|... .++.||+|++...... ......+.+|+.+++.+ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 4567999998754321 23345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999999764 45889999999999999999999988 99999999999999999999999999876543
Q ss_pred cc-ccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhcccccccCCCCC
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~--~~s~~sDIwSLG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 731 (783)
.. .......|+..|++||.+.+. .++.++|||||||++|+|++|..||..... ......+ .......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 22 112234688999999998753 367899999999999999999999964322 2222222 22344567778
Q ss_pred CHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcCc
Q 003963 732 DPRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~~ 772 (783)
++.+.+|+.+||..||.+|| ++.++ +.|+||+...
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l------~~~~~~~~~~ 275 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEI------KKHPFFQKIN 275 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHH------HcCcccccCC
Confidence 99999999999999999997 77888 6788887664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.96 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=209.1
Q ss_pred ccee-EeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHH------------HHHHHHHHHHHHHhCCCCceeeEec
Q 003963 505 EDLT-IGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDE------------VIHSFRQEVSLMKRLRHPNVLLFMG 570 (783)
Q Consensus 505 ~~y~-i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~~ 570 (783)
++|. +.+.||.|+||.||+|.+. .++.||||++........ ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999976 467899999865432210 0124678999999999999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
++...+..++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+++ |+|+||||+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 599999865 345899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccc--------------cccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003963 651 GLSRLKHET--------------YLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 715 (783)
Q Consensus 651 Gla~~~~~~--------------~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~ 715 (783)
|++...... ........+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...+....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998755411 11112234678899999987644 689999999999999999999999877765544
Q ss_pred HHhhccccc--------------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 716 GAVGFMNQR--------------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 716 ~~i~~~~~~--------------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
..+...... .......+.++.+||.+||..+|.+||++.++ +.|+||+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~------l~~~~~~ 317 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA------LKHEYFK 317 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH------hcCcccC
Confidence 333211100 01123457889999999999999999999999 6799998
Q ss_pred cCcCCCCC
Q 003963 770 ASRSTVGD 777 (783)
Q Consensus 770 ~~~~~~~~ 777 (783)
.....+.+
T Consensus 318 ~~~~~~~~ 325 (335)
T PTZ00024 318 SDPLPCDP 325 (335)
T ss_pred CCCCCCCc
Confidence 76655544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.57 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=207.4
Q ss_pred eeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCC
Q 003963 510 GEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
..+||+|+||.||++.... ++.||||++.... ......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 4679999999999998754 5679999875432 233466888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 668 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 668 (783)
+|.+++... .+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++..............|
T Consensus 103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 999988643 4788999999999999999999998 999999999999999999999999988655433222334568
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHHHhhhhCC
Q 003963 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVESCWHSDP 747 (783)
Q Consensus 669 t~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~~cL~~dP 747 (783)
++.|++||.+.+..++.++|+||||+++|+|++|..||...........+... .........+++.+.++|.+||..+|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 89999999998888899999999999999999999999877665554443221 12222345678999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhh
Q 003963 748 QCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 748 ~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+||++.++ +.|+||.
T Consensus 259 ~~R~~~~~l------l~~~~~~ 274 (292)
T cd06657 259 AQRATAAEL------LKHPFLA 274 (292)
T ss_pred ccCcCHHHH------hcChHHh
Confidence 999999999 6688884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.01 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=202.0
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecC
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
|.+++.+|.|+++.||++.. .++.||||++............+.+|+.+++.++||||+++++++......+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455555566655555544 46789999998765556667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc-----
Q 003963 587 RGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----- 660 (783)
Q Consensus 587 ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----- 660 (783)
+++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.++|+|||.+.......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999999753 345889999999999999999999998 9999999999999999999999999876443211
Q ss_pred --ccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--------------
Q 003963 661 --LTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-------------- 722 (783)
Q Consensus 661 --~~~~~~~Gt~~Y~aPE~~~~~--~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-------------- 722 (783)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 112234567889999998763 47889999999999999999999998765543322110000
Q ss_pred ------------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 723 ------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 723 ------------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.....+..++.++.+||..||..||.+|||+.++ |.|+||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l------l~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL------LNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH------hcCchHhhhc
Confidence 0000112234678999999999999999999999 6789998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=299.92 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=223.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCH-HHHHHHHHHHHHHHhC-CCCceeeEeceeecC
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP 575 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 575 (783)
.+.....+|.++++||+|+|.+|..+.++.. +-||+|+++++-.++ +-......|..++.+. +||++|-++.+|+.+
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 4455678999999999999999999998664 669999998876543 3344556677777776 599999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..+++|.||++||+|--++++. .+++++.+..+..+|+.||.|||+.| ||+||||.+|||++..|++||+|+|+++.
T Consensus 324 srlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999999998777764 46999999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC-------CCChHHHHHHhhcccccccCC
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD-------NLNSMQVIGAVGFMNQRLEIP 728 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~-------~~~~~~~~~~i~~~~~~~~~~ 728 (783)
...+...+.+++|||.|.|||+++|..|+..+|+|+||++|+||+.|+.||. +.+...++..+. +...+.+|
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-lekqirip 479 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-LEKQIRIP 479 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-hhhccccc
Confidence 7777778889999999999999999999999999999999999999999995 223334443332 44567889
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCC------CHHHHHHHHHHHHHHHhhcC
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRP------SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RP------sa~ell~~L~~L~~~~f~~~ 771 (783)
..++-....+++.-|.+||.+|. .+.++ -.|+||..+
T Consensus 480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~di------k~h~ffr~i 522 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDI------KSHAFFRSI 522 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhh------hcchhhhhC
Confidence 99999999999999999999984 23444 357777543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.09 Aligned_cols=255 Identities=26% Similarity=0.371 Sum_probs=205.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 576 (783)
..+|.+.+.||+|+||.||+|.+. .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999975 4678999998765444444556788999999999999999999987543
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+||||+. .+|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 47777653 35889999999999999999999998 999999999999999999999999998754
Q ss_pred ccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 723 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 723 (783)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 168 DAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 332 123457889999999876 4578999999999999999999999987665443322211000
Q ss_pred ---------cc--------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 724 ---------RL--------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 724 ---------~~--------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.. ...+..++.+.+||.+||+.||.+||++.++ +.|+||+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~------l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA------LEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH------hcCcchhhccc
Confidence 00 0112467889999999999999999999999 67899877654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.96 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=210.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccCC--HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
+|++.+.||+|+||.||++.+. .+..||||++...... ......+.+|+.++..+ +||||+++++++.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 3457999998754322 23345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998754 45889999999999999999999988 99999999999999999999999999875433
Q ss_pred ccc-cccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhcccccccCCCCC
Q 003963 659 TYL-TTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 659 ~~~-~~~~~~Gt~~Y~aPE~~~~~~--~s~~sDIwSLG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 731 (783)
... ......|+..|++||.+.+.. .+.++||||||+++|+|++|..||..... ......+ .......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 221 122345789999999987765 68899999999999999999999964322 1221121 23345667778
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
++.+.++|.+||+.||++|||+.++.+. +.++||++.-
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~---l~~~~~~~~~ 273 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEI---KNHPFFQGID 273 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHH---hcCcccccCC
Confidence 9999999999999999999998777554 6789997753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.39 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=208.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--C----ceeeEeceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--P----NVLLFMGAVT 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~ 573 (783)
++..++|++...+|+|+||.|..+.+... ..||||+++... ...+..+-|+++|++|.+ | -+|++.+||.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 45688999999999999999999998665 679999986543 344566779999999942 2 3788899999
Q ss_pred cCCceEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc------------
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD------------ 640 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~------------ 640 (783)
..++.|||+|.+ |-+++++|.. +-.+++...+..+++||+++++|||+++ ++|.||||+|||+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence 999999999999 6799999986 4567999999999999999999999998 99999999999983
Q ss_pred --------CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003963 641 --------KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712 (783)
Q Consensus 641 --------~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~ 712 (783)
.+..|+|+|||.|+...+.. .+.+.|..|+|||++.|-.++.+.||||+||||+|+++|..-|+..+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13468999999998766543 3556799999999999999999999999999999999999999876644
Q ss_pred HHHHHhhccccc-------------------ccCCC-------------------------CCCHHHHHHHHHhhhhCCC
Q 003963 713 QVIGAVGFMNQR-------------------LEIPK-------------------------DVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 713 ~~~~~i~~~~~~-------------------~~~~~-------------------------~~s~~l~~LI~~cL~~dP~ 748 (783)
+-+..+....+. +..+. .-..+|.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 422222111110 00000 0012589999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 749 CRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 749 ~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+|+|+.|+ |+|+||+...
T Consensus 396 ~RiTl~EA------L~HpFF~~~~ 413 (415)
T KOG0671|consen 396 RRITLREA------LSHPFFARLT 413 (415)
T ss_pred ccccHHHH------hcCHHhhcCC
Confidence 99999999 7899998654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.24 Aligned_cols=254 Identities=31% Similarity=0.448 Sum_probs=209.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
...|.+.+.||+|+||.||+|.+.. +..|++|.+..... .......+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3457888999999999999999864 46799999875432 334456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 99996 5888887665667899999999999999999999988 999999999999999999999999998654332
Q ss_pred cccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+.+|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 2346788999999975 34578899999999999999999999987765554444332222222344688899999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
|.+||..+|.+||++.++ +.++|+..
T Consensus 247 i~~cl~~~P~~Rp~~~~l------l~~~~~~~ 272 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVL------LKHRFVLR 272 (308)
T ss_pred HHHHhhCCcccCCCHHHH------hhCccccc
Confidence 999999999999999999 55676654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.05 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=208.0
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
|++.+.||+|+||.||+|.+.. ++.|++|++............+..|+.+++.++|+||+++++++...+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5678899999999999999865 678999998765433444566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccC
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 665 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 665 (783)
+ ++|.+++......+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5999999876557999999999999999999999998 999999999999999999999999998765443322223
Q ss_pred CCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------------ccc-
Q 003963 666 GKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------------QRL- 725 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------------~~~- 725 (783)
..++..|+|||.+.+. .++.++|||||||++|+|++|.+||...+....+..+.... ...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999998776 78899999999999999999999998776544433221100 000
Q ss_pred --------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 726 --------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 726 --------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
...+.++..+.++|.+||..+|.+||++.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~------l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA------LKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH------hhCcCC
Confidence 1112347889999999999999999999999 667776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.91 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=210.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 577 (783)
..++|++.+.||.|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45789999999999999999999865 5679999987654444455677889999999999999999998876554
Q ss_pred --eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 578 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 578 --~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 6799999875 35899999999999999999999998 99999999999999999999999999876
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---------- 724 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 724 (783)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 5432 224467889999999865 46789999999999999999999999876655443332111000
Q ss_pred -------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 725 -------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 725 -------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
......+++.+.+||.+||..+|.+|||+.++ +.|+||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el------l~h~~~~~~~~~ 307 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA------LAHPYLAEYHDP 307 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH------hcCCCccccCCC
Confidence 01112468899999999999999999999999 678999655433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=310.98 Aligned_cols=257 Identities=27% Similarity=0.381 Sum_probs=206.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-CCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 580 (783)
..++|++.+.||.|+||.||++.+. .++.||||++..........+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4578999999999999999999976 45779999886544444445677889999999999999999998865 457899
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
+|||+ +++|..++... +++...+..++.||+.||.|||+.+ |+|+||||.|||++.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99999 56899888643 4788888899999999999999998 999999999999999999999999998754322
Q ss_pred ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-------------------
Q 003963 661 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF------------------- 720 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~------------------- 720 (783)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223467889999998766 5689999999999999999999999977654332211110
Q ss_pred -----cccccc-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 721 -----MNQRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 721 -----~~~~~~-----~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
...... ....+++.+.++|.+||+.+|++||++.++ +.++||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el------l~~~~~~~~~~ 296 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA------LAHPYLAPYHD 296 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCCccccccC
Confidence 000001 113567899999999999999999999999 67888864443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=313.18 Aligned_cols=255 Identities=26% Similarity=0.351 Sum_probs=205.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 575 (783)
..++|.+.+.||+|+||.||++.+. .++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4578999999999999999999875 456799999876544444456788899999999999999999987543
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
...|++++++ +++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478888888 77999888643 4889999999999999999999998 99999999999999999999999999875
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 723 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 723 (783)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 4332 223467899999999876 5678899999999999999999999976655443322211000
Q ss_pred ----------ccc--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 724 ----------RLE--------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 724 ----------~~~--------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
... .....++++.+||.+||+.||.+||++.++ +.|+||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~------l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA------LAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH------hcChhhhhc
Confidence 000 112357889999999999999999999999 678999743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.30 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=202.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-CCce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 578 (783)
..|+++++||+|+||.||+|.... +..+|||.|+............-+|+.+++.|+||||+.+..+|-. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 578999999999999999996432 2369999998774333444567789999999999999999999876 7889
Q ss_pred EEEEEecCCCCHHHHHhhcC----CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC----CcEEEEec
Q 003963 579 CIVTEFLPRGSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDF 650 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~----~~vkL~DF 650 (783)
++++||.+. +|+.++..++ ..++...+..|+.||+.|++|||++. |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999977 9999986432 34888899999999999999999999 9999999999999876 99999999
Q ss_pred CCCcccccccc---cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCh-------H--HHHHH
Q 003963 651 GLSRLKHETYL---TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS-------M--QVIGA 717 (783)
Q Consensus 651 Gla~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~-------~--~~~~~ 717 (783)
|+++.+..... .....+-|..|+|||.+.|.. |+.+.|||++|||+.||+|-.+.|..... . ..+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998776532 222345688999999998865 78999999999999999998887743211 1 11111
Q ss_pred hhccccc---------ccCC--------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 718 VGFMNQR---------LEIP--------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 718 i~~~~~~---------~~~~--------------------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
|-...+. ..+| ..-++...+|+.+||+.||.+|.|+.+.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA------ 334 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA------ 334 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH------
Confidence 1000000 0011 1124457899999999999999999998
Q ss_pred HHHHHhhcC
Q 003963 763 LQRQYFQAS 771 (783)
Q Consensus 763 L~~~~f~~~ 771 (783)
|+|+||...
T Consensus 335 leh~yF~~d 343 (438)
T KOG0666|consen 335 LEHPYFTED 343 (438)
T ss_pred hcccccccC
Confidence 788999654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=297.90 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=209.2
Q ss_pred eeE-eeeeccCCcEEEEEEEE-eCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEEE
Q 003963 507 LTI-GEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 507 y~i-~~~LG~G~fG~Vy~a~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 583 (783)
|++ .+.||+|+|+.|--++. +.+.+||||++.+.. .....++.+|++++.+.+ |+||++++++|+++...|||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 443 46799999999999875 456789999998763 344567889999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC---CcEEEEecCCCccccc--
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHE-- 658 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~-- 658 (783)
-|.||+|..+++++ ..+++..+..+..+|+.||.|||.+| |.||||||+|||.... .-||||||.+..-...
T Consensus 157 Km~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred cccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999999999874 45999999999999999999999999 9999999999999654 4589999988653221
Q ss_pred -----ccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---------------HH
Q 003963 659 -----TYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNS---------------MQ 713 (783)
Q Consensus 659 -----~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~---------------~~ 713 (783)
......+.+|+..|||||+.. ...|+.+.|.||||+|||-||.|.+||.+.-. ..
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 122334668999999999853 34578999999999999999999999964421 33
Q ss_pred HHHHhhcccccccCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 714 VIGAVGFMNQRLEIPK----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 714 ~~~~i~~~~~~~~~~~----~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+++.|+ .+.+++|. .++.+.+++|..+|.+|+.+|.++.++ ++|||++.....
T Consensus 314 LFesIQ--EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~v------lnhPw~~~~~~e 370 (463)
T KOG0607|consen 314 LFESIQ--EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQV------LNHPWVQRCAPE 370 (463)
T ss_pred HHHHHh--ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhc------cCCccccccchh
Confidence 444553 34556664 478899999999999999999999998 788999776554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=314.09 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=202.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 575 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 575 (783)
..+|.+.+.||.|+||.||+|.+.. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3689999999999999999999865 56899999866543 3346678899999999999999999876543
Q ss_pred -------CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEE
Q 003963 576 -------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKV 647 (783)
Q Consensus 576 -------~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL 647 (783)
..+|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 589888864 35889999999999999999999998 999999999999974 567899
Q ss_pred EecCCCcccccccc---cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-
Q 003963 648 GDFGLSRLKHETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN- 722 (783)
Q Consensus 648 ~DFGla~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~- 722 (783)
+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999875533211 1122357889999998754 557889999999999999999999998766544332211000
Q ss_pred ----------------------cc-----ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 723 ----------------------QR-----LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 723 ----------------------~~-----~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.. ......++.++.+||.+||..||.+||++.++ +.|+||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el------l~h~~~~~ 305 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA------LMHPYMSC 305 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH------hCCCcccc
Confidence 00 01123578899999999999999999999999 67899974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=297.65 Aligned_cols=257 Identities=27% Similarity=0.380 Sum_probs=204.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHH-HhCCCCceeeEeceeecC
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~ 575 (783)
-.++...++.+-+..||.|+||+|+|..++. ++..|||.++......+ .+++..|.+.. +.-+.||||+|||++..+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 3455556677778899999999999998865 46799999987765443 45677777754 445689999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhh----cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
+..||+||+| ..+|..+... ....+++..+-+|....+.||.||... .+||||||||+|||++..|.|||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeeccc
Confidence 9999999999 4577666532 345689999999999999999999764 349999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccc-cccC
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQ-RLEI 727 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~-~~~~ 727 (783)
++-....+...+ ...|...|||||.+.. ..|+.++|+||||++|||+.||..||...+.. +.+..+..... .+..
T Consensus 214 IcGqLv~SiAkT-~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 214 ICGQLVDSIAKT-VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred chHhHHHHHHhh-hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 987766654433 4478899999999864 34789999999999999999999999988652 33333322221 1122
Q ss_pred CC---CCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003963 728 PK---DVDPRWAAIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 728 ~~---~~s~~l~~LI~~cL~~dP~~RPsa~ell~ 758 (783)
+. .++..+..||..||.+|-..||.+.++++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22 37889999999999999999999999943
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=335.88 Aligned_cols=148 Identities=28% Similarity=0.450 Sum_probs=133.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|.+.++||+|+||.||+|.+.. ++.||||++..... .......+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4789999999999999999999874 57899999976543 345567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
|||+.+++|.+++... ..+++..++.++.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 35888999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.64 Aligned_cols=256 Identities=24% Similarity=0.311 Sum_probs=201.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeec----CCc
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS----PQR 577 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~ 577 (783)
+|++.+.||+|+||.||++.+.. +..||||++..........+.+.+|+.+++.+ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 48899999999999999999764 45799999875433333456778899999999 59999999987543 245
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|++|+|+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999995 689998865 346899999999999999999999998 9999999999999999999999999987544
Q ss_pred cccc----cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-----------
Q 003963 658 ETYL----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM----------- 721 (783)
Q Consensus 658 ~~~~----~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~----------- 721 (783)
.... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1123468999999998765 56789999999999999999999999876543322211100
Q ss_pred -------------c--c---cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 722 -------------N--Q---RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 722 -------------~--~---~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
. . .......++..+.+||.+||+.||.+||++.++ +.++||..-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l------l~~~~~~~~ 298 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA------LEHPYLAIW 298 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH------hcChhhhhh
Confidence 0 0 001123467899999999999999999999999 677888533
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.14 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=201.2
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEEEe
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
|++.+.||.|+||.||+|.... ++.|+||.+........ .....+|+..++.++ ||||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 6788999999999999999865 56799999865543222 223456899999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 585 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
+ +++|.+++.... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-Y 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-c
Confidence 9 779999887643 46899999999999999999999998 99999999999999999999999999876543321 2
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 003963 664 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------ 724 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 724 (783)
....++..|+|||++.+ ..++.++|+||||+++|+|++|++||...........+......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 23457889999998754 45789999999999999999999999776654433222110000
Q ss_pred ----------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 ----------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.......+..+.+||.+||+.+|.+||++.++ +.++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei------~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA------LQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH------hhCCCC
Confidence 00112236789999999999999999999999 555665
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=321.36 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=216.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeec-----CC
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS-----PQ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-----~~ 576 (783)
.+-|++.+.||.|.+|.||++..+. ++..|+|++......+ .++..|.++|+.+. |||++.+|++|.. ++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3568899999999999999999755 4678999876554322 45667888998874 9999999999853 56
Q ss_pred ceEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+|||||||.||+.-++++. .+.++.+..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||+|||.+..
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 79999999999999999864 3567899999999999999999999988 99999999999999999999999999988
Q ss_pred cccccccccCCCCCCcccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCC
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNE-----PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPK 729 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 729 (783)
....-....+.+|||.|||||++... .|+.++|+||||++-.||.-|.+|+.++.+...+..+..-. ..+.-|.
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchh
Confidence 88777777889999999999998643 35778999999999999999999999998887665553222 1233467
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.++.++.+||..||.+|..+||+..++ |+|+|.+
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~l------l~hpFi~ 286 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEEL------LKHPFIT 286 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhh------ccCCccc
Confidence 788999999999999999999999999 5566543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=288.69 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=205.1
Q ss_pred cccceeEe-eeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeec----C
Q 003963 503 LWEDLTIG-EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS----P 575 (783)
Q Consensus 503 ~~~~y~i~-~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~ 575 (783)
+.++|.+. ++||-|-.|.|..+.++.+ +++|+|++... ...++|+++.-.. .|||||.++++|+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 45778775 5789999999999998764 67999997543 3567888876555 59999999999864 3
Q ss_pred CceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 651 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 651 (783)
..+.+|||.|+||.|+..++.++ ..+++..+..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccc
Confidence 45789999999999999997644 46999999999999999999999999 999999999999964 5679999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHhhcccccccC
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM----QVIGAVGFMNQRLEI 727 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~ 727 (783)
+|+..... ....+.+.||.|.|||++....|+...|+||||+++|-||+|.+||...... .....|. ...+.+
T Consensus 210 FAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~--~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR--TGQYEF 286 (400)
T ss_pred cccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh--ccCccC
Confidence 99865543 3455778899999999999999999999999999999999999999755432 2223332 233444
Q ss_pred C----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 728 P----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 728 ~----~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
| ..+|...+++|+.+|..+|++|.|+.++ +.|+|...
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~------m~hpwi~~ 327 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV------MDHPWINQ 327 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHh------hcCchhcc
Confidence 4 3467889999999999999999999999 66788644
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=319.39 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=203.2
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------ceE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------RLC 579 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~ 579 (783)
|...+.||+|+||.||+++++. ++.||||.+..... ..-.+...+|+++|++|+|||||+++++-+... ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4556789999999999999754 57799999987553 233466788999999999999999999876544 468
Q ss_pred EEEEecCCCCHHHHHhh--cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc--CCC--cEEEEecCCC
Q 003963 580 IVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHW--TVKVGDFGLS 653 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~--~~~--~vkL~DFGla 653 (783)
+|||||.||+|+..|.+ +...+++...+.++.+++.||.|||++| ||||||||.||++- .+| ..||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999975 4456999999999999999999999999 99999999999984 223 4799999999
Q ss_pred cccccccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhh---------
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ----VIGAVG--------- 719 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~----~~~~i~--------- 719 (783)
+-..+.. ...+.+||+.|++||++. ...|+..+|.|||||++|++.||..||....... ....+.
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9877665 455779999999999998 5889999999999999999999999996544332 221111
Q ss_pred ----ccc------ccccCCCCCCHHH----HHHHHHhhhhCCCCCC--CHHHHHHHHHHHHHH
Q 003963 720 ----FMN------QRLEIPKDVDPRW----AAIVESCWHSDPQCRP--SFQELVDKLRDLQRQ 766 (783)
Q Consensus 720 ----~~~------~~~~~~~~~s~~l----~~LI~~cL~~dP~~RP--sa~ell~~L~~L~~~ 766 (783)
..+ ..+++|..+++.+ ...+..+|..+|.+|. .+.+....+..+.+.
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 011 1233444555544 4567778899999999 888888777766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.76 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=204.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
..+.|++...+|.|+|+.|-.+.+.. ++..++|++.+.... ..+|+.++... +||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 35788898999999999999998765 467999999876322 12466555544 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE-cCCCcEEEEecCCCcccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-DKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl-~~~~~vkL~DFGla~~~~~~ 659 (783)
|||++.|+-|.+.+.... .....+..|+++|+.|+.|||.+| ||||||||+|||+ +..++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998888876544 333777789999999999999988 9999999999999 68899999999999876655
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
..+.+-|..|.|||++....++++.||||||++||+||+|+.||...... +....+ ...++...+|..+++|
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDL 542 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHH
Confidence 34556789999999999999999999999999999999999999877665 332222 3344458899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
|.+||+.||.+||++.++ ..|+||
T Consensus 543 l~~LL~~dP~~Rl~~~~i------~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEI------GAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhh------ccCcch
Confidence 999999999999999999 567887
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.76 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=209.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEeccc-----CCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-----YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS- 574 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 574 (783)
.+.++|-++.+||+|+|+.||++.+... +-||+|+-.... ......+...+|.+|.+.|.||-||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3457899999999999999999998665 458888754322 123455667899999999999999999999975
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc---CCCcEEEEecC
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFG 651 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFG 651 (783)
.+.+|-|+|||+|.+|.-+|+.++ .+++..+..|+.||+.||.||.+...+|||-||||.|||+- ..|.+||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 456899999999999999998754 58999999999999999999999999999999999999994 45889999999
Q ss_pred CCccccccccc-------ccCCCCCCcccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhh
Q 003963 652 LSRLKHETYLT-------TKTGKGTPQWMAPEVLRNE----PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVG 719 (783)
Q Consensus 652 la~~~~~~~~~-------~~~~~Gt~~Y~aPE~~~~~----~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~ 719 (783)
+++.+...... +..+.||..|++||++.-. ..+.++||||+|+|+|.++.|+.||...-.. +++....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99976543222 2345799999999987532 3588999999999999999999999754333 3332221
Q ss_pred ccc---ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 720 FMN---QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 720 ~~~---~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.++ -.++..+.++.+.++||++||...-+.|....+| ..++||
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL------A~dpyl 744 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL------ACDPYL 744 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH------ccCccc
Confidence 111 2334446789999999999999999999998888 456776
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=330.39 Aligned_cols=247 Identities=30% Similarity=0.493 Sum_probs=191.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee----------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV---------- 572 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~---------- 572 (783)
..+|+.++.||+||||.||+++++ +++.||||++.... +......+.+|+.+|.+|+|||||+||..|
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 357888899999999999999975 57889999998776 667778899999999999999999998320
Q ss_pred --------------------------------------------------e------c----------------------
Q 003963 573 --------------------------------------------------T------S---------------------- 574 (783)
Q Consensus 573 --------------------------------------------------~------~---------------------- 574 (783)
. .
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0
Q ss_pred -------------------------------CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC
Q 003963 575 -------------------------------PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623 (783)
Q Consensus 575 -------------------------------~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 623 (783)
...+||-||||+...|.+++.++...-.....|+++++|++||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0126899999999888888876542225778899999999999999999
Q ss_pred CCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc---c---------------ccccccCCCCCCcccCcccccCCC---
Q 003963 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---E---------------TYLTTKTGKGTPQWMAPEVLRNEP--- 682 (783)
Q Consensus 624 ~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~---~---------------~~~~~~~~~Gt~~Y~aPE~~~~~~--- 682 (783)
| ||||||||.||+++.++.|||+|||+++... . ........+||..|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999997511 0 001223457999999999998755
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhcccccccCC----CCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 683 SDEKSDVYSFGVILWELATEKIPWD-NLNSMQVIGAVGFMNQRLEIP----KDVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 683 ~s~~sDIwSLG~il~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~----~~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
|+.|+||||||+||+||+. ||. .+.....+..+. ...++.+ ..--+.-+.+|++||+.||.+||||.++|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 8999999999999999984 453 223333333332 1122222 11224568899999999999999999996
Q ss_pred H
Q 003963 758 D 758 (783)
Q Consensus 758 ~ 758 (783)
.
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 3
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.61 Aligned_cols=258 Identities=19% Similarity=0.294 Sum_probs=209.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
...|..++.||-|+||.|.++...+. ..||+|.+.+... ...++...+.|-.||.....+-||+||..|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34688999999999999999986554 4599999877653 446677788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc------
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------ 655 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~------ 655 (783)
|+|++||++-.+|-+.+ .+++..+.+++.++..|+++.|..| +|||||||+|||||.+|+|||+|||++.-
T Consensus 708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999987644 5899999999999999999999999 99999999999999999999999999751
Q ss_pred ---ccccc---------------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHH
Q 003963 656 ---KHETY---------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 699 (783)
Q Consensus 656 ---~~~~~---------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~el 699 (783)
+.... ......+||+.|+|||++....++...|+||.|+|||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 11000 001123599999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHhhccccc--ccCCCCCCHHHHHHHHHhhhhCCCCCC---CHHHHHHHHHHHHHHHhhcC
Q 003963 700 ATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAAIVESCWHSDPQCRP---SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 700 ltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~~LI~~cL~~dP~~RP---sa~ell~~L~~L~~~~f~~~ 771 (783)
+.|++||-...+.+....+...... +....++++++.+||.++. .+++.|. .+++| -.|+||+.|
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~v------KaHpfFkgI 934 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQV------KAHPFFKGI 934 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhh------hcCcccccc
Confidence 9999999877665544343322223 3344679999999998854 4456664 44445 357888665
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=288.51 Aligned_cols=228 Identities=19% Similarity=0.241 Sum_probs=187.6
Q ss_pred CCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCHHHHH
Q 003963 516 GSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 594 (783)
Q Consensus 516 G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L 594 (783)
|.||.||++.+.. ++.||+|++.... .+.+|...+....||||+++++++......+++|||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 8999999999865 4679999986643 1233555555667999999999999999999999999999999998
Q ss_pred hhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccC
Q 003963 595 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674 (783)
Q Consensus 595 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~a 674 (783)
.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+....... ....++..|+|
T Consensus 77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~a 150 (237)
T cd05576 77 SKFL-NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCA 150 (237)
T ss_pred HHhc-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccC
Confidence 7643 5899999999999999999999998 9999999999999999999999999876544321 23345778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCH-
Q 003963 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSF- 753 (783)
Q Consensus 675 PE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa- 753 (783)
||.+.+..++.++|+|||||++|+|++|..||...... + .......+|..+++.+.+||.+||+.||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 99998888899999999999999999999887643221 0 0112345677789999999999999999999986
Q ss_pred ----HHHHHHHHHHHHHHh
Q 003963 754 ----QELVDKLRDLQRQYF 768 (783)
Q Consensus 754 ----~ell~~L~~L~~~~f 768 (783)
.++ +.|+||
T Consensus 225 ~~~~~~~------~~h~~~ 237 (237)
T cd05576 225 VAGVEDI------KSHPFF 237 (237)
T ss_pred ccchHHH------HcCCCC
Confidence 555 567765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=319.79 Aligned_cols=263 Identities=32% Similarity=0.614 Sum_probs=226.0
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 569 (783)
.||+..++..+.+.||+|.||.|++|..++ ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 678888888999999999999999997531 235899998776655 66788999999999995 99999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+++...+.+++|+||+..|+|..+|+.++ ..++....+.++.||+.||+||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998766 34888999999999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCcccccc-cccccCCCC--CCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 710 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~G--t~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~ 710 (783)
+||||+.+..+||+|||+++..... +.......| ...|||||.+....++.++||||+|++||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999854432 222122222 456999999999999999999999999999999 899999866
Q ss_pred -hHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 711 -SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 711 -~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
...+.. ......+...|..+++++.++++.||+.+|++||++.++.+.|+.+..
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 444443 334566888999999999999999999999999999999999998644
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.61 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=207.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec------
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------ 574 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 574 (783)
.....|+-..+||+|.||.||+|+.+. ++.||+|++-.+......-....+|+.+|..|+|+|++.++++|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 344677888899999999999999765 4568888764433222233456689999999999999999998843
Q ss_pred --CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 575 --PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 575 --~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
...+|+||.+|+. +|..+|.....+++...+..++.+++.||.|+|+.. |+|||+||+|+||+.+|.+||+|||+
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 2348999999976 999999887788999999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccc----ccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--c
Q 003963 653 SRLKHETY----LTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--L 725 (783)
Q Consensus 653 a~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~ 725 (783)
++.+.... ......+-|..|++||.+.|.. ++.+.|||+.||++.||+++.+.+++....+.+..|..+-+. .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97544321 1122345689999999988754 799999999999999999999999988877766554322110 0
Q ss_pred c------------------CC-------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 726 E------------------IP-------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 726 ~------------------~~-------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+ ++ -.-+++..+|+.++|..||.+|++++++ +.|.||..-.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a------lnh~~F~kdp 322 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA------LNHDFFWKDP 322 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh------hchhhhhcCC
Confidence 0 11 0124477899999999999999999999 5677875433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=273.17 Aligned_cols=237 Identities=32% Similarity=0.494 Sum_probs=197.3
Q ss_pred CcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCHHHHHh
Q 003963 517 SCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 595 (783)
Q Consensus 517 ~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~ 595 (783)
+||.||++.+.. ++.+++|++........ ...+.+|++.++.++|+||+++++++......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999875 67899999876544322 5688899999999999999999999999899999999999999999997
Q ss_pred hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCc
Q 003963 596 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675 (783)
Q Consensus 596 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aP 675 (783)
.... ++...++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 6443 888999999999999999999998 9999999999999999999999999987665432 22345678899999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhcccccccCCCC-CCHHHHHHHHHhhhhCCCCCCCH
Q 003963 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDN-LNSMQVIGAVGFMNQRLEIPKD-VDPRWAAIVESCWHSDPQCRPSF 753 (783)
Q Consensus 676 E~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~-~s~~l~~LI~~cL~~dP~~RPsa 753 (783)
|.+.+..++.++|||+||+++|+|++|..||.. .........+............ ++.++.+++.+||..+|.+||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988889999999999999999999999987 4444443333222111111111 88999999999999999999999
Q ss_pred HHHHH
Q 003963 754 QELVD 758 (783)
Q Consensus 754 ~ell~ 758 (783)
.++++
T Consensus 236 ~~~~~ 240 (244)
T smart00220 236 EEALQ 240 (244)
T ss_pred HHHhh
Confidence 99953
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=304.11 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=220.5
Q ss_pred eeEeeeeccCCcEEEEEEEEeCC-----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGS-----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.+..++||+|+||+||+|.+... -+||||++...... +...++..|+-+|..|+|||++++++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 44568899999999999987542 25999998765533 33467889999999999999999999998765 8899
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
++|+++|.|.++++.++..+-.+..+.|..||++||.|||.++ +|||||-.+||||..-.+|||.|||+++.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999999999999999999999999999999988 99999999999999999999999999987654432
Q ss_pred cc--cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 662 TT--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 662 ~~--~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.. ....-.+.|||-|.+....++.++||||+||++||+|| |..||.+....++-..+. ...++..|+.++.++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHHH
Confidence 22 22334678999999999999999999999999999998 999999998877765554 445688899999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+.+||..|+..||+++++...+.++..
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHHhc
Confidence 999999999999999999988877643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=293.66 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=209.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC------CceeeEeceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH------PNVLLFMGAVT 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~ 573 (783)
|.+-.+|.+....|+|-|+.|..|.+.. ++.||||++...... .+.=..|++||+.|+. -++++|+-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 4566799999999999999999999854 468999999765432 2344679999999952 47899999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEec
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDF 650 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DF 650 (783)
..+++|||||-+ ..+|.++|++.+ ..|....+..++.||+.||..|-.+| |+|.||||+||||++. ..+|||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence 999999999999 679999998643 44778899999999999999999999 9999999999999875 56899999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc----
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE---- 726 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 726 (783)
|.|....+...+.. .-+..|+|||++.|.+|++..|+||+||+||||+||+.-|.+....+++.....+.+.++
T Consensus 582 GSA~~~~eneitPY--LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 582 GSASFASENEITPY--LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccccccccccHH--HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 99987766544332 236789999999999999999999999999999999999998887776654322211110
Q ss_pred --------------------------------C----C-----------CCCC-------HHHHHHHHHhhhhCCCCCCC
Q 003963 727 --------------------------------I----P-----------KDVD-------PRWAAIVESCWHSDPQCRPS 752 (783)
Q Consensus 727 --------------------------------~----~-----------~~~s-------~~l~~LI~~cL~~dP~~RPs 752 (783)
+ | ..++ ..|.+||.+||..||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 0 0 0111 25789999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhc
Q 003963 753 FQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 753 a~ell~~L~~L~~~~f~~ 770 (783)
..+. |.|+||+.
T Consensus 740 ~nqA------L~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQA------LKHPFITE 751 (752)
T ss_pred HHHH------hcCCcccC
Confidence 9999 78999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.37 Aligned_cols=256 Identities=33% Similarity=0.553 Sum_probs=203.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhC--CCCceeeEeceeecCC----ce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSPQ----RL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~----~~ 578 (783)
...++.+.||+|.||.||+|...+ +.||||++.. ...+.+..|.+|+... +|+||++|+++-.... .+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 456778899999999999999765 6999999854 3457888899988854 7999999999876544 78
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-------CCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-------NPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
+||++|.+.|+|.++|..+ .++|....+++..|++||+|||+- +++|+|||||..||||.++++..|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999999875 489999999999999999999973 2569999999999999999999999999
Q ss_pred CCccccccc--ccccCCCCCCcccCcccccCCCC-C-----chhHHHHHHHHHHHHHcC------------CCCCC----
Q 003963 652 LSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPS-D-----EKSDVYSFGVILWELATE------------KIPWD---- 707 (783)
Q Consensus 652 la~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~-s-----~~sDIwSLG~il~elltG------------~~Pf~---- 707 (783)
+|..+.... ......+||.+|||||++.|.-. . .+.||||+|.+||||++. .+||+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998765332 22234689999999999987542 2 368999999999999974 12332
Q ss_pred -CCChHHHHHHhhcccccccCCCCC-----CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 708 -NLNSMQVIGAVGFMNQRLEIPKDV-----DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 708 -~~~~~~~~~~i~~~~~~~~~~~~~-----s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.....++-..+...+.++.+|..+ ..-+.+.+..||..|++.|.|+.-+-+++.++.+..-
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 011122223333344566666543 2457899999999999999999999999999988763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=332.25 Aligned_cols=247 Identities=23% Similarity=0.396 Sum_probs=191.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
...|...+.||+|+||.||+|.+. .+..||||++...... ...|+.+++.++|||||++++++......|+||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 345677789999999999999974 4578999988644321 124688999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||+++|+|.+++.. +++..+..++.||+.||+|||.. ..+|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred eCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999999963 78899999999999999999943 2239999999999999998888775 665543221
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhhcc--c------ccccCC---
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFM--N------QRLEIP--- 728 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~~~i~~~--~------~~~~~~--- 728 (783)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......... . ....+.
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 12336789999999999999999999999999999999999998532110 111100000 0 001111
Q ss_pred ---CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 729 ---KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 729 ---~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.....++.+++.+||+.||.+||++.++++.|+++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1112356789999999999999999999999988755
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=275.98 Aligned_cols=263 Identities=27% Similarity=0.452 Sum_probs=221.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
.+...++++.-.+-+|+||+||.|.+.. .+.|.+|.++... ++-++..+..|--+|..+.|||+..+.+++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3445678888899999999999997643 2457777765443 55667788899999999999999999998754
Q ss_pred -CCceEEEEEecCCCCHHHHHhh-------cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEE
Q 003963 575 -PQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 646 (783)
Q Consensus 575 -~~~~~lV~E~~~ggsL~~~L~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vk 646 (783)
....++++.++.-|+|..+|.. ....++..+...++.|++.||+|||+++ |||.||..+|.+|++.-+||
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEE
Confidence 4678999999999999999972 2344677888899999999999999999 99999999999999999999
Q ss_pred EEecCCCccc-cccccccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q 003963 647 VGDFGLSRLK-HETYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ 723 (783)
Q Consensus 647 L~DFGla~~~-~~~~~~~~-~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 723 (783)
|+|-.+++.. +..+.... .......||+||.+.+..++.++|+||||++||||+| |+.||.+.++.++...+. ...
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-dGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-DGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-ccc
Confidence 9999998743 33322211 1223568999999999999999999999999999999 999999999998876664 567
Q ss_pred cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 724 ~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
+...|.++|+++..++..||...|++||++.++...|.++..+.
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 88899999999999999999999999999999999998887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=265.86 Aligned_cols=253 Identities=19% Similarity=0.380 Sum_probs=202.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCC--ceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--RLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~ 579 (783)
.++|++.+++|+|.|+.||.|... ++++++||+++... .+.+.+|+.||+.|. ||||++++++..++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 578999999999999999999864 45789999987654 367899999999997 999999999998764 467
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~ 658 (783)
+|+||++..+...+.. .++...+..++.+++.||.|||+.| |+|||+||.|++|+. ...++|+|+|+|.+.+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998877776654 3677788899999999999999999 999999999999985 45799999999988776
Q ss_pred ccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHhhcccc-----------cc
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPW-DNLNSMQVIGAVGFMNQ-----------RL 725 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf-~~~~~~~~~~~i~~~~~-----------~~ 725 (783)
... ....+.+..|--||.+..-+ +++.-|+|||||+|..|+..+.|| .+.+....+..+....+ .+
T Consensus 186 ~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred Cce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 533 33456688899999987654 799999999999999999999887 33333322222211100 00
Q ss_pred cCC------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 726 EIP------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 726 ~~~------------------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.++ ...++++.+|+.++|..|-.+|+|+.|. +.|+||...+.+
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa------m~HpyF~~~~~~ 331 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA------MAHPYFAPVREA 331 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH------hcCchHHHHHHH
Confidence 000 1246899999999999999999999999 778999766544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=304.80 Aligned_cols=258 Identities=19% Similarity=0.218 Sum_probs=176.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEece-----
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA----- 571 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~----- 571 (783)
...++|.+.++||+|+||.||+|.+.. +..||||++........ ... ..+....+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~--e~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMN--ERVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHH--HHHHhhchhhHHHHHHhhhccc
Confidence 356799999999999999999999865 46799998754321111 111 11222223333333222
Q ss_pred -eecCCceEEEEEecCCCCHHHHHhhcCCcc-------------------hHHHHHHHHHHHHHHHHHHHhCCCCEEecC
Q 003963 572 -VTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------------------DWRRRILMALDIARGVSYLHHCNPPIIHRD 631 (783)
Q Consensus 572 -~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l-------------------~~~~~~~i~~qi~~aL~~LH~~~~~IvHrD 631 (783)
......+++||||+++++|.+++....... ....+..++.||+.||+|||+++ |+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 234567999999999999999987543211 23345678999999999999998 99999
Q ss_pred CCCCCEEEcC-CCcEEEEecCCCcccccc-cccccCCCCCCcccCcccccCCC----------------------CCchh
Q 003963 632 LKSSNLLVDK-HWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAPEVLRNEP----------------------SDEKS 687 (783)
Q Consensus 632 IKp~NILl~~-~~~vkL~DFGla~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~----------------------~s~~s 687 (783)
|||+|||++. ++.+||+|||+++..... .......++++.|+|||.+.... ++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 579999999999754322 12233567899999999764322 23456
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------c--------ccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 688 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------R--------LEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 688 DIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------~--------~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
|||||||+||||+++..|+... .......+..... . ..+....+....+||.+||++||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999987765432 1111111110000 0 001111223456899999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 749 CRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 749 ~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+|||+.++ |+|+||+.....
T Consensus 440 kR~ta~e~------L~Hpff~~~~~~ 459 (566)
T PLN03225 440 QRISAKAA------LAHPYFDREGLL 459 (566)
T ss_pred cCCCHHHH------hCCcCcCCCCcc
Confidence 99999999 789999765543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.70 Aligned_cols=256 Identities=33% Similarity=0.597 Sum_probs=201.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHh--CCCCceeeEeceeecCC---
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ--- 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~--- 576 (783)
.+..+..+.+.||+|.||.||+|.+++. .||||+|.... .....+|.+|++. |+|+||+.|++.-..+.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCC-ceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3457789999999999999999999864 89999997643 1456778999885 59999999998765443
Q ss_pred -ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-----C-CCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 577 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-----N-PPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 577 -~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~-~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
+++||.+|.+.|+|++||.+ ..++....++++..++.||++||.. | +.|.|||||..||||.+++...|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 58999999999999999987 4588999999999999999999963 2 4599999999999999999999999
Q ss_pred cCCCcccccc----cccccCCCCCCcccCcccccCCCC-----C-chhHHHHHHHHHHHHHc----------CCCCCCCC
Q 003963 650 FGLSRLKHET----YLTTKTGKGTPQWMAPEVLRNEPS-----D-EKSDVYSFGVILWELAT----------EKIPWDNL 709 (783)
Q Consensus 650 FGla~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~-----s-~~sDIwSLG~il~ellt----------G~~Pf~~~ 709 (783)
+|+|...... .......+||.+|||||++...-. + ..+||||||.++||++. -.+||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999754433 223446689999999999864321 2 36999999999999986 26788654
Q ss_pred Ch-----HHHHHHhhcccccccCCCCCC--H---HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 710 NS-----MQVIGAVGFMNQRLEIPKDVD--P---RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 710 ~~-----~~~~~~i~~~~~~~~~~~~~s--~---~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
-+ .+....+.....++.+|..+. + .+..|++.||..+|.-|.|+-.+.+.|.++..
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 32 222222333334555555443 2 46778999999999999999999888887753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=295.54 Aligned_cols=260 Identities=19% Similarity=0.238 Sum_probs=188.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEE-----------------eCCceEEEEEEecccCCH--H----------HHHHHHHH
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVW-----------------YGSQDVAVKVFSRQEYSD--E----------VIHSFRQE 553 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-----------------~~~~~vAiK~i~~~~~~~--~----------~~~~~~~E 553 (783)
..++|.+.++||+|+||.||+|.+ ..++.||||.+....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999964 123469999986432110 0 11233446
Q ss_pred HHHHHhCCCCce-----eeEeceeec--------CCceEEEEEecCCCCHHHHHhhcC----------------------
Q 003963 554 VSLMKRLRHPNV-----LLFMGAVTS--------PQRLCIVTEFLPRGSLFRLLQRNT---------------------- 598 (783)
Q Consensus 554 i~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~L~~~~---------------------- 598 (783)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 677777653 346899999999999999986421
Q ss_pred -CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-cccCCCCCCcccCcc
Q 003963 599 -TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TTKTGKGTPQWMAPE 676 (783)
Q Consensus 599 -~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~Gt~~Y~aPE 676 (783)
..+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ ......+++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12356678889999999999999998 99999999999999999999999999865433211 122234589999999
Q ss_pred cccCCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCCCCChHHHH-----------HHhhccc
Q 003963 677 VLRNEPS----------------------DEKSDVYSFGVILWELATEKI-PWDNLNSMQVI-----------GAVGFMN 722 (783)
Q Consensus 677 ~~~~~~~----------------------s~~sDIwSLG~il~elltG~~-Pf~~~~~~~~~-----------~~i~~~~ 722 (783)
.+..... ..+.||||+||++|+|++|.+ ||......... ..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8754321 124699999999999999976 77543222111 0111112
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCC---CCCCCHHHHHHHHHHHHHHHhhc
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDP---QCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP---~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
..+......++...+||.+||..+| .+|+|+.++ |.|+||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea------L~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQA------LSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHH------hCCCCcCC
Confidence 2233445678999999999999876 689999999 78999954
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.36 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=193.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-----C---CceeeEeceeec
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----H---PNVLLFMGAVTS 574 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~ 574 (783)
..+|.+.++||-|-|++||++++..+ +.||+|+++... ...+....||.+|+.++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 47999999999999999999998654 679999987543 34456778999999984 2 479999999964
Q ss_pred ----CCceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-------
Q 003963 575 ----PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------- 642 (783)
Q Consensus 575 ----~~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~------- 642 (783)
..++|||+|++ |.+|..+|... ...++...++.|++||+.||.|||..- +|||.||||+|||+-.+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeeeccccchhhh
Confidence 45799999999 77999988753 455899999999999999999999642 39999999999998200
Q ss_pred --------------------------------------------------------------------------------
Q 003963 643 -------------------------------------------------------------------------------- 642 (783)
Q Consensus 643 -------------------------------------------------------------------------------- 642 (783)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 003963 643 -------------------------------------------------------------------------------W 643 (783)
Q Consensus 643 -------------------------------------------------------------------------------~ 643 (783)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HH---
Q 003963 644 TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-------MQ--- 713 (783)
Q Consensus 644 ~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-------~~--- 713 (783)
+|||+|||.|++....+. ....|..|+|||++.|..|+..+||||++|++|||+||.+.|+.... ..
T Consensus 392 ~vKIaDlGNACW~~khFT---~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKHFT---EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred eEEEeeccchhhhhhhhc---hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 245666666665444321 12358899999999999999999999999999999999999964322 11
Q ss_pred HHHHhhccc---------------c--------c-------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 714 VIGAVGFMN---------------Q--------R-------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 714 ~~~~i~~~~---------------~--------~-------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
+++.+..+. . + +.++..-..++.+||.-||+.+|++||||.++
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c- 547 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC- 547 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH-
Confidence 111111000 0 0 01111112368899999999999999999999
Q ss_pred HHHHHHHHHHhhcCc
Q 003963 758 DKLRDLQRQYFQASR 772 (783)
Q Consensus 758 ~~L~~L~~~~f~~~~ 772 (783)
|+|+|++...
T Consensus 548 -----l~hPwLn~~~ 557 (590)
T KOG1290|consen 548 -----LKHPWLNPVA 557 (590)
T ss_pred -----hcCccccCCC
Confidence 7899997543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=253.36 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=175.9
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCc
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 577 (783)
+++..++...+..||+|+||.|-+.++..+ .-.|+|.+...-. ....+++.+|+.+..+. ..|++|.|||.+.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 455566777788999999999999988654 5689998866543 33445677788876655 68999999999999999
Q ss_pred eEEEEEecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 578 LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
++|+||.| ..+|..+.. ..+..+++..+-+|+..+++||.|||++ ..|||||+||.||||+.+|+||+||||++-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999 458877764 3566799999999999999999999986 359999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHh
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRN----EPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAV 718 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~~sDIwSLG~il~elltG~~Pf~~~-~~~~~~~~i 718 (783)
...++...+ ...|...|||||.+.. ..|+.++||||||++++||.+++.||... .+.+.+..+
T Consensus 198 ~L~dSiAkt-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 198 YLVDSIAKT-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred eehhhhHHH-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 776654332 2457888999999864 35788999999999999999999999866 455555554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-31 Score=268.25 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=200.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----ceE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 579 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 579 (783)
+.+-.+.||.|+||+||.+.+. +++.|++|++.....+-...+.+.+|+.+|.-++|.|++..+++..-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556689999999999999984 4678999998776655566678889999999999999999988876543 368
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++.|+| ..+|.+++-. ...++...++-+.+||++||.|||+.+ |.||||||.|+||+.+..+||||||+++.....
T Consensus 134 V~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchh
Confidence 899999 4588888865 567999999999999999999999999 999999999999999999999999999865433
Q ss_pred ccccc-CCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q 003963 660 YLTTK-TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------------ 725 (783)
Q Consensus 660 ~~~~~-~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 725 (783)
..... ..+-|-.|+|||+++|.. |+.+.||||+||++.|++-.+..|...++.+.+..+..+.+.+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 22111 123478899999999865 7999999999999999999999999888877665543222111
Q ss_pred ---------cCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003963 726 ---------EIP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 726 ---------~~~-----------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~ 759 (783)
+.| ..-..+...++..+|..||.+|.+..+.+.+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 111 1122367888999999999999998888543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=262.64 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=202.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 576 (783)
..+|.-++.+|.|.- .|..+.+. .+++||+|++..........++..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 67777653 4578999998776444444567889999999999999999999987543
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+||||| ..+|...+. ..++..++..+..|++.|+.|||+.+ |+||||||+||+|..++.+||+|||+++..
T Consensus 95 e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhccc
Confidence 479999999 559988886 34788899999999999999999999 999999999999999999999999999877
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------ 724 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------ 724 (783)
..... ....+.|..|+|||++.+..+...+||||+||++.||++|..-|.+.+.......+....+.
T Consensus 169 ~~~~~-mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTDFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred Ccccc-cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 66533 33456799999999999999999999999999999999999999766543322211000000
Q ss_pred -------------cc----CCC-----------CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 725 -------------LE----IPK-----------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 725 -------------~~----~~~-----------~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.. +|. .-...+++++.+||..+|++|.+++++ |+|||++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da------L~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA------LRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH------hcCCeee
Confidence 00 110 112357899999999999999999999 7899997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=287.35 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=217.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
...++|+++..||.|+||.||+++++.+ +..|+|+++.....+ ..-+.+|+-+++..+|||||.+++.+-..+.+++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3457899999999999999999998654 668999998765432 4567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
+||||.||+|.++..- ..++++.++.+++++.++||+|||+.| =+|||||-.|||+++.|.|||+|||.+..+....
T Consensus 90 cMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999999998765 457999999999999999999999998 7999999999999999999999999998877777
Q ss_pred ccccCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---cccCCCCCCHH
Q 003963 661 LTTKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---RLEIPKDVDPR 734 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~---~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~s~~ 734 (783)
.....+.||+.|||||+- +...|....|||++|++-.|+-.-++|.-+..+.+.+........ ..+-+..+++-
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 777788999999999985 345678899999999999999999999877777776655543332 23344568899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell 757 (783)
+.+|++.||.++|++||++..+|
T Consensus 247 fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhe
Confidence 99999999999999999998885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=290.75 Aligned_cols=243 Identities=29% Similarity=0.455 Sum_probs=188.8
Q ss_pred EeeeeccCCcEE-EEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEEEecC
Q 003963 509 IGEQIGQGSCGT-VYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 509 i~~~LG~G~fG~-Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
-.+.+|.|+.|+ ||+|... +++||||.+-. +....+.+|+.+|+.-+ |||||++|+.-.++..+||++|.|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 345678988775 5778754 56999997643 33456778999999885 999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchH---HHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---C--CcEEEEecCCCccccc
Q 003963 587 RGSLFRLLQRNTTKLDW---RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---H--WTVKVGDFGLSRLKHE 658 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~---~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~--~~vkL~DFGla~~~~~ 658 (783)
..+|.+++......... ...+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++....
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 45999999864111111 344678889999999999999 999999999999975 2 4689999999987653
Q ss_pred c---cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcccc-cccCCCCCCH
Q 003963 659 T---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDP 733 (783)
Q Consensus 659 ~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~ 733 (783)
. ........||..|+|||++.....+.++|||||||++|+.++| ..||.+.-..+. +|...+. ...+......
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchH
Confidence 3 2233456799999999999999888999999999999999996 999976543322 2211111 1122222333
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
++.+||.+|+.++|..||++.++ |.||||
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~V------L~HPlF 770 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDV------LNHPLF 770 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHH------hCCCcc
Confidence 89999999999999999999999 667777
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=250.54 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=216.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE-eCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 579 (783)
+..-.|+|+++||+|+||+++.|.. ..+++||||.-...... -++..|.+.++.|. .++|...|-+..+..+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3445799999999999999999985 56789999986544322 35667889999885 699999999989888999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-----CCcEEEEecCCCc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 654 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-----~~~vkL~DFGla~ 654 (783)
||||++ |.+|.+++.-++.+++.+++..++.|++.-++|+|+++ +|+|||||+|+||.. ...|.|+|||+++
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999999 88999999999999999999999999999999999998 999999999999964 3469999999998
Q ss_pred cccc-------ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhccccc
Q 003963 655 LKHE-------TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---VIGAVGFMNQR 724 (783)
Q Consensus 655 ~~~~-------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~---~~~~i~~~~~~ 724 (783)
.+.+ ++....+..||.+||+-....|...+.+.|+-|||-|++++|-|.+||+++.... .++.|......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 6543 3455666789999999999999999999999999999999999999999876543 33444322221
Q ss_pred ---ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 725 ---LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 725 ---~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
..+...+|.++..-+...-..+-.+-|.++-+...|.++.+.
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 224466889999999999999999999999998888877654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=241.62 Aligned_cols=211 Identities=39% Similarity=0.643 Sum_probs=185.4
Q ss_pred eccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCHH
Q 003963 513 IGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 591 (783)
Q Consensus 513 LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 591 (783)
||.|.+|.||++.... ++++++|++....... ....+.+|+..++.+.|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999865 6789999987665432 3467889999999999999999999999999999999999989999
Q ss_pred HHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCcccccccccccCCCCCC
Q 003963 592 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTP 670 (783)
Q Consensus 592 ~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 670 (783)
+++......++...++.++.+++.+|++||+.+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999865456889999999999999999999998 999999999999999 89999999999876654432233445788
Q ss_pred cccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCC
Q 003963 671 QWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749 (783)
Q Consensus 671 ~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~ 749 (783)
.|++||.+... ..+.+.|+|+||+++++| ..+.+++..||..+|.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 788999999999999999 67889999999999999
Q ss_pred CCCHHHHHHH
Q 003963 750 RPSFQELVDK 759 (783)
Q Consensus 750 RPsa~ell~~ 759 (783)
||++.++++.
T Consensus 205 R~~~~~l~~~ 214 (215)
T cd00180 205 RPSAKEILEH 214 (215)
T ss_pred CcCHHHHhhC
Confidence 9999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=273.35 Aligned_cols=200 Identities=25% Similarity=0.418 Sum_probs=174.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHH-H-----HHHHHHHHHHHHhCC---CCceeeEeceee
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE-V-----IHSFRQEVSLMKRLR---HPNVLLFMGAVT 573 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~-~-----~~~~~~Ei~il~~l~---HpnIv~l~~~~~ 573 (783)
+.+|..++++|.|+||.|++|.++.+ ..|+||.+.+++.-.+ + +-.+-.|++||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 56799999999999999999998765 5699999887654211 1 123556999999997 999999999999
Q ss_pred cCCceEEEEEec-CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 574 SPQRLCIVTEFL-PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 574 ~~~~~~lV~E~~-~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
+++++||+||.. +|.+|++++..+ ..+++..+..|++|++.|+++||+.| |||||||-+||.|+.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 999999999976 456999999864 45999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDN 708 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~ 708 (783)
+.+..... ...++||..|.|||++.|..| +..-|||+||++||-++....||.+
T Consensus 717 aa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 87665543 346789999999999999887 6778999999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=236.20 Aligned_cols=199 Identities=36% Similarity=0.614 Sum_probs=172.9
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
|.+.+.||.|++|.||++.+.. ++.+++|.+...... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5678999999999999999876 678999998765433 24578889999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc-cccc
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTK 664 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 664 (783)
++++|.+++......+++..++.++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999765433788999999999999999999998 9999999999999999999999999987665432 1122
Q ss_pred CCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 003963 665 TGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDN 708 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~-~~~~~s~~sDIwSLG~il~elltG~~Pf~~ 708 (783)
...++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34578889999998 666778899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-28 Score=240.76 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=188.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEec-eeecCCceEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG-AVTSPQRLCI 580 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~-~~~~~~~~~l 580 (783)
.+.|.|.+.||+|.||.+-++.++++ ..+++|.+...... .+.|.+|..---.| .|.||+.-|+ .|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 46799999999999999999999875 57999998776543 35677777654455 4899998776 5777889999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc--CCCcEEEEecCCCccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~--~~~~vkL~DFGla~~~~~ 658 (783)
++||++.|+|..-+...+ +-+.....++.|+++|+.|+|+.+ +||||||.+||||- +..+|||||||+.+..+.
T Consensus 100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999999887544 778888999999999999999999 99999999999994 345899999999876554
Q ss_pred ccccccCCCCCCcccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhhcccc-cccCC--
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFMNQ-RLEIP-- 728 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~~~i~~~~~-~~~~~-- 728 (783)
.-. ....+..|.+||+..... ..+.+|||.||+++|.+|||.+||+..... .+.....+... .+..|
T Consensus 176 tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 176 TVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred eeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 322 222367799999865332 267899999999999999999999744221 12222222221 22333
Q ss_pred -CCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003963 729 -KDVDPRWAAIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 729 -~~~s~~l~~LI~~cL~~dP~~RPsa~ell~ 758 (783)
..+++.+..+.++-|.+++++|.-..+..+
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 457889999999999999999955444443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=250.18 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=196.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 575 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 575 (783)
..+.+.|.+.++||.|.|++||++.+.. .+.||+|.+...... .++..|+++|..+. +.||+++.+++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3456789999999999999999998654 456999998765543 35778999999995 89999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 654 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~ 654 (783)
+.+++||||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||.|||.+. .+.-.|+|||++.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 999999999999998888864 668889999999999999999999 999999999999985 4678999999986
Q ss_pred cccc---------------cc--------------------c---------cccCCCCCCcccCcccccCCC-CCchhHH
Q 003963 655 LKHE---------------TY--------------------L---------TTKTGKGTPQWMAPEVLRNEP-SDEKSDV 689 (783)
Q Consensus 655 ~~~~---------------~~--------------------~---------~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDI 689 (783)
.... .. . ......||+.|+|||++...+ .+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 1000 00 0 001124999999999987655 5889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCh-HHHHH------------Hhhccccc---------------------c----------
Q 003963 690 YSFGVILWELATEKIPWDNLNS-MQVIG------------AVGFMNQR---------------------L---------- 725 (783)
Q Consensus 690 wSLG~il~elltG~~Pf~~~~~-~~~~~------------~i~~~~~~---------------------~---------- 725 (783)
||.|++++.++++++||-.... ...+. ......+. .
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999832211 11000 00000000 0
Q ss_pred ------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 726 ------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 726 ------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
......+..+.+|+.+||..||.+|.|+++. |+|+||.
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeA------LkHpFF~ 385 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDA------LKHPFFD 385 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHH------hcCcCCc
Confidence 0001234578999999999999999999999 7889985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=221.64 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=212.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 578 (783)
.+....|.++++||+|+||.+|.+.... +.+||||+-+.....+ .+..|..++..|++ ..|..+..++.+..+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 4567899999999999999999998754 5789999976554332 45678999999975 6788888888888899
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecCCCcc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRL 655 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~ 655 (783)
.+||+++ |.+|.+++.-+...++..+++-++-|++.-++|+|.++ +|||||||+|+|+.- ...+.|+|||+|+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999 88999999888888999999999999999999999998 999999999999963 34699999999986
Q ss_pred ccc-------ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhcccc--
Q 003963 656 KHE-------TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---VIGAVGFMNQ-- 723 (783)
Q Consensus 656 ~~~-------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~---~~~~i~~~~~-- 723 (783)
+.+ ++.......||.+|.+-....+...+.+.|+-|+|++|.++.-|.+||++..... .++.|....-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 543 3344455679999999999999999999999999999999999999999886543 3333322111
Q ss_pred -cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 724 -RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 724 -~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.-.+...+|.++.-.+..|-..--++-|.+.-+-+.++-|..
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 112446788999999999999999999999888777665533
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=239.75 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=203.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCC--ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC----CceeeEecee-ecCCce
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGS--QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----PNVLLFMGAV-TSPQRL 578 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~ 578 (783)
+|++.++||+|+||.||+|.+... ..+|+|+......... ..+..|+.++..+.. .++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 899999999999999999998664 4789998766432221 146678888888863 6889999988 577889
Q ss_pred EEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-----CcEEEEecCC
Q 003963 579 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-----WTVKVGDFGL 652 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-----~~vkL~DFGl 652 (783)
||||+.+ |.+|.++..... ..++..+++.++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999999 889999986555 77999999999999999999999999 9999999999999865 4699999999
Q ss_pred Cc--cccccc-------cc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 003963 653 SR--LKHETY-------LT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 653 a~--~~~~~~-------~~-~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~ 722 (783)
++ ...... .. .....||..|+++.+..+...+++.|+|||++++.+|+.|.+||...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321111 11 123459999999999999999999999999999999999999998776432222221111
Q ss_pred cccc---CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 723 QRLE---IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 723 ~~~~---~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.... .....+.++..+...+-..+...+|.+..+...|..+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111 3345667888888888889999999999998886655443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=281.27 Aligned_cols=202 Identities=22% Similarity=0.245 Sum_probs=148.1
Q ss_pred HhCCC-CceeeEecee-------ecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 003963 558 KRLRH-PNVLLFMGAV-------TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629 (783)
Q Consensus 558 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvH 629 (783)
+.+.| +||++++++| .....++++|||+ +++|.++|......+++..++.++.||++||+|||++| |||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34555 5888888877 2334678889988 66999999765667999999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCC-------------------cEEEEecCCCccccccc----------------ccccCCCCCCcccC
Q 003963 630 RDLKSSNLLVDKHW-------------------TVKVGDFGLSRLKHETY----------------LTTKTGKGTPQWMA 674 (783)
Q Consensus 630 rDIKp~NILl~~~~-------------------~vkL~DFGla~~~~~~~----------------~~~~~~~Gt~~Y~a 674 (783)
|||||+||||+..+ .+||+|||+++...... ......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 45555666554321100 00112357899999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHH
Q 003963 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQ 754 (783)
Q Consensus 675 PE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ 754 (783)
||++.+..++.++|||||||+||||++|.+|+..... ....+.... .+.......+....++.+||.++|.+||++.
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence 9999999999999999999999999999988764321 111111111 1111112245678899999999999999999
Q ss_pred HHHHHHHHHHHHHhhcC
Q 003963 755 ELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 755 ell~~L~~L~~~~f~~~ 771 (783)
++ ++|+||+..
T Consensus 261 ei------l~h~~~~~~ 271 (793)
T PLN00181 261 EL------LQSEFINEP 271 (793)
T ss_pred HH------hhchhhhhh
Confidence 99 567887653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=217.39 Aligned_cols=163 Identities=23% Similarity=0.318 Sum_probs=129.6
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 667 (783)
|+|.+++......+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876677999999999999999999999875 999999999999999 9998765432 236
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccc-----cCCCCCCH--HHHHHH
Q 003963 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRL-----EIPKDVDP--RWAAIV 739 (783)
Q Consensus 668 Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~-----~~~~~~s~--~l~~LI 739 (783)
||+.|||||++.+..++.++|||||||++|||++|..||...... ..+..+....... ..+..++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221110111 11222333 699999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.+||..+|.+||++.++++++..+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999887765543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-22 Score=215.77 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=203.7
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHH-HHHHHHHHHHHHHhCCCC-ceeeEeceeecCCceEEEEEe
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E~ 584 (783)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788899999999999999977 6899999887665443 567899999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCcccccccc
Q 003963 585 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 585 ~~ggsL~~~L~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~ 661 (783)
+.+++|.+++.... ..+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999997776544 26889999999999999999999999 99999999999999988 799999999875544321
Q ss_pred ------cccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccc-cc-
Q 003963 662 ------TTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQR-LE- 726 (783)
Q Consensus 662 ------~~~~~~Gt~~Y~aPE~~~~---~~~s~~sDIwSLG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~~- 726 (783)
......|+..|++||.+.+ ...+...|+|++|++++++++|..||..... ......+...... ..
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 2356679999999999988 5788999999999999999999999877653 3333333222211 11
Q ss_pred -CCCCC----CHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003963 727 -IPKDV----DPRWAAIVESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 727 -~~~~~----s~~l~~LI~~cL~~dP~~RPsa~ell~~ 759 (783)
..... ...+.+++..|+..+|..|.+.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=224.24 Aligned_cols=168 Identities=18% Similarity=0.140 Sum_probs=130.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC--CceEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCceee-Eeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG--SQDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLL-FMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~ 574 (783)
.....+|.+.+.||+|+||+||+|.+.. ++.||||++..... .......+.+|+.+|+.++|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4556789999999999999999998753 45679998753311 2344567999999999999999984 5442
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCC-CCCCEEEcCCCcEEEEecCCC
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDI-Kp~NILl~~~~~vkL~DFGla 653 (783)
+..|+|||||+|++|... .. .. ...++.+++++|.|||++| |+|||| ||+|||++.++.+||+|||++
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999732 11 11 1456789999999999998 999999 999999999999999999999
Q ss_pred cccccccc--------cccCCCCCCcccCcccccCCC
Q 003963 654 RLKHETYL--------TTKTGKGTPQWMAPEVLRNEP 682 (783)
Q Consensus 654 ~~~~~~~~--------~~~~~~Gt~~Y~aPE~~~~~~ 682 (783)
+....... ...+.++++.|++||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 86543321 112446788899999986543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-24 Score=247.43 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=200.8
Q ss_pred eEeeeeccCCcEEEEEEEEeCC-ceEEEEEEe----cccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~----~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.....+|.|++|.|+.+..... ..++.|.+. ...........+..|+.+-..+.|||++..+..+.......-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457799999998888765432 224444332 22222233333667777888889999998888877766666669
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 661 (783)
|||++ +|+.++... ..+....+-.++.|++.||.|||..| |.|||+|++|++++.+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999864 35888899999999999999999999 99999999999999999999999999876654433
Q ss_pred ---cccCCCCCCcccCcccccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHH--HHh-----hcccccccCCCC
Q 003963 662 ---TTKTGKGTPQWMAPEVLRNEPSDE-KSDVYSFGVILWELATEKIPWDNLNSMQVI--GAV-----GFMNQRLEIPKD 730 (783)
Q Consensus 662 ---~~~~~~Gt~~Y~aPE~~~~~~~s~-~sDIwSLG~il~elltG~~Pf~~~~~~~~~--~~i-----~~~~~~~~~~~~ 730 (783)
.....+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+.. ... ........+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 344568999999999999999865 689999999999999999999655433221 111 111122334456
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCCCC
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 777 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~~~ 777 (783)
++...+.+|.+||+.+|.+|.|+.+| ++.+||+.+.+-.-+
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i------~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQI------LNDEWIRSIECCHVD 597 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHH------hhChHhhhcceEEec
Confidence 78889999999999999999999999 789999998775443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=208.96 Aligned_cols=252 Identities=29% Similarity=0.626 Sum_probs=209.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
.++.+..+|.+.-.|..|+|+++++ .+++|++............|..|.-.|+.+.||||+.+++.|..+..+.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3445567788999999999999876 677888877666666667888899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEE--ecCCCcccccccc
Q 003963 585 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG--DFGLSRLKHETYL 661 (783)
Q Consensus 585 ~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~--DFGla~~~~~~~~ 661 (783)
|+.|+|+..|... ...++..++..++.+|++|++|||+..+-|.---|....++||++.+.+|. |--++. .+
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--qe--- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE--- 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--ec---
Confidence 9999999999753 344778899999999999999999987433344578889999998766553 322221 11
Q ss_pred cccCCCCCCcccCcccccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s---~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
......|.||+||.++.++.+ .+.|+|||.++||||-|...||.+..+.+.--.+.....+..+|+.+++.+..|
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 123447899999999877653 579999999999999999999999999887777777777899999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+.-|+..||.+||.++.++-.|++++
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999998888764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-23 Score=234.17 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=197.8
Q ss_pred eeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEEEecC
Q 003963 512 QIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
.+|+|.||.|+++...+ +.-||+|+..+.............|..++..++ ||.+|++...++.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999987433 345899988765433222224556888899887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCC
Q 003963 587 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 666 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 666 (783)
||.|...+... ..+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 99999988653 44777777778889999999999999 999999999999999999999999999865543322
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhC
Q 003963 667 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 746 (783)
Q Consensus 667 ~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~d 746 (783)
|||..|||||++. .+..++|.||||+++++|+||..||.. +....| ......+|..++..+++++..++.++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhC
Confidence 8999999999998 567889999999999999999999987 333333 34467889999999999999999999
Q ss_pred CCCCCCH--HHHHHHHHHHHHHHhhcC
Q 003963 747 PQCRPSF--QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 747 P~~RPsa--~ell~~L~~L~~~~f~~~ 771 (783)
|..|... +.+. +..+|.||+.+
T Consensus 226 p~nrLg~~~~~~~---eik~h~f~~~i 249 (612)
T KOG0603|consen 226 PENRLGAGPDGVD---EIKQHEFFQSI 249 (612)
T ss_pred HHHHhccCcchhH---HHhccchheee
Confidence 9999754 3332 23678888554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-21 Score=194.49 Aligned_cols=175 Identities=13% Similarity=0.129 Sum_probs=135.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCH-HHHHH------HHHHHHHHHhCCCCceeeEeceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD-EVIHS------FRQEVSLMKRLRHPNVLLFMGAVT 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~-~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~ 573 (783)
.++.++|++.++||.|+||.||++.. .++.+|||++....... ..... +.+|+..+.++.||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34678999999999999999999765 56689999997655433 22233 578999999999999999988865
Q ss_pred cC--------CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcE
Q 003963 574 SP--------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 645 (783)
Q Consensus 574 ~~--------~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~v 645 (783)
.. ...+|+|||++|.+|.++.. +++ ....+++.+|..||+.| ++|||+||.||+++.+| +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-E
Confidence 33 35799999999999988742 222 23558999999999999 99999999999999988 9
Q ss_pred EEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHH
Q 003963 646 KVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELA 700 (783)
Q Consensus 646 kL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ell 700 (783)
+|+|||........... .-......++.++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987644322110 01333444667899999999987664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=223.07 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=192.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+|...+.||.+.|=+|.++++..+ .|+||++-+... +-.-..+...|++ ...+++||++.+.-+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 678889999999999999998876 499999876652 2222233333455 566789999999999888888999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc--cccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYL 661 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~--~~~~~~ 661 (783)
|+. -+|++.|..++ -+..-+.++|+.||+.||..+|..| |+|+|||.+||||+.=.-+.|+||...+. .++...
T Consensus 102 yvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 994 59999997533 4777888899999999999999999 99999999999999988999999987642 222211
Q ss_pred cc-----cCCCCCCcccCcccccCCC-----------CCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh--ccc
Q 003963 662 TT-----KTGKGTPQWMAPEVLRNEP-----------SDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVG--FMN 722 (783)
Q Consensus 662 ~~-----~~~~Gt~~Y~aPE~~~~~~-----------~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~--~~~ 722 (783)
.. .+...-..|.|||.+.... .+++-||||+||+++||++ |.+||.-. +++.... ...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNADD 254 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCccC
Confidence 11 1112234799999986421 4578899999999999998 78888421 1111110 000
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH---------HHHHHHHHhhcCcCCC
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK---------LRDLQRQYFQASRSTV 775 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~---------L~~L~~~~f~~~~~~~ 775 (783)
...-+..--+..++.||..|++.||.+|.+++++|+. |..+.+.||.+.+...
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~~~~~ 316 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRFVPLT 316 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhcCCcc
Confidence 0011112234578999999999999999999999987 6677788887666553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=196.10 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=180.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC-----------------------------c-------eEEEEEEecccC--
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----------------------------Q-------DVAVKVFSRQEY-- 542 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----------------------------~-------~vAiK~i~~~~~-- 542 (783)
....++|+|++.||+|....||.+..... + +.|||.+-.-..
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 44568999999999999999998864320 0 135665432221
Q ss_pred -CHHHHHHHHHHHH------H--------HHh--------CCCCceeeEeceeec-------------------------
Q 003963 543 -SDEVIHSFRQEVS------L--------MKR--------LRHPNVLLFMGAVTS------------------------- 574 (783)
Q Consensus 543 -~~~~~~~~~~Ei~------i--------l~~--------l~HpnIv~l~~~~~~------------------------- 574 (783)
+...++...+|.. + .+. -+|||||++..+|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 1223333333321 1 111 259999999887642
Q ss_pred --CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc--CC--CcEEEE
Q 003963 575 --PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KH--WTVKVG 648 (783)
Q Consensus 575 --~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~--~~--~~vkL~ 648 (783)
+..+|+||..... +|.+++-.+. .+......++.|+++|+.|||++| |.|||+|.+||||. ++ -.+.|+
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEc
Confidence 2347999998854 9999997543 667778888899999999999999 99999999999993 33 358999
Q ss_pred ecCCCccccc-----ccccc-cCCCCCCcccCcccccCCCC------CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 003963 649 DFGLSRLKHE-----TYLTT-KTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 716 (783)
Q Consensus 649 DFGla~~~~~-----~~~~~-~~~~Gt~~Y~aPE~~~~~~~------s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~ 716 (783)
|||++--... ++... ...-|....||||+....+- -.++|.|+.|.+-||++....||.......+..
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 9998642221 11111 12236778999999865432 358999999999999999999998754443322
Q ss_pred HhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003963 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 717 ~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~ 759 (783)
.-......+.+|..+++.+++++..+|++||.+|++.+=....
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 2222345677899999999999999999999999987655444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=188.58 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=108.9
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHH------------------------HHHHHHHHHHHHhCCCCce
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEV------------------------IHSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~HpnI 565 (783)
...||+|+||.||+|.+..++.||||+++........ .....+|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999877789999999765321100 1223459999999987776
Q ss_pred eeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCCCCEEEcCCCc
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
.....+.. ...+|||||++|++|...+.. ...++...+..++.|++.+|.+| |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43332222 223899999988777654332 34688899999999999999999 6888 99999999999998 478
Q ss_pred EEEEecCCCcccc
Q 003963 645 VKVGDFGLSRLKH 657 (783)
Q Consensus 645 vkL~DFGla~~~~ 657 (783)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=181.09 Aligned_cols=187 Identities=16% Similarity=0.198 Sum_probs=141.0
Q ss_pred eEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCC--HHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEEEe
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
-+...|++|+||+||.+.. .+.+++.+.+.....- .-....+.+|+++|++|. |++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 5667887776554331 112235789999999995 5889999886 346999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCC-CCCCEEEcCCCcEEEEecCCCcccccccc--
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 661 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDI-Kp~NILl~~~~~vkL~DFGla~~~~~~~~-- 661 (783)
+.|.+|...+.. ....++.|++.+|.+||++| |+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998765421 11346779999999999999 999999 79999999999999999999985443221
Q ss_pred ---c--------ccCCCCCCcccCcccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 003963 662 ---T--------TKTGKGTPQWMAPEVLRNE-PSD-EKSDVYSFGVILWELATEKIPWDNL 709 (783)
Q Consensus 662 ---~--------~~~~~Gt~~Y~aPE~~~~~-~~s-~~sDIwSLG~il~elltG~~Pf~~~ 709 (783)
. .....+++.|+.|+...-- ..+ .+.++++.|+.+|.++|+..|+...
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 1112368889999864432 233 6789999999999999999887543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=193.53 Aligned_cols=233 Identities=19% Similarity=0.295 Sum_probs=152.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCC----------CceeeEeceee
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH----------PNVLLFMGAVT 573 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~ 573 (783)
.+..+..||.|+|+.||.+.+.. ++++|+|++....... ...+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 56778999999999999999976 5789999987655322 345666666654444322 11222222111
Q ss_pred ---------cC---C-----ceEEEEEecCCCCHHHHHhh---c-C--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 003963 574 ---------SP---Q-----RLCIVTEFLPRGSLFRLLQR---N-T--TKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630 (783)
Q Consensus 574 ---------~~---~-----~~~lV~E~~~ggsL~~~L~~---~-~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHr 630 (783)
.. . ..+++|+-+ .++|.+++.. . . ..+.....+.+..|+++.+++||..| |||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 11 1 247788888 4588887642 1 1 12444455667789999999999999 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccC--------CCCCchhHHHHHHHHHHHHHcC
Q 003963 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--------EPSDEKSDVYSFGVILWELATE 702 (783)
Q Consensus 631 DIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~~sDIwSLG~il~elltG 702 (783)
||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|+|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999987666554432 223577999997643 2458899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 703 KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 703 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
..||......... ...+.....+|..++.||..+|+++|.+|
T Consensus 247 ~lPf~~~~~~~~~------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999765432211 11334445788999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-19 Score=209.34 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=191.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC---CCceeeEeceeecC
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSP 575 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~ 575 (783)
..+...+.|.|.+.||+|+||.||+|...+++.||||+-+..... +|.--.+++.+|+ -+.|..++.++...
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 445567789999999999999999999888888999996655432 2222344555555 24566666666777
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-------CCcEEEE
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVKVG 648 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-------~~~vkL~ 648 (783)
+..+||+||.+.|+|.+++.. ....++..+..+..||+..+..||.++ |||+||||+|+||.. .--++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 888999999999999999984 456899999999999999999999999 999999999999942 3459999
Q ss_pred ecCCCccc---ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q 003963 649 DFGLSRLK---HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL 725 (783)
Q Consensus 649 DFGla~~~---~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 725 (783)
|||.+.-+ .+. ..-...++|-.+-++|+..|.+|++.+|.|.|..+++-||.|++- . + ......
T Consensus 844 DfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q-~-~~g~~~ 910 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E-V-KNGSSW 910 (974)
T ss_pred ecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H-h-cCCcce
Confidence 99988532 222 122345678899999999999999999999999999999999631 1 1 111112
Q ss_pred c----CCCCCC-HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 726 E----IPKDVD-PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 726 ~----~~~~~s-~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
. ++..+. .-|..|+..+|..|-..=|...+|...|+.+...-|+.
T Consensus 911 ~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~ 960 (974)
T KOG1166|consen 911 MVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTG 960 (974)
T ss_pred eccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHH
Confidence 2 222222 24788999999955555588888888888887777653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=179.68 Aligned_cols=142 Identities=20% Similarity=0.193 Sum_probs=111.0
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCC----------------------H--HHHHHHHHHHHHHHhCCCCce
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS----------------------D--EVIHSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~----------------------~--~~~~~~~~Ei~il~~l~HpnI 565 (783)
.+.||+|+||.||+|.+.+++.||||++...... . .....+..|...+..+.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999877789999998765311 0 012234678999999999887
Q ss_pred eeEeceeecCCceEEEEEecCCCCHHHH-HhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCC
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRL-LQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~~~-L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~ 643 (783)
.....+... ..||||||++|+++... +.. ..++...+..++.|++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 544433332 24899999988755433 432 357788899999999999999999 88 99999999999999 78
Q ss_pred cEEEEecCCCccccc
Q 003963 644 TVKVGDFGLSRLKHE 658 (783)
Q Consensus 644 ~vkL~DFGla~~~~~ 658 (783)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=210.70 Aligned_cols=220 Identities=29% Similarity=0.441 Sum_probs=160.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
.+|..++.|-.|+||.||.+.++.. +++|+|+ .++..- +++ ++.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li------lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI------LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh------hhc---cccccCCccee-----------------
Confidence 4678899999999999999998764 6788854 222210 001 33333445444
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc--
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 661 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 661 (783)
|+-...++. ..+++. +++.+++|||+.+ |+|||+||+|+||+.-|++|++|||+++.......
T Consensus 136 ----gDc~tllk~-~g~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhccc-CCCCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 233333322 122333 3378999999998 99999999999999999999999999875332211
Q ss_pred -------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-ccccccC
Q 003963 662 -------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-MNQRLEI 727 (783)
Q Consensus 662 -------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~ 727 (783)
.....+|||.|.|||++.-..|+..+|+|+||+++|+++.|..||.+..+.+++..+.. ....++-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 12234799999999999999999999999999999999999999999988887766532 2223333
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
...++++++++|.++|+.+|..|-..... ++--+|.||+
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga---~evk~h~ff~ 319 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGA---LEVKQHGFFQ 319 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchh---hhhhhcccee
Confidence 45688999999999999999999633322 2225788875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=173.78 Aligned_cols=134 Identities=16% Similarity=0.243 Sum_probs=104.5
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCceeeEeceeecCC---ceE-E
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-----RHPNVLLFMGAVTSPQ---RLC-I 580 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~-l 580 (783)
.++||+|+||.||. +......+||++...... ....+.+|+.+++.+ .||||+++|++++++. .++ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46899999999995 444444579988664322 245789999999999 5799999999998874 434 7
Q ss_pred EEEe--cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHH-HHHHhCCCCEEecCCCCCCEEEcC----CCcEEEEecCCC
Q 003963 581 VTEF--LPRGSLFRLLQRNTTKLDWRRRILMALDIARGV-SYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFGLS 653 (783)
Q Consensus 581 V~E~--~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~IvHrDIKp~NILl~~----~~~vkL~DFGla 653 (783)
|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. ++.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5578999999753 35555 35577888777 9999999 999999999999974 347999995433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=167.05 Aligned_cols=136 Identities=25% Similarity=0.361 Sum_probs=113.4
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCCH------HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
+.||+|++|.||+|.+ .+..+++|+........ .....+.+|+.++..+.|++|+....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 45689999865443221 1224577899999999999988777777777788999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
++|++|.+++.... . ....++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 1 77888999999999999998 99999999999999 78999999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-17 Score=182.78 Aligned_cols=208 Identities=34% Similarity=0.577 Sum_probs=163.4
Q ss_pred HHhCCCCceeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCC
Q 003963 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 636 (783)
Q Consensus 557 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~N 636 (783)
|+.+.|.|+.+|++.+.+....++|.+||..|+|.+.+......+++.....++++|+.||.|||..-. ..|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence 356889999999999999999999999999999999999878889999999999999999999998652 2999999999
Q ss_pred EEEcCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCC-------CCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 637 LLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEP-------SDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 637 ILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~-------~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
.+++..+.+||+|||+....... ........-...|.|||.+.+.. .+.+.||||+|++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998765421 00011111245789999988742 3567999999999999999999996
Q ss_pred CCC----hHHHHHHhhcccc---cccCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 708 NLN----SMQVIGAVGFMNQ---RLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 708 ~~~----~~~~~~~i~~~~~---~~~~~--~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
... ..+....+..... ++.+. ...++++..++..||..+|..||++.++-..++.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 532 2234434333111 11121 1456689999999999999999999999887776544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=161.02 Aligned_cols=133 Identities=24% Similarity=0.331 Sum_probs=106.8
Q ss_pred eeccCCcEEEEEEEEeCCceEEEEEEecccCCH------HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEec
Q 003963 512 QIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585 (783)
Q Consensus 512 ~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 585 (783)
.||+|+||.||++.+. +.+|++|+........ .....+.+|+.++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999854 5689999865433211 12356778999999999887655554555666789999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875422 1 77889999999999998 99999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-16 Score=138.81 Aligned_cols=104 Identities=27% Similarity=0.522 Sum_probs=95.5
Q ss_pred CcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEEE
Q 003963 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (783)
Q Consensus 140 ~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (783)
|++|+++|.+|+|++||++|++++||++++++|+++.+++.+.........+.+++..+..+..++.+++++|..+|+.+
T Consensus 1 p~~i~i~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~ 80 (104)
T PF13426_consen 1 PDGIFILDPDGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFWVEV 80 (104)
T ss_dssp -SEEEEEETTSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEEEEE
T ss_pred CEEEEEECCcCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEEEEE
Confidence 68999999999999999999999999999999999999998777667777888999999999999999999999999999
Q ss_pred EEEEEECCCCCEEEEEEEEEehHH
Q 003963 220 TNTPFYDDDGTLVGIVCVSTDSRP 243 (783)
Q Consensus 220 ~~~Pi~d~~G~v~g~v~i~rDITe 243 (783)
++.|+.+++|++.+++++++|||+
T Consensus 81 ~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 81 SASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999996
|
... |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=165.63 Aligned_cols=145 Identities=23% Similarity=0.200 Sum_probs=111.3
Q ss_pred ceeEeeeeccCCcEEEEEEE--EeCCceEEEEEEecccCC--------------------H--HHHHHHHHHHHHHHhCC
Q 003963 506 DLTIGEQIGQGSCGTVYHAV--WYGSQDVAVKVFSRQEYS--------------------D--EVIHSFRQEVSLMKRLR 561 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~--~~~~~~vAiK~i~~~~~~--------------------~--~~~~~~~~Ei~il~~l~ 561 (783)
-|.+.+.||+|+||.||+|. ...++.||||++...... . .....+..|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999998 356788999998754321 0 11234578999999997
Q ss_pred CC--ceeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE
Q 003963 562 HP--NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 639 (783)
Q Consensus 562 Hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl 639 (783)
+. .+++++.+ ...++||||++|.+|..++... ..+.......++.||+.+|++||..| +|+|+||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 53 34444543 2358999999998887655332 34566667889999999999999875 39999999999999
Q ss_pred cCCCcEEEEecCCCcccc
Q 003963 640 DKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 640 ~~~~~vkL~DFGla~~~~ 657 (783)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 7899999999886443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=158.97 Aligned_cols=137 Identities=23% Similarity=0.206 Sum_probs=107.7
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCH--------------------HHHHHHHHHHHHHHhCCCCc--
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD--------------------EVIHSFRQEVSLMKRLRHPN-- 564 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~--------------------~~~~~~~~Ei~il~~l~Hpn-- 564 (783)
|.+.+.||+|+||.||++....++.||||++....... .....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 77889999999999999998778899999976532110 11123667888999887774
Q ss_pred eeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 565 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
++..++ ....++||||++|++|..+... .....++.+++.++.++|+.+ |+|+||||+||+++.++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 444443 2456899999999998776431 234567889999999999988 999999999999999999
Q ss_pred EEEEecCCCccc
Q 003963 645 VKVGDFGLSRLK 656 (783)
Q Consensus 645 vkL~DFGla~~~ 656 (783)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-16 Score=179.32 Aligned_cols=138 Identities=23% Similarity=0.316 Sum_probs=111.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccC-C-----HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY-S-----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~-~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..|...+.||+|+||.||++.+... .+++|+...... . ......+.+|+.+++.++|++|+..+.++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456688999999999999987654 444444322211 1 12235688999999999999998887777777788
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
++||||++|++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 24568889999999999998 9999999999999 577999999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=173.18 Aligned_cols=169 Identities=27% Similarity=0.375 Sum_probs=127.8
Q ss_pred ceEEEEEecCCCCHHHHHhh--cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 577 RLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
++||.|++|...+|.++|.+ .....++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence 58999999999999999964 33446778888999999999999 56 9999999999999999999999999976
Q ss_pred cccccc------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccC
Q 003963 655 LKHETY------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEI 727 (783)
Q Consensus 655 ~~~~~~------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 727 (783)
...... ......+||..||+||.+.+..|+.++|||+||++|+|++. -..+|+.. ..+..+......+.+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPEF 481 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChHH
Confidence 544332 12334579999999999999999999999999999999998 33333221 111122111111111
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHH
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQ 754 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ 754 (783)
..+ .++-..|+.+||.+.|.+||++.
T Consensus 482 ~~d-~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 482 LQD-YPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhc-CcHHHHHHHHhcCCCcccCchHH
Confidence 122 24456899999999999999443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-17 Score=192.84 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=198.9
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCCc--eEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGSQ--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.|.+.+.||+|+|+.|-........ .+|.|.+...............|..+-+.+. |.|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4667778999999999988764443 3677766655444555566777888888887 999999999999999999999
Q ss_pred EecCCCCHHHHH-hhcCCcchHHHHHHHHHHHHHHHHHHH-hCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCccccc-
Q 003963 583 EFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE- 658 (783)
Q Consensus 583 E~~~ggsL~~~L-~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~- 658 (783)
+|..|++++..+ .......+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999988 443335677778888999999999999 887 99999999999999999 999999999986554
Q ss_pred c--cccccCCCC-CCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH--hhcc-cccccCCCCC
Q 003963 659 T--YLTTKTGKG-TPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA--VGFM-NQRLEIPKDV 731 (783)
Q Consensus 659 ~--~~~~~~~~G-t~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~--i~~~-~~~~~~~~~~ 731 (783)
. .......+| ++.|+|||.+.+. ......|+||+|+++.-+++|..||........... .... .........+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2 223345578 9999999999885 457889999999999999999999976554332111 1111 1124455678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHH
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQEL 756 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~el 756 (783)
+....+++.+++..+|..|.+..++
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ChhhhhcccccccCCchhccccccc
Confidence 8899999999999999999999888
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-15 Score=149.48 Aligned_cols=138 Identities=25% Similarity=0.229 Sum_probs=98.1
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHH----------------------HHHHHHHHHhCCCCc--e
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHS----------------------FRQEVSLMKRLRHPN--V 565 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~----------------------~~~Ei~il~~l~Hpn--I 565 (783)
.+.||+|+||.||+|.+..++.||||++............ ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999877789999998764332111111 134566666654332 4
Q ss_pred eeEeceeecCCceEEEEEecCCCCHH-HHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCC
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~-~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~ 643 (783)
.+++++ ...++||||++++.+. ..+.... . ...+..++.+++.++.++|. .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 444443 2468999999985432 1121111 1 15677889999999999999 88 99999999999999 88
Q ss_pred cEEEEecCCCcccc
Q 003963 644 TVKVGDFGLSRLKH 657 (783)
Q Consensus 644 ~vkL~DFGla~~~~ 657 (783)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.6e-15 Score=131.84 Aligned_cols=110 Identities=24% Similarity=0.357 Sum_probs=99.0
Q ss_pred HHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEE
Q 003963 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (783)
Q Consensus 136 le~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (783)
|++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+.+++..+.....+..... +|..+
T Consensus 1 l~~~p~~i~v~D~~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 79 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DGEER 79 (110)
T ss_dssp HHHCSSEEEEEETTSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TSCEE
T ss_pred CCCCCceeEEECCCCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cCCcE
Confidence 68999999999999999999999999999999999999999999887666666778888888888776665555 89999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehHHHHH
Q 003963 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (783)
|+.+++.|++|.+|++.|++++++|||++|+
T Consensus 80 ~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 80 WFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp EEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred EEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=131.45 Aligned_cols=112 Identities=25% Similarity=0.450 Sum_probs=95.8
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEE-EEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG-QFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~-e~~~~ 208 (783)
++|+.++++++++|+++|.+|+|+|+|++|++++||+.++++|+++.++++++........+.+.+..++.... .....
T Consensus 1 e~~~~i~~~~~~~i~~~d~~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDEDGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVRFR 80 (113)
T ss_dssp HHHHHHHHCSSSEEEEEETTSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEEEE
T ss_pred CHHHHHHhcCCceEEEEeCcCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEEEE
Confidence 57999999999999999999999999999999999999999999999999877654455567777777776333 44444
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeh
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDI 241 (783)
.++|..+|+.+.+.|+++.+|++.|++++++||
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 81 LRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp ETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred ecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 479999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=136.87 Aligned_cols=134 Identities=19% Similarity=0.177 Sum_probs=111.0
Q ss_pred EeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CceeeEeceeecCCceEEEEEecC
Q 003963 509 IGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ 586 (783)
+.+.||.|.++.||++...+ ..+++|++..... ...+..|+.+++.+.| .++++++.++...+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 45789999999999999765 6899999865432 3567889999999976 589999998888888999999998
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCC-CCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 587 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 587 ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
++.+..+ +......++.+++.+|++||... .+++|+|++|.|||+++.+.++++|||.+..
T Consensus 77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8777554 34455667889999999999852 2399999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=148.06 Aligned_cols=136 Identities=20% Similarity=0.213 Sum_probs=103.1
Q ss_pred eeec-cCCcEEEEEEEEeCCceEEEEEEecccC-----------CHHHHHHHHHHHHHHHhCCCCce--eeEeceeecCC
Q 003963 511 EQIG-QGSCGTVYHAVWYGSQDVAVKVFSRQEY-----------SDEVIHSFRQEVSLMKRLRHPNV--LLFMGAVTSPQ 576 (783)
Q Consensus 511 ~~LG-~G~fG~Vy~a~~~~~~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~ 576 (783)
..|| .|+.|+||++... ++.++||.+..... .......+.+|+.++..|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4566 7788888888764 56899998854321 11233567889999999998775 66776644322
Q ss_pred ----ceEEEEEecCC-CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 577 ----RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 577 ----~~~lV~E~~~g-gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
..++||||++| .+|.+++... .++.. .+.+|+.+|.+||+.| |+|+||||.|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECC
Confidence 23599999997 6899888653 34443 2568999999999999 9999999999999998899999999
Q ss_pred CCcc
Q 003963 652 LSRL 655 (783)
Q Consensus 652 la~~ 655 (783)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8864
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-14 Score=170.69 Aligned_cols=151 Identities=16% Similarity=0.157 Sum_probs=132.2
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (783)
.+++++.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.+++++.............+..+..+..+.+.
T Consensus 153 ~~~~l~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 232 (779)
T PRK11091 153 QSSLLRSFLDASPDLVYYRNEDGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIETDEKVFRHNVSLTYEQWL 232 (779)
T ss_pred HHHHHHHHHhcCcceEEEECCCCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHHHHHHHHhcCCCeEEEEEE
Confidence 34679999999999999999999999999999999999999999999999988765444444556677788888888888
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHHH
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i~ 287 (783)
.+++|..+|+.++..|+++.+|++.|++++++|||++|+++++++.... .+..|++.++||+++||+.++.
T Consensus 233 ~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~a~~---------~~~~~~a~isHelrtPL~~I~g 303 (779)
T PRK11091 233 DYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEKASR---------DKTTFISTISHELRTPLNGIVG 303 (779)
T ss_pred EcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHHHHH---------HHHHHHHHhhHhhcCcHHHHHH
Confidence 9999999999999999999999999999999999999999998876543 3456999999999999987643
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-13 Score=158.57 Aligned_cols=150 Identities=18% Similarity=0.230 Sum_probs=129.5
Q ss_pred HHHHHHHHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (783)
...|..+++.++++|+++|. +|+|+|+|++|++++||+.+|++|+++.++++++........++..+..+..+..++
T Consensus 29 ~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (540)
T PRK13557 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEI 108 (540)
T ss_pred hHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEE
Confidence 57899999999999999995 789999999999999999999999999999887766666667788888888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~ 285 (783)
..++++|..+|+.+++.|+++.+|.+++++++.+|||+++++++++....... ....+...++|+++.||+..
T Consensus 109 ~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~~~~~-------~l~~~~~~i~h~l~~pl~~i 181 (540)
T PRK13557 109 LNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQAQKME-------ALGQLTGGIAHDFNNLLQVM 181 (540)
T ss_pred EEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHHHHHH-------HhhhhhhhhhHHhhhHHHHH
Confidence 88899999999999999999999999999999999999999998876543321 12236778889999999753
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-13 Score=149.20 Aligned_cols=144 Identities=19% Similarity=0.170 Sum_probs=121.6
Q ss_pred HHHHHHHHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (783)
.+.|+.+++..+++|+++|. +|.|+++|++|++++||+.++++|+++..+.++.........+...+..+..+..+.
T Consensus 42 ~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~ 121 (361)
T PRK13559 42 GRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVEL 121 (361)
T ss_pred hhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEE
Confidence 46789999999999999997 578999999999999999999999999877765554444556677788888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~ 285 (783)
..+++||..+|+.++..|+++.+|.+.+++++++|||++|++++..+.. ..++..++|+.+.||+.+
T Consensus 122 ~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~~~-------------~~l~~~l~H~~~n~L~~i 188 (361)
T PRK13559 122 LNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEAHE-------------RRLAREVDHRSKNVFAVV 188 (361)
T ss_pred EEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHHHH-------------HHHHHHHHHhhhhHHHHH
Confidence 8899999999999999999999999999999999999999887654332 226677788888888653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-13 Score=152.25 Aligned_cols=247 Identities=21% Similarity=0.171 Sum_probs=184.4
Q ss_pred ccceeEeeeecc--CCcEEEEEEEE--e-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCc
Q 003963 504 WEDLTIGEQIGQ--GSCGTVYHAVW--Y-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~--G~fG~Vy~a~~--~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 577 (783)
...+.+.+.+|. |.+|.||.+.. . ....+|+|.=+...........-.+|+.-.+.++ |+|.|+.+..|+..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 346778889999 99999999987 3 2356888873222211111122235666666665 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHH----HHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR----GVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGL 652 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGl 652 (783)
+|+-+|+| +.+|..+.......++...++....+... ||.++|..+ ++|-|+||+||++..+ ...+++|||+
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence 99999999 56888888766666888889999999999 999999998 9999999999999998 7899999999
Q ss_pred CcccccccccccC-----CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHhhcccccc
Q 003963 653 SRLKHETYLTTKT-----GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL--NSMQVIGAVGFMNQRL 725 (783)
Q Consensus 653 a~~~~~~~~~~~~-----~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~--~~~~~~~~i~~~~~~~ 725 (783)
...+......... ..|...|++||..++. ++...|||+||.++.+..++..+.... +....+.. .....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---~~ip~ 345 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---GYIPL 345 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---ccCch
Confidence 8776654422222 2688899999998665 668999999999999999886554322 11111111 11122
Q ss_pred cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003963 726 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 726 ~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell 757 (783)
++....+.++...+..|+..+|..|++++.+.
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 33344566778899999999999999887774
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.4e-12 Score=142.69 Aligned_cols=222 Identities=20% Similarity=0.234 Sum_probs=148.6
Q ss_pred CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHH
Q 003963 528 GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 607 (783)
Q Consensus 528 ~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~ 607 (783)
.+.+|.|++.+.... .......+-+..|+.|+||||++|+..++..+.+|||+|.+ ..|..++... ....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----HHHHHH
Confidence 356788887766554 45566778899999999999999999999999999999998 3687777653 355666
Q ss_pred HHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchh
Q 003963 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687 (783)
Q Consensus 608 ~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~s 687 (783)
..+.||+.||.|||..+ +++|++|...-|+|+..|..||++|-++..............--..|..|+.+.... -..
T Consensus 108 ~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 77889999999998432 399999999999999999999999988754333221111222233466676654333 457
Q ss_pred HHHHHHHHHHHHHcCCCCCC------CCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 688 DVYSFGVILWELATEKIPWD------NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 688 DIwSLG~il~elltG~~Pf~------~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
|.|.|||++++++.|..+-. +..+....... .....-.....+...+++..|...-+--|=.+-+++..|+
T Consensus 185 D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~---~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~fvd~~~fLe 261 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELY---CKKLGATELKRPNKLRFILECRLLGGFFRNDFVDTLLFLE 261 (690)
T ss_pred hhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHH---HHHhccccccccchhhHHHHHHhccccccchHHHHHHHHH
Confidence 99999999999999933211 11110000000 0000001111122456677777666666666666666666
Q ss_pred HH
Q 003963 762 DL 763 (783)
Q Consensus 762 ~L 763 (783)
.+
T Consensus 262 el 263 (690)
T KOG1243|consen 262 EL 263 (690)
T ss_pred hc
Confidence 55
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.3e-12 Score=143.89 Aligned_cols=148 Identities=22% Similarity=0.238 Sum_probs=99.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCH--------------------------------HHHH----
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD--------------------------------EVIH---- 548 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~--------------------------------~~~~---- 548 (783)
..|. .+.||.|++|.||+|..++++.||||+.+...... +...
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 36799999999999999888999999986432100 0000
Q ss_pred --HHHHHHHHHHhCC-----CCceeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHH-HHHHH
Q 003963 549 --SFRQEVSLMKRLR-----HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR-GVSYL 620 (783)
Q Consensus 549 --~~~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~-aL~~L 620 (783)
.+.+|+..+.++. +++|.-..-++......+|||||++|++|.++......... ...++..++. .+..+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 2444555555552 34332111122223457999999999999887653221122 2345555555 46788
Q ss_pred HhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 621 H~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|..| ++|+|++|.||+++.++.++|+|||++.....
T Consensus 274 ~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9988 99999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.9e-13 Score=158.41 Aligned_cols=266 Identities=21% Similarity=0.228 Sum_probs=195.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCc-eEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQ-DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
|....+.+.+.+.+-.|.++.++.+.-.... -.++|+...... .....+...++-.++-..++|.++....-+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 5566778889999999999999988754332 234444322211 11112233334444444567888877777777788
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.+|+++|+.+++|...|...+ ..+..........++.+++|||... ++|+|++|.|+|+..+++.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999997654 3555555556667889999999976 8999999999999999999999998432110
Q ss_pred cc-------------------------------cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 003963 658 ET-------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 706 (783)
Q Consensus 658 ~~-------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf 706 (783)
.. ........||+.|.+||...+......+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 00122345899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHhhcccc-cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 707 DNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 707 ~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
......+.++.+..... .+.-+...+++.++++...+..+|.+|..+.-..+ .-.|+||+..
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e---~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE---VKGHPFFQDV 1098 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc---cccCCccCCC
Confidence 99999988887744332 34455678899999999999999999987762211 1456777543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-12 Score=148.11 Aligned_cols=148 Identities=20% Similarity=0.241 Sum_probs=95.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC---------------------------C-----HHHH
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY---------------------------S-----DEVI 547 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~---------------------------~-----~~~~ 547 (783)
+..+.+|.. +.||.|++|.||+|..+. ++.||||+.++... . .+..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 345667777 899999999999999987 78999999975420 0 0222
Q ss_pred HHHHHHHHHHH------hCC----CCceeeEecee-ecCCceEEEEEecCCCCHHHH--HhhcCC---cchHHHHHHHHH
Q 003963 548 HSFRQEVSLMK------RLR----HPNVLLFMGAV-TSPQRLCIVTEFLPRGSLFRL--LQRNTT---KLDWRRRILMAL 611 (783)
Q Consensus 548 ~~~~~Ei~il~------~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~--L~~~~~---~l~~~~~~~i~~ 611 (783)
+.+.+|+.+.. +++ +.+.+.+-.++ ..-...+||||||.|+.|.++ +...+. .+....+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 23333433333 331 22222222222 112346799999999999775 333221 233444444444
Q ss_pred HHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC----cEEEEecCCCccccc
Q 003963 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSRLKHE 658 (783)
Q Consensus 612 qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGla~~~~~ 658 (783)
|++ ..| ++|+|+||.||+|+.++ +++++|||++.....
T Consensus 275 Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 443 467 99999999999999888 999999999875543
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-11 Score=141.00 Aligned_cols=126 Identities=18% Similarity=0.298 Sum_probs=111.4
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
.+.|+.+++.++++|+++|.+|+|+|+|+++++++||++++++|++...+..+.........+.+.+..+..+..++...
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDLKANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred hHHHHHHHHhCCceEEEECCCCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 46799999999999999999999999999999999999999999988777665555445556677777788888888888
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHh
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (783)
+++|..+|+...+.|+++.+|.+.+++++++|||+++++++++++.
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~ 128 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ 128 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999887653
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.5e-12 Score=129.34 Aligned_cols=199 Identities=24% Similarity=0.409 Sum_probs=141.4
Q ss_pred HHHHhCCCCceeeEeceeecCC-----ceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCC
Q 003963 555 SLMKRLRHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPP 626 (783)
Q Consensus 555 ~il~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~ 626 (783)
.-|-.+-|.|||+++.||.+.. ...++.||+..|+|..+|++ +...+......+|+-||+.||.|||++.++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455567999999999986543 47899999999999999975 345577888889999999999999999999
Q ss_pred EEecCCCCCCEEEcCCCcEEEEecCCCcccccc-----cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc
Q 003963 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 701 (783)
Q Consensus 627 IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt 701 (783)
|+|+++..+-|++..+|-||+.--.-.. .+.. ........+-+.|.+||.=.....+.++|||++|...++|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999888874322111 1110 011112245678999998766777889999999999999988
Q ss_pred CCCCCC-CCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003963 702 EKIPWD-NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 759 (783)
Q Consensus 702 G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~ 759 (783)
+..--. ..........+.... +.+ -...-+.+|.+|++..|..||++++++.+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i--~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVI--IGL---ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhhe--eec---cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 754321 111111111221111 111 11223568999999999999999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.6e-12 Score=143.06 Aligned_cols=248 Identities=19% Similarity=0.144 Sum_probs=180.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe--CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 579 (783)
...+|..+..||.|.|+.||++... ++..|++|-+.+..........-..|+.+...+. |.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3568889999999999999998743 3456888877665443322223345677766664 899999999998888889
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~~~~ 658 (783)
+-.|||.++++...+ .....+.+...+.+..|++.++.++|+.. ++|+|+||.||++..+ +.-++.|||+.....-
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccce
Confidence 999999998887665 22344777888999999999999999988 9999999999999876 7889999998864211
Q ss_pred ccccccCCCCCCcc-cCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 659 TYLTTKTGKGTPQW-MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y-~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
. .......+..| .++.......+..+.|+|+||..+.+.+++.+--....... .+ .............++..
T Consensus 420 ~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i--~~~~~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 420 S--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TI--RSGDTPNLPGLKLQLQV 492 (524)
T ss_pred e--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---ee--ecccccCCCchHHhhhh
Confidence 1 11111223344 35556666778899999999999999999865333222111 11 12223333344488899
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKL 760 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L 760 (783)
+.+.++.+++..||.+.++..+.
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred hhhhhcCCccccchhhhhhcccc
Confidence 99999999999999988885443
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.1e-11 Score=102.65 Aligned_cols=120 Identities=23% Similarity=0.400 Sum_probs=97.7
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe-EEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-~~~e~~~~ 208 (783)
+.++.+++.++++++++|.+|.|+++|+++++++|++..+++|+.+..++++.........+...+..+.. ......+.
T Consensus 3 ~~~~~~~~~~~~~~~~~d~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRVR 82 (124)
T ss_pred hHHHHHHhhCCceEEEEcCCCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeeeE
Confidence 56889999999999999999999999999999999999999999998877665543333344455553322 33445555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (783)
..+|..+|+.....|+. .+|...+++++++|||++++++++
T Consensus 83 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 83 RKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred cCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 88999999999999998 788899999999999999988764
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=119.32 Aligned_cols=130 Identities=15% Similarity=0.102 Sum_probs=94.7
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce-eeEeceeecCCceEEEEEecCCC
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg 588 (783)
++.|+.|.++.||++... ++.|++|+....... ...+..|+.+++.+.+.++ ++++.+.. ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 467899999999999865 568999987554311 1245678899998865444 45554433 3458999999998
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCC---CEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP---PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 589 sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~---~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
++.... . ....++.+++.+|+.||..+. .++|+|++|.||+++ ++.++|+|||.+..
T Consensus 77 ~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 775430 0 112345689999999998761 249999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-10 Score=122.56 Aligned_cols=260 Identities=14% Similarity=0.212 Sum_probs=177.1
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEece------eecCC-ce
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA------VTSPQ-RL 578 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~------~~~~~-~~ 578 (783)
...++.||+|+-+.+|-.-.. +..+.|+.......... +-+..|... .||-+-.-+.| .-+.. ..
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchh--hchhheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 456788999999999975322 24566877655432211 122333333 46543321111 11222 26
Q ss_pred EEEEEecCCCCH-HHHHh-----hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 579 CIVTEFLPRGSL-FRLLQ-----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 579 ~lV~E~~~ggsL-~~~L~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
.++|..+.|..- ..++. +......|+..+..++.|+.+.+.||..| .+-+|+.++|+||++++.|.|+|-..
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccc
Confidence 788999877632 33331 12233789999999999999999999999 88999999999999999999999765
Q ss_pred CcccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChH----HHHH-Hhhc-
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATE-KIPWDNLNSM----QVIG-AVGF- 720 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~----~~~~-~i~~- 720 (783)
.... .........+|.+.|++||... +..-+...|.|.||+++++++.| +.||.+.... .-++ .|..
T Consensus 164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 4333 2223344668999999999865 34446778999999999999986 9999754321 0111 1110
Q ss_pred --------ccccccCC-----CCCCHHHHHHHHHhhhhC--CCCCCCHHHHHHHHHHHHHHHhhcCcCCCC
Q 003963 721 --------MNQRLEIP-----KDVDPRWAAIVESCWHSD--PQCRPSFQELVDKLRDLQRQYFQASRSTVG 776 (783)
Q Consensus 721 --------~~~~~~~~-----~~~s~~l~~LI~~cL~~d--P~~RPsa~ell~~L~~L~~~~f~~~~~~~~ 776 (783)
.....+.| .-+++.+..|+.+|+..- +.-||+++.++..|..+.+++-+|+++.+-
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 11111222 236789999999999643 568999999999999999999999998764
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.6e-11 Score=144.18 Aligned_cols=129 Identities=15% Similarity=0.124 Sum_probs=106.8
Q ss_pred CCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEE
Q 003963 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (783)
Q Consensus 127 ~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (783)
..++.|+.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.+++++.............+..+.....+..
T Consensus 201 ~~~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 280 (807)
T PRK13560 201 EALHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFDADGSQIIEAE 280 (807)
T ss_pred HHHHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhccCCceEEEEE
Confidence 34566889999999999999999999999999999999999999999999988665433322233455566666777888
Q ss_pred EEcCCCCEEEEEE--EEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhh
Q 003963 207 AKTKTEERVLVVA--TNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (783)
Q Consensus 207 ~~~kdG~~~~v~~--~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~ 255 (783)
.+++||..+|+.+ +..|+.+.+|.+.|++++++|||++|++|++|+...
T Consensus 281 ~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se 331 (807)
T PRK13560 281 FQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEKE 331 (807)
T ss_pred EEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHHH
Confidence 8999999996655 456678999999999999999999999999987543
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.3e-10 Score=137.09 Aligned_cols=130 Identities=18% Similarity=0.245 Sum_probs=105.1
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCcccccccccc-chHHHHHHHHHHhCCeEEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
.+++.+++.++++|+++|.+|+|+++|+++++++||+.++++|+++.+++.+... ......+...+..+..+..+.++.
T Consensus 111 ~~~~~v~~~~~~gI~i~D~~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 190 (663)
T PRK10060 111 SFAEQVVSEANSVIVILDSRGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWIK 190 (663)
T ss_pred HHHHHHHhhCCceEEEEeCCCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEEE
Confidence 5678899999999999999999999999999999999999999999887654432 233345566788888899999999
Q ss_pred cCCCCEEEEEEEEEEEECCCCC-EEEEEEEEEehHHHHHHHHHHHHhhccccc
Q 003963 209 TKTEERVLVVATNTPFYDDDGT-LVGIVCVSTDSRPFQETRAALWDTKNSDTD 260 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~-v~g~v~i~rDITerk~~E~~L~~~~~~~~~ 260 (783)
+++|..+|+..... +.+.+|. ..+++++.+|||+++++++++++.......
T Consensus 191 ~~~G~~~~~~~~~~-~~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~L 242 (663)
T PRK10060 191 TRKGQRLFLFRNKF-VHSGSGKNEIFLICSGTDITEERRAQERLRILANTDSI 242 (663)
T ss_pred eCCCCEEEEEeeeE-EEcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCcc
Confidence 99999998876654 4444553 466888999999999999999876554443
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=137.84 Aligned_cols=127 Identities=22% Similarity=0.256 Sum_probs=112.4
Q ss_pred HHHHHHHHHhCcceEEEc---CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D---~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (783)
+.++.+++..+++|+++| .+|.|+|+|+++++++||+.++++|+++..++++.........+...+..+..+..++.
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 456789999999999997 47999999999999999999999999998888776655555567777888888888999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhc
Q 003963 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (783)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (783)
.+++||..+|+.++..|+.+.+|.+.+++++++|||++|++|+++++...
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~~~~ 277 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQRERR 277 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999876443
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-10 Score=128.75 Aligned_cols=144 Identities=15% Similarity=0.070 Sum_probs=112.7
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
...++.+++++++||+++|.+|+|+++|++|++++||+.++++|+++.++++.... ....+...+..+..+......+
T Consensus 6 ~~~~~~il~~~~~gi~~~d~~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 83 (348)
T PRK11073 6 LPDAGQILNSLINSILLLDDDLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFSL--NIELMRESLQAGQGFTDNEVTL 83 (348)
T ss_pred cchHHHHHhcCcCeEEEECCCCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcchh--hHHHHHHHHHcCCcccccceEE
Confidence 35689999999999999999999999999999999999999999999998764321 1223455666666555444555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i 286 (783)
.+||..+|+.++..|+. . .+++..++|||+++++++++....... ....+...++||+++||+...
T Consensus 84 ~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~~~~~~~-------~~~~~~~~iaHelr~pL~~i~ 149 (348)
T PRK11073 84 VIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQLQHAQQV-------AARDLVRGLAHEIKNPLGGLR 149 (348)
T ss_pred EECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHHHHHHHH-------HHHHHHHhhhHhhcChHHHHH
Confidence 67999999999999987 2 346778999999999888775543321 223488899999999998754
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.8e-10 Score=129.95 Aligned_cols=114 Identities=15% Similarity=0.030 Sum_probs=90.7
Q ss_pred HHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCC-hhhHcCCCccccccccccchHHHHHHHHHH-hCCeEEEEEEEE
Q 003963 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGERWTGQFPAK 208 (783)
Q Consensus 131 ~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys-~eEllG~~~~~l~~~~~~~~~~~~l~~~l~-~g~~~~~e~~~~ 208 (783)
.|+.++++++++|+++|.+|+|+++|++|++++||+ .++++|+++..++.+... . ...+...++ .|.....+....
T Consensus 253 ~~~~l~e~~~d~I~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~-~-~~~~~~~~~~~g~~~~~~~~~~ 330 (442)
T TIGR02040 253 NLARLYHEAPDAIVFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV-D-LRVLLSNVRRTGQVRLYATTLT 330 (442)
T ss_pred HHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc-c-HHHHHHHHhhcCceEEEEEEEE
Confidence 589999999999999999999999999999999997 578999999887764322 1 223333343 344444566678
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E 248 (783)
++||..+|+.+++.|+.+.++ ..++++++|||+|++.+
T Consensus 331 ~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~~~~ 368 (442)
T TIGR02040 331 GEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRLTMR 368 (442)
T ss_pred cCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhccCC
Confidence 999999999999999986555 45788999999998774
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-10 Score=115.66 Aligned_cols=139 Identities=20% Similarity=0.180 Sum_probs=98.6
Q ss_pred eeeeccCCcEEEEEEEEeC-------CceEEEEEEecccC--------------------CHHHHHH----HHHHHHHHH
Q 003963 510 GEQIGQGSCGTVYHAVWYG-------SQDVAVKVFSRQEY--------------------SDEVIHS----FRQEVSLMK 558 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~-------~~~vAiK~i~~~~~--------------------~~~~~~~----~~~Ei~il~ 558 (783)
...||.|--+.||.|.... +..+|||+.+.... .....+. ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 36899999743210 0111222 348999999
Q ss_pred hCCC--CceeeEeceeecCCceEEEEEecCCCCHHH-HHhhcCCcchHHHHHHHHHHHHHHHHHH-HhCCCCEEecCCCC
Q 003963 559 RLRH--PNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-LLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKS 634 (783)
Q Consensus 559 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~L~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~IvHrDIKp 634 (783)
++.. -++++++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |+.| |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 9853 456666654 45789999997654422 2222 1244455667778999999998 8888 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCcccc
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.|||+++ +.++|+|||.+....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 689999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-10 Score=144.80 Aligned_cols=130 Identities=13% Similarity=0.087 Sum_probs=110.2
Q ss_pred CCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhC-CeEEEEE
Q 003963 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG-ERWTGQF 205 (783)
Q Consensus 127 ~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g-~~~~~e~ 205 (783)
..++.++.+++.++++|+++|.+|+|+++|+++++++||+.+|++|++..+++++++.......+...+..+ ..+..+.
T Consensus 280 ~~e~r~~~l~e~~~~~i~~~d~dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~e~ 359 (1092)
T PRK09776 280 ESETRFRNAMEYSAIGMALVGTEGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEKLLSGEINSYSMEK 359 (1092)
T ss_pred HHHHHHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHHHHcCCccceeeee
Confidence 345678999999999999999999999999999999999999999999999888776544433333333332 2367788
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhc
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (783)
+..++||+.+|+..+..|+++.+|++.+++++++|||++|++|+++++..+
T Consensus 360 ~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~~ 410 (1092)
T PRK09776 360 RYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLME 410 (1092)
T ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHHH
Confidence 889999999999999999999999999999999999999999999876543
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.3e-10 Score=121.96 Aligned_cols=128 Identities=16% Similarity=0.251 Sum_probs=102.0
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
.+.++.+++.++++|+++|.+|+|++||++|++++||++++++|+++.+++.+.. +...+..+.. ...+...
T Consensus 5 ~~~l~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~-------~~~~l~~~~~-~~~~~~~ 76 (333)
T TIGR02966 5 LSRFRAAAQALPDAVVVLDEEGQIEWCNPAAERLLGLRWPDDLGQRITNLIRHPE-------FVEYLAAGRF-SEPLELP 76 (333)
T ss_pred HHHHHHHHHhCcCcEEEECCCCcEEEEcHHHHHHhCCChHHHcCCcHHHHccCHH-------HHHHHHhccc-CCCeEee
Confidence 4678999999999999999999999999999999999999999999988865432 3444444333 2234455
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~ 285 (783)
.++|..+|+.+...|+.+.+ ++.+++|||+++++++... .+...++|++++||..+
T Consensus 77 ~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~----------------~~~~~l~h~l~~pL~~i 132 (333)
T TIGR02966 77 SPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRR----------------DFVANVSHELRTPLTVL 132 (333)
T ss_pred cCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHH----------------HHHHhhhhhhcccHHHH
Confidence 68888999999999987542 6788999999998776542 27788899999999764
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.3e-10 Score=129.80 Aligned_cols=146 Identities=16% Similarity=0.222 Sum_probs=119.2
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe-EEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-~~~e~~~~ 208 (783)
..++.+++.++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++... ....+.+.+..+.. ...++...
T Consensus 262 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 339 (607)
T PRK11360 262 SLNELILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTP--FASPLLDTLEHGTEHVDLEISFP 339 (607)
T ss_pred HHHHHHHHhccCeEEEEcCCCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCchh--HHHHHHHHHhcCCCccceEEEEE
Confidence 4577899999999999999999999999999999999999999999998875432 23344556666655 33456667
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~ 285 (783)
.++|..+ +.++..|+.+.+|++.|++++++|||+++++|+++++....+ ....++..++|++++||+..
T Consensus 340 ~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~-------~l~~~~~~~~hel~~~l~~i 408 (607)
T PRK11360 340 GRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLA-------ALGELVAGVAHEIRNPLTAI 408 (607)
T ss_pred cCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHhhhHHHHH
Confidence 7888777 889999999999999999999999999999999987654322 13347888999999999764
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-09 Score=139.15 Aligned_cols=131 Identities=21% Similarity=0.208 Sum_probs=108.0
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCcccccccccc--chHHHHHHHHHHhCCe--EEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGER--WTG 203 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~--~~~~~~l~~~l~~g~~--~~~ 203 (783)
.++.++.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.++++.... ......+......+.. ...
T Consensus 534 ~~~~l~~~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (1092)
T PRK09776 534 EKERLHITLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQ 613 (1092)
T ss_pred HHHHHHHHHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccc
Confidence 456788899999999999999999999999999999999999999999887754322 1222234444444443 455
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccc
Q 003963 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSD 258 (783)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~ 258 (783)
+....++||..+|+..+..|+.+.+|++.|++++++|||++|+++++|+......
T Consensus 614 ~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~L~~~a~~D 668 (1092)
T PRK09776 614 DVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLVIQDVTESRKMLRQLSYSASHD 668 (1092)
T ss_pred eEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEEEEecchHHHHHHHHHhhcCCC
Confidence 6778899999999999999999999999999999999999999999987765543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-09 Score=112.18 Aligned_cols=142 Identities=21% Similarity=0.250 Sum_probs=104.5
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CceeeEeceeecC---CceEEEEEec
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSP---QRLCIVTEFL 585 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~ 585 (783)
+.|+.|.++.||++...+++.+++|+....... .....+.+|+.+++.+.+ .++++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998765578999997654321 123467889999999975 3456777766553 3678999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------------ 623 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------------ 623 (783)
+|.+|...+.. ..++......++.+++++|..||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888765431 2355566666677777777777742
Q ss_pred ------------CCCEEecCCCCCCEEEcC--CCcEEEEecCCCcc
Q 003963 624 ------------NPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRL 655 (783)
Q Consensus 624 ------------~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~ 655 (783)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 123799999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-09 Score=105.16 Aligned_cols=133 Identities=25% Similarity=0.338 Sum_probs=99.1
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCC-H-----HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS-D-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~-~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
..|++|+-+.+|.+.+.+. ++++|.=.++... + -...+-.+|+.++..++--.|.-.+-+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999976543 5777764333322 1 1234566799999988755554444455667778999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
++|..|.+++... ...++..+-.-+.-||..| |||+||.++||++..+ .+.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9998899888764 1345566667788899999 9999999999999877 499999999863
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-09 Score=97.74 Aligned_cols=106 Identities=22% Similarity=0.317 Sum_probs=77.4
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCC
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (783)
++.+|++++.+++++|.+++|.|+|+++.++++... ..+|+++.++.++.. ......+.+.+..|+....+.... .+
T Consensus 1 L~~il~s~~~~i~~vD~~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~-~~~l~~~i~~~~~~~~~~~~~~~~-~~ 77 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPLS-YPNLKKIIEQVRSGKEEEFEIVIP-NG 77 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HHH-HHHHHHHHHHHHTTSBSEEEEEEE-ET
T ss_pred ChHHHhcCCCCEEEEcCCCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCccc-hHHHHHHHHHHHcCCCceEEEEec-CC
Confidence 468999999999999999999999999999999764 568999999887633 344455667777887644333332 44
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
| .|+.+.+.|+++.+|++.|++.++.|||
T Consensus 78 ~--~~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 78 G--RWYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp T--EEEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred C--EEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 4 4667889999999999999999999998
|
|
| >COG5002 VicK Signal transduction histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4e-09 Score=110.48 Aligned_cols=132 Identities=20% Similarity=0.293 Sum_probs=109.3
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
+.+..++..+.|||+.+|..|+|+.+|..|++++|.+.++++|+++.+++.-++... +.+.+........+. .
T Consensus 111 ~kL~SvlayMtDGViATdRrG~iI~iN~~A~k~L~~~~E~~~~~~i~elL~i~d~y~----~~dL~e~~~s~lld~---~ 183 (459)
T COG5002 111 RKLDSVLAYMTDGVIATDRRGKIILINKPALKMLGVSKEDALGRSILELLKIEDTYT----FEDLVEKNDSLLLDS---S 183 (459)
T ss_pred HHHHHHHHHHcCceEeecCCCcEEEeccHHHHHhCcCHHHHhcccHHHHhCCcccee----HHHHHhcCCcEEEee---c
Confidence 568889999999999999999999999999999999999999999999987665433 233333333333222 2
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHH
Q 003963 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (783)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~ 284 (783)
.+++.+.+.+.-+.+.-+.|-+.|+|++..|+||+.+.|++.++ |.+.++|+++.||.+
T Consensus 184 ~~~E~~~lrv~Fs~i~rEsGfisGlIaVlhDvTEqek~e~ErRe----------------fvanvSHElRTPlts 242 (459)
T COG5002 184 DEEEGYVLRVNFSVIQRESGFISGLIAVLHDVTEQEKVERERRE----------------FVANVSHELRTPLTS 242 (459)
T ss_pred CCCccEEEEEEEEEEeecccccceeEEEEecccHHHHHHHHHHH----------------HHHhcchhhcCchHH
Confidence 26777888888888988999999999999999999999888755 888999999999977
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.4e-09 Score=129.87 Aligned_cols=125 Identities=23% Similarity=0.273 Sum_probs=105.2
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCcccccccccc-chHHHHHHHHHHhCCeEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPA 207 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~ 207 (783)
.+.+..+++.++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++... ......+...+..+..+..+.+.
T Consensus 135 ~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 214 (799)
T PRK11359 135 TRQLIIAVDHLDRPVIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLL 214 (799)
T ss_pred HHHHHHHHhcCCCcEEEEcCCCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEE
Confidence 35566789999999999999999999999999999999999999999887654433 23333455666666667778888
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHH
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (783)
.+++|..+|+.++..|+.+.+|.+.+++++++|||+++++++..+.
T Consensus 215 ~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~~ 260 (799)
T PRK11359 215 LTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEGN 260 (799)
T ss_pred eCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHHH
Confidence 8999999999999999999999999999999999999988765543
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-09 Score=128.87 Aligned_cols=147 Identities=10% Similarity=0.086 Sum_probs=116.9
Q ss_pred HHHHHHHHhCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCC--CccccccccccchHHHHHHHHHHhCC-eEEEEEE
Q 003963 131 QYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQ--DAIELLTDGRDFDVAYDIVHRIKMGE-RWTGQFP 206 (783)
Q Consensus 131 ~~~~ile~~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~--~~~~l~~~~~~~~~~~~l~~~l~~g~-~~~~e~~ 206 (783)
..+.++++.+++++..+.+ |..+.+|.....++||+.+++++. .+..++++++.......+...+..|. .+..+++
T Consensus 474 ~~~~~~e~~~~~i~~~~~~~~~~~~~~~~~~~~~G~~~~e~~~~~~~~~~~~~p~d~~~~~~~~~~~~~~g~~~~~~e~r 553 (807)
T PRK13560 474 LANLIVENSPLVLFRWKAEEGWPVELVSKNITQFGYEPDEFISGKRMFAAIIHPADLEQVAAEVAEFAAQGVDRFEQEYR 553 (807)
T ss_pred HHHHHHhcCCceEEEEecCCCceEEEecchhhhcCCCHHHhhcccchHhhhcChhhHHHHHHHHHHHHhcCCccceeEEE
Confidence 3467899999999887754 556666777788999999999863 34456666665444445555566554 3777889
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHH
Q 003963 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (783)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i 286 (783)
+.++||..+|+.....|++|.+|++.+++++++|||++|++|++|+....+ ++.|++.++||+++||+.+.
T Consensus 554 ~~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~aE~~L~~a~~~---------~~~~l~~isHelrnpL~~I~ 624 (807)
T PRK13560 554 ILGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHAEEKIKAALTE---------KEVLLKEIHHRVKNNLQIIS 624 (807)
T ss_pred EEcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHHHHHHHHHHHH---------HHHHHHHhHHHHhChHHHHH
Confidence 999999999999999999999999999999999999999999999765432 44589999999999998653
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-08 Score=82.69 Aligned_cols=103 Identities=28% Similarity=0.460 Sum_probs=86.2
Q ss_pred hCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEE
Q 003963 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (783)
Q Consensus 139 ~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (783)
++++++++|.+|.++++|+++++++|++..+++|+.+..++++.........+...+..+.....+......+|..+|+.
T Consensus 1 ~~~~i~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (103)
T cd00130 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVIWVL 80 (103)
T ss_pred CCceEEEECCCCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEEEE
Confidence 35789999999999999999999999999999999998888776654444444555555566777778888889999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEeh
Q 003963 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (783)
Q Consensus 219 ~~~~Pi~d~~G~v~g~v~i~rDI 241 (783)
....++.+.+|...+++++++||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 81 VSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEecCCCCEEEEEEEEecC
Confidence 99999998888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1e-08 Score=89.62 Aligned_cols=86 Identities=26% Similarity=0.471 Sum_probs=72.3
Q ss_pred EEEecHHHHHHcCCChhhHcCCC----ccccccccccchHHHHHHH-HHHhCCeEEEEEEEEcCCCCEEEEEEEEEEEEC
Q 003963 152 IIYWNRSAELLYGYSAEEALGQD----AIELLTDGRDFDVAYDIVH-RIKMGERWTGQFPAKTKTEERVLVVATNTPFYD 226 (783)
Q Consensus 152 Ii~~N~aae~L~Gys~eEllG~~----~~~l~~~~~~~~~~~~l~~-~l~~g~~~~~e~~~~~kdG~~~~v~~~~~Pi~d 226 (783)
|+|||+.+++|+||+.+++ +.. +..+++|++.......+.. ....+..+..+++++++||+.+|+.....+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 7899999999999999999 777 7788899988777777777 677788899999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 003963 227 DDGTLVGIVCVS 238 (783)
Q Consensus 227 ~~G~v~g~v~i~ 238 (783)
.+|+++.++++.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999998874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-08 Score=98.35 Aligned_cols=144 Identities=23% Similarity=0.217 Sum_probs=103.4
Q ss_pred EeeeeccCCcEEEEEEEEeCCceEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 509 IGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+..|-+|+-+.|+++.+.+ +.++||.-...... .-..++.++|+++|.++.--.|.-..-++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 45678899999999998765 45666653322221 123456788999999886444443333455566678999
Q ss_pred EecCC-CCHHHHHhhcCCcchHHHH-HHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---cEEEEecCCCcc
Q 003963 583 EFLPR-GSLFRLLQRNTTKLDWRRR-ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRL 655 (783)
Q Consensus 583 E~~~g-gsL~~~L~~~~~~l~~~~~-~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~ 655 (783)
||++| .++.+++......-..... ..++..|-+.+.-||..+ |||+||..+||++..++ .+.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4788888654433333333 678888999999999998 99999999999996543 468999999854
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-08 Score=114.25 Aligned_cols=116 Identities=23% Similarity=0.453 Sum_probs=94.6
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
+.|+.|++.+.++|+++|.+|+|+++|+++..++|++.++++|+++.+++.... ...+.+++..+++.......+.
T Consensus 117 ~~l~~il~~~~~~l~vvD~~G~~i~~N~~~~~~~gl~~e~~~gk~~~~v~~~~~----~s~~l~vl~~~kp~~~~~~~~~ 192 (560)
T COG3829 117 QRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGE----DSTLLEVLRTGKPIRDVVQTYN 192 (560)
T ss_pred HHHHHHHhhccCceEEEcCCCcEEEEcHHHHHHhCCCHHHHcCCcHHHHHhccC----CceehhhhhcCCcceeeeeeec
Confidence 668899999999999999999999999999999999999999999999871111 1126788999998777766665
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHh
Q 003963 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (783)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (783)
.+.. ..+..|++ .+|.+.|+|.+++|+++.+.+..++.+.
T Consensus 193 ~~~~----i~~~~pv~-~~g~l~G~v~~~~~~~~l~~l~~~~~~~ 232 (560)
T COG3829 193 GNKI----IVNVAPVY-ADGQLIGVVGISKDVSELERLTRELEES 232 (560)
T ss_pred CCce----eEeeccEe-cCCcEEEEEEeecchHHHHHHHHHHHHH
Confidence 5433 45677876 5779999999999999999887776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.2e-08 Score=105.73 Aligned_cols=219 Identities=17% Similarity=0.212 Sum_probs=153.6
Q ss_pred CcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec----CCceEEEEEecCC-CCH
Q 003963 517 SCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIVTEFLPR-GSL 590 (783)
Q Consensus 517 ~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-gsL 590 (783)
.-.+.|++... ++..|++|.+...+.... .....-++.++++.|+|||+|.++|.. +..+++|++|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45677888754 466799999843321110 011234788999999999999998863 4568999999986 477
Q ss_pred HHHHhh--------------cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 591 FRLLQR--------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 591 ~~~L~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+++... .+.+.++..+|.++.||..||.++|+.| +.-+-|.|.+||++.+.+++|.-.|+....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence 776532 1344788999999999999999999999 888999999999999989999877766544
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
..... +-+.+ -.+-|.=.||.+++.|.||..- +......+. . ...+...++.++
T Consensus 444 ~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~------~~~I~~~yS~D~ 498 (655)
T KOG3741|consen 444 QEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--H------LTRITTTYSTDL 498 (655)
T ss_pred cCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH--H------HHHhhhhhhHHH
Confidence 33210 11111 1456999999999999999543 222111111 0 122345688899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+++|..+....+++ -++.+++.+ +...||
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~---~~~~ff 527 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM---IGSRFF 527 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH---HHHHHH
Confidence 99999998888887 677777655 344444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.1e-10 Score=126.82 Aligned_cols=144 Identities=16% Similarity=0.276 Sum_probs=107.5
Q ss_pred HHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc--c-------ccCCCCCCcccCcccccCCC
Q 003963 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--T-------TKTGKGTPQWMAPEVLRNEP 682 (783)
Q Consensus 612 qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~-------~~~~~Gt~~Y~aPE~~~~~~ 682 (783)
+++.||.|+|.. .++||++|.|++|.++.++.+||+.|+++........ . .....-...|.|||.+.+..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 445899999976 3599999999999999999999999998764433111 0 01112356899999999988
Q ss_pred CCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHH--hhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHH
Q 003963 683 SDEKSDVYSFGVILWELA-TEKIPWDNLNSMQVIGA--VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756 (783)
Q Consensus 683 ~s~~sDIwSLG~il~ell-tG~~Pf~~~~~~~~~~~--i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~el 756 (783)
.+.++|+|||||++|-++ .|+..+........... ............+++.++++=|.+++..++..||++..+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 899999999999999999 56665544322221111 111223445668899999999999999999999988777
|
|
| >PRK11086 sensory histidine kinase DcuS; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.9e-08 Score=112.76 Aligned_cols=136 Identities=16% Similarity=0.239 Sum_probs=101.2
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCC---hhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS---AEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys---~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (783)
+.++.++++++++|+++|.+|+|+++|++|++++|++ ..+.+|+.+..+.+.. .+..++..+........
T Consensus 221 ~~~~~il~~~~~gIi~~D~~g~I~~~N~~a~~llg~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 293 (542)
T PRK11086 221 EQRQAMLQSIKEGVIAVDDRGEVTLINDEAKRLFNYKKGLEDDPLGTDVESWMPVS-------RLKEVLRTGTPRRDEEI 293 (542)
T ss_pred HHHHHHHHHhcCcEEEECCCCeEEEEhHHHHHHhCCCcCCcccccCCcHHHhCCch-------hHHHHHhcCCCccceEE
Confidence 3457899999999999999999999999999999875 3567788777665422 24556666665433222
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHH
Q 003963 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (783)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i 286 (783)
..+|. ++.+...|+.+ +|.+.|++.+++|+|+.+++++++....... ..+...+||++.||+.+.
T Consensus 294 --~~~g~--~~~~~~~pi~~-~g~~~g~v~~~rDite~~~l~~~l~~~~~~~----------~~l~~~sHel~npL~~I~ 358 (542)
T PRK11086 294 --NINGR--LLLTNTVPVRV-NGEIIGAIATFRDKTEVRQLAQRLDGMVNYA----------DALRAQSHEFMNKLHVIL 358 (542)
T ss_pred --EECCE--EEEEEEEEEeE-CCEEEEEEEEEEEchHHHHHHHHHHHHHHHH----------HHHHhhchhhcCHHHHHH
Confidence 22453 44566789987 8899999999999999999988886654321 244567899999998754
Q ss_pred H
Q 003963 287 A 287 (783)
Q Consensus 287 ~ 287 (783)
.
T Consensus 359 g 359 (542)
T PRK11086 359 G 359 (542)
T ss_pred H
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.6e-08 Score=98.85 Aligned_cols=127 Identities=28% Similarity=0.296 Sum_probs=82.9
Q ss_pred EEEEEEEeCCceEEEEEEecccC-----------------------C-HHHHHHHHHHHHHHHhCCCC--ceeeEeceee
Q 003963 520 TVYHAVWYGSQDVAVKVFSRQEY-----------------------S-DEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT 573 (783)
Q Consensus 520 ~Vy~a~~~~~~~vAiK~i~~~~~-----------------------~-~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~ 573 (783)
.||.|...++..+|||+.+.... . ........+|.+.|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988888999999743200 1 12345677899999999765 566776543
Q ss_pred cCCceEEEEEecC--CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHH-HHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 574 SPQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSY-LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 574 ~~~~~~lV~E~~~--ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+|+.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 3589999998 55554443321 2233445566677775555 57888 9999999999999988 9999999
Q ss_pred CCCccc
Q 003963 651 GLSRLK 656 (783)
Q Consensus 651 Gla~~~ 656 (783)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK11006 phoR phosphate regulon sensor protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.9e-08 Score=112.95 Aligned_cols=127 Identities=17% Similarity=0.237 Sum_probs=93.1
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
.+.|+.++++++++|+++|.+|+|++||++|++++||+.++++|+++.+++.... +...+..... .......
T Consensus 97 ~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~a~~l~g~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~ 168 (430)
T PRK11006 97 IKRFRSGAESLPDAVVLTTEEGNIFWCNGLAQQLLGFRWPEDNGQNILNLLRYPE-------FTQYLKTRDF-SRPLTLV 168 (430)
T ss_pred HHHHHHHHHhCCCeEEEEcCCCceeHHHHHHHHHhCCCChHhCCCcHHHHhcCHH-------HHHHHHhccc-CCCeEEE
Confidence 4678999999999999999999999999999999999999999999988765332 1222222221 1122333
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i 286 (783)
..+|. ++.+...|+.+ + +++.+++|||+++++++..+ .|++.++||+++||..+.
T Consensus 169 ~~~~~--~~~~~~~~~~~--~---~~~~~~~dit~~~~~e~~~~----------------~~~~~isHelrtPL~~i~ 223 (430)
T PRK11006 169 LNNGR--HLEIRVMPYTE--G---QLLMVARDVTQMHQLEGARR----------------NFFANVSHELRTPLTVLQ 223 (430)
T ss_pred cCCCC--EEEEEEEEcCC--C---cEEEEEehhhHHHHHHHHHH----------------HHHHHhHHHhcchHHHHH
Confidence 45554 44566667642 3 25678999999998876543 388889999999997643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.2e-08 Score=101.43 Aligned_cols=134 Identities=19% Similarity=0.147 Sum_probs=93.0
Q ss_pred CcEEEEEEEEeCCceEEEEEEecccCCHHHHH----------HHHHHHHHHHhCCCCce--eeEeceeec-----CCceE
Q 003963 517 SCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIH----------SFRQEVSLMKRLRHPNV--LLFMGAVTS-----PQRLC 579 (783)
Q Consensus 517 ~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~----------~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~~~~~ 579 (783)
....|+++.. +++.|.||........ ...+ .+.+|...+..|..-+| +..+++++. ....+
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 3344666543 4567999976432211 1111 36788888887743222 333334432 23478
Q ss_pred EEEEecCCC-CHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-------CCcEEEEec
Q 003963 580 IVTEFLPRG-SLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVKVGDF 650 (783)
Q Consensus 580 lV~E~~~gg-sL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-------~~~vkL~DF 650 (783)
+|||++++. +|.+++... ....+......++.+++..+.-||..| |+|+|+++.||||+. ++.+.|+||
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 999999876 799988532 233556677788999999999999999 999999999999975 468999999
Q ss_pred CCCc
Q 003963 651 GLSR 654 (783)
Q Consensus 651 Gla~ 654 (783)
+.+.
T Consensus 190 ~r~~ 193 (268)
T PRK15123 190 HRAQ 193 (268)
T ss_pred Cccc
Confidence 9875
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.2e-08 Score=119.48 Aligned_cols=126 Identities=15% Similarity=0.224 Sum_probs=99.7
Q ss_pred CCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EE
Q 003963 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WT 202 (783)
Q Consensus 127 ~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~ 202 (783)
..+..+..+++..+++++++|.+|+|++||+++++++||+.+|++|+++..++++.........+......+.. +.
T Consensus 9 ~~~~~~~~~le~~~~~i~~~d~~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (799)
T PRK11359 9 AADGIFFPALEQNMMGAVLINENDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMS 88 (799)
T ss_pred hhhhhHHHHHHhhcCcEEEEcCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCccccccc
Confidence 33456778899999999999999999999999999999999999999999998876654433334444444332 34
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHh
Q 003963 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (783)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (783)
.+++.+++||..+|+.+...|+. .+|.+ +++++.+|||++++++++++..
T Consensus 89 ~e~~~~~~dG~~~~v~~~~~~~~-~~g~~-~~~~~~~DiT~~~~~~~~~~~~ 138 (799)
T PRK11359 89 RELQLEKKDGSKIWTRFALSKVS-AEGKV-YYLALVRDASVEMAQKEQTRQL 138 (799)
T ss_pred eeeEEecCCcCEEEEEEEeeeec-cCCce-EEEEEEeeccchhhhHHHHHHH
Confidence 47788899999999999998874 55654 5788999999998887766543
|
|
| >PRK10820 DNA-binding transcriptional regulator TyrR; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.6e-08 Score=112.28 Aligned_cols=107 Identities=18% Similarity=0.264 Sum_probs=82.0
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
...++.||+++++||+++|.+|+|+++|++|++++|++.++++|+++.++++... +.+.++.+...... ...
T Consensus 79 ~~~L~aIL~sm~eGVi~vD~~G~I~~iN~aA~~Llg~~~eel~Gk~i~eli~~~~-------l~~~le~~~~~~~~-~~v 150 (520)
T PRK10820 79 HRALSALLEALPEPVLSIDMKGKVELANPASCQLFGQSEEKLRNHTAAQLINGFN-------FLRWLESEPQDSHN-EHV 150 (520)
T ss_pred HHHHHHHHHhCCCcEEEECCCCeeeHhHHHHHHHHCcCHHHHCCCcHHHHcCcch-------HHHHHHcCCCccce-EEE
Confidence 3568999999999999999999999999999999999999999999999887533 34456666542111 122
Q ss_pred cCCCCEEEEEEEEEEEE--CCCCCE--EEEEEEEEehHHHH
Q 003963 209 TKTEERVLVVATNTPFY--DDDGTL--VGIVCVSTDSRPFQ 245 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~--d~~G~v--~g~v~i~rDITerk 245 (783)
..+|..++ +...||. |++|.. .|+|.+++|+++..
T Consensus 151 ~~~g~~~~--v~~~PI~~~d~~g~~~~~GaVivlrd~~~l~ 189 (520)
T PRK10820 151 VINGQDFL--MEITPVYLQDENDQHVLVGAVVMLRSTARMG 189 (520)
T ss_pred EECCEEEE--EEEEeeeecCCCCceeEEEEEEEeccHHHHH
Confidence 34576555 4556776 666654 89999999998754
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-08 Score=116.35 Aligned_cols=113 Identities=11% Similarity=0.036 Sum_probs=88.0
Q ss_pred HHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCC-eEEEEEEEEcCCCCE
Q 003963 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-RWTGQFPAKTKTEER 214 (783)
Q Consensus 136 le~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~-~~~~e~~~~~kdG~~ 214 (783)
++.++|+|+++|.+|+|++||.++++++||+.+|++|+++.++++++........+...+..+. .+..+.....++|..
T Consensus 2 ~~~~~d~~~~~d~~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~ 81 (442)
T TIGR02040 2 LATAADVTLLLDAEGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPSSFE 81 (442)
T ss_pred CcccCcEEEEECCCCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCCCCc
Confidence 5678999999999999999999999999999999999999999987764444344445556554 344455555667778
Q ss_pred EEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHH
Q 003963 215 VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (783)
Q Consensus 215 ~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~ 252 (783)
+|+.++..++.+ + .+++++.+|||++++.+++|.
T Consensus 82 ~~~~~~~~~~~~--~--~~~~~i~rDi~~~~~~~~~l~ 115 (442)
T TIGR02040 82 LPMRFILVRLGA--D--RGVLALGRDLRAVAELQQQLV 115 (442)
T ss_pred cCeEEEEEEeCC--C--CeEEEEecccHHHHHHHHHHH
Confidence 888888777654 2 256789999999998877763
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.2e-08 Score=89.69 Aligned_cols=105 Identities=24% Similarity=0.354 Sum_probs=75.0
Q ss_pred HHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhH-cCCCcccccccc------ccchHHHHHHHH---HHhCCeEEEEE
Q 003963 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA-LGQDAIELLTDG------RDFDVAYDIVHR---IKMGERWTGQF 205 (783)
Q Consensus 136 le~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEl-lG~~~~~l~~~~------~~~~~~~~l~~~---l~~g~~~~~e~ 205 (783)
|+++++||+++|.+|++++||++|.+|+|++.+.+ .|.++.+++... ........+.+. ........ +
T Consensus 1 Ld~l~~Gv~v~D~~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~ 78 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS--F 78 (115)
T ss_pred CCCcCceEEEEcCCCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce--e
Confidence 47899999999999999999999999999999998 799888765311 111112222222 33333322 3
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~ 249 (783)
.....|| .|+.++..|+- +| |+|.++.|||+++++|+
T Consensus 79 ~~~~~dg--r~l~~~~~~~~--~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 79 ELRLPDG--RWLEVRAQPLP--DG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred EEECCCC--EEEEEEeEECC--CC---CEEEEEEeCCHHHHhcC
Confidence 3456777 46678888874 45 58899999999998874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-07 Score=97.83 Aligned_cols=136 Identities=26% Similarity=0.246 Sum_probs=98.1
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEeccc------------------CC--HHHHHHHHHHHHHHHhCCCC--c
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQE------------------YS--DEVIHSFRQEVSLMKRLRHP--N 564 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~------------------~~--~~~~~~~~~Ei~il~~l~Hp--n 564 (783)
+.++.+||-|.-+.||.|.+..+.++|||.-+... .+ .-......+|.++|..|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45778999999999999999888899999753221 11 12234577899999999754 6
Q ss_pred eeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 565 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
|++.+++ +...+||||++|-.|+..- +.....-.++..|+.-+.-+-..| |||+|+.+-||||+++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 7777653 5678999999987776542 122223333444444444444667 999999999999999999
Q ss_pred EEEEecCCCc
Q 003963 645 VKVGDFGLSR 654 (783)
Q Consensus 645 vkL~DFGla~ 654 (783)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999997553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.9e-07 Score=92.39 Aligned_cols=105 Identities=30% Similarity=0.308 Sum_probs=80.8
Q ss_pred HHHHHHHHHHHhCCCCc--eeeEeceeecC----CceEEEEEecCCC-CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHH
Q 003963 548 HSFRQEVSLMKRLRHPN--VLLFMGAVTSP----QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620 (783)
Q Consensus 548 ~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~L 620 (783)
.+..+|...+..|..-. +++.+++.+.. ...++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35677888777774322 34455554432 2358999999874 79999876332 56667788899999999999
Q ss_pred HhCCCCEEecCCCCCCEEEcCCC---cEEEEecCCCcc
Q 003963 621 HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRL 655 (783)
Q Consensus 621 H~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~ 655 (783)
|..| |+|+|+++.||||+.++ .+.|+||+.++.
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=98.52 E-value=8.6e-08 Score=109.93 Aligned_cols=153 Identities=8% Similarity=0.032 Sum_probs=101.1
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEE-EEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT-GQFPA 207 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~-~e~~~ 207 (783)
...++.++++++++|+++|.+|+|+++|+++++++|+...+..+..+..++.+.... .+......+..+. .+...
T Consensus 129 ~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 204 (494)
T TIGR02938 129 KLLIESVVDAAPVAFVLLDPTGRVILDNQEYKKLATDLRVKEPAHTVLDLLREAWRE----ALAENWPQQLAFSNREARF 204 (494)
T ss_pred HHHHHHHHhcccceEEEEcCCCCEEEechhHHHhhchhhhhHHHHHHHHHhhHHhhh----hhhhcchhhhccccceeee
Confidence 356789999999999999999999999999999999998888777665554433221 1111111222222 23334
Q ss_pred EcCCCC-EEEEEEEEEEEECCCCCE---------EEEEEEEEehHHHHHHHHHHHHhhccc---cccccCCchhHHHHhh
Q 003963 208 KTKTEE-RVLVVATNTPFYDDDGTL---------VGIVCVSTDSRPFQETRAALWDTKNSD---TDSNINRPRNTVTAKL 274 (783)
Q Consensus 208 ~~kdG~-~~~v~~~~~Pi~d~~G~v---------~g~v~i~rDITerk~~E~~L~~~~~~~---~~~~~~~~~~~l~~~l 274 (783)
...+|. .+|+.....++.+.+|.+ .+++++++|||++|+.|++++.....+ .........+ ++...
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~DITe~k~~ee~l~~~al~~~~~~~~~~~~l~~-~~~~~ 283 (494)
T TIGR02938 205 DRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQPYLLLTIADISNLREEQERARLSALQALMAEEERLEAIRE-TLSAA 283 (494)
T ss_pred ccCCCceeeEEEecCceEEeecchhhheeccCCCchheehHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHH
Confidence 445555 789998888887666543 345678999999999998875432221 1111222223 45556
Q ss_pred cCCchhHHHHHH
Q 003963 275 GLDSQQPLQATI 286 (783)
Q Consensus 275 ~~d~~qpl~~~i 286 (783)
.|++++||+.+.
T Consensus 284 ~h~lr~pL~~i~ 295 (494)
T TIGR02938 284 IHRLQGPMNLIS 295 (494)
T ss_pred HHHHhcHHHHHH
Confidence 699999997643
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.1e-08 Score=113.03 Aligned_cols=238 Identities=19% Similarity=0.203 Sum_probs=162.2
Q ss_pred eEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc-eeeEeceeecCCceEEEEEecC
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~ 586 (783)
...+-+++|++++++|.+....+....+++... ....-++++|.+++||| .+..++-++.+.+.+++|+++.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 344567899999999987655545556665443 23445899999999999 7777888888889999999998
Q ss_pred CC-CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccC
Q 003963 587 RG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 665 (783)
Q Consensus 587 gg-sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 665 (783)
++ +...........+..-....+.+.-++++++||+.- =+|+| ||+..+ +.+++.||+....+.... ...+
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t 389 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRT 389 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cccc
Confidence 77 222222211222444455566677788999999863 38888 777766 589999999887665554 4456
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC--CCCCHHHH-HHHHHh
Q 003963 666 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWA-AIVESC 742 (783)
Q Consensus 666 ~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~-~LI~~c 742 (783)
..+++.+++||+.....+....|.|+++.--.+|.-|.+|-... ......+......+.+. ..+++... ++...|
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~ 467 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPC 467 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccc
Confidence 67899999999999999999999999998877888887775431 11111111000001111 11222222 367788
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
+...|..++..... +.+++|
T Consensus 468 ~~g~P~~pkv~mga------cfsKvf 487 (829)
T KOG0576|consen 468 LNGLPPTPKVHMGA------CFSKVF 487 (829)
T ss_pred cCCCCCCCcchhhH------HHHHHh
Confidence 88888888887776 667777
|
|
| >COG3290 CitA Signal transduction histidine kinase regulating citrate/malate metabolism [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.2e-07 Score=99.02 Aligned_cols=114 Identities=21% Similarity=0.314 Sum_probs=94.8
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChh--hHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE--EALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~e--EllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
-.++|+++.+||+.+|+.|.|..+|.+|++|+|+... +.+|+++.++++|+.+ +..+++.+++...+...+
T Consensus 217 r~A~l~si~EGviAvd~~G~It~~N~~A~~ll~~~~~~~~~ig~~i~~v~~p~~~------l~~vl~~~~~~~~~e~~~- 289 (537)
T COG3290 217 RQAMLQSIKEGVIAVDKKGVITLINQAAQKLLGLRQPSGDPIGRSIVEVLPPDSD------LPEVLETGKPQHDEEIRI- 289 (537)
T ss_pred HHHHHHHhhceEEEECCCCeEeehhHHHHHHhcccCcCcccccccceEeeccccC------cHHHHhcCCcccchhhhc-
Confidence 3567999999999999999999999999999999765 7999999999988554 566788888766554433
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhc
Q 003963 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (783)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (783)
+| .++.++..||. .+|+++|+|..|||-||.+++-++|...++
T Consensus 290 -ng--~~~i~nr~pI~-~~~~~~GaI~tFRdktei~~L~eqLt~vr~ 332 (537)
T COG3290 290 -NG--RLLVANRVPIR-SGGQIVGAIITFRDKTEIKKLTEQLTGVRQ 332 (537)
T ss_pred -CC--eEEEEEeccEE-ECCEEeEEEEEEecHHHHHHHHHHHHHHHH
Confidence 33 46677888997 578999999999999999999999976555
|
|
| >COG3852 NtrB Signal transduction histidine kinase, nitrogen specific [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.8e-06 Score=88.37 Aligned_cols=139 Identities=19% Similarity=0.146 Sum_probs=106.0
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEE-EEEEEcC
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG-QFPAKTK 210 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~-e~~~~~k 210 (783)
-..+|+++..+|+++|.+|.|.|+|++|+.+||.+..-+.|..+..|++.... ...-+.++...+.+... ++.+. .
T Consensus 9 ~~~~Ln~~~~pVl~vd~~~~i~yaN~aAe~~~~~Sa~~L~~~~l~~l~~~gs~--ll~ll~q~~~~~~~~~~~~v~l~-~ 85 (363)
T COG3852 9 AGAILNNLINPVLLVDDELAIHYANPAAEQLLAVSARRLAGTRLSELLPFGSL--LLSLLDQVLERGQPVTEYEVTLV-I 85 (363)
T ss_pred cHhHHhccCCceEEEcCCCcEEecCHHHHHHHHHHHHHHhcCChHHHcCCCcH--HHHHHHHHHHhcCCcccceeeee-e
Confidence 35789999999999999999999999999999999999999999999987754 23345667777776433 33333 7
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHH
Q 003963 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQ 283 (783)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~ 283 (783)
+|....+++++.|+-...|- ++..++.+....++.+++.+... .+...++...++|+++.||-
T Consensus 86 ~g~~~~v~~~v~~v~~~~G~---vlle~~~~~~~~ridre~~q~a~-------~~a~~~L~r~LAHEIKNPL~ 148 (363)
T COG3852 86 LGRSHIVDLTVAPVPEEPGS---VLLEFHPRDMQRRLDREQTQHAQ-------QRAVKGLVRGLAHEIKNPLG 148 (363)
T ss_pred cCccceEEEEEeeccCCCCe---EEEEechhHHHhHhhHHHHHHHH-------HHHHHHHHHHHHHHhcCccc
Confidence 89999999999999766664 56677777777766666443222 12345688888888887774
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.4e-06 Score=85.96 Aligned_cols=136 Identities=15% Similarity=0.216 Sum_probs=83.7
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc--eeeEeceeecCCceEEEEEecCCC
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
.+||+|..+.||+. .+..+++|+..... .. ....+|.++++.+..-. +.+.+.+....+..++|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 24468889876533 22 34578999998886433 467777777777789999999885
Q ss_pred C-HHHHHh--------------h-----cCC---cchHHHHH-HHHH----------HHHHH-HHHHH--hCCCCEEecC
Q 003963 589 S-LFRLLQ--------------R-----NTT---KLDWRRRI-LMAL----------DIARG-VSYLH--HCNPPIIHRD 631 (783)
Q Consensus 589 s-L~~~L~--------------~-----~~~---~l~~~~~~-~i~~----------qi~~a-L~~LH--~~~~~IvHrD 631 (783)
. +...+. . +.. ........ .+.. .+... ..+|. .....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 211110 0 000 00111000 0000 01111 12222 1223488999
Q ss_pred CCCCCEEEcCCCcEEEEecCCCc
Q 003963 632 LKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 632 IKp~NILl~~~~~vkL~DFGla~ 654 (783)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.7e-06 Score=84.42 Aligned_cols=138 Identities=18% Similarity=0.106 Sum_probs=98.7
Q ss_pred ccCCcEEEEEEEEeCCceEEEEEEecccC-C---HHHHHHHHHHHHHHHhCCCCc--eeeEeceee---cC--CceEEEE
Q 003963 514 GQGSCGTVYHAVWYGSQDVAVKVFSRQEY-S---DEVIHSFRQEVSLMKRLRHPN--VLLFMGAVT---SP--QRLCIVT 582 (783)
Q Consensus 514 G~G~fG~Vy~a~~~~~~~vAiK~i~~~~~-~---~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~---~~--~~~~lV~ 582 (783)
|+||.+-|+.....+. .+-+|.-..... + +.-...|.+|+..|+.|..-+ +++.. ++. .+ -..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6799999999765544 688887531110 0 112467889999999885322 34444 222 12 2368999
Q ss_pred EecCC-CCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc--EEEEecCCCcc
Q 003963 583 EFLPR-GSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRL 655 (783)
Q Consensus 583 E~~~g-gsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~--vkL~DFGla~~ 655 (783)
|-++| -+|.+++.... .+.+......++.+++..+.-||+.| +.|+|+.+.|||++.++. |+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98853 48988886532 24567777788999999999999999 999999999999986667 99999986653
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.2e-06 Score=93.44 Aligned_cols=118 Identities=14% Similarity=0.199 Sum_probs=98.4
Q ss_pred HHHHHHHHHHhC--cceEEE-cC---CCcEEEecHHHHHHcCCChhhHcCCCccc--cccccccchHHHHHHHHHHhCCe
Q 003963 129 DRQYLNILQSMG--QSVHIF-DL---SDRIIYWNRSAELLYGYSAEEALGQDAIE--LLTDGRDFDVAYDIVHRIKMGER 200 (783)
Q Consensus 129 ~~~~~~ile~~~--d~I~i~-D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~--l~~~~~~~~~~~~l~~~l~~g~~ 200 (783)
+-+++.|+.... |.-+++ +. |..|+|+|..||+|.||.+.|++.++|.- +++...+......+.+.++.-+.
T Consensus 13 NTFLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~ 92 (971)
T KOG0501|consen 13 NTFLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYET 92 (971)
T ss_pred hhHHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhh
Confidence 356777776554 554543 33 68999999999999999999999988754 44455556677788888988888
Q ss_pred EEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHH
Q 003963 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (783)
-..++.++.|+...+|+.+.+.||+++.+.++-+++.|+|||..|+
T Consensus 93 ~qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQ 138 (971)
T KOG0501|consen 93 NQFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQ 138 (971)
T ss_pred cceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcC
Confidence 8889999999999999999999999999999999999999999875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.4e-06 Score=98.04 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=95.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEeccc---------------------------CC-----HHHHHH-
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQE---------------------------YS-----DEVIHS- 549 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~---------------------------~~-----~~~~~~- 549 (783)
.+..|.- +.|+.++-|.||+|+.++++.||||+.+..- .+ ++..+.
T Consensus 124 ~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 124 LFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 3344442 6899999999999999999999999975321 11 111122
Q ss_pred -----HHHHHHHHHhCC-----CCceeeEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHH
Q 003963 550 -----FRQEVSLMKRLR-----HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619 (783)
Q Consensus 550 -----~~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~ 619 (783)
+.+|...+.+++ .++|.-..-|++.-..-+|+|||++|..+.+...-....++...+.....++. +..
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHH
Confidence 233444444442 34443323333444567899999999988887432223344333333222222 222
Q ss_pred HHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 620 LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+-..| ++|.|..|.||+++.+|++.+.|||+......
T Consensus 281 ~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33356 99999999999999999999999999865443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.8e-06 Score=84.01 Aligned_cols=141 Identities=18% Similarity=0.213 Sum_probs=82.8
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCC--ceeeEeceee---cCCceEEEEEe
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT---SPQRLCIVTEF 584 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lV~E~ 584 (783)
++.|+.|..+.||++...+ +.+++|+.... .....+.+|..+++.|... .+.+++.+.. .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 4689999999999999777 69999996544 3445677888888887532 3456665432 23347899999
Q ss_pred cCCCCHHH----------------HHh---hc--C-CcchH-H--------HHHHH------------HHHHHH-HHHHH
Q 003963 585 LPRGSLFR----------------LLQ---RN--T-TKLDW-R--------RRILM------------ALDIAR-GVSYL 620 (783)
Q Consensus 585 ~~ggsL~~----------------~L~---~~--~-~~l~~-~--------~~~~i------------~~qi~~-aL~~L 620 (783)
++|..+.. .+. .. . ..+.. . ..... ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99987777 111 10 0 00000 0 00000 011222 23333
Q ss_pred Hh-----CCCCEEecCCCCCCEEEc-CCCcEEEEecCCCcc
Q 003963 621 HH-----CNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRL 655 (783)
Q Consensus 621 H~-----~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~ 655 (783)
+. ....++|+|+.|.|||++ .++.|.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 32 223499999999999999 667778999997743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-05 Score=81.81 Aligned_cols=140 Identities=16% Similarity=0.136 Sum_probs=91.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHH-HHHH------HHHHHHHHHhC---CCCceeeEece
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDE-VIHS------FRQEVSLMKRL---RHPNVLLFMGA 571 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~-~~~~------~~~Ei~il~~l---~HpnIv~l~~~ 571 (783)
+...+|.+.+.+-......|.+.... ++.+++|.........+ .... ..+.+..+..+ .-..++.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45678899898888887777776644 46899998765442221 1111 12233333333 22333333333
Q ss_pred eec-----CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEE
Q 003963 572 VTS-----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 646 (783)
Q Consensus 572 ~~~-----~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vk 646 (783)
.+. -...+++|||++|..|.++.. +++ .+...|+.++.-||..| ++|+|..|.|++++++ .++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-cEE
Confidence 322 234578999999988876542 222 13345677889999999 9999999999999966 599
Q ss_pred EEecCCCc
Q 003963 647 VGDFGLSR 654 (783)
Q Consensus 647 L~DFGla~ 654 (783)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK15053 dpiB sensor histidine kinase DpiB; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-05 Score=92.99 Aligned_cols=114 Identities=19% Similarity=0.200 Sum_probs=82.4
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCCh--hhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~--eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (783)
+.++.+++++.+||+++|.+|+|+++|++|++++|++. ++++|+++.+++++... +...... ......
T Consensus 222 ~~~~~il~~~~egii~~D~~g~I~~~N~~a~~ll~~~~~~~~~~g~~~~~~~~~~~~------~~~~~~~-~~~~~~--- 291 (545)
T PRK15053 222 RQQEALFSSVYEGLIAVDPHGYITAINRNARKMLGLSSPGRQWLGKPIAEVVRPADF------FTEQIDE-KRQDVV--- 291 (545)
T ss_pred HHHHHHHHHhCceEEEECCCCeEEeecHHHHHHhCCCCcchhhcCCcHHHhCCCchh------hhhhcCC-cccceE---
Confidence 44577999999999999999999999999999999975 57999999888764321 1111111 111111
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhc
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (783)
...+| ..+.++..|+.. +|++.|++.+++|+|+.++++.++.....
T Consensus 292 ~~~~~--~~~~~~~~~i~~-~~~~~G~v~~~~d~te~~~l~~~l~~~~~ 337 (545)
T PRK15053 292 ANFNG--LSVIANREAIRS-GDDLLGAIISFRSKDEISTLNAQLTQIKQ 337 (545)
T ss_pred EEECC--EEEEEEeeeEEE-CCeEEEEEEEEEchHHHHHHHHHHHHHHH
Confidence 12244 334567778874 56788999999999999998888866543
|
|
| >PRK09959 hybrid sensory histidine kinase in two-component regulatory system with EvgA; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-05 Score=103.73 Aligned_cols=155 Identities=10% Similarity=0.047 Sum_probs=90.6
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCcccccccccc-chHHHHHHHHHHhCCeEEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
++++.++++++++|+++|.+|+|+++|++|++++|+...+..+........+-.. .................. .....
T Consensus 576 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 654 (1197)
T PRK09959 576 SFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIY-TQVFE 654 (1197)
T ss_pred HHHHHHHhhCCCcEEEEcCCCcEEEehHHHHHHhCcccccccccccccccCchhhhHhHHHHHHHHHhhccccc-eeeEe
Confidence 5578899999999999999999999999999999987543333222211111000 000001111111111111 11122
Q ss_pred cCCCCEEEEEEE-EEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHHH
Q 003963 209 TKTEERVLVVAT-NTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287 (783)
Q Consensus 209 ~kdG~~~~v~~~-~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i~ 287 (783)
..+|...++... ..+.....+...++++.++|||++++++++++...+...... ..+..|++.++||+++||..++.
T Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dite~~~~~~~l~~~~~~~~~~~--~~~~~~~~~isHelrtPL~~i~~ 732 (1197)
T PRK09959 655 IDNGIEKRCINHWHTLCNLPASDHAVYICGWQDITETRDLIHALEVERNKAINAT--VAKSQFLATMSHEIRTPISSIMG 732 (1197)
T ss_pred eecCccceeeeeeeeeeccCCCCceEEEEEEEehhHHHHHHHHHHHHHHHHHHHH--HHHHHHHHhcChhhCccHHHHHH
Confidence 233433222222 222222334456788899999999999998877655432221 24456999999999999987543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.4e-05 Score=82.10 Aligned_cols=139 Identities=22% Similarity=0.166 Sum_probs=91.3
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccC--------------------CH--HHHHHHHHHHHHHHhCC--CCce
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY--------------------SD--EVIHSFRQEVSLMKRLR--HPNV 565 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~--------------------~~--~~~~~~~~Ei~il~~l~--HpnI 565 (783)
...|..|.-+.||+|...+...+|+|++..... .. ........|...|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 346778888999999887778999999854321 11 11223445777777764 3334
Q ss_pred eeEeceeecCCceEEEEEecCCCCH-HHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCC
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL-~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~ 643 (783)
++.+.+. ...|||||+....+ .-.|. ..++.......+..++++.+.-|-. .+ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 4444433 34799999955311 11111 1123333566666778888877765 66 99999999999999 77
Q ss_pred cEEEEecCCCcccc
Q 003963 644 TVKVGDFGLSRLKH 657 (783)
Q Consensus 644 ~vkL~DFGla~~~~ 657 (783)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999876444
|
|
| >PF14598 PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W_A 3F1P_A 3H82_A 3F1N_A 4F3L_B 4DJ3_A 2KDK_A | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.7e-05 Score=71.42 Aligned_cols=95 Identities=22% Similarity=0.307 Sum_probs=78.5
Q ss_pred EEcCCCcEEEecHH-HHHHcCCChhhHcCCCccccccccccch-HHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEEEEEE
Q 003963 145 IFDLSDRIIYWNRS-AELLYGYSAEEALGQDAIELLTDGRDFD-VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNT 222 (783)
Q Consensus 145 i~D~~G~Ii~~N~a-ae~L~Gys~eEllG~~~~~l~~~~~~~~-~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~~ 222 (783)
-.+.+|+|+++-.. ...++||..+|++|+.+.+|+++++... .......++..|+....-+++..++|..+|+.....
T Consensus 7 rhs~dgki~~~d~~~v~~~lgy~~~eLvG~s~y~~~H~~D~~~~~~~~~~~~~~~g~~~~~~yR~~~k~g~~vwvqt~~~ 86 (111)
T PF14598_consen 7 RHSLDGKITYVDSRAVSSLLGYLPEELVGRSIYDFVHPDDLQRVLKQHHREVLQKGQSVSPYYRFRTKNGGYVWVQTKAT 86 (111)
T ss_dssp EEETTSBEEEEETTHHHHHHSS-HHHHTTSBGGGGBSCCTHHHHHHHHHHHHHHHSSEEEEEEEEE-TTSSEEEEEEEEE
T ss_pred EECCCcEEEEEcCccChhhcCCCcHHHcCCchHHhCCHhhhhhHHHHHHHHHhhCCCcCcceEEEEecCCcEEEEEEEEE
Confidence 36789999999999 5999999999999999999999998764 555677888999988888999999999999999999
Q ss_pred EEECC-CCCEEEEEEEEE
Q 003963 223 PFYDD-DGTLVGIVCVST 239 (783)
Q Consensus 223 Pi~d~-~G~v~g~v~i~r 239 (783)
++.+. .+++..++++-+
T Consensus 87 ~~~n~~~~~~~~Iv~~n~ 104 (111)
T PF14598_consen 87 LFYNPWTSKPEFIVCTNT 104 (111)
T ss_dssp EEEETTTTCEEEEEEEEE
T ss_pred EEECCCCCCccEEEEEEE
Confidence 99864 456666665544
|
... |
| >COG5000 NtrY Signal transduction histidine kinase involved in nitrogen fixation and metabolism regulation [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.1e-05 Score=91.04 Aligned_cols=135 Identities=18% Similarity=0.135 Sum_probs=92.2
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
++++.+|+.++.||+.+|.+|+|.-+|+++|+|+|.+..+++|+++..+.+.- ...+...-..+.........+.
T Consensus 370 ~f~E~VLsgvtaGVi~~d~~g~i~t~N~~ae~~l~~~~~~~~G~~lsa~ap~~-----~~vf~~~~a~~~~~~~~ev~~~ 444 (712)
T COG5000 370 RFLEAVLSGLTAGVIGFDNRGCITTVNPSAEQILGKPFDQLLGQSLSAIAPEL-----EEVFAEAGAAARTDKRVEVKLA 444 (712)
T ss_pred HHHHHHHhcCceeEEEEcCCCeeEeecchHHHHhcCChhHhhcchhhhhhhHH-----HHHHHHhhhhcCCCccceeecc
Confidence 56788999999999999999999999999999999999999999977654321 1112222222333333333344
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHH
Q 003963 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (783)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~ 285 (783)
..|+.+.+.+.++-...++| .|+|.++-|||+...+++.. ....+..++.||++.||.-+
T Consensus 445 r~g~~rtl~Vq~t~~~~d~~--~gyVvt~DDITdLV~AQRs~--------------AW~dVArRIAHEIKNPLTPI 504 (712)
T COG5000 445 REGEERTLNVQATREPEDNG--NGYVVTFDDITDLVIAQRSA--------------AWGDVARRIAHEIKNPLTPI 504 (712)
T ss_pred cCCCceeeeeeeeecccccC--CceEEEecchHHHHHHHHHH--------------HHHHHHHHHHHHhcCCCchh
Confidence 45555655555544432223 47899999999999886653 12336677777777777653
|
|
| >COG2202 AtoS FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.6e-05 Score=72.10 Aligned_cols=117 Identities=25% Similarity=0.440 Sum_probs=89.4
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHH--hCCeEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK--MGERWTGQFPA 207 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~--~g~~~~~e~~~ 207 (783)
..++.+++.++++++++|.+|.|+++|+++++++||+..+.+++....+.................. .......+...
T Consensus 112 ~~~~~~~~~~~~~~~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (232)
T COG2202 112 ERLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEYRV 191 (232)
T ss_pred HHHHHHHhhCCceEEEEeCCCCEEEeCHHHHHHhCCChHHhcCCChhheEecCCCchhhHHHHHHhhccCCCCcceEEEE
Confidence 3377899999999999999999999999999999999888888887776654443211112222222 23346778888
Q ss_pred EcCCCCE-EEEEEEEEEEECCCCCEEEEEEEEEehHHHHHH
Q 003963 208 KTKTEER-VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (783)
Q Consensus 208 ~~kdG~~-~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (783)
..++|.. .++.....+... +|.+.+++....|++++++.
T Consensus 192 ~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~ 231 (232)
T COG2202 192 RRKDGERVRWILSRISPVRD-DGEIVGVVGIARDITERKQA 231 (232)
T ss_pred EecCCCEEEEEEeeeeEecC-CCceEEEEEEEechHHHhhc
Confidence 8999996 888777777654 78899999999999998764
|
|
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=2e-05 Score=94.36 Aligned_cols=107 Identities=19% Similarity=0.198 Sum_probs=81.8
Q ss_pred HHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCC
Q 003963 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (783)
Q Consensus 133 ~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG 212 (783)
..+++.+.+||+++|.+|+|+++|+++++++|++.++++|+++.+++.... .+..++..++...........+|
T Consensus 206 ~~il~~~~~gVl~vD~~G~I~~~N~aa~~llg~s~~~l~G~~i~~l~~~~~------~l~~vl~~~~~~~~~~~~l~~~g 279 (638)
T PRK11388 206 NALLESMDDGVIAWDEQGNLQFLNAQAARLLRLDATASQGRAITELLTLPA------VLQQAIKQAHPLKHVEVTFESQG 279 (638)
T ss_pred HHHHhccCCcEEEECCCCeEehhhHHHHHHhCcCHHHHCCCcHHHHhccch------HHHHHHhcCCceeeEEEEEecCC
Confidence 448899999999999999999999999999999999999999998875321 24556777776544333344567
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHH
Q 003963 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (783)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (783)
..+++.+++.|+.+..| .+++.+++|++..++.
T Consensus 280 ~~~~~~v~~~Pi~~~~g--~~~v~~l~~~~~~~~~ 312 (638)
T PRK11388 280 QFIDAVITLKPIIEGQG--TSFILLLHPVEQMRQL 312 (638)
T ss_pred ceEEEEEEEEeecccCc--eEEEEEehhhHHHHHH
Confidence 77788999999975445 3466677888775543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 783 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-93 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-92 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-43 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-43 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-43 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-43 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-40 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-40 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-40 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-40 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-40 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-40 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-40 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-40 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-40 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-39 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-39 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-37 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-36 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-36 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-36 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-35 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-35 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-34 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-34 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-34 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-34 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-34 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-34 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-34 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-34 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-34 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-34 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-34 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-34 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-34 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-34 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-34 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-34 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-34 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-34 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-34 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-34 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-34 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-34 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-34 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-34 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-34 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-34 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-34 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-34 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-34 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-34 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-34 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-34 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-34 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-34 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-33 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-33 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-33 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-33 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-33 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-33 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-33 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-33 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-33 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-33 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-33 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-33 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-33 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-33 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-33 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-33 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-33 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-33 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-33 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-33 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-33 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-33 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-33 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-33 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-33 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-32 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-32 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-32 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-32 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-32 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-32 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-32 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-32 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-32 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-32 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-32 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-32 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-32 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-32 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-31 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-31 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-31 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-31 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-31 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-31 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-31 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-31 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-31 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-31 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-31 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-31 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-31 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-31 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-31 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-31 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-31 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-30 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-30 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-30 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-30 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-30 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-30 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-30 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-30 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-30 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-30 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-30 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-30 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-30 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-29 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-29 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-29 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-29 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-29 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-29 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-29 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-29 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-29 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-29 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-29 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-29 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-29 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-29 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-29 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-29 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-29 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-28 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-28 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-28 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-28 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-28 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-28 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-28 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-28 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-28 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-28 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-28 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-28 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-28 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-28 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-28 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-28 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-28 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-28 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-28 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-28 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-28 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-27 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-27 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-27 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-27 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-27 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-27 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-27 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-27 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-27 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-27 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-27 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-27 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-27 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-27 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-27 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-27 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-27 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-27 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-27 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-27 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-27 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-27 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-27 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-27 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-26 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-26 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-26 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-26 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-26 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-26 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-26 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-26 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-26 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-26 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-25 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-25 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-25 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-25 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-25 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-25 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-25 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-25 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-25 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-25 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-24 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-24 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-24 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-24 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-23 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-22 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-22 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-22 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-22 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-22 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-22 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-22 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-22 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-22 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-22 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-22 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-21 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-21 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-21 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-21 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-21 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-21 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-21 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-21 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-21 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-21 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-21 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-21 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-21 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-21 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-21 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-21 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-21 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-21 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-21 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-21 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-21 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-20 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-20 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-20 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-20 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-19 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-19 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-15 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-158
Identities = 165/297 (55%), Positives = 218/297 (73%), Gaps = 4/297 (1%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQE 541
++ D D +I W DL I E+IG GS GTV+ A W+G DVAVK+ Q+
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQD 72
Query: 542 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK- 600
+ E ++ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ +
Sbjct: 73 FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 601 -LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659
LD RRR+ MA D+A+G++YLH+ NPPI+HR+LKS NLLVDK +TVKV DFGLSRLK T
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192
Query: 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 719
+L++K+ GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN QV+ AVG
Sbjct: 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF-QASRSTV 775
F +RLEIP++++P+ AAI+E CW ++P RPSF ++D LR L + +RS +
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-145
Identities = 77/272 (28%), Positives = 137/272 (50%), Gaps = 12/272 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
I ++ L ++ + G ++ W G D+ VKV +++S F +E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 561 RHPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGV 617
HPNVL +GA SP ++T ++P GSL+ +L T +D + + ALD+ARG+
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
++LH P I L S ++++D+ T ++ + P W+APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEA 179
Query: 678 LRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
L+ +P D +D++SF V+LWEL T ++P+ +L++M++ V R IP + P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
+ +++ C + DP RP F +V L +Q +
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-144
Identities = 104/274 (37%), Positives = 148/274 (54%), Gaps = 16/274 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVF--SRQEYSDEVIHSFRQEVSLMK 558
EI + +LT+ E IG G G VY A W G +VAVK E + I + RQE L
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
L+HPN++ G LC+V EF G L R+L ++ + A+ IARG++
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMN 119
Query: 619 YLHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDFGLSRLKHETYLTTKTGKGT 669
YLH PIIHRDLKSSN+L+ + + +K+ DFGL+R H T T + G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGA 177
Query: 670 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
WMAPEV+R + SDV+S+GV+LWEL T ++P+ ++ + V V L IP
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+A ++E CW+ DP RPSF ++D+L +
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-139
Identities = 103/277 (37%), Positives = 165/277 (59%), Gaps = 14/277 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV +++
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
+ RH N+LLFMG T+PQ L IVT++ SL+ L + TK + ++ I +A ARG+
Sbjct: 76 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPE 676
YLH + IIHRDLKS+N+ + + TVK+GDFGL+ K + G+ WMAPE
Sbjct: 135 YLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 677 VLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQR---LEIPK 729
V+R + P +SDVY+FG++L+EL T ++P+ N+N+ Q+I VG + ++
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
+ R ++ C RPSF ++ ++ +L R+
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-139
Identities = 88/280 (31%), Positives = 137/280 (48%), Gaps = 20/280 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD-----EVIHSFRQ 552
+ ++ +QIG+G G V+ VA+K + E F++
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 612
EV +M L HPN++ G + +P +V EF+P G L+ L + W ++ + LD
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSRLKHETYLTTKTGK 667
IA G+ Y+ + NPPI+HRDL+S N+ + KV DFGLS+ +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 668 GTPQWMAPEVL--RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAVGFMNQ 723
G QWMAPE + E EK+D YSF +IL+ + T + P+D + ++ I +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
R IP+D PR ++E CW DP+ RP F +V +L +L
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-137
Identities = 87/312 (27%), Positives = 155/312 (49%), Gaps = 23/312 (7%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVA 533
S +S+ ++ + L +++I +E L IGE IG+G G VYH W+G +VA
Sbjct: 6 LSLLSARSFPRKASQTSIFLQ----EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVA 59
Query: 534 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 593
+++ + +++ + +F++EV ++ RH NV+LFMGA SP L I+T +L+ +
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 594 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653
++ LD + +A +I +G+ YLH I+H+DLKS N+ D + V + DFGL
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 654 RLKHETYLTTKTGK-----GTPQWMAPEVLRN---------EPSDEKSDVYSFGVILWEL 699
+ + K G +APE++R P + SDV++ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 700 ATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 759
+ P+ + +I +G + + + I+ CW + + RP+F +L+D
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 760 LRDLQRQYFQAS 771
L L ++ + S
Sbjct: 297 LEKLPKRNRRLS 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-135
Identities = 85/273 (31%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+ I ++++ + E +G+G+ G V A W +DVA+K + F E+ + R
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRA-KDVAIKQIESESERKA----FIVELRQLSR 57
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNTTKLDWRRRILMALDIARGV 617
+ HPN++ GA +P +C+V E+ GSL+ +L + L ++GV
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 618 SYLHHCNP-PIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675
+YLH P +IHRDLK NLL+ TV K+ DFG + KG+ WMAP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAP 172
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPKDVDPR 734
EV EK DV+S+G+ILWE+ T + P+D + I R + K++
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+++ CW DP RPS +E+V + L R +
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 395 bits (1016), Expect = e-132
Identities = 87/281 (30%), Positives = 130/281 (46%), Gaps = 18/281 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
DL GE +G+G G + + + +E +F +EV +M+ L
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
HPNVL F+G + +RL +TE++ G+L +++ ++ W +R+ A DIA G++YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--------------KHETYLTTKTG 666
H N IIHRDL S N LV ++ V V DFGL+RL K T
Sbjct: 125 HSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 667 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRL 725
G P WMAPE++ DEK DV+SFG++L E+ + + +
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 726 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
P + P + I C DP+ RPSF +L L L+
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-119
Identities = 86/335 (25%), Positives = 138/335 (41%), Gaps = 53/335 (15%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV 532
S S S S + L + + + + +QIG+G G V+ W G + V
Sbjct: 12 RDLIEQSQSSGSGSGLPL-------LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG-EKV 63
Query: 533 AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIVTEFLPRG 588
AVKVF E + E+ +RH N+L F+ A +L ++T++ G
Sbjct: 64 AVKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLH------HCNPPIIHRDLKSSNLLVDKH 642
SL+ L+ T LD + + +A G+ +LH P I HRDLKS N+LV K+
Sbjct: 121 SLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 643 WTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVL------RNEPSDEKSDVYSF 692
T + D GL+ +E + T GT ++M PEVL + S +D+YSF
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238
Query: 693 GVILWELATE----------KIPWDNLNSMQ-----VIGAVGFMNQRLEIPK-----DVD 732
G+ILWE+A ++P+ +L + V R P +
Sbjct: 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+ ++ CW +P R + + L +
Sbjct: 299 RQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-115
Identities = 83/303 (27%), Positives = 138/303 (45%), Gaps = 46/303 (15%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
+ D+T+ E +G+G G V+ W G ++VAVK+FS ++ E+ L
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEKSWF---RETELYNTVML 59
Query: 561 RHPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
RH N+L F+ + S +L ++T + GSL+ LQ T LD + + L IA G
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASG 117
Query: 617 VSYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----LTTKTG 666
+++LH P I HRDLKS N+LV K+ + D GL+ + ++ +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 667 KGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATE----------KIPWDNLN 710
GT ++MAPEVL S ++ D+++FG++LWE+A K P+ ++
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 711 S-----MQVIGAVGFMNQRLEIPKDVD-----PRWAAIVESCWHSDPQCRPSFQELVDKL 760
+ V QR IP A +++ CW+ +P R + + L
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 761 RDL 763
+
Sbjct: 298 TKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-112
Identities = 86/312 (27%), Positives = 138/312 (44%), Gaps = 46/312 (14%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVS 555
L + + + E IG+G G V+ W G ++VAVK+FS +E E+
Sbjct: 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWF---REAEIY 88
Query: 556 LMKRLRHPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
LRH N+L F+ A + +L +V+++ GSLF L R T + I +AL
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLAL 146
Query: 612 DIARGVSYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT-- 663
A G+++LH P I HRDLKS N+LV K+ T + D GL+ T
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 664 --KTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELAT----------EKIP 705
GT ++MAPEVL + S +++D+Y+ G++ WE+A ++P
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 706 WDNLNSM-----QVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQE 755
+ +L ++ V R IP + A I+ CW+++ R +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 756 LVDKLRDLQRQY 767
+ L L +Q
Sbjct: 327 IKKTLSQLSQQE 338
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-108
Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 48/327 (14%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQ 540
G + VDL + L L + E +G G V+ A + VAVK+F Q
Sbjct: 2 GHHHHHHSSGVDLGTENL--YFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQ 58
Query: 541 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQR 596
+ EV + ++H N+L F+GA L ++T F +GSL L+
Sbjct: 59 DKQSWQ---NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115
Query: 597 NTTKLDWRRRILMALDIARGVSYLHH--------CNPPIIHRDLKSSNLLVDKHWTVKVG 648
N + W +A +ARG++YLH P I HRD+KS N+L+ + T +
Sbjct: 116 NV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 649 DFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELAT 701
DFGL+ ++ T GT ++MAPEVL + + D+Y+ G++LWELA+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 702 EKIPWDNLNS----------------MQVIGAVGFMNQRLEIPKDVDP-----RWAAIVE 740
D + V +R + +E
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 741 SCWHSDPQCRPSFQELVDKLRDLQRQY 767
CW D + R S + +++ +QR
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-102
Identities = 83/328 (25%), Positives = 133/328 (40%), Gaps = 61/328 (18%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQ 552
++ + + ++L + E IG+G G VY + VAVKVFS +F
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANR-----QNFIN 54
Query: 553 E--VSLMKRLRHPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR 605
E + + + H N+ F+ +V E+ P GSL + L +T DW
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVS 112
Query: 606 RILMALDIARGVSYLH-------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658
+A + RG++YLH H P I HRDL S N+LV T + DFGLS
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 659 TYL--------TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELA--- 700
L + GT ++MAPEVL E + ++ D+Y+ G+I WE+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 701 TEKIPWDNLNSMQV---------------IGAVGFMNQRLEIPKDVDPRW------AAIV 739
T+ P +++ Q+ V QR + P+ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQY 767
E CW D + R + Q +++ +L +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-78
Identities = 79/280 (28%), Positives = 133/280 (47%), Gaps = 16/280 (5%)
Query: 489 NKVDLDNDCLDYEILWEDLT-----IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY 542
N+ D + L+ + + +IG+GS TVY + + +VA ++
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 543 SDEVIHSFRQEVSLMKRLRHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNT 598
+ F++E ++K L+HPN++ F + V + + +VTE + G+L L+R
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 599 TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKH 657
+ + I +G+ +LH PPIIHRDLK N+ + +VK+GD GL+ LK
Sbjct: 125 -VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI-G 716
+ K GTP++MAPE+ + DE DVY+FG+ + E+AT + P+ + I
Sbjct: 184 AS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
V + K P I+E C + R S ++L
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 7e-76
Identities = 86/275 (31%), Positives = 137/275 (49%), Gaps = 12/275 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
+ + EDL +GEQIG+G+ G V+ + VAVK R+ ++ F QE ++
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARIL 166
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 617
K+ HPN++ +G T Q + IV E + G L+ +L + + M D A G+
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAP 675
YL IHRDL + N LV + +K+ DFG+SR + + G P +W AP
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVD 732
E L +SDV+SFG++LWE + P+ NL++ Q V G RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPCPELCP 341
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
++E CW +P RPSF + +L+ +++++
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 6e-74
Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 12/272 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+EI +DLT +++G G G V + W G DVA+K+ ++ E F +E +M
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSE--DEFIEEAKVMM 74
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
L H ++ G T + + I+TE++ G L L+ + ++ + M D+ +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
YL +HRDL + N LV+ VKV DFGLSR + T+ G P +W PEV
Sbjct: 135 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
L KSD+++FGV++WE+ + K+P++ + + + G RL P +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEK 249
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
I+ SCWH RP+F+ L+ + D+ +
Sbjct: 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 9e-74
Identities = 88/270 (32%), Positives = 141/270 (52%), Gaps = 12/270 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
E+ E++T+ +++G G G V W G DVAVK+ ++ E F QE M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSE--DEFFQEAQTMMKL 60
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
HP ++ F G + + IVTE++ G L L+ + L+ + + M D+ G+++L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLR 679
IHRDL + N LVD+ VKV DFG++R + + G P +W APEV
Sbjct: 121 ESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 680 NEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWA 736
KSDV++FG+++WE+ + K+P+D + +V+ V G RL P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYRPHLASDTIY 235
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
I+ SCWH P+ RP+FQ+L+ + L+ +
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 1e-73
Identities = 87/273 (31%), Positives = 138/273 (50%), Gaps = 12/273 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+ I +LT ++IG G G V+ W VA+K R+ E F +E +M +
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSE--EDFIEEAEVMMK 59
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
L HP ++ G +C+VTEF+ G L L+ + M LD+ G++Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVL 678
L +IHRDL + N LV ++ +KV DFG++R + T+ TG P +W +PEV
Sbjct: 120 LEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 679 RNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRW 735
KSDV+SFGV++WE+ +E KIP++N ++ +V+ + GF RL P+
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRLASTHV 234
Query: 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
I+ CW P+ RP+F L+ +L ++
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 7e-71
Identities = 92/291 (31%), Positives = 148/291 (50%), Gaps = 26/291 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQ 552
++E+ E +T+ ++GQGS G VY V G VA+K + S F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLN 77
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 603
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 604 RRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661
+ I MA +IA G++YL + +HRDL + N +V + +TVK+GDFG++R +ET
Sbjct: 138 SKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 662 TTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV 718
K GKG P +WM+PE L++ SDV+SFGV+LWE+AT + P+ L++ QV+ V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
L+ P + ++ CW +P+ RPSF E++ +++ F+
Sbjct: 254 -MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 8e-71
Identities = 88/276 (31%), Positives = 135/276 (48%), Gaps = 15/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQ----DVAVKVFSRQEYSDEVIHSFRQEV 554
Y I ED+ + +G+G G VY V+ + +VAVK +++ + + F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEA 64
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+MK L HP+++ +G + + I+ E P G L L+RN L +L +L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 673
+ ++YL N +HRD+ N+LV VK+GDFGLSR ++ E Y + +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 730
+PE + SDV+ F V +WE+ + K P+ L + VIG + G RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD---RLPKPDL 238
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
P ++ CW DP RP F ELV L D+ +
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-70
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 19/283 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHS 549
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 609
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 667
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 668 GTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQ 723
P +WMA E + + +SDV+S+GV +WEL T P+D + + ++ + G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--- 236
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
RL P I+ CW D RP F+EL+ + + R
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-70
Identities = 84/310 (27%), Positives = 130/310 (41%), Gaps = 30/310 (9%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG---- 528
S S NK++ D I L +G+ +G+G G+V
Sbjct: 8 HHHSSGLVPRGSEELQNKLE------DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 529 SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-----SPQRLCIVTE 583
S VAVK S I F E + MK HPNV+ +G + ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 584 FLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 636
F+ G L L + + + +DIA G+ YL + +HRDL + N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARN 177
Query: 637 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGV 694
++ TV V DFGLS+ + + P +W+A E L + KSDV++FGV
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 695 ILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSF 753
+WE+AT P+ + + ++ + RL+ P+D I+ SCW +DP RP+F
Sbjct: 238 TMWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF 296
Query: 754 QELVDKLRDL 763
L +L L
Sbjct: 297 SVLRLQLEKL 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-70
Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 29/294 (9%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVI 547
+L D I + T+G +G+G G+V A VAVK+ + I
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 548 HSFRQEVSLMKRLRHPNVLLFMGAVT------SPQRLCIVTEFLPRGSLFRLLQ-----R 596
F +E + MK HP+V +G ++ F+ G L L
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 597 NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
N L + + +DIA G+ YL + IHRDL + N ++ + TV V DFGLSR
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 655 LKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 711
+ + P +W+A E L + SDV++FGV +WE+ T + P+ + +
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 712 MQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
++ + G RL+ P + ++ CW +DP+ RPSF L +L ++
Sbjct: 246 AEIYNYLIGG---NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 4e-70
Identities = 89/276 (32%), Positives = 136/276 (49%), Gaps = 15/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEV 554
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 67
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 673
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 730
APE + SDV+ FGV +WE+ P+ + + VIG + G RL +P +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 241
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
P +++ CW DP RP F EL +L + +
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-69
Identities = 90/286 (31%), Positives = 135/286 (47%), Gaps = 14/286 (4%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEY--SDEVIH 548
L I +DL + E++G GS G V W + VAVK + + E +
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMD 66
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
F +EV+ M L H N++ G V +P + +VTE P GSL L+++
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTG 666
A+ +A G+ YL IHRDL + NLL+ VK+GDFGL R +++ + +
Sbjct: 126 YAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 667 KGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQR 724
+ P W APE L+ SD + FGV LWE+ T + PW LN Q++ + +R
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770
L P+D ++ CW P+ RP+F L D L + Q +A
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-69
Identities = 87/275 (31%), Positives = 130/275 (47%), Gaps = 16/275 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEVSL 556
EI + I + IG G G V + VA+K + Y++ F E S+
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASI 103
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
M + HPN++ G VT + IVTE++ GSL L+ + + + + M + G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 673
+ YL +HRDL + N+LVD + KV DFGLSR+ + TT GK +W
Sbjct: 164 MRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 730
APE + SDV+SFGV++WE+ + P+ N+ + VI +V G+ RL P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPAPMG 278
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
++ CWH D RP F ++V L L R
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-69
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 24/290 (8%)
Query: 492 DLDNDCL----DYEIL--WEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQE 541
DLD+ L D I IG+G G VYH + A+K +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRI 60
Query: 542 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK 600
+ + +F +E LM+ L HPNVL +G + P+ ++ ++ G L + ++
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 601 LDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658
+ I L +ARG+ YL +HRDL + N ++D+ +TVKV DFGL+R +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 659 T--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 713
Y + P +W A E L+ KSDV+SFGV+LWEL T P+ +++
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ + +RL P+ +++ CW +DP RP+F+ LV ++ +
Sbjct: 237 LTHFLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-69
Identities = 88/278 (31%), Positives = 145/278 (52%), Gaps = 18/278 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
++E+ E L + E++G G G V+ + G VAVK +Q +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP--DAFLAEANLMK 63
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 617
+L+H ++ VT + + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 676
+++ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733
+ KSDV+SFG++L E+ T +IP+ + + +VI + G+ R+ P +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVRPDNCPE 237
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDL----QRQY 767
++ CW P+ RP+F L L D + QY
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-69
Identities = 84/277 (30%), Positives = 137/277 (49%), Gaps = 17/277 (6%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----QDVAVKVFSRQEYSDEVIHSFRQEV 554
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEA 97
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT--P-Q 671
G+ YL + N +HRDL + N+LV+ + KV DFGLSR+ + T T G P +
Sbjct: 158 AGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIP 728
W APE + SDV+SFG+++WE+ T + P+ L++ +V+ A+ GF RL P
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPTP 272
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
D ++ CW + RP F ++V L L R
Sbjct: 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-69
Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 31/293 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVS 555
+ L +Q+G+G+ G+V + QD VAVK Q ++E + F +E+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 556 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 613
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + + I
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 670
+G+ YL IHRDL + N+LV+ VK+GDFGL+++ + + + K +P
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT----------------EKIPWDNLNSMQV 714
W APE L SDV+SFGV+L+EL T + +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
I + N RL P I+ CW+++ RPSF++L ++ ++
Sbjct: 242 IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-69
Identities = 85/294 (28%), Positives = 140/294 (47%), Gaps = 31/294 (10%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEV 554
+ L +Q+G+G+ G+V + QD VAVK Q ++E + F +E+
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREI 93
Query: 555 SLMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 612
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + +
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP 670
I +G+ YL IHRDL + N+LV+ VK+GDFGL+++ + + Y K +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 671 -QWMAPEVLRNEPSDEKSDVYSFGVILWELAT----------------EKIPWDNLNSMQ 713
W APE L SDV+SFGV+L+EL T +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+I + N RL P I+ CW+++ RPSF++L ++ ++ Q
Sbjct: 272 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-68
Identities = 83/325 (25%), Positives = 139/325 (42%), Gaps = 24/325 (7%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDY------EILWEDLTIGEQIGQGSCG 519
S+S+ + S ++ ++ L+ + + + E IG+G G
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 520 TVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575
VYH AVK + + F E +MK HPNVL +G
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 576 QR-LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDL 632
+ +V ++ G L ++ T + I L +A+G+ +L +HRDL
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDL 218
Query: 633 KSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSD 688
+ N ++D+ +TVKV DFGL+R ++ P +WMA E L+ + KSD
Sbjct: 219 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 689 VYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 747
V+SFGV+LWEL T P+ ++N+ + + +RL P+ ++ CWH
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKA 337
Query: 748 QCRPSFQELVDKLRDLQRQYFQASR 772
+ RPSF ELV ++ + +
Sbjct: 338 EMRPSFSELVSRISAIFSTFIGEHY 362
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-68
Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 16/276 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEVSL 556
E+ +++I + +G G G V VA+K + Y+++ F E S+
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASI 99
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
M + HPN++ G VT + + IVTE++ GSL L+++ + + + M IA G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 673
+ YL +HRDL + N+L++ + KV DFGL R+ E TT+ GK +W
Sbjct: 160 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 730
+PE + SDV+S+G++LWE+ + + P+ +++ VI AV G+ RL P D
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMD 274
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
++ CW D RP F+++V L L R
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 4e-68
Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 17/292 (5%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVW---YGSQDVAVKVFSRQEYSDEVIHSFRQEV 554
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 61
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 671
G+ YL N +HRDL + N+L+ K+ DFGLS+ ++Y T ++ P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
W APE + +SDV+S+GV +WE + + P+ + +V+ + +R+E P +
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQKE 782
P A++ CW + RP F + ++R + + S V
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA----CYYSLASKVEGHHHHH 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 4e-68
Identities = 90/274 (32%), Positives = 141/274 (51%), Gaps = 14/274 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
+E+ D+T+ ++G G G VY VW S VAVK +++ + F +E ++M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFLKEAAVM 63
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARG 616
K ++HPN++ +G T I+TEF+ G+L L+ N ++ + MA I+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAP 675
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G P +W AP
Sbjct: 124 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVD 732
E L KSDV++FGV+LWE+AT P+ ++ QV + + R+E P+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCP 238
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
+ ++ +CW +P RPSF E+ + ++
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 4e-68
Identities = 84/291 (28%), Positives = 136/291 (46%), Gaps = 33/291 (11%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEV 554
I D+ + ++G+G+ G V+ A Y VAVK ++ + F++E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREA 68
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 599
L+ L+H +++ F G L +V E++ G L + L+ +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 600 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657
+L + + +A IA G+ YL H +HRDL + N LV + VK+GDFG+SR +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 658 ETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQV 714
T G P +WM PE + +SDV+SFGVILWE+ T K PW L++ +V
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
I + + LE P+ ++ CW +PQ R + +E+ L L +
Sbjct: 245 IECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-68
Identities = 91/324 (28%), Positives = 151/324 (46%), Gaps = 36/324 (11%)
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVW 526
+ S SS+S S + + + D+ + ++G+G+ G V+ A
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 527 YG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580
+ VAVK +E S+ F++E L+ L+H +++ F G T + L +
Sbjct: 63 HNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 581 VTEFLPRGSLFRLLQRN--------------TTKLDWRRRILMALDIARGVSYL--HHCN 624
V E++ G L R L+ + L + + +A +A G+ YL H
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF- 179
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEP 682
+HRDL + N LV + VK+GDFG+SR + T G+ P +WM PE +
Sbjct: 180 ---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 683 SDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741
+SDV+SFGV+LWE+ T K PW L++ + I + + LE P+ P AI+
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRG 295
Query: 742 CWHSDPQCRPSFQELVDKLRDLQR 765
CW +PQ R S +++ +L+ L +
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQ 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 9e-68
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 29/290 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVS 555
L +G+G G V + D VAVK + E I ++E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIE 75
Query: 556 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 613
+++ L H N++ + G T + ++ EFLP GSL L +N K++ ++++ A+ I
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 670
+G+ YL +HRDL + N+LV+ VK+GDFGL++ + Y T K + +P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT---------------EKIPWDNLNSMQVI 715
W APE L SDV+SFGV L EL T + +++
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
+ +RL P + ++ CW P R SFQ L++ L +
Sbjct: 254 NTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 9e-68
Identities = 83/292 (28%), Positives = 129/292 (44%), Gaps = 20/292 (6%)
Query: 492 DLDNDCLDYEIL--WEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDE 545
+L I + E IG+G G VYH AVK +
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 68
Query: 546 VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTTKLDWR 604
+ F E +MK HPNVL +G + +V ++ G L ++ T +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 605 RRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 660
I L +A+G+ YL +HRDL + N ++D+ +TVKV DFGL+R ++ Y
Sbjct: 129 DLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 661 LTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGA 717
P +WMA E L+ + KSDV+SFGV+LWEL T P+ ++N+ +
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244
Query: 718 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ +RL P+ ++ CWH + RPSF ELV ++ + +
Sbjct: 245 LL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-67
Identities = 86/273 (31%), Positives = 146/273 (53%), Gaps = 18/273 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+ + ++L + + IG+G G V + G VAVK + + + + +F E S+M
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCI-KNDATAQ---AFLAEASVMT 69
Query: 559 RLRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARG 616
+LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
+ YL N +HRDL + N+LV + KV DFGL++ E T TGK +W APE
Sbjct: 130 MEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPE 184
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733
LR + KSDV+SFG++LWE+ + ++P+ + V+ V G+ +++ P P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPP 241
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
++++CWH D RPSF +L ++L ++
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-67
Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 32/290 (11%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEV 554
EI + E++G+ G VY +G +Q VA+K + + + FR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEA 63
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 599
L RL+HPNV+ +G VT Q L ++ + G L L +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 600 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657
L+ + + IA G+ YL HH +H+DL + N+LV VK+ D GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 658 ETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQV 714
G P +WMAPE + SD++S+GV+LWE+ + P+ ++ V
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
+ + Q L P D A++ CW+ P RP F+++ +LR
Sbjct: 240 VEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-67
Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 31/292 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVS 555
L +G+G G V + + D VAVK + + + ++QE+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID 85
Query: 556 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 613
+++ L H +++ + G L +V E++P GSL L R+ + + +L A I
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQI 143
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 670
G++YLH + IHRDL + N+L+D VK+GDFGL++ + Y + +P
Sbjct: 144 CEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT---------------EKIPWDNLNSMQVI 715
W APE L+ SDV+SFGV L+EL T I + +++
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+ +RL P ++++CW ++ RP+F+ L+ L+ + +Y
Sbjct: 262 ELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 7e-67
Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 23/280 (8%)
Query: 501 EILWE----DLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFR 551
+ +L + +G G GTV+ VW + V +KV + + +
Sbjct: 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT 63
Query: 552 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
+ + L H +++ +G L +VT++LP GSL ++++ L + + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGT 669
IA+G+ YL ++HR+L + N+L+ V+V DFG++ L + L K T
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK-T 179
Query: 670 P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRL 725
P +WMA E + +SDV+S+GV +WEL T P+ L +V + G RL
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RL 236
Query: 726 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
P+ ++ CW D RP+F+EL ++ + R
Sbjct: 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 7e-67
Identities = 89/269 (33%), Positives = 145/269 (53%), Gaps = 14/269 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 235
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 618
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
KSDV+SFG++L EL T+ ++P+ + + +V+ V G+ R+ P +
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 409
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRDL 763
++ CW +P+ RP+F+ L L D
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 7e-67
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 19/283 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHS 549
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 550 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 609
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 667
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 668 GTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQ 723
P +WMA E + + +SDV+S+GV +WEL T P+D + + ++ + G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--- 236
Query: 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
RL P I+ CW D RP F+EL+ + + R
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 9e-67
Identities = 97/316 (30%), Positives = 156/316 (49%), Gaps = 22/316 (6%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDV 532
T+ + + V + D +E+ D+T+ ++G G G VY VW S V
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYD--KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV 248
Query: 533 AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 592
AVK +++ + F +E ++MK ++HPN++ +G T I+TEF+ G+L
Sbjct: 249 AVKTL-KEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305
Query: 593 LLQ-RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651
L+ N ++ + MA I+ + YL N IHR+L + N LV ++ VKV DFG
Sbjct: 306 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFG 363
Query: 652 LSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL 709
LSRL T G P +W APE L KSDV++FGV+LWE+AT P+ +
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 710 NSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+ QV + + R+E P+ + ++ +CW +P RPSF E+ + ++
Sbjct: 424 DLSQVYELLEKDY---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE- 479
Query: 768 FQASRSTVGDSTQKEL 783
S++ D +KEL
Sbjct: 480 -----SSISDEVEKEL 490
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 232 bits (592), Expect = 2e-66
Identities = 89/276 (32%), Positives = 136/276 (49%), Gaps = 15/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEV 554
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 442
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 673
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 502 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 730
APE + SDV+ FGV +WE+ P+ + + VIG + G RL +P +
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 616
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
P +++ CW DP RP F EL +L + +
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-66
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEV 554
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 84
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 608
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 609 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 663
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 664 KTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV-- 718
K G P +WM PE K+D +SFGV+LWE+ + +P+ + ++ +V+ V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
G R++ PK+ I+ CW P+ RP+F +++++ +
Sbjct: 261 GG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-65
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 30/292 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVS 555
L Q+G+G+ G+V + D VAVK Q + F++E+
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQ 76
Query: 556 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 613
++K L ++ + G P R L +V E+LP G L LQR+ +LD R +L + I
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 670
+G+ YL +HRDL + N+LV+ VK+ DFGL++L + Y + +P
Sbjct: 137 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 671 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT---------------EKIPWDNLNSMQVI 715
W APE L + +SDV+SFGV+L+EL T D +++
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+ QRL P +++ CW PQ RPSF L +L L
Sbjct: 255 ELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-65
Identities = 78/312 (25%), Positives = 135/312 (43%), Gaps = 48/312 (15%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEV 546
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 35 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 93
Query: 547 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 606
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 607 -----------------------ILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDK 641
+ +A +A G++YL +HRDL + N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGE 209
Query: 642 HWTVKVGDFGLSRLKHET--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILW 697
+ VK+ DFGLSR + Y G P +WM PE + +SDV+++GV+LW
Sbjct: 210 NMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 698 ELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQ 754
E+ + P+ + +VI V G L P++ ++ CW P RPSF
Sbjct: 268 EIFSYGLQPYYGMAHEEVIYYVRDG---NILACPENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 755 ELVDKLRDLQRQ 766
+ L+ + +
Sbjct: 325 SIHRILQRMCER 336
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-65
Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 14/270 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+EI E L + +++G G G V+ A + VAVK + +F E ++MK
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSV--EAFLAEANVMK 238
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGV 617
L+H ++ VT + + I+TEF+ +GSL L+ + +K + I + IA G+
Sbjct: 239 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 676
+++ N IHRDL+++N+LV K+ DFGL+R+ + T + G P +W APE
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733
+ KSDV+SFG++L E+ T +IP+ +++ +VI A+ G+ R+ P++
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCPE 412
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
I+ CW + P+ RP+F+ + L D
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-65
Identities = 67/295 (22%), Positives = 124/295 (42%), Gaps = 33/295 (11%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD--------VAVKVFSRQEYSDEVIHSFR 551
++I EDL E +GQG+ ++ V D V +KV + SF
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 552 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
+ S+M +L H +++L G +V EF+ GSL L++N ++ ++ +A
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 612 DIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSRLKHETYL 661
+A + +L + IH ++ + N+L+ + +K+ D G+S +
Sbjct: 121 QLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 662 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 719
+ W+ PE + N + + +D +SFG LWE+ + P L+S + +
Sbjct: 177 LQERIP----WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774
+L PK A ++ +C +P RPSF+ ++ L L S
Sbjct: 233 -DRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 6e-65
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEV 554
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 125
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 608
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 609 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 663
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 664 KTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV-- 718
K G P +WM PE K+D +SFGV+LWE+ + +P+ + ++ +V+ V
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
G R++ PK+ I+ CW P+ RP+F +++++ +
Sbjct: 302 GG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 8e-65
Identities = 85/272 (31%), Positives = 146/272 (53%), Gaps = 18/272 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+ + ++L + + IG+G G V + G VAVK + + + + +F E S+M
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCI-KNDATAQ---AFLAEASVMT 241
Query: 559 RLRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARG 616
+LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
+ YL N +HRDL + N+LV + KV DFGL++ E T TGK +W APE
Sbjct: 302 MEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPE 356
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 733
LR + KSDV+SFG++LWE+ + ++P+ + V+ V G+ +++ P P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPP 413
Query: 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
++++CWH D RP+F +L ++L ++
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-64
Identities = 89/269 (33%), Positives = 145/269 (53%), Gaps = 14/269 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 318
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 618
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 677
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 378 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 734
KSDV+SFG++L EL T+ ++P+ + + +V+ V G+ R+ P +
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 492
Query: 735 WAAIVESCWHSDPQCRPSFQELVDKLRDL 763
++ CW +P+ RP+F+ L L D
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-64
Identities = 84/308 (27%), Positives = 153/308 (49%), Gaps = 40/308 (12%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFS 538
V++ +L D +E + LT+G+ +G+G+ G V A G + VAVK+
Sbjct: 18 GVSEYELPED-PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML- 75
Query: 539 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 597
+ + +++ + E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 76 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 598 ---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVD 640
++ ++ + +ARG+ YL C IHRDL + N+LV
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVT 191
Query: 641 KHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWE 698
++ +K+ DFGL+R + KT G P +WMAPE L + +SDV+SFGV++WE
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251
Query: 699 LATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQE 755
+ T P+ + ++ + G R++ P + ++ CWH+ P RP+F++
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 308
Query: 756 LVDKLRDL 763
LV+ L +
Sbjct: 309 LVEDLDRI 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 8e-64
Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 44/301 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQ 552
+E ++L +G+ +G+G G V A + VAVK+ ++ S +
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS 75
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------- 597
E +++K++ HP+V+ GA + L ++ E+ GSL L+ +
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 598 --------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKV 647
L I A I++G+ YL +HRDL + N+LV + +K+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKI 191
Query: 648 GDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KI 704
DFGLSR +E K +G P +WMA E L + +SDV+SFGV+LWE+ T
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 705 PWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762
P+ + ++ + G R+E P + ++ CW +P RP F ++ L
Sbjct: 252 PYPGIPPERLFNLLKTGH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
Query: 763 L 763
+
Sbjct: 309 M 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 8e-64
Identities = 85/319 (26%), Positives = 156/319 (48%), Gaps = 36/319 (11%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----- 528
T S+ + + V++ +L D +E + LT+G+ +G+G G V A G
Sbjct: 51 TRLSSTADTPMLAGVSEYELPED-PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 529 ---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEF 584
+ VAVK+ + + +++ + E+ +MK + +H N++ +GA T L ++ E+
Sbjct: 110 PKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168
Query: 585 LPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPI 627
+G+L L+ ++ ++ + +ARG+ YL C
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---- 224
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDE 685
IHRDL + N+LV ++ +K+ DFGL+R + KT G P +WMAPE L +
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284
Query: 686 KSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
+SDV+SFGV++WE+ T P+ + ++ + R++ P + ++ CWH
Sbjct: 285 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWH 343
Query: 745 SDPQCRPSFQELVDKLRDL 763
+ P RP+F++LV+ L +
Sbjct: 344 AVPSQRPTFKQLVEDLDRI 362
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 8e-64
Identities = 70/282 (24%), Positives = 128/282 (45%), Gaps = 13/282 (4%)
Query: 499 DYEILWEDLTIGEQ-IGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEV 554
+ + + LT+ ++ +G G+ GTV + + VAVK+ + + E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
++M++L +P ++ +G + + +V E G L + LQ+N + + I + ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVS 127
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 671
G+ YL N +HRDL + N+L+ K+ DFGLS+ E Y +T P +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
W APE + KSDV+SFGV++WE + + P+ + +V + +R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772
++ CW D + RP F + +LR+
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-63
Identities = 84/304 (27%), Positives = 142/304 (46%), Gaps = 36/304 (11%)
Query: 489 NKVDLDNDCLDY-EILWEDLTIGEQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSD 544
+ + D Y + W D+ + IG+G+ G V A D A+K ++ S
Sbjct: 8 HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASK 66
Query: 545 EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------ 597
+ F E+ ++ +L HPN++ +GA L + E+ P G+L L+++
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 598 ---------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVK 646
+ L ++ + A D+ARG+ YL IHRDL + N+LV +++ K
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAK 182
Query: 647 VGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KI 704
+ DFGLSR E Y+ G+ P +WMA E L SDV+S+GV+LWE+ +
Sbjct: 183 IADFGLSR-GQEVYVKKTMGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
Query: 705 PWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762
P+ + ++ + G+ RLE P + D ++ CW P RPSF +++ L
Sbjct: 241 PYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 763 LQRQ 766
+ +
Sbjct: 298 MLEE 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-62
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 40/297 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQ 552
+E L+ G+ +G G+ G V A YG + VAVK+ + +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMS 75
Query: 553 EVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------- 597
E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 598 ---TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652
LD + + +A+G+++L +C IHRDL + N+L+ K+ DFGL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGL 191
Query: 653 SRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL 709
+R G P +WMAPE + N +SDV+S+G+ LWEL + P+ +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 710 -NSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ + GF R+ P+ I+++CW +DP RP+F+++V +
Sbjct: 252 PVDSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-62
Identities = 85/300 (28%), Positives = 143/300 (47%), Gaps = 47/300 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKV----FSRQEYSDEV 546
+E+ + L +G+ +G+G+ G V A G VAVK+ + ++ SD
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-- 120
Query: 547 IHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL--------------- 590
E+ +MK + +H N++ +GA T L ++ E+ +G+L
Sbjct: 121 ---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 591 FRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVG 648
+ +L + + A +ARG+ YL C IHRDL + N+LV + +K+
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIA 233
Query: 649 DFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIP 705
DFGL+R H KT G P +WMAPE L + +SDV+SFGV+LWE+ T P
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 706 WDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ + ++ + G R++ P + ++ CWH+ P RP+F++LV+ L +
Sbjct: 294 YPGVPVEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-61
Identities = 76/324 (23%), Positives = 146/324 (45%), Gaps = 37/324 (11%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----- 528
+ S S + ++ L + +E +L G+ +G G+ G V A +G
Sbjct: 16 WKIIESYEGNSYTFIDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 74
Query: 529 -SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 586
VAVK+ + + + E+ +M L +H N++ +GA T + ++TE+
Sbjct: 75 AVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 587 RGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRD 631
G L L+R + R + + +A+G+++L +C IHRD
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRD 189
Query: 632 LKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDV 689
+ + N+L+ K+GDFGL+R G P +WMAPE + + +SDV
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 690 YSFGVILWELATE-KIPWDNLNS-MQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHS 745
+S+G++LWE+ + P+ + + V G+ ++ P +I+++CW
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAFAPKNIYSIMQACWAL 306
Query: 746 DPQCRPSFQELVDKLRDLQRQYFQ 769
+P RP+FQ++ L++ ++ +
Sbjct: 307 EPTHRPTFQQICSFLQEQAQEDRR 330
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-61
Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 26/290 (8%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVI 547
+ VDL + L ++ + E ++IG+GS G + +K + S +
Sbjct: 9 SGVDLGTENLYFQSM-EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 548 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK------- 600
R+EV+++ ++HPN++ + + L IV ++ G LF+ +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660
LDW +I +AL ++H I+HRD+KS N+ + K TV++GDFG++R+ + T
Sbjct: 128 LDWFVQICLALK------HVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 720
+ GTP +++PE+ N+P + KSD+++ G +L+EL T K ++ + ++ +
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-- 237
Query: 721 MNQRLE-IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
++ + ++V + +P+ RPS + L++ +
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI------LEKGFIA 281
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-61
Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHS 549
D +E + L +G+ +G+G+ G V A +G + VAVK+ ++ + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA 76
Query: 550 FRQEVSLMKRL-RHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRN---------- 597
E+ ++ + H NV+ +GA T P L ++ EF G+L L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 598 -----TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650
L I + +A+G+ +L C IHRDL + N+L+ + VK+ DF
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDF 192
Query: 651 GLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWD 707
GL+R ++ + G P +WMAPE + + +SDV+SFGV+LWE+ + P+
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 708 NLNS-MQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
+ + + G R+ P P + CWH +P RP+F ELV+ L +L
Sbjct: 253 GVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 8e-61
Identities = 71/295 (24%), Positives = 134/295 (45%), Gaps = 21/295 (7%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWY---GSQDVAVKVFSRQEYSDEVIHSFRQEV 554
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 387
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 671
G+ YL N +HR+L + N+L+ K+ DFGLS+ ++Y T ++ P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIP 728
W APE + +SDV+S+GV +WE + + P+ + +V+ + G R+E P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECP 561
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQKEL 783
+ P A++ CW + RP F + ++R + + S V + E+
Sbjct: 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA----CYYSLASKVEGGSALEV 612
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-60
Identities = 83/313 (26%), Positives = 135/313 (43%), Gaps = 46/313 (14%)
Query: 488 VNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQE 541
V+ + + D L +E E+L G+ +G G+ G V +A YG S VAVK+ +++
Sbjct: 29 VDFREYEYD-LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEK 86
Query: 542 YSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--- 597
+ E+ +M +L H N++ +GA T + ++ E+ G L L+
Sbjct: 87 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 598 -------------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 636
L + + A +A+G+ +L C +HRDL + N
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARN 202
Query: 637 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGV 694
+LV VK+ DFGL+R G P +WMAPE L KSDV+S+G+
Sbjct: 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 695 ILWELATE-KIPWDNL-NSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+LWE+ + P+ + + GF +++ P I++SCW D + R
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGF---KMDQPFYATEEIYIIMQSCWAFDSRKR 319
Query: 751 PSFQELVDKLRDL 763
PSF L L
Sbjct: 320 PSFPNLTSFLGCQ 332
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-59
Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 13/281 (4%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEY 542
S + + D ++D L+Y+ +++ +G+G+ G VY +Q +A+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-- 58
Query: 543 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD 602
+E++L K L+H N++ ++G+ + + I E +P GSL LL+ L
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 603 WRRRILM--ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 659
+ + I G+ YLH I+HRD+K N+L++ + +K+ DFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 660 YLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFG-VILWELATEKIPWDNL-NSMQVI 715
T+T GT Q+MAPE++ P + +D++S G I+ E+AT K P+ L +
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAM 235
Query: 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
VG EIP+ + A + C+ DP R +L
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-59
Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 37/287 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
DYE+L IG GS G + + K ++ EV+L+
Sbjct: 7 DYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 558 KRLRHPNVLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRR 606
+ L+HPN++ + + + L IV E+ G L ++ + T + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 607 ILMALDIARGVSYLHHCNPP---IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663
+ +AL H + ++HRDLK +N+ +D VK+GDFGL+R+ +
Sbjct: 120 LTLALK------ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 723
KT GTP +M+PE + +EKSD++S G +L+EL P+ + ++ G +
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REG 231
Query: 724 RLE-IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ IP I+ + RPS +E+ L+
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI------LENPLIL 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-56
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 25/267 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 562
+ I ++IG+G VY A VA+K + D +E+ L+K+L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRILMALDI 613
PNV+ + + L IV E G L R+++ + + ++ AL+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE- 150
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 673
++H ++HRD+K +N+ + VK+GD GL R + GTP +M
Sbjct: 151 -----HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLE-IPKD 730
+PE + + KSD++S G +L+E+A + P+ D +N + + +P D
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSD 261
Query: 731 V-DPRWAAIVESCWHSDPQCRPSFQEL 756
+V C + DP+ RP +
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 564
+I +QIG G V+ + Q A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 623
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 91 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 146
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 681
I+H DLK +N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 682 PS-----------DEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPK 729
S KSDV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ +++ C DP+ R S EL
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 69/328 (21%), Positives = 130/328 (39%), Gaps = 34/328 (10%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
S + + A + + SSSA + + Y I
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR--IYSI---- 60
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-- 564
+QIG G V+ + Q A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 61 ---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 565 -VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHH 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 118 IIRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQ 173
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRN 680
I+H DLK +N L+ +K+ DFG++ T + + G +M PE +++
Sbjct: 174 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 681 EPS-----------DEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIP 728
S KSDV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ +++ C DP+ R S EL
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-54
Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 564
+I +QIG G V+ + Q A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 623
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 72 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 127
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 681
I+H DLK +N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 128 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 682 PS-----------DEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPK 729
S KSDV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQEL 756
+ +++ C DP+ R S EL
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-54
Identities = 56/312 (17%), Positives = 106/312 (33%), Gaps = 16/312 (5%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H + N + S + + + S + + +
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPE------SFFQQS 58
Query: 507 LTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPN 564
++G GS G V+ + AVK + + S K +HP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
+ A L + TE SL + + L + D +++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
++H D+K +N+ + K+GDFGL + +G P++MAPE+L
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELL-QGSYG 233
Query: 685 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 744
+DV+S G+ + E+A Q + G++ E + +++
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-GYL--PPEFTAGLSSELRSVLVMMLE 290
Query: 745 SDPQCRPSFQEL 756
DP+ R + + L
Sbjct: 291 PDPKLRATAEAL 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-54
Identities = 62/296 (20%), Positives = 115/296 (38%), Gaps = 60/296 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
D++ + E IG G G V+ A + +K +EV +
Sbjct: 12 DFKEI-------ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 558 KRLRHPNVLLFMGA----------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTK- 600
+L H N++ + G + + L I EF +G+L + +++ +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 601 ------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
L+ +I +D Y+H +I+RDLK SN+ + VK+GDFGL
Sbjct: 119 LDKVLALELFEQITKGVD------YIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 655 -LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 713
LK++ T G T ++M+PE + ++ ++ D+Y+ G+IL EL +
Sbjct: 171 SLKNDGKRTRSKG--TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ I D + +++ P+ RP+ E+ L+
Sbjct: 229 T------DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI------LRTLTVW 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 7e-53
Identities = 70/303 (23%), Positives = 115/303 (37%), Gaps = 23/303 (7%)
Query: 462 WGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTV 521
W S S+ + + + G + + VD + Y +T ++G+GS G V
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-----YREEVHWMTHQPRVGRGSFGEV 74
Query: 522 YHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580
+ AVK + + +E+ L P ++ GAV + I
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 640
E L GSL +L+ + L R + G+ YLH I+H D+K+ N+L+
Sbjct: 128 FMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS 184
Query: 641 KH-WTVKVGDFGLSR-----LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 694
+ DFG + ++ LT GT MAPEV+ +P D K D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244
Query: 695 ILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDPQCRPSF 753
++ + PW + + EIP P A ++ +P R S
Sbjct: 245 MMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA 304
Query: 754 QEL 756
EL
Sbjct: 305 MEL 307
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 74/291 (25%), Positives = 115/291 (39%), Gaps = 54/291 (18%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
D +GQG+ G V A + A+K ++E + + EV L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQ 62
Query: 564 NVLLFMGA-------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD----WR-- 604
V+ + A V L I E+ G+L+ L+ WR
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 663
R+IL AL Y+H IIHRDLK N+ +D+ VK+GDFGL++ H +
Sbjct: 123 RQILEALS------YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 664 -------------KTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNL 709
+ GT ++A EVL +EK D+YS G+I +E+ +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGM 232
Query: 710 NSMQVIGAVGFMNQRLEIPKDVDPRWAA----IVESCWHSDPQCRPSFQEL 756
+ ++ + + +E P D D I+ DP RP + L
Sbjct: 233 ERVNILKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-51
Identities = 76/270 (28%), Positives = 132/270 (48%), Gaps = 28/270 (10%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572
IG G G VY V VA+K + + S + I F E+ + RHP+++ +G
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 573 TSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ ++ +++ G+L R L T + W +R+ + + ARG+ YLH IIH
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIH 162
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPE-VLRNEPSDE 685
RD+KS N+L+D+++ K+ DFG+S+ E T+L+T KGT ++ PE ++ + E
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV-KGTLGYIDPEYFIKGRLT-E 220
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAV---GFMNQRLEIPKDVDP--------- 733
KSDVYSFGV+L+E+ + +++ + ++ + VDP
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 734 ---RWAAIVESCWHSDPQCRPSFQELVDKL 760
++ C + RPS +++ KL
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 63/295 (21%), Positives = 109/295 (36%), Gaps = 45/295 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 561
D + +G+G G V+ A + A+K +E + E +EV + +L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE---KVMREVKALAKLE 61
Query: 562 HPNVLLFMGA------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 609
HP ++ + A + L I + + +L + T + R + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 610 --ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT-- 665
L IA V +LH ++HRDLK SN+ VKVGDFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 666 ----------GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 715
GT +M+PE + K D++S G+IL+EL + ++ +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL 237
Query: 716 GAVGFMNQRL-EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
V N + + P +V+ P RP + ++ F+
Sbjct: 238 TDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI------IENAVFE 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-50
Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 38/283 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
Y + E+IG G G+V+ V A+K + + +EV
Sbjct: 8 RYTTEFH---ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 558 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 613
L +H +V+ + A + I E+ GSL + R + + L +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 614 ARGVSYLHHCNPPIIHRDLKSSNLLVDKH-------------------WTVKVGDFGLSR 654
RG+ Y+H + ++H D+K SN+ + + K+GD G
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 655 LKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 713
+ +G +++A EVL+ N K+D+++ + + A + N +
Sbjct: 183 RISS----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
I + IP+ + + +++ H DP+ RPS L
Sbjct: 239 EI----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-50
Identities = 77/206 (37%), Positives = 118/206 (57%), Gaps = 16/206 (7%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+G G VY VAVK Q + F+ EV ++ H N+L
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHRNLLRLR 93
Query: 570 G-AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTK--LDWRRRILMALDIARGVSYLH-HCN 624
G +T +RL +V ++ GS+ L +R ++ LDW +R +AL ARG++YLH HC+
Sbjct: 94 GFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEP 682
P IIHRD+K++N+L+D+ + VGDFGL++L +T++TT +GT +APE L
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGK 211
Query: 683 SDEKSDVYSFGVILWELATEKIPWDN 708
S EK+DV+ +GV+L EL T + +D
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDL 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 31/284 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ +++G+G V + A+K E D ++E + + HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHP 86
Query: 564 NVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW--RRRIL-MALDIARG 616
N+L + + ++ F RG+L+ ++R K ++ +IL + L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---------TGK 667
+ +H HRDLK +N+L+ + D G ++ +
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 668 GTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMN 722
T + APE+ + DE++DV+S G +L+ + + P+D V AV
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---Q 261
Query: 723 QRLEIPKD--VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
+L IP+ ++ S DP RP L+ +L LQ
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-49
Identities = 82/272 (30%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 513 IGQGSCGTVYHAVWYGSQDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
+G+G G VY + + VAVK + ++E+ F QE+ +M + +H N++ +G
Sbjct: 39 MGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 571 AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPII 628
+ LC+V ++P GSL RL + T L W R +A A G+++LH I
Sbjct: 98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHI 155
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDE 685
HRD+KS+N+L+D+ +T K+ DFGL+R + T +T++ GT +MAPE LR E +
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI-VGTTAYMAPEALRGEIT-P 213
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQ--VIGAVGFMNQRLEIPKDVDP---------- 733
KSD+YSFGV+L E+ T D Q + ++ I +D
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273
Query: 734 -RWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
++ C H RP +++ L+++
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 13/255 (5%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 566
G +G+G + + + A K+ + E+S+ + L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
F G + +V E R SL L +R + R + I G YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 135
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
+IHRDLK NL +++ VK+GDFGL+ K GTP ++APEVL + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 687 SDVYSFGVILWELATEKIPWD--NLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
DV+S G I++ L K P++ L I + IPK ++P A++++
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-----SIPKHINPVAASLIQKML 250
Query: 744 HSDPQCRPSFQELVD 758
+DP RP+ EL++
Sbjct: 251 QTDPTARPTINELLN 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 9/253 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 562
ED IG +G+G G VY A S +A+KV + + V H R+EV + LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
PN+L G R+ ++ E+ P G+++R LQ+ + + R + +A +SY H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+IHRD+K NLL+ +K+ DFG S H GT ++ PE++
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
DEK D++S GV+ +E K P++ + + P V ++
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 241
Query: 743 WHSDPQCRPSFQE 755
+P RP +E
Sbjct: 242 LKHNPSQRPMLRE 254
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 13/255 (5%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 566
G +G+G + + + A K+ + E+S+ + L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
F G + +V E R SL L +R + R + I G YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 161
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
+IHRDLK NL +++ VK+GDFGL+ K GTP ++APEVL + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 687 SDVYSFGVILWELATEKIPWD--NLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
DV+S G I++ L K P++ L I + IPK ++P A++++
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-----SIPKHINPVAASLIQKML 276
Query: 744 HSDPQCRPSFQELVD 758
+DP RP+ EL++
Sbjct: 277 QTDPTARPTINELLN 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 15/256 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 562
+D IG +G+G G VY A + +A+KV + + + V H R+E+ + LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
PN+L +R+ ++ EF PRG L++ LQ++ + R M ++A + Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCHE 132
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+IHRD+K NLL+ +K+ DFG S H L +T GT ++ PE++ +
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDVDPRWAAIV 739
DEK D++ GV+ +E P+D+ + + I V L+ P + ++
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----DLKFPPFLSDGSKDLI 243
Query: 740 ESCWHSDPQCRPSFQE 755
P R +
Sbjct: 244 SKLLRYHPPQRLPLKG 259
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 90/284 (31%), Positives = 146/284 (51%), Gaps = 26/284 (9%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQ 540
+ S + N D E L+ L E+IG+GS G V+ + +Q VA+K+ +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL---EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 541 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 600
E DE I +QE++++ + P V + G+ +L I+ E+L GS LL+
Sbjct: 59 EAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660
IL +I +G+ YLH IHRD+K++N+L+ +H VK+ DFG++ +T
Sbjct: 118 ETQIATILR--EILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 720
+ T GTP WMAPEV++ D K+D++S G+ ELA + P L+ M+V+ F
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL----F 229
Query: 721 MNQRLEIPKDVDPR----WAAI----VESCWHSDPQCRPSFQEL 756
+ IPK+ P ++ VE+C + +P RP+ +EL
Sbjct: 230 L-----IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSL 556
D+++ G +G+GS VY A + +VA+K+ ++ Y ++ + EV +
Sbjct: 12 DFKV-------GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIAR 615
+L+HP++L + +V E G + R L+ R M I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIIT 123
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675
G+ YLH I+HRDL SNLL+ ++ +K+ DFGL+ + T GTP +++P
Sbjct: 124 GMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDVD 732
E+ +SDV+S G + + L + P+D + + E+P +
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-----EMPSFLS 236
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVD 758
++ +P R S ++D
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 77/307 (25%), Positives = 136/307 (44%), Gaps = 39/307 (12%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQ 552
D+ L + I +D + E IG G+ V A + VA+K + ++ + +
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLK 62
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 612
E+ M + HPN++ + + L +V + L GS+ +++ K + + +L
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 613 IA-------RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 665
IA G+ YLH IHRD+K+ N+L+ + +V++ DFG+S T+
Sbjct: 123 IATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 666 GK-----GTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 719
GTP WMAPEV+ + D K+D++SFG+ ELAT P+ M+V+
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---- 236
Query: 720 FMNQRLEIPKDVDPRWAAI------------VESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+ + + P + C DP+ RP+ EL L+ ++
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL------LRHKF 290
Query: 768 FQASRST 774
FQ +++
Sbjct: 291 FQKAKNK 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-46
Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 24/290 (8%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQ 540
GS+ S + D + + + + +G G+ GT+ + + ++DVAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE 59
Query: 541 EYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 599
+S +EV L++ HPNV+ + Q I E +L +++
Sbjct: 60 CFSFA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF 113
Query: 600 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR 654
I + G+++LH N I+HRDLK N+L+ + DFGL +
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 655 L---KHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATE-KIPWD 707
++ GT W+APE+L + D++S G + + + +E P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 708 NLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756
Q +G + L K D ++E DPQ RPS + +
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 74/322 (22%), Positives = 131/322 (40%), Gaps = 46/322 (14%)
Query: 472 NSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSQ 530
S + G S V + E+ L + + +G VY A +
Sbjct: 3 GPGSLGGASGRDQSDFVGQT--------VELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 531 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA-------VTSPQRLCIVT 582
+ A+K E + QEV MK+L HPN++ F A + Q ++
Sbjct: 55 EYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 583 EFLPRGSLFRLL--QRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPIIHRDLKSSNLLV 639
L +G L L + L +L + R V ++H PPIIHRDLK NLL+
Sbjct: 113 TELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171
Query: 640 DKHWTVKVGDFGLSRLKHETYLTTKTGK------------GTPQWMAPEVL---RNEPSD 684
T+K+ DFG + + + + TP + PE++ N P
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 685 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD--VDPRWAAIVESC 742
EK D+++ G IL+ L + P+++ ++++ N + IP + +++ +
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKLRIV------NGKYSIPPHDTQYTVFHSLIRAM 285
Query: 743 WHSDPQCRPSFQELVDKLRDLQ 764
+P+ R S E+V +L+++
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIA 307
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-45
Identities = 54/265 (20%), Positives = 108/265 (40%), Gaps = 30/265 (11%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVK 535
+ S S+ N + L+ + + D I + QG + + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-KFYALK 60
Query: 536 VFSRQE---------------YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580
+ + F+ E+ ++ +++ L G +T+ + I
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLHHCNPPIIHRDL 632
+ E++ S+ + + LD + + + + SY+H+ I HRD+
Sbjct: 121 IYEYMENDSILKFDEYFF-VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDV 178
Query: 633 KSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVY 690
K SN+L+DK+ VK+ DFG S ++ K +GT ++M PE NE + K D++
Sbjct: 179 KPSNILMDKNGRVKLSDFGES--EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 691 SFGVILWELATEKIPWDNLNSMQVI 715
S G+ L+ + +P+ S+ +
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVEL 261
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-44
Identities = 77/281 (27%), Positives = 137/281 (48%), Gaps = 19/281 (6%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQ 540
+ + K+D D+ E +++ L E++G+GS G+VY A+ + Q VA+K +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPEEVFDVL---EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE 65
Query: 541 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 600
E+I +E+S+M++ P+V+ + G+ L IV E+ GS+ +++
Sbjct: 66 SDLQEII----KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660
L + +G+ YLH IHRD+K+ N+L++ K+ DFG++ +T
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 720
T GTP WMAPEV++ + +D++S G+ E+A K P+ +++ M+ I F
Sbjct: 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI----F 235
Query: 721 MNQRLEIPKDVDP-RWAAI----VESCWHSDPQCRPSFQEL 756
M P P W+ V+ C P+ R + +L
Sbjct: 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-44
Identities = 49/226 (21%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 565
+ + +GQG+ V+ + A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 566 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 620
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 621 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 675
I+HR++K N++ D K+ DFG +R L+ + + GT +++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHP 184
Query: 676 EVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 713
++ + D++S GV + AT +P+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSL 556
LD +WE + ++G G+ G VY A + A KV + S+E + + E+ +
Sbjct: 15 LDPNEVWEIV---GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEI 69
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
+ HP ++ +GA +L I+ EF P G++ ++ L + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
+++LH IIHRDLK+ N+L+ +++ DFG+S +T + GTP WMAPE
Sbjct: 130 LNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 677 VLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
V+ E D K+D++S G+ L E+A + P LN M+V+ + + P +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKIAKSDPPTLL 243
Query: 732 DP-RWAAI----VESCWHSDPQCRPSFQEL 756
P +W+ ++ +P+ RPS +L
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 19/264 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
D + + E+IGQG+ GTVY A+ + Q+VA++ + Q+ E+ +M
Sbjct: 17 DPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVM 71
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 617
+ ++PN++ ++ + L +V E+L GSL ++ + + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--RECLQAL 129
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
+LH +IHRD+KS N+L+ +VK+ DFG T GTP WMAPEV
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 678 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP-RWA 736
+ + K D++S G++ E+ + P+ N N ++ + ++ P+ +P + +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGTPELQNPEKLS 243
Query: 737 AI----VESCWHSDPQCRPSFQEL 756
AI + C D + R S +EL
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 49/226 (21%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 565
+ + +GQG+ V+ + A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 566 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 620
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 621 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 675
I+HR++K N++ D K+ DFG +R L+ + + GT +++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHP 184
Query: 676 EVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 713
++ + D++S GV + AT +P+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 87/287 (30%), Positives = 135/287 (47%), Gaps = 27/287 (9%)
Query: 482 STSSSAVNKVDLDNDCL--DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFS 538
+ ++ D+ D E L+ DL +IG GS G VY A + + VA+K S
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 539 -RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 597
+ S+E +EV +++LRHPN + + G +V E+ GS LL+ +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH 147
Query: 598 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657
L + +G++YLH N +IHRD+K+ N+L+ + VK+GDFG +
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA---- 201
Query: 658 ETYLT-TKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLNSMQ 713
+ + + GTP WMAPEV+ D K DV+S G+ ELA K P N+N+M
Sbjct: 202 -SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAI----VESCWHSDPQCRPSFQEL 756
+ + + E P W+ V+SC PQ RP+ + L
Sbjct: 261 AL----YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 82/296 (27%), Positives = 143/296 (48%), Gaps = 35/296 (11%)
Query: 482 STSSSAVNKVDLDNDCL-DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSR 539
++ S A + ++D L D ++E + E +G G+ G VY + Q A+KV
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELV---ELVGNGTYGQVYKGRHVKTGQLAAIKV--- 56
Query: 540 QEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA------VTSPQRLCIVTEFLPRGSLFR 592
+ + + +QE++++K+ H N+ + GA +L +V EF GS+
Sbjct: 57 MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 593 LLQRNTTKL---DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649
L++ +W I +I RG+S+LH +IHRD+K N+L+ ++ VK+ D
Sbjct: 117 LIKNTKGNTLKEEWIAYIC--REILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172
Query: 650 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-----DEKSDVYSFGVILWELATEKI 704
FG+S T T GTP WMAPEV+ + + D KSD++S G+ E+A
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 705 PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI----VESCWHSDPQCRPSFQEL 756
P +++ M+ + F+ R P+ +W+ +ESC + RP+ ++L
Sbjct: 233 PLCDMHPMRAL----FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 16/258 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
L +IG+GS G V A S + VAVK+ ++ EV +M+ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
NV+ + + L ++ EFL G+L ++ + + + + + ++YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVC--EAVLQALAYLHAQ 160
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
+IHRD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+
Sbjct: 161 G--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP-RWAAI---- 738
+ D++S G+++ E+ + P+ + + +Q + + PK + + + +
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----KRLRDSPPPKLKNSHKVSPVLRDF 274
Query: 739 VESCWHSDPQCRPSFQEL 756
+E DPQ R + QEL
Sbjct: 275 LERMLVRDPQERATAQEL 292
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-42
Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 55/289 (19%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVL 566
+ +G GS GTV + + VAVK E+ L+ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVI 72
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR------RILMALDIARGVSY 619
+ + T+ + L I E +L + +N + + + L+ IA GV++
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL-RQIASGVAH 130
Query: 620 LHHCNPPIIHRDLKSSNLLVD-------------KHWTVKVGDFGLSRL----KHETYLT 662
LH IIHRDLK N+LV ++ + + DFGL + +
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 663 TKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELATEKIP--WDNLNSMQ 713
GT W APE+L D++S G + + + ++ D +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAI-------VESCWHSDPQCRPSFQE 755
I + + + ++ + DP RP+ +
Sbjct: 249 NI-----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 6e-42
Identities = 56/308 (18%), Positives = 107/308 (34%), Gaps = 37/308 (12%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY---- 542
A+ ++ L N L E + ++ ++ ++A + +
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 543 ------SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 596
S + + ++ M N + + + L I + + +L + R
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 597 NTTKLDWRRRILMAL--DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
+ D + + + IA V +LH ++HRDLK SN+ VKVGDFGL
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 655 LKHETYLTTKT------------GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 702
+ GT +M+PE + K D++S G+IL+EL
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
Query: 703 KIPWDNLNSMQVIGAVGFMNQRL-EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761
++I V N + + P+ +V+ P RP ++
Sbjct: 273 FSTQMERV--RIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI----- 323
Query: 762 DLQRQYFQ 769
++ F+
Sbjct: 324 -IENAIFE 330
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 3e-41
Identities = 64/268 (23%), Positives = 105/268 (39%), Gaps = 22/268 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ E++G G G V + + + VA+K RQE S + + E+ +MK+L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 567 -LF-----MGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKL--DWRRRILMALDIARG 616
+ + + E+ G L + L + N L R +L DI+
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS--DISSA 133
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQW 672
+ YLH IIHRDLK N+++ + K+ D G ++ L T GT Q+
Sbjct: 134 LRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQY 189
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
+APE+L + D +SFG + +E T P+ I D
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKL 760
A S + +++
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERW 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-41
Identities = 53/245 (21%), Positives = 100/245 (40%), Gaps = 28/245 (11%)
Query: 505 EDLTIGEQIGQG--SCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
+ IG+G TV A + + + V V+ + + S+E++ + E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVS 618
HPN++ + + L +VT F+ GS L+ + IL + + +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL--QGVLKALD 142
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTPQ 671
Y+HH +HR +K+S++L+ V + + +
Sbjct: 143 YIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 672 WMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
W++PEVL+ D KSD+YS G+ ELA +P+ ++ + Q++ LE
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LEKLN 251
Query: 730 DVDPR 734
P
Sbjct: 252 GTVPC 256
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 38/256 (14%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQ------------------------EY 542
T+ ++IG+GS G V A + A+KV S++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 543 SDEVIHSFRQEVSLMKRLRHPNVL-LF--MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 599
I QE++++K+L HPNV+ L + L +V E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPL 134
Query: 600 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659
D R D+ +G+ YLH+ IIHRD+K SNLLV + +K+ DFG+S +
Sbjct: 135 SEDQARFYFQ--DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 660 YLTTKTGKGTPQWMAPEVLRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQVIG 716
GTP +MAPE L + DV++ GV L+ + P+ + M +
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 717 AVGFMNQRLEIPKDVD 732
+ +Q LE P D
Sbjct: 251 KI--KSQALEFPDQPD 264
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-41
Identities = 63/302 (20%), Positives = 121/302 (40%), Gaps = 52/302 (17%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQEYSDEVIHSFRQEVSLMK 558
E+ +D ++G G+ G V+ S V A K+ E + + +E+ ++
Sbjct: 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 86
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 616
P ++ F GA S + I E + GSL ++L++ +IL +++ + +G
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKG 143
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
++YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE
Sbjct: 144 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 200
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------------------ 718
L+ +SD++S G+ L E+A + P ++ ++
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 719 ---------------GFMNQRLEIPKDVDPRWAAI---------VESCWHSDPQCRPSFQ 754
I + P+ + V C +P R +
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 755 EL 756
+L
Sbjct: 321 QL 322
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
E +G G+ V+ + + A+K + + S E++++K+++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
S +V + + G LF R+L+R T+ D I + V YLH
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---VLSAVKYLHENG 126
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
I+HRDLK NLL +++ + + DFGLS+++ ++T G TP ++APEVL +
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG--TPGYVAPEVLAQK 182
Query: 682 PSDEKSDVYSFGVIL 696
P + D +S GVI
Sbjct: 183 PYSKAVDCWSIGVIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 40/280 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVY---HAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVS- 555
E+ +DL ++G+G+ G V H Q +AVK R + + ++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP--SGQIMAVKRI-RATVNSQEQKRLLMDLDI 58
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LM 609
M+ + P + F GA+ + I E + SL + ++ K + I +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDK---GQTIPEDILGKI 114
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-- 667
A+ I + + +LH +IHRD+K SN+L++ VK+ DFG+S YL K
Sbjct: 115 AVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISG-----YLVDDVAKDI 168
Query: 668 --GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGF 720
G +MAPE + E + KSD++S G+ + ELA + P+D+ + Q + V
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-- 226
Query: 721 MNQRLEIPKDVDPRWAAI----VESCWHSDPQCRPSFQEL 756
P+ +++A C + + RP++ EL
Sbjct: 227 --VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 45/300 (15%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSQDVAVKVFSRQE 541
S + K+ + + ++ EDL +IG+G+ G+V G Q +AVK R
Sbjct: 2 SIESSGKLKISPE-QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSG-QIMAVKRI-RST 58
Query: 542 YSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 600
++ ++ +M+ P ++ F GA+ I E + S + + +
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSV 117
Query: 601 LDWR--RRIL--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656
LD IL + L + +++L N IIHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS--- 173
Query: 657 HETYLTTKTGK----GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDN 708
L K G +MAPE + S D +SDV+S G+ L+ELAT + P+
Sbjct: 174 --GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 709 LNSMQVIGAVGFMNQRLEIPKDVDPR--------WAAI----VESCWHSDPQCRPSFQEL 756
NS+ +Q ++ K P+ ++ V C D RP ++EL
Sbjct: 232 WNSV--------FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 39/298 (13%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSR 539
GS+ SS L Y+ DL ++G G+CG V+ +AVK R
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-R 59
Query: 540 QEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRN 597
+ + E ++ ++K P ++ G + + I E + + + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 598 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657
++ + I + + YL + +IHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 120 PIPERILGKM--TVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGIS---- 172
Query: 658 ETYLTTKTGK----GTPQWMAPEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDN 708
L K G +MAPE + D ++DV+S G+ L ELAT + P+ N
Sbjct: 173 -GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 709 LNSMQVIGAVGFMNQRLEIPKD------VDPRWAAI----VESCWHSDPQCRPSFQEL 756
+ ++ ++ ++ V+ C D + RP + +L
Sbjct: 232 CKTD--------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-40
Identities = 44/309 (14%), Positives = 91/309 (29%), Gaps = 36/309 (11%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHSFR 551
++++ + + + +G+G+ VY A D +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGT 115
Query: 552 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRI 607
Q + +K + F A +V E G+L + + I
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----------DKHWTVKVGDFGLSRLK 656
A+ + + +H C IIH D+K N ++ D + + D G S
Sbjct: 176 SFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 657 --HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 714
T + E+L N+P + + D + ++ + +
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774
+D W + +D LR ++ FQ +
Sbjct: 294 -----KPEGLFRRLPHLDM-WNEFFHVMLNIPDCHHLP---SLDLLRQKLKKVFQQHYTN 344
Query: 775 VGDSTQKEL 783
+ + L
Sbjct: 345 KIRALRNRL 353
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ E++G+G+ V V + + A K+ + ++ S +E + ++L+HPN++
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 125
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
I+HR+LK NLL+ K VK+ DFGL+ + GTP +++PEVL+
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKK 181
Query: 681 EPSDEKSDVYSFGVIL 696
+P + D+++ GVIL
Sbjct: 182 DPYSKPVDIWACGVIL 197
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSD--EVIHSFRQEVSLMKRL 560
+GE +G G V+ A +D VAVKV R + + FR+E L
Sbjct: 16 LGEILGFGGMSEVHLA-----RDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 69
Query: 561 RHPN-VLLF-MGAVTSPQRLC--IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
HP V ++ G +P IV E++ +L ++ + +R I + D +
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQA 128
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGK--GTPQWM 673
+++ H IIHRD+K +N+++ VKV DFG++R ++ + T+T GT Q++
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
+PE R + D +SDVYS G +L+E+ T + P+ + + V A + + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPPSARHE 244
Query: 734 R----WAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 765
A+V +P+ R + E+ L +
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 68/273 (24%), Positives = 127/273 (46%), Gaps = 28/273 (10%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSD--EVIHSFRQEVSLMKRL 560
I +++G G TVY A +D VA+K + E + F +EV +L
Sbjct: 15 IVDKLGGGGMSTVYLA-----EDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQL 68
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
H N++ + +V E++ +L ++ + L I I G+ +
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA 127
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVL 678
H I+HRD+K N+L+D + T+K+ DFG+++ ET LT T GT Q+ +PE
Sbjct: 128 HDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQA 184
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-----EIPKDVDP 733
+ E +DE +D+YS G++L+E+ + P++ ++ + A+ + + ++ KD+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKDIPQ 242
Query: 734 RWAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 765
+ ++ D R + QE+ D L +
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 12/253 (4%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ + IG+G+ V A ++VA+K+ + + + + +EV +MK L HPN++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ + + L ++ E+ G +F L+ K R I V Y H
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--QIVSAVQYCHQKR- 134
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
I+HRDLK+ NLL+D +K+ DFG S L G P + APE+ + + D
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYD 191
Query: 685 -EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
+ DV+S GVIL+ L + +P+D N ++ V + + IP + +++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFL 249
Query: 744 HSDPQCRPSFQEL 756
+P R + +++
Sbjct: 250 VLNPIKRGTLEQI 262
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+ + +G+G+ G V AV + + VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLRNEP 682
I HRD+K NLL+D+ +K+ DFGL+ + E L GT ++APE+L+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRRE 183
Query: 683 SD-EKSDVYSFGVILWELATEKIPWD 707
E DV+S G++L + ++PWD
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 15/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I +G+GS G V + Q+ AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 681 EPSDEKSDVYSFGVIL 696
DEK DV+S GVIL
Sbjct: 197 GTYDEKCDVWSAGVIL 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 4e-38
Identities = 75/356 (21%), Positives = 137/356 (38%), Gaps = 85/356 (23%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEV 546
L D +E + L +G+ +G+G+ G V A +G + VAVK+ ++ +
Sbjct: 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSE 68
Query: 547 IHSFRQEVSL---------------------------MKRLRHPNVLLF----------- 568
+ E+ + ++ + N+ +
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 569 ---------------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------- 606
V +RL +T S + +++ + ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 607 -------ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KH 657
I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R K
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL-NSMQVI 715
Y+ + +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 716 GAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ G R+ P P + CWH +P RP+F ELV+ L +L + Q
Sbjct: 307 RRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ E++G+G+ V V + + A K+ + ++ S +E + ++L+HPN++
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 148
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
I+HR+LK NLL+ K VK+ DFGL+ + GTP +++PEVL+
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKK 204
Query: 681 EPSDEKSDVYSFGVIL 696
+P + D+++ GVIL
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 60/260 (23%), Positives = 116/260 (44%), Gaps = 19/260 (7%)
Query: 509 IGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 565
+G+ +G+GS G V + AVK+ +++ + ++E+ L++RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 566 L-LF--MGAVTSPQRLCIVTEFLPRGS--LFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
+ L + Q++ +V E+ G + + + + G+ YL
Sbjct: 69 IQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC--QLIDGLEYL 125
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKGTPQWMAPEVL 678
H I+H+D+K NLL+ T+K+ G++ H +T +G+P + PE+
Sbjct: 126 HSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 679 RNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
S K D++S GV L+ + T P++ N ++ +G IP D P +
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCGPPLS 241
Query: 737 AIVESCWHSDPQCRPSFQEL 756
+++ +P R S +++
Sbjct: 242 DLLKGMLEYEPAKRFSIRQI 261
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+ + +G+G+ G V AV + + VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLRNEP 682
I HRD+K NLL+D+ +K+ DFGL+ + E L GT ++APE+L+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRRE 183
Query: 683 SD-EKSDVYSFGVILWELATEKIPWD 707
E DV+S G++L + ++PWD
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNV 565
+G+ +G G+ G V + VAVK+ +RQ+ S +V+ ++E+ +K RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
+ +++P +V E++ G LF + + + RR+ I V Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ--QILSAVDYCHRHM 131
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
++HRDLK N+L+D H K+ DFGLS + + +T G+P + APEV+
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYA 188
Query: 685 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 713
+ D++S GVIL+ L +P+D+ +
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-37
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ E++G+G+ V V + Q+ A + + ++ S +E + + L+HPN++
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
+++ ++ + + G LF ++ R ++ D I V + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQMG 130
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
++HR+LK NLL+ K VK+ DFGL+ GTP +++PEVLR +
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 682 PSDEKSDVYSFGVIL 696
P + D+++ GVIL
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 35/271 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRL 560
+ + +G G+CG V A + + VA+++ S+++++ + + E+ ++K+L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 619
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 198 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQY 254
Query: 620 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 675
LH IIHRDLK N+L+ ++ +K+ DFG S+ L + + T GTP ++AP
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLAP 310
Query: 676 EVLRNEPS---DEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDV 731
EVL + + + D +S GVIL+ + P ++ + + + + +
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYNFI--- 365
Query: 732 DPRWAAI-------VESCWHSDPQCRPSFQE 755
WA + V+ DP+ R + +E
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQ------EYSDEVIHSFRQEVSLMKRL 560
+ + +G G+CG V A + + VA+K+ S++ + + E+ ++K+L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 619
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQY 129
Query: 620 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
LH IIHRDLK N+L+ ++ +K+ DFG S++ ET L +T GTP ++APE
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPE 186
Query: 677 VLRNEPS---DEKSDVYSFGVIL 696
VL + + + D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 562
IGE++G G V + + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 621
NV+ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 622 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 676
I H DLK N+++ +K+ DFGL+ ++ G TP+++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAPE 188
Query: 677 VLRNEPSDEKSDVYSFGVIL 696
++ EP ++D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSR-------QEYSDEVIHSFRQEVSLMKR 559
E +G+G V + + ++ AVK+ E E+ + +EV ++++
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 560 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARG 616
+ HPN++ + +V + + +G LF L ++ T ++ + R+ + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEV 136
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 675
+ LH N I+HRDLK N+L+D +K+ DFG S L L GTP ++AP
Sbjct: 137 ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 676 EVLRNEPS------DEKSDVYSFGVIL 696
E++ + ++ D++S GVI+
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKV-----FSRQEYSDEVIHSFRQEVSLMKRLR 561
+ E IG+G V + + Q AVK+ F+ ++E S+ L+
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS--TEDLKREASICHMLK 84
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDW--RRRILMALDIARGVS 618
HP+++ + +S L +V EF+ L +++R + I +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 619 YLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675
Y H N IIHRD+K +L+ + VK+G FG++ E+ L GTP +MAP
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 676 EVLRNEPSDEKSDVYSFGVIL 696
EV++ EP + DV+ GVIL
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 22/252 (8%)
Query: 452 EGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGE 511
+ S + +++S ++ ++ G+ S +D N + L + +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSN----RDALSDFFEVES 59
Query: 512 QIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 570
++G+G+ VY G+ + A+KV + R E+ ++ RL HPN++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 571 AVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPII 628
+P + +V E + G LF R++++ ++ D I V+YLH I+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---AVKQILEAVAYLHENG--IV 170
Query: 629 HRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
HRDLK NLL +K+ DFGLS+ ++H+ + T G TP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG--TPGYCAPEILRGCAYG 228
Query: 685 EKSDVYSFGVIL 696
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSR------QEYSDEVIHSFRQEVSLMKRL 560
+ IG+G V V + + AVK+ E +EV + R+E +++++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 561 R-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGV 617
HP+++ + + S + +V + + +G LF L ++ ++ + R + + V
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS---IMRSLLEAV 213
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 676
S+LH N I+HRDLK N+L+D + +++ DFG S L+ L GTP ++APE
Sbjct: 214 SFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 677 VLRNEPS------DEKSDVYSFGVIL 696
+L+ ++ D+++ GVIL
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 1e-36
Identities = 44/315 (13%), Positives = 99/315 (31%), Gaps = 50/315 (15%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR--- 561
L G +GQ A + + V V E I ++EV ++ LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 562 -------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ--- 595
P + + + +++ F + +L +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 596 ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 653 SRLKHETYLT-TKTGKGTPQWMAPEVLRNEPSDEK-----SDVYSFGVILWELATEKIPW 706
+ ++ G P+ A +L D ++ G+ ++ + +P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 707 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK--LRDLQ 764
+ ++ + IP+ V A++E + R + ++ L+
Sbjct: 318 TDDAALGGSEWI--FRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
Query: 765 RQYFQASRSTVGDST 779
+ A D
Sbjct: 372 TELSAALPLYQTDGE 386
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 562
+GE++G G V G+ ++ A K +EV++++ +RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 621
PN++ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH 125
Query: 622 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 676
I H DLK N+++ + +K+ DFG++ ++ G TP+++APE
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG--TPEFVAPE 181
Query: 677 VLRNEPSDEKSDVYSFGVIL 696
++ EP ++D++S GVI
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 58/273 (21%), Positives = 105/273 (38%), Gaps = 34/273 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSD--EVIHSFRQEVSLMKR 559
+ +G+G G VY A +D VA+K+ + S ++E R
Sbjct: 37 RLRRLVGRGGMGDVYEA-----EDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGR 90
Query: 560 LRHPNVLLFMGAV----TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 615
L+ P+V+ + +L + + L +L+R L R + + I
Sbjct: 91 LQEPHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGS 145
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTPQWMA 674
+ H HRD+K N+LV + DFG++ + LT GT +MA
Sbjct: 146 ALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
PE + ++D+Y+ +L+E T P+ + + V +NQ + P V P
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSV--MGAHINQAIPRPSTVRPG 260
Query: 735 ----WAAIVESCWHSDPQCR-PSFQELVDKLRD 762
+ A++ +P+ R + +L
Sbjct: 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHA 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 3e-36
Identities = 43/316 (13%), Positives = 98/316 (31%), Gaps = 66/316 (20%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-- 561
L G +GQ A + + V V E I ++EV ++ LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 562 --------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ-- 595
P + + + +++ F + +L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 596 ----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 652 LSRLKHETYLTTKTGKGTPQWMAPEVL-----------RNEPSDEKSDVYSFGVILWELA 700
+++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLVRDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 701 TEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS-------- 752
+P ++ + IP+ V A++E + R
Sbjct: 308 CADLPITKDAALGGSEWI--FRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETP 361
Query: 753 -FQELVDKLRDLQRQY 767
+++L +L Y
Sbjct: 362 EYEQLRTELSAALPLY 377
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 30/315 (9%), Positives = 73/315 (23%), Gaps = 60/315 (19%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP 563
L + E + G V+ +D A+KVF+ + + + RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 564 NVLLFMGA--------------------------VTSPQRLCIVTEFLPRGSLFRLLQR- 596
+ + ++ L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 597 -----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651
++ + R + L ++H NL + + +GD
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 652 LSRLKHETYLTTKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDN 708
+ P AP + + G+ ++ + +P+
Sbjct: 240 ALWKVGTRGPAS----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 709 LNS-------MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS--------- 752
+ + G + + ++ + D + R
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 753 FQELVDKLRDLQRQY 767
F +L +++
Sbjct: 356 FLQLQNEISSSLSTG 370
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
Y + +++G+G V + + Q+ A K ++ + E+++++
Sbjct: 30 YILT------SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 559 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARG 616
+ P V+ + + ++ E+ G +F L + I + I G
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 617 VSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQW 672
V YLH N I+H DLK N+L+ +K+ DFG+SR + H L G TP++
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG--TPEY 199
Query: 673 MAPEVLRNEPSDEKSDVYSFGVIL 696
+APE+L +P +D+++ G+I
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 65/304 (21%), Positives = 120/304 (39%), Gaps = 28/304 (9%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDND-CLDYEILWEDLTIGEQIGQGSCGTVYHA 524
SS + + +S + GS + + + E L +G +G G G+VY
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 525 V-WYGSQDVAVKVFSRQEYSDEVIHSF----RQEVSLMKRLRH--PNVLLFMGAVTSPQR 577
+ + VA+K + SD EV L+K++ V+ + P
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 578 LCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIARGVSYLHHCNPPIIHRDLKS 634
++ E P LF + L R + V + H+C ++HRD+K
Sbjct: 123 FVLILERPEPVQDLFDFITERG-ALQEELARSFFW--QVLEAVRHCHNCG--VLHRDIKD 177
Query: 635 SNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSF 692
N+L+D +K+ DFG L +T T GT + PE +R + V+S
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 693 GVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS 752
G++L+++ IP+++ + + ++ + V ++ C P RP+
Sbjct: 236 GILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPT 287
Query: 753 FQEL 756
F+E+
Sbjct: 288 FEEI 291
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ IG G+ G + + VAVK R DE + ++E+ + LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIV 79
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVS 618
F + +P L I+ E+ G L+ + R + D AR GVS
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNA------GR---FSEDEARFFFQQLLSGVS 130
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
Y H I HRDLK N L+D +K+ DFG S+ K+ GTP ++APE
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPE 187
Query: 677 VLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQ 713
VL + D + +DV+S GV L+ + P+++ +
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 65/306 (21%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSR---QEYSDEVIHSFRQEVSLMKRLRHP 563
+ IGQGS G V A+ + A+K+ ++ ++ + + + + EV LMK+L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL----------- 611
N+ Q +C+V E G L +L ++
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 612 ---------------------------DIARGVSYLHHCNPPIIHRDLKSSNLLV--DKH 642
I + YLH+ I HRD+K N L +K
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206
Query: 643 WTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVIL 696
+ +K+ DFGLS+ + Y T GTP ++APEVL NE K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 697 WELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI-------VESCWHSDPQC 749
L +P+ +N I V +N++L +P + + + + + +
Sbjct: 267 HLLLMGAVPFPGVNDADTISQV--LNKKLCFE---NPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 750 RPSFQE 755
R
Sbjct: 322 RFDAMR 327
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 562
GE++G G V + A K + +EVS++K ++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 621
PNV+ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH 131
Query: 622 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 676
I H DLK N+++ +K+ DFGL+ + G TP+++APE
Sbjct: 132 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG--TPEFVAPE 187
Query: 677 VLRNEPSDEKSDVYSFGVIL 696
++ EP ++D++S GVI
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 562
IGE++G G V + + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 621
PN++ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 622 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 676
I H DLK N+++ +K+ DFGL+ ++ G TP+++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAPE 188
Query: 677 VLRNEPSDEKSDVYSFGVIL 696
++ EP ++D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 45/194 (23%), Positives = 90/194 (46%), Gaps = 13/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I E +G+G G V+ V S + K + ++ ++E+S++ RH N+L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---KKEISILNIARHRNIL 64
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ S + L ++ EF+ +F R+ +L+ R + + + +LH N
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 626 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 682
I H D++ N++ + T+K+ +FG +R LK P++ APEV +++
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDV 179
Query: 683 SDEKSDVYSFGVIL 696
+D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 29/263 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSR----QEYSDEVIHSFRQEVSLMKRLR- 561
+G +G+G GTV+ VA+KV R + EV+L+ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 562 ---HPNVLLFMGAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIAR 615
HP V+ + + + +V E LP LF + L R +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFG--QVVA 150
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
+ + H ++HRD+K N+L+D + K+ DFG L H+ T GT +
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD--GTRVYSP 206
Query: 675 PEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
PE + + V+S G++L+++ IP++ + + L P V P
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------LEAELHFPAHVSP 258
Query: 734 RWAAIVESCWHSDPQCRPSFQEL 756
A++ C P RPS +E+
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEI 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 17/196 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
T+ IG+GS G V AV A K + D + F+QE+ +MK L HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNII 69
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
+ +V E G LF R++ + + D R + D+ V+Y H N
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCHKLN 126
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
+ HRDLK N L +K+ DFGL+ K + TK GTP +++P+VL
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG 182
Query: 681 EPSDEKSDVYSFGVIL 696
+ D +S GV++
Sbjct: 183 -LYGPECDEWSAGVMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I E++G G+ G V+ V + + K + D ++ + E+S+M +L HP ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
A + ++ EFL G LF R+ + K+ I G+ ++H +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 626 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 682
I+H D+K N++ K +VK+ DFGL+ L + + T T ++ APE++ EP
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDREP 226
Query: 683 SDEKSDVYSFGVIL 696
+D+++ GV+
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 59/256 (23%), Positives = 116/256 (45%), Gaps = 21/256 (8%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 561
ED G+ +G+GS TV A + A+K+ ++ ++V + +E +M RL
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLD 88
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 616
HP + ++L + G L + +++ + + R I+ AL+
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---- 144
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMA 674
YLH IIHRDLK N+L+++ +++ DFG +++ + GT Q+++
Sbjct: 145 --YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734
PE+L + + + SD+++ G I+++L P+ N + + + + P+ P+
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPK 258
Query: 735 WAAIVESCWHSDPQCR 750
+VE D R
Sbjct: 259 ARDLVEKLLVLDATKR 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 77/253 (30%), Positives = 129/253 (50%), Gaps = 14/253 (5%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 566
I E +G+GS G V A Y + Q VA+K SRQ ++ +E+S +K LRHP+++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+T+P + +V E+ G LF ++++ D RR I + Y H
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQ--QIICAIEYCHRHK- 128
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
I+HRDLK NLL+D + VK+ DFGLS + +L KT G+P + APEV+ +
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVINGKLYA 185
Query: 685 -EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
+ DV+S G++L+ + ++P+D+ + V + +P + P +++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMI 243
Query: 744 HSDPQCRPSFQEL 756
+DP R + QE+
Sbjct: 244 VADPMQRITIQEI 256
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-35
Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 25/261 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+++G G+ G V + + A+K+ + S +EV+++K L HPN++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ +V E G LF ++ R K + ++ + GV+YLH N
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 626 PIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNE 681
I+HRDLK NLL+ +K +K+ DFGLS + +++ + + GT ++APEVLR +
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR-K 212
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI--- 738
DEK DV+S GVIL+ L P+ +++ V + P W +
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFD---SPEWKNVSEG 267
Query: 739 ----VESCWHSDPQCRPSFQE 755
++ D Q R S Q+
Sbjct: 268 AKDLIKQMLQFDSQRRISAQQ 288
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 48/197 (24%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 565
+ E IG GS + + + AVK+ + + +E+ ++ R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNI 78
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHC 623
+ + + +VTE + G L ++L++ ++ + + I + V YLH
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVEYLHAQ 135
Query: 624 NPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
++HRDLK SN+L ++++ DFG ++ T T ++APEVL
Sbjct: 136 G--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 680 NEPSDEKSDVYSFGVIL 696
+ D D++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 27/263 (10%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE------YSDEVIHSFRQEVSLMKRL 560
+ +G G+ G V+ AV ++V VK +++ D + E++++ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGS-LFRLLQRNTTKLDWR--RRILMALDIARGV 617
H N++ + + +V E G LF + R+ +LD I + V
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFR--QLVSAV 143
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPE 676
YL + IIHRD+K N+++ + +T+K+ DFG + + T GT ++ APE
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPE 199
Query: 677 VLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
VL P + +++S GV L+ L E+ P+ L + + P V
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKEL 251
Query: 736 AAIVESCWHSDPQCRPSFQELVD 758
++V P+ R + ++LV
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVT 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 11/210 (5%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 566
+G+ +G G+ G V + VAVK+ +RQ+ S +V+ R+E+ +K RHP+++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+++P + +V E++ G LF + + RR+ I GV Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ--QILSGVDYCHRHM- 136
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 684
++HRDLK N+L+D H K+ DFGLS + +L +T G+P + APEV+
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISGRLYA 193
Query: 685 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 713
+ D++S GVIL+ L +P+D+ +
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 75/264 (28%), Positives = 122/264 (46%), Gaps = 29/264 (10%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I +G+GS G V + Q+ AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 624
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRN 680
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 681 EPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI- 738
DEK DV+S GVIL+ L + P + N ++ V + P+W I
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRV--ETGKYAFD---LPQWRTIS 250
Query: 739 ------VESCWHSDPQCRPSFQEL 756
+ P R + +
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQC 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
++ E +G G G V+ + +A K+ + D + E+S+M +L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHAN 147
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
++ A S + +V E++ G LF R++ + L IL I G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQM 206
Query: 624 NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
I+H DLK N+L +K+ DFGL+R K L G TP+++APEV+
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG--TPEFLAPEVVNY 262
Query: 681 EPSDEKSDVYSFGVIL 696
+ +D++S GVI
Sbjct: 263 DFVSFPTDMWSVGVIA 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 36/277 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
Y++ + +G+GS V S Q AVK+ S++ ++ ++E++ +
Sbjct: 9 HYDLD----LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-----TQKEITAL 59
Query: 558 KRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIA 614
K HPN++ +V E L G LF R+ ++ ++ + + +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLV 116
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 671
VS++H ++HRDLK NLL + + +K+ DFG +RLK KT T
Sbjct: 117 SAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQ----RLE 726
+ APE+L DE D++S GVIL+ + + ++P + S+ AV M +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 727 IPKDVDPRWAAI-------VESCWHSDPQCRPSFQEL 756
W + ++ DP R L
Sbjct: 235 FE---GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-34
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 26/263 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNV 565
+G+GS G V + Q+ AVKV S+++ + S +EV L+K+L HPN+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
+ +V E G LF ++ R + + + G++Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK 146
Query: 625 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRN 680
I+HRDLK NLL+ K +++ DFGLS + + K GT ++APEVL
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLH- 201
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI-- 738
DEK DV+S GVIL+ L + P++ N ++ V + P+W +
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFE---LPQWKKVSE 256
Query: 739 -----VESCWHSDPQCRPSFQEL 756
+ P R S ++
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDA 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 14/197 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
++G G+ G V+ S + +K ++ + E+ ++K L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNII 83
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTK--LDWRRRILMALDIARGVSYLHHC 623
+ IV E G L R++ L + + ++Y H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 624 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLR 679
+ ++H+DLK N+L H +K+ DFGL+ K + + T GT +MAPEV +
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFK 199
Query: 680 NEPSDEKSDVYSFGVIL 696
K D++S GV++
Sbjct: 200 -RDVTFKCDIWSAGVVM 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
DY++ + +G G G V + Q A+K+ RQEV
Sbjct: 29 DYQLS------KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHH 75
Query: 558 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 611
+ P+++ + + L I+ E + G LF R+ +R R +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 668
DI + +LH N I HRD+K NLL +K +K+ DFG ++ + L T
Sbjct: 136 DIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-- 191
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVIL 696
TP ++APEVL E D+ D++S GVI+
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 66/276 (23%), Positives = 102/276 (36%), Gaps = 36/276 (13%)
Query: 432 NESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKV 491
+ S Q P P ++ + V S +A+
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSF 550
DY++ + +G G G V + + A+K+
Sbjct: 62 -------DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KA 101
Query: 551 RQEVSLMKRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWR 604
R+EV L R + P+++ + + L IV E L G LF R+ R R
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETY 660
+ I + YLH N I HRD+K NLL + +K+ DFG ++
Sbjct: 162 EASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 696
LTT TP ++APEVL E D+ D++S GVI+
Sbjct: 220 LTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 32/268 (11%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-V 565
+ I G G +Y A+ + V +K E E + + HP+ V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 566 LLF----MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
+F IV E++ SL R + KL I L+I +SYLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH 199
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLR 679
+++ DLK N+++ + +K+ D G G GTP + APE++R
Sbjct: 200 SIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSR------INSFGYLYGTPGFQAPEIVR 250
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
P+ +D+Y+ G L L + + + + + ++
Sbjct: 251 TGPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLL 301
Query: 740 ESCWHSDPQCRP-SFQELVDKLRDLQRQ 766
DP+ R + +E+ +L + R+
Sbjct: 302 RRAIDPDPRQRFTTAEEMSAQLTGVLRE 329
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
I E++G G+ G V+ + + A K SD + R+E+ M LRHP ++
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLV 217
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
A + ++ EF+ G LF ++ + K+ + + +G+ ++H N
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 626 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+H DLK N++ + +K+ DFGL+ L + + TG T ++ APEV +P
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEGKP 332
Query: 683 SDEKSDVYSFGVIL 696
+D++S GV+
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-32
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 41/304 (13%)
Query: 481 GSTSSSAVNKVDLDNDCL---DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKV 536
+ + ++ + E ++G G+ G V + A+KV
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 537 FSRQ-----------EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 585
+ + ++ E+SL+K L HPN++ + +VTEF
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 586 PRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 641
G LF +++ R+ K D + I G+ YLH N I+HRD+K N+L+ +
Sbjct: 129 EGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNS 184
Query: 642 HWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELA 700
+K+ DFGLS + L + GT ++APEVL+ + +EK DV+S GVI++ L
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL 241
Query: 701 TEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI-------VESCWHSDPQCRPS 752
P N +I V + W I ++ D R +
Sbjct: 242 CGYPPFGGQ-NDQDIIKKV--EKGKYYFD---FNDWKNISDEAKELIKLMLTYDYNKRCT 295
Query: 753 FQEL 756
+E
Sbjct: 296 AEEA 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLF 568
+ +G+G+ V + + Q+ AVK+ +Q +EV ++ + + H NVL
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLEL 76
Query: 569 MGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPP 626
+ R +V E + GS+ + +R +L+ + D+A + +LH+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG-- 131
Query: 627 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTPQWMAPE 676
I HRDLK N+L ++ VK+ DF L + G+ ++MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 677 VLRNEPS-----DEKSDVYSFGVIL 696
V+ D++ D++S GVIL
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 55/254 (21%), Positives = 116/254 (45%), Gaps = 22/254 (8%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 561
+ + +G GS G V S + A+K+ +Q+ ++ H+ E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVN 99
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 616
P ++ + L +V E++ G +F L+R + R I++ +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
YLH + +I+RDLK NLL+D+ ++V DFG ++ T T GTP+ +APE
Sbjct: 156 --YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPE 208
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
++ ++ ++ D ++ GV+++E+A P+ +Q+ + ++ ++ P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 737 AIVESCWHSDPQCR 750
++ + D R
Sbjct: 267 DLLRNLLQVDLTKR 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 21/240 (8%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 561
ED + + IG+G+ G V ++ V A+K+ S+ E + F +E +M
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN 127
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARGV 617
P V+ A + L +V E++P G L L+ W R +++ALD
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD----- 182
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 676
+H IHRD+K N+L+DK +K+ DFG ++ E + T GTP +++PE
Sbjct: 183 -AIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 677 VLRNEPSDEK----SDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
VL+++ D D +S GV L+E+ P+ + + + L P D D
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 55/244 (22%), Positives = 109/244 (44%), Gaps = 24/244 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 561
ED I + IG+G+ G V + V A+K+ ++ E E FR+E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGD 132
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIAR 615
+ A L +V ++ G L LL + +L + R +++A+D
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID--- 189
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 674
+H + +HRD+K N+L+D + +++ DFG +L + + + GTP +++
Sbjct: 190 ---SVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 675 PEVLRNEPSDEKS-----DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729
PE+L+ + D +S GV ++E+ + P+ + ++ G + +R + P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 730 DVDP 733
V
Sbjct: 305 QVTD 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 45/234 (19%), Positives = 98/234 (41%), Gaps = 16/234 (6%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+G+ V + V A+K+ ++ + EV FR+E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH 127
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
A L +V E+ G L LL + ++ +I + +H +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVH 185
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 688
RD+K N+L+D+ +++ DFG +L+ + + + GTP +++PE+L+ +
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 689 VY-------SFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
Y + GV +E+ + P+ ++ + G + ++ + + +
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--VHYKEHLSLPLVDEG 297
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 72/308 (23%), Positives = 138/308 (44%), Gaps = 19/308 (6%)
Query: 446 PESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE 505
+ + A S + + S + + ++V ++ ++E L
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----EFEYL-- 153
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRH 562
+ +G+G+ G V + A+K+ ++ DEV H+ E +++ RH
Sbjct: 154 -----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRH 207
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
P + + + RLC V E+ G LF L R + R R A +I + YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+++RDLK NL++DK +K+ DFGL + + T KT GTP+++APEVL +
Sbjct: 267 EKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
D + GV+++E+ ++P+ N + ++ + + + + P+ + P +++
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGL 383
Query: 743 WHSDPQCR 750
DP+ R
Sbjct: 384 LKKDPKQR 391
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 66/241 (27%), Positives = 119/241 (49%), Gaps = 9/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+G+ G V + A+K+ ++ DEV H+ E +++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTALK 71
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
A + RLC V E+ G LF L R + R R A +I + YLH + +++
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVY 128
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RD+K NL++DK +K+ DFGL + T KT GTP+++APEVL + D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749
+ GV+++E+ ++P+ N + ++ + + + + P+ + P +++ DP+
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 750 R 750
R
Sbjct: 247 R 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 64/254 (25%), Positives = 124/254 (48%), Gaps = 22/254 (8%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 561
+D I +G GS G V+ + A+KV ++ +V H+ E ++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVT 64
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 616
HP ++ G Q++ ++ +++ G LF LL+++ + + + +AL+
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---- 120
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
YLH + II+RDLK N+L+DK+ +K+ DFG ++ + T T GTP ++APE
Sbjct: 121 --YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPE 173
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
V+ +P ++ D +SFG++++E+ P+ + N+M+ + +N L P +
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVK 231
Query: 737 AIVESCWHSDPQCR 750
++ D R
Sbjct: 232 DLLSRLITRDLSQR 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 14/246 (5%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+GS G V ++ + A+K ++Q+ +EV + F+ E+ +M+ L HP ++
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNLW 81
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + + +V + L G L LQ+N + ++ + ++ + YL + IIH
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR--IIH 138
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS- 687
RD+K N+L+D+H V + DF ++ L ET +TT GT +MAPE+ + S
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGAGYSF 196
Query: 688 --DVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLEIPKDVDPRWAAIVESCWH 744
D +S GV +EL + P+ +S V F + P ++++
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 745 SDPQCR 750
+P R
Sbjct: 257 PNPDQR 262
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 56/245 (22%), Positives = 117/245 (47%), Gaps = 13/245 (5%)
Query: 513 IGQGSCGTVY---HAVWYGSQDV-AVKVFSRQ---EYSDEVIHSFRQEVSLMKRLRHPNV 565
+G+G G V+ + + A+KV + + + H+ + E ++++ ++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 625
+ + A + +L ++ E+L G LF L+R ++ +A +I+ + +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKG- 141
Query: 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 685
II+RDLK N++++ VK+ DFGL + T T GT ++MAPE+L +
Sbjct: 142 -IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 745
D +S G +++++ T P+ N + I + + +L +P + +++
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKLNLPPYLTQEARDLLKKLLKR 258
Query: 746 DPQCR 750
+ R
Sbjct: 259 NAASR 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 61/241 (25%), Positives = 112/241 (46%), Gaps = 8/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+GS G V+ A + + A+K + D+V + ++ L HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ + L V E+L G L +Q K D R A +I G+ +LH I++
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVY 141
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+DK +K+ DFG+ + T T GTP ++APE+L + + D
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 749
+SFGV+L+E+ + P+ + ++ ++ P+ ++ ++ + +P+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 750 R 750
R
Sbjct: 260 R 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 70/337 (20%), Positives = 141/337 (41%), Gaps = 24/337 (7%)
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
K W ++ E P G++ + + + ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG-----QGTKAPEEKTA 323
Query: 477 VSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV-AVK 535
+ ++ +++ L D+ L +G+GS G V + G+ ++ AVK
Sbjct: 324 NTISKFDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 536 VFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 593
+ + D+V + ++ L + P + + RL V E++ G L
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 594 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653
+Q+ + + A +IA G+ +L II+RDLK N+++D +K+ DFG+
Sbjct: 433 IQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 713
+ +TTKT GTP ++APE++ +P + D ++FGV+L+E+ + P++ + +
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ ++ M + PK + AI + P R
Sbjct: 550 LFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 19/278 (6%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV-AV 534
S ++ N++ +D ++E + +G+GS G V A + D+ AV
Sbjct: 5 SSKEGNGIGVNSSNRLGID----NFEFI-------RVLGKGSFGKVMLARVKETGDLYAV 53
Query: 535 KVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 592
KV + D+V + ++ L HP + +P RL V EF+ G L
Sbjct: 54 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113
Query: 593 LLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652
+Q+ + + D R A +I + +LH II+RDLK N+L+D K+ DFG+
Sbjct: 114 HIQK-SRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712
+ +TT T GTP ++APE+L+ D ++ GV+L+E+ P++ N
Sbjct: 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230
Query: 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ A+ +N + P + I++S +P R
Sbjct: 231 DLFEAI--LNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHS--FRQEVSL 556
Y L E+IG+G+ G VY A + A+K R E DE I S R E+S+
Sbjct: 3 KYHGL-------EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIR-EISI 53
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 615
+K L+H N++ + + +RL +V E L + L +LL L+ + + L +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-LQLLN 111
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ- 671
G++Y H ++HRDLK NLL+++ +K+ DFGL+R Y T +
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEI 161
Query: 672 ---WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
W AP+VL D++S G I E+
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 63/274 (22%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVY---HAVWYGSQDV-AVKVF 537
K D +E+L + +GQGS G V+ ++ + A+KV
Sbjct: 12 HHVKEGHEKADPS----QFELL-------KVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 538 SRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 596
+ + + + + E ++ + HP ++ A + +L ++ +FL G LF L +
Sbjct: 61 KKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 597 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656
+ + +A ++A + +LH II+RDLK N+L+D+ +K+ DFGLS+
Sbjct: 120 EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176
Query: 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 716
+ + GT ++MAPEV+ + +D +SFGV+++E+ T +P+ + + +
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ + +L +P+ + P +++ + +P R
Sbjct: 237 MI--LKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 33/217 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHS--FRQEVSL 556
Y+ L E++G+G+ G VY A + VA+K R + DE I S R E+SL
Sbjct: 22 KYQKL-------EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIR-EISL 72
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 615
+K L HPN++ + + S + L +V EF+ + L ++L N T L + +I + + R
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL-YQLLR 130
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ- 671
GV++ H I+HRDLK NLL++ +K+ DFGL+R +Y T +
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEV 180
Query: 672 ---WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
W AP+VL D++S G I E+ T K
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 68/281 (24%), Positives = 132/281 (46%), Gaps = 21/281 (7%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV 532
+T++VS ++ +++ L D+ L +G+GS G V + G+ ++
Sbjct: 1 TTNTVSK--FDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDEL 47
Query: 533 -AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 589
AVK+ + D+V + ++ L + P + + RL V E++ G
Sbjct: 48 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 107
Query: 590 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649
L +Q+ + + A +IA G+ +L II+RDLK N+++D +K+ D
Sbjct: 108 LMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIAD 164
Query: 650 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 709
FG+ + +TTKT GTP ++APE++ +P + D ++FGV+L+E+ + P++
Sbjct: 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
Query: 710 NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
+ ++ ++ M + PK + AI + P R
Sbjct: 225 DEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 19/288 (6%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV 525
+ N + S + S+ D+ L + IG+GS G V A
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPS----DFHFL-------KVIGKGSFGKVLLAR 58
Query: 526 WYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582
+ AVKV ++ E H + L+K ++HP ++ + + +L V
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 642
+++ G LF LQR L+ R R A +IA + YLH N I++RDLK N+L+D
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN--IVYRDLKPENILLDSQ 175
Query: 643 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 702
+ + DFGL + E TT T GTP+++APEVL +P D D + G +L+E+
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 703 KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 750
P+ + N+ ++ + +N+ L++ ++ ++E D R
Sbjct: 236 LPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHS--FRQEVS 555
YE L E+IG+G+ GTV+ A + + VA+K R + DE + S R E+
Sbjct: 3 KYEKL-------EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALR-EIC 53
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 614
L+K L+H N++ + S ++L +V EF + L + LD + + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-FQLL 111
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ 671
+G+ + H N ++HRDLK NLL++++ +K+ +FGL+R Y + +
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAE 161
Query: 672 ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEKIP 705
W P+VL D++S G I ELA P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHS--FRQEVS 555
YE + +IG+GS G V+ + Q VA+K F + D VI R E+
Sbjct: 4 KYEKI-------GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALR-EIR 54
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 614
++K+L+HPN++ + +RL +V E+ ++ L R + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT-WQTL 112
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQ 671
+ V++ H N IHRD+K N+L+ KH +K+ DFG +R + Y +
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--------DDE 162
Query: 672 ----WM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
W +PE+L + DV++ G + EL +
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 63/253 (24%), Positives = 121/253 (47%), Gaps = 23/253 (9%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
IG+GS V + + A+KV ++ +++ ++ + HP ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 629
+ RL V E++ G L +QR + R A +I+ ++YLH II+
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--IIY 133
Query: 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 689
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 690 YSFGVILWELATEKIPW-----------DNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAA 737
++ GV+++E+ + P+ + + + QVI + +++ IP+ + + A+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----LEKQIRIPRSLSVKAAS 248
Query: 738 IVESCWHSDPQCR 750
+++S + DP+ R
Sbjct: 249 VLKSFLNKDPKER 261
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHS--FRQEVS 555
YE L +G+GS G V + + VA+K F + D+++ R E+
Sbjct: 26 KYENL-------GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMR-EIK 76
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 614
L+K+LRH N++ + +R +V EF+ ++ L+ LD++ + + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL-FQII 134
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ--- 671
G+ + H N IIHRD+K N+LV + VK+ DFG +R L +
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVAT 187
Query: 672 -WM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
W APE+L + K+ DV++ G ++ E+ +
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 47/208 (22%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
DY++ + +G G G V + + A+K+ R+EV L
Sbjct: 18 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 64
Query: 558 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 611
R + P+++ + + L IV E L G LF R+ R R +
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 668
I + YLH N I HRD+K NLL + +K+ DFG
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVIL 696
A E E D+ D++S GVI+
Sbjct: 167 -----AKETTG-EKYDKSCDMWSLGVIM 188
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 68/319 (21%), Positives = 139/319 (43%), Gaps = 35/319 (10%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H ++ + + + + + S A + + L D+++L
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMN-TRESGKASSSLGLQ----DFDLL--- 57
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHP 563
IG+GS V + + A++V ++ +++ ++ + HP
Sbjct: 58 ----RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
++ + RL V E++ G L +QR + R A +I+ ++YLH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER 172
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
II+RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E
Sbjct: 173 G--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 684 DEKSDVYSFGVILWELATEKIPW-----------DNLNSM-QVIGAVGFMNQRLEIPKDV 731
D ++ GV+++E+ + P+ + + + QVI + +++ IP+ +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----LEKQIRIPRSL 285
Query: 732 DPRWAAIVESCWHSDPQCR 750
+ A++++S + DP+ R
Sbjct: 286 SVKAASVLKSFLNKDPKER 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 9e-25
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNVLLF 568
+++G+G+ TVY + VA+K R E+ + + R EVSL+K L+H N++
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLHHCNPPI 627
+ + + L +V E+L + L + L ++ ++ + + RG++Y H +
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQK--V 121
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ----WM-APEVLR 679
+HRDLK NLL+++ +K+ DFGL+R K +TY + W P++L
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWYRPPDILL 173
Query: 680 NEPS-DEKSDVYSFGVILWELATEK 703
+ D++ G I +E+AT +
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEV-IHSFR 551
++ L E++G G+ TVY + VA+K + + + + R
Sbjct: 6 QFKQL-------EKLGNGTYATVYKG-----LNKTTGVYVALKEV-KLDSEEGTPSTAIR 52
Query: 552 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR------ 605
E+SLMK L+H N++ + + +L +V EF+ L + + T R
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLT 662
+ + +G+++ H I+HRDLK NLL++K +K+GDFGL+R T+
Sbjct: 111 KYFQ-WQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-- 165
Query: 663 TKTGKGTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
+ + W AP+VL + D++S G IL E+ T K
Sbjct: 166 ------SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 45/225 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD------VA---VKVFSRQEYSDEV-IH 548
YE L + +G+G TVY A +D VA +K+ R E D +
Sbjct: 11 RYEKL-------DFLGEGQFATVYKA-----RDKNTNQIVAIKKIKLGHRSEAKDGINRT 58
Query: 549 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RI 607
+ R E+ L++ L HPN++ + A + +V +F+ L +++ N+ L +
Sbjct: 59 ALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK---HETYLTTK 664
M L +G+ YLH I+HRDLK +NLL+D++ +K+ DFGL++ + Y
Sbjct: 117 YM-LMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY---- 169
Query: 665 TGKGTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
T Q W APE+L D+++ G IL EL
Sbjct: 170 ----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 11/246 (4%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+G G V+ + + A K +++ + E ++ ++ ++
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLA 251
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 626
A + LC+V + G + + R I I G+ +LH N
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
II+RDLK N+L+D V++ D GL+ TK GTP +MAPE+L E D
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 687 SDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWH 744
D ++ GV L+E+ + P+ + + Q + P P E+
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 745 SDPQCR 750
DP+ R
Sbjct: 430 KDPEKR 435
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 55/245 (22%), Positives = 97/245 (39%), Gaps = 12/245 (4%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 569
+G+G G V + + A K ++ + E +++++ V+
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 570 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 628
A + LC+V + G L + R + A +I G+ LH I+
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IV 308
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKS 687
+RDLK N+L+D H +++ D GL+ H T K GT +MAPEV++NE
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 688 DVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHS 745
D ++ G +L+E+ + P+ V E + P+ ++
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCK 426
Query: 746 DPQCR 750
DP R
Sbjct: 427 DPAER 431
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 32/256 (12%), Positives = 63/256 (24%), Gaps = 49/256 (19%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHS-FRQEVSLMKRLR 561
+ G + A+ D VA+ Q + + + R+
Sbjct: 35 LLIFHGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
P V + V + +V E++ GSL + + I +A H
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH 146
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
+ S + V V +
Sbjct: 147 RAG--VALSIDHPSRVRVSIDGDVVLAYPATMP--------------------------- 177
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-MNQRLEIPKDVDPR----WA 736
++ + D+ G L+ L + P + + P D+D +
Sbjct: 178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237
Query: 737 AIVESCWHSDPQCRPS 752
A+ D R +
Sbjct: 238 AVAARSVQGDGGIRSA 253
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 64/326 (19%), Positives = 131/326 (40%), Gaps = 42/326 (12%)
Query: 448 SHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVN------KVDLDNDCLDYE 501
+H + + + G+ +S + N KV ++ ++E
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE----NFE 57
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDV----AVKVFSRQ---EYSDEVIHSFRQEV 554
+L + +G G+ G V+ D A+KV + + + H+ +
Sbjct: 58 LL-------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
L + P ++ A + +L ++ +++ G LF L + + +I + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK-HETYLTTKTGKGTPQWM 673
+ +LH II+RD+K N+L+D + V + DFGLS+ + GT ++M
Sbjct: 170 LALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 674 APEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNS-------MQVIGAVGFMNQR 724
AP+++R S D+ D +S GV+++EL T P+ + I +
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-----LKSE 282
Query: 725 LEIPKDVDPRWAAIVESCWHSDPQCR 750
P+++ +++ DP+ R
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEVIHS--F 550
Y + ++G+G+ G VY A D VA+K R E+ +E +
Sbjct: 35 RYRRI-------TKLGEGTYGEVYKA-----IDTVTNETVAIKRI-RLEHEEEGVPGTAI 81
Query: 551 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 610
R EVSL+K L+H N++ + RL ++ E+ L + + +N + +
Sbjct: 82 R-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL- 138
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRLK---HETYLT 662
+ GV++ H +HRDLK NLL+ +K+GDFGL+R +
Sbjct: 139 YQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-- 194
Query: 663 TKTGKGTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
T + W PE+L D++S I E+ +
Sbjct: 195 ------THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 55/247 (22%), Positives = 107/247 (43%), Gaps = 16/247 (6%)
Query: 513 IGQGSCGTVYHAVWYGSQDV-AVKVFSRQE--YSDEVIHSF--RQEVSLMKRLRHPNVLL 567
IG+G G VY + + A+K ++ + R +SL+ P ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 568 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 627
A +P +L + + + G L L ++ A +I G+ ++H+ +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--V 313
Query: 628 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 687
++RDLK +N+L+D+H V++ D GL+ + GT +MAPEVL+ + + S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 688 -DVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743
D +S G +L++L P+ + ++ + +E+P P +++E
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGLL 429
Query: 744 HSDPQCR 750
D R
Sbjct: 430 QRDVNRR 436
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 47/226 (20%), Positives = 81/226 (35%), Gaps = 40/226 (17%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQ------- 552
Y + I GS G V V VA+K ++
Sbjct: 24 YTVQ-------RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 553 --EVSLMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKL-DWR 604
E+ L+ HPN+L + L +VTE + L +++ +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET----- 659
+ M I G+ LH ++HRDL N+L+ + + + DF L+R
Sbjct: 136 IQYFM-YHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 660 YLTTKTGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
Y+T +W APE++ + D++S G ++ E+ K
Sbjct: 193 YVTH-------RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 49/221 (22%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
T + IG GS G V+ A S +VA+K V + + R E+ +M+ ++HPNV+
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NR-ELQIMRIVKHPNVV 95
Query: 567 LFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD-------- 612
S L +V E++P +++R + + + M +
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQ 149
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR--LKHET---YLTTKTG 666
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++ + E Y+ ++
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-- 205
Query: 667 KGTPQWM-APEVLRNEPSDEKS---DVYSFGVILWELATEK 703
+ APE++ + + D++S G ++ EL +
Sbjct: 206 -----YYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 46/223 (20%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK-VFSRQEYSDEVIHSFR--QEVSLMKRLRHP 563
+ GQG+ GTV + VA+K V + R Q + + L HP
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------QDPRFRNRELQIMQDLAVLHHP 79
Query: 564 NVLLFMGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD---- 612
N++ + L +V E++P +L R + +RR++
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-----RNYYRRQVAPPPILIKV 133
Query: 613 ----IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET-----YLT 662
+ R + LH + + HRD+K N+LV++ T+K+ DFG ++ + Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 663 TKTGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
++ + APE++ D++S G I E+ +
Sbjct: 194 SR-------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVK---VFSRQEYSDEVIHSFRQEVS 555
+++ +G+G+ G V A + + VA+K F + ++ + + R E+
Sbjct: 13 FQLK-------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---LRTLR-EIK 61
Query: 556 LMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 610
++K +H N++ + I+ E + L R++ D + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-- 118
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 670
R V LH N +IHRDLK SNLL++ + +KV DFGL+R+ E+ G
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 671 QWM----------APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
M APEV+ DV+S G IL EL +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
T + IG GS G VY A S + VA+K V + + R E+ +M++L H N+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKLDHCNI 109
Query: 566 LLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD------- 612
+ S L +V +++P +++R+ + R + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-----RHYSRAKQTLPVIYVKLYMY 163
Query: 613 -IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET-----YLTTKT 665
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++ Y+ ++
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 220
Query: 666 GKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
+ APE++ S DV+S G +L EL +
Sbjct: 221 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 7e-22
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+Q + ++ + DL II WN+ +E LYGYS E+A+GQ + +L D +
Sbjct: 7 KQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQP-VNMLHVPGDTEHIT 65
Query: 190 -DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ ++ +WTG+ K + + P Y ++ +VG + ++ D
Sbjct: 66 SEVISAVENQGKWTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRD 117
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 562
+ IG G+ G V A ++VA+K F Q ++ ++R E+ LMK + H
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 83
Query: 563 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
N++ + T + L IV E + +L +++Q R L+ + G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 139
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
+ +LH IIHRDLK SN++V T+K+ DFGL+R +++ T T + APE
Sbjct: 140 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPE 196
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEK 703
V+ E D++S G I+ E+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 66/227 (29%), Positives = 93/227 (40%), Gaps = 42/227 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDEVIHSF-----RQ 552
YE + +IG G+ GTVY A S VA+K R R
Sbjct: 10 RYEPV-------AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVR- 60
Query: 553 EVSLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDW 603
EV+L++RL HPNV+ M + + ++ +V E + + L L + L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYL 661
+ RG+ +LH I+HRDLK N+LV TVK+ DFGL+R+
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL- 176
Query: 662 TTKTGKGTPQ----WM-APEVLRNEPSDEKSDVYSFGVILWELATEK 703
TP W APEVL D++S G I E+ K
Sbjct: 177 -------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 562
+G G+ G+V A+ S + VA+K F + ++ ++R E+ L+K ++H
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYR-ELLLLKHMQH 82
Query: 563 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
NV+ + T L +V F+ L +++ + + + + L+ + +G
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQYLV-YQMLKG 138
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQW-MAP 675
+ Y+H ++HRDLK NL V++ +K+ DFGL+R TG +W AP
Sbjct: 139 LKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAP 192
Query: 676 EVLRNEPS-DEKSDVYSFGVILWELATEK 703
EV+ + ++ D++S G I+ E+ T K
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 30/222 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVKVFSRQEYSDE--VIHSFRQEVS 555
YE L +IGQG+ G V+ A + VA+K E E I + R E+
Sbjct: 18 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR-EIK 68
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLC--------IVTEFLPRGSLFRLLQRNTTKLDWRRRI 607
+++ L+H NV+ + + +V +F L LL K
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667
+ + G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R ++ +
Sbjct: 128 RVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNR 184
Query: 668 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
T + W PE+L E D++ G I+ E+ T
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSQDVAVKVFSRQEYSDEVIHS--FRQEV 554
YE + +IG+G+ G V+ A + G + VA+K R + +E + R EV
Sbjct: 12 QYECV-------AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIR-EV 62
Query: 555 SLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDWRR 605
++++ L HPNV+ T + +L +V E + + L L + +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTT 663
M + RG+ +LH ++HRDLK N+LV +K+ DFGL+R+
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--- 176
Query: 664 KTGKGTPQ----WM-APEVLRNEPSDEKSDVYSFGVILWELATEK 703
T W APEVL D++S G I E+ K
Sbjct: 177 -----TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 40/242 (16%)
Query: 499 DYEIL---WE---DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFR 551
DYE W D + ++G+G V+ A+ + + V VK+ + ++
Sbjct: 24 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIK---- 78
Query: 552 QEVSLMKRLR-HPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
+E+ +++ LR PN++ V P +V E + +L Q T D+ R
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDIRFY 135
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET-----YLT 662
M +I + + Y H I+HRD+K N+++D +H +++ D+GL+ H +
Sbjct: 136 M-YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 663 TKTGKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEKIPW----DNLNSMQVIG 716
++ + PE+L + + S D++S G +L + K P+ DN + + I
Sbjct: 193 SR-------YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 717 AV 718
V
Sbjct: 246 KV 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 6e-21
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 562
+ IG G+ G V A ++VA+K F Q ++ ++R E+ LMK + H
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 120
Query: 563 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
N++ + T + L +V E + +L +++Q R L+ + G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 176
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQ 671
+ +LH IIHRDLK SN++V T+K+ DFGL+R + Y+ T +
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-------R 227
Query: 672 WM-APEVLRNEPSDEKSDVYSFGVILWELATEKI 704
+ APEV+ E D++S G I+ E+ KI
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+G G+ G+V A + VAVK F ++ ++R E+ L+K ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYR-ELRLLKHMKHENV 90
Query: 566 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
+ + T + L +VT + L +++ D + ++ I RG+ Y
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIY--QILRGLKY 147
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---YLTTKTGKGTPQW-MAP 675
+H + IIHRDLK SNL V++ +K+ DFGL+R + Y+ T +W AP
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT-------RWYRAP 198
Query: 676 EVLRNEPS-DEKSDVYSFGVILWELATEK 703
E++ N ++ D++S G I+ EL T +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
G ++G+G+ G VY A +D A+K S +E++L++ L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNV 80
Query: 566 LLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD--------IAR 615
+ S ++ ++ ++ L+ +++ + ++ + + I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL--KHETYLTTKTGKGT 669
G+ YLH ++HRDLK +N+LV + VK+ D G +RL L
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 670 PQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 703
W APE+L K+ D+++ G I EL T +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
+ +G G+ G V AV + VA+K F + ++ ++R E+ L+K +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYR-ELRLLKHMRHENV 86
Query: 566 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
+ + T + L +V F+ L +L++ KL R + + +G+ Y
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRY 143
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVL 678
+H IIHRDLK NL V++ +K+ DFGL+R + TG +W APEV+
Sbjct: 144 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVI 197
Query: 679 RNEPS-DEKSDVYSFGVILWELATEK 703
N + D++S G I+ E+ T K
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 49/232 (21%), Positives = 97/232 (41%), Gaps = 52/232 (22%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVF-SRQEYSDEVIHSFRQEVSLM 557
Y ++ ++G G TV+ A + VA+K+ + Y++ E+ L+
Sbjct: 21 YILV-------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLL 69
Query: 558 KRLR--------HPNV-----LL--FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 600
+R+ LL F + + +V E L +L L+++ +
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128
Query: 601 -LDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGL 652
L + ++I + + G+ Y+H C IIH D+K N+L++ +K+ D G
Sbjct: 129 PLIYVKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 653 SRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 701
+ E + T+ ++ +PEVL P +D++S +++EL T
Sbjct: 185 ACWYDEHYTNSIQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVK--VFSRQEYSDEVIHSFRQEVSL 556
Y L + +G G G V+ AV + VA+K V + + H+ R E+ +
Sbjct: 13 YMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALR-EIKI 61
Query: 557 MKRLRHPNVLLFMGAVTSPQRLC--------------IVTEFLPRGSLFRLLQRNTTKLD 602
++RL H N++ + IV E++ L +L++ +
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEE 120
Query: 603 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL 661
R + + RG+ Y+H N ++HRDLK +NL ++ +K+GDFGL+R+ Y
Sbjct: 121 HARLFMY--QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 662 TTK--TGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
+ +W +P +L + + + D+++ G I E+ T K
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
T IG+G+ G V A + VA+K F Q Y + R E+ ++ R RH
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC---QRTLR-EIKILLRFRHE 85
Query: 564 NVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
N++ + +P + IV + + L++LL+ D L I RG+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLY--QILRGLK 142
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWM-AP 675
Y+H N ++HRDLK SNLL++ +K+ DFGL+R+ + T T +W AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 676 EVLRNEPS-DEKSDVYSFGVILWELATEK 703
E++ N + D++S G IL E+ + +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 48/233 (20%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-VAVK----VFSRQEYSDEVIHSFRQEV 554
Y I IG+GS G VY A ++ VA+K +F R E+
Sbjct: 28 YIIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILR-EI 76
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILM 609
+++ RL+ ++ + L IV E L +L + + + ++
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL 135
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR------------LKH 657
++ G +++H IIHRDLK +N L+++ +VKV DFGL+R
Sbjct: 136 -YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 658 ETYLTTKTGKGTPQWM----------APEVLRNEPS-DEKSDVYSFGVILWEL 699
E K + + APE++ + + + D++S G I EL
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 42/243 (17%)
Query: 483 TSSSAVNKVDLDNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKV 536
+ N D+D Y + + + + IG+GS G V A + Q VA+K+
Sbjct: 70 GMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM 129
Query: 537 F-SRQEYSDEVIHSFRQ---EVSLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLP 586
+ + + RQ E+ +++ LR NV+ + T +C+ E L
Sbjct: 130 VRNEKRF-------HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL- 181
Query: 587 RGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DK 641
+L+ L+++N + L R+ A I + + LH IIH DLK N+L+
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKNR--IIHCDLKPENILLKQQG 237
Query: 642 HWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 698
+KV DFG S +H+ TY+ ++ + APEV+ D++S G IL E
Sbjct: 238 RSGIKVIDFGSSCYEHQRVYTYIQSR------FYRAPEVILGARYGMPIDMWSLGCILAE 291
Query: 699 LAT 701
L T
Sbjct: 292 LLT 294
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 61/277 (22%), Positives = 101/277 (36%), Gaps = 47/277 (16%)
Query: 461 AWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGT 520
+ + V+ + S+ + D++I + I IG GS G
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHLIGTGSYGH 68
Query: 521 VYHAVWYGSQD-VAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575
V A + VA+K VF R E++++ RL H +V+ + V
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILR-EIAILNRLNHDHVVKVLDIVIPK 124
Query: 576 QRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 630
+V E +L + + + L+ ++ GV Y+H I+HR
Sbjct: 125 DVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL-YNLLVGVKYVHSAG--ILHR 180
Query: 631 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM----------------- 673
DLK +N LV++ +VKV DFGL+R +P+
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 674 ----------APEVLRNEPS-DEKSDVYSFGVILWEL 699
APE++ + + E DV+S G I EL
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 494 DNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVF-SRQEYSDEV 546
D+D DY E + I IG+GS G V A + VA+K+ +++ + ++
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 547 IHSFRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 600
+ EV L++ + ++ LC+V E L +L+ LL+ +
Sbjct: 98 ----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR 152
Query: 601 ---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRL 655
L+ R+ A + + +L IIH DLK N+L+ K +K+ DFG S
Sbjct: 153 GVSLNLTRKF--AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210
Query: 656 KHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 701
+ Y+ ++ + +PEVL P D D++S G IL E+ T
Sbjct: 211 LGQRIYQYIQSR------FYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 78/252 (30%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
++G+ +G GS G V S + A+K V Y R E+ +MK L H N+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NR-ELDIMKVLDHVNI 62
Query: 566 ---------------------------------LLFMGAVTSPQR-----LCIVTEFLPR 587
+ L ++ E++P
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP- 121
Query: 588 GSLFRLLQRNTTKLDWRRRILMALD--------IARGVSYLHHCNPPIIHRDLKSSNLLV 639
+L ++L K R + ++ + R V ++H I HRD+K NLLV
Sbjct: 122 DTLHKVL-----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174
Query: 640 D-KHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQWM-APEVLRNEPS-DEKSDVYS 691
+ K T+K+ DFG ++ + Y+ ++ + APE++ D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWS 227
Query: 692 FGVILWELATEK 703
G + EL K
Sbjct: 228 IGCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 51/234 (21%), Positives = 104/234 (44%), Gaps = 46/234 (19%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVK----VFSRQEYSDEVIHSFRQEV 554
YE++ +++G+G+ G V+ ++ + + VAVK F + +FR E+
Sbjct: 11 YELV-------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFR-EI 59
Query: 555 SLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
++ L H N++ + + + + + +V +++ L +++ N + ++ ++
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVV--Y 116
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-----------LKHETY 660
+ + + YLH ++HRD+K SN+L++ VKV DFGLSR +
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 661 LTTKTGKGTPQWM----------APEVLRNEPS-DEKSDVYSFGVILWELATEK 703
T+ + APE+L + D++S G IL E+ K
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 28/98 (28%), Positives = 41/98 (41%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
V I DL RI+Y N + + Y EE +GQD + + D+ I G W
Sbjct: 2 VSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQ 61
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
G+F + K R V +T P D+ G + + D
Sbjct: 62 GEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRD 99
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-15
Identities = 25/122 (20%), Positives = 46/122 (37%), Gaps = 8/122 (6%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + + + + + D + RIIY N + G + E LGQ +L
Sbjct: 107 EAQLARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQS-PSILDSPLAD 165
Query: 186 DVAY-DIVHRIKMGERWTGQFPAKTKTE------ERVLVVATNTPFYDDDGTLVGIVCVS 238
+ ++ G+ W+G+ + +T E + TP + D LVG V +
Sbjct: 166 QETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
Query: 239 TD 240
D
Sbjct: 226 HD 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 58/243 (23%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSQDVAVKVF-SRQEYSDEVIHS 549
D L YEI+ + +G+G+ G V + G + VAVK+ + Y +
Sbjct: 9 GDVLSARYEIV-------DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--- 58
Query: 550 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 600
R E+ +++ L + + +CIV E L S + ++ N
Sbjct: 59 -RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFR 116
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT--------------- 644
LD R++ A I + V++LH + H DLK N L V +T
Sbjct: 117 LDHIRKM--AYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 645 ---VKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 698
+KV DFG + E T ++T+ + APEV+ + DV+S G IL E
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTR------HYRAPEVILALGWSQPCDVWSIGCILIE 226
Query: 699 LAT 701
Sbjct: 227 YYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 56/243 (23%), Positives = 96/243 (39%), Gaps = 58/243 (23%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSQDVAVKVF-SRQEYSDEVIHS 549
D L YEI+ +G+G+ G V + G VA+K+ + +Y +
Sbjct: 14 GDWLQERYEIV-------GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--- 63
Query: 550 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 600
R E++++K+++ +L +CI E L + F L+ N +
Sbjct: 64 -RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYP 121
Query: 601 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVD------------------K 641
L R + A + + +LH + H DLK N L V+ K
Sbjct: 122 LPHVRHM--AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 642 HWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 698
+ +++V DFG + HE T + T+ + PEV+ + DV+S G IL+E
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATR------HYRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 699 LAT 701
Sbjct: 232 YYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 55/247 (22%), Positives = 107/247 (43%), Gaps = 62/247 (25%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVF-SRQEYSDEVIHSF 550
L+ + ++ ++G G+ G V + AVKV + ++Y+ S
Sbjct: 30 GMLLNNAFLVI-------RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR----SA 78
Query: 551 RQEVSLMKRLRH-----PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LD 602
+ E ++K++++ N++ + G +C++ E L SL+ ++ RN ++
Sbjct: 79 KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 603 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT----------------- 644
+ ++I + ++YL + + H DLK N LL D ++
Sbjct: 138 DIKLY--CIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 645 -------VKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 694
+K+ DFG + K + + + T+ Q+ APEV+ N D SD++SFG
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTR------QYRAPEVILNLGWDVSSDMWSFGC 247
Query: 695 ILWELAT 701
+L EL T
Sbjct: 248 VLAELYT 254
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 54/274 (19%), Positives = 103/274 (37%), Gaps = 79/274 (28%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAV-WYGSQDVAVKVF-SRQEYSDEVIHSFRQEVSLMK 558
++ + ++G G TV+ + G + VA+KV S + Y++ + E+ L+K
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLK 88
Query: 559 RLR-----HPN-----VLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK---LDW 603
+R PN LL ++ +C+V E L L + + ++ + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 604 RRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLV----------------------- 639
++I+ + +G+ YLH C IIH D+K N+L+
Sbjct: 148 VKKIIQ--QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 640 --------------------------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 673
+ VK+ D G + H+ + T Q+
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYR 260
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 707
+ EVL + +D++S + +ELAT ++
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* Length = 96 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG 198
M ++ RI WN+ AE L+G E LG+ +L ++ +
Sbjct: 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENK 57
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E F K ER + +PF + L+ V ++ D
Sbjct: 58 EPVFLNF---YKFGERYFNI-RFSPFRNAKTQLLEGVIITID 95
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 67/284 (23%), Positives = 104/284 (36%), Gaps = 34/284 (11%)
Query: 509 IGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 563
+G +IG GS G +Y ++VA+K E E + K ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
+ G +V E L SL L + K + +L+A + + Y+H
Sbjct: 69 TIRWC-G--AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 624 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTPQWM 673
N IHRD+K N L+ K V + DFGL++ +H Y K GT ++
Sbjct: 125 N--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 674 APEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNL---NSMQVIGAVGFMNQRLEIP- 728
+ L E S + D+ S G +L +PW L Q + I
Sbjct: 183 SINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 729 --KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL-QRQYFQ 769
K +A + C +P + L R+L RQ F
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} Length = 349 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 7/112 (6%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
R + +IL+S+ ++ RI WN+ AE L+G E LG+ +L DF+
Sbjct: 7 RNFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLP----DFEEI 62
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + + F K ER + + L G++ D
Sbjct: 63 GSVAESVFENKE--PVFLNFYKFGERYFNIRFSPFRNAKTQLLEGVIITIDD 112
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 29/220 (13%)
Query: 509 IGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 563
+G +IG+GS G ++ +Q VA+K E R E K L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
NV F G +V + L SL LL K + + A + V +H
Sbjct: 70 NVYYF-G--QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 624 NPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTPQ 671
+ +++RD+K N L+ + + + V DFG+ + +H Y K GT +
Sbjct: 126 S--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 672 WMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 710
+M+ L E S + D+ + G + +PW L
Sbjct: 184 YMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 33/222 (14%)
Query: 509 IGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 563
+G++IG G+ G + Y ++ VA+K+ E E K+L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 564 NVLLFMGAVTSPQRL--CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
V F P +V E L SL L + +++A+ + + Y+H
Sbjct: 69 QVYYF-----GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVG-----DFGLSRL-------KHETYLTTKTGKGT 669
N +I+RD+K N L+ + DF L++ KH Y K+ GT
Sbjct: 123 SKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 670 PQWMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 710
++M+ L E S + D+ + G + +PW L
Sbjct: 181 ARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 1e-11
Identities = 73/521 (14%), Positives = 153/521 (29%), Gaps = 159/521 (30%)
Query: 312 MDREGGSGDSHHSD--HGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFS--HVDEKS 367
MD E G + D F DA + + D DV P + S +D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNF--DCK---------DVQDMPKSILSKEEIDH-- 53
Query: 368 PGKSVRDSGDESEGKPAIHKIITSK----AEQWMG---KKGLSW---PWKGNEREGSDAK 417
+ S D G + + SK ++++ + + P K E+
Sbjct: 54 ----IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK-TEQRQPSMM 108
Query: 418 TARFAWPWSHGDQDNESVQQKSPSYGTKPESHMY--EGNRSVNNEAWGSWSSSVNVNSTS 475
T + D+ Q + ++ + ++ + + V ++
Sbjct: 109 TRMYI---EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN------VLIDG-- 157
Query: 476 SVSSCGSTS--SSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVA 533
V G T + +D++I W L + + + + Y +
Sbjct: 158 -VLGSGKTWVALDVCLSYKVQ-CKMDFKIFW--LNLKNCNSPETVLEMLQKLLY---QID 210
Query: 534 VKVFSRQEYSDEV---IHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 589
SR ++S + IHS + E+ L+K + N LL +
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL------------V--------- 249
Query: 590 LFRLLQRNTTKLD--WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL---VDKHWT 644
L + A ++ C + R + ++ L H +
Sbjct: 250 -----------LLNVQNAKAWNAFNL--------SCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 645 VKVGDFGLSRLKHET------YLTTKTG-------KGTPQWMA--PEVLRNEPSDEKSDV 689
+ L+ E YL + P+ ++ E +R+ +
Sbjct: 291 LDHHSMTLT--PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA------ 342
Query: 690 YSFGVILWELATEKIPWDNLNSMQVIGAVG-FMN-----------QRLEI-PKDVD-PRW 735
W+ W ++N ++ + +N RL + P P
Sbjct: 343 ------TWD------NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP-- 388
Query: 736 AAIVESCWHSDPQCRPSFQELVDKLRD---LQRQYFQASRS 773
++ W + +V+KL +++Q +++ S
Sbjct: 389 TILLSLIWFDVIKSDV--MVVVNKLHKYSLVEKQPKESTIS 427
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-11
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL +M + I D I Y N +AELL+ SA+ + Q +L+ +
Sbjct: 11 AILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL--LTQ 68
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ G+ T +++ T +P ++
Sbjct: 69 PLQSGQSITDSDVTFVVDGRPLMLEVTVSPITWQRQLML 107
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-11
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
N L+++ + I + R++Y N + GY+ EE + I +T I+
Sbjct: 3 NFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMH-ILTITSAGKMAEGEKILA 61
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPF-YDDDGTLVGIV 235
+ G++ + + K + A + ++ L I+
Sbjct: 62 ELFAGKKESLPLSLEKKEGTSIPAKARIWQGKWHNEPCLFAII 104
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 43/265 (16%), Positives = 70/265 (26%), Gaps = 64/265 (24%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKV------FSRQEYSDEVIHSFRQEVSLMK 558
E L E+IG+G G V+ + VA+K+ + E+ + K
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 559 RL---------RHPNVLLFMGA------------------------------VTSPQRLC 579
L R + +L
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 639
IV EF G L Q T + + ++ + HRDL N+L+
Sbjct: 139 IVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLL 195
Query: 640 DKH-----------WTVKVGDFGLSRLKHETYLTTKTGKGTPQWM---APEVLRNEPSDE 685
K + + GL + L+ G + E L D
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255
Query: 686 KSDVYSF-GVILWELATEKIPWDNL 709
+ D+Y E P+ N+
Sbjct: 256 QFDIYRLMKKENNNRWGEYHPYSNV 280
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 43/234 (18%), Positives = 84/234 (35%), Gaps = 41/234 (17%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHS----FRQEVSLMKRLRHPN 564
+G IGQG G +Y A S+ V +V S E+ +R P
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 565 VLLFMGAVTSPQRLCI-------------------VTEFLPRGSLFRLLQRNTTKLDWRR 605
+ + L + + + L ++ + N + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKT 153
Query: 606 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------K 656
+ ++L I + Y+H +H D+K+SNLL++ +V D+GL+ K
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 657 HETYLTTKTGKGTPQWMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNL 709
+ GT ++ + + PS + D+ G + + T +PW++
Sbjct: 212 AYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 19/214 (8%)
Query: 509 IGEQIGQGSCGTVYHAV-WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVL 566
+G +IG GS G +Y +++VA+K E E + + L+ +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
+V + L SL L + KL + +++A + V ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 627 IIHRDLKSSNLLVDKHWT---VKVGDFGLSRL-------KHETYLTTKTGKGTPQWMAPE 676
+HRD+K N L+ V + DFGL++ +H Y K GT ++ +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 710
+ D+ S G +L +PW L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-10
Identities = 17/112 (15%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ +FD R + +R YG + LG ++ + + +
Sbjct: 3 ERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFPEIGEEWKSV 62
Query: 190 DIVHRIKMGERWTG-QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
R GE + + P+Y+ +G + G+V + D
Sbjct: 63 H--RRGLAGEVIRVEEDCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 44/229 (19%), Positives = 82/229 (35%), Gaps = 34/229 (14%)
Query: 509 IGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 567
+G++IG G G +Y A + A V + + + S E+ +R+ + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS---ELKFYQRVAKKDCIK 97
Query: 568 FMGAVTSPQRLCIVT-----EFLPRGSLFR-----LLQRNTTKL-DWRRR-----ILM-A 610
L I +G +R L + K+ +L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 611 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------KHETYL 661
+ + + Y+H +H D+K++NLL+ +V D+GLS K
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 662 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 709
K GT ++ + + + S +SDV G + K+PW+
Sbjct: 216 PRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 43/232 (18%), Positives = 86/232 (37%), Gaps = 37/232 (15%)
Query: 509 IGEQIGQGSCGTVYHAV---------WYGSQDVAVKVFSRQ-----EYSDEVIHSFRQEV 554
+ + + G +Y A Q ++K+ ++ E + + +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 555 SLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
+ K+L P + F G R +V L R SL L + + R +L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSLGR-SLQSALDVSPKHVLSERSVL 162
Query: 609 M-ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-----KHETY 660
A + + +LH +H ++ + N+ VD +V +G + KH Y
Sbjct: 163 QVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 661 LTTKTGK--GTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 709
+ G ++++ ++ + PS +SD+ S G + + +PW N
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} Length = 152 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 21/128 (16%), Positives = 41/128 (32%), Gaps = 11/128 (8%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A + +L + ++ I I+ N E + E G++ +EL +
Sbjct: 16 AMAKSRLLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPESA 75
Query: 184 DF------DVAYDIVHRIKMGERWTGQFPAK-----TKTEERVLVVATNTPFYDDDGTLV 232
D+ E+ P K + EE++ P + +DGT+
Sbjct: 76 DYLKRKIDTALVIESSSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIE 135
Query: 233 GIVCVSTD 240
+ D
Sbjct: 136 HVCLCVYD 143
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
Y + + + I D + N + GY+ +E L D +L+ G D A
Sbjct: 11 NAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALD-WGVLSRGVDSGWAA 69
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIV 235
+ RI GE + T+ +++ V + DG ++GI
Sbjct: 70 ASLARIVGGEPLREERTVWTRNGDQLTVELSAHLL--PDGKILGIA 113
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-08
Identities = 13/91 (14%), Positives = 24/91 (26%), Gaps = 2/91 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKMGERWTGQFPAKT 209
I N ++ + + +G+ L +F+ + I + + K
Sbjct: 23 VIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKR 82
Query: 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E T D L V D
Sbjct: 83 AGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-08
Identities = 13/111 (11%), Positives = 29/111 (26%), Gaps = 6/111 (5%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+++ +++ + + I+ N S G + +GQ ++
Sbjct: 19 KKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLE 78
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + R P D VS D
Sbjct: 79 AGKSAVENGTATRSE----DAVGGRHYHN-QYIPV-DSHRKSDTFQLVSRD 123
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 6e-08
Identities = 16/111 (14%), Positives = 34/111 (30%), Gaps = 3/111 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ + + D I N+ GY E LG+ E D +
Sbjct: 17 SRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLM-FDAEDVQ 75
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + ER + + + + V F + + +S D
Sbjct: 76 TQLSGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNLEGEDR--FLAISRD 124
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-08
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-DFDVA 188
+ ++ ++ I DL I+Y NR+ + GY +EE LG++ +L++G V
Sbjct: 5 EIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNE-SILSNGTTPRLVY 63
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ R+ + W+G + K + L T P ++ G + + + D
Sbjct: 64 QALWGRLAQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRD 115
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-08
Identities = 15/111 (13%), Positives = 40/111 (36%), Gaps = 7/111 (6%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ ++ + ++ + + +Y N + + YS E+ L + ++ D D A
Sbjct: 13 KFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFAL 67
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
I+ +T + ++++ LV + T D + +
Sbjct: 68 HDWEEIRQKNNYTFKTRYRSQSGRIFLVEMSLTFLEDQERRF--SCVFVRE 116
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} Length = 190 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 22/116 (18%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+L+++ + V D+ ++ N ++ L+G + A +L+ F+
Sbjct: 80 LALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLI---NGFNF-- 134
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVL----VVATNTPFY----DDDGTLVGIVCV 237
RW P + E V+ + TP Y +D L G V +
Sbjct: 135 ---------LRWLESEPQDSHNEHVVINGQNFLMEITPVYLQDENDQHVLTGAVVM 181
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} Length = 129 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-07
Identities = 16/119 (13%), Positives = 40/119 (33%), Gaps = 11/119 (9%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + +Q + +++ + + + I N+ + L GQD LT+
Sbjct: 3 HSSLETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQA 62
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVL---------VVATNTPFYDDDGTLVGIV 235
+ H +++G P + +E L V + + + V ++
Sbjct: 63 RYDNLLSHDVQLGTN--CGQPVQHPAQETTLICASGKAKDVELSISYIPGHEPMFVMVM 119
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* Length = 130 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 12/45 (26%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
IL ++ + + I+ +N +A +GY+ EE +GQ+ + +L
Sbjct: 21 ILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQN-LRIL 64
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* Length = 119 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-06
Identities = 12/35 (34%), Positives = 22/35 (62%), Gaps = 1/35 (2%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ D I ++ +AE L+G+S EA+GQ+ + +L
Sbjct: 8 VIDGHGIIQLFSTAAERLFGWSELEAIGQN-VNIL 41
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* Length = 167 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 16/56 (28%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
A N D + L+ + + +D ++++N +AE L+GY EE +G + I++L
Sbjct: 34 ADNAADGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNN-IDML 88
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 Length = 114 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-06
Identities = 13/103 (12%), Positives = 31/103 (30%), Gaps = 5/103 (4%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGERWT----GQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ +++ E++ V +
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCC 105
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 26/163 (15%), Positives = 56/163 (34%), Gaps = 2/163 (1%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211
+I N++ L GYS EE +G++ L G + + I ++ + + K
Sbjct: 88 LIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVLVEILNYKKD 147
Query: 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVT 271
P YDDD L+ + + Q + ++ ++ + VT
Sbjct: 148 GTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLKTLSPRQLEVT 207
Query: 272 AKLGLDSQQPLQATI--ASKISNLATKVSNKVKSRIRTGDNFM 312
+ + A S+ + + K ++T + +
Sbjct: 208 TLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSADLV 250
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 20/90 (22%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I++ N + L GY A+E +G++ L G D I I + K
Sbjct: 21 PIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKK 80
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ E +P ++ +G L V D
Sbjct: 81 SGEAFWNRLHISPVHNANGRLQHFVSSQLD 110
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 18/62 (29%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDV 187
N+ G D RIIY N S +E LG+ E+L T G FD
Sbjct: 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDA 71
Query: 188 AY 189
Sbjct: 72 LC 73
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} Length = 233 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 28/180 (15%), Positives = 61/180 (33%), Gaps = 7/180 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD---GRDFDVAY- 189
+ L ++ +V I D IIY NR+ + G + + + + G + DV +
Sbjct: 26 SALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEAD-IRKQLPNFDAGRLMGANIDVFHK 84
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249
+ H+ + TG A+ R + P ++D +G TD
Sbjct: 85 NPAHQRHLLANLTGVHKAELNLGGRRFSL-DVVPVFNDANERLGSAVQWTDRTEEHRAEQ 143
Query: 250 ALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ + + ++ R K G + ++ + +++ + GD
Sbjct: 144 EVSQLVQAAAAGDFSK-RVEEAGKEGFFLRLAKDLNSLVDTADRGLRDVSRMLGALAQGD 202
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 23/90 (25%), Positives = 30/90 (33%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
+IY N + E L GYS +E L QD L D RD I + G K
Sbjct: 49 ILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRK 108
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ TP D + + D
Sbjct: 109 DGSAFWNELSITPVKSDFDQRTYFIGIQKD 138
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A Length = 158 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 17 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 74
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 75 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 131
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 37 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 94
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 95 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 151
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 1e-04
Identities = 22/85 (25%), Positives = 31/85 (36%), Gaps = 1/85 (1%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I+Y N+ + GY EE LG++ L D +I ++ E T Q K
Sbjct: 23 PIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKK 82
Query: 211 TEERVLVVATNTPFYDDDGTL-VGI 234
P +D T VGI
Sbjct: 83 DGTMFWNELNIDPMEIEDKTYFVGI 107
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} Length = 151 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 21/128 (16%), Positives = 47/128 (36%), Gaps = 6/128 (4%)
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSA---ELLYGYSAEEALGQDAIELLTDGR 183
+ Q IL + + + D Y+N S E+++ + +G++ +
Sbjct: 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFKRT-PSQVGRNVELCHPP-K 73
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D + ++ G+R +++ + + V T D G G++ D +P
Sbjct: 74 VLDKVKKVFELLRNGQRDKVNMWFQSERLGKFVYV-TYAAVRDQAGDFQGVLEYVQDIKP 132
Query: 244 FQETRAAL 251
F E +
Sbjct: 133 FFELDSEF 140
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 18/107 (16%), Positives = 30/107 (28%), Gaps = 5/107 (4%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVH 193
LQ+ + + RIIY + +++L GY E +G L + D +
Sbjct: 4 PLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE----DQFLVESY 59
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
F K V V A + +
Sbjct: 60 FYNEHHLMPCTFRFIKKDHTIVWVEAAVEIVTTRAERTEREIILKMK 106
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 33/183 (18%), Positives = 61/183 (33%), Gaps = 37/183 (20%)
Query: 491 VDLDNDCLDYEILWEDL------TIGEQIGQGSCGTVYHAVWYGSQDVAVKVF------- 537
L L + IG+ +G+G V++ + VK
Sbjct: 70 STFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSF 129
Query: 538 ----SRQEYSD-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 588
+++Y D I S R E +++L+ V + ++ E +
Sbjct: 130 KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK 185
Query: 589 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 648
L+R+ N ++ I V+ +H I+H DL N+LV + +
Sbjct: 186 ELYRVRVENPDEVLD--------MILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234
Query: 649 DFG 651
DF
Sbjct: 235 DFP 237
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} Length = 118 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 18/106 (16%), Positives = 39/106 (36%), Gaps = 15/106 (14%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE---EALGQDAIELLTDGRDFDVAYDI 191
+LQS+ + V D + N +A+ L Y E L + +V
Sbjct: 20 MLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVDVSEV---- 75
Query: 192 VHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
++ G + + ++R+L++ P +G ++G +
Sbjct: 76 ---LRDGTPRRDE---EITIKDRLLLI-NTVPVR-SNGVIIGAIST 113
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 19/90 (21%), Positives = 31/90 (34%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I+Y +R L GYS ++ LG++ L D I + I G + +
Sbjct: 59 PIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQ 118
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ D G +V V V +
Sbjct: 119 DGTTFWNLFFVAGLRDSKGNIVNYVGVQSK 148
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} Length = 369 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 24/167 (14%), Positives = 58/167 (34%), Gaps = 10/167 (5%)
Query: 80 PDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPSAFNFTDRQYLNILQSM 139
P+ T + + Q + + +G + I +++
Sbjct: 193 PELNVEQLLTLPKEVQQALRGQPLEFDKTQLKREEDIDLGTG----YLNIEELKAIFEAL 248
Query: 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE 199
V D DR+ +++ E ++ + LG+ + V I+ K G
Sbjct: 249 PVDVTFIDKDDRVRFFSP-GERIFTRT-PSVLGRPVQLCHPP-KSVYVVNKILKAFKEGR 305
Query: 200 RWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
+ F + E+ V + P +++ G +G + ++ D P+++
Sbjct: 306 KKEATFWLR-LREKYVYI--KYVPLFNEKGEYIGTLEMTMDIAPYKK 349
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 23/90 (25%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + S L YS EE LG++ L D I I T Q TK
Sbjct: 26 PIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 85
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ ++ + P D G + + V D
Sbjct: 86 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLD 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 783 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.77 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.76 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.75 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.72 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.72 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.7 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.69 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.68 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.66 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.66 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.65 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.64 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.63 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.62 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.62 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.62 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.6 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.6 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.59 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.58 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.57 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.56 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.55 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.54 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.52 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.51 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.49 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.49 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.48 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.48 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.48 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.44 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.44 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.44 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.44 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.43 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.43 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.41 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.38 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.38 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.38 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.31 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.31 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.29 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 99.22 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.21 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.19 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.12 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 99.09 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.08 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 99.07 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 99.07 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.07 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.48 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.46 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 97.74 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.6 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 97.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.22 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.17 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.06 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.78 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 96.54 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.5 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.38 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.29 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.28 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 96.2 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 95.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.33 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.13 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 90.64 | |
| 4dah_A | 217 | Sporulation kinase D; alpha-beta-alpha structure, | 90.53 | |
| 1p0z_A | 131 | Sensor kinase CITA; transferase; HET: FLC MO7; 1.6 | 84.8 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=473.85 Aligned_cols=263 Identities=22% Similarity=0.384 Sum_probs=233.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|+++++||+|+||+||+|.+.. ++.||||++.+.... ....+.+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3689999999999999999999865 567999999865432 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc--
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 659 (783)
||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.|||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999764 46999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.....+.+||+.|||||++.+..++.++|||||||+||+|++|++||...+..+.+..+. ...+.+|..+++++++||
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCcccCHHHHHHH
Confidence 223456789999999999999999999999999999999999999999988888877764 345677889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+||.+||.+|||+.|++..-.=++|+||+.+
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 99999999999999998766555789999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=476.66 Aligned_cols=259 Identities=23% Similarity=0.409 Sum_probs=226.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|+++++||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.|+|||||++++++++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4799999999999999999999865 578999999988777777889999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 583 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 583 E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+||+|.++|... ...+++..++.++.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999999754 345789999999999999999999999 99999999999999999999999999987665433
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
...+.+||+.|||||++.+..++.++|||||||+||||++|++||...+..+.+..+... ...+++..+++++.+||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHH
Confidence 344567999999999999999999999999999999999999999999888877776432 2345677899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
||++||.+|||+.++ |+|+||+..
T Consensus 260 ~L~~dP~~R~s~~e~------l~hp~~~~~ 283 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSI------LEKGFIAKR 283 (350)
T ss_dssp HTCSSGGGSCCHHHH------HTSHHHHTT
T ss_pred HccCChhHCcCHHHH------hcCHHhhcC
Confidence 999999999999999 678888653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=463.53 Aligned_cols=268 Identities=35% Similarity=0.579 Sum_probs=227.7
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..||+..++|++.++||+|+||+||+|.+. ..||||+++......+..+.|.+|+.+|+.++|||||++++++.. +.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 457888999999999999999999999864 369999998777777778899999999999999999999998864 56
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|||||||++|+|.++|.....++++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 89999999999999999877778999999999999999999999998 9999999999999999999999999998654
Q ss_pred cc--cccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-c---cccCC
Q 003963 658 ET--YLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-Q---RLEIP 728 (783)
Q Consensus 658 ~~--~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~---~~~~~ 728 (783)
.. .......+||+.|||||++.+ ..++.++|||||||+||||+||+.||.+.+....+..+.... . ...++
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 32 223345689999999999864 358999999999999999999999998876654443332221 1 23456
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
..+++++.+||.+||+.||.+|||+.+|++.|+.|+|++.+-
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 789999999999999999999999999999999999987553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=467.22 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=227.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+.|+++++||+|+||.||+|.++. ++.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4679999999999999999999865 5779999997654332 346789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|||+||+|.+++.+. ++++..+..++.||+.||+|||+++ ||||||||+||||+.+|.|||+|||+|+........
T Consensus 151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999999763 5999999999999999999999999 999999999999999999999999999877655555
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~LI~~ 741 (783)
..+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.... .....+..+++++++||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 567899999999999999999999999999999999999999999988888776664322 2334456789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||.+|||+.|+ |+|+||+...
T Consensus 307 ~L~~dP~~R~ta~e~------l~Hp~~~~~~ 331 (346)
T 4fih_A 307 LLVRDPAQRATAAEL------LKHPFLAKAG 331 (346)
T ss_dssp HSCSSTTTSCCHHHH------TTCGGGGGCC
T ss_pred HcCCChhHCcCHHHH------hcCHhhcCCC
Confidence 999999999999999 7899998643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=457.81 Aligned_cols=260 Identities=32% Similarity=0.567 Sum_probs=223.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
++..++|.+.++||+|+||.||+|.+++ +..||||+++.. .....+.|.+|+.+|+.|+|||||+++++|.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4556799999999999999999998742 467999999653 45566789999999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC--------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 640 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~ 640 (783)
.+.+|||||||++|+|.++|.... .++++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 999999999999999999997532 35899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 003963 641 KHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGA 717 (783)
Q Consensus 641 ~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~ 717 (783)
.++.+||+|||+++..... .......+||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999999999865432 222334579999999999999999999999999999999999 8999999988887776
Q ss_pred hhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 718 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 718 i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+.. ..+++.|..+++++.+||.+||+.||++|||+.+|+++|+.+.+
T Consensus 273 i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 273 ITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 643 34677888999999999999999999999999999999988764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=448.62 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=211.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|++.+.||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.+|+.++|||||++++++++++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3689999999999999999999854 5789999998765433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||| +|+|.+++.+. .++++..+..++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 67999999764 46999999999999999999999999 9999999999999999999999999998655432
Q ss_pred cccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
...+.+||+.|||||++.+..+ +.++|||||||++|+|++|++||...+....+..+. ...+.+|..+++++++||.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 3346789999999999998876 689999999999999999999999988877776663 3456778899999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+||++||.+|||+.|+ ++|+|||...
T Consensus 245 ~~L~~dP~~R~s~~ei------l~hpw~k~~~ 270 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEI------MQDDWFKVDL 270 (275)
T ss_dssp HHSCSSGGGSCCHHHH------HHCHHHHTTC
T ss_pred HHccCChhHCcCHHHH------HcCcccccCC
Confidence 9999999999999999 6899998543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=451.29 Aligned_cols=254 Identities=31% Similarity=0.525 Sum_probs=219.3
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec----CCceEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIV 581 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV 581 (783)
|++.++||+|+||.||+|.+.. +..||+|++..........+.|.+|+.+|+.|+|||||+++++|+. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4788899999999999999865 4679999998887777777889999999999999999999999865 3568999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~ 660 (783)
||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++.+||||||||+||||+. ++.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999764 4699999999999999999999998777999999999999974 789999999999865433
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
...+.+||+.|||||++.+ .++.++|||||||+||||+||++||.+... ......+........++..+++++.+||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 2346689999999999876 599999999999999999999999976554 4444444433334456677899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||.+||.+|||+.++ |+|+||+.
T Consensus 264 ~~~L~~dP~~R~s~~e~------l~Hp~~~~ 288 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDL------LNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCCHHHH------HTSGGGC-
T ss_pred HHHccCChhHCcCHHHH------hcCccccC
Confidence 99999999999999999 78999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=463.73 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=219.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.++|++++.||+|+||+||+|++.. ++.||||++.+..........+.+|+.+|+.++|||||++++++++++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 3689999999999999999998742 357999999765433222335778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
||||||+||+|.+++.+. ..+++..+..++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999999864 46999999999999999999999999 999999999999999999999999999866554
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.....+.+||+.|||||++.+..++.++|||||||+||||+||++||.+.+..+.+..+. ...+.+|..+|+++.+||
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHHHHH
Confidence 444557789999999999999999999999999999999999999999998888877764 345677889999999999
Q ss_pred HHhhhhCCCCCCCH-----HHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPSF-----QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPsa-----~ell~~L~~L~~~~f~~~ 771 (783)
.+||++||.+|||+ +|+ ++|+||+.+
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~ei------l~Hp~f~~i 288 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEI------KRHSFFSTI 288 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHH------HTSGGGTTC
T ss_pred HHHcccCHHHCCCCCcCCHHHH------HcCccccCC
Confidence 99999999999984 677 679999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=451.62 Aligned_cols=260 Identities=30% Similarity=0.542 Sum_probs=227.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
++..++|.+.++||+|+||.||+|.+.. +..||||+++.. .....+.|.+|+.+|++|+|||||+++++|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 4566899999999999999999998742 456999999653 45566789999999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 642 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~ 642 (783)
++.+|||||||++|+|.++|...+ ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 999999999999999999997542 46899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 003963 643 WTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVG 719 (783)
Q Consensus 643 ~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~ 719 (783)
+.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+....+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543322 2223468999999999999999999999999999999999 999999999888877764
Q ss_pred cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 720 ~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
. ...++.|..+|+++.+||.+||+.||++|||+.+|+..|+++..
T Consensus 245 ~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 Q-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp H-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3 34567888999999999999999999999999999998887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=469.77 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=228.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+.|+++++||+|+||.||+|.++. ++.||||++....... .+.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 4679999999999999999999865 5779999997654332 346789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|||+||+|.+++... .+++..+..++.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+........
T Consensus 228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999999753 5999999999999999999999999 999999999999999999999999999877655445
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~LI~~ 741 (783)
..+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.... .....+..+++++++||.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 567789999999999999999999999999999999999999999988888777664322 2345566799999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
||.+||.+|||+.|+ |+|+||+..
T Consensus 384 ~L~~dP~~R~ta~el------l~Hp~~~~~ 407 (423)
T 4fie_A 384 LLVRDPAQRATAAEL------LKHPFLAKA 407 (423)
T ss_dssp HSCSSTTTSCCHHHH------TTCGGGGGC
T ss_pred HcCCChhHCcCHHHH------hcCHHhcCC
Confidence 999999999999999 789999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=452.90 Aligned_cols=254 Identities=25% Similarity=0.300 Sum_probs=219.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
....+.|++.++||+|+||.||+|.++. ++.||||++...... .+|+.+|+.|+|||||++++++.+++.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3445789999999999999999999865 578999999876543 36999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 658 (783)
||||||+||+|.++|.+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+....
T Consensus 127 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999999999999764 46999999999999999999999998 99999999999999887 699999999986543
Q ss_pred cc-----ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccCCCCCC
Q 003963 659 TY-----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVD 732 (783)
Q Consensus 659 ~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s 732 (783)
.. ......+||+.|||||++.+..++.++|||||||+||||++|++||...+....+..+..... ...++..++
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 22 122345799999999999999999999999999999999999999988776665555543332 245788999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+.+.+||.+||++||.+|||+.||+++|....
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=448.60 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=225.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe------CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
++...++++.++||+|+||.||+|.+. .++.||||++.... .....+.|.+|+.+|++|+|||||+++++|..
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 456678999999999999999999863 24579999987543 33445689999999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 639 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl 639 (783)
++.++||||||++|+|.++|... ...+++..++.++.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 99999999999999999999643 235899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 003963 640 DKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIG 716 (783)
Q Consensus 640 ~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~ 716 (783)
+.++.+||+|||+++..... .......+||+.|||||++.+..++.++|||||||+||||+| |..||.+.+..+...
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432 222345679999999999999999999999999999999998 899999999888877
Q ss_pred HhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 717 ~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
.+. ....++.|..+++++.+||.+||+.||.+|||+.+|++.|+.
T Consensus 259 ~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 764 344567888999999999999999999999999999998864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=448.72 Aligned_cols=265 Identities=29% Similarity=0.533 Sum_probs=228.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CceeeEec
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMG 570 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~ 570 (783)
..||+..++|+++++||+|+||.||+|.+.+. +.||||++.... .....+.|.+|+.+|..+.| ||||++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 45788899999999999999999999998653 469999987654 34456789999999999975 89999999
Q ss_pred eeecC-CceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 571 AVTSP-QRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 571 ~~~~~-~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+|..+ +.+|||||||++|+|.++|+... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 98764 57899999999999999997532 34889999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+||||+.++.+||+|||+|+..... .......+||+.|||||++.+..++.++|||||||+||||+| |..||.+.+.
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432 223334578999999999999999999999999999999998 9999998775
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.+.+........++..|..+++++.+||.+||+.||.+|||+.+|+++|+++.+
T Consensus 294 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 554444433455778889999999999999999999999999999999988764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=441.46 Aligned_cols=259 Identities=21% Similarity=0.330 Sum_probs=219.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec------CC
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 576 (783)
.++|+++++||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3689999999999999999999865 5789999998776666667788999999999999999999998753 36
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|||||||+ |+|.+++... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999995 6899999764 56999999999999999999999999 999999999999999999999999999865
Q ss_pred ccc----cccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q 003963 657 HET----YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------ 725 (783)
Q Consensus 657 ~~~----~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------ 725 (783)
... .....+.+||+.|||||++.+. .++.++|||||||++|||++|++||.+.+....+..+......+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 432 1223456899999999998875 46999999999999999999999999988877666553221111
Q ss_pred -----------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 726 -----------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 726 -----------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+.+.+++++.+||.+||..||.+|||+.|+ |+|+||+...
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~------L~Hp~f~~~~ 352 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA------LRHPFLAKYH 352 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH------TTSGGGTTTC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH------hcCHhhCcCC
Confidence 0123578999999999999999999999999 7899998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=428.62 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=198.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-------
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------- 576 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 576 (783)
++|++++.||+|+||.||+|.++. ++.||||++.... .....+.+.+|+.+|+.|+|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 579999999999999999999864 5789999997654 3445678899999999999999999999987544
Q ss_pred -----ceEEEEEecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 577 -----RLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 577 -----~~~lV~E~~~ggsL~~~L~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
++|||||||++|+|.+++..... ..++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976432 2445678899999999999999999 99999999999999999999999
Q ss_pred cCCCcccccccc------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 003963 650 FGLSRLKHETYL------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIG 716 (783)
Q Consensus 650 FGla~~~~~~~~------------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~ 716 (783)
||+|+....... ...+.+||+.|||||++.+..++.++|||||||+||||++ ||..... ...+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999986543221 1234579999999999999999999999999999999996 7754321 12222
Q ss_pred HhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 717 ~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+.. ...++.+...++.+.+||.+||++||.+|||+.++ ++|+||+..
T Consensus 239 ~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei------l~h~~~~~~ 286 (299)
T 4g31_A 239 DVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI------IENAVFEDL 286 (299)
T ss_dssp HHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGCCC
T ss_pred HHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH------hcCHhhCCC
Confidence 2211 11122223456778999999999999999999999 678999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=422.55 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=206.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 577 (783)
+.++|++.++||+|+||.||+|.++ .++.||||++..... ...+.+|+.+|+.+ +|||||+++++|.+.++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 4578999999999999999999875 245799999866432 24577899999998 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGla~~~ 656 (783)
+|||||||+||+|.+++. .+++..+..++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999984 3889999999999999999999999 9999999999999876 79999999999754
Q ss_pred ccccc----------------------------cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 657 HETYL----------------------------TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 657 ~~~~~----------------------------~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
..... ...+.+||+.|||||++.+.. ++.++|||||||++|+|++|++||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 33211 122457999999999998764 8999999999999999999999995
Q ss_pred CC-ChHHHHHHhhccc----------------------------------------------------ccccCCCCCCHH
Q 003963 708 NL-NSMQVIGAVGFMN----------------------------------------------------QRLEIPKDVDPR 734 (783)
Q Consensus 708 ~~-~~~~~~~~i~~~~----------------------------------------------------~~~~~~~~~s~~ 734 (783)
.. +....+..+.... ........++++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 43 3333222211000 001123457899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+.+||.+||+.||.+|||+.|+ |+|+||+.+.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~ea------L~Hp~f~~i~ 360 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEA------LLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHH------HTSGGGTTC-
T ss_pred HHHHHHHHCcCChhHCcCHHHH------hcCcccCCCC
Confidence 9999999999999999999999 7899998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=416.25 Aligned_cols=256 Identities=32% Similarity=0.497 Sum_probs=199.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----ceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 579 (783)
.++|.+.++||+|+||.||+|.+ .++.||||++.... .....+..|+..+..++|||||++++++..++ .+|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 36799999999999999999987 46789999986543 11122334666667889999999999998654 579
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC------CCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
||||||++|+|.++|... ++++..++.++.|++.||+|||++ .++||||||||+||||+.++.+||+|||++
T Consensus 78 lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999764 489999999999999999999986 123999999999999999999999999999
Q ss_pred cccccccc----cccCCCCCCcccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCC----------CC----
Q 003963 654 RLKHETYL----TTKTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELATEKIPWD----------NL---- 709 (783)
Q Consensus 654 ~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~------~~s~~sDIwSLG~il~elltG~~Pf~----------~~---- 709 (783)
+....... .....+||+.|||||++.+. .++.++|||||||+||||+||.+||. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86544322 12245799999999999765 35679999999999999999977653 21
Q ss_pred -ChHHHHHHhhcccccccCCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 710 -NSMQVIGAVGFMNQRLEIPKD-----VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 710 -~~~~~~~~i~~~~~~~~~~~~-----~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
........+.....++.+|.. +++.+.+||.+||+.||.+|||+.+|++.|++|.+
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 112222233222333444433 23578999999999999999999999999998865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=445.58 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=218.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
+..++|+++++||+|+||.||+|.++. ++.||||++.+... ..........++.+++.++|||||+++++|++.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 345789999999999999999999865 56799999976432 2233333444567777889999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|||||||+||+|.++|.+. ..+++..+..++.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999999864 46999999999999999999999999 999999999999999999999999999866
Q ss_pred ccccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhcccccccCCCCCC
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~s 732 (783)
... ...+.+||+.|||||++. +..|+.++|||||||+||||++|.+||...+ .......+ ......+|..++
T Consensus 343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~S 418 (689)
T 3v5w_A 343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFS 418 (689)
T ss_dssp SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTSC
T ss_pred CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccCC
Confidence 543 344679999999999996 5679999999999999999999999997543 22333332 344567888999
Q ss_pred HHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcC
Q 003963 733 PRWAAIVESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~~ 771 (783)
+++++||.+||.+||.+|++ +.+| +.|+||+.+
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei------~~HpfF~~i 456 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEV------KESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHH------TTSGGGTTC
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHH------hcCccccCC
Confidence 99999999999999999998 7888 689999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=444.07 Aligned_cols=259 Identities=21% Similarity=0.369 Sum_probs=228.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++++.||+|+||.||+|.++. ++.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.++..+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 45789999999999999999999865 5679999997654 33356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC--CcEEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH--WTVKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~ 659 (783)
||||+||+|.++|......+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999766667999999999999999999999999 9999999999999854 89999999999876543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~~ 737 (783)
. .....+||+.|||||++.+..++.++|||||||+||+|++|.+||.+.+..+.+..+...... ...+..+++++++
T Consensus 311 ~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp S-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred C-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 233568999999999999999999999999999999999999999999988888777544332 2334678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||.+||.+|||+.|+ |+|+||+...
T Consensus 390 li~~~L~~dp~~R~t~~e~------l~Hpw~~~~~ 418 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQA------LEHPWLTPGN 418 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HHSTTTSCCC
T ss_pred HHHHHccCChhHCcCHHHH------hcCcCcCCCC
Confidence 9999999999999999999 6789998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=396.77 Aligned_cols=268 Identities=60% Similarity=1.033 Sum_probs=228.7
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..+++...+|++.++||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34567788999999999999999999986 46689999998877777777889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
+++||||+++++|.+++..... .+++..++.++.||+.||+|||+++.+|+||||||+||||+.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999976432 38899999999999999999999876699999999999999999999999999986
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........++..+++++
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 65554444566799999999999999999999999999999999999999999988888777766667778889999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+||.+||..||.+|||+.++++.|+.+...
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999998877654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=397.39 Aligned_cols=260 Identities=24% Similarity=0.434 Sum_probs=231.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
....++|++.+.||+|+||.||+|.+. .++.||||++..........+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 445679999999999999999999984 4678999999888777777788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999999764 45899999999999999999999998 999999999999999999999999999765443
Q ss_pred cccccCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s-~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.......+. .....+|..+++++.+|
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENL 244 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHH
Confidence 2 33456899999999999988875 79999999999999999999999988877776653 34556778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
|.+||..||.+|||+.++ ++|+||+...
T Consensus 245 i~~~L~~dP~~R~t~~ei------l~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQI------MKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHH------TTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHH------hcCHhhcCCC
Confidence 999999999999999999 6789997654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=389.72 Aligned_cols=265 Identities=26% Similarity=0.350 Sum_probs=221.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
+...++|+++++||+|+||.||+|.+..++.||||++............+.+|+.+++.++||||+++++++.....+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 45668999999999999999999999778899999997665555556778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999974 899998877777999999999999999999999998 9999999999999999999999999998765444
Q ss_pred ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------------
Q 003963 661 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------------- 724 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 724 (783)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44445678999999999877 56899999999999999999999999877655444333211100
Q ss_pred -------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 725 -------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 725 -------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
..+...+++++.+||.+||..||.+|||+.++ |+|+||+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~~~ 310 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA------MNHPYFKDLDPQ 310 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH------HTSGGGTTSCTT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH------hcCcccccCCcc
Confidence 01123577899999999999999999999999 789999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=396.05 Aligned_cols=258 Identities=24% Similarity=0.444 Sum_probs=226.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++++.||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45789999999999999999999864 57799999976432 11234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||++||+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 83 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999764 46899999999999999999999998 9999999999999999999999999998654444
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 44556789999999999999999999999999999999999999999888777766653 3455678889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
+||..||.+|| ++.++ ++|+||+.+
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei------~~h~~f~~~ 267 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEV------MEHRFFLSI 267 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHH------HTSGGGTTC
T ss_pred HHhhcCHHHhcCCCCCCHHHH------HcCCCcCCC
Confidence 99999999999 89999 678999654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=395.15 Aligned_cols=264 Identities=29% Similarity=0.575 Sum_probs=228.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 569 (783)
.+++..++|++++.||+|+||.||+|.+.. +..||||++.... .......+.+|+.+++.+ +|||||+++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 345667899999999999999999998752 2359999987653 445567899999999999 899999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 99999999999999999999999997643 24789999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998654322 22334467889999999999999999999999999999999 9999998887
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+....+. .......+..+++++.+||.+||..||.+||++.++++.|+++...
T Consensus 312 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 312 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 76665543 3335667788999999999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=385.06 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=226.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++....... ...+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 45789999999999999999999754 5789999997655433 35678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||||++++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999764 4899999999999999999999998 99999999999999999999999999987665544
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-ccccccCCCCCCHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-MNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~l~~LI~ 740 (783)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .......+..+++.+.+||.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 45566899999999999999999999999999999999999999998877665544432 22244556778999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+||+.||.+|||+.++ ++|+||+.....
T Consensus 252 ~~l~~dp~~Rps~~el------l~h~~~~~~~~~ 279 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKEL------LQHQFLKIAKPL 279 (297)
T ss_dssp HHSCSSTTTSCCHHHH------TTCGGGGGCCCG
T ss_pred HHccCChhHCcCHHHH------hhChhhcccCcc
Confidence 9999999999999999 689999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=398.75 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=221.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
+..++|++.++||+|+||.||+|.++. ++.||||++.+... .......+.+|+.+++.+ +||||+++++++...+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 445789999999999999999999865 56799999976532 123345678899999988 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999999764 45999999999999999999999998 99999999999999999999999999986554
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....+. .....+|..+++.+.+|
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHH
Confidence 4445556789999999999999999999999999999999999999999988888777763 34566788899999999
Q ss_pred HHHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPsa------~ell~~L~~L~~~~f~~~ 771 (783)
|.+||.+||.+||++ .++ ++|+||+.+
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~i------l~hp~f~~~ 287 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAI------LRHPFFKEI 287 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHH------HTSGGGTTC
T ss_pred HHHHhhhCHHHccCCcccCCHHHH------hhCCcccCC
Confidence 999999999999998 777 689999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=371.87 Aligned_cols=261 Identities=30% Similarity=0.576 Sum_probs=230.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.|.+..++|++.+.||+|+||.||+|.+..++.||+|++....... +.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4566678999999999999999999999888889999998765544 4678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999877777999999999999999999999998 99999999999999999999999999976544
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.. .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..+++.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccCCCCCcCCHHHH
Confidence 32 22234456888999999999999999999999999999999 9999999888777666543 234556777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+||.+||..||.+||++.+++++|+++..
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=382.15 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=214.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++|++.++||+|+||.||+|.+..++.||+|++............+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999987678899999976544333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++ +|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 999999876677999999999999999999999998 99999999999999999999999999876554333334
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------------
Q 003963 665 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------- 724 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 724 (783)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 55789999999999764 5899999999999999999999999988776655443211000
Q ss_pred --------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 725 --------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 725 --------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
......+++++.+||.+||..||.+|||+.++ ++|+||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~ 287 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------LEHAYFKEN 287 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGGC-
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH------hcCcchhhc
Confidence 01224578999999999999999999999999 679999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=395.63 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=221.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
+..++|+++++||+|+||.||+|.++. ++.||||++.+..... .....+.+|..++..+ +|||||++++++.....+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 445789999999999999999999875 4679999998765433 3445677899999887 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999986444
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHhhcccccccCCC
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---------SMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~ 729 (783)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.... .......+ ......+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCCC
Confidence 4445567789999999999999999999999999999999999999996432 11222222 344567888
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcC
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa------~ell~~L~~L~~~~f~~~ 771 (783)
.+++++.+||.+||++||.+||++ .++ +.|+||+.+
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei------~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADI------QGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHH------HHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHH------hcCccccCC
Confidence 999999999999999999999985 555 689999765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.22 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=215.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
+..++|++.+.||+|+||.||+|.+. .++.||||++.+.... ......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45578999999999999999999974 4678999999765432 23345678899999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
+.+|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999999764 35889999999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
...........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLTQEA 248 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSCHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHH
Confidence 5443333445679999999999999999999999999999999999999999888777666653 33556778899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 736 AAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
.+||.+||..||.+|| ++.++ ++|+||+.+
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~------l~hp~f~~~ 283 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEV------QAHPFFRHI 283 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHH------HHSGGGSSC
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHH------HcCCcccCC
Confidence 9999999999999999 78888 779999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=382.52 Aligned_cols=264 Identities=32% Similarity=0.508 Sum_probs=228.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
..++..++|++.+.||+|+||.||+|.+.. +..||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 345667899999999999999999999853 2359999997543 45556789999999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
.+.+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999999876677999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 655 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 655 ~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 278 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPAPMG 278 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCCCCCCCC
Confidence 6544321 2223346788999999999999999999999999999999 9999999888877766543 345567788
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+++.+.+||..||..||.+||++.++++.|+.+...
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=378.78 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=215.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH------------------------HHHHHHHHHHHHH
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD------------------------EVIHSFRQEVSLM 557 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~------------------------~~~~~~~~Ei~il 557 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 35789999999999999999999865 5679999997654221 1235688999999
Q ss_pred HhCCCCceeeEeceeec--CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCC
Q 003963 558 KRLRHPNVLLFMGAVTS--PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 635 (783)
Q Consensus 558 ~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~ 635 (783)
+.++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 99999999999999986 5678999999999999887643 46899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003963 636 NLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNSM 712 (783)
Q Consensus 636 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~~sDIwSLG~il~elltG~~Pf~~~~~~ 712 (783)
||||+.++.+||+|||++..............||+.|+|||++.+.. .+.++|||||||++|+|++|..||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987655433344567999999999998765 378899999999999999999999988776
Q ss_pred HHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 713 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.....+.......+....+++++.+||.+||..||.+||++.++ ++|+||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~------l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI------KLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH------TTCHHHHC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHH------hcCccccC
Confidence 66655543333344446789999999999999999999999999 67899863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=386.64 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=222.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 579 (783)
..++|++++.||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.+++.+ +|||||++++++.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 45789999999999999999999865 56799999987654 345567788999999988 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999999764 46999999999999999999999998 999999999999999999999999999864444
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHhhcccccccCCCC
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL---------NSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~ 730 (783)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+ ......+|..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCCC
Confidence 34455678999999999999999999999999999999999999999652 122222222 2345667888
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcC
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa------~ell~~L~~L~~~~f~~~ 771 (783)
+++++.+||.+||..||.+||++ .++ +.|+||+.+
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i------~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADI------QGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHH------HTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHH------hcCCccCCC
Confidence 99999999999999999999985 566 689999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=383.97 Aligned_cols=255 Identities=24% Similarity=0.437 Sum_probs=224.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 35789999999999999999999864 5789999997643211 234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||++||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999999764 46899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Confidence 335689999999999999999999999999999999999999999888877766653 3345677889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
+||..||.+|| ++.++ +.|+||+.+
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i------~~hp~f~~~ 265 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDV------KNHPWFKEV 265 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHH------HTSGGGSSC
T ss_pred HHhccCHHHcCCCcCCCHHHH------hcCccccCC
Confidence 99999999999 88998 678999653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=375.19 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=219.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|++.++||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 689999999999999999999865 5679999998776666666788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|+++ +|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9965 777777666677999999999999999999999998 9999999999999999999999999998766554445
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhcccc------------------
Q 003963 664 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQ------------------ 723 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~P-f~~~~~~~~~~~i~~~~~------------------ 723 (783)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+....+..+.....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5667899999999998766 79999999999999999988777 555555544443321110
Q ss_pred ---------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 724 ---------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 724 ---------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.......+++.+.+||.+||+.||.+|||+.++ ++|+||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA------LQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH------hcCcccccC
Confidence 011223578999999999999999999999999 789999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.63 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=224.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
...++|++++.||+|+||.||+|.+.. ++.||||++.+.... ......+..|..++..+ +||||+++++++...+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 456799999999999999999999876 467999999764321 12345677899999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++++||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999999764 35999999999999999999999998 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||...+.......+. .....+|..+++++.+|
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHH
Confidence 4444556789999999999999999999999999999999999999999988877776663 34566788899999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~~ 771 (783)
|.+||.+||.+||+ +.++ +.|+||+.+
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i------~~h~~f~~~ 283 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDI------KEHAFFRYI 283 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHH------HTSGGGTTC
T ss_pred HHHHhhcCHHHcCCCCCCCHHHH------hcCccccCC
Confidence 99999999999995 5777 678999654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=370.67 Aligned_cols=260 Identities=33% Similarity=0.599 Sum_probs=228.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
+++..++|++.+.||+|+||.||++.+.++..||+|++....... ..+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 356678999999999999999999998887789999998765544 46789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999877667999999999999999999999998 999999999999999999999999999765443
Q ss_pred c-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 Y-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
. .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22233456788999999999889999999999999999999 999999888877665553 23345566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
||.+||..||.+|||+.++++.|+.++.
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999999999999999999987754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=391.75 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=224.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
...++|++.+.||+|+||.||+|.++. ++.||||++.+.... ......+..|..++..+ +||||+++++++.....+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 456799999999999999999999865 567999999764321 12235677899999876 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999999764 45899999999999999999999998 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....+|..+++++.+|
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDL 248 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHHH
Confidence 33345567899999999999999999999999999999999999999999888777766643 3456778899999999
Q ss_pred HHHhhhhCCCCCCCHH-HHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPSFQ-ELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~-ell~~L~~L~~~~f~~~ 771 (783)
|.+||..||.+||++. ++ ++|+||+.+
T Consensus 249 i~~lL~~dp~~R~~~~~~i------~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDI------RQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCG------GGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHH------HcCccccCC
Confidence 9999999999999997 77 678999765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=398.24 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=225.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.++|||||++++++...+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45789999999999999999999864 56799999988776666677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc---CCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~ 658 (783)
||||.||+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999999764 46999999999999999999999998 99999999999998 467899999999987665
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--CCCCCCHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--IPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~ 736 (783)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.......+ ....+++++.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 44444566899999999999999999999999999999999999999999888877777654433322 2347899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+||.+||..||.+|||+.++ |+|+||+.
T Consensus 246 ~li~~~L~~dP~~Rpta~e~------L~hp~~~~ 273 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEA------LKHPWISH 273 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHH------HHSCTTHH
T ss_pred HHHHHHcCCChhHCCCHHHH------hcCccccC
Confidence 99999999999999999999 56777754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=394.09 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=218.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHH-HHhCCCCceeeEeceeecCCce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~ 578 (783)
...++|++++.||+|+||.||+|.++. ++.||||++.+..... .....+..|..+ ++.++|||||++++++...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 345789999999999999999999875 4679999998765432 334456667776 5678999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999764 45889999999999999999999999 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++..+++.+.+|
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHL 269 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--HSCCCCCSSSCHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcccCCCCCCCHHHHHH
Confidence 4444556789999999999999999999999999999999999999999888877776663 33556778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|.+||++||.+||++.+.++.+ +.|+||+.+
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i--~~h~~f~~~ 300 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEI--KSHVFFSLI 300 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHH--HTSGGGTTC
T ss_pred HHHHcccCHHhCCCCCCCHHHH--hCCccccCC
Confidence 9999999999999985443333 678999654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=370.93 Aligned_cols=263 Identities=30% Similarity=0.543 Sum_probs=228.2
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..+++..++|++.+.||+|+||.||++.+..+..||||++....... ..+.+|+.+++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 34567778999999999999999999998888889999998765554 467899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999876667999999999999999999999998 9999999999999999999999999997654
Q ss_pred ccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 658 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 658 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.. ......+..+++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccCCCCCCcCCHHH
Confidence 432 12233456788999999999999999999999999999998 9999999888777666542 23455677789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+||.+||..||.+|||+.++++.|.++...
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999999887653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=388.06 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=223.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...++|++++.||+|+||.||+|.+.. ++.||+|++....... .....+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 345789999999999999999999865 5679999998765322 12457889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC----cEEEEecCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 652 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGl 652 (783)
.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999999764 46999999999999999999999998 99999999999998776 799999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKD 730 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~ 730 (783)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+...... ...+..
T Consensus 166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 98665432 234567999999999999999999999999999999999999999998888777666433322 123367
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+++.+.+||.+||..||.+|||+.++ ++|+||+.
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~------l~hp~~~~ 278 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEA------LRHPWITP 278 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH------HTSTTTSC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHH------hcCcCcCC
Confidence 89999999999999999999999999 67888864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=369.56 Aligned_cols=259 Identities=29% Similarity=0.593 Sum_probs=229.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--Cce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 578 (783)
++..++|++.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456789999999999999999999975 66899999988777777778899999999999999999999999887 788
Q ss_pred EEEEEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
++||||+++++|.+++..... .+++..++.++.||+.||.|||+++..|+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999986543 5899999999999999999999977679999999999999999999999999875432
Q ss_pred cccccccCCCCCCcccCcccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDE---KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~---~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
. ....||+.|+|||++.+..++. ++|||||||++|+|++|..||...+.......+........++..++++
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 2456799999999998876544 8999999999999999999999988887766665556667788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+.+||.+||..||.+|||+.++++.|+++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999988753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=386.70 Aligned_cols=258 Identities=21% Similarity=0.372 Sum_probs=224.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.+.||+|+||.||+|.+.. ++.||+|++..........+.+.+|+.+++.++|||||++++++...+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34789999999999999999999864 57899999988777777778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC---CcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~~~ 658 (783)
||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999999764 46899999999999999999999998 9999999999999764 4599999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC--CCCCCHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~ 736 (783)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.......+. ...+++++.
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred Cc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 233567999999999999999999999999999999999999999988887776666433322222 246799999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+||.+||..||.+||++.++ |+|+||+.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~------l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQA------LKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHH------TTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHH------hcCcccCC
Confidence 99999999999999999999 56777754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=381.83 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=223.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.+.||+|+||.||+|.+.. ++.||+|++.... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 45789999999999999999999865 4679999986432 3345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC--CCcEEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 659 (783)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999876667999999999999999999999998 999999999999987 789999999999866543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--cCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~ 737 (783)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....... .....+++++.+
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 2 2234568999999999999889999999999999999999999999888877766654332221 123578999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||..||.+|||+.++ |+|+||+...
T Consensus 237 li~~~L~~dp~~Rpt~~e~------l~hp~~~~~~ 265 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEA------LQHPWLKQKI 265 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HHSHHHHSCG
T ss_pred HHHHHcCCChhHCcCHHHH------hcChhhccCc
Confidence 9999999999999999999 6789997653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=402.69 Aligned_cols=260 Identities=25% Similarity=0.446 Sum_probs=217.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
....++|++.++||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 3456789999999999999999999865 56799999976532 233456678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
|+|||||++++|.+++... ..+++..++.++.||+.||+|||+ ++ ||||||||+||||+.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999999764 468999999999999999999998 88 9999999999999999999999999998655
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.........+||+.|+|||++.+..++.++|||||||+||+|++|+.||...+.......+. .....+|..+++++.+
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLGPEAKS 378 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHH
Confidence 44444556789999999999999999999999999999999999999999888877766653 3455678889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
||.+||..||.+|| ++.++ ++|+||+.+
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~el------l~hp~f~~~ 411 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEI------MQHRFFAGI 411 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHH------HTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHH------HhCccccCC
Confidence 99999999999999 99999 789999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=390.87 Aligned_cols=264 Identities=31% Similarity=0.541 Sum_probs=230.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.|++..++|++.++||+|+||.||+|.+. .++.||||++... ........+.+|+.+|+.++|||||++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 45677789999999999999999999986 4678999998754 345556678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+||||+++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999877667999999999999999999999998 9999999999999999999999999997644
Q ss_pred cccccc--cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 658 ETYLTT--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 658 ~~~~~~--~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .....+.|..+++.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 332111 11234678999999998889999999999999999998 999999988877665553 34456778889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+.+||.+||..||.+|||+.++++.|+++...
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=386.95 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=225.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++++.||+|+||.||+|.+.. ++.||||++.+.... ......+.+|+.+|+.++||||+++++++.....+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 345799999999999999999999864 578999999764321 123457888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||++||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999764 35899999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.. ....+|..+++++.+||
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 2356799999999999999999999999999999999999999998888777766643 35667888999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~~ 771 (783)
.+||+.||.+||+ +.++ +.|+||+.+
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei------~~h~~f~~~ 300 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDI------KNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHH------HTSGGGTTC
T ss_pred HHHhhcCHHhccCCccCCHHHH------HhCcCcCCC
Confidence 9999999999998 8888 678999653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=376.62 Aligned_cols=262 Identities=34% Similarity=0.527 Sum_probs=221.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||+|.+.. ++.||+|++.. ........+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 45799999999999999999999865 56799998854 3456678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999999887777999999999999999999999999 99999999999999999999999999976543321
Q ss_pred c--------------ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hccccccc
Q 003963 662 T--------------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLE 726 (783)
Q Consensus 662 ~--------------~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i-~~~~~~~~ 726 (783)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||............ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 1 11457999999999999999999999999999999999999998654321110000 00011233
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.+..+++.+.+||.+||..||.+|||+.++++.|+.++..+-
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 567889999999999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.99 Aligned_cols=264 Identities=33% Similarity=0.591 Sum_probs=217.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 573 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 573 (783)
.++++..++|++.+.||+|+||.||+|.+... ..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 34677789999999999999999999997542 358999876543 4556678999999999999999999999985
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccc
Confidence 56789999999999999999877667999999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCC
Q 003963 654 RLKHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 654 ~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 731 (783)
........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. .....++..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~ 242 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CCCCCCCCCC
Confidence 76544321 2233456889999999999999999999999999999997 9999998877766655532 2345677889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
++.+.+||.+||..||.+||++.++++.|+++...
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=385.27 Aligned_cols=269 Identities=29% Similarity=0.521 Sum_probs=227.9
Q ss_pred CCcccccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceee
Q 003963 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLL 567 (783)
Q Consensus 495 ~~~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 567 (783)
.+...|++..++|++.++||+|+||.||+|.+.+ ++.||||++.... .....+.+.+|+.+++.+ +|||||+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3445677888999999999999999999998643 2579999997543 445567889999999999 7899999
Q ss_pred EeceeecCC-ceEEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q 003963 568 FMGAVTSPQ-RLCIVTEFLPRGSLFRLLQRNTT----------------------------------------------- 599 (783)
Q Consensus 568 l~~~~~~~~-~~~lV~E~~~ggsL~~~L~~~~~----------------------------------------------- 599 (783)
+++++...+ .+++|||||++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988755 48999999999999999976432
Q ss_pred ------------------cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc-
Q 003963 600 ------------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 660 (783)
Q Consensus 600 ------------------~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 660 (783)
.+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1889999999999999999999998 9999999999999999999999999997653321
Q ss_pred -ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 661 -LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 661 -~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....................+..+++++.+|
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 22334567899999999999999999999999999999998 9999988765554444434445667788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
|.+||..||.+|||+.+++++|+++...
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999988764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=396.75 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=223.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.+..++|+++++||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.+++.++|||||++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4456899999999999999999999875 4679999997532111 1123467899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999999999754 5899999999999999999999998 99999999999999999999999999976554
Q ss_pred cc-ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC--CCC
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDV 731 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~----~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 731 (783)
.. ....+.+||+.|+|||++.+.. ++.++|||||||+||+|++|.+||...+....+..+........+| ..+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 32 2334678999999999998765 7889999999999999999999999988887777765433333333 479
Q ss_pred CHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcC
Q 003963 732 DPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~~ 771 (783)
++++++||.+||..+|.+ ||++.+| ++|+||+.+
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei------~~Hp~f~~~ 336 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEI------KRHLFFKND 336 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHH------HTSGGGCCS
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHH------hcCccccCC
Confidence 999999999999988888 9999999 789999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.01 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=215.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 4789999999999999999999865 578999999877666666788899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999889888765 346899999999999999999999998 999999999999999999999999999876544444
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------------
Q 003963 663 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------ 723 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 723 (783)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 445678999999999986 5679999999999999999999999988877655443321100
Q ss_pred -ccc----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 724 -RLE----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 724 -~~~----------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
... ....+++.+.+||.+||..||.+|||+.++ ++|+||+..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~~~ 294 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL------LHHPYFENIREI 294 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH------HTSGGGTTCC--
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH------hcChHHHhccCH
Confidence 000 013578899999999999999999999999 689999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=386.28 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=220.0
Q ss_pred cccccceeEeeeeccC--CcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 501 EILWEDLTIGEQIGQG--SCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G--~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
....++|++.++||+| +||.||+|.+.. ++.||||++............+.+|+.+++.++|||||++++++...+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3445789999999999 999999999874 5789999999887777778889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|+|||||++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999999764 356899999999999999999999999 999999999999999999999999987643
Q ss_pred ccc-------cccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-----
Q 003963 657 HET-------YLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----- 722 (783)
Q Consensus 657 ~~~-------~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~----- 722 (783)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 221 112233478999999999988 678999999999999999999999998765544332221000
Q ss_pred ---------------------------------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 723 ---------------------------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 723 ---------------------------------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.....+..+++.+.+||.+||+.||.+|||+.++ |
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el------l 332 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL------L 332 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH------T
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH------h
Confidence 0112345678999999999999999999999999 6
Q ss_pred HHHHhhcCcC
Q 003963 764 QRQYFQASRS 773 (783)
Q Consensus 764 ~~~~f~~~~~ 773 (783)
+|+||+....
T Consensus 333 ~hp~f~~~~~ 342 (389)
T 3gni_B 333 NHSFFKQIKR 342 (389)
T ss_dssp TSGGGGGC--
T ss_pred cCHHHHHHhh
Confidence 8999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=377.46 Aligned_cols=260 Identities=24% Similarity=0.360 Sum_probs=222.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...++|++.+.||+|+||.||+|.+.. ++.||+|++....... .....+.+|+.+|+.++||||+++++++....
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 345789999999999999999999865 5689999997654321 12457889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC----cEEEEecCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 652 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGl 652 (783)
.+++|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999999753 46999999999999999999999998 99999999999998877 899999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKD 730 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~ 730 (783)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ...+..
T Consensus 165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 98664332 233557999999999999999999999999999999999999999988877766655433222 122357
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+++.+.+||.+||..||.+|||+.++ |+|+||+..
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~~ 278 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDS------LQHPWIKPK 278 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHH------HHSTTTSCC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHH------hcCCCccCC
Confidence 89999999999999999999999999 678888653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=399.02 Aligned_cols=263 Identities=20% Similarity=0.353 Sum_probs=224.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.+..++|+++++||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.++..++|||||+++++|.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 3456899999999999999999999876 4679999997532111 1123477899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999999999876667999999999999999999999998 99999999999999999999999999976544
Q ss_pred cc-ccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC---C
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---K 729 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~ 729 (783)
.. ......+||+.|+|||++. ...++.++|||||||+||||++|++||...+..+.+..+........+| .
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 32 2233468999999999987 5568999999999999999999999999988887777764433334444 4
Q ss_pred CCCHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcC
Q 003963 730 DVDPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~--RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+++++++||.+||..+|++ ||++.++ ++|+||+.+
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~ei------l~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDF------KKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHH------HTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHH------hCCCccCCC
Confidence 58999999999999888888 9999999 789999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=364.07 Aligned_cols=260 Identities=21% Similarity=0.364 Sum_probs=227.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.+.||+|+||.||+|.+.. ++.||+|++............+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4789999999999999999999865 568999999888777777788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc---EEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGla~~~~~~ 659 (783)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999988764 45899999999999999999999998 999999999999976655 999999999765543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--CCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--IPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~ 737 (783)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........ ....+++++.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 3 22345789999999999999999999999999999999999999998888777766544333222 23578999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
||.+||+.||.+|||+.++ ++|+||+....
T Consensus 241 li~~~l~~dp~~Rps~~~~------l~h~~~~~~~~ 270 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQA------LKVPWICNRER 270 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHH------TTSHHHHSCCC
T ss_pred HHHHHcccChhhCCCHHHH------hcCccccCChh
Confidence 9999999999999999999 67899976544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=381.90 Aligned_cols=265 Identities=31% Similarity=0.567 Sum_probs=231.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC--------ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 569 (783)
.+++..++|++.++||+|+||.||+|.+... ..||||++.... .......+.+|+.+++.+ +|||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 4567788999999999999999999997532 359999987653 455567889999999999 899999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+++...+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 219 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCc
Confidence 99999999999999999999999997643 35899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654432 22334467889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.+....+. .......+..+++++.+||.+||..||.+|||+.++++.|+++....
T Consensus 300 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 300 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 77766553 33456677889999999999999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=378.72 Aligned_cols=266 Identities=27% Similarity=0.491 Sum_probs=228.6
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEece
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 571 (783)
..+++..++|++.+.||+|+||.||+|.+.+. +.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34566778999999999999999999998642 679999987543 45566789999999999999999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhcC-----------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPII 628 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~Iv 628 (783)
+...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 999999999999999999999997642 56899999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 003963 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 705 (783)
Q Consensus 629 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~P 705 (783)
||||||+||||+.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999987553321 22234567899999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 706 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 706 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
|......+....+.. ......+..+++.+.+||.+||..||.+||++.++++.|+++...+
T Consensus 277 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 998888777665532 3345667889999999999999999999999999999998876654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=395.50 Aligned_cols=262 Identities=19% Similarity=0.318 Sum_probs=222.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.+..++|++.++||+|+||.||+|.++. ++.||||++.+.... ......+.+|+.++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3456899999999999999999999864 578999999764321 12234578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||+||+|.+++.+....+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999999999876667999999999999999999999998 99999999999999999999999999976554
Q ss_pred ccc-cccCCCCCCcccCccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC---
Q 003963 659 TYL-TTKTGKGTPQWMAPEVLR-------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--- 727 (783)
Q Consensus 659 ~~~-~~~~~~Gt~~Y~aPE~~~-------~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--- 727 (783)
... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+.+..+........+
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 322 233568999999999987 356899999999999999999999999998888777666433322333
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCC---CCHHHHHHHHHHHHHHHhhcC
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCR---PSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~R---Psa~ell~~L~~L~~~~f~~~ 771 (783)
+..+++++++||.+||. +|.+| |++.++ +.|+||+.+
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei------~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDF------RTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH------HTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH------hcCCCcCCC
Confidence 35799999999999999 99998 589999 689999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=362.57 Aligned_cols=260 Identities=31% Similarity=0.584 Sum_probs=229.0
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|.+..++|++.+.||+|+||.||++.+..++.||+|++....... +.+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 455668999999999999999999998878889999998765543 46789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999877677999999999999999999999998 999999999999999999999999998765432
Q ss_pred c-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 660 Y-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
. .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHHHH
Confidence 2 12234457889999999998899999999999999999999 8999998887776666543 2344566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
||.+||..||.+||++.++++.|+++..
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=384.10 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=215.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++|||||++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34689999999999999999999864 57899999865321 111245788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc---EEEEecCC
Q 003963 579 CIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGL 652 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGl 652 (783)
|+|||||++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998887543 335899999999999999999999998 999999999999986554 99999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKD 730 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~ 730 (783)
+.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......+..... .......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 9876655444456689999999999999999999999999999999999999998753 333333322111 1112256
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+++++.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~------l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEA------LNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHH------hcChhhcC
Confidence 89999999999999999999999999 56777764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=371.04 Aligned_cols=263 Identities=29% Similarity=0.546 Sum_probs=227.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 572 (783)
.+++..++|++.+.||+|+||.||+|.+.. ++.||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 456677899999999999999999998742 2579999987543 455667899999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC-----------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 629 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvH 629 (783)
...+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 99999999999999999999997643 24889999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 003963 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPW 706 (783)
Q Consensus 630 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf 706 (783)
|||||+|||++.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997654322 22334467889999999999889999999999999999999 99999
Q ss_pred CCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 707 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 707 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
...........+. .......+..+++.+.+||.+||..||.+||++.++++.|+++..
T Consensus 254 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 254 PGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9888776665543 233556778899999999999999999999999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=386.09 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=219.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
++..++|++++.||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+|+.++|||||+++++|.....+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567899999999999999999999865 467999999764321 12346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||.||+|..++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhcccccccCCCCCC
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~sDIwSLG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s 732 (783)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+ ......+|..++
T Consensus 168 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWS 244 (384)
T ss_dssp TC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSC
T ss_pred CC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCC
Confidence 32 3346689999999999874 4588999999999999999999999974432 2333232 234566788899
Q ss_pred HHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHHHHHHhhcC
Q 003963 733 PRWAAIVESCWHSDPQCRPS-FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPs-a~ell~~L~~L~~~~f~~~ 771 (783)
+.+.+||.+||..||.+||+ +.++ +.|+||+.+
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l------~~hp~f~~~ 278 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDV------QNFPYMNDI 278 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHH------HTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHH------HcChhhhcC
Confidence 99999999999999999998 7777 578888654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=380.85 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=204.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
+...++|++.+.||+|+||.||+|.+.. ++.||||++.... ..+.+.+|+.+++.++||||+++++++.....++
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4456789999999999999999999875 4679999997643 2346778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecCCCccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLK 656 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~~ 656 (783)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999999764 45899999999999999999999998 999999999999975 889999999999765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccc--ccCCCCCCH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQR--LEIPKDVDP 733 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~--~~~~~~~s~ 733 (783)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+...... ......++.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 4432 2235578999999999999999999999999999999999999997766544 33333222221 223357899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
++.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~~~~ 314 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQA------LQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHH------HHSTTTTSTTC
T ss_pred HHHHHHHHHccCChhhCcCHHHH------hcCcccCCCcc
Confidence 99999999999999999999999 67999976654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=377.12 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=204.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|+++++||+|+||.||+|.+.. ++.||||++...... .....+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3679999999999999999999764 567999999765422 22346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcC-----CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 583 EFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
||++ ++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 59999986532 35889999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------- 723 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------- 723 (783)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 443344456789999999999874 589999999999999999999999998887665544421100
Q ss_pred -------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 724 -------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 724 -------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
....+..+++++.+||.+||+.||.+|||+.++ |+|+||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~~~~ 303 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA------LHHPWFAEYYHH 303 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH------TTSGGGGGGCC-
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH------hCChhhhcccch
Confidence 011223578899999999999999999999999 689999876554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.92 Aligned_cols=262 Identities=25% Similarity=0.427 Sum_probs=199.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+. .++.||||++....... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3478999999999999999999985 46789999997543211 224678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999999876677999999999999999999999998 9999999999999999999999999998665443
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .......+..++.++.+||.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHHHH
Confidence 3344567899999999999998999999999999999999999999876655444333 22345567789999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 741 ~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+||..||.+||++.++ +.|+||+...+.
T Consensus 245 ~~l~~dp~~Rps~~~~------l~h~~~~~~~~~ 272 (278)
T 3cok_A 245 QLLRRNPADRLSLSSV------LDHPFMSRNSST 272 (278)
T ss_dssp HHSCSSGGGSCCHHHH------TTSTTTC-----
T ss_pred HHcccCHhhCCCHHHH------hcCccccCCCCc
Confidence 9999999999999999 678999876554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=376.13 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=227.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|.+.+.||+|+||.||++.+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 445789999999999999999999865 46799999976643 3456678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999998764 46899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++..+++.+.+||
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 272 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLI 272 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHH
Confidence 444445679999999999999999999999999999999999999999887766655543 234567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+||+.||.+||++.++ ++|+||+..
T Consensus 273 ~~~l~~dp~~Rps~~el------l~~~~~~~~ 298 (335)
T 2owb_A 273 QKMLQTDPTARPTINEL------LNDEFFTSG 298 (335)
T ss_dssp HHHTCSSGGGSCCGGGG------GGSHHHHTS
T ss_pred HHHccCChhHCcCHHHH------hcCccccCC
Confidence 99999999999999999 678999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=386.06 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=218.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.+++.++||||+++++++.....+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999854 5789999987543211 123468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 67999988764 45999999999999999999999999 9999999999999999999999999998655432
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ ......+|..+++++.+||
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHH
Confidence 3345689999999999998876 78999999999999999999999876544332222 2234567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+||..||.+|||+.++ ++|+||+...
T Consensus 240 ~~~L~~dP~~Rpt~~ei------l~hp~~~~~~ 266 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEI------RRDPWFNVNL 266 (336)
T ss_dssp HTTSCSSGGGSCCHHHH------TTCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHH------HhChhhccCC
Confidence 99999999999999999 6789997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=377.60 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=214.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||+|+||.||+|.+. .++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 478999999999999999999986 4577999998755432 23356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 660 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 660 (783)
|||++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999999753 45999999999999999999999998 9999999999999999999999999997654221
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccccCCCCCCHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22335679999999999988775 77999999999999999999999766543 22222222222233345689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
|.+||..||.+|||+.++ ++|+||+...
T Consensus 242 i~~~L~~dP~~R~t~~ei------l~h~~~~~~~ 269 (323)
T 3tki_A 242 LHKILVENPSARITIPDI------KKDRWYNKPL 269 (323)
T ss_dssp HHHHSCSSTTTSCCHHHH------TTCTTTTCCC
T ss_pred HHHHccCChhhCcCHHHH------hhChhhcccc
Confidence 999999999999999999 6789997543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.63 Aligned_cols=258 Identities=39% Similarity=0.696 Sum_probs=212.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
++..++|++.++||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 455689999999999999999999975 668999998765332 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCC-CEEecCCCCCCEEEcC--------CCcEEEEe
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGD 649 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~IvHrDIKp~NILl~~--------~~~vkL~D 649 (783)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++. +|+||||||+|||++. ++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999964 468999999999999999999999873 3889999999999986 77899999
Q ss_pred cCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 650 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 650 FGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........++.
T Consensus 160 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 160 FGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred CCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 99997654432 2245789999999999999999999999999999999999999999888777766655555677788
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.+++.+.+||.+||..||.+|||+.+++++|++|
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 8999999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=376.18 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=218.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~ 578 (783)
++..++|++.++||+|+||.||++.+..++.||||++............+.+|+.+|+.++| |||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34567899999999999999999998777889999998877777777889999999999986 9999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||+. +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||++.....
T Consensus 85 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECG-NIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCC-SEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeCC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999955 78999999864 46899999999999999999999998 99999999999997 57899999999986543
Q ss_pred ccc--cccCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccc
Q 003963 659 TYL--TTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQR 724 (783)
Q Consensus 659 ~~~--~~~~~~Gt~~Y~aPE~~~~-----------~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~ 724 (783)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322 2235579999999999865 6688999999999999999999999987543 3333344334455
Q ss_pred ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 725 ~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..++...+.++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~------l~hp~~~~~~ 281 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL------LAHPYVQIQT 281 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHSCC
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHH------HhCccccccC
Confidence 66778889999999999999999999999999 6789997543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=368.75 Aligned_cols=266 Identities=27% Similarity=0.477 Sum_probs=226.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 570 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 570 (783)
..+++..++|++.+.||+|+||.||+|.+.. ++.||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 4567778899999999999999999998632 3579999997554 344567889999999999 8999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcCC-----------------cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCC
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT-----------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 633 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~-----------------~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIK 633 (783)
++...+..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999976543 4899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003963 634 SSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 710 (783)
Q Consensus 634 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~ 710 (783)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999876554322 1223456789999999999999999999999999999999 999998776
Q ss_pred hHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 711 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 711 ~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.................+..+++.+.+||.+||..||.+|||+.++++.|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 55444343333344556778999999999999999999999999999999887765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=367.68 Aligned_cols=261 Identities=30% Similarity=0.508 Sum_probs=216.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS- 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 574 (783)
++..++|++.++||+|+||.||+|.+. .++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345689999999999999999999852 3567999998654 35556789999999999999999999999854
Q ss_pred -CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 575 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 575 -~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999887777999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----------------HH
Q 003963 654 RLKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM----------------QV 714 (783)
Q Consensus 654 ~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~----------------~~ 714 (783)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 8654332 1222345677899999999999999999999999999999999998643221 11
Q ss_pred HHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 715 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 715 ~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
... .........+..+++++.+||.+||..||.+|||+.++++.|+++...
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHH-HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHH-HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111 112335567788999999999999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=367.61 Aligned_cols=262 Identities=37% Similarity=0.642 Sum_probs=211.7
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..+++..++|++.++||+|+||.||++.+. ..||+|++..........+.+.+|+.+++.++||||+++++++ ....
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 455778899999999999999999999754 3699999987777777788899999999999999999999965 4567
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccc
Confidence 89999999999999999877778999999999999999999999998 9999999999999999999999999987544
Q ss_pred cc--cccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hccc---ccccCC
Q 003963 658 ET--YLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMN---QRLEIP 728 (783)
Q Consensus 658 ~~--~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i-~~~~---~~~~~~ 728 (783)
.. ........||+.|+|||++. +..++.++|||||||++|+|++|..||............ .... ....++
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 32 11223456899999999986 667888999999999999999999999876654433332 2111 122344
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
..+++.+.+||.+||..||.+||++.++++.|+++.
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 578999999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=382.52 Aligned_cols=265 Identities=30% Similarity=0.524 Sum_probs=218.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
..++...+|++.+.||+|+||.||+|.+. .+..||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 33556679999999999999999999875 34569999987543 45566789999999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
.+.+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999999877777999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 655 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 655 ~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+.. ......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~ 274 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 6544321 1122345778999999999999999999999999999998 9999998888777666532 234556678
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
++..+.+||.+||+.||.+||++.++++.|+++....
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=371.74 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=220.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
.|...++||+|+||.||+|.+. .++.||||++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 4788889999999999999986 46789999997654332 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999875 35899999999999999999999998 99999999999999999999999999987655444445
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccCCCCCCHHHHHHHHHhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~LI~~cL 743 (783)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ....+..+++.+.+||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 66899999999999999999999999999999999999999998887766655532221 22334468899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
..||.+|||+.++ +.|+||+..
T Consensus 280 ~~dp~~Rps~~el------l~hp~~~~~ 301 (321)
T 2c30_A 280 VRDPQERATAQEL------LDHPFLLQT 301 (321)
T ss_dssp CSSTTTSCCHHHH------HTSGGGGGC
T ss_pred cCChhhCcCHHHH------hcChhhccC
Confidence 9999999999999 678999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=375.25 Aligned_cols=266 Identities=29% Similarity=0.470 Sum_probs=222.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 570 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 570 (783)
..+++..++|++.+.||+|+||.||+|.+.. +..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3567788999999999999999999999742 3469999997543 233456788999999999 8999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcCC----------------------cchHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT----------------------KLDWRRRILMALDIARGVSYLHHCNPPII 628 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~----------------------~l~~~~~~~i~~qi~~aL~~LH~~~~~Iv 628 (783)
++...+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 99999999999999999999999976542 3788999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 003963 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 705 (783)
Q Consensus 629 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~P 705 (783)
||||||+||||+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999976543321 1223456889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 706 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 706 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
|...........+.........+..+++++.+||.+||..||.+|||+.+++++|+.+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9887655544444334445667788999999999999999999999999999999877554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.93 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=222.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++.+.||+|+||.||+|.+..+ ..||+|++....... .....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 4568999999999999999999998664 579999987643222 22456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999999764 45899999999999999999999998 999999999999999999999999988654433
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..+++.+.+||
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHHH
Confidence 2234578999999999999999999999999999999999999999888777666553 234566788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.+||..||.+||++.++ ++|+||+...+.
T Consensus 239 ~~~l~~~p~~Rps~~e~------l~h~~~~~~~~~ 267 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREV------LEHPWITANSSK 267 (279)
T ss_dssp HHHCCSSGGGSCCHHHH------HHCHHHHHHCSS
T ss_pred HHHhccChhhCCCHHHH------hhCccccCCccC
Confidence 99999999999999999 678999776544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=374.00 Aligned_cols=266 Identities=29% Similarity=0.475 Sum_probs=210.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCc----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQ----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
...+..++|++.+.||+|+||.||+|.+.... .||||++..........+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34566789999999999999999999876543 69999998765555667889999999999999999999999987
Q ss_pred CCce------EEEEEecCCCCHHHHHhhcC-----CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC
Q 003963 575 PQRL------CIVTEFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 575 ~~~~------~lV~E~~~ggsL~~~L~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~ 643 (783)
.... ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCC
Confidence 6654 99999999999999996432 25899999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc
Q 003963 644 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 720 (783)
Q Consensus 644 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~ 720 (783)
.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~- 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-
Confidence 99999999997654332 12223456789999999999999999999999999999999 999999888777665553
Q ss_pred ccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 721 ~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.......+..+++++.+||.+||..||.+|||+.++++.|+++....
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 23355667889999999999999999999999999999999885443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=381.20 Aligned_cols=263 Identities=26% Similarity=0.467 Sum_probs=225.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe------CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
++..++|+++++||+|+||.||+|.+. .++.||||++.... .......+.+|+.+++.++|||||++++++..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 456789999999999999999999853 23569999986543 44455678899999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---cE
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TV 645 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~---~v 645 (783)
....++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999997643 35889999999999999999999999 99999999999998554 59
Q ss_pred EEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003963 646 KVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 646 kL~DFGla~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~ 722 (783)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998754322 122234467899999999999999999999999999999998 999999988877776654 33
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.....+..+++.+.+||.+||+.||.+||++.++++.|+.+....
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 355667889999999999999999999999999999999886654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.55 Aligned_cols=267 Identities=25% Similarity=0.473 Sum_probs=229.1
Q ss_pred cccccceeEee-eeccCCcEEEEEEEEe---CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 501 EILWEDLTIGE-QIGQGSCGTVYHAVWY---GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 501 e~~~~~y~i~~-~LG~G~fG~Vy~a~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
.+..++|.+.+ .||+|+||.||+|.+. .+..||||++.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 44567888887 9999999999999864 45679999997653 4556678999999999999999999999994 56
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 799999999999999999876677999999999999999999999998 999999999999999999999999999865
Q ss_pred ccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 657 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 657 ~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. .....++..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcCCCCCCcC
Confidence 43221 1223456899999999998889999999999999999998 9999998887776655532 34566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+++.+||..||..||.+||++.++++.|+.+....-....
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 9999999999999999999999999999988877654443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=374.75 Aligned_cols=268 Identities=26% Similarity=0.339 Sum_probs=220.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
....++|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 3456899999999999999999999865 46799999976431 2344578899999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhc---------------------------------------CCcchHHHHHHHHHHHHHHH
Q 003963 577 RLCIVTEFLPRGSLFRLLQRN---------------------------------------TTKLDWRRRILMALDIARGV 617 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL 617 (783)
..++|||||++++|.+++... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521 22357888899999999999
Q ss_pred HHHHhCCCCEEecCCCCCCEEEcCCC--cEEEEecCCCccccccc----ccccCCCCCCcccCcccccC--CCCCchhHH
Q 003963 618 SYLHHCNPPIIHRDLKSSNLLVDKHW--TVKVGDFGLSRLKHETY----LTTKTGKGTPQWMAPEVLRN--EPSDEKSDV 689 (783)
Q Consensus 618 ~~LH~~~~~IvHrDIKp~NILl~~~~--~vkL~DFGla~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDI 689 (783)
+|||+++ |+||||||+||||+.++ .+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 182 ~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 182 HYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 9999998 99999999999998766 89999999997653321 12235579999999999975 678899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC--CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 690 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 690 wSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
|||||++|+|++|..||...........+......... ...+++.+.+||.+||..||.+||++.++ |+|+|
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~------l~hp~ 333 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA------LQHPW 333 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH------HHSHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH------hcChh
Confidence 99999999999999999988887776665433322222 23488999999999999999999999999 78999
Q ss_pred hhcCcCCCC
Q 003963 768 FQASRSTVG 776 (783)
Q Consensus 768 f~~~~~~~~ 776 (783)
|+.....+.
T Consensus 334 ~~~~~~~~~ 342 (345)
T 3hko_A 334 ISQFSDKIY 342 (345)
T ss_dssp HHTTSSCSS
T ss_pred hccChHhhE
Confidence 998776543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=381.80 Aligned_cols=261 Identities=21% Similarity=0.375 Sum_probs=224.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.+|+.++|||||++++++.....+++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 45789999999999999999999864 5679999987543 23345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC--CCcEEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 659 (783)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999876667999999999999999999999998 999999999999974 578999999999866543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~ 737 (783)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+..... ....+..+++++.+
T Consensus 205 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 205 EI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp SC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred cc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 22 2234789999999999999999999999999999999999999998887776666543322 22334578999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
||.+||..||.+|||+.++ |+|+||+...+.
T Consensus 284 li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~~ 314 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDA------LEHPWLKGDHSN 314 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HTSTTTSSCCTT
T ss_pred HHHHHcCCChhHCcCHHHH------hhCccccCCccc
Confidence 9999999999999999999 678999765543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=366.38 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=217.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
+...++|++.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 3456899999999999999999999864 56899999866543 446677899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+||||+++++|.+++... .++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999999764 36899999999999999999999998 99999999999999999999999999986544
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc---ccccCCCCCCHH
Q 003963 659 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN---QRLEIPKDVDPR 734 (783)
Q Consensus 659 ~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~s~~ 734 (783)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+............ .....+..+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 32 22234568999999999999999999999999999999999999999887765443322111 112356778999
Q ss_pred HHHHHHHhhhhCCCCCC-CHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRP-SFQELVDKLRDL 763 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RP-sa~ell~~L~~L 763 (783)
+.++|.+||.+||.+|| ++.++++.|..+
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 99999999999999998 888887776654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=378.73 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=213.4
Q ss_pred ceeE--eeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 506 DLTI--GEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 506 ~y~i--~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.|.+ .+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.+++.++|||||++++++...+.+++||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3444 6789999999999999854 5789999997654 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE--cCCCcEEEEecCCCccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl--~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++.......
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999999999999876667999999999999999999999998 9999999999999 567899999999998665432
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCCCHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAAI 738 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~~L 738 (783)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+...... ......+++++.+|
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence 233457999999999999999999999999999999999999999988887766665433221 12235689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|.+||..||.+||++.++ |+|+||+..
T Consensus 323 i~~~L~~dp~~Rps~~e~------l~hp~~~~~ 349 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEA------LKHPWLSDH 349 (373)
T ss_dssp HHTTSCSSGGGSCCHHHH------HHSHHHHCH
T ss_pred HHHHcCCChhhCCCHHHH------hcCcCcCCC
Confidence 999999999999999999 678888543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=378.25 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=205.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||++.+.. ++.||||++....... ..+.+|+.+++.++|||||++++++.....+|+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 35789999999999999999999864 5679999997654333 4577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc--EEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~--vkL~DFGla~~~~~~ 659 (783)
||||++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|||+++.....
T Consensus 95 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999999764 35999999999999999999999999 999999999999987665 999999998743322
Q ss_pred cccccCCCCCCcccCcccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhcccccccCCCCCCHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEK-SDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~-sDIwSLG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
. .....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||..... ......+.......+....++++
T Consensus 172 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 172 S-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred C-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 2 2334579999999999988887655 8999999999999999999976543 23333332222233334468999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+.+||.+||..||.+|||+.++ ++|+||+..
T Consensus 251 ~~~li~~~L~~dP~~Rps~~el------l~hp~f~~~ 281 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEI------KTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHH------HTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHH------HhCcchhcC
Confidence 9999999999999999999999 778999654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=372.03 Aligned_cols=272 Identities=32% Similarity=0.542 Sum_probs=233.5
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 572 (783)
.+++..++|++.+.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 456777899999999999999999998752 4579999987543 344556788999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~ 643 (783)
...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 99999999999999999999997532 34688999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc
Q 003963 644 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 720 (783)
Q Consensus 644 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~ 720 (783)
.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999997654332 22234457889999999999999999999999999999999 8999998887776665532
Q ss_pred ccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 721 ~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
......+..+++.+.+||.+||..||.+|||+.++++.|+++..++|+.....
T Consensus 256 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 256 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 33455677899999999999999999999999999999999888888665543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=377.40 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=211.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|+++++||+|+||.||+|.+. .++.||||++...... .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 68999999999999999999986 4567999998654321 112234579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
|++ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 996 5999999887777999999999999999999999998 9999999999999999999999999987655444444
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 003963 664 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------ 724 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 724 (783)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 45678999999999887 56899999999999999999999999988877655544221111
Q ss_pred ----------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCC
Q 003963 725 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 775 (783)
Q Consensus 725 ----------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~ 775 (783)
......+++++.+||.+||+.||.+|||+.++ |+|+||+......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA------MKHPFFLSLGERI 292 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH------TTSGGGGGGCSTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH------hcChhhhhccccc
Confidence 01123578899999999999999999999999 7899998776543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=369.91 Aligned_cols=255 Identities=20% Similarity=0.217 Sum_probs=210.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++.++||+|+||.||+|.+. .++.||||++............+..|+..+..+ +||||+++++++...+.+|
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34578999999999999999999987 467899999876655554445555666655555 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999999 67999999877778999999999999999999999998 999999999999999999999999998765543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+........++..+++++.+||
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 211 G-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred C-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHH
Confidence 2 2334569999999999887 689999999999999999999766654322 2222222223345567899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||+.||.+|||+.++ |+|+||+.
T Consensus 286 ~~~L~~dP~~Rpt~~el------l~hp~~~~ 310 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEAL------LALPVLRQ 310 (311)
T ss_dssp HHHSCSSTTTSCCHHHH------HTSGGGSC
T ss_pred HHHcCCChhhCcCHHHH------HhCccccC
Confidence 99999999999999999 67899975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=380.66 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=217.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l 580 (783)
...+|++.++||+|+||.||++.+..++.||||++............+.+|+.+|+.+. |||||++++++...+.+|+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34679999999999999999999877788999999887777777788999999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||+ .+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++......
T Consensus 134 v~E~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEec-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9995 5789999998754 6888899999999999999999998 99999999999995 5799999999998654332
Q ss_pred --ccccCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccc
Q 003963 661 --LTTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLE 726 (783)
Q Consensus 661 --~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~ 726 (783)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.... ....+..+........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 12335679999999999876 368899999999999999999999998754 3344444433344556
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
++...+.++.+||.+||..||.+||++.++ |+|+||+..
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~el------l~hp~~~~~ 327 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPEL------LAHPYVQIQ 327 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHSC
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHH------hhCcCcccc
Confidence 777789999999999999999999999999 678898754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=374.59 Aligned_cols=256 Identities=31% Similarity=0.457 Sum_probs=221.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.+.|++.+.||+|+||.||+|.+. .++.||||++...... ......+.+|+.+++.++|||||++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 457999999999999999999975 4577999999766443 34557889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+. |+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 99996 6898888766677999999999999999999999998 999999999999999999999999999765432
Q ss_pred cccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
....||+.|+|||++. +..++.++|||||||++|+|++|..||...+.......+.........+..+++.+.+|
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 3457899999999985 56789999999999999999999999998887766655543333334456789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
|.+||+.||.+|||+.++ ++|+||...+
T Consensus 286 i~~~l~~dP~~Rps~~~l------l~h~~~~~~~ 313 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVL------LKHRFVLRER 313 (348)
T ss_dssp HHHHTCSSGGGSCCHHHH------TTCHHHHSCC
T ss_pred HHHHcccChhhCcCHHHH------hhChhhhccC
Confidence 999999999999999999 5678886554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=389.42 Aligned_cols=260 Identities=25% Similarity=0.289 Sum_probs=199.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-----CCc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 577 (783)
.++|+++++||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999999864 5679999997766666667889999999999999999999999843 356
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999999 5699999975 356999999999999999999999998 9999999999999999999999999998654
Q ss_pred ccc---------------------------ccccCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHc--------
Q 003963 658 ETY---------------------------LTTKTGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELAT-------- 701 (783)
Q Consensus 658 ~~~---------------------------~~~~~~~Gt~~Y~aPE~~-~~~~~s~~sDIwSLG~il~ellt-------- 701 (783)
... ......+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 112345789999999986 56679999999999999999999
Q ss_pred ---CCCCCCCCChH--------------------HHHHHhhcc-----------------------------cccccCCC
Q 003963 702 ---EKIPWDNLNSM--------------------QVIGAVGFM-----------------------------NQRLEIPK 729 (783)
Q Consensus 702 ---G~~Pf~~~~~~--------------------~~~~~i~~~-----------------------------~~~~~~~~ 729 (783)
|.++|.+.... ..+..+... ........
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 67777554310 111110000 00011234
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.+++++.+||.+||..||.+|||+.++ |+|+||+..+.
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~------L~Hp~f~~~~~ 405 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINEC------LAHPFFKEVRI 405 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHH------hcCHhhhhcCC
Confidence 568999999999999999999999999 78999987643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=363.29 Aligned_cols=257 Identities=35% Similarity=0.636 Sum_probs=217.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCH--HHH---HHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSD--EVI---HSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~--~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
...++|++.+.||+|+||.||+|.+. .++.||||++....... ... +.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34578999999999999999999985 45789999987654322 111 6788999999999999999999998765
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc-----EEEEec
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDF 650 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~-----vkL~DF 650 (783)
. ++||||+++++|.+++......+++..++.++.||+.||+|||+++.+|+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 799999999999999987777899999999999999999999998766999999999999988776 999999
Q ss_pred CCCcccccccccccCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHhhccccccc
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV--IGAVGFMNQRLE 726 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~ 726 (783)
|+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+........
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999754432 33467899999999984 45578999999999999999999999987654333 334434445667
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
++..+++.+.+||.+||..||.+|||+.++++.|++|
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 7888999999999999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=368.55 Aligned_cols=266 Identities=29% Similarity=0.555 Sum_probs=228.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEe--------CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 569 (783)
.+++..++|++.+.||+|+||.||+|.+. .+..||||++.... .......+.+|+.+++.+ +||||++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 45667789999999999999999999874 34569999987543 445567889999999999 899999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+++...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 185 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 185 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCcc
Confidence 99999999999999999999999997643 23889999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+||||+.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999997654432 12234457889999999998889999999999999999999 9999998887
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
......+.. ......+..+++++.+||.+||..||.+||++.++++.|+++....-
T Consensus 266 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 EELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 776655432 23456678899999999999999999999999999999999976543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.00 Aligned_cols=262 Identities=32% Similarity=0.567 Sum_probs=226.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
+|++..++|++.+.||+|+||.||+|.+.+++.||||++....... ..+.+|+.+++.++||||+++++++. .+..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH---HHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 4677789999999999999999999998877789999997655443 56889999999999999999999886 4568
Q ss_pred EEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999997532 25899999999999999999999998 9999999999999999999999999998665
Q ss_pred cccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 658 ETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 658 ~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. ......+..+++++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEEL 239 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccCCCCcccccHHH
Confidence 4322 2233456889999999998889999999999999999999 9999998888776665532 23455677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.+||.+||..||.+|||+.++++.|+++....
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999998876554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.57 Aligned_cols=271 Identities=31% Similarity=0.483 Sum_probs=220.8
Q ss_pred CCCCcccccccccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeE
Q 003963 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 568 (783)
Q Consensus 493 ~~~~~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 568 (783)
+......+.+..++|.+.+.||+|+||.||+|.+.. +..||||++............+.+|+.+++.++||||+++
T Consensus 22 l~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp --CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 344445566778899999999999999999998764 2469999998777677777889999999999999999999
Q ss_pred eceeecCC-----ceEEEEEecCCCCHHHHHhh-----cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEE
Q 003963 569 MGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL 638 (783)
Q Consensus 569 ~~~~~~~~-----~~~lV~E~~~ggsL~~~L~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NIL 638 (783)
++++.... ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIl 179 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCM 179 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEE
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEE
Confidence 99997654 45999999999999999843 2356899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 003963 639 VDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVI 715 (783)
Q Consensus 639 l~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~ 715 (783)
|+.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 9999999999999997654322 12233457889999999999999999999999999999999 99999888777666
Q ss_pred HHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 716 ~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
..+. .......+..+++.+.+||.+||..||.+||++.++++.|+++...
T Consensus 260 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 5543 2335566788999999999999999999999999999999988765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=376.70 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=207.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++.....+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 35789999999999999999999764 56799999977665555566788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-----CCCcEEEEecCCCccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-----KHWTVKVGDFGLSRLK 656 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-----~~~~vkL~DFGla~~~ 656 (783)
|||++ ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+ ..+.+||+|||++...
T Consensus 112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99997 59999997654 5899999999999999999999998 99999999999994 5556999999999766
Q ss_pred ccccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc---------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--------- 726 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 726 (783)
...........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........+..+......+.
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 54444444567899999999998754 79999999999999999999999998877665554422111000
Q ss_pred -------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 727 -------------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 727 -------------------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
++..+++++.+||.+||+.||.+|||+.++ |+|+||+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~ 326 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA------LEHPYFSHND 326 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGSSSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH------hCCcccCCCC
Confidence 011267899999999999999999999999 7899998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=387.27 Aligned_cols=257 Identities=32% Similarity=0.605 Sum_probs=222.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-c
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-R 577 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~ 577 (783)
.+++..++|++.++||+|+||.||++.+. ++.||||+++.... .+.+.+|+.+|+.++|||||++++++.... .
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 45677889999999999999999999876 56899999976542 356889999999999999999999987655 7
Q ss_pred eEEEEEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|+|||||++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999986543 3689999999999999999999998 999999999999999999999999999754
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... .....+++.|+|||++.+..++.++|||||||+||||++ |..||...+..+....+. ...+...|..+++.+
T Consensus 340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 415 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 332 223467889999999999999999999999999999998 999999887766665553 334567788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+||.+||..||.+|||+.++++.|+.++..
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999888654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=391.09 Aligned_cols=260 Identities=27% Similarity=0.524 Sum_probs=226.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
....++|.+++.||+|+||.||+|.+. .++.||||++....... +....+.+|+.+++.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345689999999999999999999986 46789999997653221 2346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999999754 46999999999999999999999998 99999999999999999999999999986554
Q ss_pred ccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+. ......|..+++++.+
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVIS 245 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHHH
T ss_pred cc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHHH
Confidence 32 2345689999999999998775 789999999999999999999999888777666653 3345667889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||..||.+|||+.++ +.|+||+...
T Consensus 246 Li~~~L~~dP~~Rpt~~ei------l~hp~~~~~~ 274 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDI------REHEWFKQDL 274 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHH------HTCHHHHTTC
T ss_pred HHHHHcCCCchhCcCHHHH------HhCHHhhhcC
Confidence 9999999999999999999 6789997643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.83 Aligned_cols=260 Identities=31% Similarity=0.504 Sum_probs=219.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec----CC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~ 576 (783)
.....|++.+.||+|+||.||+|.+.. +..||+|++..........+.+.+|+.+++.++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 345679999999999999999999865 4679999998887777778889999999999999999999998865 35
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~ 655 (783)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+.+|+|+||||+|||++ .++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 689999999999999999764 458999999999999999999999766699999999999997 789999999999975
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccccCCCCCCHH
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .....+........++..++++
T Consensus 182 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 182 KRASF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp CCTTS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ccccc--cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 44432 234568999999998875 4899999999999999999999999875443 3444443333344556678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 259 l~~li~~~l~~dp~~Rps~~el------l~h~~f~~~ 289 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDL------LNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHH------HTSGGGC--
T ss_pred HHHHHHHHccCChhhCCCHHHH------hhCcccccC
Confidence 9999999999999999999999 688999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=367.77 Aligned_cols=268 Identities=29% Similarity=0.519 Sum_probs=225.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEec
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 570 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 570 (783)
..+++..++|++.+.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 4556778899999999999999999998642 3579999997654 445567889999999999 6999999999
Q ss_pred eeecCC-ceEEEEEecCCCCHHHHHhhcCCc---------------chHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 571 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK---------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 571 ~~~~~~-~~~lV~E~~~ggsL~~~L~~~~~~---------------l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
++...+ .+++||||+++++|.+++...... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 987654 589999999999999999765432 899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+||||+.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999999999997654322 12223457889999999999999999999999999999998 9999987765
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
................+..+++.+.++|.+||..||.+|||+.+++++|+.+.+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 443333323334566778899999999999999999999999999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.50 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=228.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|.+.+.||+|+||.||++.+.. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 445789999999999999999999865 46799999977643 3456678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999998764 46899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .....++..+++.+.+||
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLI 246 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHH
Confidence 334445678999999999999999999999999999999999999999887766655543 334567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+||..||.+||++.++ +.|+||+...
T Consensus 247 ~~~l~~~p~~Rps~~~l------l~~~~~~~~~ 273 (294)
T 2rku_A 247 QKMLQTDPTARPTINEL------LNDEFFTSGY 273 (294)
T ss_dssp HHHTCSSGGGSCCGGGG------GGSHHHHTSC
T ss_pred HHHcccChhhCcCHHHH------hhChheecCC
Confidence 99999999999999999 6789997653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=367.45 Aligned_cols=265 Identities=31% Similarity=0.509 Sum_probs=223.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC-----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 573 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 573 (783)
..++..++|++.+.||+|+||.||+|.+... ..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3466778999999999999999999987643 249999987543 4455667899999999999999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
..+.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999999999876677999999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 654 RLKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 654 ~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 273 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPM 273 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCT
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-CCcCCCcc
Confidence 86543321 1223346789999999999999999999999999999999 9999998888777666542 23455677
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.+++.+.+||.+||..||.+||++.++++.|+++....
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 89999999999999999999999999999999887653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.08 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=226.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.+++.++||||+++++++...+.++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 445799999999999999999999865 4679999987543211 12357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999999764 35899999999999999999999998 999999999999999999999999998655432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++..++..+.+||
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHHH
Confidence 2335578999999999999999999999999999999999999999887776655543 344567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCCCC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 777 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~~~ 777 (783)
.+||..||.+||++.++ +.|+||+.....+.+
T Consensus 244 ~~~l~~~p~~Rps~~~l------l~h~~~~~~~~~~~p 275 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGV------MEHPWVKANSRRVLP 275 (284)
T ss_dssp HHHSCSSGGGSCCHHHH------HTCHHHHHHCCCCCC
T ss_pred HHHhhcCHhhCCCHHHH------hhCHHHHhhccccCC
Confidence 99999999999999999 678999876655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=389.76 Aligned_cols=259 Identities=31% Similarity=0.569 Sum_probs=225.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..+++..++|++.++||+|+||.||+|.+..+..||||++...... .+.+.+|+.+|+.++|||||++++++. ...
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 3467788999999999999999999999887888999999865543 457889999999999999999999987 567
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 899999999999999997532 35888899999999999999999998 999999999999999999999999999865
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... ......+++.|+|||++.+..++.++|||||||+||||++ |..||...+..+....+.. ....+.|..++++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHH
Confidence 43321 1223346789999999998999999999999999999999 9999999888877766542 3456677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+.+||.+||..||.+|||+.+|++.|+++
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999887654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=374.25 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=214.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-----CCceeeEeceee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----HPNVLLFMGAVT 573 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~ 573 (783)
.....++|++.++||+|+||.||+|.+.. ++.||||++... ......+..|+.+++.+. |||||++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34567899999999999999999999854 567999998642 344567788999999996 999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-----------
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----------- 641 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~----------- 641 (783)
..+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence 999999999999 889999997643 35899999999999999999999998 999999999999975
Q ss_pred --------------CCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 642 --------------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 642 --------------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999764432 235578999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHhhcccccc------------------------cCC--------------------CCCCHHHHHHHHHhh
Q 003963 708 NLNSMQVIGAVGFMNQRL------------------------EIP--------------------KDVDPRWAAIVESCW 743 (783)
Q Consensus 708 ~~~~~~~~~~i~~~~~~~------------------------~~~--------------------~~~s~~l~~LI~~cL 743 (783)
..+.......+....... ..+ ...++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 877666554432211100 011 112477889999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
+.||.+|||+.++ |+|+|||
T Consensus 341 ~~dP~~Rpta~el------L~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAEL------LKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHH------TTSGGGC
T ss_pred cCChhhCCCHHHH------hcCcccC
Confidence 9999999999999 6889986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=379.70 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=207.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCC--c
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--R 577 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~ 577 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++............+.+|+.+++.+. |||||++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 346799999999999999999999864 577999999776656666778889999999997 999999999997544 6
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+|||||+ ++|..++... .+++..+..++.||+.||+|||+.| |+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 899999996 5999999763 5889999999999999999999999 9999999999999999999999999997543
Q ss_pred cc---------------------cccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003963 658 ET---------------------YLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 715 (783)
Q Consensus 658 ~~---------------------~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~ 715 (783)
.. .......+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 111234579999999999987 67899999999999999999999999988776655
Q ss_pred HHhhccccc---------------------------------------------ccCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 716 GAVGFMNQR---------------------------------------------LEIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 716 ~~i~~~~~~---------------------------------------------~~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
..+...... ...+..+++++.+||.+||..||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 444211110 01123678999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhcCc
Q 003963 751 PSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 751 Psa~ell~~L~~L~~~~f~~~~ 772 (783)
||+.++ |+|+||+...
T Consensus 321 ~t~~e~------l~Hp~~~~~~ 336 (388)
T 3oz6_A 321 ISANDA------LKHPFVSIFH 336 (388)
T ss_dssp CCHHHH------TTSTTTTTTC
T ss_pred CCHHHH------hCCHHHHHhc
Confidence 999999 6899986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=374.84 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=212.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 576 (783)
.++|++.+.||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4789999999999999999999854 578999999776656666778999999999999999999999997653
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7899999976 35899999999999999999999999 999999999999999999999999999865
Q ss_pred ccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 723 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 723 (783)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 432 234578999999999887 6789999999999999999999999998876655444321110
Q ss_pred -----------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 724 -----------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 724 -----------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
...+...+++.+.+||.+||..||.+|||+.++ |.|+||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~------l~hp~f~~~~~ 316 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------LAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGTTTC-
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH------hcChHHHhhcC
Confidence 112345678999999999999999999999999 67999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=363.22 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=206.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
+++..++|++.+.||+|+||.||+|.+. .++.||||++............+.++..+++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3566789999999999999999999985 457799999976654445555566666678889999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 579 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999996 488887753 456799999999999999999999997 8 9999999999999999999999999997
Q ss_pred ccccccccccCCCCCCcccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccccccCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVL----RNEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~ 729 (783)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.... .................+.
T Consensus 159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 655432 22344789999999996 56678899999999999999999999998643 3333333322222333345
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.+++++.+||.+||+.||.+|||+.++ ++|+||+...+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~------l~hp~f~~~~~~ 276 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPEL------MQHPFFTLHESK 276 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHH------TTSHHHHHHHHS
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHH------HhCcccccCccc
Confidence 789999999999999999999999999 679999876554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.44 Aligned_cols=262 Identities=32% Similarity=0.564 Sum_probs=222.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
+.+..++|++.+.||+|+||.||+|.+... ..||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 455668999999999999999999987643 249999987653 34556789999999999999999999999875
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4578999999999999999877777999999999999999999999998 99999999999999999999999999876
Q ss_pred cccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 656 KHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 656 ~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 544321 2233457889999999999999999999999999999998 999998777666554443 2334566778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+.+||.+||..||.+||++.++++.|+++...
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=362.37 Aligned_cols=264 Identities=33% Similarity=0.580 Sum_probs=229.1
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
...|++..++|++.++||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34677888999999999999999999999875 56799999875432 346788999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999999763 345899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 655 LKHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 655 ~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .......+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 6554322 2223346788999999999999999999999999999999 999999888776665553 233556678899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+.+.+||.+||..||.+|||+.++++.|+.+...
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=371.71 Aligned_cols=260 Identities=30% Similarity=0.446 Sum_probs=209.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc-
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 577 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 577 (783)
++.+..++|++.++||+|+||.||+|.+. ++.||||++.... .....+.+|+.+++.++|||||++++++.....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 44556789999999999999999999876 5789999986543 233455668999999999999999999987543
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC----------CCCEEecCCCCCCEEEcCCCc
Q 003963 578 ---LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC----------NPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 578 ---~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~IvHrDIKp~NILl~~~~~ 644 (783)
+++|||||++|+|.+++... .+++..++.++.||+.||+|||+. + |+||||||+||||+.++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCe
Confidence 69999999999999999764 489999999999999999999998 7 999999999999999999
Q ss_pred EEEEecCCCcccccccc--cccCCCCCCcccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCh------
Q 003963 645 VKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNE-----PSDEKSDVYSFGVILWELATEKIPWDNLNS------ 711 (783)
Q Consensus 645 vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~-----~~s~~sDIwSLG~il~elltG~~Pf~~~~~------ 711 (783)
+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999976544322 22345799999999999874 345688999999999999999999965321
Q ss_pred ----------HHHHHHhhcccccccCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 712 ----------MQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 712 ----------~~~~~~i~~~~~~~~~~~-----~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
......+......+.++. ..++++.+||.+||+.||.+|||+.++++.|++|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 112222211122222222 1235699999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.35 Aligned_cols=260 Identities=18% Similarity=0.284 Sum_probs=219.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 578 (783)
....++|++.+.||+|+||.||+|.+. .++.||||++...... ..+.+|+.+++.+ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 345678999999999999999999974 4578999998755432 3467899999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc-----EEEEecCCC
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLS 653 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~-----vkL~DFGla 653 (783)
++||||+ +++|.+++.....++++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 89999999877667999999999999999999999998 999999999999987765 999999999
Q ss_pred cccccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhcc--
Q 003963 654 RLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGAVGFM-- 721 (783)
Q Consensus 654 ~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~---~~~~~~~i~~~-- 721 (783)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 86554321 2345579999999999999999999999999999999999999998753 33333332211
Q ss_pred -cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 722 -NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 722 -~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.....+...+++++.+||.+||..||.+||++.+|++.|+++....
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1122344578999999999999999999999999999999887653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.54 Aligned_cols=266 Identities=26% Similarity=0.480 Sum_probs=226.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEece
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 571 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 571 (783)
.+++..++|++.+.||+|+||.||+|.+... ..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4567788999999999999999999997542 369999987654 344567889999999999 89999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhc-------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEE
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL 638 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NIL 638 (783)
+...+.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999999753 234789999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 003963 639 VDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVI 715 (783)
Q Consensus 639 l~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~ 715 (783)
|+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999976543321 2223456789999999999999999999999999999998 99999877655544
Q ss_pred HHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 716 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 716 ~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
..+.........+..+++.+.+||.+||+.||.+|||+.++++.|+++....
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 4443334455667788999999999999999999999999999999887653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=395.20 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=222.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.+|+.++||||+++++++.....+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 45789999999999999999999864 5789999997653221 224567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 581 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
|||||+||+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|++||+|||+++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999753 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhcccccccCCCCCCH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN----SMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.... .......+ ......+|..+++
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i--~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV--LEQAVTYPDKFSP 418 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH--hhcccCCCcccCH
Confidence 54444445689999999999999999999999999999999999999997653 23333333 2345567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCH-----HHHHHHHHHHHHHHhhcC
Q 003963 734 RWAAIVESCWHSDPQCRPSF-----QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa-----~ell~~L~~L~~~~f~~~ 771 (783)
.+.+||.+||.+||.+||++ .++ +.|+||+.+
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei------~~Hpff~~i 455 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGL------RTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHH------HTSGGGTTC
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHH------HcCccccCC
Confidence 99999999999999999965 677 678999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.76 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=220.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.++||+|+||.||+|.+... ..||+|++....... ...+.+|+.+++.++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 46899999999999999999998764 579999987654332 357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~~ 659 (783)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999998764 45899999999999999999999999 9999999999999 78899999999999765543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCC----CCCCHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP----KDVDPRW 735 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~s~~l 735 (783)
. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+.... ...+ ..+++.+
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 163 K-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT--FTFPEKDWLNVSPQA 238 (277)
T ss_dssp S-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCHHHHTTSCHHH
T ss_pred c-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCchhhhcCCHHH
Confidence 2 33456789999999998765 8899999999999999999999999888777666653322 2222 3689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.+||.+||+.||.+||++.++ |+|+||+...+.
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~------l~h~~~~~~~~~ 271 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQA------LEHEWFEKQLSS 271 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHH------TTSHHHHHHHCC
T ss_pred HHHHHHHccCChhhCcCHHHH------hcCHHHhccccc
Confidence 999999999999999999999 678999876544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=372.04 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=216.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
...++|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++...+.+|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 345799999999999999999999865 5789999998777677777788899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 102 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999998888887654 346999999999999999999999998 9999999999999999999999999998665544
Q ss_pred ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------
Q 003963 661 LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---------------- 723 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 723 (783)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+.....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 444456789999999999875 689999999999999999999999988876655443321100
Q ss_pred -ccc------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 724 -RLE------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 724 -~~~------------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
... ....+++.+.+||.+||..||.+|||+.++ |+|+||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL------LHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG------GGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH------hcCchhccC
Confidence 000 113578999999999999999999999999 678999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=360.12 Aligned_cols=262 Identities=23% Similarity=0.397 Sum_probs=209.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+. .++.||||++.... ........+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4578999999999999999999985 45789999997644 345566788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 581 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999864 3456899999999999999999999998 9999999999999999999999999987665
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhcccccccCCCCCCHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--SMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
..........|++.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.........+..+++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333445578999999999999999999999999999999999999996543 2333333332222223346789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.+||.+||..||.+||++.++++.|++|+..
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.16 Aligned_cols=260 Identities=27% Similarity=0.508 Sum_probs=216.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-c----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-Q----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...++|++.++||+|+||.||+|.+... + +||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3457899999999999999999997543 2 35777765433 2334567889999999999999999999998754
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.++||||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999999887778999999999999999999999998 999999999999999999999999999765
Q ss_pred ccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 657 HETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 657 ~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43321 2223456889999999999999999999999999999999 999999887766655543 3335566778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
++.+||.+||+.||.+||++.++++.|+.+...
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999988653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.45 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=215.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE-----eCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVW-----YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP- 575 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 575 (783)
.....|++.++||+|+||.||+|.+ ..++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3356799999999999999999984 245679999987554 223346788999999999999999999999876
Q ss_pred -CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 576 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 576 -~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence 6789999999999999999777777999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------------hHHHHHH
Q 003963 655 LKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--------------SMQVIGA 717 (783)
Q Consensus 655 ~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~--------------~~~~~~~ 717 (783)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||.... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 655432 22334568889999999999999999999999999999999998864221 1111111
Q ss_pred hhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 718 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 718 i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
..........+..+++.+.+||.+||..||.+|||+.++++.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22233455677889999999999999999999999999999998874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=370.77 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=205.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 576 (783)
.++|++.++||+|+||.||+|.+. .++.||||++.... .....+.+.+|+.+|+.++|||||+++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 468999999999999999999986 46789999997654 2334577899999999999999999999885433
Q ss_pred ---------------------------------------------------ceEEEEEecCCCCHHHHHhhcCC--cchH
Q 003963 577 ---------------------------------------------------RLCIVTEFLPRGSLFRLLQRNTT--KLDW 603 (783)
Q Consensus 577 ---------------------------------------------------~~~lV~E~~~ggsL~~~L~~~~~--~l~~ 603 (783)
.+++|||||++++|.+++..... ...+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999976432 2456
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc------------ccccCCCCCCc
Q 003963 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY------------LTTKTGKGTPQ 671 (783)
Q Consensus 604 ~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~------------~~~~~~~Gt~~ 671 (783)
..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 678899999999999999998 9999999999999999999999999998665432 12234579999
Q ss_pred ccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCC
Q 003963 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRP 751 (783)
Q Consensus 672 Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RP 751 (783)
|+|||++.+..++.++|||||||++|+|++|..|+... ......+. .......+...++++.+||.+||+.||.+||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99999999999999999999999999999997765321 11111111 1111112234567889999999999999999
Q ss_pred CHHHHHHHHHHHHHHHhhcC
Q 003963 752 SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 752 sa~ell~~L~~L~~~~f~~~ 771 (783)
|+.++ ++|+||+..
T Consensus 319 s~~~~------l~~~~f~~~ 332 (332)
T 3qd2_B 319 EATDI------IENAIFENL 332 (332)
T ss_dssp CHHHH------HHSTTCCCC
T ss_pred CHHHH------hhchhhhcC
Confidence 99999 688999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=391.12 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=222.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.++||+|+||.||+|.+. .++.||||++............+.+|+.+|+.++|||||++++++.....+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3478999999999999999999986 457899999975433222346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc---CCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~ 658 (783)
||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999998764 46899999999999999999999999 99999999999995 456799999999976554
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--CCCCCCHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--IPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~ 736 (783)
.. .....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||...+....+..+........ .+..+++++.
T Consensus 177 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 177 NT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp C-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CC-ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 32 23356799999999999874 89999999999999999999999999888887777654433332 2356899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+||.+||..||.+|||+.++ |+|+||+...+.
T Consensus 255 ~li~~~L~~dp~~R~t~~~~------l~hp~~~~~~~~ 286 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQC------LEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHH------HHCHHHHHTCCC
T ss_pred HHHHHHcCCChhhCcCHHHH------hcCHhhccCccc
Confidence 99999999999999999999 678999876554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=406.54 Aligned_cols=260 Identities=24% Similarity=0.408 Sum_probs=226.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC-ceEEEEEEecccC-CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCc
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 577 (783)
.+..++|+++++||+|+||.||+|.+... +.||||++.+... .......+..|..++..+ +||||+++++++...+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45568999999999999999999998764 5699999976432 112335677899999987 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+||||||++||+|..++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++++||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999999864 46999999999999999999999998 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.........+||+.|+|||++.+..++.++|||||||+||||++|.+||...+..+.+..+. .....+|..+++++.+
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVA 571 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHH
Confidence 44445567789999999999999999999999999999999999999999998888877763 4456778899999999
Q ss_pred HHHHhhhhCCCCCCCH-----HHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRPSF-----QELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa-----~ell~~L~~L~~~~f~~~ 771 (783)
||.+||++||.+||++ .+| +.|+||+.+
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei------~~h~ff~~i 604 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDI------KEHAFFRYI 604 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHH------HSSGGGSSC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHH------hcCccccCC
Confidence 9999999999999987 677 678999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.86 Aligned_cols=257 Identities=18% Similarity=0.272 Sum_probs=214.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+. .++.||||++...... ..+.+|+.+++.+ +||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4578999999999999999999975 4577999998765432 2467899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc-----EEEEecCCCcc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL 655 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~-----vkL~DFGla~~ 655 (783)
||||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 89999999876677999999999999999999999998 999999999999998887 99999999986
Q ss_pred cccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccc-
Q 003963 656 KHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFMNQR- 724 (783)
Q Consensus 656 ~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~~~i~~~~~~- 724 (783)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543321 124567999999999999999999999999999999999999999875433 222222111111
Q ss_pred --ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 725 --LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 725 --~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
......++ ++.+||..||..||.+||++.+|++.|+++....
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11123355 9999999999999999999999999998887653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=358.15 Aligned_cols=262 Identities=26% Similarity=0.471 Sum_probs=221.4
Q ss_pred cccccceeEee-eeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 501 EILWEDLTIGE-QIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 501 e~~~~~y~i~~-~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
.+..++|++.+ .||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 44567899998 99999999999997643 35799999987655556677899999999999999999999999 567
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 789999999999999999764 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 657 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 657 ~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Confidence 43321 1223456789999999998889999999999999999999 9999999888776655542 34566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
+.+.+||.+||..||.+||++.++++.|+++...-
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998886653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=367.44 Aligned_cols=260 Identities=26% Similarity=0.312 Sum_probs=208.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC---HHHHHHHHHHHHHHHhC---CCCceeeEeceeec
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS 574 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~ 574 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 445799999999999999999999754 567999998754321 11123455677776666 49999999999976
Q ss_pred CC-----ceEEEEEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEE
Q 003963 575 PQ-----RLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 648 (783)
Q Consensus 575 ~~-----~~~lV~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~ 648 (783)
.. .+++||||+. ++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 55 4899999996 599999976543 3899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q 003963 649 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--- 725 (783)
Q Consensus 649 DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--- 725 (783)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+.......
T Consensus 163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999997654332 2234578999999999999999999999999999999999999999888776655542211100
Q ss_pred ----------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 726 ----------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 726 ----------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.....+++.+.+||.+||+.||.+|||+.++ |+|+||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA------LQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSTTC---
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH------hcCccccCC
Confidence 1124578999999999999999999999999 789999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=366.14 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=222.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 345789999999999999999999865 5789999997654321 12467889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC----cEEEEecCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 652 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGl 652 (783)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999999763 46899999999999999999999998 99999999999999887 799999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKD 730 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~ 730 (783)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ..++..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 97655432 223457899999999999999999999999999999999999999988877766665432221 122357
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+++.+.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~------l~hp~~~~~ 279 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEA------LRHPWITPV 279 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHH------HHSTTTSCS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHH------hcCccccCC
Confidence 88999999999999999999999999 668888654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.80 Aligned_cols=256 Identities=22% Similarity=0.389 Sum_probs=212.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|.+.++||+|+||.||++.+.. +..||+|++....... ....+.+|+.+++.++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3689999999999999999999864 5679999997765322 2457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCccc
Q 003963 583 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 583 E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~ 656 (783)
||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++...
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999998542 356999999999999999999999998 9999999999999 45678999999999765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc-CCCCCCHHH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-IPKDVDPRW 735 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l 735 (783)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+........ ....+++++
T Consensus 178 ~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 178 KSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred CCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 5432 233557899999999986 4578999999999999999999999998887776655543332222 224478999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~------l~hp~f~~ 284 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQV------LHHEWFKQ 284 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHH------HTSGGGGC
T ss_pred HHHHHHHccCChhhCcCHHHH------hcCHHhhc
Confidence 999999999999999999999 67899975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.37 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=213.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.++. ++.||||++.+.... ..+|++++..+ +||||+++++++.+...+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999999865 567999999776432 24588888887 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC----CcEEEEecCCCccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLK 656 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~----~~vkL~DFGla~~~ 656 (783)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||+... +.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999764 46899999999999999999999998 9999999999998543 35999999999876
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccc--ccCCCCC
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL---NSMQVIGAVGFMNQR--LEIPKDV 731 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~--~~~~~~~ 731 (783)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+...... ...+..+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 55444445678999999999999888899999999999999999999999753 344444444322222 2234678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
++++.+||.+||..||.+||++.++ ++|+||+.
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~i------l~hp~~~~ 283 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALV------LRHPWIVH 283 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHH------TTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHH------hcCCeecC
Confidence 9999999999999999999999999 67899854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.88 Aligned_cols=260 Identities=30% Similarity=0.564 Sum_probs=221.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCCc----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce-EE
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGSQ----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL-CI 580 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~l 580 (783)
.|.+.++||+|+||.||+|.+.... .||+|++.... .....+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 5777899999999999999875432 59999986533 445567889999999999999999999999876655 99
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999876777999999999999999999999998 9999999999999999999999999997554321
Q ss_pred ----ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 661 ----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 661 ----~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.......+++.|+|||.+.+..++.++|||||||++|+|++ +.+||...+.......+. .......+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 12234467889999999999999999999999999999999 566676666665554443 333556677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+||.+||..||.+|||+.++++.|+++...+..
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=389.30 Aligned_cols=260 Identities=33% Similarity=0.587 Sum_probs=226.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..+++...+|++.++||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++|||||++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 3467778899999999999999999999875 567999999765443 357889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+|+|||||++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999763 345899999999999999999999998 99999999999999999999999999986
Q ss_pred ccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 656 KHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 656 ~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
..... .......+++.|+|||++.+..++.++|||||||+||||++ |..||...+..+....+. .......+..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54332 22233456789999999999889999999999999999999 999999888776665543 3345667888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 999999999999999999999999988765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=362.09 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=218.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
...++|++.+.||+|+||.||+|.+.. ++.||||++...... ..+.+|+.+++.++||||+++++++...+.+|+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL----QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH----HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 445789999999999999999999865 578999999765432 467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999866677999999999999999999999998 9999999999999999999999999997765544
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~LI 739 (783)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..+++.+.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 44455678999999999999999999999999999999999999999887766554432221 22334556899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+||..||.+||++.++ ++|+||+...
T Consensus 260 ~~~l~~dp~~Rpt~~~l------l~~~~~~~~~ 286 (314)
T 3com_A 260 KQCLVKSPEQRATATQL------LQHPFVRSAK 286 (314)
T ss_dssp HHHTCSCTTTSCCHHHH------TTSHHHHTCC
T ss_pred HHHccCChhhCcCHHHH------HhCHHHhcCC
Confidence 99999999999999999 6789997654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.02 Aligned_cols=262 Identities=34% Similarity=0.542 Sum_probs=216.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC--c--eEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS--Q--DVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~--~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
.+..++|++.++||+|+||.||+|.+... + .||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 34457999999999999999999986532 2 5899998765432 35567889999999999999999999999876
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
. .++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 5 89999999999999999876667999999999999999999999998 99999999999999999999999999976
Q ss_pred cccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCC
Q 003963 656 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 656 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 731 (783)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.........+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 543321 2223457889999999998889999999999999999999 999999998888777775555566677889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
++++.++|.+||..||.+||++.++++.|++++.
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 9999999999999999999999999999887754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=364.43 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=216.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC--------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS--------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 572 (783)
++..++|++.+.||+|+||.||+|.+... ..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45568999999999999999999987643 3599999865432 3346788999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc--------
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------- 644 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~-------- 644 (783)
...+..++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999887767999999999999999999999999 999999999999998877
Q ss_pred EEEEecCCCcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003963 645 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 645 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~ 722 (783)
+||+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++ +.+||............ .
T Consensus 160 ~kl~Dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCHH----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCcc----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 9999999986544321 2346888999999987 678999999999999999999 56666666655443332 2
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
....++..+++++.+||.+||+.||.+|||+.++++.|+++..+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 34556677889999999999999999999999999999877554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=358.98 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=220.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.++|++.+.||+|+||.||+|.+.. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4689999999999999999999874 5789999997654322 1246788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC----cEEEEecCCCc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSR 654 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGla~ 654 (783)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999763 46899999999999999999999998 99999999999998876 89999999997
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCCC
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVD 732 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s 732 (783)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ...+..++
T Consensus 161 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 161 KIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp ECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 654432 223456899999999999999999999999999999999999999988877766655433221 22335788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+.+.+||.+||..||.+||++.++ +.|+||+..+..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~------l~h~~~~~~~~~ 275 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQS------LEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHH------HHCHHHHHHHHC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHH------HhCHHHHHHHHH
Confidence 999999999999999999999999 678898776543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.93 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=212.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeec----
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS---- 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---- 574 (783)
....++|++.+.||+|+||.||+|.+. .++.||||++....... ..+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT---HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH---HHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 345689999999999999999999985 45789999997654332 4678899999999 79999999999976
Q ss_pred --CCceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecC
Q 003963 575 --PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 651 (783)
Q Consensus 575 --~~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFG 651 (783)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46789999999999999999764 346899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 726 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 726 (783)
++..............|++.|+|||++. +..++.++|||||||++|+|++|..||...+.......+........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 9986654433344567899999999987 56688999999999999999999999998887766555433333333
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+..+++.+.+||.+||..||.+||++.++ ++|+||+...
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l------l~hp~~~~~~ 294 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQL------MKHPFIRDQP 294 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHH------HTSHHHHCCT
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHH------hhChHHhhCc
Confidence 456789999999999999999999999999 6788887543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=388.83 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=215.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|+++++||+|+||.||+|.+.. +..||||++............+.+|+.+++.++|||||++++++.....+|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34689999999999999999999864 56799999987654443356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla~~~~~ 658 (783)
||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999988764 45899999999999999999999998 999999999999976 45599999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--CCCCCCHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--IPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~ 736 (783)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.......+........ ....+++.+.
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred Cc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 32 2345679999999999864 589999999999999999999999999988887777654433322 2357899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
+||.+||+.||.+|||+.++ |+|+||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~------l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQA------LEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHH------HTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHH------hcCcccccC
Confidence 99999999999999999999 677888653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.34 Aligned_cols=262 Identities=31% Similarity=0.527 Sum_probs=220.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee-ecCCce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRL 578 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~ 578 (783)
..+|++.++||+|+||.||+|.+..+ ..||+|++.... .......+.+|+.+++.++||||+++++++ ..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 45799999999999999999986432 248999886533 445567889999999999999999999985 456688
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999876777899999999999999999999998 99999999999999999999999999976543
Q ss_pred ccc----cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 659 TYL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 659 ~~~----~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
... ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+. .......+..+++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCH
Confidence 221 1223457889999999999999999999999999999999 677887776665554443 2334555778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+.+||.+||..||.+||++.++++.|+++...++.
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999998876653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=361.54 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=221.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee--cCCceEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCI 580 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 580 (783)
.++|++.+.||+|+||.||++.+.. ++.||+|++..........+.+.+|+.+++.++||||+++++++. ....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4789999999999999999999864 577999999887777777788999999999999999999999874 4678999
Q ss_pred EEEecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHHHHhCC---CCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 581 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ .+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 234899999999999999999999975 239999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.............|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .....++..++++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 655432222344689999999999999999999999999999999999999998887766655532 2334667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
+.+||.+||..||.+||++.++ +.++|+.....
T Consensus 244 l~~li~~~l~~~p~~Rps~~~l------l~~~~~~~~~~ 276 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEI------LENPLILEHHH 276 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH------HTSTTCCGGGS
T ss_pred HHHHHHHHcCCCcccCCCHHHH------HhChhhhhhcc
Confidence 9999999999999999999999 55666665543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=385.51 Aligned_cols=259 Identities=33% Similarity=0.587 Sum_probs=220.7
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..+++..++|++.++||+|+||.||+|.+..+..||||++....... +.+.+|+.+|+.++||||+++++++.. +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 34677889999999999999999999999887789999998665443 468899999999999999999999876 67
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 89999999999999999753 345899999999999999999999998 999999999999999999999999999865
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... ......+++.|+|||++.+..++.++|||||||+||||++ |..||......+....+. .....+.+..+++.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43321 2223456789999999999999999999999999999999 999999988877776654 33456677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+.+||.+||..||.+|||+.+|++.|+++
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=372.55 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=215.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
+.+...++|++.+.||+|+||.||+|.+..++.||||++..... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34456689999999999999999999987778999999876543 2356788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 579 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999996543 35899999999999999999999998 99999999999999999999999999976
Q ss_pred ccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HH---H-hhc--ccc-
Q 003963 656 KHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IG---A-VGF--MNQ- 723 (783)
Q Consensus 656 ~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~---~~---~-i~~--~~~- 723 (783)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .. . ... ...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 44321 122234589999999999998999999999999999999999999965432211 00 0 000 000
Q ss_pred -cc----cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 724 -RL----EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 724 -~~----~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.. .++..++..+.++|.+||..||.+|||+.++++.|+.+.+
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 01 1222345678999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=371.45 Aligned_cols=259 Identities=27% Similarity=0.469 Sum_probs=217.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ce----EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
+..++|++.++||+|+||.||+|.+... +. ||+|++..... ......+.+|+.+++.++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 3457899999999999999999998654 33 77787754322 122245667999999999999999999886 56
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
..++||||+.+|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 789999999999999999876667999999999999999999999998 999999999999999999999999999865
Q ss_pred ccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 657 HETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 657 ~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
..... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcH
Confidence 43321 2234457889999999999999999999999999999999 999999887766665553 3345566777899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
++.+||.+||..||.+||++.++++.|+.+..
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999988754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=373.16 Aligned_cols=264 Identities=18% Similarity=0.239 Sum_probs=209.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHH----HH-----HHHHHHHHHHHhCCCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDE----VI-----HSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~----~~-----~~~~~Ei~il~~l~HpnI 565 (783)
++..++|++.++||+|+||.||+|.+..+ +.||||++........ .. ..+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 45567999999999999999999998653 5799999876532110 00 123345556677789999
Q ss_pred eeEeceeecC----CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-
Q 003963 566 LLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD- 640 (783)
Q Consensus 566 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~- 640 (783)
+++++++... ...||||||| +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998764 4589999999 99999999887678999999999999999999999998 99999999999999
Q ss_pred -CCCcEEEEecCCCccccccccc-------ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003963 641 -KHWTVKVGDFGLSRLKHETYLT-------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712 (783)
Q Consensus 641 -~~~~vkL~DFGla~~~~~~~~~-------~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~ 712 (783)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||+||+|++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999765433211 12345999999999999999999999999999999999999999853222
Q ss_pred -HHHHHhhc--------ccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 713 -QVIGAVGF--------MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 713 -~~~~~i~~--------~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
........ .......+..+++++.+||..||..||.+||++.+|++.|+++....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 21111100 00011123678999999999999999999999999999998887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.60 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=213.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.+++.++||||+++++++.....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 45789999999999999999999864 5789999987543221 2234678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++ +|..++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999975 899999877777899999999999999999999999 99999999999999999999999999987655
Q ss_pred ccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------------ 725 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 725 (783)
.........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+....+..+.......
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 44444556789999999999764 47899999999999999999999999888766555442211100
Q ss_pred --------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 726 --------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 726 --------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+...+++++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~h~~f~~~~ 299 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRP 299 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH------HTSGGGTSSS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH------hcChhhhcCC
Confidence 0114567899999999999999999999999 7899997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.50 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=213.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|++.+.||+|+||.||+|.+. .++.||||++............+.+|+.++..+ +||||+++++++...+.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999986 467899999987665555567888999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-----------------
Q 003963 582 TEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----------------- 641 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~----------------- 641 (783)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999997542 45899999999999999999999998 999999999999984
Q ss_pred --CCcEEEEecCCCcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh
Q 003963 642 --HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV 718 (783)
Q Consensus 642 --~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i 718 (783)
...+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+........ +
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE---I 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH---H
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH---H
Confidence 447999999998765543 234689999999999876 566899999999999999999988765433222 2
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
. ......++..+++++.+||.+||..||.+|||+.++ ++|+||+..
T Consensus 241 ~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~ 286 (289)
T 1x8b_A 241 R-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL------VKHSVLLSA 286 (289)
T ss_dssp H-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH------HTCTTC---
T ss_pred H-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHH------hhChHhhhh
Confidence 1 233456778899999999999999999999999999 788999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.21 Aligned_cols=260 Identities=25% Similarity=0.490 Sum_probs=215.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.+..++|++.+.||+|+||.||+|.+. .++.||||++...... ......+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345689999999999999999999986 4678999998764321 12345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999999764 35899999999999999999999998 99999999999999999999999999876544
Q ss_pred ccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 737 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 737 (783)
.. ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...........+. .....++..++..+.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHH
Confidence 32 2234568999999999988765 689999999999999999999999887776665553 2344567788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||+.||.+|||+.++ +.|+||+...
T Consensus 241 li~~~l~~~p~~Rps~~~~------l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDI------REHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHH------HHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHH------HhChhhccCc
Confidence 9999999999999999999 6789997543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=387.41 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=220.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-----------HHHHHHHHHHHHHHhCCCCceeeEec
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-----------EVIHSFRQEVSLMKRLRHPNVLLFMG 570 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~ 570 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++....... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999865 4679999997654321 23467889999999999999999999
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---cEEE
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKV 647 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~---~vkL 647 (783)
++.....+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999999999998764 46999999999999999999999998 99999999999998775 6999
Q ss_pred EecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc-
Q 003963 648 GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE- 726 (783)
Q Consensus 648 ~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~- 726 (783)
+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+....+..+........
T Consensus 191 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9999998665443 2345679999999999875 589999999999999999999999999988887777654332222
Q ss_pred -CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 727 -IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 727 -~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.+..+++++.+||.+||..||.+|||+.++ |+|+||+.....
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~------l~h~~~~~~~~~ 311 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEA------LNSRWIKKYANN 311 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHHTCCC
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHH------hcCHhhhhchhc
Confidence 225789999999999999999999999999 678999776544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=376.18 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=202.4
Q ss_pred ccccceeEe-eeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHH-hCCCCceeeEeceeec----
Q 003963 502 ILWEDLTIG-EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTS---- 574 (783)
Q Consensus 502 ~~~~~y~i~-~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~---- 574 (783)
...++|.+. ++||+|+||.||++.+.. ++.||||++... ..+.+|+.++. .++||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 345778887 789999999999999865 567999998642 24567888874 5589999999998875
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEec
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDF 650 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DF 650 (783)
...+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEec
Confidence 567899999999999999997643 45899999999999999999999998 999999999999987 789999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhhcccccc-
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ----VIGAVGFMNQRL- 725 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~----~~~~i~~~~~~~- 725 (783)
|+++...... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||....... ....+.......
T Consensus 209 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 209 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred ccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 9998654332 2335678999999999999999999999999999999999999997654321 122222111111
Q ss_pred -cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 726 -EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 726 -~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.....+++++.+||.+||..||.+|||+.++ +.|+||+...
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei------l~hp~~~~~~ 329 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIMQST 329 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH------HHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHH------hcCccccCCC
Confidence 2225689999999999999999999999999 6789997543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.63 Aligned_cols=265 Identities=29% Similarity=0.552 Sum_probs=222.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ce--EEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCc
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~--vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 577 (783)
+.+++|++.+.||+|+||.||+|.+... .. +++|++.... .......+.+|+.+++.+ +||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 4458999999999999999999998654 33 5999887533 334456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 642 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~ 642 (783)
+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999997643 36899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003963 643 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 643 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~ 721 (783)
+.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~- 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ- 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-
Confidence 99999999998743322 22234457889999999998889999999999999999998 9999999888777665532
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
......+..+++.+.+||.+||..||.+||++.++++.|.++........
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 23455677899999999999999999999999999999998877654333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=394.17 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=221.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
+..++|++.+.||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.+|+.++|||||++++++...+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 445789999999999999999999864 5789999997643211 22356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+|||||+||+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999997643 34899999999999999999999998 99999999999999999999999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhcccccccCCCCCCHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN----SMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.... .......+ ......++..++++
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSPQ 415 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCHH
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCHH
Confidence 32 2235689999999999999999999999999999999999999997653 23333333 22345567889999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 735 WAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
+.+||.+||..||.+|| ++.++ ++|+||+.+
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~ei------l~HpfF~~i 451 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREV------KEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHH------HTSGGGTTC
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHH------HhChhhccC
Confidence 99999999999999999 78888 678999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.72 Aligned_cols=259 Identities=32% Similarity=0.597 Sum_probs=216.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-Cc
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-QR 577 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~ 577 (783)
.+.+..++|++.+.||+|+||.||++.+. ++.||||++.... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 34566789999999999999999999875 6689999987543 245788999999999999999999986544 57
Q ss_pred eEEEEEecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 9999999999999999976432 3788999999999999999999998 999999999999999999999999998755
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
.... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .......+..+++.+
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 168 SSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHH
T ss_pred cccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHH
Confidence 4332 23457889999999999999999999999999999998 999999887766665553 223456778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
.++|.+||..||.+||++.++++.|+.++...+
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 999999999999999999999999999877643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.94 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=223.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.+.|++.+.||+|+||.||+|.+.. ++.||||++...... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4679999999999999999999754 568999999765433 23567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999975 45899999999999999999999998 999999999999999999999999999876554444
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.. .....++..++..+.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHHHHHH
Confidence 4566799999999999999999999999999999999999999998887766655432 234456778999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|..||.+|||+.++ ++|+||+..
T Consensus 255 l~~dp~~Rps~~~l------l~~~~~~~~ 277 (303)
T 3a7i_A 255 LNKEPSFRPTAKEL------LKHKFILRN 277 (303)
T ss_dssp CCSSGGGSCCHHHH------TTCHHHHHH
T ss_pred cCCChhhCcCHHHH------hhChhhhcC
Confidence 99999999999999 567777544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=366.84 Aligned_cols=260 Identities=27% Similarity=0.513 Sum_probs=215.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-ce----EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-QD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~----vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
+..++|++.++||+|+||.||+|.+... +. |++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4457899999999999999999997643 33 5777665433 2233467889999999999999999999998754
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999887778999999999999999999999998 999999999999999999999999999865
Q ss_pred ccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 657 HETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 657 ~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43221 2223456889999999999999999999999999999999 999999888776665543 3345667788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
++.+||.+||..||.+||++.++++.|+++...
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999988743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=365.32 Aligned_cols=269 Identities=30% Similarity=0.433 Sum_probs=217.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE-----eCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee--cC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVW-----YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SP 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~ 575 (783)
..++|++.++||+|+||.||+|.+ ..++.||||++... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 357999999999999999999985 23567999998754 3455677899999999999999999999886 45
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..+|+||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence 6689999999999999999876667999999999999999999999998 99999999999999999999999999986
Q ss_pred cccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--------------HHHHHh
Q 003963 656 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--------------QVIGAV 718 (783)
Q Consensus 656 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~--------------~~~~~i 718 (783)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 543321 223446888999999999998999999999999999999999998643321 111111
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCC
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 775 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~ 775 (783)
.........+..+++.+.+||.+||..||.+|||+.+++++|+.+....-.+.....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 313 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------------
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccccc
Confidence 222334566788999999999999999999999999999999988776654444433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.20 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=214.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 574 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 574 (783)
.++|+++++||+|+||.||+|.+. .++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 479999999999999999999985 45789999987665444344567789999999999999999999876
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
.+.+|+||||+++ +|.+.+......+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3468999999965 888888776677999999999999999999999998 9999999999999999999999999997
Q ss_pred ccccc----cccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--C
Q 003963 655 LKHET----YLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--I 727 (783)
Q Consensus 655 ~~~~~----~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~ 727 (783)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+........ .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 65422 122234578999999999887 4579999999999999999999999998887766555432211111 1
Q ss_pred CCC----------------------------CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 728 PKD----------------------------VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 728 ~~~----------------------------~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
... .++.+.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA------LNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGGSSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH------hCCCCcCCCC
Confidence 010 26789999999999999999999999 7799997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.66 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=194.6
Q ss_pred ccceeEe---eeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCce
Q 003963 504 WEDLTIG---EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 504 ~~~y~i~---~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 578 (783)
.++|.+. ++||+|+||.||+|.+.. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 3566665 789999999999999864 5779999997542 346678999999997 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---cEEEEecCCCcc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRL 655 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~---~vkL~DFGla~~ 655 (783)
|+|||||++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999999764 46999999999999999999999998 99999999999997765 899999999986
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHhhcccccccCC
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-------MQVIGAVGFMNQRLEIP 728 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~ 728 (783)
...........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+. .+....+.. ....++
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~ 236 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFE 236 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCC
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCC
Confidence 65544444566789999999999999999999999999999999999999976443 233333322 222222
Q ss_pred ----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 729 ----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 729 ----~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
..+++++.+||.+||..||.+|||+.++ ++|+||+....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el------l~h~w~~~~~~ 279 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL------RYNEWLQDGSQ 279 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS------TTCGGGCTTCC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHH------hcChhhccCcc
Confidence 3589999999999999999999999999 68999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.02 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=206.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc--
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-- 577 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 577 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 445789999999999999999999854 57799999987543 34566788999999999999999999999876654
Q ss_pred --eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 578 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 578 --~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 49999999999999999764 36899999999999999999999998 99999999999999999999999999976
Q ss_pred ccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCC
Q 003963 656 KHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKD 730 (783)
Q Consensus 656 ~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~ 730 (783)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................. ....+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 54332 122345689999999999999999999999999999999999999998887665544322221 1123456
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQEL 756 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~el 756 (783)
+++++.+||.+||..||.+||++.++
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 89999999999999999999987776
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=385.59 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=208.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 576 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.++|||||++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35799999999999999999999865 567999999877666667788999999999999999999999996553
Q ss_pred -ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 -~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 46999999965 67777753 3889999999999999999999998 99999999999999999999999999986
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL---------- 725 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------- 725 (783)
..... .....+||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+....+..+......+
T Consensus 214 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 65432 2335679999999999999999999999999999999999999999887665554432111100
Q ss_pred ----------c---------CCCC-----------CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 726 ----------E---------IPKD-----------VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 726 ----------~---------~~~~-----------~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
. ++.. .++++.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~------L~Hp~~~~ 361 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA------LQHPYINV 361 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH------HTSTTTGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH------hcChhhhh
Confidence 0 0000 15679999999999999999999999 78999974
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=362.38 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=217.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEe-----CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC--Cce
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWY-----GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 578 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 578 (783)
.|+++++||+|+||.||++.+. .++.||||++.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 3499999999999999998653 45679999997653 455567899999999999999999999999874 568
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999999764 3899999999999999999999999 99999999999999999999999999986654
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--------------HHHHhhcc
Q 003963 659 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--------------VIGAVGFM 721 (783)
Q Consensus 659 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~--------------~~~~i~~~ 721 (783)
.. .......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 32 12334567889999999999989999999999999999999999996532210 01111122
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
......+..+++++.+||.+||..||.+|||+.++++.|+.+...+-..
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 3355667889999999999999999999999999999999998887544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.98 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=217.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 45789999999999999999999865 56799999865432 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999999876677999999999999999999999998 99999999999999999999999998764333322
Q ss_pred cccCCCCCCcccCcccc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-cccCCCCCCHHH
Q 003963 662 TTKTGKGTPQWMAPEVL-----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRW 735 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~-----~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l 735 (783)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 33455789999999998 467789999999999999999999999998887766555433222 223456789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.+||.+||..||.+|||+.++ ++|+||+....
T Consensus 253 ~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~~~ 284 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQL------LEHPFVSSITS 284 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHH------TTSTTTTTCCC
T ss_pred HHHHHHHcccChhhCCCHHHH------hcChHHhhhcc
Confidence 999999999999999999999 67899987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.76 Aligned_cols=263 Identities=22% Similarity=0.370 Sum_probs=221.8
Q ss_pred cccccceeEe-eeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCc
Q 003963 501 EILWEDLTIG-EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 577 (783)
Q Consensus 501 e~~~~~y~i~-~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 577 (783)
+...++|.+. ++||+|+||.||+|.+.. ++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4556788887 899999999999999864 578999999876555444567889999999995 6999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecCCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLS 653 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGla 653 (783)
+++||||+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999999998543 356899999999999999999999998 999999999999987 789999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCCC
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDV 731 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 731 (783)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ....+..+
T Consensus 182 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 182 RKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp EEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 86654322 2345799999999999999999999999999999999999999998887776665543332 23344678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
++.+.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~l------l~h~~~~~~~ 295 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEIC------LSHSWLQQWD 295 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHH------TTCGGGCCCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHH------hCCHhhcccc
Confidence 9999999999999999999999999 6899997653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=369.64 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=218.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
++..++|++.++||+|+||.||++.+.. ++.||+|++.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 4456899999999999999999999864 5679999987653 4556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+. + |+||||||+||||+.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999999764 3589999999999999999999985 8 99999999999999999999999999875533
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-------------------
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG------------------- 719 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~------------------- 719 (783)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 2234578999999999999999999999999999999999999998766544322211
Q ss_pred -----------------------cccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 720 -----------------------FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 720 -----------------------~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
........+..++.++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~ 332 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL------MVHAFIKRSD 332 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH------HTSHHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH------hhChHhhcch
Confidence 0111111223478999999999999999999999999 6789997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=358.51 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=220.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|.+.+.||+|+||.||++.+. .++.||||++...... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3578999999999999999999986 4578999999764322 235678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 658 (783)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999998764 35899999999999999999999998 9999999999999 7788999999999875443
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--cccCCCCCCHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~ 736 (783)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ....+..+++.+.
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 162 GI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp BT--THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred Cc--cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 21 2233589999999999999999999999999999999999999998887776666543322 2234467899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 775 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~ 775 (783)
+||.+||..||.+||++.++ +.|+||+......
T Consensus 240 ~li~~~l~~dp~~Rps~~~~------l~h~~~~~~~~~~ 272 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKA------LSHPWIDGNTALH 272 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHH------HTSHHHHSSCSCC
T ss_pred HHHHHHcCCChhHCcCHHHH------hcCccccCCCccc
Confidence 99999999999999999999 6789998765443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.94 Aligned_cols=267 Identities=28% Similarity=0.477 Sum_probs=217.2
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
...+....++|.....||+|+||.||+|.+.. ++.||||++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 34455556677777799999999999999865 46799999876542 3346788999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 652 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGl 652 (783)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999997643 34668889999999999999999998 999999999999987 89999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHhhcccccccCCC
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQV-IGAVGFMNQRLEIPK 729 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~ 729 (783)
+..............|++.|+|||++.+.. ++.++|||||||++|+|++|..||........ ............++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 986654433344567899999999987654 78999999999999999999999976543322 222222334556778
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.+++++.+||.+||..||.+||++.++ ++|+||+....
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~l------l~~~~~~~~~~ 287 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDL------LVDEFLKVSSK 287 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHH------HTSGGGCC---
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHH------hcChhhhhccc
Confidence 899999999999999999999999999 78899976553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=375.40 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=209.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----C
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 576 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|+.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 45799999999999999999999865 46799999987665666678899999999999999999999999766 5
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 6899999995 599999975 356999999999999999999999999 999999999999999999999999999865
Q ss_pred ccccc----------------------cccCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHcCC----------
Q 003963 657 HETYL----------------------TTKTGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEK---------- 703 (783)
Q Consensus 657 ~~~~~----------------------~~~~~~Gt~~Y~aPE~~-~~~~~s~~sDIwSLG~il~elltG~---------- 703 (783)
..... .....+||+.|+|||++ .+..++.++|||||||+||||++|.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 43321 12456799999999986 5666899999999999999999854
Q ss_pred -CCCCCCCh-----------------HHHHHH------------------------hhccccccc-----CCCCCCHHHH
Q 003963 704 -IPWDNLNS-----------------MQVIGA------------------------VGFMNQRLE-----IPKDVDPRWA 736 (783)
Q Consensus 704 -~Pf~~~~~-----------------~~~~~~------------------------i~~~~~~~~-----~~~~~s~~l~ 736 (783)
++|.+.+. ...+.. +........ ....+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 44433221 011100 000000111 1145899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+||.+||..||.+|||+.++ |+|+||+..+..
T Consensus 340 dLl~~mL~~dP~~R~ta~e~------L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQA------LDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHH------HTCGGGTTTCCT
T ss_pred HHHHHHhcCCcccCCCHHHH------hcChhhhhccCc
Confidence 99999999999999999999 789999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=364.81 Aligned_cols=258 Identities=19% Similarity=0.354 Sum_probs=208.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC--ceE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RLC 579 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 579 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++....... ....+.+|+.+++.++||||+++++++.... .+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 45789999999999999999999875 5789999997644222 2456778999999999999999999987655 789
Q ss_pred EEEEecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE----cCCCcEEEEecCCC
Q 003963 580 IVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLS 653 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGla 653 (783)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999999976433 3899999999999999999999998 9999999999999 77888999999999
Q ss_pred cccccccccccCCCCCCcccCccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhcc
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFM 721 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~----~~~~~~i~~~ 721 (783)
+...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ......+...
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 8665443 223557999999999986 57789999999999999999999999965432 2222222111
Q ss_pred cc-------------------cc----cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 722 NQ-------------------RL----EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 722 ~~-------------------~~----~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
.. .. .++..++..+.+||.+||+.||.+|||+.+++++..+-.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 10 01 112234567899999999999999999999988776543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=389.52 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=223.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++.++||+|+||.||+|.+. .++.||||++...... ......+.+|+.+++.++|||||++++++...+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999986 4578999999765432 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~ 656 (783)
+|||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999764 46999999999999999999999998 9999999999999 56789999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC--CCCCCHH
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPR 734 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~ 734 (783)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.......+......... +..++++
T Consensus 180 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 180 EASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp CCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 4432 2234578999999999987 5899999999999999999999999999888877776544433332 3568999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~------l~h~~~~~~~ 289 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDA------LDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH------HTSHHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHH------hhChhhcccc
Confidence 9999999999999999999999 6789987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=373.64 Aligned_cols=264 Identities=31% Similarity=0.522 Sum_probs=214.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee-cCCceE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLC 579 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~ 579 (783)
..|++.++||+|+||.||+|.+... ..||+|++.... .......+.+|+.+++.++||||+++++++. ..+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4688999999999999999987532 248999886533 3345678999999999999999999999865 456889
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999877777899999999999999999999998 999999999999999999999999999755332
Q ss_pred cc----cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 660 YL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 660 ~~----~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+. .......+..+++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 11 1123357889999999999999999999999999999999 788998776655544442 23345567789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+.+||.+||..||.+||++.++++.|+++...+.....
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 99999999999999999999999999999888765443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=368.00 Aligned_cols=259 Identities=24% Similarity=0.422 Sum_probs=220.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC--C----HHHHHHHHHHHHHHHhC-CCCceeeEeceee
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY--S----DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT 573 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~--~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 573 (783)
...++|++.+.||+|+||.||+|.+. .++.||||++..... . ......+.+|+.+++.+ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34578999999999999999999986 467899999976542 1 23356788999999999 7999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
.....|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+|+||||+||||+.++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence 999999999999999999999754 46899999999999999999999998 999999999999999999999999998
Q ss_pred cccccccccccCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc-
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE- 726 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~- 726 (783)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 7655432 2335679999999999863 3578899999999999999999999988877766655533222221
Q ss_pred -CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 727 -IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 727 -~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+..+++.+.+||.+||..||.+||++.++ ++|+||+.
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~el------l~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQA------LQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHH------hcCcccCC
Confidence 225688999999999999999999999999 78999973
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=358.21 Aligned_cols=252 Identities=33% Similarity=0.563 Sum_probs=202.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHh--CCCCceeeEeceeec----C
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTS----P 575 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~----~ 575 (783)
...++|++.++||+|+||.||+|.+ .++.||||++.... ...+.+|.+++.. ++||||+++++++.. .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 4467999999999999999999987 56789999986542 2445667777777 789999999998654 3
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHH--------hCCCCEEecCCCCCCEEEcCCCcEEE
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVKV 647 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~IvHrDIKp~NILl~~~~~vkL 647 (783)
..+++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +++ |+||||||+||||+.++.+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred ceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 458999999999999999964 35899999999999999999999 877 999999999999999999999
Q ss_pred EecCCCccccccccc----ccCCCCCCcccCcccccCC------CCCchhHHHHHHHHHHHHHcC----------CCCCC
Q 003963 648 GDFGLSRLKHETYLT----TKTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELATE----------KIPWD 707 (783)
Q Consensus 648 ~DFGla~~~~~~~~~----~~~~~Gt~~Y~aPE~~~~~------~~s~~sDIwSLG~il~elltG----------~~Pf~ 707 (783)
+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999765433221 2334799999999999877 345799999999999999999 88885
Q ss_pred CCCh-----HHHHHHhhcccccccCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 708 NLNS-----MQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 708 ~~~~-----~~~~~~i~~~~~~~~~~~-----~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.... ......+........++. .+++.+.+||.+||+.||.+|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4322 222222222222333332 2457899999999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=391.31 Aligned_cols=261 Identities=25% Similarity=0.481 Sum_probs=219.7
Q ss_pred cccccceeEee-eeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 501 EILWEDLTIGE-QIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 501 e~~~~~y~i~~-~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
.+..+++.+.+ +||+|+||.||+|.+.. +..||||++..... ....+.+.+|+.+|+.++|||||++++++.. +
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 44556777776 89999999999998763 34699999976532 2335678999999999999999999999976 5
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+++|||||++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 699999999999999999877777999999999999999999999998 999999999999999999999999999865
Q ss_pred ccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 657 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 657 ~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
..... ......+++.|+|||++.+..++.++|||||||+||||++ |..||...+..+....+. .......+..++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 565 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 565 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 43211 1223346789999999999999999999999999999998 999999988877776654 334567788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+++.+||..||..||.+||++.+|++.|+.+...
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988766444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=370.41 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=215.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHH------HHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
..++|++.++||+|+||.||+|.+.. ++.||||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999999754 56799999987643221 234567799999999999999999999999
Q ss_pred CceEEEEEecCCC-CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 576 QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 576 ~~~~lV~E~~~gg-sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
+.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999766 999999764 35999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
...... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ........+..+++
T Consensus 179 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSK 249 (335)
T ss_dssp ECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCH
T ss_pred ECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCH
Confidence 665432 2234578999999999998876 8899999999999999999999976322 12334456677999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
++.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~el------l~hp~~~~~~ 282 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKL------VTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH------HHCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHH------hcCccccCCc
Confidence 99999999999999999999999 6789997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=353.70 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=217.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|++.+.||+|+||.||+|.+.. ++.||||++...... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4689999999999999999999864 578999999765433 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 660 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 660 (783)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999998653 46899999999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccccCCCCCCHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
.......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++.+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 12335578999999999988765 77999999999999999999999766543 22222222222223345689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
|.+||..||.+|||+.++ ++|+||+.....
T Consensus 242 i~~~l~~~p~~Rps~~~i------l~~~~~~~~~~~ 271 (276)
T 2yex_A 242 LHKILVENPSARITIPDI------KKDRWYNKPLKK 271 (276)
T ss_dssp HHHHSCSSTTTSCCHHHH------TTCTTTTCCCC-
T ss_pred HHHHCCCCchhCCCHHHH------hcCccccChhhc
Confidence 999999999999999999 678999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=390.25 Aligned_cols=258 Identities=33% Similarity=0.592 Sum_probs=225.0
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
.|++..++|++.++||+|+||.||+|.+..+..||||++....... +.|.+|+.+|+.++|||||++++++.. ..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4677788999999999999999999999887889999998765443 468899999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 579 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
|||||||.+|+|.++|... ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999999753 345889999999999999999999998 9999999999999999999999999998654
Q ss_pred ccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 658 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 658 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
... .......++..|+|||++.+..++.++|||||||+||||++ |+.||......+....+. ...+...+..++..+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 493 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 332 12223456789999999999999999999999999999999 999999988877776654 334566778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
.+||.+||..||++|||+.+|++.|+.+
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999887654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.66 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=213.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhC------CCCceeeEeceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL------RHPNVLLFMGAVT 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~ 573 (783)
+....+|++.++||+|+||.||+|.+.. ++.||||++... ......+.+|+.+++.+ +|+||+++++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4456789999999999999999999865 567999998653 34456677888888887 5779999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc--EEEEec
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDF 650 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~--vkL~DF 650 (783)
....+|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++. +||+||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999995 69999987644 45899999999999999999999998 999999999999999887 999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----- 725 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----- 725 (783)
|+++..... ....+||+.|+|||++.+..++.++|||||||+||+|++|.+||...+....+..+......+
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 999765432 235678999999999999999999999999999999999999999887766554332110000
Q ss_pred ----------------------------------------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q 003963 726 ----------------------------------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSF 753 (783)
Q Consensus 726 ----------------------------------------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa 753 (783)
.++...++.+.+||.+||+.||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0122347889999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhcCcCC
Q 003963 754 QELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 754 ~ell~~L~~L~~~~f~~~~~~ 774 (783)
.++ |+|+||+.....
T Consensus 404 ~e~------L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 404 GQA------LRHPWLRRRLPK 418 (429)
T ss_dssp HHH------HTSTTTC-----
T ss_pred HHH------hCChhhccCCCC
Confidence 999 789999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.82 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=207.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeec--CCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~ 579 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++.... ...+.+|+.+++.++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 4789999999999999999999754 5789999986433 256889999999997 9999999999987 56789
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 658 (783)
+||||+++++|.+++.. +++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999998853 788899999999999999999999 99999999999999776 899999999986554
Q ss_pred ccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcc-------------cc
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFM-------------NQ 723 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~-------------~~ 723 (783)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+... ..
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2335578999999999987 668999999999999999999999995432 22222111000 00
Q ss_pred ----------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 724 ----------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 724 ----------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
....+..+++++.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~------l~hp~f~~~~~ 328 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA------MEHPYFYTVVK 328 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH------HTSGGGTTCC-
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH------hcCccHhhhcc
Confidence 001122378999999999999999999999999 78999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.46 Aligned_cols=263 Identities=26% Similarity=0.458 Sum_probs=220.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe------CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY------GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
++..++|++.+.||+|+||.||+|.+. .++.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 455689999999999999999999842 34579999986443 44556678899999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcE
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTV 645 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~v 645 (783)
....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997653 34889999999999999999999998 999999999999984 4569
Q ss_pred EEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003963 646 KVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 646 kL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~ 722 (783)
||+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 999999987543221 12223457889999999999999999999999999999998 999999888777665553 23
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.....+..+++.+.+||.+||..||.+||++.++++.|+.+....
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 355667789999999999999999999999999999999886643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.37 Aligned_cols=253 Identities=33% Similarity=0.625 Sum_probs=207.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+..++|++.+.||+|+||.||++.+. ++.||||++... ...+.+.+|+.+++.++||||+++++++. +..++|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence 34578999999999999999999875 568999998643 23467889999999999999999999887 358999
Q ss_pred EEecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHHHHh---CCCCEEecCCCCCCEEEcCCCc-EEEEecCCCcc
Q 003963 582 TEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHH---CNPPIIHRDLKSSNLLVDKHWT-VKVGDFGLSRL 655 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~~~IvHrDIKp~NILl~~~~~-vkL~DFGla~~ 655 (783)
|||+++++|.+++..... .++...++.++.||+.||+|||+ ++ |+||||||+|||++.++. +||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999976432 36788999999999999999999 66 999999999999998886 79999999875
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhhcccccccCCCCCCH
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~s~ 733 (783)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ........+..+++
T Consensus 156 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 156 IQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCH
T ss_pred cccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCH
Confidence 5432 12346899999999999999999999999999999999999999865432 222222 22334566778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.+.+||.+||..||.+|||+.++++.|+.+...+
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999886554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=371.88 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=210.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 576 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 576 (783)
+....+|++.++||+|+||.||+|.+..+..||+|++...... ..+|+.+++.++|||||++++++...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 3445789999999999999999999987778999988654322 236999999999999999999985443
Q ss_pred --ceEEEEEecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEEEec
Q 003963 577 --RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDF 650 (783)
Q Consensus 577 --~~~lV~E~~~ggsL~~~L~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DF 650 (783)
.+++|||||++ +|...+. .....+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+||
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 38899999976 4544432 23456899999999999999999999998 99999999999999 7899999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----- 724 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----- 724 (783)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+......
T Consensus 187 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 187 GSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998654432 23355789999999998775 4899999999999999999999999988776555443221000
Q ss_pred ----------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 725 ----------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 725 ----------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
..++..+++++.+||.+||..||.+|||+.++ +.|+||+..+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~~ 331 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA------LCHPFFDELRTG 331 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH------HTSGGGSTTTSS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH------hcChhhhhhccc
Confidence 11334588999999999999999999999999 679999877654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=373.37 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=213.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe----CCceEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCceeeEeceeec
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----GSQDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 574 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 574 (783)
...++|++.++||+|+||.||+|.+. .++.||||++..... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 44579999999999999999999984 457899999865321 111223466799999999 69999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
...+++|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999764 36899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccc-cccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhcccccccC
Q 003963 655 LKHET-YLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLN----SMQVIGAVGFMNQRLEI 727 (783)
Q Consensus 655 ~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~--~~s~~sDIwSLG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~ 727 (783)
..... .......+||+.|+|||++.+. .++.++|||||||+||+|++|..||.... .......+ ......+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCC
Confidence 65332 2223345789999999999863 46899999999999999999999996432 22222222 2345567
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
+..++..+.+||.+||..||.+|| ++.++ ++|+||+..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el------l~h~~f~~~ 328 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI------KEHLFFQKI 328 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH------HTSGGGTTC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH------HcCcchhcC
Confidence 788999999999999999999999 99999 678898754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.42 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=201.1
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..|....++|++.+.||+|+||.||+|.+. .++.||||++............+.++..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 456677899999999999999999999986 4578999999876654444555666667788899999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+++||||+ ++.+..++......+++..++.++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 6677777665566799999999999999999999985 8 99999999999999999999999999876
Q ss_pred cccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcc-cccccCC
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFM-NQRLEIP 728 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~-~~~~~~~i~~~-~~~~~~~ 728 (783)
..... ......|++.|+|||++. +..++.++|||||||++|+|++|..||.... .......+... ....+..
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 54432 223456899999999984 5567899999999999999999999998743 33333333211 1122223
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 729 ~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
..+++++.+||.+||..||.+||++.++ ++|+||+..
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~ 290 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKL------LEHSFIKRY 290 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHH------TTSHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHH------hhCHHHHhc
Confidence 4689999999999999999999999999 567777654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=371.66 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=208.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec------
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------ 574 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 574 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++...... ..+|+.+++.++|||||++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 445789999999999999999999854 578999998765322 2369999999999999999999843
Q ss_pred --------------------------------CCceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHH
Q 003963 575 --------------------------------PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 619 (783)
Q Consensus 575 --------------------------------~~~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~ 619 (783)
...+++||||++ ++|.+.+.. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999997 588777753 35569999999999999999999
Q ss_pred HHhCCCCEEecCCCCCCEEEc-CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHH
Q 003963 620 LHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILW 697 (783)
Q Consensus 620 LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~ 697 (783)
||++| |+||||||+||||+ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 157 LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99998 99999999999997 68899999999998654432 233557899999999988754 899999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHhhcccc---------------------------cccCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 698 ELATEKIPWDNLNSMQVIGAVGFMNQ---------------------------RLEIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 698 elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
+|++|++||...+....+..+..... ...++..+++++.+||.+||..||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999998877665544422111 111455688999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhcCc
Q 003963 751 PSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 751 Psa~ell~~L~~L~~~~f~~~~ 772 (783)
||+.++ |+|+||+..+
T Consensus 314 ~t~~e~------l~hp~f~~~~ 329 (383)
T 3eb0_A 314 INPYEA------MAHPFFDHLR 329 (383)
T ss_dssp CCHHHH------HTSGGGHHHH
T ss_pred CCHHHH------hcCHHHHHHH
Confidence 999999 6788887654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=375.88 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=207.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------C
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 576 (783)
..+|++.++||+|+||.||+|.+.. ++.||||++..... .+.+|+.+|+.++|||||+++++|... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4579999999999999999999864 57899999876432 223699999999999999999988432 2
Q ss_pred ceEEEEEecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-CcEEEEecCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGL 652 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-~~vkL~DFGl 652 (783)
++++||||+++ +|.+++. .....+++..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 47899999975 7776664 23566999999999999999999999998 9999999999999955 6789999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc---------
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN--------- 722 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------- 722 (783)
++...... .....+||+.|+|||++.+. .++.++|||||||+||||++|++||...+....+..+....
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654332 23356789999999999775 68999999999999999999999999887665444332110
Q ss_pred ------cccc------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 723 ------QRLE------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 723 ------~~~~------------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
.... ++..+++++.+||.+||..||.+||++.++ +.|+||+..+..
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~~ 346 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA------CAHSFFDELRDP 346 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGGGGGCT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH------hCCHhhcccccc
Confidence 0011 234578999999999999999999999999 679999876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.75 Aligned_cols=261 Identities=24% Similarity=0.436 Sum_probs=217.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCceeeEeceee--cCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~ 577 (783)
..++|++.+.||+|+||.||++.+.. ++.||+|++...... ......+.+|+.+++.++||||+++++++. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 35789999999999999999999854 468999999764321 234567899999999999999999999984 4568
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.|+||||++++ |.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 99999999775 7777754 3456899999999999999999999998 999999999999999999999999999765
Q ss_pred ccc--cccccCCCCCCcccCcccccCCCC--CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 657 HET--YLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 657 ~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~--s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
... ........||+.|+|||++.+... +.++|||||||++|+|++|..||...+.......+. .....++..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~ 237 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCG 237 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccC
Confidence 432 122335568999999999987544 789999999999999999999999888777666653 23456778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
+.+.+||.+||..||.+||++.++ ++|+||+.....
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~l------l~~~~~~~~~~~ 273 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQI------RQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHH------HHSHHHHSCCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHH------hcCcccccCCCC
Confidence 999999999999999999999999 678999776543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.98 Aligned_cols=257 Identities=21% Similarity=0.245 Sum_probs=202.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCCHH---------HHHHHHHHHHHHHhCCCCceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYSDE---------VIHSFRQEVSLMKRLRHPNVLL 567 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~ 567 (783)
++..++|++.++||+|+||.||+|.+.. ...||||++........ ....+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 4556799999999999999999999863 46799999876542110 1123567888999999999999
Q ss_pred Eeceeec----CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC
Q 003963 568 FMGAVTS----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 568 l~~~~~~----~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~ 643 (783)
+++++.. ...+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 9999887 67899999999 999999997654 7999999999999999999999998 99999999999998877
Q ss_pred --cEEEEecCCCcccccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--ChH
Q 003963 644 --TVKVGDFGLSRLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL--NSM 712 (783)
Q Consensus 644 --~vkL~DFGla~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~--~~~ 712 (783)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... +..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999976543211 113457999999999999999999999999999999999999999542 222
Q ss_pred HHHHHhhcccccccCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 713 QVIGAVGFMNQRLEIP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~~---------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
....... .....++ ..+++++.+||..||..||.+||++.+|++.|+.+
T Consensus 269 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 269 AVQTAKT--NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHH--HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHH--hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 2211111 1111112 27899999999999999999999999999887654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=365.41 Aligned_cols=255 Identities=26% Similarity=0.336 Sum_probs=205.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC-----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 576 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 45799999999999999999999864 567999999876666667778899999999999999999999997655
Q ss_pred -ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 577 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 577 -~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
.+|+|||||+ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 6899999996 488888853 4889999999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------- 724 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 724 (783)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 54432 223457899999999999999999999999999999999999999988776655443221110
Q ss_pred ---------cc--------------CCC------CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 725 ---------LE--------------IPK------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 725 ---------~~--------------~~~------~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.. .+. ..++++.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~------l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA------LQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH------HHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH------hCCcchhh
Confidence 00 010 015679999999999999999999999 67899964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=370.62 Aligned_cols=256 Identities=26% Similarity=0.348 Sum_probs=199.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC------C
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 576 (783)
.++|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4799999999999999999999754 56799999977655666677889999999999999999999998654 5
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899999875 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------- 724 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 724 (783)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 234578999999999987 67899999999999999999999999988776555443211100
Q ss_pred ----------c--------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 725 ----------L--------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 725 ----------~--------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
. .....+++.+.+||.+||..||.+|||+.++ |.|+||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~------L~hp~~~~~~~ 320 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA------LAHAYFAQYHD 320 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTTCC
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH------hcChhhhhccC
Confidence 0 1123568899999999999999999999999 68999976543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=352.62 Aligned_cols=260 Identities=24% Similarity=0.402 Sum_probs=221.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC---C----HHHHHHHHHHHHHHHhCC-CCceeeEeceee
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY---S----DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT 573 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~---~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 573 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++..... . ......+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45789999999999999999999865 57799999976531 1 234567889999999996 999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
.....++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999764 46899999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLR------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 727 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 727 (783)
....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+.........
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 7654332 233557899999999985 456789999999999999999999999988877666555433322222
Q ss_pred C--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 728 P--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 728 ~--~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+ ..++..+.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~~ 291 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA------LAHPFFQQYV 291 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH------TTSGGGCTTC
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHH------HhChHhhhcc
Confidence 2 4688999999999999999999999999 6799997654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=355.31 Aligned_cols=264 Identities=24% Similarity=0.384 Sum_probs=217.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCceeeEeceeecCCc
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQR 577 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~ 577 (783)
..+..++|++.+.||+|+||.||++.+..++.||||++............+.+|+.+++.++ ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34566789999999999999999999877788999999887777777788999999999997 5999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||++....
T Consensus 103 ~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEECC-CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEec-CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999995 478999999864 46899999999999999999999998 999999999999965 799999999997654
Q ss_pred cccc--cccCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccc
Q 003963 658 ETYL--TTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQ 723 (783)
Q Consensus 658 ~~~~--~~~~~~Gt~~Y~aPE~~~~-----------~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~ 723 (783)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 3321 2234568999999999876 4678899999999999999999999976543 333333333344
Q ss_pred cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 724 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 724 ~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
...++..++.++.+||.+||..||.+||++.++ ++|+||+.....
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el------l~h~~~~~~~~~ 302 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL------LAHPYVQIQTHP 302 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHCC---
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHH------hcCccccCCCCc
Confidence 556777889999999999999999999999999 678999765443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.03 Aligned_cols=262 Identities=20% Similarity=0.281 Sum_probs=211.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccC---------CHHHHHHHHHHHHHHHhCCCCceeeEece
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY---------SDEVIHSFRQEVSLMKRLRHPNVLLFMGA 571 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 571 (783)
....++|++.+.||+|+||.||+|.+..++.||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 455789999999999999999999988788999999865432 23445788999999999999999999999
Q ss_pred eec-----CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEE
Q 003963 572 VTS-----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 646 (783)
Q Consensus 572 ~~~-----~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vk 646 (783)
+.. ...+|+||||++ ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEE
Confidence 843 346899999996 6999998876677999999999999999999999998 99999999999999999999
Q ss_pred EEecCCCcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--
Q 003963 647 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-- 723 (783)
Q Consensus 647 L~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-- 723 (783)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999997544332 2234578999999999887 6789999999999999999999999998876655544321110
Q ss_pred ----------------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 724 ----------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 724 ----------------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
....+..+++.+.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~ 324 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA------LRHPYFESLF 324 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGTTTC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH------HcCchhhhcc
Confidence 011234568899999999999999999999999 7899998763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=365.77 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=213.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce---
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL--- 578 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--- 578 (783)
..++|.+.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34799999999999999999999865 57799999987766677778899999999999999999999999877654
Q ss_pred ---EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 579 ---CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 579 ---~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
|+||||+. ++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 588888743 4899999999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 723 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 723 (783)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5432 234578999999999987 6789999999999999999999999998876655544321110
Q ss_pred ------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 724 ------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 724 ------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
....+..+++.+.+||.+||+.||.+|||+.++ |+|+||+..+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~ 331 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA------LTHPFFEPFR 331 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH------HTSGGGTTTC
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH------hcCcccccCC
Confidence 011234578999999999999999999999999 7899997654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=367.21 Aligned_cols=259 Identities=22% Similarity=0.388 Sum_probs=219.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCH---------------HHHHHHHHHHHHHHhCCCCce
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD---------------EVIHSFRQEVSLMKRLRHPNV 565 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnI 565 (783)
....++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++.++||||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 34568999999999999999999998 77899999987543221 112678899999999999999
Q ss_pred eeEeceeecCCceEEEEEecCCCCHHHH------Hhhc-CCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCE
Q 003963 566 LLFMGAVTSPQRLCIVTEFLPRGSLFRL------LQRN-TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNL 637 (783)
Q Consensus 566 v~l~~~~~~~~~~~lV~E~~~ggsL~~~------L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NI 637 (783)
+++++++...+.+++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ ++ |+|+||||+||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 9999999999999999999999999998 5442 4568999999999999999999999 88 99999999999
Q ss_pred EEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCh-HHH
Q 003963 638 LVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDE-KSDVYSFGVILWELATEKIPWDNLNS-MQV 714 (783)
Q Consensus 638 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~-~sDIwSLG~il~elltG~~Pf~~~~~-~~~ 714 (783)
|++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||..... ...
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999999765443 33455789999999999887 5655 99999999999999999999987766 555
Q ss_pred HHHhhcccccccCC-------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 715 IGAVGFMNQRLEIP-------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 715 ~~~i~~~~~~~~~~-------------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
...+... ...++ ..+++++.+||.+||..||.+||++.++ ++|+||+...
T Consensus 262 ~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~------l~hp~f~~~~ 330 (348)
T 2pml_X 262 FNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA------LKHEWLADTN 330 (348)
T ss_dssp HHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH------HTSGGGTTCC
T ss_pred HHHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH------hcCccccCCC
Confidence 5554322 22333 5689999999999999999999999999 6789997654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.63 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=220.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
...++|++.++||+|+||.||+|.+. .++.||||++............+.+|+.+++.++||||+++++++...+.+++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34579999999999999999999986 45789999997765444445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC---CcEEEEecCCCcccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKH 657 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~---~~vkL~DFGla~~~~ 657 (783)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||||+.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999988754 35899999999999999999999998 9999999999999754 479999999987654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccC--CCCCCHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRW 735 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l 735 (783)
... ......|++.|+|||++.+. ++.++|||||||++|+|++|..||...+.......+......... ...+++++
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred CCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 332 12233478899999998765 889999999999999999999999988877766665433322222 25789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.+||.+||..||.+|||+.++ +.|+||+...+
T Consensus 254 ~~li~~~l~~dp~~Rps~~el------l~hp~~~~~~~ 285 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQC------LEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH------HHSHHHHHHCC
T ss_pred HHHHHHHcccChhhCcCHHHH------hcCHHHhcccc
Confidence 999999999999999999999 67899986543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.79 Aligned_cols=264 Identities=30% Similarity=0.463 Sum_probs=202.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHH--HHhCCCCceeeEeceee-----
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSL--MKRLRHPNVLLFMGAVT----- 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~----- 573 (783)
.+..++|++.++||+|+||.||+|.+ .++.||||++..... ..+..|.++ +..++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 45568999999999999999999976 567899999975431 233344444 44589999999997543
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC---------CCCEEecCCCCCCEEEcCCCc
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC---------NPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~IvHrDIKp~NILl~~~~~ 644 (783)
....+++|||||++|+|.+++.... .++..++.++.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 2335789999999999999997644 58888999999999999999998 7 999999999999999999
Q ss_pred EEEEecCCCccccccc--------ccccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 003963 645 VKVGDFGLSRLKHETY--------LTTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELATEKIPWDNL 709 (783)
Q Consensus 645 vkL~DFGla~~~~~~~--------~~~~~~~Gt~~Y~aPE~~~~-------~~~s~~sDIwSLG~il~elltG~~Pf~~~ 709 (783)
+||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997654321 12224569999999999987 34567899999999999999997765321
Q ss_pred Ch------------------HHHHHHhhcccccccCCCC------CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 710 NS------------------MQVIGAVGFMNQRLEIPKD------VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 710 ~~------------------~~~~~~i~~~~~~~~~~~~------~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.. ......+........++.. +++.+.+||.+||..||.+|||+.++++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 1111112222233344443 34589999999999999999999999999999999
Q ss_pred HHhhcCcCC
Q 003963 766 QYFQASRST 774 (783)
Q Consensus 766 ~~f~~~~~~ 774 (783)
.|-++....
T Consensus 319 ~~~~~~~~~ 327 (336)
T 3g2f_A 319 IWERNKSVS 327 (336)
T ss_dssp CCCC-----
T ss_pred HHHhcccCC
Confidence 988665543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.51 Aligned_cols=261 Identities=26% Similarity=0.348 Sum_probs=214.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe--CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC---CCCceeeEeceee-----
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT----- 573 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 573 (783)
.++|++.+.||+|+||.||+|.+. .++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999984 456799999876543322223455677777666 8999999999987
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567899999997 59999997643 34899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN---------- 722 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------- 722 (783)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 97655332 2335678999999999999999999999999999999999999999887766554432110
Q ss_pred ---------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 723 ---------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 723 ---------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
....++..++..+.+||.+||..||.+||++.++ +.|+||+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~~~~~ 306 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQDLERC 306 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGTTCCCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH------hcCccccccchh
Confidence 0112345688999999999999999999999999 679999766543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=349.94 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=212.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee-ecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+. .++.||||++....... .+.+|+.+++.++|++++..+.++ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 3478999999999999999999984 45789999987655432 477899999999988766655554 56677899
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCcccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~ 657 (783)
||||+ +++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 88999999866677999999999999999999999998 9999999999999 488899999999998655
Q ss_pred cccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc---cccc
Q 003963 658 ETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGF---MNQR 724 (783)
Q Consensus 658 ~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~~~i~~---~~~~ 724 (783)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 4322 123557999999999999999999999999999999999999999764321 12222211 1111
Q ss_pred ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 725 ~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
..++..+++++.+||.+||+.||.+||++.++++.|+++....
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 2234678999999999999999999999999999998886664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=349.81 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=208.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee-ecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV 581 (783)
.++|++.+.||+|+||.||+|.+. .++.||||++...... ..+.+|+.+++.++|++++..+.++ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 478999999999999999999984 4567999987654432 3467899999999988777666554 667788999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 658 (783)
|||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 88999999876677999999999999999999999999 9999999999999 7889999999999986544
Q ss_pred ccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc---ccccc
Q 003963 659 TYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGF---MNQRL 725 (783)
Q Consensus 659 ~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~~~i~~---~~~~~ 725 (783)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .....+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 321 223557899999999999999999999999999999999999999765432 11111111 11112
Q ss_pred cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 726 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 726 ~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.....+++++.+||..||..||.+||++.++++.|+++....
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 233678999999999999999999999999999999887764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.09 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=205.0
Q ss_pred ccceeEe-eeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 504 WEDLTIG-EQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 504 ~~~y~i~-~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
.+.|++. +.||+|+||.||+|.+. .++.||||++...... ....+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3578885 78999999999999975 4578999999765432 235788899999985 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc---EEEEecCCCcccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKH 657 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGla~~~~ 657 (783)
||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999764 45899999999999999999999998 999999999999988765 9999999987543
Q ss_pred ccc-------ccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--------------
Q 003963 658 ETY-------LTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNS-------------- 711 (783)
Q Consensus 658 ~~~-------~~~~~~~Gt~~Y~aPE~~~~-----~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-------------- 711 (783)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 11224468999999999875 4578899999999999999999999976542
Q ss_pred -HHHHHHhhcccccccCC----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 712 -MQVIGAVGFMNQRLEIP----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 712 -~~~~~~i~~~~~~~~~~----~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
......+.. ....++ ..+++.+.+||.+||..||.+|||+.++ ++|+||+.....
T Consensus 246 ~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~------l~hp~~~~~~~~ 305 (316)
T 2ac3_A 246 QNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV------LQHPWVQGCAPE 305 (316)
T ss_dssp HHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSTTCC-----
T ss_pred HHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH------hcChhhcCCCCc
Confidence 122223321 222333 4688999999999999999999999999 789999876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=369.81 Aligned_cols=261 Identities=30% Similarity=0.475 Sum_probs=209.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..+...++|++.+.||+|+||.||+|.+..++.||||++....... ....+.+|+.+++.++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 3456678999999999999999999987777889999987654221 123578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHHHHhC---CCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 579 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHC---NPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCcc
Confidence 99999999999999997543 3489999999999999999999998 8 99999999999999999999999999
Q ss_pred Cccccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccc--
Q 003963 653 SRLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-----NSMQVIGAVGFMNQR-- 724 (783)
Q Consensus 653 a~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~~-- 724 (783)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 98654332 2233456999999999999888999999999999999999999999521 111111111100000
Q ss_pred ----------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 725 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 725 ----------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
...+...+..+.+||.+||+.||.+|||+.+++++|+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11112234679999999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=378.03 Aligned_cols=250 Identities=15% Similarity=0.177 Sum_probs=199.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHH---HHHhCCCCceeeEe-------ce
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVS---LMKRLRHPNVLLFM-------GA 571 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 571 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+. +++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4789999999999999999999754 67899999986532 3345678889994 55555799999998 55
Q ss_pred eecCC-----------------ceEEEEEecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 003963 572 VTSPQ-----------------RLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPII 628 (783)
Q Consensus 572 ~~~~~-----------------~~~lV~E~~~ggsL~~~L~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~Iv 628 (783)
+...+ ..|+||||+ +|+|.+++.... ..+++..++.++.||+.||+|||+++ |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 54443 378999999 679999997532 23446888889999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCC-----------CCCchhHHHHHHHHHH
Q 003963 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-----------PSDEKSDVYSFGVILW 697 (783)
Q Consensus 629 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~s~~sDIwSLG~il~ 697 (783)
||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||+||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999999999999999985433 2335567 999999999887 8999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 698 ELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 698 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+|++|+.||......... ......+..+++++.+||.+||..||.+||++.++ ++|+||+..+
T Consensus 305 elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~------l~hp~f~~~~ 367 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA------METPEYEQLR 367 (377)
T ss_dssp HHHHSSCCC------CCS------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHH------HTSHHHHHHH
T ss_pred HHHHCCCCCcccccccch------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHH------hhChHHHHHH
Confidence 999999999765433221 12223446789999999999999999999999999 5677876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=356.45 Aligned_cols=258 Identities=19% Similarity=0.258 Sum_probs=209.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 45799999999999999999999864 56799999876543 34556788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999764 45899999999999999999999998 9999999999999999999999999987654432
Q ss_pred -ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHHHH
Q 003963 661 -LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAI 738 (783)
Q Consensus 661 -~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~L 738 (783)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..+++.+.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 12234568999999999999999999999999999999999999998876554433332222 2234567899999999
Q ss_pred HHHhhhhCCCCCC-CHHHHHHHHHHH
Q 003963 739 VESCWHSDPQCRP-SFQELVDKLRDL 763 (783)
Q Consensus 739 I~~cL~~dP~~RP-sa~ell~~L~~L 763 (783)
|.+||..||.+|| ++.++++.|+.+
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 9999999999999 999998887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.53 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=213.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----Cc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 577 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3689999999999999999999864 4679999987533 445567889999999999999999999998654 46
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+||||+. ++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999996 5999999754 4899999999999999999999998 9999999999999999999999999998655
Q ss_pred ccccc---ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------
Q 003963 658 ETYLT---TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------- 724 (783)
Q Consensus 658 ~~~~~---~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 724 (783)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 43221 234579999999998754 55899999999999999999999999887765544443211000
Q ss_pred --------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 725 --------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 725 --------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
..+...+++++.+||.+||..||.+|||+.++ |+|+||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~~~~~ 320 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA------LAHPYLEQY 320 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGTTT
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCcchhhc
Confidence 11224678999999999999999999999999 689999765
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.77 Aligned_cols=266 Identities=31% Similarity=0.557 Sum_probs=219.4
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 497 ~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...+++..++|++.+.||+|+||.||+|.+.. .||+|++..........+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 35667788999999999999999999998754 6999998765443333455778999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||++...
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999876667999999999999999999999998 99999999999998 679999999998754
Q ss_pred ccc-----cccccCCCCCCcccCcccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 003963 657 HET-----YLTTKTGKGTPQWMAPEVLRN---------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 722 (783)
Q Consensus 657 ~~~-----~~~~~~~~Gt~~Y~aPE~~~~---------~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~ 722 (783)
... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 112223458999999999875 447889999999999999999999999888877766654433
Q ss_pred ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 723 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 723 ~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.....+..++.++.+||.+||..||.+|||+.++++.|+++....
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 333334468899999999999999999999999999999887654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=374.00 Aligned_cols=257 Identities=12% Similarity=0.080 Sum_probs=193.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCC-HHHHHHHHHHHHHHHhC--CCCceeeEec-------ee
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL--RHPNVLLFMG-------AV 572 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l--~HpnIv~l~~-------~~ 572 (783)
..+|++.++||+|+||.||+|.+. .++.||||++...... ......+.+|+.+++.| +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346999999999999999999986 4578999999887653 34556777885555555 6999888653 33
Q ss_pred ecC-----------------CceEEEEEecCCCCHHHHHhhcCCcchHHHH------HHHHHHHHHHHHHHHhCCCCEEe
Q 003963 573 TSP-----------------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------ILMALDIARGVSYLHHCNPPIIH 629 (783)
Q Consensus 573 ~~~-----------------~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~IvH 629 (783)
... ..+|+|||||+ ++|.+++......+....+ +.++.||+.||+|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 322 23799999998 7999999865444555555 677799999999999999 999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 630 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
|||||+||||+.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543321 3356799999999987 678999999999999999999999997
Q ss_pred CCChHHHH--HH---hhcc--cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 708 NLNSMQVI--GA---VGFM--NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 708 ~~~~~~~~--~~---i~~~--~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
........ .. .... ......+..+++.+.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~~ 360 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA------METPEFLQLQ 360 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH------TTSHHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCHHHHHHH
Confidence 66432110 00 0001 11222335789999999999999999999999999 6788887543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.81 Aligned_cols=262 Identities=30% Similarity=0.496 Sum_probs=218.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE-----eCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVW-----YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
...++|+++++||+|+||.||++.+ ..++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 3457899999999999999999984 24567999998764 3345678899999999999999999999887654
Q ss_pred --ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 577 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 577 --~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 789999999999999999887677999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH------------H---HHH
Q 003963 655 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM------------Q---VIG 716 (783)
Q Consensus 655 ~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~------------~---~~~ 716 (783)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... . .+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 6544321 122345778899999999988999999999999999999999998642110 0 000
Q ss_pred HhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 717 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 717 ~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
...........+..+++++.+||.+||..||.+||++.++++.|+.++..+
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111122345567889999999999999999999999999999999998775
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=358.25 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=215.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe--CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCC------ceeeEecee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP------NVLLFMGAV 572 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~ 572 (783)
+...++|++.+.||+|+||.||+|.+. .++.||||++... ......+.+|+.+++.++|+ +|+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 455689999999999999999999973 4577999998643 34556788999999988655 599999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC----------
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---------- 641 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---------- 641 (783)
...+.+|+||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999999 889999997644 36889999999999999999999998 999999999999987
Q ss_pred ---------CCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003963 642 ---------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712 (783)
Q Consensus 642 ---------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~ 712 (783)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764432 23557899999999999999999999999999999999999999887766
Q ss_pred HHHHHhhccccc------------------------------------------ccCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 713 QVIGAVGFMNQR------------------------------------------LEIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 713 ~~~~~i~~~~~~------------------------------------------~~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
.....+...... ...+...++++.+||.+||..||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 544333211110 01112235779999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhcCcC
Q 003963 751 PSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 751 Psa~ell~~L~~L~~~~f~~~~~ 773 (783)
||+.++ ++|+||+..+.
T Consensus 321 pt~~el------l~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREA------LKHPFFDLLKK 337 (339)
T ss_dssp CCHHHH------TTSGGGGGGGC
T ss_pred cCHHHH------hcCHHHHHHhc
Confidence 999999 78999998765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=360.39 Aligned_cols=267 Identities=29% Similarity=0.496 Sum_probs=197.3
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
..+.+..++|++.+.||+|+||.||+|.+. .++.||||++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 345667789999999999999999999875 457899999865432 233467888999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhh-------cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 577 RLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEe
Confidence 99999999999999999864 2445899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccccc-----ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-
Q 003963 650 FGLSRLKHETY-----LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN- 722 (783)
Q Consensus 650 FGla~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~- 722 (783)
||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99886544321 11234568999999999876 568999999999999999999999998877655443321111
Q ss_pred -------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 723 -------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 723 -------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
........+++++.+||.+||..||.+||++.++ ++|+||+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~~~ 296 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL------LRHKFFQKAKN 296 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH------HTSTTC-----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHH------hhChhhhcCCC
Confidence 1122345688999999999999999999999999 67899976543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=356.22 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=198.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceee---
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT--- 573 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--- 573 (783)
..++...+|++.++||+|+||.||+|.+.. ++.||||++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 345556799999999999999999999864 578999998654 3445567889999999996 999999999983
Q ss_pred -----cCCceEEEEEecCCCCHHHHHhh--cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEE
Q 003963 574 -----SPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 646 (783)
Q Consensus 574 -----~~~~~~lV~E~~~ggsL~~~L~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vk 646 (783)
....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++.+|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3445899999995 699998864 34569999999999999999999999766699999999999999999999
Q ss_pred EEecCCCccccccccc------------ccCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 003963 647 VGDFGLSRLKHETYLT------------TKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 711 (783)
Q Consensus 647 L~DFGla~~~~~~~~~------------~~~~~Gt~~Y~aPE~~---~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~ 711 (783)
|+|||++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999765432211 1134589999999998 566788999999999999999999999976554
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
...... ......+..++..+.+||.+||+.||.+||++.++++.|+.+....
T Consensus 259 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 LRIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhhcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 433221 2233445667888999999999999999999999999999887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=388.69 Aligned_cols=259 Identities=26% Similarity=0.484 Sum_probs=218.6
Q ss_pred ccceeEe-eeeccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 504 WEDLTIG-EQIGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 504 ~~~y~i~-~~LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.+.+.+. ++||+|+||.||+|.+.. ++.||||+++.........+.+.+|+.+|+.++|||||++++++.. +.++
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 3445553 489999999999997643 3579999998766555556789999999999999999999999974 5689
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 446 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 999999999999999764 46899999999999999999999998 999999999999999999999999999765432
Q ss_pred c---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHH
Q 003963 660 Y---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 660 ~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 735 (783)
. .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+..+....+. .......+..+++++
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 601 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREM 601 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 2 12223456789999999999999999999999999999998 999999998887776654 334567788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
.+||..||..||.+||++.+|++.|+++...+
T Consensus 602 ~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 602 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998776554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=357.69 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=213.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----C
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 576 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 45799999999999999999999864 5679999986433 345566788999999999999999999987654 6
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
..|+||||+. ++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999996 5999998763 5899999999999999999999998 999999999999999999999999999865
Q ss_pred cccccc----------ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-
Q 003963 657 HETYLT----------TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR- 724 (783)
Q Consensus 657 ~~~~~~----------~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~- 724 (783)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432111 123478999999998765 67899999999999999999999999887765544332111000
Q ss_pred -----------------------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 725 -----------------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 725 -----------------------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
...+..+++++.+||.+||..||.+|||+.++ ++|+||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~~ 315 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA------LEHPYLQTYHDP 315 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTTCCT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH------hcCccccccCCc
Confidence 01124688999999999999999999999999 679999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=375.01 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=203.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
...++|.+.++||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+|+.++|||||++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346789999999999999999999865 478999999865421 1223357889999999999999999999864
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC---cEEEEecC
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFG 651 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~---~vkL~DFG 651 (783)
..+|+|||||++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 4589999999999999998754 46999999999999999999999998 99999999999997544 59999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccc--ccc
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMN--QRL 725 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~~--~~~ 725 (783)
+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ....+.... ...
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 998765432 2335679999999999864 567889999999999999999999997654322 222221111 112
Q ss_pred cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 726 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 726 ~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
..+..+++.+.+||.+||+.||.+||++.++ |+|+||+.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~------l~hp~~~~ 405 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEA------LRHPWLQD 405 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGCC
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHH------hCCcccCC
Confidence 2335689999999999999999999999999 67899965
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=355.78 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=204.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhC--CCCceeeEeceeecC---
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSP--- 575 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~--- 575 (783)
....++|++.++||+|+||.||+|.+. ++.||||++.... ...+.+|.+++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 445679999999999999999999876 6789999986543 13344566666554 899999999998876
Q ss_pred -CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC--------CCCEEecCCCCCCEEEcCCCcEE
Q 003963 576 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC--------NPPIIHRDLKSSNLLVDKHWTVK 646 (783)
Q Consensus 576 -~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~IvHrDIKp~NILl~~~~~vk 646 (783)
..+|+||||+++++|.+++... .+++..++.++.|++.||.|||+. + |+||||||+||||+.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEE
Confidence 6789999999999999999754 589999999999999999999998 7 99999999999999999999
Q ss_pred EEecCCCccccccccc----ccCCCCCCcccCcccccCCCCCch------hHHHHHHHHHHHHHcC----------CCCC
Q 003963 647 VGDFGLSRLKHETYLT----TKTGKGTPQWMAPEVLRNEPSDEK------SDVYSFGVILWELATE----------KIPW 706 (783)
Q Consensus 647 L~DFGla~~~~~~~~~----~~~~~Gt~~Y~aPE~~~~~~~s~~------sDIwSLG~il~elltG----------~~Pf 706 (783)
|+|||++......... .....||+.|+|||++.+...... +|||||||++|+|++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999765433221 224579999999999988776554 9999999999999999 7777
Q ss_pred CCCCh-----HHHHHHhhcccccccCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 707 DNLNS-----MQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 707 ~~~~~-----~~~~~~i~~~~~~~~~~~-----~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
..... ......+........++. .+++++.+||.+||..||.+|||+.+++++|+++...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 65422 122222222222333332 4567899999999999999999999999999988653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.27 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=213.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 577 (783)
..++|.+.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 34789999999999999999999864 5789999998766666667889999999999999999999999987654
Q ss_pred --eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 578 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 578 --~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999996 588887743 4899999999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------
Q 003963 656 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------ 722 (783)
Q Consensus 656 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------ 722 (783)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+....
T Consensus 176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 5432 234578999999999887 678999999999999999999999998877655444332110
Q ss_pred -----------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 723 -----------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 723 -----------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.....+..+++++.+||.+||..||.+|||+.++ +.|+||+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~------l~hp~f~~~~~ 314 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA------LTHPFFEPFRD 314 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH------HTSGGGTTTCC
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH------hcCcchhhccC
Confidence 0112335678999999999999999999999999 68999976543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=354.28 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=209.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee----cC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT----SP 575 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~ 575 (783)
.+..++|++.+.||+|+||.||++.+. .++.||||++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 345678999999999999999999984 4578999998653 3455678899999999999999999999986 34
Q ss_pred CceEEEEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 652 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGl 652 (783)
...++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCc
Confidence 478999999999999999975 3566899999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccccc---------ccCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHh
Q 003963 653 SRLKHETYLT---------TKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAV 718 (783)
Q Consensus 653 a~~~~~~~~~---------~~~~~Gt~~Y~aPE~~~~~~---~s~~sDIwSLG~il~elltG~~Pf~~~~~--~~~~~~i 718 (783)
+......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 8754321110 11234799999999988665 58899999999999999999999953211 0111111
Q ss_pred hcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 719 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 719 ~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
. .....+.+..+++.+.+||.+||..||.+||++.++++.|+.++.
T Consensus 261 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 Q-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1 122334456789999999999999999999999999999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=361.16 Aligned_cols=256 Identities=15% Similarity=0.198 Sum_probs=210.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC---------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceee------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG---------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL------ 567 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~------ 567 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++... ..+.+|+.+++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 35799999999999999999999864 578999998764 25678999999999999998
Q ss_pred ---------Eeceeec-CCceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCC
Q 003963 568 ---------FMGAVTS-PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 636 (783)
Q Consensus 568 ---------l~~~~~~-~~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~N 636 (783)
+++++.. ...+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 4555554 67889999999 99999999864 356999999999999999999999998 9999999999
Q ss_pred EEEcCCC--cEEEEecCCCcccccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 637 LLVDKHW--TVKVGDFGLSRLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 637 ILl~~~~--~vkL~DFGla~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999976543321 1123478999999999999999999999999999999999999998
Q ss_pred CCC--hHHHHHHhhc-ccccccCC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 708 NLN--SMQVIGAVGF-MNQRLEIP------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 708 ~~~--~~~~~~~i~~-~~~~~~~~------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
... .......... ......++ ..+++++.+||.+||..||.+||++.++++.|+++....-
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 653 2222222211 11111111 2568999999999999999999999999999998877753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=347.17 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=211.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-------
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------- 574 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 574 (783)
...+|++.+.||+|+||.||+|.+. .++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4578999999999999999999986 46789999997653 246689999999999999999998854
Q ss_pred ---------CCceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc
Q 003963 575 ---------PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 644 (783)
Q Consensus 575 ---------~~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~ 644 (783)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCC
Confidence 34589999999999999999753 356899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc
Q 003963 645 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR 724 (783)
Q Consensus 645 vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~ 724 (783)
+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||... ......+ ..
T Consensus 161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----RD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----HT
T ss_pred EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----hc
Confidence 9999999987665432 223457899999999999999999999999999999999999887432 1222222 12
Q ss_pred ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003963 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768 (783)
Q Consensus 725 ~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f 768 (783)
..++..+++.+.+||.+||..||.+||++.++++.|..+++..-
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 34567789999999999999999999999999999987765433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.44 Aligned_cols=260 Identities=17% Similarity=0.204 Sum_probs=212.2
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEE------EeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC---CCceeeE
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV------WYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLF 568 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l 568 (783)
..+++..++|.+.++||+|+||.||+|. ...++.||||++.... ...+..|+.+++.++ |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3455667899999999999999999994 3445789999986543 245777888888887 8999999
Q ss_pred eceeecCCceEEEEEecCCCCHHHHHhh----cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---
Q 003963 569 MGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--- 641 (783)
Q Consensus 569 ~~~~~~~~~~~lV~E~~~ggsL~~~L~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~--- 641 (783)
++++...+..|+|||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999974 3456999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEEecCCCccccc--ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 003963 642 --------HWTVKVGDFGLSRLKHE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 711 (783)
Q Consensus 642 --------~~~vkL~DFGla~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~ 711 (783)
++.+||+|||+++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975432 22233456799999999999999999999999999999999999999954322
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHHHHhhc
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR-PSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~R-Psa~ell~~L~~L~~~~f~~ 770 (783)
.. ........ ....++.+.+++..||..+|.+| |++.++.+.|+++...-++.
T Consensus 291 ~~-----~~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~ 344 (365)
T 3e7e_A 291 GE-----CKPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344 (365)
T ss_dssp TE-----EEECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTT
T ss_pred Cc-----eeechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhh
Confidence 11 00011111 11246789999999999999998 58888888888877765543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=367.12 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=205.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC--------CCceeeEecee
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--------HPNVLLFMGAV 572 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~ 572 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++... ......+.+|+.+++.++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 445899999999999999999999865 567999998643 345567889999999985 78899999998
Q ss_pred e----cCCceEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCC---
Q 003963 573 T----SPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHW--- 643 (783)
Q Consensus 573 ~----~~~~~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~--- 643 (783)
. ....+|+||||+ +++|.+++.. ....+++..++.++.||+.||+|||++ | |+||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence 7 556799999999 5567666654 335699999999999999999999998 8 99999999999998775
Q ss_pred ----------------------------------------------cEEEEecCCCcccccccccccCCCCCCcccCccc
Q 003963 644 ----------------------------------------------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677 (783)
Q Consensus 644 ----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~ 677 (783)
.+||+|||++...... ....+||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999765543 234578999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------HHHHHHhhcccc----------------------------
Q 003963 678 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS------MQVIGAVGFMNQ---------------------------- 723 (783)
Q Consensus 678 ~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~------~~~~~~i~~~~~---------------------------- 723 (783)
+.+..++.++|||||||+||+|++|..||...+. ...+..+.....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999976542 111111110000
Q ss_pred ------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 724 ------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 724 ------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
....+...++.+.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC------LRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH------HTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH------hhCccccC
Confidence 001122334678999999999999999999999 78899963
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=351.45 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=207.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee-------
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT------- 573 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------- 573 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 345799999999999999999999875 578999998754 3455678899999999999999999998873
Q ss_pred -------cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcE
Q 003963 574 -------SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 645 (783)
Q Consensus 574 -------~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~v 645 (783)
....+|+||||++ ++|.+++.. .++++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999975 45889999999999999999999998 99999999999997 56799
Q ss_pred EEEecCCCcccccccc---cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q 003963 646 KVGDFGLSRLKHETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 646 kL~DFGla~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~ 721 (783)
||+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986543211 1223457899999998865 67899999999999999999999999988766554433211
Q ss_pred cc----------------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 722 NQ----------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 722 ~~----------------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.. ....+..+++++.+||.+||..||.+|||+.++ ++|+||+...-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~ 314 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA------LSHPYMSIYSF 314 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH------HTSHHHHTTCC
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH------hCCcccccccC
Confidence 10 011235689999999999999999999999999 78999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.04 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=204.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
..++|++.+.||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45789999999999999999999865 467999998765321 12334578999999999999999999998765
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc---EEEEecCC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGL 652 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFGl 652 (783)
. +|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 89999999999999998753 46899999999999999999999998 999999999999987654 99999999
Q ss_pred CcccccccccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcc--ccccc
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFM--NQRLE 726 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~--~~~~~ 726 (783)
+........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+... .....
T Consensus 164 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 164 SKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 986654321 22346899999999974 566889999999999999999999999765432 122222111 11122
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+..+++.+.+||.+||..||.+||++.++ ++|+||+
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~------l~h~~~~ 279 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEA------LRHPWLQ 279 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGC
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHH------hhCcCcC
Confidence 335689999999999999999999999999 4566663
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=383.01 Aligned_cols=264 Identities=33% Similarity=0.591 Sum_probs=225.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 573 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 573 (783)
..+++..++|++.+.||+|+||.||+|.+... ..||||++.... .....+.+.+|+.+++.++|||||++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 35567778999999999999999999998542 358999876533 4556678999999999999999999999985
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
++.+|+||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence 46789999999999999999877667999999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCC
Q 003963 654 RLKHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 654 ~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 731 (783)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+.. .....++..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCCccc
Confidence 86544321 2223457889999999999999999999999999999997 9999999888777666542 3355678889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
++.+.+||.+||..||.+||++.++++.|+++...
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=351.53 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=207.3
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
|..+++||+|+||.||+|.+ .++.||||++.... ......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 44558999999999999986 46789999987543 2234567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--
Q 003963 585 LPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 660 (783)
Q Consensus 585 ~~ggsL~~~L~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 660 (783)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9999999999643 345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH----HHHhhccc---------ccccC
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV----IGAVGFMN---------QRLEI 727 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~----~~~i~~~~---------~~~~~ 727 (783)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||........ ...+.... .....
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 122345789999999998764 78999999999999999999999976543221 11111000 01112
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~ 764 (783)
+..++..+.++|.+||..||.+||++.++++.|+++.
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2334567999999999999999999999999998874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.01 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=204.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 574 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 574 (783)
.++|++.+.||+|+||.||+|.+. .++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 368999999999999999999985 4578999998653 3456788899999999999999999998754
Q ss_pred -----CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 575 -----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 575 -----~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
...+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 35689999999999999999877777889999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccccc--------------ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHH
Q 003963 650 FGLSRLKHETY--------------LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNL-NSMQ 713 (783)
Q Consensus 650 FGla~~~~~~~--------------~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~-~~~~ 713 (783)
||++....... .......|++.|+|||++.+. .++.++|||||||++|+|++ ||... ....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987654221 122345689999999999865 68999999999999999998 55432 2223
Q ss_pred HHHHhhccc--ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 714 VIGAVGFMN--QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 714 ~~~~i~~~~--~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
....+.... ....++...++.+.+||.+||..||.+|||+.++ ++|+||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL------LNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH------HHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHH------hCCCCcCCC
Confidence 333332211 1233455677889999999999999999999999 678998653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=366.86 Aligned_cols=261 Identities=19% Similarity=0.352 Sum_probs=210.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC--ce
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 578 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 578 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++...... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 345789999999999999999999875 578999999764422 22456778999999999999999999998655 78
Q ss_pred EEEEEecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE----cCCCcEEEEecCC
Q 003963 579 CIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 652 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl----~~~~~vkL~DFGl 652 (783)
|+|||||++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999999975432 3899999999999999999999998 9999999999999 7788899999999
Q ss_pred CcccccccccccCCCCCCcccCcccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhc
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRN--------EPSDEKSDVYSFGVILWELATEKIPWDNLN----SMQVIGAVGF 720 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~~sDIwSLG~il~elltG~~Pf~~~~----~~~~~~~i~~ 720 (783)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98665432 2335579999999999875 456789999999999999999999996432 2223322211
Q ss_pred ccc-------------------ccc----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 721 MNQ-------------------RLE----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 721 ~~~-------------------~~~----~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
... ..+ ++..+++.+.+||.+||..||.+||++.++++.++++.+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 011 1123456789999999999999999999999999887654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.42 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=200.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc--
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-- 577 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 577 (783)
....++|++.++||+|+||.||+|.+.. ++.||||++....... ..+.+++..+..++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3456899999999999999999999864 5789999986643322 245567888889999999999999865433
Q ss_pred -----eEEEEEecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHHHH--hCCCCEEecCCCCCCEEEcC-CCcEE
Q 003963 578 -----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLH--HCNPPIIHRDLKSSNLLVDK-HWTVK 646 (783)
Q Consensus 578 -----~~lV~E~~~ggsL~~~L~---~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~IvHrDIKp~NILl~~-~~~vk 646 (783)
+++||||+++ +|...+. .....+++..++.++.||+.||.||| +++ |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 7899999976 6655543 23556889999999999999999999 877 999999999999996 89999
Q ss_pred EEecCCCcccccccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--
Q 003963 647 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-- 723 (783)
Q Consensus 647 L~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-- 723 (783)
|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 173 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp ECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 99999998665432 233557899999999987655 79999999999999999999999998877665544421100
Q ss_pred ----------------------------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 724 ----------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 724 ----------------------------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
....+..+++++.+||.+||+.||.+|||+.++ |+|+||+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~~~~ 324 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA------LCHPYFDELHDP 324 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH------TTSGGGGGGGCT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH------hcCccccccCCc
Confidence 011223367899999999999999999999999 789999887654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=369.25 Aligned_cols=257 Identities=20% Similarity=0.307 Sum_probs=213.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~l 580 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++....... .+.+|+.+++.|.| ++|+.+..++......||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 45789999999999999999999854 5789999987654332 46789999999987 566666667777888999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE---cCCCcEEEEecCCCcccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl---~~~~~vkL~DFGla~~~~ 657 (783)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||| +.++.+||+|||+++...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999 88999999876778999999999999999999999998 9999999999999 688999999999998655
Q ss_pred cccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhcc---ccc
Q 003963 658 ETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFM---NQR 724 (783)
Q Consensus 658 ~~~~-------~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~---~~~~~~i~~~---~~~ 724 (783)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||..... ...+..+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4321 22356799999999999999999999999999999999999999987544 2222222111 112
Q ss_pred ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 725 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 725 ~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
..++..+++++.+||..||..+|.+||++.+|++.|+.+...
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 233467899999999999999999999999999999888654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.67 Aligned_cols=256 Identities=32% Similarity=0.543 Sum_probs=209.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHh--CCCCceeeEeceeecCC--
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ-- 576 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~-- 576 (783)
....++|++.+.||+|+||.||++.+. ++.||||++.... ...+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 455689999999999999999999874 6789999986532 2466789999988 78999999999998776
Q ss_pred --ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHH--------hCCCCEEecCCCCCCEEEcCCCcEE
Q 003963 577 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVK 646 (783)
Q Consensus 577 --~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~IvHrDIKp~NILl~~~~~vk 646 (783)
.+++||||+++++|.+++... .+++..++.++.||+.||.||| +.+ |+||||||+||||+.++.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999764 5899999999999999999999 777 99999999999999999999
Q ss_pred EEecCCCcccccccc----cccCCCCCCcccCcccccCCCC------CchhHHHHHHHHHHHHHcC----------CCCC
Q 003963 647 VGDFGLSRLKHETYL----TTKTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELATE----------KIPW 706 (783)
Q Consensus 647 L~DFGla~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~~------s~~sDIwSLG~il~elltG----------~~Pf 706 (783)
|+|||++........ ......||+.|+|||++.+... +.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999999976544321 2234579999999999987632 3689999999999999999 7898
Q ss_pred CCCC-----hHHHHHHhhcccccccCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 707 DNLN-----SMQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 707 ~~~~-----~~~~~~~i~~~~~~~~~~~-----~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.... .......+........++. .+++.+.+||.+||..||.+|||+.+++++|+++..+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7653 2233333322222333332 2346799999999999999999999999999988764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.87 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=190.6
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHH-HHHhCCCCceeeEeceeecC
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~ 575 (783)
..+++..++|++.+.||+|+||.||+|.+. .++.||||++..... ......+..|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 455667789999999999999999999986 457899999976543 333345555655 77778999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhh----cCCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 576 QRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
+..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 88887753 245689999999999999999999998 8 999999999999999999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVL----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRL 725 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~ 725 (783)
|++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ....+. .....
T Consensus 171 g~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~ 248 (327)
T 3aln_A 171 GISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDPP 248 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCCC
T ss_pred CCceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCCC
Confidence 99976554322 2234689999999998 46668999999999999999999999998754321 111111 11111
Q ss_pred cC----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 726 EI----PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 726 ~~----~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+ ...+++.+.+||.+||..||.+||++.++ ++|+||+.
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el------l~hp~~~~ 291 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL------LKHPFILM 291 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH------TTSHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH------HhChHHHH
Confidence 22 24689999999999999999999999999 56777754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=358.75 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=210.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CC-----ceeeEeceee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HP-----NVLLFMGAVT 573 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~ 573 (783)
+...++|++.++||+|+||.||+|.+.. ++.||||++... ......+..|+.+++.+. |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4456899999999999999999999865 467999998643 344567788999988885 44 4999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc--CCCcEEEEec
Q 003963 574 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDF 650 (783)
Q Consensus 574 ~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~--~~~~vkL~DF 650 (783)
..+.+|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999995 59999997653 458999999999999999999995333499999999999995 4788999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----- 725 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----- 725 (783)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|++||...+....+..+......+
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999866432 235678999999999999999999999999999999999999999887766554432211000
Q ss_pred -----------cCCC------------------C----------------------------CCHHHHHHHHHhhhhCCC
Q 003963 726 -----------EIPK------------------D----------------------------VDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 726 -----------~~~~------------------~----------------------------~s~~l~~LI~~cL~~dP~ 748 (783)
.++. . .++++.+||.+||+.||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0000 0 014789999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 749 CRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 749 ~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+|||+.++ |+|+||+...
T Consensus 363 ~Rpta~e~------L~hp~f~~~~ 380 (382)
T 2vx3_A 363 TRIQPYYA------LQHSFFKKTA 380 (382)
T ss_dssp TSCCHHHH------TTSGGGCC--
T ss_pred hCCCHHHH------hcCcccccCC
Confidence 99999999 7899998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=365.57 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=191.4
Q ss_pred ccceeE-eeeeccCCcEEEEEEEEe---CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceee--cCCc
Q 003963 504 WEDLTI-GEQIGQGSCGTVYHAVWY---GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQR 577 (783)
Q Consensus 504 ~~~y~i-~~~LG~G~fG~Vy~a~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~ 577 (783)
.+.|++ +++||+|+||.||+|.+. .++.||||++....... .+.+|+.+|+.++|||||++++++. ....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 456776 568999999999999976 34679999997665443 5678999999999999999999994 4678
Q ss_pred eEEEEEecCCCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE----cCCCcE
Q 003963 578 LCIVTEFLPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTV 645 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl----~~~~~v 645 (783)
+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcE
Confidence 999999996 5888887532 124889999999999999999999999 9999999999999 677899
Q ss_pred EEEecCCCccccccc---ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH---------
Q 003963 646 KVGDFGLSRLKHETY---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM--------- 712 (783)
Q Consensus 646 kL~DFGla~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~--------- 712 (783)
||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||+||+|++|.+||......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998655321 223345789999999999874 4899999999999999999999999754431
Q ss_pred HHHHHhhcccccc------------------------------------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHH
Q 003963 713 QVIGAVGFMNQRL------------------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 756 (783)
Q Consensus 713 ~~~~~i~~~~~~~------------------------------------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~el 756 (783)
..+..+......+ ......++.+.+||.+||..||.+|||+.++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1111111000000 0111236789999999999999999999999
Q ss_pred HHHHHHHHHHHhhcCc
Q 003963 757 VDKLRDLQRQYFQASR 772 (783)
Q Consensus 757 l~~L~~L~~~~f~~~~ 772 (783)
|+|+||+...
T Consensus 332 ------L~hp~f~~~~ 341 (405)
T 3rgf_A 332 ------MQDPYFLEDP 341 (405)
T ss_dssp ------HTSGGGTSSS
T ss_pred ------hcChhhccCC
Confidence 7899997654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.24 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=211.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC--ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc------eeeEecee
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS--QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN------VLLFMGAV 572 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~ 572 (783)
+...++|++.+.||+|+||.||+|.+... +.||||++... ......+.+|+.+++.++|++ |+.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 44568999999999999999999998543 57999998643 344567888999999997655 89999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEE------------
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV------------ 639 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl------------ 639 (783)
...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 9999999999999 667777776543 56899999999999999999999998 9999999999999
Q ss_pred -------cCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003963 640 -------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 712 (783)
Q Consensus 640 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~ 712 (783)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999764432 23457899999999999999999999999999999999999999987766
Q ss_pred HHHHHhhcccccc------------------------------------------cCCCCCCHHHHHHHHHhhhhCCCCC
Q 003963 713 QVIGAVGFMNQRL------------------------------------------EIPKDVDPRWAAIVESCWHSDPQCR 750 (783)
Q Consensus 713 ~~~~~i~~~~~~~------------------------------------------~~~~~~s~~l~~LI~~cL~~dP~~R 750 (783)
.....+....... ......++++.+||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 5443332111100 0011124578999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhcCc
Q 003963 751 PSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 751 Psa~ell~~L~~L~~~~f~~~~ 772 (783)
||+.++ |+|+||+...
T Consensus 326 pt~~e~------l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITLAEA------LLHPFFAGLT 341 (355)
T ss_dssp CCHHHH------TTSGGGGGCC
T ss_pred cCHHHH------hcChhhcCCC
Confidence 999999 7899998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.30 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=203.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhC----CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRL----RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~ 569 (783)
..+...++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.++..+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 345566899999999999999999998754 5689999997654322 1223456799999998 899999999
Q ss_pred ceeecCCceEEEEEe-cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEE
Q 003963 570 GAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKV 647 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~-~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL 647 (783)
+++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 7889999999764 35899999999999999999999998 99999999999999 8899999
Q ss_pred EecCCCcccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc
Q 003963 648 GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 726 (783)
Q Consensus 648 ~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 726 (783)
+|||++....... .....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||..... . ......
T Consensus 182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~------~~~~~~ 251 (312)
T 2iwi_A 182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--I------LEAELH 251 (312)
T ss_dssp CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHTCCC
T ss_pred EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--H------hhhccC
Confidence 9999998665432 234568999999999887666 4589999999999999999999975321 1 123455
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCCCC
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 776 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~~~ 776 (783)
++..+++.+.+||.+||..||.+||++.++ ++|+||+.....+.
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~------l~~~~~~~~~~~~~ 295 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEI------LLDPWMQTPAEDVP 295 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HHSTTTCC------
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHH------hcChhhcCchhccc
Confidence 677899999999999999999999999999 68899987665543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.86 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=183.1
Q ss_pred cccceeEee-eeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec----CC
Q 003963 503 LWEDLTIGE-QIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQ 576 (783)
Q Consensus 503 ~~~~y~i~~-~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~ 576 (783)
..++|.+.+ .||+|+||.||+|.+.. ++.||||++.... . ...+....++.+.||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457899965 69999999999999874 5789999986532 1 12223344677899999999999876 45
Q ss_pred ceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecCC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGL 652 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFGl 652 (783)
.+++|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999997653 46999999999999999999999998 999999999999976 45599999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH----hhccc--cccc
Q 003963 653 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA----VGFMN--QRLE 726 (783)
Q Consensus 653 a~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~----i~~~~--~~~~ 726 (783)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +.... ....
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9765432 22345789999999999888899999999999999999999999976654432111 11111 1122
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
....+++++.+||.+||..||.+|||+.++ ++|+||+....
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~ 296 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQF------MNHPWINQSMV 296 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HHSHHHHTGGG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHH------hcCcccccccc
Confidence 235789999999999999999999999999 67999976543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.49 Aligned_cols=254 Identities=23% Similarity=0.415 Sum_probs=212.9
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCC--CCceeeEecee
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAV 572 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~ 572 (783)
.+...++|++.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34567899999999999999999999754 5679999997654321 11234567999999996 59999999999
Q ss_pred ecCCceEEEEEecCC-CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEEEec
Q 003963 573 TSPQRLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDF 650 (783)
Q Consensus 573 ~~~~~~~lV~E~~~g-gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DF 650 (783)
...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999976 8999999764 46899999999999999999999998 99999999999999 7889999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCC
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 729 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 729 (783)
|++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... . ......++.
T Consensus 195 g~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~------~~~~~~~~~ 264 (320)
T 3a99_A 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--I------IRGQVFFRQ 264 (320)
T ss_dssp TTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHCCCCCSS
T ss_pred cccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--h------hcccccccc
Confidence 9998665432 234568999999999887665 6889999999999999999999975321 1 122345667
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+++++.+||.+||..||.+||++.++ ++|+||+...
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~l------l~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEI------QNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHH------hcCHhhcCcc
Confidence 899999999999999999999999999 6789997654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=354.65 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=206.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-----------CCceeeEe
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFM 569 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~ 569 (783)
...++|++.++||+|+||.||+|.+.. ++.||||++... ......+.+|+.+++.+. ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 345789999999999999999999854 577999998643 334567788999999886 89999999
Q ss_pred ceeecCC----ceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhC-CCCEEecCCCCCCEEEc---
Q 003963 570 GAVTSPQ----RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVD--- 640 (783)
Q Consensus 570 ~~~~~~~----~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~IvHrDIKp~NILl~--- 640 (783)
+++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ + |+||||||+||||+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9987654 789999999 88999999763 34589999999999999999999997 8 99999999999994
Q ss_pred ---CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-----
Q 003963 641 ---KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM----- 712 (783)
Q Consensus 641 ---~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~----- 712 (783)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3448999999999765543 23457899999999999999999999999999999999999999765421
Q ss_pred -HHHHHhhc-c---------------------------------------cccccCCCCCCHHHHHHHHHhhhhCCCCCC
Q 003963 713 -QVIGAVGF-M---------------------------------------NQRLEIPKDVDPRWAAIVESCWHSDPQCRP 751 (783)
Q Consensus 713 -~~~~~i~~-~---------------------------------------~~~~~~~~~~s~~l~~LI~~cL~~dP~~RP 751 (783)
..+..+.. . .....++..+++++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111100 0 001123344567899999999999999999
Q ss_pred CHHHHHHHHHHHHHHHhhcCcC
Q 003963 752 SFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 752 sa~ell~~L~~L~~~~f~~~~~ 773 (783)
|+.++ |+|+||+....
T Consensus 327 t~~el------l~hp~f~~~~~ 342 (373)
T 1q8y_A 327 DAGGL------VNHPWLKDTLG 342 (373)
T ss_dssp CHHHH------HTCGGGTTCTT
T ss_pred CHHHH------hhChhhhcccC
Confidence 99999 78999987643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=363.36 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=198.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
+...+|.+.++||+|+||.||......++.||||++...... .+.+|+.+|+.+ +|||||++++++.....+|+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 344579999999999999977655566789999998654322 245799999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-----CCcEEEEecCCCcc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSRL 655 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-----~~~vkL~DFGla~~ 655 (783)
|||||. |+|.+++......+....++.++.||+.||.|||+++ |+||||||+||||+. ...+||+|||+++.
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999995 5999999876655666677889999999999999999 999999999999953 33688999999976
Q ss_pred ccccc---ccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc-ccC
Q 003963 656 KHETY---LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQR-LEI 727 (783)
Q Consensus 656 ~~~~~---~~~~~~~Gt~~Y~aPE~~~---~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-~~~ 727 (783)
..... ......+||+.|+|||++. ...++.++|||||||++|+|++ |..||...........+...... ...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence 54321 2233457999999999998 4567889999999999999999 99999766554443332211111 112
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 728 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 728 ~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
+...+..+.+||.+||+.||.+|||+.++ ++|+||+.
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~ev------l~hp~f~~ 289 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHV------LKHPFFWS 289 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHH------HTSTTTCC
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHH------HhCccccC
Confidence 23345678999999999999999999999 56677643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.05 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=191.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+.|.+.+.||+|+||+||.+....++.||||++.... ...+.+|+.+++.+ +|||||++++++.....+|+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4566778999999999988766677899999986543 24567899999876 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcc------hHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC-------------Cc
Q 003963 584 FLPRGSLFRLLQRNTTKL------DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-------------WT 644 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l------~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~-------------~~ 644 (783)
||+ |+|.+++....... .+..++.++.||+.||+|||+++ |+||||||+||||+.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 59999997643211 22345679999999999999998 9999999999999754 48
Q ss_pred EEEEecCCCcccccccc----cccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 003963 645 VKVGDFGLSRLKHETYL----TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 712 (783)
Q Consensus 645 vkL~DFGla~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~-------~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~ 712 (783)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999986654321 1224579999999999976 568999999999999999999 99999765443
Q ss_pred HHHHHhhcccccccC----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 713 QVIGAVGFMNQRLEI----PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 713 ~~~~~i~~~~~~~~~----~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
... .+......... +..+++++.+||.+||+.||.+|||+.++ ++|+||.
T Consensus 247 ~~~-i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei------l~hp~f~ 300 (434)
T 2rio_A 247 ESN-IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV------LRHPLFW 300 (434)
T ss_dssp HHH-HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGS
T ss_pred HHH-HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH------HhCCccC
Confidence 321 11111111111 11245789999999999999999999999 5677774
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.09 Aligned_cols=232 Identities=16% Similarity=0.136 Sum_probs=192.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
...++|++.+.||+|+||.||+|.+.. ++.||||++...... ......+.+|+.++..++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 455789999999999999999999865 578999999876543 566678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
+||||++|++|.+++... .....+..++.||+.||+|||++| |+||||||+||||+.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999643 344567889999999999999999 9999999999999999999997544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-hhcccc----cccCCCCCCHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA-VGFMNQ----RLEIPKDVDPR 734 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~-i~~~~~----~~~~~~~~s~~ 734 (783)
|++ .++.++|||||||++|+|++|+.||...+....+.. ...... ...++..++++
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 333 367999999999999999999999987654321100 000111 11234678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+.+||.+||+.||.+| |+.++++.|+++...
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 9999999999999999 999999999887543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=326.76 Aligned_cols=236 Identities=23% Similarity=0.388 Sum_probs=189.9
Q ss_pred ccccceeEe-eeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHH-HhCCCCceeeEeceeec----
Q 003963 502 ILWEDLTIG-EQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTS---- 574 (783)
Q Consensus 502 ~~~~~y~i~-~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~---- 574 (783)
...++|.+. +.||+|+||.||++.+.. ++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 345678887 789999999999999854 568999998642 2456788887 66689999999999876
Q ss_pred CCceEEEEEecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEec
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDF 650 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DF 650 (783)
...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 677999999999999999997653 46999999999999999999999999 999999999999998 789999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--ccccccCC
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIP 728 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~ 728 (783)
|++.... +..++.++|||||||++|+|++|..||.............. ......++
T Consensus 165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 9985432 23467899999999999999999999977654433211111 11122222
Q ss_pred ----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 729 ----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 729 ----~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
..+++++.+||.+||..||.+|||+.++ ++|+||+.....
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~------l~hp~~~~~~~~ 266 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIMQSTKV 266 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHTGGGS
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHH------hcChhhcccccC
Confidence 5689999999999999999999999999 679999776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=346.44 Aligned_cols=242 Identities=15% Similarity=0.151 Sum_probs=188.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCC-CceeeE------------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRH-PNVLLF------------ 568 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~l------------ 568 (783)
...|.+.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.++| +|+..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3568899999999999999999764 57899999874332 22335678899999999977 322111
Q ss_pred ---------eceeec-----CCceEEEEEecCCCCHHHHHh------hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 003963 569 ---------MGAVTS-----PQRLCIVTEFLPRGSLFRLLQ------RNTTKLDWRRRILMALDIARGVSYLHHCNPPII 628 (783)
Q Consensus 569 ---------~~~~~~-----~~~~~lV~E~~~ggsL~~~L~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~Iv 628 (783)
+.++.. ...++++|+++ +++|.+++. .....+++..++.++.||+.||+|||+++ ||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 111111 22467788877 679999984 22455888899999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccc----------cCCCCCchhHHHHHHHHHHH
Q 003963 629 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL----------RNEPSDEKSDVYSFGVILWE 698 (783)
Q Consensus 629 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~----------~~~~~s~~sDIwSLG~il~e 698 (783)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998765543 345577 999999999 55567889999999999999
Q ss_pred HHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003963 699 LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 758 (783)
Q Consensus 699 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~ 758 (783)
|++|+.||...+...... ........+++++.+||.+||..||.+||++.++++
T Consensus 310 lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGSCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhhhHH------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999998765433221 122233568899999999999999999999999854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=342.87 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=191.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccC------CHHHHHHHHHHHHHHHhCC---------C----
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRLR---------H---- 562 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------H---- 562 (783)
+..++|++.++||+|+||.||+|.+ .++.||||++..... .....+.+.+|+.+++.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4457899999999999999999998 567899999987542 1223357888999999886 4
Q ss_pred -------------CceeeEeceeec-------------CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHH
Q 003963 563 -------------PNVLLFMGAVTS-------------PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616 (783)
Q Consensus 563 -------------pnIv~l~~~~~~-------------~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~a 616 (783)
|||+++++++.. .+.+|+|||||++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 555555555544 6789999999999977666643 458999999999999999
Q ss_pred HHHHH-hCCCCEEecCCCCCCEEEcCCC--------------------cEEEEecCCCcccccccccccCCCCCCcccCc
Q 003963 617 VSYLH-HCNPPIIHRDLKSSNLLVDKHW--------------------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675 (783)
Q Consensus 617 L~~LH-~~~~~IvHrDIKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aP 675 (783)
|+||| +++ |+||||||+||||+.++ .+||+|||+++..... ..+||+.|+||
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 99999 888 99999999999999887 8999999999866543 34789999999
Q ss_pred ccccCCCCCchhHHHHHHHH-HHHHHcCCCCCCCCChHH-HHHHhh-ccccc----ccCCCCCCHHHHHHHHHhhhhCCC
Q 003963 676 EVLRNEPSDEKSDVYSFGVI-LWELATEKIPWDNLNSMQ-VIGAVG-FMNQR----LEIPKDVDPRWAAIVESCWHSDPQ 748 (783)
Q Consensus 676 E~~~~~~~s~~sDIwSLG~i-l~elltG~~Pf~~~~~~~-~~~~i~-~~~~~----~~~~~~~s~~l~~LI~~cL~~dP~ 748 (783)
|++.+.. +.++||||||++ .+++++|..||....... ....+. ..... ...+..+++++.+||.+||++|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 9999877 899999998887 778899999985421111 111111 01111 1112346789999999999976
Q ss_pred CCCCHHHHHHHHHHH-HHHHhh
Q 003963 749 CRPSFQELVDKLRDL-QRQYFQ 769 (783)
Q Consensus 749 ~RPsa~ell~~L~~L-~~~~f~ 769 (783)
|+.++ | +|+||+
T Consensus 324 ---sa~e~------l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDL------LCQHSLFK 336 (336)
T ss_dssp ---SHHHH------HHHCGGGC
T ss_pred ---CHHHH------HhcCCCcC
Confidence 99999 6 789985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=363.42 Aligned_cols=257 Identities=22% Similarity=0.257 Sum_probs=203.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec------CC
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 576 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++... ........+.+|+.+++.++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4789999999999999999999754 578999998754 345566789999999999999999999998765 67
Q ss_pred ceEEEEEecCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCc---EEEEecC
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFG 651 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~---vkL~DFG 651 (783)
..|+|||||++++|.+++.... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997643 25889999999999999999999998 999999999999997664 9999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---------HHhh---
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI---------GAVG--- 719 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~---------~~i~--- 719 (783)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765433 233567899999999999999999999999999999999999999764332110 0000
Q ss_pred cccc------ccc----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 720 FMNQ------RLE----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 720 ~~~~------~~~----~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.... ..+ ++..+++.+.+||.+||..||.+|||+.++ +.|+||+.
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el------L~hp~F~~ 303 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN------PNVGCFQA 303 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC------CCCTTHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH------hcCHHHHH
Confidence 0000 111 222356889999999999999999999997 45566544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=361.79 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=200.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEe--CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc-
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 577 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 577 (783)
+...++|++.++||+|+||.||++.+. .++.||||++.... .......+.+|+.+++.++|||||++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 455689999999999999999999986 46789999986543 44556788899999999999999999999987665
Q ss_pred ----eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 578 ----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 578 ----~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++| ||||||||+||||+.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988754 5899999999999999999999998 9999999999999886 9999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
+..... ....||+.|+|||++.+.. +.++|||||||+||+|++|.+||....... . ........+++
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------~-~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------L-PEDDPVLKTYD 295 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------C-CTTCHHHHHCH
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------c-cccccccccCH
Confidence 765443 3557999999999987764 899999999999999999999886421100 0 00000012357
Q ss_pred HHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRP-SFQELVDKLRDLQRQY 767 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RP-sa~ell~~L~~L~~~~ 767 (783)
.+.+||.+||..||.+|| ++.++...|..+....
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 899999999999999999 5677777777665443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=296.20 Aligned_cols=186 Identities=16% Similarity=0.098 Sum_probs=132.1
Q ss_pred eeeccCCcEEEEEEEE-eCCceEEEEEEecccC--------CHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCceEE
Q 003963 511 EQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEY--------SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~-~~~~~vAiK~i~~~~~--------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 580 (783)
...+.|++|.+..++. ..++.|++|++.+... .....+.|.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567788887777653 3467899999976532 123456799999999999 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||||+|++|.++|... .+++.. .|+.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999864 456654 47889999999999999 9999999999999999999999999998766554
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCC
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK 703 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~ 703 (783)
....+.+||+.|||||++.+. +..++|+|++|+++++|+++.
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 444566799999999999875 567899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=263.34 Aligned_cols=186 Identities=18% Similarity=0.189 Sum_probs=146.1
Q ss_pred eEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCH------HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
...++||+|+||.||++. ..++.+++|++....... ...+.+.+|+.+|+.++||||+++..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 446789999999999994 345689999876544321 1245689999999999999999666666677788999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||||++++|.+++.. ++.++.||+.||.|||+++ |+||||||+|||++. .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999875 5678999999999999998 999999999999998 999999999987654321
Q ss_pred c-------ccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003963 662 T-------TKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 707 (783)
Q Consensus 662 ~-------~~~~~Gt~~Y~aPE~~~~--~~~s~~sDIwSLG~il~elltG~~Pf~ 707 (783)
. ....+||+.|||||++.+ ..|+...|+|+..+-.++.+.++-+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 234578999999999987 556778899999999888888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-22 Score=214.17 Aligned_cols=146 Identities=22% Similarity=0.203 Sum_probs=116.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCH----------------HHHHHHHHHHHHHHhCCCCceeeEe
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSD----------------EVIHSFRQEVSLMKRLRHPNVLLFM 569 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~l~ 569 (783)
.|.+++.||+|+||.||+|.+..++.||||++....... .....+.+|+.+++.++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 456779999999999999999557789999986533211 23567889999999999 5 6666
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEe
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 649 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~D 649 (783)
+++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65543 56799999999999988 422 123468999999999999999 99999999999999 99999999
Q ss_pred cCCCcccccccccccCCCCCCcccCccccc
Q 003963 650 FGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679 (783)
Q Consensus 650 FGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 679 (783)
||+++. +..|+|||.+.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHH
T ss_pred CCCCeE-------------CCCCCHHHHHH
Confidence 999852 34478888863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-19 Score=186.49 Aligned_cols=139 Identities=19% Similarity=0.220 Sum_probs=107.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE-eCCce--EEEEEEecccCC----------------------HHHHHHHHHHHHHHHhC
Q 003963 506 DLTIGEQIGQGSCGTVYHAVW-YGSQD--VAVKVFSRQEYS----------------------DEVIHSFRQEVSLMKRL 560 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~-~~~~~--vAiK~i~~~~~~----------------------~~~~~~~~~Ei~il~~l 560 (783)
-|.+.+.||+|+||.||+|.+ ..++. ||||++...... ......+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998 56778 999997543211 01224678899999999
Q ss_pred CCCce--eeEeceeecCCceEEEEEecCC-C----CHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHH-hCCCCEEecCC
Q 003963 561 RHPNV--LLFMGAVTSPQRLCIVTEFLPR-G----SLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDL 632 (783)
Q Consensus 561 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~IvHrDI 632 (783)
.|++| +.++.+ ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++| ||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 88754 344432 367899999942 3 67666432 234567789999999999999 988 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCCccc
Q 003963 633 KSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 633 Kp~NILl~~~~~vkL~DFGla~~~ 656 (783)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999643
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.1e-18 Score=156.05 Aligned_cols=118 Identities=20% Similarity=0.320 Sum_probs=107.0
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (783)
.++.|+.++++++++|+++|.+|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+..++..
T Consensus 3 ~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (120)
T 2gj3_A 3 LPEIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVN 82 (120)
T ss_dssp CHHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred hHHHHHHHHHhCCCeEEEECCCCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEEEEEE
Confidence 45789999999999999999999999999999999999999999999998877665544455677888889999999999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHH
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk 245 (783)
+++||..+|+.+++.|++|.+|++.+++++++|||++|
T Consensus 83 ~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 83 RRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp ECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 99999999999999999999999999999999999864
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=167.19 Aligned_cols=121 Identities=13% Similarity=0.131 Sum_probs=113.3
Q ss_pred HHHHHHHHHhCcceEEEcCC---CcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLS---DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~---G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (783)
+.++.++++++++|+++|.+ |+|+|+|++|++++||+.++++|+++..++++.........+...+..+..+..++.
T Consensus 7 ~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 86 (176)
T 4hia_A 7 EKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVVLR 86 (176)
T ss_dssp HHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEE
T ss_pred HHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEEEE
Confidence 56889999999999999999 999999999999999999999999999998887766666778888999999999999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHH
Q 003963 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (783)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (783)
.+++||..+|+.+++.|+++.+|.+.+++++++|||++|++|++
T Consensus 87 ~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~ 130 (176)
T 4hia_A 87 NYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEA 130 (176)
T ss_dssp EECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHH
T ss_pred EEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHH
Confidence 99999999999999999999999999999999999999999988
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-17 Score=154.46 Aligned_cols=123 Identities=22% Similarity=0.166 Sum_probs=105.3
Q ss_pred HHHHHHhCcceEEEcCCC---cEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 133 LNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 133 ~~ile~~~d~I~i~D~~G---~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
+.++++++++|+++|.+| +|+|+|++|++++||+.+|++|+++..+.++.........+...+..+..+..++..++
T Consensus 2 ~~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 81 (132)
T 2pr5_A 2 SHMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYK 81 (132)
T ss_dssp ----CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEEC
T ss_pred hhHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEe
Confidence 357899999999999976 99999999999999999999999998877666554445567778888888999999999
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhcc
Q 003963 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (783)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~ 257 (783)
+||..+|+.+++.|+.+.+ +.+++++++|||++|++|++|++...+
T Consensus 82 kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e~~l~~~~~~ 127 (132)
T 2pr5_A 82 KDGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYEKLLEDSLTE 127 (132)
T ss_dssp TTSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHHHHHHHHHHH
T ss_pred cCCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHHHHHHHHHHH
Confidence 9999999999999998765 889999999999999999999876554
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.4e-17 Score=168.40 Aligned_cols=122 Identities=18% Similarity=0.181 Sum_probs=107.2
Q ss_pred CCCCHHHHHHHHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeE
Q 003963 125 FNFTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (783)
Q Consensus 125 ~~~~~~~~~~ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~ 201 (783)
+...++.|+.++++++++|+++|. +|+|+|||++|++++||+.+|++|+++.+++++.........+...+..+..+
T Consensus 58 l~~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~l~~~~~~ 137 (258)
T 3p7n_A 58 VQPPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPV 137 (258)
T ss_dssp ---CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCE
T ss_pred HHhHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHHHHHHcCCCe
Confidence 445568899999999999999999 89999999999999999999999999999988877766667788889999999
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHH
Q 003963 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (783)
..++..+++||..+|+.+++.|++|.+|.+.+++++++|||++|+
T Consensus 138 ~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~ 182 (258)
T 3p7n_A 138 LVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQP 182 (258)
T ss_dssp EEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-----
T ss_pred EEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhh
Confidence 999999999999999999999999999999999999999999943
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.2e-17 Score=145.46 Aligned_cols=105 Identities=23% Similarity=0.287 Sum_probs=95.9
Q ss_pred hCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEE
Q 003963 139 MGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (783)
Q Consensus 139 ~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (783)
++++|+++|. +|+|+|+|++|++|+||+.+|++|+++..+.++.........+++++..++.+..++..++|||+.+
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEE
Confidence 6789999994 7999999999999999999999999988887766655556678889999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehHH
Q 003963 216 LVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (783)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDITe 243 (783)
|+.+++.|++|++|++.+++++++|||+
T Consensus 82 ~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999999999999999999984
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-16 Score=150.16 Aligned_cols=126 Identities=20% Similarity=0.134 Sum_probs=114.2
Q ss_pred CCHHHHHHHHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEE
Q 003963 127 FTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (783)
Q Consensus 127 ~~~~~~~~ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~ 203 (783)
...+.++.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..++++.........+...+..+..+..
T Consensus 32 ~~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (166)
T 3ue6_A 32 DPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSV 111 (166)
T ss_dssp CCCCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEE
T ss_pred HHHHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHHHHHhcCCceEE
Confidence 3446799999999999999999 7999999999999999999999999999888877766666677888889999999
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHH
Q 003963 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (783)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~ 252 (783)
++...+++|..+|+.+++.|+.+.+|.+.|++++++|||++|+++...+
T Consensus 112 e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~~~~~e 160 (166)
T 3ue6_A 112 CLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLLVNE 160 (166)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHHHHHHH
T ss_pred EEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHHHHHHh
Confidence 9999999999999999999999999999999999999999998876643
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.9e-16 Score=147.30 Aligned_cols=134 Identities=19% Similarity=0.153 Sum_probs=121.0
Q ss_pred CCCCHHHHHHHHHHhCcceEEEcCCC---cEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeE
Q 003963 125 FNFTDRQYLNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (783)
Q Consensus 125 ~~~~~~~~~~ile~~~d~I~i~D~~G---~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~ 201 (783)
.....+.++.++++++++|+++|.+| +|+++|+++++++||+.++++|+++..++++.........+...+..+..+
T Consensus 20 ~~~~~~~~~~i~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (162)
T 3sw1_A 20 HMINAQLLQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPC 99 (162)
T ss_dssp -CCCHHHHHHHHHTCSSEEEEEEEETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCE
T ss_pred ccchHHHHHHHHhhccCcEEEEeCCCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCC
Confidence 34567899999999999999999999 999999999999999999999999999888776666666788888999999
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhccc
Q 003963 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSD 258 (783)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~ 258 (783)
..++...+++|..+|+.+++.|+.+.+|.+.+++++++|||++++++++|+......
T Consensus 100 ~~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~e~~l~~~~~~l 156 (162)
T 3sw1_A 100 REVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVELERELAELRARP 156 (162)
T ss_dssp EEEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHHHHHHHHHTC--
T ss_pred cceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHHHHHHHHHHHHH
Confidence 989999999999999999999999999999999999999999999999998876653
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-16 Score=143.99 Aligned_cols=119 Identities=19% Similarity=0.143 Sum_probs=103.4
Q ss_pred HHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCC
Q 003963 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (783)
Q Consensus 135 ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (783)
++++++++|+++|. +|+|+++|++|++++||+.++++|+++..++++.........+...+..+..+..++...+++
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 81 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKKS 81 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcCC
Confidence 46788999999999 999999999999999999999999999998887766666667788888899899999999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHH
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (783)
|..+|+.+++.|+.+.+|.+.+++++++|||++|++|++..+
T Consensus 82 g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~~~ 123 (128)
T 3t50_A 82 GEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSLEH 123 (128)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-------
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhhhh
Confidence 999999999999999999999999999999999999888654
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8.9e-16 Score=146.01 Aligned_cols=128 Identities=15% Similarity=0.131 Sum_probs=108.9
Q ss_pred CHHHHHHHHHHhCcceEEEc-CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEE-E
Q 003963 128 TDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ-F 205 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D-~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e-~ 205 (783)
..+.|+.++++++++|+++| .+|+|+++|+++++++|++ +++|+++.+++++.........+.+++..|++...+ .
T Consensus 15 ~~~~~~~~~~~~~~~i~~~d~~~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 92 (158)
T 3k3c_A 15 AAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEW 92 (158)
T ss_dssp CHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCEEEEEE
T ss_pred HHHHHHHHHhcCCceEEEEECCCcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcccccce
Confidence 45789999999999999999 9999999999999999999 999999999998776555556677888888875443 2
Q ss_pred EE--EcC-C-CCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhcc
Q 003963 206 PA--KTK-T-EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (783)
Q Consensus 206 ~~--~~k-d-G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~ 257 (783)
.. .+. + |..+|+.++..|+++.+|.+.|++++++|||++|++|++|+....+
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~e~~l~~~~~~ 148 (158)
T 3k3c_A 93 RLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEARVEE 148 (158)
T ss_dssp EEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHHH
T ss_pred eEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHHHHHHHHHHHH
Confidence 22 232 3 7789999999999999999999999999999999999999765544
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=145.29 Aligned_cols=117 Identities=13% Similarity=0.192 Sum_probs=98.2
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHH-hCCeEEEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGERWTGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~-~g~~~~~e~~~~ 208 (783)
+++..+++++++.|+++|.+|+|+|+|+++++++||+++|++|+++.++++|++.......+...+. .+..+..+++++
T Consensus 2 ~~~~ll~e~~~d~i~~~d~~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~ 81 (121)
T 3f1p_B 2 EFKGLNVCQPTRFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFR 81 (121)
T ss_dssp ------CCCCCEEEEEECTTSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEEEE
T ss_pred CcccceecCCCceEEEECCCceEEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEEEE
Confidence 4567789999999999999999999999999999999999999999999998886555555666664 455688899999
Q ss_pred cCCCCEEEEEEEEEEEECC-CCCEEEEEEEEEehHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (783)
++||..+|+..+..|++|. +|++.+++++.+|||++|+
T Consensus 82 ~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 82 SKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp CTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred ecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 9999999999999999987 7899999999999999875
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=7.8e-16 Score=139.62 Aligned_cols=113 Identities=17% Similarity=0.140 Sum_probs=81.1
Q ss_pred hCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EEEEEEEEcCCCCE
Q 003963 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEER 214 (783)
Q Consensus 139 ~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~~kdG~~ 214 (783)
++++|+++|.+|+|+++|++|++|+||+.+|++|+++..++++.........+......+.. ...++..+++||+.
T Consensus 2 ~~d~i~~~d~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG~~ 81 (119)
T 2vv6_A 2 IPDAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTT 81 (119)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCE
T ss_pred CcceEEEECCCCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeCCCCE
Confidence 67899999999999999999999999999999999999887765433222333444444443 23466778999999
Q ss_pred EEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHH
Q 003963 215 VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (783)
Q Consensus 215 ~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (783)
+|+.+++.|+.+.+ ..+++++++|||++|++|++|++
T Consensus 82 ~~~~~~~~~~~~~~--~~~~~~~~~DITerk~~e~~l~~ 118 (119)
T 2vv6_A 82 FPMHLSIGEMQSGG--EPYFTGFVRDLTEHQQTQARLQE 118 (119)
T ss_dssp EEEEEEEEEEEETT--EEEEEEEEEECC-----------
T ss_pred EEEEEEEEEEEECC--eEEEEEEEEEcHHHHHHHHHHHh
Confidence 99999999998643 35689999999999999998864
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-15 Score=141.53 Aligned_cols=133 Identities=9% Similarity=0.170 Sum_probs=113.9
Q ss_pred CCCCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcC--CCccccccccccchHHHHHHHHHHhCCeEE
Q 003963 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (783)
Q Consensus 125 ~~~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG--~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~ 202 (783)
+..+++.|+.+++.++++++.+|.++.++++|+++++++||+.+++.+ ..+..+++|++.......+..++..+..+.
T Consensus 4 L~~se~rl~~~~~~~~~g~w~~d~~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~ 83 (142)
T 3mr0_A 4 LSASEERFQLAVSGASAGLWDWNPKTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEHRDTYD 83 (142)
T ss_dssp -----CCHHHHHHHTTCEEEEECTTTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHHCCCEE
T ss_pred HHHHHHHHHHHHHhCCcEEEEEEcCCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhCCCceE
Confidence 445567799999999999999999999999999999999999999877 345677888887666667778888888899
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhcc
Q 003963 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (783)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~ 257 (783)
.+++++++||..+|+.....|++|.+|++.+++++++|||++|++|++|+...+.
T Consensus 84 ~e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E~~L~~~~~~ 138 (142)
T 3mr0_A 84 VEYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDEDALRVSREE 138 (142)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999876543
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-15 Score=133.93 Aligned_cols=110 Identities=24% Similarity=0.197 Sum_probs=98.9
Q ss_pred HHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCC
Q 003963 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (783)
Q Consensus 135 ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (783)
.+++++++|+++|. +|+|+|+|+++++++||+.++++|+++..++++.........+...+..+..+..++...+++
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTKS 81 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecCC
Confidence 47889999999999 999999999999999999999999999888877766556667788888999888899999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 82 g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer 114 (115)
T 4eet_B 82 GKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114 (115)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECSCC
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEeeccc
Confidence 999999999999999999999999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-16 Score=171.05 Aligned_cols=136 Identities=16% Similarity=0.144 Sum_probs=99.3
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccC---------------CH-H----HHHHHHHHHHHHHhCCCCcee
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEY---------------SD-E----VIHSFRQEVSLMKRLRHPNVL 566 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~---------------~~-~----~~~~~~~Ei~il~~l~HpnIv 566 (783)
|.++++||.|+||.||+|.+..++.||||+++.... .. . ......+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 899999999999999999988888999999753211 00 0 011223566677777544432
Q ss_pred --eEeceeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-
Q 003963 567 --LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW- 643 (783)
Q Consensus 567 --~l~~~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~- 643 (783)
..++. ...+|||||++|++|.++... .....++.||+.+|.+||++| ||||||||.||||++++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 22221 234799999999888665421 123457789999999999998 99999999999998876
Q ss_pred ---------cEEEEecCCCcc
Q 003963 644 ---------TVKVGDFGLSRL 655 (783)
Q Consensus 644 ---------~vkL~DFGla~~ 655 (783)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997643
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.2e-16 Score=140.32 Aligned_cols=114 Identities=11% Similarity=0.074 Sum_probs=94.1
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCcccccccccc-chHHHHHHHHHHhCCeEEEEEEEEcC
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKTK 210 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (783)
|+.+|++++++|+ +|.+|+|+++|++|++|+||+.++++|+++..++++... ......+...+..+..+..+...+++
T Consensus 5 ~~~~~~~~~~~i~-~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 83 (120)
T 3mqq_A 5 YKTAFHLAPIGLV-LSRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83 (120)
T ss_dssp HHHHHHHCSSEEE-EEETTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEEEECT
T ss_pred HHHHHhcCCceEE-EecCCEEHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEEEEeC
Confidence 8999999999996 588999999999999999999999999999888765433 22333456667778888889999999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHH
Q 003963 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (783)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (783)
||..+|+.++..|+ +.+|...+++++++|||++|++
T Consensus 84 dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 84 GGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp TSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred CCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 99999999999998 5666677899999999999976
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8e-16 Score=138.74 Aligned_cols=108 Identities=19% Similarity=0.228 Sum_probs=97.8
Q ss_pred hCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEE
Q 003963 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (783)
Q Consensus 139 ~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (783)
.++.|+++|.+|+|+|+|+++++++||+++|++|+++.++++|++.......+...+..+..+..+++++++||..+|+.
T Consensus 8 ~~~~i~~~d~~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~ 87 (117)
T 3f1p_A 8 SKTFLSEHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLE 87 (117)
T ss_dssp GGEEEEEECTTCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEEEEE
T ss_pred CccEEEEECCCceEEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEEEEE
Confidence 46788899999999999999999999999999999999999988876666667778888888888999999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEehHHHHH
Q 003963 219 ATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 219 ~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (783)
++..|++|. +|.+.+++++.+|||++|+
T Consensus 88 ~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 88 TQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EeeEEEECCCCCCceEEEEEeeecccccc
Confidence 999999987 8999999999999998864
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.1e-15 Score=131.93 Aligned_cols=120 Identities=23% Similarity=0.410 Sum_probs=105.3
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (783)
..+.++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++..++++.........+...+..+..+..+...
T Consensus 5 ~~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (124)
T 3lyx_A 5 ILKQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRM 84 (124)
T ss_dssp HHHHHHHGGGTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEEEEEE
T ss_pred HHHHHHHHHhhcCceEEEECCCCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccceEEE
Confidence 35778999999999999999999999999999999999999999999996666555444455677888889988889999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHH
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (783)
..++|..+|+.++..|+.+.+|.+.|++++++|||++|++
T Consensus 85 ~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~l 124 (124)
T 3lyx_A 85 LHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKKE 124 (124)
T ss_dssp ECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC---
T ss_pred EccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhcC
Confidence 9999999999999999999999999999999999998753
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.1e-15 Score=135.13 Aligned_cols=114 Identities=19% Similarity=0.198 Sum_probs=92.2
Q ss_pred CcCCCCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEE
Q 003963 123 SAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (783)
Q Consensus 123 ~a~~~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~ 202 (783)
..+..+++.|+.++++++++|+++|.+|+|+++|+++++|+||+++|++|+++..+.++.. ......+...+..+..+.
T Consensus 4 ~~l~~se~~~~~l~e~~~d~i~~~d~~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 82 (117)
T 2r78_A 4 ENLYFQSNAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGVD-SGWAAASLARIVGGEPLR 82 (117)
T ss_dssp CSHHHHHHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCST-TSHHHHHHHHHHTTCCEE
T ss_pred hHHHHhHHHHHHHHhcCCceEEEECCCCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCccc-hhHHHHHHHHHHcCCcEE
Confidence 3445567889999999999999999999999999999999999999999999876644332 222334556677777788
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
.+.+.+++||+.+|+.+++.|+. +|+ ++++++|||
T Consensus 83 ~e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 83 EERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp EEEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred EEEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 88899999999999999999985 566 567899997
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.8e-15 Score=131.86 Aligned_cols=122 Identities=20% Similarity=0.278 Sum_probs=105.9
Q ss_pred HHHHHHHHHHhCcceEEEc---CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D---~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (783)
++.++.++++++++|+++| .+|+|+++|+++++++|++.++++|+++..++++.........+...+..+..+..++
T Consensus 5 ~~~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (130)
T 2z6d_A 5 SQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRL 84 (130)
T ss_dssp --CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCcceeEE
Confidence 3568999999999999999 9999999999999999999999999999988887665555666778888888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (783)
...+++|..+|+.+...|+.+.+|.+.+++++++|||+++++|++
T Consensus 85 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e~e 129 (130)
T 2z6d_A 85 LNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVND 129 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC-----
T ss_pred EEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhhcc
Confidence 888999999999999999999999999999999999999987653
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.8e-15 Score=150.70 Aligned_cols=112 Identities=28% Similarity=0.351 Sum_probs=102.6
Q ss_pred eEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEEEEEE
Q 003963 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNT 222 (783)
Q Consensus 143 I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~~ 222 (783)
|+++|.+|+|++||++|++|+||+++|++|+++..+.++.........++..+..+..+..++..+++||+.+|+.+++.
T Consensus 2 i~i~D~~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~ 81 (227)
T 3ewk_A 2 VSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDSTIV 81 (227)
T ss_dssp EEEEETTCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEEEEE
T ss_pred EEEECCCCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeeeEEE
Confidence 78899999999999999999999999999999988876665555566778888999999999999999999999999999
Q ss_pred EEECCCCCEEEEEEEEEehHHHHHHHHHHHHh
Q 003963 223 PFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (783)
Q Consensus 223 Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (783)
|++|.+|++.+++++++|||++|++|++|+..
T Consensus 82 p~~d~~g~~~~~~~~~~DIT~~k~~e~~l~~~ 113 (227)
T 3ewk_A 82 PLMDNAGKPRQYISIRRDITAQKEAEAQLARL 113 (227)
T ss_dssp EEECSSSCEEEEEEEEEECTTTTHHHHHHHHH
T ss_pred EEEcCCCCEEEEEEEEEehhhHHHHHHHHHHH
Confidence 99999999999999999999999999998654
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.60 E-value=3e-15 Score=134.51 Aligned_cols=121 Identities=6% Similarity=0.099 Sum_probs=93.9
Q ss_pred CCCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcC--CCccccccccccchHHHHHHHHHHhCCeEEE
Q 003963 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (783)
Q Consensus 126 ~~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG--~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~ 203 (783)
...++.|+.+++.++++|+++|.+|.++++|+++++++||+.++++| ..+..++++++.......+..++..+..+..
T Consensus 3 ~~~~~~l~~~~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 82 (125)
T 3nja_A 3 AMAEKLLHTAESDAGIGSWVLHMESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGDRPFDV 82 (125)
T ss_dssp --------------CCEEEEEETTTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSCCCEEE
T ss_pred HHHHHHHHHHHHhCCeeEEEEEcCCCcEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcCCCceE
Confidence 34567899999999999999999999999999999999999999999 5566677777665555566777888888888
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHH
Q 003963 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (783)
++++.+++|..+|+.+...|+.+.+|++.+++++++|||++|+
T Consensus 83 e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 83 EYRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred EEEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 9999999999999999999999999999999999999999874
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=144.80 Aligned_cols=118 Identities=14% Similarity=0.134 Sum_probs=94.0
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEE----
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF---- 205 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~---- 205 (783)
..++.||+++++||+++|.+|+|++||+++++++|++.++++|+++.++++. ........+..++..|.+.....
T Consensus 22 ~~l~~il~~~~~gi~v~D~~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~~~~~~~~~~~ 100 (152)
T 3mxq_A 22 LLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIESSSFSSWEQKP 100 (152)
T ss_dssp HHHHHHHHHHCCEEEEEETTSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTSCEEEECCSSS
T ss_pred HHHHHHHhcCCCCEEEEcCCCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCCceeeeccccc
Confidence 4578999999999999999999999999999999999999999999999987 43444456788888887643211
Q ss_pred -----EE---EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHH
Q 003963 206 -----PA---KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (783)
Q Consensus 206 -----~~---~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E 248 (783)
.. ..++|..+|..+++.|++|.+|++.|++.+++|||+++.+.
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a~ 151 (152)
T 3mxq_A 101 HLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQQ 151 (152)
T ss_dssp CSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC----
T ss_pred ccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhcc
Confidence 11 23567788899999999999999999999999999988653
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-14 Score=128.34 Aligned_cols=112 Identities=16% Similarity=0.178 Sum_probs=92.1
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEE-EEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG-QFPA 207 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~-e~~~ 207 (783)
++.++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.++++ +.... .......+..++.... +...
T Consensus 2 e~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 79 (114)
T 3luq_A 2 DERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFP-EIGEE-WKSVHRRGLAGEVIRVEEDCF 79 (114)
T ss_dssp CHHHHHHHHTCSSEEEEEETTCBEEEECHHHHHHTTCCSSCCTTCBHHHHCT-TCCHH-HHHHHHHHHTTCCEEEEEEEE
T ss_pred hHHHHHHHhcCCceEEEEcCCcEEEEECHHHHHHHCCCHHHHcCCcHHHHCC-ccHHH-HHHHHHHHhcCCcceeeeeEE
Confidence 3679999999999999999999999999999999999999999999999884 33322 3333344444555444 3477
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
.+++|..+|+.++..|+++.+|++.|++++++|||
T Consensus 80 ~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 80 VRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 88999999999999999999999999999999997
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.7e-15 Score=144.01 Aligned_cols=124 Identities=15% Similarity=0.094 Sum_probs=102.1
Q ss_pred CHHHHHHHHHHhCcceEEEc-CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D-~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (783)
.++.|+.++++++++|+++| .+|+|+++|+++++++||+ +++|+++.+++++.........+..++..|+....+..
T Consensus 35 ~~~~l~~l~~~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 112 (185)
T 3kx0_X 35 AAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEW 112 (185)
T ss_dssp CHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCEEEEEE
T ss_pred hHHHHHHHHhcCCceEEEEECCCcEEEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCcccccce
Confidence 45789999999999999999 9999999999999999999 99999999999877655555667788888888655432
Q ss_pred EE---cCC--CCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHH
Q 003963 207 AK---TKT--EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (783)
Q Consensus 207 ~~---~kd--G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (783)
.. +++ |..+|+.+++.|+++.+|.+.|++++++|||++|++|+++..
T Consensus 113 ~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~~~~ 164 (185)
T 3kx0_X 113 RLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEA 164 (185)
T ss_dssp EEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC----
T ss_pred eEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHHHHH
Confidence 22 222 778999999999999999999999999999999999888433
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=157.06 Aligned_cols=117 Identities=24% Similarity=0.209 Sum_probs=108.2
Q ss_pred HHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCC
Q 003963 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (783)
Q Consensus 135 ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (783)
+++.++++|+++|. +|+|+|||++|++++||+++|++|+++.+++++.........+...+..+..+..+.+.+++|
T Consensus 16 ~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~d 95 (332)
T 2wkq_A 16 TLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTKS 95 (332)
T ss_dssp CGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred HhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcCC
Confidence 47899999999999 999999999999999999999999999999887766666667888899999999999999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHH
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL 251 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L 251 (783)
|..+|+.+++.|++|.+|++.|++++++|||+++++++++
T Consensus 96 G~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e~~~ 135 (332)
T 2wkq_A 96 GKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAER 135 (332)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHHHH
T ss_pred CCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhhhhc
Confidence 9999999999999999999999999999999998887765
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-14 Score=131.45 Aligned_cols=111 Identities=14% Similarity=0.158 Sum_probs=89.2
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQF 205 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~ 205 (783)
+.|+.++++++++|+++|.+|+|++||++|++|+||+.+|++|+++..++++.........+......+.. ...++
T Consensus 16 ~~~~~l~~~~~d~i~~~d~~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 95 (130)
T 1d06_A 16 AHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVV 95 (130)
T ss_dssp SCHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTSCEEE
T ss_pred HHHHHHHhhCcCeEEEECCCCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHHHHHhcCCccccCCeeEE
Confidence 34889999999999999999999999999999999999999999999988765543323334444444443 23466
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
..+++||+.+|+.+++.|+.+.+ ..+++++++|||
T Consensus 96 ~~~~kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 130 (130)
T 1d06_A 96 SGQRKDGSTFPMKLAVGEMRSGG--ERFFTGFIRDLT 130 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEEETT--EEEEEEEEEECC
T ss_pred EEEeCCCCEEEEEEEEEEEEECC--eEEEEEEEEECc
Confidence 77899999999999999997633 356889999997
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.3e-14 Score=147.75 Aligned_cols=129 Identities=13% Similarity=0.142 Sum_probs=99.0
Q ss_pred CCCcCCCCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHc------------CCChhhHcCCCccccccccccchHH
Q 003963 121 GPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLY------------GYSAEEALGQDAIELLTDGRDFDVA 188 (783)
Q Consensus 121 ~~~a~~~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~------------Gys~eEllG~~~~~l~~~~~~~~~~ 188 (783)
|-.+.....+.++.+|++++++|+++|.+|+|+|+|++|++|+ ||+.++++|+++..+++... ..
T Consensus 13 ~~~~~~~e~~~l~~iLd~~~~~vii~D~~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~~~---~~ 89 (233)
T 3vol_A 13 GLVPRGSHMARIKSALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQ 89 (233)
T ss_dssp -----CTHHHHHHHHHTTSSSEEEEEETTSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSSHH---HH
T ss_pred cCCchHHHHHHHHHHHhcCCCcEEEECCCCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCCHH---HH
Confidence 3444555568899999999999999999999999999999998 89999999999998875321 12
Q ss_pred HHHHHHHHhCCeEEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhcccc
Q 003963 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDT 259 (783)
Q Consensus 189 ~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~ 259 (783)
..++..+. ..+..++. .+| .|+.++++||+|.+|++.|++++++|||+++++|++++...+.+.
T Consensus 90 ~~~~~~~~--~~~~~~~~---~~g--~~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~e~ei~~l~~a~~ 153 (233)
T 3vol_A 90 RHLLANLT--GVHKAELN---LGG--RRFSLDVVPVFNDANERLGSAVQWTDRTEEHRAEQEVSQLVQAAA 153 (233)
T ss_dssp HHHHHTCC--SCEEEEEE---ETT--EEEEEEEEEEECTTCCEEEEEEEEEECHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcc--cceeEEEE---ECC--EEEEEEEEEEECCCCCEEEEEEEEehhhHHHHHHHHHHHHHHHHh
Confidence 22333222 23444432 355 367899999999999999999999999999999999988776544
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.2e-14 Score=129.39 Aligned_cols=116 Identities=22% Similarity=0.205 Sum_probs=105.5
Q ss_pred HHHHHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
++.++++++++|+++|. +|+|+++|+++++++||+.++++|+++..++++.........+...+..+..+..++...
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINY 83 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEEEE
Confidence 45678999999999999 999999999999999999999999999998877766555667788888898888899999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (783)
+++|..+|+.++..|+.+.+|.+.+++++++|||++++.
T Consensus 84 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~ 122 (146)
T 2v0u_A 84 TKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRD 122 (146)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCH
T ss_pred ecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHH
Confidence 999999999999999999999999999999999999873
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.51 E-value=1e-13 Score=141.35 Aligned_cols=111 Identities=23% Similarity=0.336 Sum_probs=103.1
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
+.++.++++++++|+++|.+|+|+++|++|++++||+.+|++|+++..+.++.........+++.+..++.+..++..++
T Consensus 111 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 190 (227)
T 3ewk_A 111 ARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRR 190 (227)
T ss_dssp HHHHHHHHTCCSEEEEECTTSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEE
T ss_pred HHHHHHHhcCcCeEEEEcCCCcEEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHHHcCCceeEEEEEEC
Confidence 45778899999999999999999999999999999999999999999998877766677788899999999999999999
Q ss_pred CCCC------EEEEEEEEEEEECCCCCEEEEEEEEEe
Q 003963 210 KTEE------RVLVVATNTPFYDDDGTLVGIVCVSTD 240 (783)
Q Consensus 210 kdG~------~~~v~~~~~Pi~d~~G~v~g~v~i~rD 240 (783)
+||. .+|+.+++.|++|.+|++.+++++++|
T Consensus 191 k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 191 RTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp ECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred CCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 9997 899999999999999999999999988
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.49 E-value=6e-14 Score=126.06 Aligned_cols=111 Identities=12% Similarity=0.048 Sum_probs=95.0
Q ss_pred hCcceEEEc-CCCcEEEecHHHHHHcCCChhhHcCCC-ccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEE
Q 003963 139 MGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQD-AIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (783)
Q Consensus 139 ~~d~I~i~D-~~G~Ii~~N~aae~L~Gys~eEllG~~-~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (783)
++++|+.+| .+|+|+|+|+++++|+||+.++++|.. +..+++|++.......+..++..+..+..+++++++||..+|
T Consensus 2 a~~giw~~d~~~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w 81 (115)
T 3h9w_A 2 TKAIPWKINWQTMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHYVW 81 (115)
T ss_dssp -CCEEEEEETTTTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred cceEEEEEEcCCCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCEEE
Confidence 467899999 679999999999999999999999932 345777777666666677888888888999999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEehHHHHHHHH
Q 003963 217 VVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (783)
Q Consensus 217 v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~ 249 (783)
+.....|++|.+|++++++++..|||++|++|+
T Consensus 82 ~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 82 IRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp EEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred EEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 999999999999999999999999999998875
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.6e-14 Score=126.76 Aligned_cols=121 Identities=12% Similarity=0.114 Sum_probs=88.0
Q ss_pred HHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCC
Q 003963 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (783)
Q Consensus 133 ~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG 212 (783)
+.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++.........+...+..+.. ..++...+++|
T Consensus 2 ~~l~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~g 80 (126)
T 3mjq_A 2 KNFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKKE-SLPLSLEKKEG 80 (126)
T ss_dssp CTTGGGCSSEEEEEETTSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCCS-EEEEEEECTTS
T ss_pred hhHHhhCCceEEEEeCCCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCCc-eeEEEEEccCC
Confidence 45789999999999999999999999999999999999999999988766544333344444444444 66788889999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHhhc
Q 003963 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (783)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (783)
..+|+.++..|+.+ + ...+++++++|||+++++++++.....
T Consensus 81 ~~~~~~~~~~~~~~-~-~~~~~~~~~~DITe~k~a~~~~~~~~~ 122 (126)
T 3mjq_A 81 TSIPAKARIWQGKW-H-NEPCLFAIIKDLSKEERASSPPFLEHH 122 (126)
T ss_dssp CEEEEEEEEEEEES-S-SSEEEEEEEEECC--------------
T ss_pred CEEEEEEEEEeeeE-C-CceEEEEEEEechHHHHhhcccchhhc
Confidence 99999999988764 3 356889999999999999988765543
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.8e-13 Score=119.91 Aligned_cols=107 Identities=13% Similarity=0.075 Sum_probs=89.4
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
.+.++.++++++++|+++|.+|+|+++|+++++++||++++++|+++.++++...... +..+..+..+..+....
T Consensus 12 ~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~~ 86 (118)
T 3olo_A 12 FKFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQKNNYTFKTRYR 86 (118)
T ss_dssp HHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHHSEEEEEEEEE
T ss_pred HHHHHHHHhcCCceEEEECCCCcEEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhcCcEEEEEEEE
Confidence 3567899999999999999999999999999999999999999999999886543322 34455566778888899
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
+++|..+|+.++..|+.+.+ . .+++++++|||
T Consensus 87 ~~~g~~~~~~~~~~~~~~~~-~-~~~~~~~~DIT 118 (118)
T 3olo_A 87 SQSGRIFLVEMSLTFLEDQE-R-RFSCVFVREKS 118 (118)
T ss_dssp CTTCCEEEEEEEEEEEEETT-E-EEEEEEEEEC-
T ss_pred ccCCCEEEEEEEEEEEEECC-c-cEEEEEEEeCC
Confidence 99999999999999997643 3 46789999997
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.5e-14 Score=125.00 Aligned_cols=115 Identities=11% Similarity=0.119 Sum_probs=103.2
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCc--cccccccccchHHHHHHHHHHhCCeEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDA--IELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~--~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (783)
+++.|+.++++++++|+.+|.+|.++++|+++++++||+.++++|+.. ..++++++.......+...+..+..+..++
T Consensus 2 s~~~~~~l~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~e~ 81 (118)
T 3icy_A 2 NAEELQALVDNIPAAIYHLDVSGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLTLVY 81 (118)
T ss_dssp HHHHHHHHHTTCCCCCEEECTTSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEEEEE
T ss_pred cHHHHHHHHhcCCceEEEEEcCCCceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCceEEE
Confidence 357899999999999999999999999999999999999999988754 567777776555566777788888888999
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
++.+++|..+|+.....|+++.+|.+.+++++++|||
T Consensus 82 r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 82 RIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999999999999999999997
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.48 E-value=5.8e-14 Score=134.84 Aligned_cols=121 Identities=18% Similarity=0.269 Sum_probs=100.2
Q ss_pred CCHHHHHHHHHHhCcceEEEcCCCcEEEecHH---HHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEE
Q 003963 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRS---AELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (783)
Q Consensus 127 ~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~a---ae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~ 203 (783)
++.++++.||++++++|+++|.+|+|+|+|++ +++++| ..++++|+++.+++++.. ....+.+..++++|+....
T Consensus 16 l~~~~l~~IL~~~~~gI~~vD~~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~~-~~~v~~i~~~l~~g~~~~~ 93 (151)
T 2qkp_A 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPKV-LDKVKKVFELLRNGQRDKV 93 (151)
T ss_dssp ECHHHHHHHHHHSSSEEEEEETTSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHHH-HHHHHHHHHHHHTTSBSEE
T ss_pred ecHHHHHHHHHhCCCceEEEcCCCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHHH-HHHHHHHHHHHHcCCccEE
Confidence 55688999999999999999999999999999 999999 567899999998876433 3345667888999988766
Q ss_pred EEEEEcCC-CCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHH
Q 003963 204 QFPAKTKT-EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL 251 (783)
Q Consensus 204 e~~~~~kd-G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L 251 (783)
+++....+ | .++.++..||+|++|+++|++.+++|||+.++++++.
T Consensus 94 ~~~~~~~~~~--~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~r 140 (151)
T 2qkp_A 94 NMWFQSERLG--KFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSEF 140 (151)
T ss_dssp EEEEEETTTT--EEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC-
T ss_pred EEEEecCCCC--eEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhhh
Confidence 66654332 4 4578889999999999999999999999988776653
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.5e-13 Score=124.02 Aligned_cols=110 Identities=18% Similarity=0.214 Sum_probs=92.5
Q ss_pred HHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhC-CeEEEEEEEEcCCCC
Q 003963 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG-ERWTGQFPAKTKTEE 213 (783)
Q Consensus 135 ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g-~~~~~e~~~~~kdG~ 213 (783)
++++.+++|+++|.+|+|+|+|+++++++||+.+|++|+++.+++++++.......+...+..+ .....+++++++||.
T Consensus 8 ~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~ 87 (121)
T 2kdk_A 8 INVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGS 87 (121)
T ss_dssp CCCCSSEEEEEECTTSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECSSSC
T ss_pred cccCCccEEEEECCCeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCC
Confidence 5667899999999999999999999999999999999999999988876544444455556553 446778889999999
Q ss_pred EEEEEEEEEEEECCC-CCEEEEEEEEEehHHH
Q 003963 214 RVLVVATNTPFYDDD-GTLVGIVCVSTDSRPF 244 (783)
Q Consensus 214 ~~~v~~~~~Pi~d~~-G~v~g~v~i~rDITer 244 (783)
.+|+.++..|++|.+ +.+.+++++.+||++.
T Consensus 88 ~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~ 119 (121)
T 2kdk_A 88 FVTLKSQWFSFTNPDTKELEYIVSVNTLVLGH 119 (121)
T ss_dssp EEEEEEEEEEEECCSSSCEEEEEEEEECCSSC
T ss_pred EEEEEEEEEEEECCCCCeeeEEEEEEEecccc
Confidence 999999999999876 5677788999999864
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-13 Score=120.36 Aligned_cols=116 Identities=14% Similarity=0.161 Sum_probs=97.4
Q ss_pred CCCHHHHHHHHHHhCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCCC--ccccccccccchHHHHHHHHHHhCCeEE
Q 003963 126 NFTDRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWT 202 (783)
Q Consensus 126 ~~~~~~~~~ile~~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~~--~~~l~~~~~~~~~~~~l~~~l~~g~~~~ 202 (783)
...++.++.++++++++|+++|.+ |+|+++|+++++++||+.++++|+. +..+++++...... .....+..+..+.
T Consensus 7 ~~~~~~~~~~~~~~~~~i~~~d~~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 85 (125)
T 3eeh_A 7 AKSERRVRELTEATNDILWEFTADLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDRELMK-DTMQSLMDGESAD 85 (125)
T ss_dssp ---CHHHHHHHSCCCCEEEEEETTSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHHHH-HHHHHHHTTCCEE
T ss_pred HHHHHHHHHHHhcCCceEEEEEcCCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHHHH-HHHHHHHcCCCcc
Confidence 344578999999999999999999 9999999999999999999999987 45566655433332 3334467788888
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
.++...+++|..+|+.++..|+.+.+|.+.+++++++|||
T Consensus 86 ~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 86 VECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp EEEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 8888899999999999999999999999999999999997
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.5e-13 Score=127.81 Aligned_cols=124 Identities=15% Similarity=0.238 Sum_probs=86.9
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQ 204 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e 204 (783)
++.++.++++++++|+++|.+|+|+++|+++++++||+.++++|+++..++++.........+......+.. +..+
T Consensus 39 ~~~~~~~l~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (167)
T 1v9y_A 39 DGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 118 (167)
T ss_dssp -CCHHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CE
T ss_pred hHHHHHHHHhCCCCEEEECCCCcEEEECHHHHHHhCCCHHHHcCCChhhccCccccchHHHHHHHHhhcCCCcccccceE
Confidence 345899999999999999999999999999999999999999999999988776654433344444443333 3446
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHHh
Q 003963 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (783)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (783)
+...+++|..+|+.+...|+ +.+|.+ +++++++|||++++++++|+.+
T Consensus 119 ~~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~l~~l 166 (167)
T 1v9y_A 119 LQLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTRQL 166 (167)
T ss_dssp EEEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC--------------
T ss_pred EEEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHHHHhh
Confidence 77789999999999999999 456766 4899999999999999887653
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.1e-13 Score=125.21 Aligned_cols=111 Identities=14% Similarity=0.093 Sum_probs=84.4
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCC-------eEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-------RWT 202 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~-------~~~ 202 (783)
+.++.++++++++|+++|.+|+|+++|++|++|+||+.++++|+++.+++++.........+......+. .+.
T Consensus 7 ~~l~~i~~~~~d~i~~~D~~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (129)
T 3mfx_A 7 ETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPVQHPA 86 (129)
T ss_dssp HHHHHHHTTCSSEEEEEETTSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCSCEEE
T ss_pred HHHHHHHhcCCceEEEECCCCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCcccccccCCCc
Confidence 5688999999999999999999999999999999999999999999999987654321111111112222 245
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHH
Q 003963 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (783)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITe 243 (783)
.++..+++||+.+|+.++++|+.+ ++.+ ++++++|+..
T Consensus 87 ~E~~~~rkdG~~~~velsis~i~~-~~~~--~v~~~~~~~~ 124 (129)
T 3mfx_A 87 QETTLICASGKAKDVELSISYIPG-HEPM--FVMVMHDLEH 124 (129)
T ss_dssp EEEEEECTTSCEEEEEEEEEEECS-SSCE--EEEEEEEC--
T ss_pred eEEEEEcCCCCEEEEEEEEEEecC-CCcE--EEEEEechhh
Confidence 688889999999999999999983 3322 7788899754
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.4e-12 Score=112.67 Aligned_cols=104 Identities=17% Similarity=0.132 Sum_probs=88.1
Q ss_pred cceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCC--ccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEE
Q 003963 141 QSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (783)
Q Consensus 141 d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~--~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (783)
++|+++|. +|+|+++|+++++++||+.++++|++ ...+.++.........+...+..+..+..+...++++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 57899997 59999999999999999999999998 34444444333445567778888888888888899999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
|+.++..|+.+.+|.+.+++++++|||++
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999963
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.43 E-value=9.2e-13 Score=119.37 Aligned_cols=113 Identities=16% Similarity=0.135 Sum_probs=94.9
Q ss_pred HHHHHHHhCcceEEEcC---CCcEEEecHHHHHHcCCChhhHcCCC--ccccccccccchHHHHHHHHHHhCCeEEEEEE
Q 003963 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~---~G~Ii~~N~aae~L~Gys~eEllG~~--~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (783)
+...+++++++|+++|. +|+|+++|+++++++||+.++++|++ +..+.++.........+...+..+..+..+..
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIA 100 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEEEE
T ss_pred HHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeEEE
Confidence 44445559999999999 99999999999999999999999999 45455554444444556777777777888888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
..+++|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 101 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 101 FYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 88999999999999999999999999999999999863
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-12 Score=122.78 Aligned_cols=105 Identities=17% Similarity=0.205 Sum_probs=92.3
Q ss_pred HHHHhCcceEEEc---CCCcEEEecHHHHHHcCCChhhHcCCCccccccccc-----------cchHHHHHHHHHHhCCe
Q 003963 135 ILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-----------DFDVAYDIVHRIKMGER 200 (783)
Q Consensus 135 ile~~~d~I~i~D---~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~-----------~~~~~~~l~~~l~~g~~ 200 (783)
+++. +++|+++| .+|+|+|+|+++++++||+.+|++|+++..+++++. .......+...+..+..
T Consensus 31 ~~~~-~~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (149)
T 3d72_A 31 PVDT-SVALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAE 109 (149)
T ss_dssp SCCT-TSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCCCTTCCCSSSCHHHHHHHHHHHHHTCC
T ss_pred hhcC-CccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCccccccccccccccChHHHHHHHHHHHCCCc
Confidence 3445 38999999 799999999999999999999999999998887763 44445567788888888
Q ss_pred EEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEe
Q 003963 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (783)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rD 240 (783)
+..+...+++||..+|+.+++.|+++.+|++.+++++++|
T Consensus 110 ~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 110 VQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp EEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred eEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 8889999999999999999999999999999999999887
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.8e-12 Score=116.57 Aligned_cols=110 Identities=14% Similarity=0.115 Sum_probs=82.2
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhH--cCCCccccccccccchHHHHHHHHHHhCCeEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA--LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEl--lG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (783)
.++.|+.++++++++|+++|.+|+|+++|+++++++||+.+|+ +|+++..+++ .. ......+.....+.....+.
T Consensus 15 ~~~~~~~l~e~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~e~ 91 (126)
T 3bwl_A 15 TSSRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DA-EDVQTQLSGFSVDERRKFEG 91 (126)
T ss_dssp HHHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CH-HHHHHHHHTCCTTCEEEEEE
T ss_pred HHHHHHHHHhhCCcEEEEEcCCCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CH-HHHHHHHHHHhcCCCcceEE
Confidence 3567899999999999999999999999999999999999999 5677777765 21 11111111122334455566
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
...++||..+|+.++..++.+ +|.. +++++++|||
T Consensus 92 ~~~~~dG~~~~~~~~~~~~~~-~~~~-~~~~~~~DIT 126 (126)
T 3bwl_A 92 LYERRDGSTMSVEVHLLRFNL-EGED-RFLAISRDIT 126 (126)
T ss_dssp EEECTTSCEEEEEEEEEEEEE-TTEE-EEEEEEEEC-
T ss_pred EEEeCCCCEEEEEEEeEEEec-CCcE-EEEEEEEeCC
Confidence 777999999999999888753 4543 5788999997
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.38 E-value=2e-12 Score=115.67 Aligned_cols=108 Identities=18% Similarity=0.146 Sum_probs=88.4
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeE-EEEEEEE
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~-~~e~~~~ 208 (783)
.....++++++++|+++|.+|+|+++|++|++++|++.++++|+++.+++++... ....+.+++..+... ..+....
T Consensus 7 ~l~~~il~~~~~~i~~~D~~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 84 (115)
T 3b33_A 7 SLPSAILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVTFV 84 (115)
T ss_dssp CHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEEEE
T ss_pred ccHHHHHhhcCceEEEECCCCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceEEe
Confidence 4567799999999999999999999999999999999999999999998765432 122355667777664 3455555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
++|..+|+.+++.|+.+ +|. .+++.+++||+
T Consensus 85 -~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 85 -VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp -ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred -cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 78999999999999998 776 68999999985
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.6e-12 Score=118.62 Aligned_cols=105 Identities=16% Similarity=0.220 Sum_probs=80.6
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcC------------CChhhHcCCCccccccccccchHHHHHHHHHHh
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYG------------YSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM 197 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~G------------ys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~ 197 (783)
.+++.+|++++++|+++|.+|+|+|+|++|++|+| |+.++++|+++.++++... ....+.....
T Consensus 5 ~rl~~il~~~~~gviv~D~~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~~~---~~~~~~~~~~- 80 (121)
T 4hi4_A 5 ARIASALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQRHLLANLT- 80 (121)
T ss_dssp HHHHHHHTTSSSEEEEEETTCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSSHH---HHHHHHHHCS-
T ss_pred HHHHHHHhcCCccEEEEcCCCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCCHH---HHHHHHhCcC-
Confidence 56899999999999999999999999999999995 8999999999998875321 1122222222
Q ss_pred CCeEEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 198 g~~~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
..+..++. .+|. ++.++++||+|.+|++.|++++++|||+.
T Consensus 81 -~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 81 -GVHKAELN---LGGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp -SCEEEEEE---ETTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred -CCcEEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 23343332 2453 45788999999999999999999999973
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-12 Score=119.34 Aligned_cols=107 Identities=17% Similarity=0.079 Sum_probs=86.8
Q ss_pred HHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEc
Q 003963 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (783)
Q Consensus 130 ~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (783)
..++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+.+++..|+....++....
T Consensus 12 ~~~~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (118)
T 3fg8_A 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQTRVDSLY 91 (118)
T ss_dssp -CCCCSSSCTTCEEEEECTTCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEEEEECSS
T ss_pred chHHHHHhhCCceEEEECCCCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEEEEEEEc
Confidence 45677899999999999999999999999999999999999999999998776555555567788888988776433333
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
.+| .|+.+++.|+.+ |++++++|||++
T Consensus 92 ~~g--~~~~~~~~p~~~------g~v~~~~DITer 118 (118)
T 3fg8_A 92 SPG--MTIEVTAAADSG------ALVVHFRDVTAE 118 (118)
T ss_dssp STT--CEEEEEEEEETT------EEEEEEEECSCC
T ss_pred CCC--eEEEEEEEEcCC------cEEEEEEeccCC
Confidence 466 577888888753 378899999974
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.31 E-value=9.8e-13 Score=118.70 Aligned_cols=108 Identities=11% Similarity=0.064 Sum_probs=77.1
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEE
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (783)
.++.|+.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++.............+..++..
T Consensus 17 ~~~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT------ 90 (125)
T ss_dssp ---------CCSCCEEEEEETTSBEEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE------
T ss_pred HHHHHHHHHhcCCCeEEEEcCCCeEEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE------
Confidence 45779999999999999999999999999999999999999999999999884332222222224556666644
Q ss_pred EcCCCC-EEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 208 KTKTEE-RVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 208 ~~kdG~-~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
..++|. .+|+.+++.|+.+. |.+.|++++++|||
T Consensus 91 ~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 RSEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp EEEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred EeEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 223444 68899999998764 66678999999997
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=135.38 Aligned_cols=119 Identities=17% Similarity=0.324 Sum_probs=99.1
Q ss_pred CCCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEE
Q 003963 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (783)
Q Consensus 126 ~~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (783)
.+..+.++.||+++++||+++|.+|+|+|+|++ ++++ ++.++++|+++.+++++.. ....+.+..++++|+....++
T Consensus 235 ~~~~~~l~~IL~~l~dgIivvD~~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~~-~~~~~~l~~~l~~g~~~~~~~ 311 (369)
T 3cax_A 235 YLNIEELKAIFEALPVDVTFIDKDDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPPKS-VYVVNKILKAFKEGRKKEATF 311 (369)
T ss_dssp EECHHHHHHHHHHSSSEEEEECTTSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCGGG-HHHHHHHHHHHHHTSCSCEEE
T ss_pred hhhHHHHHHHHHhCCCcEEEECCCCcEEEEcCH-HHcc-CChHHHcCCcHHHHCChhh-HHHHHHHHHHHHcCCceEEEE
Confidence 355688999999999999999999999999999 9999 9999999999999887543 334456778888888755555
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (783)
... .+| .++.++.+||+|.+|+++|++.+++|||++++++++
T Consensus 312 ~~~-~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~ 353 (369)
T 3cax_A 312 WLR-LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGE 353 (369)
T ss_dssp EEE-ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSC
T ss_pred EEe-eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHH
Confidence 443 346 578889999999999999999999999998876543
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.21 E-value=9.2e-13 Score=142.78 Aligned_cols=145 Identities=17% Similarity=0.181 Sum_probs=107.9
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
.++++.++++++++|+++|.+|+|++||++|++++||+.++++|+++.++..+. .....+...+..+......
T Consensus 7 ~~~~~~i~~~~~~~i~~~d~~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~---- 79 (349)
T 3a0r_A 7 RNFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENKEPVFLN---- 79 (349)
T ss_dssp --CCCSSGGGSSSEEEEEESSSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTTT---HHHHHHHHHHHHCCCCEEE----
T ss_pred HHHHHHHHhhhcCeEEEECCCCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcChh---HHHHHHHHHHhcCCceeec----
Confidence 345778999999999999999999999999999999999999999999883322 2223345556666654322
Q ss_pred cCCCCEEEEEEEEEEEECCCCCE-EEEEEEEEehHHHHHHHHHHHHhhccccccccCCchhHHHHhhcCCchhHHHHHHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTL-VGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v-~g~v~i~rDITerk~~E~~L~~~~~~~~~~~~~~~~~~l~~~l~~d~~qpl~~~i~ 287 (783)
...+..+|+.+...|+.+.+|.. .|++++++|||+++++++++++.... .....|++.++||+++||+.+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~~~~~~-------~~~~~~~~~i~Helr~pL~~i~~ 152 (349)
T 3a0r_A 80 FYKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERL-------SILGEMTARVAHEIRNPITIIGG 152 (349)
T ss_dssp CCCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTTHHHHH-------HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHHHHHHH-------HHHHHHHHHHHHHhcchHHHHHH
Confidence 12223357888999999888765 58999999999999887766443221 12345889999999999977543
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=109.99 Aligned_cols=92 Identities=21% Similarity=0.166 Sum_probs=68.6
Q ss_pred HHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHh-CCeEEEEEEEEcCCC
Q 003963 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAKTKTE 212 (783)
Q Consensus 134 ~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~-g~~~~~e~~~~~kdG 212 (783)
.+++++++.|+++|.+|+|+|+|+++++++||+.+|++|+++.++++|++..... ..+.. +.....+++++++||
T Consensus 3 ~lle~~~d~i~v~d~~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~~----~~~~~~~~~~~~e~r~~~kdG 78 (111)
T 2vlg_A 3 FPLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLVE----SYFYNEHHLMPCTFRFIKKDH 78 (111)
T ss_dssp ------CCEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHH----HHHHCSCCSSCEEEEEECTTS
T ss_pred chhhcCCCEEEEEcCCCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHHH----HHHhccCCCccEEEEEEcCCC
Confidence 5789999999999999999999999999999999999999999999988754332 22322 333455788889999
Q ss_pred CEEEEEEEEEEEECCCC
Q 003963 213 ERVLVVATNTPFYDDDG 229 (783)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G 229 (783)
+.+|+.+++.++.+.++
T Consensus 79 ~~~wve~~~~~v~~~~~ 95 (111)
T 2vlg_A 79 TIVWVEAAVEIVTTRAE 95 (111)
T ss_dssp CEEEEEEEEEEC-----
T ss_pred CEEEEEEEEEEEecccC
Confidence 99999999999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3e-11 Score=125.84 Aligned_cols=142 Identities=15% Similarity=0.031 Sum_probs=110.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 582 (783)
...|++...++.|+++.||++... ++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 457889999999999999999744 5789999987532111 135778999999885 677889999998888999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-------------------------------------- 624 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------- 624 (783)
||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999998876421 1123366778999999999810
Q ss_pred -------------------CCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 625 -------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 625 -------------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..++|+|++|.|||++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 228999999999999876556799999774
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=131.66 Aligned_cols=109 Identities=16% Similarity=0.138 Sum_probs=97.6
Q ss_pred CcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEEE
Q 003963 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (783)
Q Consensus 140 ~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (783)
.+.+...|.+|+|+|+|++++.++||+++|++|+++.++++|++.......+...+..|+....+++++++||..+|+..
T Consensus 251 ~~f~~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv~~ 330 (361)
T 4f3l_A 251 EEFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQT 330 (361)
T ss_dssp CEEEEEECTTSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEEEE
T ss_pred ceeEEEEcCCceEEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEEEE
Confidence 34566688999999999999999999999999999999999988766666677888888877778999999999999999
Q ss_pred EEEEEECC-CCCEEEEEEEEEehHHHHHHH
Q 003963 220 TNTPFYDD-DGTLVGIVCVSTDSRPFQETR 248 (783)
Q Consensus 220 ~~~Pi~d~-~G~v~g~v~i~rDITerk~~E 248 (783)
+..|++|. +|++.+++++.+|||+++..+
T Consensus 331 ~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 331 HYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp EEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred EEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 99999998 799999999999999998764
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.6e-11 Score=109.89 Aligned_cols=101 Identities=17% Similarity=0.235 Sum_probs=75.8
Q ss_pred hCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHH-HHh-CCeE---EEEEEEEcCCC
Q 003963 139 MGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR-IKM-GERW---TGQFPAKTKTE 212 (783)
Q Consensus 139 ~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~-l~~-g~~~---~~e~~~~~kdG 212 (783)
.+++|+++|.+ |+|+++|++|++|+||+.+|++|+++.+++++... .....+... +.. +... ..++..+++||
T Consensus 7 ~~~~i~~~d~~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG 85 (114)
T 1ll8_A 7 FNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDS-DVVEALSEEHMEADGHAAVVFGTVVDIISRSG 85 (114)
T ss_dssp TTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTT-HHHHHTTSSTTSSSSCSSCCCSSSEEECCTTC
T ss_pred CCceEEEEECCCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcchh-HHHHHHHHHhhccCCcceeccCcEEEEEecCC
Confidence 45799999999 99999999999999999999999999999887543 111222211 111 2211 23466789999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
+.+|+.++++|+.+.++ .+++++++|++
T Consensus 86 ~~~~v~~~~~~~~~~~~--~~~v~~~~~~~ 113 (114)
T 1ll8_A 86 EKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp CCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred CEEEEEEEEEeeccCCc--cEEEEEEeecC
Confidence 99999999999987654 35788899875
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=99.09 E-value=9.4e-10 Score=101.06 Aligned_cols=101 Identities=9% Similarity=-0.035 Sum_probs=79.6
Q ss_pred HHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccc-cccccchHHHHHHHHHHhCCeEEEEEEEEcCC
Q 003963 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (783)
Q Consensus 133 ~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~-~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (783)
..+++++++||+++|.+|+|++||+++++++||++++++|+++.+.+ +....+.+...+.+.++.|.-........+++
T Consensus 20 ~~~ld~l~~Gii~lD~~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~l~~~~~~v~~~~ 99 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFDYQ 99 (125)
T ss_dssp HHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEEECTT
T ss_pred HHHHhccCceEEEECCCCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCceeEEEEEEEcCC
Confidence 44799999999999999999999999999999999999999998754 44444666667788888888433334445899
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEE
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIV 235 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v 235 (783)
|..+ .+.+.+..+.+|...+++
T Consensus 100 ~~p~--~v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 100 MTPT--KVKVHMKKALSGDSYWVF 121 (125)
T ss_dssp SCCE--EEEEEEEECSSSSEEEEE
T ss_pred CCEE--EEEEEEEEcCCCCEEEEE
Confidence 9855 555556777888877664
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.9e-10 Score=127.34 Aligned_cols=108 Identities=15% Similarity=0.112 Sum_probs=89.9
Q ss_pred hCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe-EEEEEEEEcCCCCEEEE
Q 003963 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAKTKTEERVLV 217 (783)
Q Consensus 139 ~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-~~~e~~~~~kdG~~~~v 217 (783)
..+-+...|.+|+|+|+|++++.++||+++|++|+++.++++|++.......+...+..+.. ...+++++++||..+|+
T Consensus 277 ~~~fi~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~vWv 356 (387)
T 4f3l_B 277 SMEYVSRHAIDGKFVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSFITL 356 (387)
T ss_dssp CCEEEEEECTTSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCEEEE
T ss_pred CceEEEEECCCCEEEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCEEEE
Confidence 34567778999999999999999999999999999999999988865555555566655554 55689999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEehHHHHH
Q 003963 218 VATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (783)
.....+++|. +|++.++|++.+|||+||.
T Consensus 357 ~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 357 RSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999987 8899999999999999874
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=8.4e-10 Score=92.74 Aligned_cols=95 Identities=20% Similarity=0.247 Sum_probs=72.9
Q ss_pred hCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEE
Q 003963 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (783)
Q Consensus 139 ~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (783)
++++|+++|.+|+|+++|+++++++||+.++++|+++.++ + .. ......+...+..+..+... .. +|..+|+.
T Consensus 1 ~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~-~-~~-~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~ 73 (96)
T 3a0s_A 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDL-P-DF-EEIGSVAESVFENKEPVFLN--FY--KFGERYFN 73 (96)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGS-T-TC-HHHHHHHHHHHHHTCCEEEE--EE--EETTEEEE
T ss_pred CCceEEEEcCCCCEeehhHHHHHHhCCCHHHhcCCCHHHC-c-ch-HHHHHHHHHHhccCCeEEEE--EE--cCCcEEEE
Confidence 4789999999999999999999999999999999999888 2 22 22333455666666665322 22 34446899
Q ss_pred EEEEEEECCCCC-EEEEEEEEEe
Q 003963 219 ATNTPFYDDDGT-LVGIVCVSTD 240 (783)
Q Consensus 219 ~~~~Pi~d~~G~-v~g~v~i~rD 240 (783)
+++.|+.+.+|. +.|++++++|
T Consensus 74 ~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 74 IRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEeEcCCCCeeeEEEEEecC
Confidence 999999988665 6799999887
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.2e-09 Score=100.50 Aligned_cols=101 Identities=12% Similarity=-0.062 Sum_probs=78.9
Q ss_pred HHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccc-cccccchHHHHHHHHHHhCCeEEEEEEEEcCC
Q 003963 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (783)
Q Consensus 133 ~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~-~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (783)
..+++++++||+++|.+|+|++||+++++++||++++++|+++.+.+ +....+.+...+.+.++.|.-........+++
T Consensus 25 ~~~ld~l~~GiivlD~dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~l~~~~~yv~~~~ 104 (129)
T 1mzu_A 25 TAEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVFDFQ 104 (129)
T ss_dssp CTTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEEECS
T ss_pred HHHHhccCceEEEECCCCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCceeEEEEEEEcCC
Confidence 34699999999999999999999999999999999999999998754 44444666667788888777333333444899
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEE
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIV 235 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v 235 (783)
|..+ .+.+.++.+.+|...+++
T Consensus 105 ~~p~--~v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 105 MAPV--RVQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp SCEE--EEEEEEEECSSTTEEEEE
T ss_pred CCEE--EEEEEEEEcCCCCEEEEE
Confidence 9855 455556677888877664
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.3e-11 Score=106.97 Aligned_cols=106 Identities=18% Similarity=0.216 Sum_probs=84.3
Q ss_pred CCCCHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCC---ChhhHcCCCccccccccccchHHHHHHHHHHhCCeE
Q 003963 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGY---SAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (783)
Q Consensus 125 ~~~~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gy---s~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~ 201 (783)
+....+.++.++++++++|+++|.+|+|+++|++|++++|| +.++++|+++.+++++.. +...+..+...
T Consensus 10 l~~~~~~~~~il~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~ 82 (118)
T 2w0n_A 10 ISTLFEQRQAMLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVLRDGTPR 82 (118)
T ss_dssp HCTTHHHHHHHHHCCCCCCEEEBTTTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhhccccEEEECCCCcEeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHhccCcee
Confidence 34456789999999999999999999999999999999998 889999999998876532 44556666543
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
.... ...+| .|+.++..|+.+ +|++.|++++++|||
T Consensus 83 ~~~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 83 RDEE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp CCCC--EESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred ccEE--EEECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 2211 22355 467788899987 888889999999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=2.7e-10 Score=117.79 Aligned_cols=138 Identities=17% Similarity=0.118 Sum_probs=99.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc--eeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV 581 (783)
...|.+....+.|..+.||++...+++.+++|+..... ...+.+|+.+++.+.+.+ +++++.++...+..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 34566654445666799999976556679999976542 134677999999886444 56788888888889999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN------------------------------------- 624 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 624 (783)
|||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9999998874 211 11 1245566777777777642
Q ss_pred -------------------CCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 625 -------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 625 -------------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1199999999999998776677999998753
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.9e-10 Score=113.22 Aligned_cols=105 Identities=14% Similarity=0.203 Sum_probs=81.9
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCC-e-EEEEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-R-WTGQFP 206 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~-~-~~~e~~ 206 (783)
.+.++.+++++++||+++|.+|+|+++|++|++++|++.++++|+++.++++... +...+..+. . ...++.
T Consensus 79 ~~~l~~il~~~~~gvi~~D~~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 151 (190)
T 2jhe_A 79 HLALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLINGFN-------FLRWLESEPQDSHNEHVV 151 (190)
T ss_dssp HHHHHHHHHHCSSCEEEECTTCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTCC-------HHHHHHTCCCSCEEEEEE
T ss_pred HHHHHHHHHhCCCcEEEEcCCCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCCC-------HHHHHhcCCCCCcceEEE
Confidence 3678999999999999999999999999999999999999999999999876543 233455554 2 333333
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCC----EEEEEEEEEehHHHH
Q 003963 207 AKTKTEERVLVVATNTPFYDDDGT----LVGIVCVSTDSRPFQ 245 (783)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~----v~g~v~i~rDITerk 245 (783)
. +|. ++.+.+.|+.+.+|+ +.|++.+++|||+++
T Consensus 152 ~---~g~--~~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 152 I---NGQ--NFLMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp E---TTE--EEEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred E---CCe--EEEEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 2 664 356778899876665 889999999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.2e-09 Score=119.43 Aligned_cols=146 Identities=19% Similarity=0.233 Sum_probs=106.5
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEe--cccCCHHHHHHHHHHHHHHHhCC--CCceeeEeceeecC---CceE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFS--RQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSP---QRLC 579 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~--~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~ 579 (783)
....+.|+.|.++.||++... ++.+++|+.. ..... .....+.+|+.+++.|. +..+++++.++.+. +..|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 334678999999999998764 4689999865 32211 12346778999999997 45578888888766 4589
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------ 623 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------ 623 (783)
+||||++|..+.+.. ...++......++.+++..|..||..
T Consensus 118 ~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999999987774321 12356777788889999999999973
Q ss_pred --------------------CCCEEecCCCCCCEEEcCCCc--EEEEecCCCcccc
Q 003963 624 --------------------NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKH 657 (783)
Q Consensus 624 --------------------~~~IvHrDIKp~NILl~~~~~--vkL~DFGla~~~~ 657 (783)
...++|+|++|.|||++.++. +.|+||+.+....
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 134999999999999987653 6999999987543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2.7e-09 Score=113.80 Aligned_cols=185 Identities=21% Similarity=0.208 Sum_probs=120.7
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCc--eeeEeceeecCC---ceEEEEE
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPN--VLLFMGAVTSPQ---RLCIVTE 583 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E 583 (783)
++.++.|.+..||++. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3568999999999873 57999985432 34567889999998884 322 445555443333 3589999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------- 624 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------- 624 (783)
+++|..|...... .++......++.+++..|..||+..
T Consensus 97 ~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 97 KIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999887653321 2556666677777777777777511
Q ss_pred -----------------CCEEecCCCCCCEEEcC--CCcEEEEecCCCcccccccccccCCCCCCcccCccccc------
Q 003963 625 -----------------PPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR------ 679 (783)
Q Consensus 625 -----------------~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~------ 679 (783)
..++|+|++|.|||++. ...+.|+||+.+................ .-..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHc
Confidence 23899999999999998 5568899999987543322111110000 002232211
Q ss_pred CCCC--------CchhHHHHHHHHHHHHHcCCCCC
Q 003963 680 NEPS--------DEKSDVYSFGVILWELATEKIPW 706 (783)
Q Consensus 680 ~~~~--------s~~sDIwSLG~il~elltG~~Pf 706 (783)
+... ....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1100 12368999999999999998776
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.71 E-value=4.6e-08 Score=105.92 Aligned_cols=105 Identities=12% Similarity=0.033 Sum_probs=88.8
Q ss_pred CcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe-----EEEEEEEEcCCCCE
Q 003963 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-----WTGQFPAKTKTEER 214 (783)
Q Consensus 140 ~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-----~~~e~~~~~kdG~~ 214 (783)
.+.|+..|.+|+|+|+|+++..++||+++|++|+++.++++|++.......+...++.|+. ...+++++++||..
T Consensus 154 ~~fi~r~~~dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kdG~~ 233 (339)
T 3rty_A 154 PKFAIRHTATGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQNGCY 233 (339)
T ss_dssp CEEEEEEETTCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTTSCE
T ss_pred ceEEEEECCCCeEEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccCCCE
Confidence 4567779999999999999999999999999999999999999876655566777777774 35678999999999
Q ss_pred EEEEEEEEEEECCC-CCEEEEEEEEEehHHH
Q 003963 215 VLVVATNTPFYDDD-GTLVGIVCVSTDSRPF 244 (783)
Q Consensus 215 ~~v~~~~~Pi~d~~-G~v~g~v~i~rDITer 244 (783)
+|+..+..+++|.. +++.++|++-+.|+..
T Consensus 234 vWlet~~~~~~np~s~~~~~II~~h~vi~~p 264 (339)
T 3rty_A 234 VLLETEWTSFVNPWSRKLEFVVGHHRVFQGP 264 (339)
T ss_dssp EEEEEEEEEEECTTTCSEEEEEEEEEEEECC
T ss_pred EEEEEEEEEEECCCCCCeeEEEEEEEECCCC
Confidence 99999999999875 5677788877766544
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.07 E-value=3.4e-09 Score=113.39 Aligned_cols=112 Identities=16% Similarity=0.132 Sum_probs=80.6
Q ss_pred HHHHhCcceEEEcCCCcEEEecHHHHHHcC---CChhhHcCCCcccccccc---cc-c-hHHHHHHHHHHh-CCeEEEEE
Q 003963 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYG---YSAEEALGQDAIELLTDG---RD-F-DVAYDIVHRIKM-GERWTGQF 205 (783)
Q Consensus 135 ile~~~d~I~i~D~~G~Ii~~N~aae~L~G---ys~eEllG~~~~~l~~~~---~~-~-~~~~~l~~~l~~-g~~~~~e~ 205 (783)
+++.+++||+++|.+|+|+|+|++|++++| +. ++++|+++.+++... .. . .....+..++.. +.....++
T Consensus 175 ~~~~~~dGIivvD~~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~~~~ei 253 (305)
T 2ykf_A 175 SSPRAGDGFIRLDVDGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKGMRMEV 253 (305)
Confidence 456899999999999999999999999985 54 789999999988654 11 0 111112223433 33332222
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHHHHHHHHHHHH
Q 003963 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (783)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (783)
. .+| .++.++..|+++ +|++.|++.+++|||+++++|++|+.
T Consensus 254 ~---~~~--~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL~~ 295 (305)
T 2ykf_A 254 D---AGG--ATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRALIS 295 (305)
Confidence 1 122 466788899986 68889999999999999999999854
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.48 E-value=5.7e-07 Score=96.39 Aligned_cols=102 Identities=12% Similarity=0.041 Sum_probs=83.4
Q ss_pred cceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe---EEEEEEEEcCCCCEEEE
Q 003963 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTKTEERVLV 217 (783)
Q Consensus 141 d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~---~~~e~~~~~kdG~~~~v 217 (783)
+-+...|.+|+|+|+|+++..++||.++|++|+++.+++++++.......+.+.++.+.. ...+++++++||..+|+
T Consensus 175 ~Fitrh~~dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwv 254 (317)
T 4dj3_A 175 IFTTTHTPGCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVIL 254 (317)
T ss_dssp EEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEE
T ss_pred ceEEEecCCCeEEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEE
Confidence 334557889999999999999999999999999999999999876665566677776554 35688999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEehH
Q 003963 218 VATNTPFYDD-DGTLVGIVCVSTDSR 242 (783)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDIT 242 (783)
+....+++|. .+++.++|+.-+-|+
T Consensus 255 et~~~~~~np~s~~~e~II~~h~v~~ 280 (317)
T 4dj3_A 255 DSSWSSFVNPWSRKVSFIIGRHKVRT 280 (317)
T ss_dssp EEEEEEEECSSSCCEEEEEEEEEECC
T ss_pred EEEEEEEECCCCCcccEEEEEEEecc
Confidence 9999999986 456666776666443
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.46 E-value=8.9e-07 Score=94.58 Aligned_cols=102 Identities=10% Similarity=0.041 Sum_probs=84.4
Q ss_pred ceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe-EE-EEEEEEcCCCCEEEEEE
Q 003963 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WT-GQFPAKTKTEERVLVVA 219 (783)
Q Consensus 142 ~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-~~-~e~~~~~kdG~~~~v~~ 219 (783)
-+...+.+|+|+|+|+++..++||.++|++|+.+.+++++++.......+.+.++.+.. .. ..++++++||..+|++.
T Consensus 167 Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwvet 246 (309)
T 3gdi_A 167 FTTTHTPNCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLDT 246 (309)
T ss_dssp EEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEEE
T ss_pred EEEEecCCCeEEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEEE
Confidence 45558889999999999999999999999999999999998865554555666775543 55 58999999999999999
Q ss_pred EEEEEECC-CCCEEEEEEEEEehHH
Q 003963 220 TNTPFYDD-DGTLVGIVCVSTDSRP 243 (783)
Q Consensus 220 ~~~Pi~d~-~G~v~g~v~i~rDITe 243 (783)
...++.+. .+++.++|+.-+-|+.
T Consensus 247 ~~~~~~np~s~~~e~ii~~h~v~~g 271 (309)
T 3gdi_A 247 SWSSFINPWSRKISFIIGRHKVRVG 271 (309)
T ss_dssp EEEEEECTTTCCEEEEEEEEEEEEC
T ss_pred EEEEEECCCCCcccEEEEEEEEccC
Confidence 99999876 5778888888777654
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.41 E-value=7.3e-07 Score=95.65 Aligned_cols=104 Identities=12% Similarity=0.041 Sum_probs=84.0
Q ss_pred CcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHh-CCeE-EEEEEEEcCCCCEEEE
Q 003963 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERW-TGQFPAKTKTEERVLV 217 (783)
Q Consensus 140 ~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~-g~~~-~~e~~~~~kdG~~~~v 217 (783)
.+-+...|.+|+|+|+|+++..++||.++|++|+.+.+++++++.......+.+.++. |... ..+++++++||..+|+
T Consensus 176 ~~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwv 255 (320)
T 4dj2_A 176 RIFTTRHTPSCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVTM 255 (320)
T ss_dssp CEEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEEE
T ss_pred ceEEEEecCCceEEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEEE
Confidence 3445558899999999999999999999999999999999998865544445556664 4445 3588999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEehHH
Q 003963 218 VATNTPFYDD-DGTLVGIVCVSTDSRP 243 (783)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDITe 243 (783)
+....++.+. .+++.++|+.-+-|+.
T Consensus 256 et~~~~~~np~s~~~e~II~~h~v~~g 282 (320)
T 4dj2_A 256 DTSWAGFVHPWSRKVAFVLGRHKVRTA 282 (320)
T ss_dssp ECEEEEEECTTTCSEEEEEEEEEESSC
T ss_pred EEEEEEEECCCCCCccEEEEEEEEccC
Confidence 9999999876 5778888887776654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3e-06 Score=90.38 Aligned_cols=136 Identities=18% Similarity=0.147 Sum_probs=90.5
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCC---ceeeEeceee-cCCceEEEEEec
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP---NVLLFMGAVT-SPQRLCIVTEFL 585 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~ 585 (783)
++.++.|....||++ ++.+++|+-. .......+.+|+.+|+.|.+. .|.+++.++. ..+..|+||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456788999999988 5689999842 234456788999999999742 3556666663 456688999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 003963 586 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------------ 623 (783)
Q Consensus 586 ~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------------ 623 (783)
+|..|....-. .++......++.++...|..||+.
T Consensus 96 ~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99877653211 122222333333333333333321
Q ss_pred ----------------CCCEEecCCCCCCEEEcC---CCc-EEEEecCCCccc
Q 003963 624 ----------------NPPIIHRDLKSSNLLVDK---HWT-VKVGDFGLSRLK 656 (783)
Q Consensus 624 ----------------~~~IvHrDIKp~NILl~~---~~~-vkL~DFGla~~~ 656 (783)
...++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 123799999999999987 455 489999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.1e-06 Score=87.03 Aligned_cols=133 Identities=17% Similarity=0.205 Sum_probs=93.4
Q ss_pred eccCCcE-EEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEEEEecCCCC
Q 003963 513 IGQGSCG-TVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGS 589 (783)
Q Consensus 513 LG~G~fG-~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggs 589 (783)
+..|..+ .||+..... +..+++|+-... ....+.+|..+|+.|. +--|.+++.++.+++..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 3445444 689877654 457999986533 2456788999999885 3236788888888899999999999988
Q ss_pred HHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 003963 590 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------------- 624 (783)
Q Consensus 590 L~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------------- 624 (783)
+.+...... .....++.++...|..||...
T Consensus 107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654321 112234455666666666421
Q ss_pred -----------CCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 625 -----------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 625 -----------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0179999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=4.4e-06 Score=90.74 Aligned_cols=82 Identities=9% Similarity=-0.004 Sum_probs=55.5
Q ss_pred eEeeee-ccCCcEEEEEEEEe-------CCceEEEEEEeccc---CCHHHHHHHHHHHHHHHhCC-C--CceeeEeceee
Q 003963 508 TIGEQI-GQGSCGTVYHAVWY-------GSQDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVT 573 (783)
Q Consensus 508 ~i~~~L-G~G~fG~Vy~a~~~-------~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~ 573 (783)
...+.| +.|....+|++... .++.+++|+..... ... ...+.+|+.+++.|. + -.+.+++.++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 445778 88999999998754 24579999865432 100 124567888888774 2 34667777766
Q ss_pred cC---CceEEEEEecCCCCHH
Q 003963 574 SP---QRLCIVTEFLPRGSLF 591 (783)
Q Consensus 574 ~~---~~~~lV~E~~~ggsL~ 591 (783)
.. +..|+||||++|..+.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 55 4578999999886543
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.96 E-value=4.5e-05 Score=83.30 Aligned_cols=64 Identities=14% Similarity=0.169 Sum_probs=56.1
Q ss_pred CHHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHH
Q 003963 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191 (783)
Q Consensus 128 ~~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l 191 (783)
.+++...+++++.+.|+++|.+|+|+|+|++++.++||+.+|++|+++.++++|++.......+
T Consensus 84 ~~~~~~~~l~a~~~~i~v~~~~G~i~yvs~~~~~~lGy~~~el~g~~~~~~ihp~D~~~~~~~l 147 (361)
T 4f3l_A 84 NEEFTQLMLEALDGFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKIL 147 (361)
T ss_dssp HHHHHHHHHHHTTEEEEEEETTSBEEEECTTHHHHHCCCHHHHTTSBGGGGSCGGGHHHHHHHH
T ss_pred HHHHHHHHHHhcCceEEEEcCCccEEEEechhhhhcCCCHHHhcCCcHHHhcCHHHHHHHHHHh
Confidence 3466778899999999999999999999999999999999999999999999998865544443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=7.9e-05 Score=79.72 Aligned_cols=138 Identities=16% Similarity=0.083 Sum_probs=77.2
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CceeeEec------eeecCCceEEE
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMG------AVTSPQRLCIV 581 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~------~~~~~~~~~lV 581 (783)
.+.|+.|..+.||++...+ +.+++|+.... . ..+..|+.+++.|.. -.+++++. +....+..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDS-GAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEETT-EEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeCC-CCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 4567777889999987643 46999998652 2 223345555555531 12334443 12345678999
Q ss_pred EEecCCCCHH-----------HHH---hh--cCC--c---------chHHH-----------------------------
Q 003963 582 TEFLPRGSLF-----------RLL---QR--NTT--K---------LDWRR----------------------------- 605 (783)
Q Consensus 582 ~E~~~ggsL~-----------~~L---~~--~~~--~---------l~~~~----------------------------- 605 (783)
|+|++|..+. ..| .. ... + ..+..
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999985431 111 11 000 0 01110
Q ss_pred --HHHHHHHHHHHHHHHHh-----------CCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 606 --RILMALDIARGVSYLHH-----------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 606 --~~~i~~qi~~aL~~LH~-----------~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
...+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 00111123345566652 12349999999999999878899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=3.8e-05 Score=84.73 Aligned_cols=78 Identities=21% Similarity=0.156 Sum_probs=49.4
Q ss_pred EeeeeccCCcEEEEEEEEe-CCceEEEEEEecccC--CH---HHHHHHHHHHHHHHhCCC--C-ceeeEeceeecCCceE
Q 003963 509 IGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEY--SD---EVIHSFRQEVSLMKRLRH--P-NVLLFMGAVTSPQRLC 579 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~--~~---~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~ 579 (783)
..+.||.|.++.||++... +++.++||....... .. .....+..|.++|+.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999754 356899998653211 00 012345678888887742 3 34456543 345568
Q ss_pred EEEEecCCC
Q 003963 580 IVTEFLPRG 588 (783)
Q Consensus 580 lV~E~~~gg 588 (783)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.74 E-value=6.9e-05 Score=82.64 Aligned_cols=60 Identities=18% Similarity=0.257 Sum_probs=52.6
Q ss_pred HHHHHHHHHHhCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCCCccccccccccchHH
Q 003963 129 DRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~ 188 (783)
+++...+++++...|++++.+ |+|+|+|++++.++||+.+|++|+++.++++|++...+.
T Consensus 85 ~~~~~~ll~~~~gfi~v~~~~~G~i~yvs~~~~~~lG~~~~el~g~~~~~~ihp~D~~~~~ 145 (387)
T 4f3l_B 85 DELKHLILRAADGFLFVVGCDRGKILFVSESVFKILNYSQNDLIGQSLFDYLHPKDIAKVK 145 (387)
T ss_dssp HHHHHHHHHTCCSEEEEEETTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHH
T ss_pred HHHHHHHHhcCCCEEEEEecCCeEEEEEchhhHHHcCCCHHHHCCCcHHHhcCCCCHHHHH
Confidence 345577889999999999987 999999999999999999999999999999998864443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00028 Score=75.34 Aligned_cols=77 Identities=23% Similarity=0.195 Sum_probs=60.4
Q ss_pred eEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC---CCceeeEeceeecCCceEEEEEe
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
.-.+.|+.|.+..+|++.. .++.+++|+..... ...+..|...|+.|. ...+++++.++...+..++||||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 3457799999999999875 45689999876432 356788999888884 35678888888878889999999
Q ss_pred cCCCCH
Q 003963 585 LPRGSL 590 (783)
Q Consensus 585 ~~ggsL 590 (783)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998753
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00016 Score=77.99 Aligned_cols=97 Identities=15% Similarity=0.141 Sum_probs=66.7
Q ss_pred eEEEc-CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeE------------EEEEEEE-
Q 003963 143 VHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW------------TGQFPAK- 208 (783)
Q Consensus 143 I~i~D-~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~------------~~e~~~~- 208 (783)
+++++ .+|+|+|+|+++..++||+.+|++|+++.+++++++... ++..+..|.++ ....+..
T Consensus 6 ~~vv~~~~G~i~yvS~~~~~~LGy~~~el~G~s~~d~ihp~D~~~----f~~~L~~gl~~~~~~~~~~~~~rsffcR~~r 81 (339)
T 3rty_A 6 CCVISMHDGIVLYTTPSITDVLGYPRDMWLGRSFIDFVHLKDRAT----FASQITTGIPIAESRGSVPKDAKSTFCVMLR 81 (339)
T ss_dssp EEEEETTTCBEEEECTTHHHHHCCCTTSSTTSBGGGGBCHHHHHH----HHHHHHTTSCCC----------CCEEEEEEE
T ss_pred EEEEECCCcEEEEEChHHHHHcCCCHHHHCCCcHHHhcCHHHHHH----HHHHHhcCCCCCccccCCCCCCceEEEEEEe
Confidence 45677 799999999999999999999999999999999887543 44555555322 1111111
Q ss_pred ---------------cCCCCEEEEEEEEEEEECC---------CCCEEEEEEEEEehHH
Q 003963 209 ---------------TKTEERVLVVATNTPFYDD---------DGTLVGIVCVSTDSRP 243 (783)
Q Consensus 209 ---------------~kdG~~~~v~~~~~Pi~d~---------~G~v~g~v~i~rDITe 243 (783)
.+++..+|+..+..++.++ +|...+++.+..+|+.
T Consensus 82 r~~~l~s~gy~v~~~~~~~~p~~l~~~~~~~~~e~~~~~~~~~~g~~~~lv~~a~~i~s 140 (339)
T 3rty_A 82 RYRGLKSGGFGVIGRPVSYEPFRLGLTFREAPEEARPDNYMVSNGTNMLLVICATPIKS 140 (339)
T ss_dssp CCC-------------CCEEEEEEEEEEEECCCC----------CCCEEEEEEEEECCC
T ss_pred ccCCCCcCCcceecccccceeEEEEEEEeccccccccccccccCCceEEEEEEcccCCc
Confidence 1223345555555666555 5677788889999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00034 Score=77.72 Aligned_cols=76 Identities=16% Similarity=0.112 Sum_probs=47.7
Q ss_pred CEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCCC-CCCcccCcccccCCC---CCchhHHHHHHHHHHHHHc
Q 003963 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-GTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELAT 701 (783)
Q Consensus 626 ~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~-Gt~~Y~aPE~~~~~~---~s~~sDIwSLG~il~ellt 701 (783)
.++|+|++|.|||++.++ ++|+||+.+.............. -...|++|+...... .....++..+...+|+.++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 399999999999998876 99999999876543221111000 013456665543211 1234556677888887776
Q ss_pred C
Q 003963 702 E 702 (783)
Q Consensus 702 G 702 (783)
+
T Consensus 312 ~ 312 (420)
T 2pyw_A 312 K 312 (420)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0011 Score=66.36 Aligned_cols=139 Identities=12% Similarity=0.138 Sum_probs=95.7
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccccCC
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 666 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 666 (783)
.+|.++|+..+.+++++++|.++.|.+.+|.-+-. .. -..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 38999999989999999999999999999887622 11 11233456899999999998753 1110
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhh-
Q 003963 667 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS- 745 (783)
Q Consensus 667 ~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~- 745 (783)
.....+.+||... ...+.+.=|||||++||.-+--..| ...+..+++.|.+||..|..-
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcc
Confidence 1123466888763 3456888999999999998754332 223456899999999999765
Q ss_pred ------------------------CCCCCCCHHHHHHHHH
Q 003963 746 ------------------------DPQCRPSFQELVDKLR 761 (783)
Q Consensus 746 ------------------------dP~~RPsa~ell~~L~ 761 (783)
.+..|+++++|++.-.
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 2357889999987654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=69.24 Aligned_cols=80 Identities=14% Similarity=0.083 Sum_probs=57.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC---CceeeEeceeecCCceEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH---PNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~l 580 (783)
.....-.+.+|.|..+.||++...+++.|++|+........ ...+..|+..|+.|.- --+++++++. .-++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 34566778899999999999998888899999865443221 1346789999998842 1345555542 3488
Q ss_pred EEEecCCCC
Q 003963 581 VTEFLPRGS 589 (783)
Q Consensus 581 V~E~~~ggs 589 (783)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00066 Score=62.08 Aligned_cols=81 Identities=9% Similarity=-0.019 Sum_probs=69.1
Q ss_pred EcCCCcEEEecHHHHHHcCCCh--hhHcCCCccccccccccc--hHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEEEEE
Q 003963 146 FDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDF--DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (783)
Q Consensus 146 ~D~~G~Ii~~N~aae~L~Gys~--eEllG~~~~~l~~~~~~~--~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (783)
.|.+|+|+++..... ..+|.. +||+|+.+.+++++++.. .......+++..|+....-++++.++|..+|+....
T Consensus 13 h~~dGKf~~vDq~~~-r~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~~qT~s 91 (132)
T 1oj5_A 13 QDTTGKIISIDTSSL-RAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRC 91 (132)
T ss_dssp ECTTCCEEEEECHHH-HTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEE
T ss_pred ecCCCcEEEEecccc-cccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEEEEEEE
Confidence 788999999999987 477777 999999999999998854 555566778888888888899999999999999998
Q ss_pred EEEECC
Q 003963 222 TPFYDD 227 (783)
Q Consensus 222 ~Pi~d~ 227 (783)
..+++.
T Consensus 92 k~f~np 97 (132)
T 1oj5_A 92 KLCYPQ 97 (132)
T ss_dssp EEECC-
T ss_pred EEecCC
Confidence 888764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.001 Score=70.26 Aligned_cols=71 Identities=13% Similarity=0.140 Sum_probs=44.4
Q ss_pred eeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce-eeEeceeecCCceEEEEEec-CC
Q 003963 510 GEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFL-PR 587 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~g 587 (783)
++.|+.|....+|++ +.+++|+....... .....+|+.+++.+...++ .+++.+. ...-++++||+ +|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678899999999998 57999987643110 1112357777776642222 4555443 33457899999 66
Q ss_pred CCH
Q 003963 588 GSL 590 (783)
Q Consensus 588 gsL 590 (783)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=70.07 Aligned_cols=33 Identities=36% Similarity=0.443 Sum_probs=28.0
Q ss_pred CEEecCCCCCCEEEcCC----CcEEEEecCCCccccc
Q 003963 626 PIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLKHE 658 (783)
Q Consensus 626 ~IvHrDIKp~NILl~~~----~~vkL~DFGla~~~~~ 658 (783)
.++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 39999999999999874 6899999999875443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0015 Score=69.38 Aligned_cols=143 Identities=17% Similarity=0.142 Sum_probs=79.0
Q ss_pred eEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc--eeeEece------eecCCceE
Q 003963 508 TIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGA------VTSPQRLC 579 (783)
Q Consensus 508 ~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 579 (783)
.-.+.|+.|....+|++...+ +.+++|+....... ..+..|+.+++.|.... +++++.. ....+..+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-CCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eEeeccCCCcccceEEEEeCC-ccEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 445678889999999997644 47999998653111 23456777777664212 3333321 12235678
Q ss_pred EEEEecCCCCHH-----------HHH---hhc----CCc-------chHHHHHH------------HHHHHHHHHHHHHh
Q 003963 580 IVTEFLPRGSLF-----------RLL---QRN----TTK-------LDWRRRIL------------MALDIARGVSYLHH 622 (783)
Q Consensus 580 lV~E~~~ggsL~-----------~~L---~~~----~~~-------l~~~~~~~------------i~~qi~~aL~~LH~ 622 (783)
++|+|++|..+. ..| ... ..+ ..+...+. +...+...+.++..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999885421 111 110 000 01111000 00113344555542
Q ss_pred C-----CCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 623 C-----NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 623 ~-----~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
. ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 1 12399999999999998876568999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0025 Score=71.04 Aligned_cols=72 Identities=14% Similarity=0.202 Sum_probs=48.4
Q ss_pred EeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc-eeeEeceeecCCceE
Q 003963 509 IGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 579 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 579 (783)
-++.|+.|....||++.... ++.+++|+..... . ...+.+|..+++.|...+ .+++++.+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 35678889999999998653 3679999874321 1 123446888888875333 3566765542 3
Q ss_pred EEEEecCCC
Q 003963 580 IVTEFLPRG 588 (783)
Q Consensus 580 lV~E~~~gg 588 (783)
+||||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0086 Score=63.56 Aligned_cols=75 Identities=11% Similarity=0.061 Sum_probs=47.9
Q ss_pred eeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCC--ceeeEece-----eecCCceEEEEE
Q 003963 511 EQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGA-----VTSPQRLCIVTE 583 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~-----~~~~~~~~lV~E 583 (783)
..|+ |....||++...+++.+++|+........ ..+..|..+++.|... .+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 88889998876555679999986443333 3455677777777421 24444443 122455688999
Q ss_pred ecCCCC
Q 003963 584 FLPRGS 589 (783)
Q Consensus 584 ~~~ggs 589 (783)
|++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998743
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0009 Score=71.58 Aligned_cols=65 Identities=18% Similarity=0.143 Sum_probs=53.9
Q ss_pred CcCCCCHHHHHHH-----HHHhCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCCCccccccccccchH
Q 003963 123 SAFNFTDRQYLNI-----LQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDV 187 (783)
Q Consensus 123 ~a~~~~~~~~~~i-----le~~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~ 187 (783)
++.-++++.++.+ |+++..=++++..+ |+|+|+++.+..++||+.+|++|+.+.+++++++...+
T Consensus 14 ~~~~~s~eel~~l~~e~lLqaldGF~~vvs~~~G~i~yvS~sv~~~Lg~~~~~l~g~s~~d~iHp~D~~~f 84 (320)
T 4dj2_A 14 DMSTYTLEELEHITSEYTLRNQDTFSVAVSFLTGRIVYISEQAGVLLRCKRDVFRGARFSELLAPQDVGVF 84 (320)
T ss_dssp CCSEECHHHHHHHHHHHTTSCSSEEEEEEETTTCBEEEECTHHHHHHTSCSTTTTTSBGGGGBCHHHHHHH
T ss_pred CccccCHHHHHHHHHHHHHhccCCEEEEEECCCceEEEECcHHHHHhCcCHHHHcCCcHHHhcCHHHHHHH
Confidence 3455677888877 66676666778875 99999999999999999999999999999999885443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0059 Score=66.82 Aligned_cols=142 Identities=13% Similarity=0.151 Sum_probs=80.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCC
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 576 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 576 (783)
.++ ++.|..|-...+|++.... .+.|++|+...... ....+.+|..+++.|. +.-..++++++..
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE-- 125 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence 344 3567778899999988642 35799998533211 1234558999888874 3333567766653
Q ss_pred ceEEEEEecCCCCHH--------------HHHh---hcC----Ccc--hHHHHHHHHHHHHH------------------
Q 003963 577 RLCIVTEFLPRGSLF--------------RLLQ---RNT----TKL--DWRRRILMALDIAR------------------ 615 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~--------------~~L~---~~~----~~l--~~~~~~~i~~qi~~------------------ 615 (783)
.+||||++|..|. +.|. ... ... -+.++..+..++-.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 3899999875432 1111 111 011 23344444433211
Q ss_pred -HHHH----HHhCC--CCEEecCCCCCCEEEcCC----CcEEEEecCCCcc
Q 003963 616 -GVSY----LHHCN--PPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRL 655 (783)
Q Consensus 616 -aL~~----LH~~~--~~IvHrDIKp~NILl~~~----~~vkL~DFGla~~ 655 (783)
.+.. |...+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1222 22221 238999999999999876 7899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0052 Score=69.04 Aligned_cols=74 Identities=11% Similarity=0.091 Sum_probs=47.1
Q ss_pred EeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce-eeEeceeecCCceEEEEEecC
Q 003963 509 IGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLP 586 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 586 (783)
-++.|+.|-...+|++...+ .+.+++|+..... .. . -...+|..+++.|...++ +++++++. + .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-I-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-C-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-h-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 35678889999999998654 3679999874321 10 0 011468889998864444 56777663 2 35999998
Q ss_pred CCC
Q 003963 587 RGS 589 (783)
Q Consensus 587 ggs 589 (783)
|..
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.017 Score=62.09 Aligned_cols=32 Identities=22% Similarity=0.347 Sum_probs=27.9
Q ss_pred CEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 626 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 626 ~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.++|+|+.+.|||++.++.+.|+||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 39999999999999988889999999876543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.0034 Score=68.17 Aligned_cols=73 Identities=11% Similarity=0.124 Sum_probs=43.1
Q ss_pred eeeeccCCcEEEEEEEEeC---------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCc-eeeEeceeecCCceE
Q 003963 510 GEQIGQGSCGTVYHAVWYG---------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 579 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 579 (783)
.+.|+.|..-.+|++...+ .+.+++|+...... .......|..+++.|...+ ++++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4678889889999998653 15789998654211 0112346788888775323 446665442 37
Q ss_pred EEEEecCCCC
Q 003963 580 IVTEFLPRGS 589 (783)
Q Consensus 580 lV~E~~~ggs 589 (783)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998743
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0014 Score=70.03 Aligned_cols=53 Identities=11% Similarity=0.107 Sum_probs=47.2
Q ss_pred HHHHhCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCCCccccccccccchH
Q 003963 135 ILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDV 187 (783)
Q Consensus 135 ile~~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~ 187 (783)
+++++..=+++++.+ |+|+|+++++..++||+.+|++|+.+.+++++++...+
T Consensus 31 ~L~aldgF~~vvs~~~G~i~yvS~~~~~~Lg~~~~el~g~s~~d~ihp~D~~~f 84 (317)
T 4dj3_A 31 TSKNTDTFAAVFSFLSGRLVHISEQAALILNSKRGFLKSVHFVDLLAPQDVRAF 84 (317)
T ss_dssp HTSCTTEEEEEEETTTCBEEEECTTHHHHTTCCHHHHHTSBGGGGBCGGGHHHH
T ss_pred HHhccCCEEEEEEcCCcEEEEECCHHHHHcCCCHHHHcCCchhhhcChhhHHHH
Confidence 488888778888886 99999999999999999999999999999999886443
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.0029 Score=67.27 Aligned_cols=55 Identities=11% Similarity=0.123 Sum_probs=38.9
Q ss_pred HHHHHHhCcceEEEcCC-CcEEEecHHHHHHcCCChhhHcCCCccccccccccchH
Q 003963 133 LNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDV 187 (783)
Q Consensus 133 ~~ile~~~d~I~i~D~~-G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~ 187 (783)
+.+|+++..=+++++.+ |+|+|+++++..++||+.+|++|+.+.+++++++...+
T Consensus 18 ~lll~a~dgF~~vvs~~~G~i~yvS~s~~~~Lg~~~~el~g~s~~d~iHp~D~~~~ 73 (309)
T 3gdi_A 18 EYIVKNADMFAVAVSLVSGKILYISNQVASIFHCKKDAFSDAKFVEFLAPHDVSVF 73 (309)
T ss_dssp C----CTTEEEEEECTTTCBEEEECTTTTTTC-------CCSBGGGGBCTTTHHHH
T ss_pred HHHHHhcCCEEEEEECCCceEEEECCHHHHHcCCCHHHHcCCchhhccCHhHHHHH
Confidence 35678888888889986 99999999999999999999999999999999886443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.24 E-value=0.13 Score=56.85 Aligned_cols=74 Identities=9% Similarity=0.126 Sum_probs=47.1
Q ss_pred EeeeeccCCcEEEEEEEEeC--------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceE
Q 003963 509 IGEQIGQGSCGTVYHAVWYG--------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 579 (783)
-++.|..|-...+|++.... ++.|++|+..... . ..-...+|..+++.|. +.-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--G-KFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 34667778899999998652 4679999864321 1 0111246788887774 322455665432 37
Q ss_pred EEEEecCCCC
Q 003963 580 IVTEFLPRGS 589 (783)
Q Consensus 580 lV~E~~~ggs 589 (783)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999998854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.13 E-value=0.11 Score=57.12 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=24.8
Q ss_pred EEecCCCCCCEEE------cCCCcEEEEecCCCcc
Q 003963 627 IIHRDLKSSNLLV------DKHWTVKVGDFGLSRL 655 (783)
Q Consensus 627 IvHrDIKp~NILl------~~~~~vkL~DFGla~~ 655 (783)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3456799999998864
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=90.64 E-value=0.31 Score=52.12 Aligned_cols=75 Identities=16% Similarity=0.097 Sum_probs=49.5
Q ss_pred eEEEcC-CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe---EEEEEEEEcC-CCCEEEE
Q 003963 143 VHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTK-TEERVLV 217 (783)
Q Consensus 143 I~i~D~-~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~---~~~e~~~~~k-dG~~~~v 217 (783)
++++|. +++|+.+|..+++++|++.++++|+++.+++++.. ...+...+..+.. ....+..... +|..||+
T Consensus 45 Ll~~~~~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~~----~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~~f~~ 120 (337)
T 2ool_A 45 LFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGGDPAAINPIRLDVVTPDGERAFNG 120 (337)
T ss_dssp EEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC----CCCSEEEEEEETTEEEEEEE
T ss_pred EEEEECCCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHHH----HHHHHHHHhcCCccccCcEEEEEeccCCCeEEEE
Confidence 345676 48999999999999999999999999999987654 2234444443321 1223333333 4566776
Q ss_pred EEEE
Q 003963 218 VATN 221 (783)
Q Consensus 218 ~~~~ 221 (783)
.++.
T Consensus 121 ~~Hr 124 (337)
T 2ool_A 121 ILHR 124 (337)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 6554
|
| >1p0z_A Sensor kinase CITA; transferase; HET: FLC MO7; 1.60A {Klebsiella pneumoniae} SCOP: d.110.6.1 PDB: 2v9a_A 2j80_A* | Back alignment and structure |
|---|
Probab=84.80 E-value=7.7 Score=34.80 Aligned_cols=86 Identities=16% Similarity=0.195 Sum_probs=49.6
Q ss_pred HHHHHHHhC-cceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcC
Q 003963 132 YLNILQSMG-QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (783)
Q Consensus 132 ~~~ile~~~-d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (783)
++.+-+... +-|+++|.+|.+++... .+.+|+++.. ... +..++ .|+.+.... ...
T Consensus 41 ~~~~~~~~~~~~i~v~d~~G~~~a~~~----------~~~iG~~~~~----~~~------~~~al-~G~~~~~~~--~g~ 97 (131)
T 1p0z_A 41 IDPMRSFSDATYITVGDASGQRLYHVN----------PDEIGKSMEG----GDS------DEALI-NAKSYVSVR--KGS 97 (131)
T ss_dssp HHHHHHHSCCSEEEEEETTSBEEECSS----------GGGTTSBCCS----SCC------HHHHH-HCCCEEEEE--EET
T ss_pred HHHHHHhcCCCEEEEEcCCCcEEEecC----------hhhCCCcccC----CCc------HHHHh-CCCeEEEEE--Ecc
Confidence 344333332 47888999998876432 3447775431 111 23445 455544322 122
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEehHH
Q 003963 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (783)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITe 243 (783)
.| +......||++++|+++|++.+-.++..
T Consensus 98 ~g---~~~~~~~PV~~~~g~viGvv~vg~~l~~ 127 (131)
T 1p0z_A 98 LG---SSLRGKSPIQDATGKVIGIVSVGYTIEQ 127 (131)
T ss_dssp TE---EEEEEEEEEECTTCCEEEEEEEEEEGGG
T ss_pred ce---eeEEEEEeEECCCCCEEEEEEEEEEhHH
Confidence 22 2333445999889999999999888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 783 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-88 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-79 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-77 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-76 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-75 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-75 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-74 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-73 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-73 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-73 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-73 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-72 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-72 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-72 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-71 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-70 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-68 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-67 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-67 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-65 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-64 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-63 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-62 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-60 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-50 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-14 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 4e-12 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 8e-07 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 4e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 4e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 9e-05 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 2e-04 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 3e-04 | |
| d1v9ya_ | 113 | d.110.3.2 (A:) Direct oxygen sensor protein, DOS { | 7e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (709), Expect = 4e-88
Identities = 97/276 (35%), Positives = 155/276 (56%), Gaps = 14/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV +++
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 618
+ RH N+LLFMG T+PQ L IVT++ SL+ L TK + + I +A A+G+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 619 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTTKTGKGTPQWMAPE 676
YLH IIHRDLKS+N+ + + TVK+GDFGL+ +K + G+ WMAPE
Sbjct: 119 YLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 677 VLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV----GFMNQRLEIPK 729
V+R + P +SDVY+FG++L+EL T ++P+ N+N+ I + ++
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
+ ++ C RP F +++ + L R
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 2e-79
Identities = 79/264 (29%), Positives = 130/264 (49%), Gaps = 8/264 (3%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
I +DLT +++G G G V + W G DVA+K+ S++ F +E +M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
H ++ G T + + I+TE++ G L L+ + ++ + M D+ + YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPEVLRN 680
+HRDL + N LV+ VKV DFGLSR + T+ G K +W PEVL
Sbjct: 118 S--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 681 EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
KSD+++FGV++WE+ + K+P++ + + + RL P + I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 740 ESCWHSDPQCRPSFQELVDKLRDL 763
SCWH RP+F+ L+ + D+
Sbjct: 235 YSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 1e-77
Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 14/270 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+ + ++L + + IG+G G V + G VAVK + F E S+M +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQA----FLAEASVMTQ 56
Query: 560 LRHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 617
LRH N++ +G V L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 677
YL N +HRDL + N+LV + KV DFGL++ T TGK +W APE
Sbjct: 117 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEA 171
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
LR + KSDV+SFG++LWE+ + ++P+ + V+ V +++ P P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 230
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
++++CWH D RPSF +L ++L ++
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 1e-76
Identities = 86/276 (31%), Positives = 143/276 (51%), Gaps = 14/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
++E+ E L + E++G G G V+ + G VAVK + S + +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMK 63
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 617
+L+H ++ VT + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAPE 676
+++ N IHRDL+++N+LV + K+ DFGL+RL + Y + K +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
+ KSDV+SFG++L E+ T +IP+ + + +VI + R+ P +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239
Query: 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771
++ CW P+ RP+F L L D +F A+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLED----FFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 4e-76
Identities = 82/265 (30%), Positives = 134/265 (50%), Gaps = 8/265 (3%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
I +LT ++IG G G V+ W VA+K S+E F +E +M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HP ++ G +C+V EF+ G L L+ + M LD+ G++YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 680
+IHRDL + N LV ++ +KV DFG++R + + Y ++ K +W +PEV
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 681 EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
KSDV+SFGV++WE+ +E KIP++N ++ +V+ + RL P+ I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQ 764
CW P+ RP+F L+ +L ++
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 1e-75
Identities = 65/263 (24%), Positives = 117/263 (44%), Gaps = 10/263 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
ED + IG GS G + + K ++ EV+L++ L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 564 NVLLFMGAVT--SPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVS 618
N++ + + + L IV E+ G L ++ + T + LD + + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 619 YLH---HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675
H ++HRDLK +N+ +D VK+GDFGL+R+ + K GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
E + +EKSD++S G +L+EL P+ + ++ G + + IP
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 736 AAIVESCWHSDPQCRPSFQELVD 758
I+ + RPS +E+++
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 8e-75
Identities = 88/274 (32%), Positives = 137/274 (50%), Gaps = 11/274 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD----VAVKVFSRQEYSDEVIHSFRQEV 554
DYEI E + +G IG+G G V+ ++ ++ VA+K + SD V F QE
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 59
Query: 555 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 60 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 673
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
APE + SDV+ FGV +WE+ P+ + + VIG + +RL +P +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
P +++ CW DP RP F EL +L + +
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 1e-74
Identities = 90/272 (33%), Positives = 128/272 (47%), Gaps = 12/272 (4%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSD-EVIHSFRQEVSL 556
I +DL + E++G GS G V W VAVK S E + F +EV+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
M L H N++ G V +P + +VTE P GSL L+++ A+ +A G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 673
+ YL IHRDL + NLL+ VK+GDFGL R + Y+ + K W
Sbjct: 124 MGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
APE L+ SD + FGV LWE+ T + PW LN Q++ + +RL P+D
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
++ CW P+ RP+F L D L + Q
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 2e-73
Identities = 90/268 (33%), Positives = 143/268 (53%), Gaps = 10/268 (3%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMK 558
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 67
Query: 559 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIARGV 617
+LRH ++ V S + + IVTE++ +GSL L+ T K + + MA IA G+
Sbjct: 68 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPE 676
+Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G K +W APE
Sbjct: 127 AYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 677 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
KSDV+SFG++L EL T+ ++P+ + + +V+ V R+ P +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 243
Query: 736 AAIVESCWHSDPQCRPSFQELVDKLRDL 763
++ CW +P+ RP+F+ L L D
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 238 bits (607), Expect = 4e-73
Identities = 92/288 (31%), Positives = 142/288 (49%), Gaps = 14/288 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
+E+ D+T+ ++G G G VY VW VAVK E F +E ++M
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVM 67
Query: 558 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARG 616
K ++HPN++ +G T I+TEF+ G+L L + N ++ + MA I+
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAP 675
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G K +W AP
Sbjct: 128 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 735
E L KSDV++FGV+LWE+AT + + + + + R+E P+ +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245
Query: 736 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQKEL 783
++ +CW +P RPSF E+ + ++ S++ D +KEL
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQE------SSISDEVEKEL 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 4e-73
Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 562
ED IG +G+G G VY A S +A+KV + + V H R+EV + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
PN+L G R+ ++ E+ P G+++R LQ+ + K D +R ++A +SY H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+IHRD+K NLL+ +K+ DFG S + T GT ++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
DEK D++S GV+ +E K P++ + + P V ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 743 WHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773
+P RP +E+ L+ + A+ S
Sbjct: 239 LKHNPSQRPMLREV------LEHPWITANSS 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 7e-73
Identities = 83/315 (26%), Positives = 135/315 (42%), Gaps = 39/315 (12%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSQD------ 531
T SS +D +Y++ WE +L G+ +G G+ G V +A YG
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 532 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 590
VAVK+ + S E E+ +M +L H N++ +GA T + ++ E+ G L
Sbjct: 70 VAVKMLKEKADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 591 FRLLQRNTTK----------------------LDWRRRILMALDIARGVSYLHHCNPPII 628
L+ K L + + A +A+G+ +L + +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186
Query: 629 HRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 686
HRDL + N+LV VK+ DFGL+R Y+ + +WMAPE L K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 687 SDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 745
SDV+S+G++LWE+ + P+ + + +++ P I++SCW
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 746 DPQCRPSFQELVDKL 760
D + RPSF L L
Sbjct: 307 DSRKRPSFPNLTSFL 321
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 236 bits (603), Expect = 2e-72
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 14/275 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQD----VAVKVFSRQEYSDEVIHSFRQEVSL 556
EI + I + IG G G V VA+K + Y+++ F E S+
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 80
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
M + HPNV+ G VT + I+TEF+ GSL L++N + + + M IA G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTPQ 671
+ YL N +HRDL + N+LV+ + KV DFGLSR TY + GK +
Sbjct: 141 MKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 730
W APE ++ SDV+S+G+++WE+ + + P+ ++ + VI A+ + RL P D
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
++ CW D RP F ++V+ L + R
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 2e-72
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 17/272 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ I ++G G+ G VY A + A KV + S+E + + E+ ++ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 69
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ + A L I+ EF G++ ++ L + ++ ++YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL----- 678
IIHRDLK+ N+L +K+ DFG+S T + GTP WMAPEV+
Sbjct: 130 K--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAA 737
++ P D K+DV+S G+ L E+A + P LN M+V+ + L P +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
++ C + R + +L LQ +
Sbjct: 248 FLKKCLEKNVDARWTTSQL------LQHPFVT 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 3e-72
Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 13/267 (4%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
++L I + ++G G+ G+V V+ DVA+KV +Q +E +M +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 66
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
+P ++ +G V + L +V E G L + L ++ + ++ G+ YL
Sbjct: 67 DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEV 677
N +HRDL + N+L+ K+ DFGLS+ Y GK +W APE
Sbjct: 126 EEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ +SDV+S+GV +WE + + P+ + +V+ + +R+E P + P
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELY 242
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDL 763
A++ CW + RP F + ++R
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 8e-72
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 565
L +IG+GS TVY + + +VA ++ + F++E ++K L+HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 566 LLFMGAVTSPQR----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
+ F + S + + +VTE + G+L L+R + + I +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 129
Query: 622 HCNPPIIHRDLKSSN-LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
PPIIHRDLK N + +VK+GD GL+ LK ++ K GTP++MAPE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE 187
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
DE DVY+FG+ + E+AT + P+ N+ Q+ V + K P I+
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
E C + R S ++L L +FQ
Sbjct: 247 EGCIRQNKDERYSIKDL------LNHAFFQ 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 1e-71
Identities = 69/266 (25%), Positives = 124/266 (46%), Gaps = 13/266 (4%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 560
+ LT+ + ++G G+ GTV + + VAVK+ + + E ++M++L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 561 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
+P ++ +G + + +V E G L + LQ+N + + I + ++ G+ YL
Sbjct: 66 DNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL 123
Query: 621 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEV 677
N +HRDL + N+L+ K+ DFGLS+ Y GK +W APE
Sbjct: 124 EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ KSDV+SFGV++WE + + P+ + +V + +R+ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMY 240
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRD 762
++ CW D + RP F + +LR+
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (591), Expect = 1e-70
Identities = 80/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
+ W D+ + IG+G+ G V A D A+K ++ S + F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVL 64
Query: 558 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKL 601
+L HPN++ +GA L + E+ P G+L L+++ + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 602 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 125 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 720
G+ +WMA E L SDV+S+GV+LWE+ + P+ + ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
RLE P + D ++ CW P RPSF +++ L + +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (590), Expect = 1e-70
Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 36/303 (11%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD------VAVKVFSRQEYSDEV 546
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 59
Query: 547 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-------- 598
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 599 ---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643
L ++ +A +A G++YL +HRDL + N LV ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM 177
Query: 644 TVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 701
VK+ DFGLSR + + Y +WM PE + +SDV+++GV+LWE+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 702 -EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 760
P+ + +VI V L P++ ++ CW P RPSF + L
Sbjct: 238 YGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 761 RDL 763
+ +
Sbjct: 297 QRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 3e-68
Identities = 61/263 (23%), Positives = 124/263 (47%), Gaps = 6/263 (2%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
E+ +D ++G G+ G V+ S +A K+ E + + +E+ ++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHE 60
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
P ++ F GA S + I E + GSL ++L++ ++ + +++ + +G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTY 119
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
L + I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 120 LREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 176
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
+SD++S G+ L E+A + P ++ ++ G + PR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 740 ESCWHSDPQCRPSFQELVDKLRD 762
S + D + + EL+D + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVN 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-68
Identities = 85/290 (29%), Positives = 133/290 (45%), Gaps = 16/290 (5%)
Query: 492 DLDNDCLDYEILWEDLTI--GEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDE 545
+L I L + E IG+G G VYH + AVK +R E
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 546 VIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 604
V F E +MK HPNVL +G + S +V ++ G L ++ T +
Sbjct: 72 VSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 605 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TY 660
I L +A+G+ + +HRDL + N ++D+ +TVKV DFGL+R ++ +
Sbjct: 131 DLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 719
K +WMA E L+ + KSDV+SFGV+LWEL T P+ ++N+ + +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL- 247
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+RL P+ ++ CWH + RPSF ELV ++ + +
Sbjct: 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 5e-68
Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 34/303 (11%)
Query: 489 NKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFS 538
N V +D L Y+ WE L+ G+ +G G+ G V A YG VAVK+
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 539 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR- 596
+ E + E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 63 PSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 597 ----------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 640
+ LD + + +A+G+++L N IHRDL + N+L+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179
Query: 641 KHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 698
K+ DFGL+R Y+ + +WMAPE + N +SDV+S+G+ LWE
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 699 LATEKIPWD-NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 757
L + + + R+ P+ I+++CW +DP RP+F+++V
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 758 DKL 760
+
Sbjct: 300 QLI 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (572), Expect = 1e-67
Identities = 81/264 (30%), Positives = 122/264 (46%), Gaps = 15/264 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQ-EYSDEVIHSFRQEVSL 556
D E L+ DL +IG GS G VY A S+ VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 557 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
+++LRHPN + + G +V E+ + L L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQG 127
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 676
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + + GTP WMAPE
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPE 181
Query: 677 VLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733
V+ D K DV+S G+ ELA K P N+N+M + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 734 RWAAIVESCWHSDPQCRPSFQELV 757
+ V+SC PQ RP+ + L+
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-67
Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 13/270 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKR 559
+ + +G G+ GTVY +W + VA+K R+ S + E +M
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 67
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
+ +P+V +G + + ++T+ +P G L ++ + + + + + IA+G++Y
Sbjct: 68 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEV 677
L ++HRDL + N+LV VK+ DFGL++L E + GK +WMA E
Sbjct: 127 LEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 678 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736
+ + +SDV+S+GV +WEL T P+D + + ++ + +RL P
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 243
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766
I+ CW D RP F+EL+ + + R
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-67
Identities = 89/289 (30%), Positives = 145/289 (50%), Gaps = 22/289 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQ 552
++E+ E +T+ ++GQGS G VY V G VA+K + E I F
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 72
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 603
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 604 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYL 661
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +E Y
Sbjct: 133 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 720
G +WM+PE L++ SDV+SFGV+LWE+AT + P+ L++ QV+ V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-M 249
Query: 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
L+ P + ++ CW +P+ RPSF E++ +++ F+
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 2e-67
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 11/273 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQD-----VAVKVFSRQEYSDEVIHSFRQEVS 555
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 61
Query: 556 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 615
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 616 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQW 672
G + N +HRDL + N+LV+ + KV DFGLSR+ E TT GK +W
Sbjct: 122 G--MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 673 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732
APE + SDV+SFG+++WE+ T S + RL P D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765
++ CW + RP F ++V L L R
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-67
Identities = 70/272 (25%), Positives = 130/272 (47%), Gaps = 14/272 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ T E+IGQG+ GTVY A+ + Q+VA++ + Q+ + E+ +M+ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ ++ + L +V E+L GSL ++ + + + + +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV--CRECLQALEFLHSN 135
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
+IHRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ +
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESC 742
K D++S G++ E+ + P+ N N ++ + + L+ P+ + + + C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 743 WHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774
D + R S +EL LQ Q+ + ++
Sbjct: 254 LDMDVEKRGSAKEL------LQHQFLKIAKPL 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (565), Expect = 6e-67
Identities = 82/302 (27%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
+ + E IG+G G V+ W G ++VAVK+FS +E E+ LRH N
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWF---REAEIYQTVMLRHEN 58
Query: 565 VLLFMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
+L F+ A +L +V+++ GSLF L R + I +AL A G+++L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHL 116
Query: 621 HH------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTP 670
H P I HRDLKS N+LV K+ T + D GL+ + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 671 QWMAPEVLRNE------PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ----------- 713
++MAPEVL + S +++D+Y+ G++ WE+A Q
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 714 ----VIGAVGFMNQRLEIPKDVDP-----RWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 764
+ V R IP A I+ CW+++ R + + L L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 765 RQ 766
+Q
Sbjct: 297 QQ 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-66
Identities = 59/269 (21%), Positives = 118/269 (43%), Gaps = 9/269 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 562
ED G+ +G+GS TV A + ++ A+K+ ++ E + +E +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
P + ++L + G L + +++ D +I + YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 126
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRN 680
IIHRDLK N+L+++ +++ DFG +++ + GT Q+++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740
+ + + SD+++ G I+++L P+ N + + + + P+ P+ +VE
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 741 SCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
D R +E+ +F+
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 15/270 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
ED + + +G+G+ G V AV + + VAVK+ + + + + ++E+ + K L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
NV+ F G + E+ G LF ++ + + + GV YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 681
I HRD+K NLL+D+ +K+ DFGL+ + + GT ++APE+L+
Sbjct: 123 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 682 P-SDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
E DV+S G++L + ++PWD + S Q L K +D A++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+P R + ++ + +++
Sbjct: 241 HKILVENPSARITIPDI------KKDRWYN 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-64
Identities = 80/290 (27%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQ 552
+E + L +G+ +G+G+ G V A +G + VAVK+ E +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 553 EVSLMKRLRHPNVLLFMGAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTK----------- 600
L+ H NV+ +GA T P L ++ EF G+L L+ +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 601 ----LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL- 655
L I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 656 -KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 713
K Y+ + +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 714 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
R+ P P + CWH +P RP+F ELV+ L +L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 6e-64
Identities = 82/292 (28%), Positives = 143/292 (48%), Gaps = 31/292 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQD--------VAVKVFSRQEYSDEVIHSF 550
+E+ + L +G+ +G+G+ G V A G VAVK+ + + +++ +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 65
Query: 551 RQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------ 597
E+ +MK + +H N++ +GA T L ++ E+ +G+L LQ
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 598 ---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
+L + + A +ARG+ YL IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 655 LKHE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 711
H Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T P+ +
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763
++ + R++ P + ++ CWH+ P RP+F++LV+ L +
Sbjct: 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (545), Expect = 2e-63
Identities = 57/278 (20%), Positives = 124/278 (44%), Gaps = 16/278 (5%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
+++ I E++G G+ G V+ V + + K + D+ ++ + E+S+M +L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLH 84
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HP ++ A + ++ EFL G LF + K+ I G+ ++H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 622 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
+ I+H D+K N++ + K +VK+ DFGL+ + + T T ++ APE++
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVD 201
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 737
EP +D+++ GV+ + L + P+ + ++ + V + + V P
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 775
+++ +P+ R + + L+ + + S +
Sbjct: 262 FIKNLLQKEPRKRLTVHDA------LEHPWLKGDHSNL 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 213 bits (543), Expect = 4e-63
Identities = 58/270 (21%), Positives = 110/270 (40%), Gaps = 16/270 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ I E++G G+ G V+ + + A K SD+ + R+E+ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHP 83
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
++ A + ++ EF+ G LF + K+ + + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 624 NPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
N +H DLK N++ + +K+ DFGL+ + K GT ++ APEV +
Sbjct: 144 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGK 200
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIV 739
P +D++S GV+ + L + P+ N + + V N + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+DP R + + L+ +
Sbjct: 261 RKLLLADPNTRMTIHQA------LEHPWLT 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-62
Identities = 55/272 (20%), Positives = 115/272 (42%), Gaps = 17/272 (6%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 561
L+E I E +G+G G V+ V S + K + ++E+S++ R
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIAR 59
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
H N+L + S + L ++ EF+ +F + + +L+ R + + + +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 622 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
N I H D++ N++ + T+K+ +FG +R + P++ APEV +
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQ 176
Query: 680 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAA 737
++ +D++S G +++ L + P+ + Q+I + E K++
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
V+ + + R + E LQ + +
Sbjct: 237 FVDRLLVKERKSRMTASEA------LQHPWLK 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-60
Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 13/268 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR 561
ED + + +G+GS G V+ A + + Q A+K + D+V + ++ L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 562 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
HP + + + L V E+L G L +Q K D R A +I G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 681
I++RDLK N+L+DK +K+ DFG+ + T T GTP ++APE+L +
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 682 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741
+ D +SFGV+L+E+ + P+ + ++ ++ P+ ++ ++
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ +P+ R + + Q F+
Sbjct: 237 LFVREPEKRLGVRGDI-----RQHPLFR 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 4e-60
Identities = 62/275 (22%), Positives = 118/275 (42%), Gaps = 17/275 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ + +G G+ V A + + VA+K +++ + S E++++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHP 67
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ S L ++ + + G LF + R + + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL 126
Query: 624 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 680
I+HRDLK NLL D+ + + DFGLS+++ + + T GTP ++APEVL
Sbjct: 127 G--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQ 183
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAI 738
+P + D +S GVI + L P+ + N ++ + + P D+
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773
+ DP+ R + ++ LQ + +
Sbjct: 244 IRHLMEKDPEKRFTCEQA------LQHPWIAGDTA 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 199 bits (508), Expect = 4e-59
Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 27/283 (9%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQ-------EYSDEVIHSFRQEVS 555
+E+ E +G+G V + + ++ AVK+ E E+ + +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 556 LMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
+++++ HPN++ + +V + + +G LF L L + + +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALL 120
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
+ LH N I+HRDLK N+L+D +K+ DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLA 177
Query: 675 PEVLRNEPSD------EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 728
PE++ +D ++ D++S GVI++ L P+ + M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 729 --KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
D +V PQ R + +E L +FQ
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA------LAHPFFQ 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 9e-57
Identities = 67/275 (24%), Positives = 117/275 (42%), Gaps = 15/275 (5%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRL 560
L + +GE +G G V+ A +DVAVKV D FR+E L
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 561 RHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 616
HP ++ + IV E++ +L ++ + +R I + D +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQA 123
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 673
+++ H IIHRD+K +N+++ VKV DFG++R + T GT Q++
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 674 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDV 731
+PE R + D +SDVYS G +L+E+ T + P+ + + V + + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 732 DPRWAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 765
A+V +P+ R + E+ L +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (494), Expect = 1e-56
Identities = 62/268 (23%), Positives = 127/268 (47%), Gaps = 13/268 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 562
+D I +G GS G V+ + + A+KV ++ + + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
P ++ G Q++ ++ +++ G LF LL+++ + + A ++ + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 122
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
II+RDLK N+L+DK+ +K+ DFG ++ + T GTP ++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
++ D +SFG++++E+ P+ + N+M+ + +N L P + ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 743 WHSDPQCRP-SFQELVDKLRDLQRQYFQ 769
D R + Q + + +F+
Sbjct: 236 ITRDLSQRLGNLQNGTEDV--KNHPWFK 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 7e-55
Identities = 63/265 (23%), Positives = 125/265 (47%), Gaps = 18/265 (6%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEY-SDEVI 547
KV ++ D++ L + +G+G+ G V + + A+K+ ++ + + +
Sbjct: 1 KVTMN----DFDYL-------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV 49
Query: 548 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 607
E +++ RHP + A + RLC V E+ G LF L R + R R
Sbjct: 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 608 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 667
A +I + + + +++RD+K NL++DK +K+ DFGL + T KT
Sbjct: 110 YGA-EIVSALE--YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 668 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 727
GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + + +
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRF 224
Query: 728 PKDVDPRWAAIVESCWHSDPQCRPS 752
P+ + P +++ DP+ R
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
DY++ + +G G G V + + A+K+ R+EV L
Sbjct: 12 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 58
Query: 558 KRL-RHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMAL 611
R + P+++ ++ + L IV E L G LF +Q R R +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTTKTGKG 668
I + YLH N I HRD+K NLL +K+ DFG ++ + T
Sbjct: 119 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCY 175
Query: 669 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLE 726
TP ++APEVL E D+ D++S GVI++ L P+ + + + + + + E
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 727 IP----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
P +V ++ + ++P R + E + +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIM 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-54
Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 27/271 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR- 561
+G +G G G+VY + VA+K + SD EV L+K++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 562 -HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 620
V+ + P ++ E L + V +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 621 HHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 679
H+C ++HRD+K N+L+D + +K+ DFG L +T T G T + PE +R
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG--TRVYSPPEWIR 182
Query: 680 NEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738
+ V+S G++L+++ IP+++ + + ++ + V +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHL 234
Query: 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ C P RP+F+E+ + Q
Sbjct: 235 IRWCLALRPSDRPTFEEI------QNHPWMQ 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 6e-54
Identities = 57/280 (20%), Positives = 106/280 (37%), Gaps = 24/280 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+G +IG GS G +Y + ++VA+K+ + + E + K ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGI 65
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
+ + ++ L SL L + K + +L+A + + Y+H N
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 627 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTPQWMAPE 676
IHRD+K N L+ K V + DFGL++ +H Y K GT ++ +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 677 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------LEIPKD 730
+ D+ S G +L +PW L + ++++ + K
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL-QRQYFQ 769
+A + C +P + L R+L RQ F
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 59/273 (21%), Positives = 105/273 (38%), Gaps = 21/273 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE----VIHSFRQEVSLMKRLRH 562
GE++G G V + A K ++ +EVS++K ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
PNV+ + + ++ E + G LF L L I GV +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY--YL 129
Query: 623 CNPPIIHRDLKSSNLLVDKHWT----VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 678
+ I H DLK N+++ +K+ DFGL+ GTP+++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIV 188
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWA 736
EP ++D++S GVI + L + P+ + + V +N E +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ DP+ R + Q+ LQ + +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDS------LQHPWIK 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 187 bits (476), Expect = 1e-53
Identities = 57/255 (22%), Positives = 111/255 (43%), Gaps = 12/255 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDE----VIHSFRQEVSLMKR 559
D ++ IG+G G VY + + A+K ++ + + + R +SL+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 560 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 619
P ++ A +P +L + + + G L L ++ + R A +I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 122
Query: 620 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL- 678
+H+ +++RDLK +N+L+D+H V++ D GL+ + GT +MAPEVL
Sbjct: 123 MHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 679 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG-AVGFMNQRLEIPKDVDPRWAA 737
+ D +D +S G +L++L P+ + + +E+P P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 738 IVESCWHSDPQCRPS 752
++E D R
Sbjct: 239 LLEGLLQRDVNRRLG 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (470), Expect = 1e-53
Identities = 50/279 (17%), Positives = 97/279 (34%), Gaps = 25/279 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+G +IG+GS G ++ +Q VA+K R+ + + R E K L +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGI 63
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
+ ++ L SL LL K + + A + V +H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 627 IIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTPQWMA 674
+++RD+K N L+ + + + V DFG+ + +H Y K GT ++M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRL---EIP 728
+ D+ + G + +PW L + Q +G Q E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 729 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767
+ + + P + L + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 37/294 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
E+ E+IG+G+ G VY A + + VA+K ++ V + +E+SL+K L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ + + + +L +V EFL + + T + + +G+++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP- 682
++HRDLK NLL++ +K+ DFGL+R T T + APE+L
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVI----------------GAVGFMNQRLE 726
D++S G I E+ T + + + + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 727 IPK-----------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
PK +D +++ H DP R S + L +FQ
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA------LAHPFFQ 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 9e-50
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 44/300 (14%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-- 560
+ +IG+G+ G V+ A G + VA+K Q + + S +EV++++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 561 -RHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 614
HPNV+ T + +L +V E + + L + + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 615 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 674
RG+ +LH ++HRDLK N+LV +K+ DFGL+R+ + + + T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 675 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV---------------- 718
PEVL D++S G I E+ K + + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 719 ---------GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ D+D ++ C +P R S L YFQ
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQ 297
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 173 bits (438), Expect = 3e-49
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 37/293 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
E E+IG+G+ G VY A + A+K ++ + + + +E+S++K L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 565 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 624
++ + + +RL +V E L L +LL L+ L + G++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 625 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS- 683
++HRDLK NLL+++ +K+ DFGL+R T + AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 684 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------------------------- 718
D++S G I E+ + ++ + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 719 --GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
K +D ++ DP R + ++ L+ YF+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------LEHAYFK 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 1e-48
Identities = 56/268 (20%), Positives = 117/268 (43%), Gaps = 13/268 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 562
+ + +G GS G V S A+K+ +Q+ + I E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 563 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
P ++ + L +V E++ G +F L+R + A I YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS 159
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 682
+ +I+RDLK NLL+D+ ++V DFG ++ T GTP+ +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEIILSKG 214
Query: 683 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742
++ D ++ GV+++E+A P+ +Q+ + ++ ++ P ++ +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 743 WHSDPQCR-PSFQELVDKLRDLQRQYFQ 769
D R + + V+ + ++F
Sbjct: 273 LQVDLTKRFGNLKNGVNDI--KNHKWFA 298
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-48
Identities = 62/290 (21%), Positives = 113/290 (38%), Gaps = 40/290 (13%)
Query: 511 EQIGQGSCGTVYHAVWYGS-QDVAVKVFS---RQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ +G+G TVY A + Q VA+K R E D + + +E+ L++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 567 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 626
+ A + +V +F+ L +++ N+ L L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 627 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DE 685
I+HRDLK +NLL+D++ +K+ DFGL++ T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 686 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--------------------------G 719
D+++ G IL EL + + + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 720 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
I +++ + +P R + + L+ +YF
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFS 284
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 59/278 (21%), Positives = 118/278 (42%), Gaps = 18/278 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSQD----VAVKVFSRQEYSD--EVIHSFRQEVSLMK 558
E+ + + +G G+ G V+ D A+KV + + R E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 559 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 617
+R P ++ A + +L ++ +++ G LF L + + + +I +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 618 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 676
+LH II+RD+K N+L+D + V + DFGLS + GT ++MAP+
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 677 VLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVD 732
++R S D+ D +S GV+++EL T P+ + + P+++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 733 PRWAAIVESCWHSDPQCRPSF-QELVDKLRDLQRQYFQ 769
+++ DP+ R D++ + +FQ
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEI--KEHLFFQ 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-45
Identities = 64/300 (21%), Positives = 116/300 (38%), Gaps = 49/300 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
T IG+G+ G V A + VA+K S E +E+ ++ R RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENII 69
Query: 567 LFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 622
+ +P + + L L++LL+ L I RG+ Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS 127
Query: 623 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLR 679
N ++HRDLK SNLL++ +K+ DFGL+R+ H+ T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 680 NE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------------------GF 720
N + D++S G IL E+ + + + + + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 721 MNQRLEIP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
N L +P + D + +++ +P R ++ L Y +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA------LAHPYLE 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 60/315 (19%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
YE L +IGQG+ G V+ A + Q VA+K + + + +E+ ++
Sbjct: 11 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 558 KRLRHPNVLLFMGAVTSPQ--------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 609
+ L+H NV+ + + + +V +F L K +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRV 122
Query: 610 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKT 665
+ G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R K+
Sbjct: 123 MQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 666 GKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------ 718
T + PE+L E D++ G I+ E+ T + +
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 719 -----------GFMNQRLEIPKD-------------VDPRWAAIVESCWHSDPQCRPSFQ 754
+ ++LE+ K DP +++ DP R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 755 ELVDKLRDLQRQYFQ 769
+ L +F
Sbjct: 301 DA------LNHDFFW 309
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-44
Identities = 63/295 (21%), Positives = 118/295 (40%), Gaps = 39/295 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 563
+ E+IG+G+ GTV+ A + + VA+K + + V S +E+ L+K L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 564 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 623
N++ + S ++L +V EF + N + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLKGLGFCHSR 120
Query: 624 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 683
N ++HRDLK NLL++++ +K+ +FGL+R T + P+VL
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 684 -DEKSDVYSFGVILWELATEKIPW----DNLNSMQVIGAVGFM----------------- 721
D++S G I ELA P D + ++ I +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 722 -------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
+ + ++ ++++ +P R S +E LQ YF
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA------LQHPYFS 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-41
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 49/298 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ +G G+ G V AV + VA+K R S+ +E+ L+K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 567 LFMGAVTSPQRLCIVTEF-----LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 621
+ T + L T+F L +L++ KL R + + +G+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 138
Query: 622 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN- 680
HRDLK NL V++ +K+ DFGL+R T + APEV+ N
Sbjct: 139 AAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNW 193
Query: 681 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--------------- 725
+ D++S G I+ E+ T K + + + + + +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 726 --------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
I + P ++E D + R + E L YF+
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------LAHPYFE 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 54/301 (17%), Positives = 92/301 (30%), Gaps = 51/301 (16%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 564
T + IG GS G VY A S + VA+K + + +E+ +M++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 565 VLLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARG 616
++ S L +V +++P R L L + R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 617 VSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 675
++Y+H I HRD+K NLL+D +K+ DFG ++
Sbjct: 135 LAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 676 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV----------------- 718
+ DV+S G +L EL + + + + + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 719 ----------GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 768
P A+ P R + E +F
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA------CAHSFF 306
Query: 769 Q 769
Sbjct: 307 D 307
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 63/265 (23%), Positives = 111/265 (41%), Gaps = 21/265 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLM 557
+ +L + + IG G+ G V A ++VA+K SR + +E+ LM
Sbjct: 12 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 558 KRLRHPNVLLFMGAVTSP------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
K + H N++ + T Q + +V E + + D R +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLY 126
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 671
+ G+ +LH IHRDLK SN++V T+K+ DFGL+R +++ T T
Sbjct: 127 QMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRY 183
Query: 672 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731
+ APEV+ E D++S G I+ E+ KI + + + N+ +E
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ------WNKVIEQLGTP 237
Query: 732 DPRWAAIVESCWHSDPQCRPSFQEL 756
P + ++ + + RP + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGL 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 70/308 (22%), Positives = 118/308 (38%), Gaps = 52/308 (16%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSL 556
+ +WE +G G+ G+V A + VAVK SR S +E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 557 MKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
+K ++H NV+ + T + L + L L +++ KL +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIY 128
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 671
I RG+ Y+H + IIHRDLK SNL V++ +K+ DFGL+ T T
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 183
Query: 672 WMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI--------------- 715
+ APE+ L ++ D++S G I+ EL T + + + + +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 716 ------GAVGFMNQRLEIPK--------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761
A ++ ++PK +P ++E D R + +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA----- 298
Query: 762 DLQRQYFQ 769
L YF
Sbjct: 299 -LAHAYFA 305
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 141 bits (355), Expect = 2e-37
Identities = 59/319 (18%), Positives = 122/319 (38%), Gaps = 63/319 (19%)
Query: 496 DCLDYEILW---EDLTIGEQIGQGSCGTVYHAVW-YGSQDVAVKVFSRQEYSDEVIHSFR 551
D + + W +D + ++G+G V+ A+ ++ V VK+ + +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IK 77
Query: 552 QEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 608
+E+ +++ LR PN++ V P + +V E + +L Q L
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 609 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGK 667
+I + + Y H I+HRD+K N+++D +H +++ D+GL+ H
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV- 190
Query: 668 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS--------MQVIGAV 718
+ + PE+L + D D++S G +L + K P+ + + +V+G
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 719 GFMNQRLEIPKDVDPRWAAI----------------------------VESCWHSDPQCR 750
+ + ++DPR+ I ++ D Q R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 751 PSFQELVDKLRDLQRQYFQ 769
+ +E ++ YF
Sbjct: 311 LTAREA------MEHPYFY 323
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 3e-29
Identities = 50/330 (15%), Positives = 108/330 (32%), Gaps = 81/330 (24%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGS-QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 566
+ ++G G TV+ A + VA+K+ + E + E+ L++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72
Query: 567 L---------------FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 611
F + + +V E L L + + + ++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 612 DIARGVSYLHHCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGLSRLKHETYLTTKT 665
+ G+ Y+H IIH D+K N+L++ +K+ D G + E Y +
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI- 190
Query: 666 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD------------------ 707
T ++ +PEVL P +D++S +++EL T ++
Sbjct: 191 --QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 708 ----------------------------NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739
N++ ++ + ++ + KD + +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769
DP+ R L + + +
Sbjct: 309 SPMLQLDPRKRADAGGL------VNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 29/162 (17%), Positives = 55/162 (33%), Gaps = 31/162 (19%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSQDVAVKVF----------------SRQEYSDEVIHSFRQ 552
IG+ +G+G V++ + VK +S I S R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 553 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 612
E +++L+ V ++ E + + +++ +L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK------ELYRVRVENPDEVL--DM 111
Query: 613 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654
I V+ +H I+H DL N+LV + + + DF S
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 68.3 bits (166), Expect = 1e-14
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 139 MGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI 195
+ + + D + ++Y + + GY +E LG + L +G D I I
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 196 KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K GE + + K + T TP DG + V V D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 61.1 bits (147), Expect = 4e-12
Identities = 20/90 (22%), Positives = 31/90 (34%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + L Y+ EE LG + L G D I +K T Q TK
Sbjct: 14 PIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTK 73
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ D++G + + V +
Sbjct: 74 GGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 45.9 bits (108), Expect = 8e-07
Identities = 13/99 (13%), Positives = 24/99 (24%), Gaps = 1/99 (1%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR 194
++ D S I +NR+ L G E +G++ + +
Sbjct: 8 EFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMD 67
Query: 195 IKMGERWTGQFP-AKTKTEERVLVVATNTPFYDDDGTLV 232
+F V V D +
Sbjct: 68 GVTSGTLDARFDFVFDFQMAPVRVQIRMQNAGVPDRYWI 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 41.3 bits (95), Expect = 4e-05
Identities = 15/102 (14%), Positives = 29/102 (28%), Gaps = 6/102 (5%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK----MG 198
+ + D I ++ +AE L+G+S EA+GQ+ L+ + I
Sbjct: 3 MIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHI 62
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K + + + D
Sbjct: 63 IGIGRIVTGKRRDGTTFPMHLSIGEMQSGGEP--YFTGFVRD 102
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 4e-05
Identities = 14/107 (13%), Positives = 35/107 (32%), Gaps = 6/107 (5%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGT-LVGIV 235
++ + +++ E++ V + V ++
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCCVVVL 109
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (93), Expect = 9e-05
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
+ + + Y + L GY EE LG+ A E ++ + G+ +
Sbjct: 9 LSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVS 68
Query: 203 GQFPAKTKTEERVLVVATNTPFYDD-DGTLVGIVCVSTD 240
GQ+ K V + T Y+ + I+CV+
Sbjct: 69 GQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYV 107
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 2e-04
Identities = 17/92 (18%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGERWTGQFPAK 208
+IY N L GYS E + + G A I + E +
Sbjct: 15 AVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFY 74
Query: 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K L + P ++DG ++ +
Sbjct: 75 RKDGSCFLCLVDVVPVKNEDGAVIMFILNFEV 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 39.6 bits (91), Expect = 3e-04
Identities = 17/116 (14%), Positives = 37/116 (31%), Gaps = 6/116 (5%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
D +IL ++ + + I+ +N +A +GY+ EE +GQ+ L+ + +
Sbjct: 15 DAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHD 74
Query: 189 YDIVHRIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + GE+ + K + D
Sbjct: 75 GYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGER--FFTGFIRD 128
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} Length = 113 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Score = 37.9 bits (86), Expect = 7e-04
Identities = 18/113 (15%), Positives = 42/113 (37%), Gaps = 6/113 (5%)
Query: 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191
+ L+ + + +D ++++N +AE L+GY EE +G + L+ I
Sbjct: 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYI 62
Query: 192 VHRIKMG----ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
H + G E + + + K ++ + + + + D
Sbjct: 63 RHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVSAEGKVYY--LALVRD 113
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 783 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.79 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.69 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.69 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.61 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.58 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.57 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.55 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.38 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.36 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.18 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.7 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.96 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 93.3 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 91.39 | |
| d1p0za_ | 131 | Sensor kinase CitA {Klebsiella pneumoniae [TaxId: | 80.36 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=444.44 Aligned_cols=256 Identities=29% Similarity=0.504 Sum_probs=227.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|++++.||+|+||.||+|.++. ++.||||++.+..... .....+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999865 5679999997644322 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999764 46999999999999999999999998 9999999999999999999999999997665432
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
....+||+.|||||++.+..++.++|||||||+||+|++|++||...+..+....+. ...+.+|..+++++.+||.+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHH
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 335679999999999999999999999999999999999999999988887776663 34566788899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||++||.+|||+.|+ |+|+||+.+.
T Consensus 238 ~L~~dp~~R~t~~ei------l~hp~~~~~s 262 (263)
T d2j4za1 238 LLKHNPSQRPMLREV------LEHPWITANS 262 (263)
T ss_dssp HTCSSGGGSCCHHHH------HTCHHHHHHC
T ss_pred HccCCHhHCcCHHHH------HcCcCcCCcC
Confidence 999999999999999 6799998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=442.17 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=226.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|+++++||+|+||.||+|.+.. ++.||||++....... .+.+.+|+.+|+.++|||||++++++..++.+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 3579999999999999999999754 5789999998655433 356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|||+||+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++........
T Consensus 97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999999988753 5999999999999999999999999 999999999999999999999999999876655445
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cccccCCCCCCHHHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~LI~~ 741 (783)
....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..+... ......+..+++++++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 55678999999999999999999999999999999999999999988877666554322 23455667899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 742 CWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 742 cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||.+|||+.|+ |+|+||+...
T Consensus 253 ~L~~dP~~R~s~~ei------l~Hp~~~~~~ 277 (293)
T d1yhwa1 253 CLDMDVEKRGSAKEL------LQHQFLKIAK 277 (293)
T ss_dssp HTCSSTTTSCCHHHH------TTCGGGGGCC
T ss_pred HccCChhHCcCHHHH------hcCHhhCCCC
Confidence 999999999999999 7899997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=444.37 Aligned_cols=263 Identities=22% Similarity=0.387 Sum_probs=229.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|++++.||+|+||.||+|.+.. ++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 3689999999999999999999864 578999999764321 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc--
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 659 (783)
||||+||+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999998764 46999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.......+||+.|||||++.+..++.++|||||||+||+|++|.+||...+....+..+. ...+.+|..+++++++||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 223345679999999999999999999999999999999999999999988888777663 345677889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.+||+.||.+|||+.|++....=++|+||+.+
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999999998877666789999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=436.52 Aligned_cols=262 Identities=36% Similarity=0.608 Sum_probs=221.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
+||+..++|+++++||+|+||.||+|.+. ..||||++..........+.|.+|+.+|+.++|||||++++++.. +.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 46788899999999999999999999754 469999998776666667889999999999999999999998754 568
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
++|||||++|+|.+++.....++++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999999999877778999999999999999999999998 99999999999999999999999999986543
Q ss_pred cc--ccccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----ccccCCC
Q 003963 659 TY--LTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----QRLEIPK 729 (783)
Q Consensus 659 ~~--~~~~~~~Gt~~Y~aPE~~~~~---~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~ 729 (783)
.. .......||+.|||||++.+. .++.++|||||||+||||+||+.||.+.+....+....... ....++.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 22 223456799999999998753 47899999999999999999999999877654443322111 1234667
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 730 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 730 ~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.+++++.+||.+||..||.+|||+.+|++.|+.|+.
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 899999999999999999999999999999998875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=436.56 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=210.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--CCceEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCI 580 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 580 (783)
.++|++++.||+|+||.||+|.++. ++.||||++......+...+.+.+|+.+|+.++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 3689999999999999999999865 5679999998887777777889999999999999999999999864 567899
Q ss_pred EEEecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHHHHhCC---CCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 581 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
|||||++|+|.+++.+ ....+++..++.++.||+.||+|||+.+ .+||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 3456999999999999999999999854 249999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
............+||+.|||||++.+..++.++|||||||++|||++|++||...+..+....+... ....+|..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHH
Confidence 7665444445678999999999999999999999999999999999999999998888777666432 334677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELV 757 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell 757 (783)
+.+||.+||+.||.+|||+.|++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=440.40 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=225.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
+.|+++++||+|+||.||+|.+.. ++.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 469999999999999999999865 56799999976532 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
||++|+|.+++.+....+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998776677999999999999999999999999 9999999999999999999999999998665544444
Q ss_pred cCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-ccccCCCCCCHHHHH
Q 003963 664 KTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAA 737 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~-----~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~ 737 (783)
.+.+||+.|||||++. +..++.++|||||||+||+|++|++||...+..+.+..+.... .....+..+++++.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 4557899999999999999999999999988877766654332 234456779999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
||.+||++||.+|||+.|+ ++|+||+..
T Consensus 248 li~~~L~~dp~~R~t~~el------l~hp~~~~~ 275 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQL------LQHPFVTVD 275 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHH------TTSGGGCCC
T ss_pred HHHHHccCChhHCcCHHHH------hcCcccCCC
Confidence 9999999999999999999 678999743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=435.31 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=217.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
.++|+++++||+|+||.||+|.++. ++.||||++...... +..+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3689999999999999999999865 578999999765432 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc--
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 660 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 660 (783)
|||++|+|.+++.. ...+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999975 346999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccccCCCCCCHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
......+||+.|||||++.+..+ +.++|||||||+||+|++|++||...... .....+.........+..+++++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 22345689999999999988876 57899999999999999999999765433 22222222222333445789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
|.+||+.||.+|||+.++ |+|+||+....
T Consensus 240 i~~~L~~dP~~R~t~~ei------l~hpwf~~~l~ 268 (271)
T d1nvra_ 240 LHKILVENPSARITIPDI------KKDRWYNKPLK 268 (271)
T ss_dssp HHHHSCSSTTTSCCHHHH------TTCTTTTCCCC
T ss_pred HHHHcCCChhHCcCHHHH------hcCHhhCcCCC
Confidence 999999999999999999 68999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=429.44 Aligned_cols=253 Identities=32% Similarity=0.527 Sum_probs=217.9
Q ss_pred eeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec----CCceEEE
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIV 581 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV 581 (783)
|++.++||+|+||+||+|.+.. ++.||+|++..........+.+.+|+++|+.++|||||+++++|+. ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4778899999999999999865 4679999998887777777889999999999999999999999864 3458999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc-CCCcEEEEecCCCccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~ 660 (783)
||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++.+||||||||+||||+ .++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999764 468999999999999999999999877799999999999996 5789999999999765443
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
.....+||+.|||||++.+ .++.++|||||||+||+|++|+.||..... ......+........++..+++++.+||
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 2335689999999999876 489999999999999999999999976654 4444444433334456677899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
.+||++||++|||+.|+ |+|+|||
T Consensus 247 ~~~l~~dp~~R~s~~el------l~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDL------LNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHH------HTSGGGC
T ss_pred HHHccCCHhHCcCHHHH------hCCcccC
Confidence 99999999999999999 7789996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=425.33 Aligned_cols=255 Identities=31% Similarity=0.594 Sum_probs=218.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++|+++++||+|+||.||+|.+.+++.||||++....... +.|.+|+.+++.++|||||++++++..++.+++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 5899999999999999999998888889999998765544 4688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-cc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 663 (783)
|++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....... ..
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 9999999999877778999999999999999999999998 99999999999999999999999999986654322 22
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+.. ......|..+++++.+||.+|
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHH
Confidence 34578999999999999999999999999999999999 6788888777777766643 345667888999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~L~~ 765 (783)
|+.||++|||+.+|+++|++++.
T Consensus 239 l~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=441.01 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=229.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 580 (783)
..++|++++.||+|+||.||+|.++. ++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 45789999999999999999999864 578999999865321 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc
Q 003963 581 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 660 (783)
Q Consensus 581 V~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 660 (783)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+......
T Consensus 83 v~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999764 46899999999999999999999999 9999999999999999999999999998765554
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHH
Q 003963 661 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 740 (783)
Q Consensus 661 ~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~ 740 (783)
......+||+.|||||++.+..++.++|||||||++|||++|++||...+.......+. ...+.+|..+++++++||.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 45556789999999999999999999999999999999999999999998887776653 3457788999999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcC
Q 003963 741 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 741 ~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~~ 771 (783)
+||++||.+|++ +.++ ++|+||+.+
T Consensus 238 ~~L~~dP~~R~~~~~~~~~ei------l~Hp~f~~i 267 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEV------MEHRFFLSI 267 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHH------HTSGGGTTC
T ss_pred hhccCCchhhcccccccHHHH------HcCcccccC
Confidence 999999999995 8888 678999654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-50 Score=430.14 Aligned_cols=261 Identities=32% Similarity=0.537 Sum_probs=218.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCCc----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSQ----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 576 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 576 (783)
++..++|++.++||+|+||.||+|.++... .||||++.... .....+.|.+|+.+|+.++|||||++++++...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 455678999999999999999999975432 47888876543 4556678999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+++|||||++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999877777999999999999999999999998 999999999999999999999999999865
Q ss_pred cccccc-----ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCC
Q 003963 657 HETYLT-----TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 730 (783)
Q Consensus 657 ~~~~~~-----~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 730 (783)
...... .....||+.|||||++.+..++.++|||||||+||||+| |.+||.+.+..+....+. ....++.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 433211 122357899999999999999999999999999999998 899999998887776664 3445677888
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 731 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
+++++.+||.+||+.||.+|||+.+|++.|+++..
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-50 Score=433.87 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=209.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
+.+.|++.++||+|+||.||+|.++. ++.||||++....... ....+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 44679999999999999999999865 5679999998765433 235678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc---CCCcEEEEecCCCccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~ 658 (783)
||||+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999764 46999999999999999999999998 99999999999995 578999999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCCCHHHH
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWA 736 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~ 736 (783)
.. ...+.+||+.|||||++.+..++.++|||||||+||+|++|++||.+.........+...... .+.+..+|+++.
T Consensus 163 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 32 234568999999999999999999999999999999999999999998888777666544333 234467999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+||.+||.+||.+|||+.|+ ++|+||+...
T Consensus 242 ~li~~~L~~dP~~R~s~~ei------l~hp~~~~~~ 271 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQA------LQHPWIAGDT 271 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHH------HHSTTTTSSC
T ss_pred HHHHHHccCCHhHCcCHHHH------hcCHhhCCCC
Confidence 99999999999999999999 6789997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=438.45 Aligned_cols=261 Identities=23% Similarity=0.387 Sum_probs=217.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
|+..++|+++++||+|+||+||+|.+.. ++.||+|++.... .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4556899999999999999999999865 5679999997653 3344578899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
+|||||+||+|.+++.+. ..+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999999764 359999999999999999999997 58 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-------------------
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG------------------- 719 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~------------------- 719 (783)
. ...+.+||+.|||||++.+..++.++|||||||++|||++|+.||...+.........
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 2335689999999999999999999999999999999999999997654322110000
Q ss_pred ----------------------cccccccCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 720 ----------------------FMNQRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 720 ----------------------~~~~~~~~~-~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
.....+.++ ..+++++.+||.+||..||.+|||+.|+ |+|+||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~------L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL------MVHAFIKRSDA 306 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHH------hhCHhhCcCCc
Confidence 000011111 2368899999999999999999999999 67899986543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-50 Score=431.99 Aligned_cols=255 Identities=30% Similarity=0.431 Sum_probs=222.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 582 (783)
+.|+++++||+|+||.||+|.+.. ++.||||++....... ...+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 459999999999999999999865 5679999998766543 55677999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
|||.+|+|..++.. ..++++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999888766654 456999999999999999999999999 999999999999999999999999999765432
Q ss_pred ccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHH
Q 003963 663 TKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 739 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~---~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI 739 (783)
...+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.+....+..+.........+..+++++.+||
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 35679999999999865 35789999999999999999999999988887777666544444445567899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 740 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 740 ~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
.+||+.||.+|||+.++ |+|+||+..+
T Consensus 248 ~~~L~~dP~~Rpt~~el------l~Hp~~~~~~ 274 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVL------LKHRFVLRER 274 (309)
T ss_dssp HHHTCSSGGGSCCHHHH------TTCHHHHSCC
T ss_pred HHHCcCChhHCcCHHHH------HhCHHhcCCC
Confidence 99999999999999999 5678886543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-50 Score=427.29 Aligned_cols=259 Identities=34% Similarity=0.592 Sum_probs=223.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
.||+..++|++.++||+|+||.||+|.+.. ++.||||++....... +.|.+|+.+|+.++|||||+++++|.+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH---HHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 478888999999999999999999999865 5679999987655443 568899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+++|||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999965 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
...... .....|++.|+|||++.+..++.++|||||||++|||++|..| |...+.......+ .....+..|..++++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHH
Confidence 544322 2233578999999999999999999999999999999996555 5555655554444 334567788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999999998877654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=421.91 Aligned_cols=258 Identities=32% Similarity=0.572 Sum_probs=223.4
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
-+||+..++|++.++||+|+||.||+|.+++++.||||++....... +.|.+|+.+|+.++|||||++++++.. +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 35678889999999999999999999998877889999997665443 468899999999999999999998764 56
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+++|||||++|+|.+++... ..++++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 79999999999999987543 335899999999999999999999998 999999999999999999999999999876
Q ss_pred cccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.... .......||+.|||||++.+..++.++|||||||+||||+| |.+||...+..+....+. ....+..|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 5432 22334578999999999999899999999999999999999 566677777777666654 33466678899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~ 762 (783)
+.+||.+||+.||++|||+.+|++.|++
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 9999999999999999999999887654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-50 Score=437.33 Aligned_cols=261 Identities=21% Similarity=0.376 Sum_probs=228.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++.... ......+.+|+.+|+.|+|||||+++++|.+++.+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34689999999999999999999864 5789999987654 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc--CCCcEEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~--~~~~vkL~DFGla~~~~~~ 659 (783)
||||+||+|.+++.....++++..++.++.||+.||+|||++| ||||||||+||||+ .++.|||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999998777778999999999999999999999999 99999999999997 5789999999999876543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~l~~ 737 (783)
. ......||+.|+|||++.+..++.++|||||||+||+|++|++||.+.+....+..+...... ...+..+++++.+
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 233557899999999999999999999999999999999999999998888877776544332 2344679999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
||.+||++||.+|||+.|+ |+|+||+.....
T Consensus 262 li~~~L~~dp~~R~s~~ei------l~Hp~~~~~~~~ 292 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDA------LEHPWLKGDHSN 292 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HTSTTTSSCCTT
T ss_pred HHHHHccCChhHCcCHHHH------hcCHhhCCCcch
Confidence 9999999999999999999 678999765443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.7e-50 Score=436.69 Aligned_cols=259 Identities=21% Similarity=0.377 Sum_probs=226.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
..++|++++.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.+|+.|+|||||++++++.+.+.+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45799999999999999999999864 5789999997543 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC--CCcEEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 659 (783)
||||+||+|.+++.....++++..++.++.||+.||.|||++| ||||||||+||||+. ++.+||+|||+++.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999766667999999999999999999999999 999999999999964 678999999999876543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--cCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~ 737 (783)
. ...+..||+.|||||++.+..++.++|||||||++|+|++|++||...+..+.+..+....... ..+..+++++++
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred c-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 2335689999999999999999999999999999999999999999988888777765443322 233568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
||.+||..||.+|||+.++ |+|+||+...
T Consensus 259 li~~~L~~dP~~R~t~~ei------l~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQA------LEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHH------HHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHH------hcCcccCCCC
Confidence 9999999999999999999 6789997654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=417.58 Aligned_cols=252 Identities=30% Similarity=0.567 Sum_probs=227.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++|+++++||+|+||+||+|.+++++.||||+++...... +.|.+|+.+++.++|||||++++++..++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 6889999999999999999999877889999998776554 4688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc-cc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 663 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 663 (783)
+++|+|..++......+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....... ..
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999999998877778999999999999999999999998 99999999999999999999999999986554322 23
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHh
Q 003963 664 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 742 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~c 742 (783)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+.. ..+...|..+++++.+||.+|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHHHH
Confidence 34568999999999999999999999999999999998 8999999998888777653 446778889999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHH
Q 003963 743 WHSDPQCRPSFQELVDKLRD 762 (783)
Q Consensus 743 L~~dP~~RPsa~ell~~L~~ 762 (783)
|+.||++|||+.+++++|.+
T Consensus 238 l~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCSSGGGSCCHHHHHHHHHC
T ss_pred ccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-50 Score=430.83 Aligned_cols=254 Identities=24% Similarity=0.436 Sum_probs=225.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|+++++||+|+||.||+|.++. ++.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4789999999999999999999865 578999999764322 12346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||||+||+|..++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999998764 45888899999999999999999998 999999999999999999999999999876543
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
..+.+||+.|||||++.+..++.++|||||||+||+|++|+.||...+..+....+. .....+|..+++++.++|.+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 235689999999999999999999999999999999999999999998888777663 34567788899999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 742 CWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 742 cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
||.+||.+|+ |+.++ ++|+||+.+
T Consensus 235 ~L~~dp~~R~~~~r~t~~~i------l~Hp~f~~i 263 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDV------KNHPWFKEV 263 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHH------HTSGGGSSC
T ss_pred HhhhCHHhccccchhhHHHH------HcCcccccC
Confidence 9999999996 89999 678999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=419.55 Aligned_cols=262 Identities=25% Similarity=0.481 Sum_probs=224.8
Q ss_pred cccceeEeee-eccCCcEEEEEEEEeC---CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCce
Q 003963 503 LWEDLTIGEQ-IGQGSCGTVYHAVWYG---SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 578 (783)
Q Consensus 503 ~~~~y~i~~~-LG~G~fG~Vy~a~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 578 (783)
..++|.+... ||+|+||.||+|.++. +..||||++.... .....+.|.+|+.+|+.++|||||++++++.. +.+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 3467888884 9999999999998743 2369999997543 45567789999999999999999999999875 468
Q ss_pred EEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccc
Q 003963 579 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 658 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 658 (783)
|||||||++|+|.+++...+..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999999998776778999999999999999999999998 99999999999999999999999999986543
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 659 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 659 ~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+. ...++++|..+|++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 32 12234568999999999999999999999999999999998 999999988877766664 34467788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
+.+||.+||..||++|||+.+|++.|+.+...+.+
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999887655444333
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=432.26 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=222.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCCc------eEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEece
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQ------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 571 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 571 (783)
.||+..++|+++++||+|+||.||+|.+.... .||+|++..... ......+.+|+.+|..+ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 46777889999999999999999999986532 589998865432 33446788999999998 89999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhcC----------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 629 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvH 629 (783)
+...+.+|+|||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ |||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 999999999999999999999997543 24788999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 003963 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPW 706 (783)
Q Consensus 630 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf 706 (783)
|||||+|||++.++.+||+|||+|+....... ...+..||+.|||||++.+..++.++|||||||+||||+| |.+||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999986554322 2234467999999999999999999999999999999998 89999
Q ss_pred CCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003963 707 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 761 (783)
Q Consensus 707 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~ 761 (783)
.+.+....+..+.....+++.|..+++++.+||.+||+.||++|||+.+|+++|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9877666555554455677788899999999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=424.24 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=225.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..++|+++++||+|+||+||+|.++. ++.||||++.+..... ...+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44679999999999999999999864 5789999997654322 235678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC----cEEEEecCCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLS 653 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~----~vkL~DFGla 653 (783)
+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999999764 46999999999999999999999999 99999999999998766 5999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCC
Q 003963 654 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDV 731 (783)
Q Consensus 654 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~ 731 (783)
....... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..+.+..+...... ...+..+
T Consensus 165 ~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 165 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp EECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 8765443 334567999999999999999999999999999999999999999998888877776544332 2334678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
|+++.+||.+||..||.+|||+.++ ++|+||+..
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~ei------l~hp~~~~~ 277 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDS------LQHPWIKPK 277 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHH------HHSTTTCC-
T ss_pred CHHHHHHHHHHccCChhHCcCHHHH------hcCcccCCC
Confidence 9999999999999999999999999 679999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=417.73 Aligned_cols=263 Identities=33% Similarity=0.597 Sum_probs=220.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 574 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 574 (783)
+||+..++|++++.||+|+||.||+|.+... ..||||++.... .......+.+|+.+|+.++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4788889999999999999999999987543 347888875433 4556678999999999999999999999986
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
++.+|+|||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 46789999999999999998877778999999999999999999999998 9999999999999999999999999998
Q ss_pred cccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCC
Q 003963 655 LKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 732 (783)
Q Consensus 655 ~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 732 (783)
...... .......||+.|+|||++.+..++.++|||||||+||||++ |.+||...+..+....+. .....++|..+|
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 654332 22334568999999999999999999999999999999998 899999988887776664 344567888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 733 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 733 ~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+++.+||.+||..||.+|||+.+|++.|+++..+
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999988654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=414.43 Aligned_cols=261 Identities=31% Similarity=0.523 Sum_probs=219.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEeCC-----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC
Q 003963 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 575 (783)
Q Consensus 501 e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 575 (783)
|+...+|++.++||+|+||.||+|.++.. ..||||++.... .......|.+|+.+|+.++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 45557899999999999999999987653 359999986543 445566789999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
+.+++|||||.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999998877778999999999999999999999998 99999999999999999999999999986
Q ss_pred cccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcccccccCCCCC
Q 003963 656 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDV 731 (783)
Q Consensus 656 ~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 731 (783)
...... ......||+.|||||++.+..++.++|||||||+||||++| .+||...+..+....+. ...+++.+..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 544321 22234689999999999999999999999999999999995 56666667766665553 34466778889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 732 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999988765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=413.74 Aligned_cols=251 Identities=26% Similarity=0.509 Sum_probs=213.2
Q ss_pred eeeccCCcEEEEEEEEeCC---ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEecCC
Q 003963 511 EQIGQGSCGTVYHAVWYGS---QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 587 (783)
Q Consensus 511 ~~LG~G~fG~Vy~a~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 587 (783)
++||+|+||.||+|.+..+ +.||||++..........+.|.+|+.+|+.++|||||++++++.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 5799999999999987643 469999997766555667789999999999999999999999875 457899999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccc---cccc
Q 003963 588 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LTTK 664 (783)
Q Consensus 588 gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 664 (783)
|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...... ....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999764 46999999999999999999999998 9999999999999999999999999998654332 1223
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhh
Q 003963 665 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 743 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL 743 (783)
...||+.|||||++.+..++.++|||||||++|||++ |++||.+.+..+....+. ...++++|..+|+++.+||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4568999999999999999999999999999999998 899999998887776664 34567788899999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003963 744 HSDPQCRPSFQELVDKLRDLQRQYFQ 769 (783)
Q Consensus 744 ~~dP~~RPsa~ell~~L~~L~~~~f~ 769 (783)
+.||.+|||+.+|++.| ++.||+
T Consensus 248 ~~dp~~RPs~~~i~~~L---~~~~~~ 270 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRL---RNYYYD 270 (277)
T ss_dssp CSSTTTSCCHHHHHHHH---HHHHHH
T ss_pred CCCHhHCcCHHHHHHHh---hCHHhh
Confidence 99999999999998765 445554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-49 Score=431.68 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=225.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
.++|+++++||+|+||.||+|.++. ++.||||++.+.... ....+.+.+|+.+|+.++|||||++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 4789999999999999999999864 578999999764322 13346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
|||+.+|+|..++.+.. .+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999997644 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
....+||+.|||||++.+..++.++|||||||+||+|++|++||.+.+....+..+. ...+.+|..+++++.+||.+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHH
Confidence 235679999999999999999999999999999999999999999988887777663 34566788899999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcC
Q 003963 742 CWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 742 cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~ 771 (783)
||.+||.+|+ |+.++ ++|+||+.+
T Consensus 272 ~L~~dP~kR~~~~r~t~~el------l~Hp~f~~~ 300 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDI------KNHKWFATT 300 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHH------HTSGGGTTC
T ss_pred HhhhCHHhccccccccHHHH------HcCccccCC
Confidence 9999999994 89999 678999654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=424.22 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=223.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-HHHHHHHHHHHHHHH-hCCCCceeeEeceeecCCceEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-DEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
++|+++++||+|+||+||+|.+.. ++.||||++.+.... ......+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 689999999999999999999865 567999999764321 122345556666654 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 661 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 661 (783)
||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999999764 46899999999999999999999998 99999999999999999999999999987655545
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCHHHHHHHHH
Q 003963 662 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 741 (783)
Q Consensus 662 ~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~ 741 (783)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. ...+.+|..+++++.+||.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 5556789999999999999999999999999999999999999999998888777764 34567788999999999999
Q ss_pred hhhhCCCCCCCHH-HHHHHHHHHHHHHhhcC
Q 003963 742 CWHSDPQCRPSFQ-ELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 742 cL~~dP~~RPsa~-ell~~L~~L~~~~f~~~ 771 (783)
||.+||.+||++. ++ ++|+||+.+
T Consensus 237 ~L~~dP~~R~s~~~~l------~~hpff~~~ 261 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDI------RQHPLFREI 261 (320)
T ss_dssp HSCSSGGGSBTTBSCG------GGSGGGTTC
T ss_pred hcccCCCCCcCHHHHH------HhCchhccC
Confidence 9999999999995 77 568888654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-48 Score=410.17 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=223.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC-------HHHHHHHHHHHHHHHhCC-CCceeeEeceeec
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS 574 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 574 (783)
.++|++.+.||+|+||+||+|++.. ++.||||++.+.... ....+.+.+|+.+++.++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4789999999999999999999854 567999999876432 234456889999999997 9999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
++.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999764 46999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--c
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--E 726 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~ 726 (783)
...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|++||...+.......+......+ +
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 766543 3345689999999999863 346889999999999999999999999988877766664433322 2
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.+..+|+++++||.+||+.||++|||+.++ ++|+||+.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~ei------l~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA------LAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHH------TTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHH------HcCHHHHH
Confidence 334789999999999999999999999999 78999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=422.34 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=223.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 581 (783)
++++|++++.||+|+||.||+|.++. ++.||||++..... ....+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 56899999999999999999999865 56799999976542 234678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC--CCcEEEEecCCCcccccc
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 659 (783)
||||+||+|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++. ...+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999877667999999999999999999999999 999999999999985 458999999999865443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--cCCCCCCHHHHH
Q 003963 660 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 737 (783)
Q Consensus 660 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~l~~ 737 (783)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|.+||...+....+..+......+ ..+..+++++++
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 2 2334568999999999999999999999999999999999999999998888777764332221 223468999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 738 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 738 LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
||.+||.+||.+|||+.|+ ++|+||+..
T Consensus 237 li~~~L~~dp~~R~s~~ei------l~hp~~~~~ 264 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEA------LQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HHSHHHHSC
T ss_pred HHHHHccCChhHCcCHHHH------hcCHhhccC
Confidence 9999999999999999999 678999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=411.73 Aligned_cols=258 Identities=33% Similarity=0.532 Sum_probs=217.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..++|++.+.||+|+||.||+|.+... ..||||++.+.... .+..+.|.+|+.+|+.++|||||++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 357899999999999999999987543 26899998765543 3556789999999999999999999999976 46
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 78999999999999998877778999999999999999999999998 9999999999999999999999999998754
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 658 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 658 ~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
.... ......|+..|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+......++.+..+|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 4322 2223457889999999999999999999999999999998 89999999999888887666667788889999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
++.+||.+||..||++|||+.+|++.|++.
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999888765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-48 Score=425.44 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=216.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCC----HHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++.+.... .........++.+++.++|||||++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 35789999999999999999999865 578999999754322 2222333445777778889999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
+|+|||||+||+|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999999764 46889999999999999999999999 9999999999999999999999999998665
Q ss_pred cccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hcccccccCCCCCCHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLEIPKDVDPRW 735 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~s~~l 735 (783)
.. .....+||+.|+|||++. +..++.++|||||||+||+|++|+.||...+........ ........+|..+++++
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 234568999999999986 456899999999999999999999999865543322222 12344566778899999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcC
Q 003963 736 AAIVESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 736 ~~LI~~cL~~dP~~RPs-----a~ell~~L~~L~~~~f~~~ 771 (783)
.+||.+||.+||.+||| +.++ ++|+||+.+
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~ei------l~Hp~f~~i 271 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEV------KESPFFRSL 271 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHH------HTSGGGTTC
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHH------HcCccccCC
Confidence 99999999999999999 7888 679999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=416.43 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=216.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|+++++||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 689999999999999999999854 5789999997665444445788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHH-hhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccc
Q 003963 584 FLPRGSLFRLL-QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 662 (783)
Q Consensus 584 ~~~ggsL~~~L-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 662 (783)
||.+ ++..++ ......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9965 555544 445567999999999999999999999999 999999999999999999999999999877665555
Q ss_pred ccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------cc
Q 003963 663 TKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------RL 725 (783)
Q Consensus 663 ~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------------~~ 725 (783)
.....||+.|+|||++.... ++.++|||||||++|+|++|+.||...+....+..+..... ..
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 55668999999999987766 48899999999999999999999998877665544321100 00
Q ss_pred c-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcCC
Q 003963 726 E-----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 774 (783)
Q Consensus 726 ~-----------~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~~ 774 (783)
. ....+++++.+||.+||..||.+|||+.|+ ++|+||+.+..-
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el------l~H~ff~~~~~p 292 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA------LAHPFFQDVTKP 292 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGTTCCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH------hCCHhhccCCCC
Confidence 0 113567899999999999999999999999 689999877543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=411.50 Aligned_cols=264 Identities=33% Similarity=0.596 Sum_probs=219.8
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCc
Q 003963 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 498 ~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 577 (783)
..|++..++|++.+.||+|+||.||+|.+.+++.||||++....... +.|.+|+.+++.++|||||++++++.+ +.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 34667789999999999999999999999888889999997665543 468899999999999999999999864 56
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
+++|||||++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999888643 345899999999999999999999998 999999999999999999999999999876
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcccccccCCCCCCHH
Q 003963 657 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 734 (783)
Q Consensus 657 ~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 734 (783)
..... ......||+.|+|||++.+..++.++|||||||+||||++| .+||......+.+..+. .....+.+..++++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHH
Confidence 54332 22345689999999999999999999999999999999995 56666666666666554 34456788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 735 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 735 l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
+.+||.+||+.||++||++++|++.| ++||....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L----~~~~~~~~ 276 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFL----EDYFTSTE 276 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH----HTTTSCSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHH----hhhhcCCC
Confidence 99999999999999999999997654 45665543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=411.08 Aligned_cols=267 Identities=29% Similarity=0.522 Sum_probs=216.7
Q ss_pred CcccccccccceeEeeeeccCCcEEEEEEEEeCC------ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 003963 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 568 (783)
Q Consensus 496 ~~~~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 568 (783)
+...|++..++|+++++||+|+||.||+|.+... +.||||++.... .....+.+.+|+.++.++ +|+|||.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3456788889999999999999999999997642 469999987544 334456677788877776 68999999
Q ss_pred eceeecC-CceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCC
Q 003963 569 MGAVTSP-QRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 632 (783)
Q Consensus 569 ~~~~~~~-~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDI 632 (783)
++++... ..+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987654 56899999999999999996532 34889999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 003963 633 KSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL 709 (783)
Q Consensus 633 Kp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf~~~ 709 (783)
||+||||+.++.+||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||++| .+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654332 223355799999999999999999999999999999999986 6788877
Q ss_pred ChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 710 NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 710 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.....+.........+.+|..+++++.+||.+||+.||++|||+.+++++|+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 65554444434455677888999999999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-47 Score=405.27 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=216.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 576 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 576 (783)
+.++|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.++|||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 34789999999999999999999864 57899999987654 3456678999999999999999999999987654
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|||||||+|++|.+++... .++++..++.++.||+.||+|||++| ||||||||+||||+.++.++|+|||++...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhh
Confidence 379999999999999998764 46999999999999999999999999 999999999999999999999999998754
Q ss_pred cccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--ccCCCCC
Q 003963 657 HETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDV 731 (783)
Q Consensus 657 ~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~ 731 (783)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+||++||...+..+....+...... ......+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 3322 2334557999999999999999999999999999999999999999988887766554333222 2345679
Q ss_pred CHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHH
Q 003963 732 DPRWAAIVESCWHSDPQCRP-SFQELVDKLRDLQ 764 (783)
Q Consensus 732 s~~l~~LI~~cL~~dP~~RP-sa~ell~~L~~L~ 764 (783)
|+++.+||.+||++||.+|| |++++++.|.+++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999999999999999 8999998888775
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=405.03 Aligned_cols=256 Identities=32% Similarity=0.608 Sum_probs=218.3
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-CCce
Q 003963 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRL 578 (783)
Q Consensus 500 ~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 578 (783)
|++..++|+++++||+|+||.||+|.++ +.+||||+++.... .+.+.+|+.++++++|||||++++++.+ .+.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 6778899999999999999999999985 56899999976442 3568899999999999999999998854 5678
Q ss_pred EEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 579 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
|+||||+++|+|.++|... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999999999653 345899999999999999999999998 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.. .....+++.|+|||++.+..++.++|||||||++|||+| |++||...+..+....+. ...+++++..+++++.
T Consensus 155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHH
Confidence 33 234567999999999999999999999999999999998 799999888887777764 3456778889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+||.+||..||.+|||+.+++++|++++..
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-47 Score=408.42 Aligned_cols=261 Identities=28% Similarity=0.495 Sum_probs=226.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 572 (783)
.+|...++|+++++||+|+||.||+|.+++ ++.||||++.... .....+.|.+|+.+|+.++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 456777899999999999999999999864 2569999987543 455667899999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC-----------------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 629 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~-----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvH 629 (783)
......+++|||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999996432 23788899999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCC
Q 003963 630 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPW 706 (783)
Q Consensus 630 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf 706 (783)
|||||+||||+.++.+||+|||+++...... ....+..|++.|+|||++.+..++.++|||||||++|||++| .+||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999997553322 223345789999999999999999999999999999999998 4789
Q ss_pred CCCChHHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 707 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 707 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
...+..+....+.. ...+.+|..+++++.+||.+||+.||.+|||+.+|++.|+++
T Consensus 244 ~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99888888777653 335677889999999999999999999999999999998876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=411.88 Aligned_cols=257 Identities=27% Similarity=0.519 Sum_probs=218.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC-c----eEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS-Q----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 579 (783)
.+|+++++||+|+||.||+|.+... + +||+|++.... .....+.+.+|+.+++.++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 5799999999999999999997543 2 48888876433 233456789999999999999999999999864 567
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++|||+.+++|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 888999999999999887888999999999999999999999998 999999999999999999999999999865443
Q ss_pred cc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccccCCCCCCHHHH
Q 003963 660 YL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 736 (783)
Q Consensus 660 ~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 736 (783)
.. ......||+.|||||++.+..++.++|||||||+||||+| |.+||...+..+....+. ...+++.|..+++++.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVY 243 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 22 2234468999999999999999999999999999999998 899999888777665553 3455677889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 737 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 737 ~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
+||.+||..||.+|||+.+|+++|..+...
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999888654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.2e-48 Score=408.29 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=214.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
++|+++++||+|+||+||+|.++.++.||||++..........+.+.+|+.+|+.++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999998888999999977654444457888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
+.++.+..+. .....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++...........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 9765555554 44567999999999999999999999998 99999999999999999999999999987665544455
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------------
Q 003963 665 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------------- 723 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 723 (783)
...|++.|+|||.+.+. .++.++|||||||++|||++|++||...+..+.+..+.....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 66789999999998765 468999999999999999999999998877665544321100
Q ss_pred -------cccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 724 -------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 724 -------~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
.......+++.+.+||.+||+.||++|||+.|+ |+|+||+.
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el------l~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------LEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH------hcCcccCc
Confidence 012345678999999999999999999999999 68999973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=409.89 Aligned_cols=259 Identities=25% Similarity=0.329 Sum_probs=214.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC--CceEEEEEEecccCCHHHHHHHHHHHHHHHhC---CCCceeeEeceeec-----
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG--SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS----- 574 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~----- 574 (783)
++|+++++||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.| +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 689999999999999999999853 35689999976544332233455677776665 79999999999853
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
...++++||||.++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35689999999887776666666667999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------ 722 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------ 722 (783)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+.+..+....
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 654432 3446789999999999999999999999999999999999999999888776655442110
Q ss_pred -------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 723 -------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 723 -------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
....++..+++.+.+||.+||++||.+|||+.|+ |+|+||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~------L~Hpff~~i~ 300 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQDLE 300 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGTTCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH------hcChhhcCch
Confidence 0112345688999999999999999999999999 7899998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=404.46 Aligned_cols=263 Identities=31% Similarity=0.579 Sum_probs=225.5
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeCC--------ceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 569 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 569 (783)
.|++..++|+++++||+|+||.||+|.+... ..||||++.... .......+.+|+..+..+ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3778889999999999999999999987543 259999987654 445567788899999888 799999999
Q ss_pred ceeecCCceEEEEEecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 570 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 570 ~~~~~~~~~~lV~E~~~ggsL~~~L~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
++|.+++.+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999997543 34899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+|||++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|||||||++|||++ |.+||...+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999986654322 2334568999999999999999999999999999999998 7999999888
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 765 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~ 765 (783)
.+....+. ....+..|..+++++.+||.+||+.||.+|||+.+|++.|++|..
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 87776654 345677888999999999999999999999999999999988753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=408.25 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=210.4
Q ss_pred EeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH---HHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEEe
Q 003963 509 IGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 584 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 584 (783)
.+++||+|+||+||+|.+.. ++.||||++....... .....+.+|+.+|+.++|||||++++++..++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999865 5789999987654322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccccccccccc
Q 003963 585 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 664 (783)
Q Consensus 585 ~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 664 (783)
|.++++..++ .....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9876665554 44567999999999999999999999999 99999999999999999999999999987766555555
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------------
Q 003963 665 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------- 724 (783)
Q Consensus 665 ~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 724 (783)
..+||+.|+|||++.+. .++.++|||||||++|||++|.+||...+..+.+..+......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 67899999999998754 5799999999999999999999999988877766554221100
Q ss_pred -------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 725 -------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 725 -------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..+...+++++.+||.+||+.||++|||+.|+ |+|+||+...
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~------L~Hp~f~~~p 287 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRP 287 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH------HTSGGGTSSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH------hCCHhhCCCC
Confidence 00123568899999999999999999999999 6899998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=413.17 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=208.2
Q ss_pred cccceeEee-eeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHh-CCCCceeeEeceeec----C
Q 003963 503 LWEDLTIGE-QIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS----P 575 (783)
Q Consensus 503 ~~~~y~i~~-~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~----~ 575 (783)
..++|++.+ .||+|+||.||+|.+.. ++.||||++... ..+.+|+.++.+ ++|||||+++++|++ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 457899875 59999999999999854 578999998653 346689988655 589999999999875 4
Q ss_pred CceEEEEEecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC---CCcEEEEecC
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 651 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~---~~~vkL~DFG 651 (783)
..+|||||||+||+|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 6689999999999999999764 356999999999999999999999999 999999999999975 5679999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--ccccccCC-
Q 003963 652 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIP- 728 (783)
Q Consensus 652 la~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~- 728 (783)
+++...... .....+||+.|||||++.+..++.++|||||||+||+|+||++||.+.+.......+.. ......+|
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 998665433 33466899999999999999999999999999999999999999976654443322211 11222333
Q ss_pred ---CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 729 ---KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 729 ---~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
..+++++.+||.+||++||.+|||+.++ ++|+||+...
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei------l~hp~~~~~~ 279 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIMQST 279 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSHHHHTTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHH------HcCHHhhCCC
Confidence 2578999999999999999999999999 6789997544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=406.37 Aligned_cols=261 Identities=30% Similarity=0.572 Sum_probs=222.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeCC-c--eEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEeceeecCCc
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS-Q--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 577 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 577 (783)
+.+++|++.++||+|+||.||+|.++.+ . .||||.+.... ..+..+.+.+|+.+|+.+ +|||||++++++...+.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 4568999999999999999999998654 2 47788875443 233456789999999999 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCC
Q 003963 578 LCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 642 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~ 642 (783)
+++|||||++|+|.++|... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.+
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence 99999999999999999643 356899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcc
Q 003963 643 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFM 721 (783)
Q Consensus 643 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~~~i~~~ 721 (783)
+.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. .
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~ 241 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 241 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-h
Confidence 999999999997655433 23355689999999999999999999999999999999996 56898888888777664 3
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 767 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~ 767 (783)
..++.+|..+++++.+||.+||..||++|||+.+|++.|+++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 4567788899999999999999999999999999999999886543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=407.16 Aligned_cols=270 Identities=33% Similarity=0.548 Sum_probs=235.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEecee
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 572 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 572 (783)
.||+..++|+++++||+|+||.||+|.+.+ ...||||++.... .......|.+|+.++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 467888999999999999999999998753 3579999997543 445556789999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC
Q 003963 573 TSPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 643 (783)
Q Consensus 573 ~~~~~~~lV~E~~~ggsL~~~L~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~ 643 (783)
..+...++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 99999999999999999999986432 23688899999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhc
Q 003963 644 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGF 720 (783)
Q Consensus 644 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG-~~Pf~~~~~~~~~~~i~~ 720 (783)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||+||||+|| .+||...+..+.+..+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999998654432 223345689999999999999999999999999999999998 689999988888776643
Q ss_pred ccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 721 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 721 ~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
...++.|..+++.+.+||.+||+.+|.+|||+.+|++.|++..+++|+...
T Consensus 251 -~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 251 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred -CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 345677889999999999999999999999999999999999888887643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=403.70 Aligned_cols=265 Identities=28% Similarity=0.485 Sum_probs=229.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEeC------CceEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCceeeEece
Q 003963 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 571 (783)
Q Consensus 499 ~~e~~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 571 (783)
.|++..++|+++++||+|+||.||+|.+.. .+.||||++.... .......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 577888999999999999999999998753 2469999997654 345566789999999999 69999999999
Q ss_pred eecCCceEEEEEecCCCCHHHHHhhcC-----------------CcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCC
Q 003963 572 VTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 634 (783)
Q Consensus 572 ~~~~~~~~lV~E~~~ggsL~~~L~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp 634 (783)
+...+.+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999997542 25889999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003963 635 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 711 (783)
Q Consensus 635 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~ellt-G~~Pf~~~~~ 711 (783)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998665432 22334578999999999999999999999999999999998 7777877776
Q ss_pred HHHHHHhhcccccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 712 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 712 ~~~~~~i~~~~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
...+..+.....++..+..+++++.+||.+||+.||++|||+.+|++.|++....
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 6655555445566777888999999999999999999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=403.01 Aligned_cols=250 Identities=22% Similarity=0.417 Sum_probs=211.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCH----HHHHHHHHHHHHHHhCC--CCceeeEeceeecCC
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 576 (783)
.++|++.++||+|+||.||+|.+.. ++.||||++.+..... .....+.+|+.+|+.++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3689999999999999999999864 5789999997654321 11234567999999997 899999999999999
Q ss_pred ceEEEEEecCC-CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-CCcEEEEecCCCc
Q 003963 577 RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 654 (783)
Q Consensus 577 ~~~lV~E~~~g-gsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-~~~vkL~DFGla~ 654 (783)
.+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 5788888653 46999999999999999999999999 999999999999985 5799999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccccCCCCCCH
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 733 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 733 (783)
..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ . + ......++..+|+
T Consensus 160 ~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 160 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQVFFRQRVSS 229 (273)
T ss_dssp ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCCCCCSSCCCH
T ss_pred ecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcccCCCCCCCH
Confidence 65543 2335689999999999987765 677999999999999999999997632 1 1 2234567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 734 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 734 ~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
++.+||.+||..||.+|||+.|+ ++|+||+.+.
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~ei------l~hp~~~~~~ 262 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEI------QNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH------HTSGGGSSCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHH------hcCHhhCCCC
Confidence 99999999999999999999999 6899998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=398.60 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=216.4
Q ss_pred EeeeeccCCcEEEEEEEEeCC----ceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec-CCceEEEEE
Q 003963 509 IGEQIGQGSCGTVYHAVWYGS----QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVTE 583 (783)
Q Consensus 509 i~~~LG~G~fG~Vy~a~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E 583 (783)
+.++||+|+||+||+|.+..+ ..||||++... ........|.+|+++|++++|||||++++++.. ++.+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 467899999999999997543 24899998653 355667889999999999999999999999765 567999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccc--
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 661 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-- 661 (783)
||++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999877777889999999999999999999998 99999999999999999999999999986543321
Q ss_pred --cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhcccccccCCCCCCHHHHHH
Q 003963 662 --TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN-LNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 738 (783)
Q Consensus 662 --~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~l~~L 738 (783)
......||+.|+|||.+.+..++.++|||||||+||||+||..||.. .+..+....+. ...++..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHHH
Confidence 12234689999999999999999999999999999999997666644 33333333332 345667788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003963 739 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 770 (783)
Q Consensus 739 I~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~ 770 (783)
|.+||+.||++||++.||+++|+.++..|...
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999998886654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=400.05 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=212.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 576 (783)
.++|+++++||+|+||+||+|.+.. ++.||||++..........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 5799999999999999999999865 577999999877667777788999999999999999999999997654
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+||||| +.+|..++... .+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 479999999 66888887643 5999999999999999999999999 999999999999999999999999999865
Q ss_pred ccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------- 722 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------- 722 (783)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+....
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 543 2356789999999998764 56899999999999999999999998877665443321110
Q ss_pred ----------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 723 ----------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 723 ----------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
........+++++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei------L~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------LAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH------hcChhhCcCC
Confidence 0112345678999999999999999999999999 6899998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=390.25 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=208.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec--------
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 574 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 574 (783)
.++|+++++||+|+||+||+|.+. .++.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 479999999999999999999986 45789999987665555455678899999999999999999998754
Q ss_pred CCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 575 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 575 ~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
.+.+|+|||||.++.+ ..+......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~-~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHH-HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCcc-chhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 3468999999976544 455455667899999999999999999999998 9999999999999999999999999997
Q ss_pred cccccc----ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccc--C
Q 003963 655 LKHETY----LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--I 727 (783)
Q Consensus 655 ~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~-~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~ 727 (783)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+......+. .
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 654321 223345799999999998865 589999999999999999999999998877665554422211110 0
Q ss_pred C----------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 728 P----------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 728 ~----------------------------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
. ...++.+.+||.+||+.||++|||+.|+ |.|+||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el------L~Hpff~~~ 311 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA------LNHDFFWSD 311 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH------HcChhhccC
Confidence 0 0136678899999999999999999999 789999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=385.36 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=219.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCCceEEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 583 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 583 (783)
++|+++++||+|+||+||+|++.. ++.||||+++...........+.+|+.+|+.++|||||++++++......++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999999999865 4679999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccccccc
Q 003963 584 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 663 (783)
Q Consensus 584 ~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 663 (783)
++.+++|..++.. ...+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9988888877764 456899999999999999999999998 9999999999999999999999999998776655455
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhccc-------------------
Q 003963 664 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWD-NLNSMQVIGAVGFMN------------------- 722 (783)
Q Consensus 664 ~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~-~~~~~~~~~~i~~~~------------------- 722 (783)
....+++.|+|||++.+.. ++.++|||||||++|+|++|..||. ..+..+....+....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 5566789999999987765 6899999999999999999999864 444444443321110
Q ss_pred --------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 723 --------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 723 --------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.....+..+++.+.+||.+||+.||.+|||++|+ |+|+||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~------L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA------LQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------TTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH------hcChhhcCC
Confidence 1112334578899999999999999999999999 789999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=392.05 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=207.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEe-CCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----ceE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWY-GSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLC 579 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 579 (783)
.+|+++++||+|+||+||+|.+. .++.||||++.... .....+.+.+|+.+|+.|+|||||++++++..+. ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999985 45779999997644 3455678899999999999999999999987653 234
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 659 (783)
++|+|+.+|+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 445566689999999754 5899999999999999999999998 999999999999999999999999999765443
Q ss_pred cc---cccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003963 660 YL---TTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 723 (783)
Q Consensus 660 ~~---~~~~~~Gt~~Y~aPE~~~-~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 723 (783)
.. .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||...+.............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 234567999999999985 45678999999999999999999999987765544332211000
Q ss_pred ------------c-----ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 724 ------------R-----LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 724 ------------~-----~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
. ......+++++.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~------L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA------LAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH------hcCHhhccCCC
Confidence 0 01234678899999999999999999999999 67899975443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=395.76 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=205.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec------CCce
Q 003963 506 DLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQRL 578 (783)
Q Consensus 506 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 578 (783)
+|+.+++||+|+||+||+|.+.. ++.||||++...... +.+|+.+|+.++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 79999999999999999999865 577999999765432 2469999999999999999999853 2357
Q ss_pred EEEEEecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCc
Q 003963 579 CIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 654 (783)
Q Consensus 579 ~lV~E~~~ggsL~~~L~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~ 654 (783)
|||||||+++ +...+. .....+++..++.++.||+.||+|||++| ||||||||+||||+.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence 8999999765 443332 34556999999999999999999999998 99999999999999765 89999999998
Q ss_pred ccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------
Q 003963 655 LKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---------- 723 (783)
Q Consensus 655 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------- 723 (783)
...... ...+.+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+....+..+.....
T Consensus 172 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 172 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp ECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654432 2345689999999998875 4689999999999999999999999988876655444321100
Q ss_pred -----c------------ccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCcC
Q 003963 724 -----R------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 773 (783)
Q Consensus 724 -----~------------~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~~ 773 (783)
. ......+++++.+||.+||..||.+|||+.|+ |+|+||+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~------L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA------CAHSFFDELRD 311 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGGGGGC
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH------hcCHhhccccC
Confidence 0 01123578999999999999999999999999 78999987644
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=394.28 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=216.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeC----CceEEEEEEecccCC--HHHHHHHHHHHHHHHhCCC-CceeeEeceeecC
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYG----SQDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSP 575 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~ 575 (783)
..++|+++++||+|+||.||+|.+.. ++.||||++.+.... ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 34789999999999999999998743 467999998654321 1223467789999999976 8999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 576 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 576 ~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..++++|||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999997654 4778889999999999999999999 99999999999999999999999999976
Q ss_pred cccc-cccccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--cccccccCCCC
Q 003963 656 KHET-YLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKD 730 (783)
Q Consensus 656 ~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~--~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~ 730 (783)
.... ........|++.|++||.+.+.. ++.++|||||||+||+|++|..||...+.......+. .....+.+|..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 5432 22334567899999999997653 6889999999999999999999997665433222221 23345667788
Q ss_pred CCHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcCc
Q 003963 731 VDPRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 731 ~s~~l~~LI~~cL~~dP~~RP-----sa~ell~~L~~L~~~~f~~~~ 772 (783)
+++++.+||.+||.+||.+|| +++|+ ++|+||+.+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei------l~Hpff~~i~ 299 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEI------KEHLFFQKIN 299 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH------HTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHH------HcCHhhcCCC
Confidence 999999999999999999999 47888 6899997654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-43 Score=382.95 Aligned_cols=251 Identities=21% Similarity=0.350 Sum_probs=204.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeec--CCceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~ 579 (783)
.++|+++++||+|+||+||+|++.. ++.||||+++... .+.+.+|+.+|+.++ ||||++++++|.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 4689999999999999999999864 5679999986543 356788999999995 9999999999874 45699
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCC-cEEEEecCCCccccc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 658 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 658 (783)
+|||||.+++|..+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.++ .+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999987764 34899999999999999999999999 99999999999998654 699999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcc-------------c-
Q 003963 659 TYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFM-------------N- 722 (783)
Q Consensus 659 ~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~-~~~~i~~~-------------~- 722 (783)
.. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ....+... .
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 334567899999999988754 7999999999999999999999997654321 11111000 0
Q ss_pred ---------------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 723 ---------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 723 ---------------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
........+++++.+||++||..||.+|||+.|+ |+|+||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~------L~Hp~F~~v~ 326 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA------MEHPYFYTVV 326 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTSC
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH------hcCcccCCCC
Confidence 0001113478899999999999999999999999 7899998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=389.56 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=211.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecC-----Cc
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 577 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 577 (783)
.++|+++++||+|+||+||+|.+.. ++.||||++.+........+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4789999999999999999999864 67899999987776766777899999999999999999999998643 33
Q ss_pred eEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCcccc
Q 003963 578 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 657 (783)
Q Consensus 578 ~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~~ 657 (783)
.+++|+|+.+|+|.+++.. .++++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 4666777789999999965 35999999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------
Q 003963 658 ETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------ 724 (783)
Q Consensus 658 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------ 724 (783)
.. ..+..|++.|+|||++.+.. ++.++|||||||++|+|++|++||...+.......+......
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 33 33567899999999877754 689999999999999999999999887766554443211110
Q ss_pred ---------c--------cCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcCc
Q 003963 725 ---------L--------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 772 (783)
Q Consensus 725 ---------~--------~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~~ 772 (783)
. .....+++++.+||.+||..||.+|||+.|+ |+|+||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el------L~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA------LAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH------hcCHhhCCCC
Confidence 0 0123578999999999999999999999999 7899998654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=380.33 Aligned_cols=257 Identities=32% Similarity=0.478 Sum_probs=198.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeecCC----ceE
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLC 579 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 579 (783)
.++|.+.+.||+|+||.||+|++ .++.||||++.... ........|+..+..++|||||++++++...+ .+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 36799999999999999999986 56789999986543 11112233455556789999999999997654 579
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhC------CCCEEecCCCCCCEEEcCCCcEEEEecCCC
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 653 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~IvHrDIKp~NILl~~~~~vkL~DFGla 653 (783)
+|||||++|+|.++|++. .+++..++.++.|++.||+|||.. .++||||||||+||||+.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999864 488999999999999999999973 123999999999999999999999999999
Q ss_pred cccccccc----cccCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCC-------------
Q 003963 654 RLKHETYL----TTKTGKGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLN------------- 710 (783)
Q Consensus 654 ~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~------~s~~sDIwSLG~il~elltG~~Pf~~~~------------- 710 (783)
+....... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86644322 223467999999999987654 4668999999999999999988763211
Q ss_pred --hHHHHHHhhcccccccCCCCC-----CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 711 --SMQVIGAVGFMNQRLEIPKDV-----DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 711 --~~~~~~~i~~~~~~~~~~~~~-----s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.......+.....++.++..+ ...+.+|+.+||+.||.+|||+.+|++.|++|..+
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 112222222222233333322 24589999999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-43 Score=373.93 Aligned_cols=258 Identities=19% Similarity=0.277 Sum_probs=214.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CceeeEeceeecCCceE
Q 003963 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 579 (783)
Q Consensus 502 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 579 (783)
++.++|+++++||+|+||.||+|.+.. ++.||||++...... ..+.+|+++++.|.| +||+.+++++......|
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 345789999999999999999999865 567999998665432 245678999999975 89999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcC-----CCcEEEEecCCCc
Q 003963 580 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 654 (783)
Q Consensus 580 lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~-----~~~vkL~DFGla~ 654 (783)
+||||+ +++|.+++......++...++.++.|++.||+|||++| ||||||||+||||+. .+.+||+|||+|+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999 78999999887778999999999999999999999999 999999999999964 5789999999998
Q ss_pred cccccc-------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhcc---
Q 003963 655 LKHETY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFM--- 721 (783)
Q Consensus 655 ~~~~~~-------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~---~~~~~i~~~--- 721 (783)
...... ......+||+.|||||++.+..++.++|||||||++|||++|..||...... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 654321 1233557999999999999999999999999999999999999999755432 222222111
Q ss_pred cccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003963 722 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 766 (783)
Q Consensus 722 ~~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~ 766 (783)
.....++..+|+++.+|+..||..+|++||+++.+.+.|+++...
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 122334567899999999999999999999999998888777554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-43 Score=374.33 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=203.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce-eeEeceeecCCceEEEE
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVT 582 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~ 582 (783)
++|+++++||+|+||.||+|.+.. ++.||||++...... ..+.+|+++++.++|+|+ +.+..++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 579999999999999999999854 578999998765432 246789999999987664 55566667788899999
Q ss_pred EecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEc---CCCcEEEEecCCCcccccc
Q 003963 583 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHET 659 (783)
Q Consensus 583 E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~ 659 (783)
||| +++|...+......+++..++.++.|++.||+|||++| ||||||||+|||++ .+..+||+|||+|+.....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 56888887776778999999999999999999999999 99999999999986 3557999999999865432
Q ss_pred c-------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc------cccccc
Q 003963 660 Y-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF------MNQRLE 726 (783)
Q Consensus 660 ~-------~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~------~~~~~~ 726 (783)
. ......+||+.|||||++.+..++.++|||||||++|||++|..||...........+.. ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2 223455799999999999999999999999999999999999999987655433322211 111223
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003963 727 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 763 (783)
Q Consensus 727 ~~~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L 763 (783)
++..+|+++.+||..||+.+|++||++.++.+.|+.+
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 4567999999999999999999999999998776554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=389.19 Aligned_cols=255 Identities=27% Similarity=0.349 Sum_probs=202.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCceeeEeceeec------CC
Q 003963 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 576 (783)
Q Consensus 504 ~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 576 (783)
.++|+++++||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 4789999999999999999999875 6789999998877777777889999999999999999999999854 36
Q ss_pred ceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEecCCCccc
Q 003963 577 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 656 (783)
Q Consensus 577 ~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~~~ 656 (783)
.+|+|||||.+ ++.+.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcc
Confidence 78999999965 5555553 34889999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 003963 657 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------- 723 (783)
Q Consensus 657 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------- 723 (783)
.... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||...+.......+.....
T Consensus 170 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 170 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 5432 33455789999999999999999999999999999999999999987765544333210000
Q ss_pred -------cc--------------cCC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 003963 724 -------RL--------------EIP------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 771 (783)
Q Consensus 724 -------~~--------------~~~------~~~s~~l~~LI~~cL~~dP~~RPsa~ell~~L~~L~~~~f~~~ 771 (783)
.. ..+ ...++++.+||++||..||++|||+.|+ |+|+||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el------L~Hpw~~~~ 317 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA------LQHPYINVW 317 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH------HTSTTTGGG
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH------hcCcccCCC
Confidence 00 000 1135678999999999999999999999 789999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-38 Score=345.25 Aligned_cols=252 Identities=19% Similarity=0.321 Sum_probs=192.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEeC-CceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-----------CCceeeEecee
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFMGAV 572 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~ 572 (783)
++|+++++||+|+||+||+|++.. ++.||||++.... .....+.+|+.+++.+. |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 469999999999999999999864 5789999997543 33456778999888875 57899999888
Q ss_pred ecC--CceEEEEEecCCCCHHHH--HhhcCCcchHHHHHHHHHHHHHHHHHHHh-CCCCEEecCCCCCCEEEcCCC----
Q 003963 573 TSP--QRLCIVTEFLPRGSLFRL--LQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW---- 643 (783)
Q Consensus 573 ~~~--~~~~lV~E~~~ggsL~~~--L~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~IvHrDIKp~NILl~~~~---- 643 (783)
... ...+++|+++..+..... .......+++..++.++.||+.||+|||+ +| |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 643 456677777655433222 23345568899999999999999999997 77 99999999999998654
Q ss_pred --cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH------HH
Q 003963 644 --TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ------VI 715 (783)
Q Consensus 644 --~vkL~DFGla~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~~sDIwSLG~il~elltG~~Pf~~~~~~~------~~ 715 (783)
.++|+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||....... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999765443 245679999999999999999999999999999999999999997543211 11
Q ss_pred HH-hhccc---------------------------------------ccccCCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q 003963 716 GA-VGFMN---------------------------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQE 755 (783)
Q Consensus 716 ~~-i~~~~---------------------------------------~~~~~~~~~s~~l~~LI~~cL~~dP~~RPsa~e 755 (783)
.. +.... .....+...++++.+||.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00 00000 001111234567999999999999999999999
Q ss_pred HHHHHHHHHHHHhhc
Q 003963 756 LVDKLRDLQRQYFQA 770 (783)
Q Consensus 756 ll~~L~~L~~~~f~~ 770 (783)
+ |+|+||+.
T Consensus 325 ~------L~Hp~f~~ 333 (362)
T d1q8ya_ 325 L------VNHPWLKD 333 (362)
T ss_dssp H------HTCGGGTT
T ss_pred H------hcCcccCC
Confidence 9 78999983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.4e-23 Score=202.04 Aligned_cols=167 Identities=20% Similarity=0.168 Sum_probs=122.1
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCC----------------HHHHHHHHHHHHHHHhCCCCceeeEec
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYS----------------DEVIHSFRQEVSLMKRLRHPNVLLFMG 570 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~~ 570 (783)
+.++++||+|+||.||+|.+..++.||||+++....+ ......+..|...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4688999999999999999888889999987532110 122344567889999999999998886
Q ss_pred eeecCCceEEEEEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCCCCEEecCCCCCCEEEcCCCcEEEEec
Q 003963 571 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 650 (783)
Q Consensus 571 ~~~~~~~~~lV~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~IvHrDIKp~NILl~~~~~vkL~DF 650 (783)
+.. .+++|||+++..+.+ ++...+..++.||+.+|.|||++| |+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 532 389999998755432 334445678899999999999999 9999999999999976 5899999
Q ss_pred CCCcccccccccccCCCCCCcccCc--c---cccCCCCCchhHHHHHHHHH
Q 003963 651 GLSRLKHETYLTTKTGKGTPQWMAP--E---VLRNEPSDEKSDVYSFGVIL 696 (783)
Q Consensus 651 Gla~~~~~~~~~~~~~~Gt~~Y~aP--E---~~~~~~~s~~sDIwSLG~il 696 (783)
|+|......... .|+.. + .+....++.++|+||+.-.+
T Consensus 147 G~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 998654332111 12111 0 01235567889999976544
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.79 E-value=4.5e-19 Score=158.45 Aligned_cols=104 Identities=23% Similarity=0.285 Sum_probs=97.8
Q ss_pred hCcceEEEc---CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEE
Q 003963 139 MGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (783)
Q Consensus 139 ~~d~I~i~D---~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (783)
+.++++|+| +||+|+|||++|++|+||+++|++|+++..+++++........+.++++.++.+..++..++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 578999999 58999999999999999999999999999888887767777788999999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 216 LVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
|+.+++.|++|++|++.+++++++|||
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DIT 108 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVT 108 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECC
Confidence 999999999999999999999999998
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=6.5e-17 Score=144.14 Aligned_cols=103 Identities=17% Similarity=0.123 Sum_probs=91.0
Q ss_pred ceEEEc---CCCcEEEecHHHHHHcCCChhhHcCCCccccc--cccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEE
Q 003963 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (783)
Q Consensus 142 ~I~i~D---~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~--~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (783)
..+|+| +|+.|+|||++|++|+||+.+|++|+++..++ +++........+..+++.++.+..++..++++|+.+|
T Consensus 3 ~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w 82 (110)
T d1bywa_ 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFL 82 (110)
T ss_dssp EEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeecccceee
Confidence 357788 46789999999999999999999999987644 3444455667788999999999999999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 217 v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
+.+++.||+|++|++++++++++|||||
T Consensus 83 ~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 83 CLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 9999999999999999999999999975
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.69 E-value=9.5e-17 Score=141.46 Aligned_cols=100 Identities=23% Similarity=0.174 Sum_probs=94.1
Q ss_pred ceEEEc---CCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEE
Q 003963 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (783)
Q Consensus 142 ~I~i~D---~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (783)
.++|+| +||+|+|+|++|++++||+.+|++|+++.+++++.........+...++.++.+..+++.+++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 367888 58999999999999999999999999999998888877778888999999999999999999999999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEeh
Q 003963 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (783)
Q Consensus 219 ~~~~Pi~d~~G~v~g~v~i~rDI 241 (783)
+++.|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999997
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.61 E-value=9.4e-16 Score=140.13 Aligned_cols=112 Identities=15% Similarity=0.177 Sum_probs=95.6
Q ss_pred HHHHHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EEEE
Q 003963 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQ 204 (783)
Q Consensus 129 ~~~~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e 204 (783)
+++|+.|+++++++|+++|.+|+|++||+++++|+||+++|++|+++..++++.........+...+..+.. ...+
T Consensus 15 e~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 94 (130)
T d1ew0a_ 15 DAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRV 94 (130)
T ss_dssp TSCHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHHHHHHCCCSSTTSCEE
T ss_pred HHHHHHHHHcCCCeEEEEeCCccEEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHHHHHHhCCCccccceee
Confidence 345899999999999999999999999999999999999999999999888877765555555666666654 4668
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
+..+++||..+|+.+++.|+.+.++ ..++++++|||
T Consensus 95 ~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 95 VSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred EEEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 8889999999999999999987554 34888999997
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.58 E-value=4.9e-15 Score=129.52 Aligned_cols=102 Identities=15% Similarity=0.112 Sum_probs=84.6
Q ss_pred cceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EEEEEEEEcCCCCEEE
Q 003963 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEERVL 216 (783)
Q Consensus 141 d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~~kdG~~~~ 216 (783)
|||+++|.+|+|+++|++|++|+||+.+|++|+++..++++.........+...+..+.. ...++..+++||..+|
T Consensus 1 dgi~~~D~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~ 80 (106)
T d1xj3a1 1 DAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFP 80 (106)
T ss_dssp CCEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCEEE
T ss_pred CEEEEECCCCcEEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccceEEE
Confidence 689999999999999999999999999999999999988876654444444444554433 4567888999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEehHHH
Q 003963 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (783)
Q Consensus 217 v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (783)
+.+++.|+.+.++ .+++++++||||.
T Consensus 81 v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 81 MHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999997554 4588999999984
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.57 E-value=6.7e-15 Score=130.36 Aligned_cols=107 Identities=16% Similarity=0.252 Sum_probs=86.1
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCC----eEEEEEEE
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE----RWTGQFPA 207 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~----~~~~e~~~ 207 (783)
|.++|++.+++|+++|.+|+|+++|++|++|+||+++|++|+++..+++..........+...+..+. ....+...
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRELQL 82 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CEEEE
T ss_pred HHHHHHcCcCcEEEEeCCCCEEEEchhHhhhhccchhhhcCcceecccccccccccccccccccccccccccccceeeee
Confidence 78899999999999999999999999999999999999999999998877665444444444443332 24557888
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEe
Q 003963 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (783)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rD 240 (783)
+++||+.+|+.+++.|+.+++|. .++++++|
T Consensus 83 ~~~dG~~~~v~~~~~~i~~~~~~--~~~~v~rD 113 (113)
T d1v9ya_ 83 EKKDGSKIWTRFALSKVSAEGKV--YYLALVRD 113 (113)
T ss_dssp ECTTSCEEEEEEEEEEEEETTEE--EEEEEEEC
T ss_pred ccccceeEEEEEEEEEEEECCeE--EEEEEEEC
Confidence 99999999999999999986653 37888887
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.4e-15 Score=134.48 Aligned_cols=106 Identities=19% Similarity=0.261 Sum_probs=92.0
Q ss_pred cceEE--EcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEEcCCCCEEEEE
Q 003963 141 QSVHI--FDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (783)
Q Consensus 141 d~I~i--~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (783)
..+++ .|.+|+|+|+|+++++++||+.+|++|+++.+++++++.......+...+..+..+..+++++++||+.+|+.
T Consensus 5 ~~~fi~r~~~dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~ 84 (114)
T d1p97a_ 5 SKTFLSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLE 84 (114)
T ss_dssp CEEEEEEECTTTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEE
T ss_pred cCEEEEEECCCCcEEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcceEEE
Confidence 34444 6999999999999999999999999999999999888765555555666666666888999999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEehHHHHH
Q 003963 219 ATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (783)
Q Consensus 219 ~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (783)
++..|++|. +|++.+++++.+|||++|+
T Consensus 85 ~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 85 TQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 999999987 6899999999999999864
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.38 E-value=1.2e-12 Score=119.18 Aligned_cols=106 Identities=10% Similarity=0.000 Sum_probs=87.6
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCcccccccccc-chHHHHHHHHHHhCCeEEEEEEEEcC
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKTK 210 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (783)
+..++|++++||+++|.+|+|+++|+++++++||++++++|+++.+++.|... ......+.+++..|.....+....++
T Consensus 19 ~d~~ld~~p~gi~~lD~~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 98 (125)
T d1nwza_ 19 DDGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFDY 98 (125)
T ss_dssp CHHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEEECT
T ss_pred HHHHHhCCCccEEEEeCCCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEEEEecc
Confidence 57899999999999999999999999999999999999999999887765544 44555678888899887777777899
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEeh
Q 003963 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (783)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDI 241 (783)
+|..+|+.+.+.++.+ |.- +..+++||
T Consensus 99 ~G~~~~v~v~l~~~~~--g~~--~~v~V~di 125 (125)
T d1nwza_ 99 QMTPTKVKVHMKKALS--GDS--YWVFVKRV 125 (125)
T ss_dssp TSCCEEEEEEEEECSS--SSE--EEEEEEEC
T ss_pred CCcEEEEEEEEEEecC--CCE--EEEEEEEC
Confidence 9999999999888754 433 33467775
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.36 E-value=1.2e-12 Score=116.50 Aligned_cols=95 Identities=13% Similarity=-0.055 Sum_probs=78.5
Q ss_pred HHHHHHHhCcceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccc-cchHHHHHHHHHHhCCeEEEEEEEEcC
Q 003963 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-DFDVAYDIVHRIKMGERWTGQFPAKTK 210 (783)
Q Consensus 132 ~~~ile~~~d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~-~~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (783)
+.++||++|+||+++|.+|+|++||+++++|+||+++|++|+++.+++.|.. .......+.+.+.+|+.........++
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~l~~ 84 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVFDF 84 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEEEC
T ss_pred HHHHHhCCCcEEEEEcCCCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEEEec
Confidence 5678999999999999999999999999999999999999999987665543 345556778889998875444444678
Q ss_pred CCCEEEEEEEEEEEEC
Q 003963 211 TEERVLVVATNTPFYD 226 (783)
Q Consensus 211 dG~~~~v~~~~~Pi~d 226 (783)
+|..+++.++..+..+
T Consensus 85 ~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 85 QMAPVRVQIRMQNAGV 100 (110)
T ss_dssp SSCEEEEEEEEEECSS
T ss_pred CCceEEEEEEEEEecC
Confidence 9999999999888754
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=2.4e-12 Score=114.73 Aligned_cols=104 Identities=15% Similarity=0.183 Sum_probs=80.6
Q ss_pred HHhCcceEEEcC-CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe----EEEEEEEEcCC
Q 003963 137 QSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKT 211 (783)
Q Consensus 137 e~~~d~I~i~D~-~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~~kd 211 (783)
+.+.++|+++|. +|+|+++|+++++||||+++|++|+++.+|+++.........+...+..+.. +..++...+++
T Consensus 5 ~~~n~AI~~id~~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 84 (114)
T d1ll8a_ 5 PEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISRS 84 (114)
T ss_dssp TTTTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCTT
T ss_pred hhcCcEEEEEECCCCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEccC
Confidence 456789999995 6999999999999999999999999999999877653332222333444332 33367788999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehH
Q 003963 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (783)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (783)
|..+|+++++.++.. +|+.. ++++++||+
T Consensus 85 G~~~pvevs~~~i~~-~~~~~-~l~vi~dV~ 113 (114)
T d1ll8a_ 85 GEKIPVSVWMKRMRQ-ERRLC-CVVVLEPVE 113 (114)
T ss_dssp CCCEEEECCEECCBS-SSSBE-EEEEEEECC
T ss_pred CcEEEEEEEEEEEEE-CCeEE-EEEEEEECc
Confidence 999999999999975 44543 789999984
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.77 E-value=3.5e-09 Score=93.32 Aligned_cols=86 Identities=10% Similarity=0.003 Sum_probs=71.5
Q ss_pred EEcCCCcEEEecHHHHHHcCCC-hhhHcCCCccccccccccchH-HH-HHHHHHHhCCeEEEEEEEEcCCCCEEEEEEEE
Q 003963 145 IFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFDV-AY-DIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (783)
Q Consensus 145 i~D~~G~Ii~~N~aae~L~Gys-~eEllG~~~~~l~~~~~~~~~-~~-~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (783)
-.|.+|+|+++|+++.+++||. .+|++|+++.+|++|++.... .. ....++..|+....++++++|||..+|+..+.
T Consensus 7 rh~~~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~ 86 (109)
T d1oj5a_ 7 KQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRC 86 (109)
T ss_dssp EECTTCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEE
T ss_pred EECCCceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEEEE
Confidence 3689999999999999999997 599999999999999886432 22 34567788888888999999999999999999
Q ss_pred EEEECCCCC
Q 003963 222 TPFYDDDGT 230 (783)
Q Consensus 222 ~Pi~d~~G~ 230 (783)
.+++|..|.
T Consensus 87 ~~~~~~~~~ 95 (109)
T d1oj5a_ 87 KLCYPQSPD 95 (109)
T ss_dssp EEECC----
T ss_pred EEEECCCCC
Confidence 999987543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=1.6e-06 Score=87.26 Aligned_cols=144 Identities=15% Similarity=0.048 Sum_probs=95.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecCCceEEE
Q 003963 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIV 581 (783)
Q Consensus 503 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 581 (783)
..+.|++.+..+-++.+.||++. .+++.++||+........ ...+.+|..++..|. +--+.+++.++..++..++|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 34677877776656667999886 345678899876543211 124567888888774 33356778888888889999
Q ss_pred EEecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 003963 582 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN------------------------------------- 624 (783)
Q Consensus 582 ~E~~~ggsL~~~L~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 624 (783)
|++++|..+.+...... ....++.++...+..||+..
T Consensus 89 ~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999887765432211 01112333444444444311
Q ss_pred --------------------CCEEecCCCCCCEEEcCCCcEEEEecCCCcc
Q 003963 625 --------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 655 (783)
Q Consensus 625 --------------------~~IvHrDIKp~NILl~~~~~vkL~DFGla~~ 655 (783)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1178999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=2.9e-05 Score=77.23 Aligned_cols=74 Identities=18% Similarity=0.146 Sum_probs=52.1
Q ss_pred eeccCC-cEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CceeeEeceeecCCceEEEEEecCCC
Q 003963 512 QIGQGS-CGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 512 ~LG~G~-fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg 588 (783)
.+..|. ...||++...++..+++|....... ..+..|...++.|.. -.+.+++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344444 3678999877676789998655432 235667787777642 23667888888888999999999875
Q ss_pred CH
Q 003963 589 SL 590 (783)
Q Consensus 589 sL 590 (783)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.00034 Score=74.52 Aligned_cols=78 Identities=21% Similarity=0.122 Sum_probs=47.9
Q ss_pred eeeeccCCcEEEEEEEEeC-CceEEEEEEeccc-C----CHHHHHHHHHHHHHHHhCC-C--CceeeEeceeecCCceEE
Q 003963 510 GEQIGQGSCGTVYHAVWYG-SQDVAVKVFSRQE-Y----SDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVTSPQRLCI 580 (783)
Q Consensus 510 ~~~LG~G~fG~Vy~a~~~~-~~~vAiK~i~~~~-~----~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 580 (783)
.+.||.|....||++.... ++.|+||.-.... . .+....+...|...|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 4578998643210 0 0001123456777777663 2 345666654 3456689
Q ss_pred EEEecCCCC
Q 003963 581 VTEFLPRGS 589 (783)
Q Consensus 581 V~E~~~ggs 589 (783)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.70 E-value=0.00084 Score=58.15 Aligned_cols=52 Identities=15% Similarity=0.100 Sum_probs=41.5
Q ss_pred ceEEEcC-CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHh
Q 003963 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM 197 (783)
Q Consensus 142 ~I~i~D~-~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~ 197 (783)
.++++|. +|+|+|+.+....++|++.++++|+++.+++++... ..+.+.+..
T Consensus 19 ~Llvld~~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~~----~~i~~~l~~ 71 (114)
T d2oola2 19 YLFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAASA----ARLTHALHG 71 (114)
T ss_dssp EEEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHHH----HHHHHHHCC
T ss_pred EEEEEECCCCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHHH----HHHHHHHhc
Confidence 3456885 699999999999999999999999999999987652 334444443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.59 E-value=0.0035 Score=64.43 Aligned_cols=68 Identities=12% Similarity=0.066 Sum_probs=44.9
Q ss_pred cEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCce--eeEe-----ceeecCCceEEEEEecCCC
Q 003963 518 CGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV--LLFM-----GAVTSPQRLCIVTEFLPRG 588 (783)
Q Consensus 518 fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lV~E~~~gg 588 (783)
--.||++...++..|++|+......+. +++..|...+..|....| +..+ ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999988778889999987665444 346678888877742221 1111 1234456688999999763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.72 E-value=0.016 Score=60.93 Aligned_cols=76 Identities=17% Similarity=0.274 Sum_probs=50.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEeCC--------ceEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCceeeEeceeecC
Q 003963 505 EDLTIGEQIGQGSCGTVYHAVWYGS--------QDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 575 (783)
Q Consensus 505 ~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 575 (783)
+++++ +.|+.|-.=.+|++..... +.|++++..... .. ....+|..+++.+. +.-.+++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 6788899999999986532 347777765322 11 23457888888885 3334577777653
Q ss_pred CceEEEEEecCCCC
Q 003963 576 QRLCIVTEFLPRGS 589 (783)
Q Consensus 576 ~~~~lV~E~~~ggs 589 (783)
++||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 78999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.96 E-value=0.082 Score=53.12 Aligned_cols=143 Identities=15% Similarity=0.022 Sum_probs=72.5
Q ss_pred eeEeeeeccCCcEEEEEEEEeCCceEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-----CceeeEec---eeecCCce
Q 003963 507 LTIGEQIGQGSCGTVYHAVWYGSQDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-----PNVLLFMG---AVTSPQRL 578 (783)
Q Consensus 507 y~i~~~LG~G~fG~Vy~a~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~~---~~~~~~~~ 578 (783)
..-.+.|..|---..|++...+ +.+++|++...... ..+..|+.++..|.. |..+...+ +.......
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp EEEEEEECC---EEEEEEEESS-CCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred ceEeecCCCCcccCeEEEEECC-CcEEEEEcCCCCCH----HHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 3444556677778889988654 47999998653221 234456777777642 22221110 11223455
Q ss_pred EEEEEecCCCCHH-----------HHH---hh----cC------C----------------cchHHHHHHHHHHHHHHHH
Q 003963 579 CIVTEFLPRGSLF-----------RLL---QR----NT------T----------------KLDWRRRILMALDIARGVS 618 (783)
Q Consensus 579 ~lV~E~~~ggsL~-----------~~L---~~----~~------~----------------~l~~~~~~~i~~qi~~aL~ 618 (783)
+.++.++.+.... .++ .. .. . ..........+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 6677777653210 010 00 00 0 0000011111222222223
Q ss_pred HHHh--CCCCEEecCCCCCCEEEcCCCcEEEEecCCCc
Q 003963 619 YLHH--CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 654 (783)
Q Consensus 619 ~LH~--~~~~IvHrDIKp~NILl~~~~~vkL~DFGla~ 654 (783)
..+. ...++||+|+.++||+++.+...-|+||+.+.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222 11239999999999999988777899999875
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=93.30 E-value=0.078 Score=46.25 Aligned_cols=74 Identities=12% Similarity=0.048 Sum_probs=51.4
Q ss_pred eEEEcC-CCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCe--EEEEEEEEcCCCCEEEEEE
Q 003963 143 VHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER--WTGQFPAKTKTEERVLVVA 219 (783)
Q Consensus 143 I~i~D~-~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~--~~~e~~~~~kdG~~~~v~~ 219 (783)
++++|. +++|+.++.....++|++.++++|+++.++++.. ...+...+..... ..........+|..+++.+
T Consensus 38 LLald~~~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~ 112 (127)
T d2o9ca2 38 LLTADGHSGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAGHLSLTV 112 (127)
T ss_dssp EEEEETTTCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSSEEEEEE
T ss_pred EEEEECCCCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHH-----HHHHHHHhhhcCcccccceeeeecCCCceEEEEE
Confidence 455785 7999999999999999999999999999998543 2223333333322 3333444456777787766
Q ss_pred EE
Q 003963 220 TN 221 (783)
Q Consensus 220 ~~ 221 (783)
..
T Consensus 113 Hr 114 (127)
T d2o9ca2 113 HR 114 (127)
T ss_dssp EE
T ss_pred EE
Confidence 64
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=91.39 E-value=0.054 Score=47.33 Aligned_cols=41 Identities=20% Similarity=0.186 Sum_probs=35.5
Q ss_pred eEEEcC-CCcEEEecHHHHHHcCCChhhHcCCCccccccccc
Q 003963 143 VHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183 (783)
Q Consensus 143 I~i~D~-~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~ 183 (783)
++++|. +++|+.+......++|++.++++|+++.+++.+..
T Consensus 29 LLald~~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 29 VVVLQEPDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEETTTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEEECCCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHH
Confidence 455774 78999999999999999999999999999987654
|
| >d1p0za_ d.110.6.1 (A:) Sensor kinase CitA {Klebsiella pneumoniae [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: Sensory domain-like family: Sensory domain of two-component sensor kinase domain: Sensor kinase CitA species: Klebsiella pneumoniae [TaxId: 573]
Probab=80.36 E-value=3.9 Score=34.75 Aligned_cols=88 Identities=13% Similarity=0.144 Sum_probs=52.9
Q ss_pred HHHHHHHHHhC-cceEEEcCCCcEEEecHHHHHHcCCChhhHcCCCccccccccccchHHHHHHHHHHhCCeEEEEEEEE
Q 003963 130 RQYLNILQSMG-QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (783)
Q Consensus 130 ~~~~~ile~~~-d~I~i~D~~G~Ii~~N~aae~L~Gys~eEllG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (783)
..++.+.+... +-|+++|.+|+++.... .+.+|+++.. .. ..+++..|+.+.....
T Consensus 39 ~~~~~l~~~~~~~~i~v~D~~G~v~a~~~----------~~~iG~~~~~---~~--------~~~a~~~g~~~~~~~~-- 95 (131)
T d1p0za_ 39 ALIDPMRSFSDATYITVGDASGQRLYHVN----------PDEIGKSMEG---GD--------SDEALINAKSYVSVRK-- 95 (131)
T ss_dssp HHHHHHHHHSCCSEEEEEETTSBEEECSS----------GGGTTSBCCS---SC--------CHHHHHHCCCEEEEEE--
T ss_pred HHHHHHHHHcCCcEEEEECCCCCEEEccC----------hhhcCCcccc---cc--------hHHHHHcCCcEEEEEe--
Confidence 33455544443 35778999999876432 2345665431 11 1345666766543222
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehHH
Q 003963 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (783)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITe 243 (783)
. .+. +......||+|.+|+++|+|.+--++.+
T Consensus 96 g-~~g--~~~~~~~PI~~~~G~viGvV~Vg~~l~~ 127 (131)
T d1p0za_ 96 G-SLG--SSLRGKSPIQDATGKVIGIVSVGYTIEQ 127 (131)
T ss_dssp E-TTE--EEEEEEEEEECTTCCEEEEEEEEEEGGG
T ss_pred c-CCc--cEEEEEEEEECCCCcEEEEEEEEEEhHH
Confidence 2 222 2345677999999999999999888764
|